Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Mono-phosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (69)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (86)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (104)
Photoredox Rutheniums Catalysts (37)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (92)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (166)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18939)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Bcat (11)
Boronic Acids (13202)
MIDA Boronates (363)
Pinacol Boronates (16140)
Pinane Boronates (96)
Potassium Organotrifluoroborate Salts (1076)
Other Boronates (132)
Heterocyclic Building Blocks
Acridines (640)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (18)
Aliphatic Heterocycles (103)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (8)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2997)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (5)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4428)
Benzimidazole-Carboxylic Acid (43)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (697)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3713)
Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (6)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)
Benzothiazoles (2422)
Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)
Benzothiophenes (1116)
Benzothiophene-Carboxylic Acid (58)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)
Benzoxazoles (2804)
Benzoxazole-Carboxylic Acid (25)2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)
Carbazole Series (482)
Carbazolyl-Phenyl-Boronic Acid/Ester (14)1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
Epoxy (7)Oxirane (64)7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)
Furans (7000)
Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (37)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (31)Furan-2-Ylmethanol (5)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)
Imidazoles (833)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (19)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3081)
Indazol-Amide (3)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (7)1-Ethyl-1H-Indazole (7)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)
Indoles (7683)
Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (28)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (4)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (10)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (85)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (4)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (21)
Indolines (4489)
Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)
Isoquinolines (2729)
Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)
Isothiazoles (343)
Methylisothiazole (5)Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)
Isoxazoles (3403)
Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)
Morpholines (4988)
Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)
Naphthyridines (939)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3559)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1298)
Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Dihydrophthalazine (15)Phthalazine (16)
Piperazines (7427)
Isobutylpiperazine (6)Propylpiperazine (10)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (5)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)
Piperidines (21889)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (6)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2020)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1095)
Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (10)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16157)
Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (23)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)
Pyridazines (2753)
Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)
Pyridines (70617)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (288)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (26)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (342)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (436)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (8)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (52)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (50)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (153)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14557)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4953)
Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (26)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)
Pyrrolidines (14879)
Acetylpyrrolidine (9)Benzylpyrrolidine (33)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (129)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (8)(S)-3-Phenylpyrrolidine (14)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (26)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3143)
Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)
Quinolines (11910)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (18)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1411)
Dichloroquinoxaline (8)Dihydroquinoxalin (7)1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)
Quinuclidines (202)
Spiroes (4763)
Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)
Tetrahydrofurans (2265)
Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (7)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (7)
Tetrahydroisoquinolines (1291)
Tetrahydroisoquinoline-Carboxylic Acid (48)(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)
Tetrahydropyrans (3359)
Chroman-Amine (1)Difluorochroman (16)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)
Tetrahydroquinolines (1464)
Tetrahydroquinoline-Carboxylic Acid (18)1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)
Tetrazoles (82)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (15)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6687)
Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)
Thiazolidines (1260)
Thioxothiazolidin (23)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)
Thiomorpholines (454)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (960)
Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (58)Trithiophene (5)(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (11)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)
Triazines (1387)
1,2,4-Triazine (9)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7749)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37751)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3025)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45771)
Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (39)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (21)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (102)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (77)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)
Aldehydes (18914)
Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (153)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)
Aliphatic Chain Hydrocarbons (12579)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (69)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11046)
Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (185)Azetidine (185)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (176)Cyclohexa (176)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (12)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (94)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (355)Cyclopropyl (355)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (7)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (175)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (12)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (19)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)
Alkenyls (16078)
Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (4)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (36)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)
Alkyls (195)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2698)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90371)
Acetamide (651)Acetamide (651)Acetamido (156)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1564)
Carbamimidoyl (16)Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)
Amines (139951)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (490)Dimethylamino (490)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (241)Methylamino (241)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (15)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (6)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (19)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (4)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (20)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (17)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (315)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
Dianhydride (3)1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)
Aryls (187653)
Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (132)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (176)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (17)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (39)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (28)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (17)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)
Azides (42)
Azoes (112)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (19035)
Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (142)Benzaldehyde (1601)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (989)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (345)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (403)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (257)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (22)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (46)Ethoxyphenyl (46)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (338)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1749)Methoxybenzene (1749)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (56)Methoxynaphthalene (56)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (529)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (465)Naphthalene (465)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (727)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (4)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (10)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (70)Phenylethyl (70)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (418)Tolyl (418)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (7)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (19)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (5)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (6)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (181)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (5)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (251)Triphenyl Phosphate (6)
Benzyl Bromides (1065)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
Dichlorobenzyl (39)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)
Bromides (52859)
Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (760)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Dibromopropoxy (1)Dibromopropoxy (1)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (21)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (4)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)
Carbamates (7957)
Carboxylic Acid Salts (668)
Carboxylic Acids (58191)
Aceticacid (1249)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (11)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (175)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1167)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (19)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (39)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3519)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (31)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (21)
Chlorides (77875)
Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (479)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (39)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (10)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (112)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)
Diazoes (3)
Difluoromethyls (32566)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51168)
Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (53)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1539)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (42)Propanoate (296)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (2)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (70)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (36)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (20)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Ethers (82526)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (223)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (235)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (17)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (19)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (197)2-Methoxypyrazine (45)2-Methoxypyridine (436)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (6)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (52)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (70)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (19)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (99063)
Dichlorofluorobenzene (23)Difluoro (901)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (200)Difluoromethoxy (200)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (480)Trifluoromethoxy (480)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (73)1,2,3-Trifluorobenzene (156)1,2,4-Trifluorobenzene (210)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (361)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (255)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)
Guanidines (776)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)Pyrazine-2-Carbohydrazide (3)
Hydrazines (6277)
Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)
Hydrazones (2042)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14083)
Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)
Isocyanates and Isothiocyanates (237)
Isocyanate (4)Isocyanate (4)(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (40074)
Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1026)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (10)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (11)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (14)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1120)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (7)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)
Mercaptos (11)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28529)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23714)
Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2309)
Oximes (561)
Phenols (1786)
Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (98)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-Hydroxyanthracene-9,10-Dione (11)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (21)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (197)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (112)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (131)Resorcinol (146)
Phosphoruses (827)
Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)
Polycyclic Aromatic Hydrocarbons (6)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)
Sulfamides (10218)
Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)
Sulfides (10123)
Methylthio (432)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)
Sulfonates (1160)
4-Methylbenzenesulfonate (9)
Sulfones (3927)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1261)
Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)
Sulfonyl Chlorides (4029)
Fluorobenzenesulfonyl (12)1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (468)
Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)
Thiophenols (3045)
Thioureas (1128)
Carbamimidothioate (4)1,3-Diphenylthiourea (8)1-Phenylthiourea (33)
Trifluoromethyls (28951)
Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (21)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1336)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (11)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)
Ureas (1841)
Other Function Groups (5)
Organometallic Reagents
Organoborons (34729)
Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1286)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Specialty Synthesis
Ionic Liquids (738)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (74)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25506)
Phase Transfer Catalysts (29)
Other Synthetic Reagents (106)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (77)
Liquid Crystal (LC) Materials (413)
Molecular Conductors (80)
Organic Field-Effect Transistors (OFETs) (86)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (249)
Silane Coupling Agents (176)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (738)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (93)
Ligands for Functional Metal Complexes (198)
Liquid Crystal (LC) Building Blocks (558)
Phthalocyanine Building Blocks (71)
Small Molecule Semiconductor Building Blocks (1878)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1693)
Metal Organic Frameworks (MOFs) (85)
Organic Framework Building Blocks (218)
Supramolecular Host Materials  (185)
Polymer Additives
Antioxidants (81)
Crosslinking Agents (75)
Flame Retardants (35)
Light Stabilizers (67)
Plasticizers (84)
Polymerization Catalysts (156)
Polymerization Initiators (141)
Polymerization Reagents (170)
Surfactants (340)
Other Additives (34)
Polymer Reagents
Dendrimer Materials (59)
Ion Exchange Resins (7)
Monomers (3050)
Photopolymer Monomers (180)
Polybenzoxazole and Polyimide Raw Materials (240)
Polymer Semiconductor Monomers (269)
Polymers (375)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (45)
Quantum Dots (QD) Capping Agents (178)
Quantum Dots (QD) Synthetic Reagents (13)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1029)
Dye-Sensitized Solar Cell (DSSC) Materials (130)
Dyes and Pigments (392)
Organic Non-Linear Optical (NLO) Materials (39)
Organic Phto-Voltaics (OPV) Materials (185)
Perovskite Solar Cell (PSC) Materials (278)
Visible Light Photoredox Catalysts (29)
Other Functional Materials
Aggregation-Induced Emission Materials (169)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (50)
Life Science
Inhibitors/Agonists
ADC (371)
ADC Linker (371)
Angiogenesis (1714)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (403)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (112)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (271)
Anti-Infection (4763)
3CLpro (41)Antibacterial (2101)Antifungal (525)Antiparasitic (648)Antiprotozoal (2)Antiviral (48)Arenavirus (5)BVDV (3)CMV (30)Dengue Virus (36)EBV (14)Enterovirus (33)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (151)HCV (222)HHV (1)HIV (447)HIV Integrase (39)HIV Protease (68)HPV (10)HRV (3)HSV (75)Influenza Virus (251)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (28)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (4)Reverse Transcriptase (99)RSV (43)SAMHD1 (1)SARS-CoV (298)SQLE (5)TMV (12)Viral MTase (3)Virus Protease (62)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (647)
ADC Linker (371)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2443)
Apoptosis (2143)Apoptosis Inducer (1407)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (1)IAP (48)IDO (70)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (745)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (730)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4595)
Antifolate (31)APC (6)Aurora Kinase (87)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (17)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (620)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (336)HGF (1)HSF (4)HSP (161)IRE1 (27)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (1)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1441)p21 (1)PAK (30)PDI (1)PKMYT1 (2)PLK (50)PPAR (193)PTEN (5)RAD51 (18)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (90)Separase (1)Sirtuin (129)SRPK (51)STK33 (2)TACC (3)Telomerase (21)TOPK (1)Topoisomerase (271)Wee1 (16)YB-1 (5)
Cytoskeleton (728)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (134)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (30)ROCK (90)Spastin (1)
DNA Damage (3023)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (87)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (620)HDR (1)HSP (161)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1441)OGG (3)p97 (15)PARP (175)RAD51 (18)RAD52 (3)Telomerase (21)Topoisomerase (271)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (184)Androgen Receptor (96)Aromatase (8)ERR (218)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (567)
Antioxidant (33)IRE1 (27)JNK (79)PDI (1)PERK (35)ROS (398)
Epigenetics (2366)
AMPK (105)Aurora Kinase (87)DNA Methyltransferase (43)Epigenetic Reader Domain (396)FTO (15)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)SF3B1 (3)Sirtuin (129)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (25)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3483)
5-HT Receptor (402)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (184)Amylin receptor (1)Angiotensin Receptor (72)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (34)Cannabinoid Receptor (65)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (50)GNRH Receptor (19)GPCR (203)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (31)HCAR (2)Histamine Receptor (239)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (31)mGluR (226)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (38)PAR (55)Prostaglandin Receptor (217)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (53)SOS (7)SRPK (51)SSTR (28)SUCNR1 (4)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (832)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (126)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (14)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (344)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (239)HMGB (1)IFNAR (24)IL (172)IL Receptor (9)Immunology & Inflammation Related (75)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (186)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (30)PSMA (13)Pyroptosis (13)ROS (398)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (98)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (837)
EGFR (403)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (712)
AP-1 (14)ERK (166)HPK1 (2)JNK (79)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (99)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1711)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (269)CFTR (61)Chloride Channel (30)CRAC Channel (14)CRM1 (17)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (188)GLUT (32)Glutamate transporter (21)Glycine transporter (23)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (16)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (287)Proton Pump (54)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (195)SV2 (2)TRP Channel (182)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3492)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (2)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (49)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (1)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (121)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (8)Dehydrogenase (156)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (32)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (8)Factor Xa (45)Farnesyl Transferase (4)FAS (35)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (71)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (131)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (25)GSNOR (3)GST (16)Hexokinase (8)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (24)IDH (37)IDO (70)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (109)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (98)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (43)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (49)αKGD (2)
Neuronal Signaling (3852)
5-HT Receptor (402)AAK1 (17)AChE (43)AChR (348)Adenosine Kinase (5)Adrenergic Receptor (184)AMPAR (54)Amylin receptor (1)Amyloid-β (172)Calcium Channel (269)CaMK (54)Cannabinoid Receptor (65)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (235)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (188)Glucosylceramide Synthase (13)GluR (208)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (239)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (195)Melanocortin Receptor (31)mGluR (226)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (50)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (53)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (182)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (540)
IKK (74)MALT1 (24)NF-κB (419)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (763)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (90)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1044)
Akt (207)AMPK (105)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (126)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (340)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2131)
ACS (3)Akt (207)AMPK (105)AQP (5)Bcl-6 (6)FABP (8)FATP (3)IL (172)LXR (27)MMP (179)NF-κB (419)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (193)RAR/RXR (86)RGS (6)ROS (398)SCD (18)SGK (15)Sirtuin (129)STAT (160)TNF-alpha (30)
Protease (697)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (24)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (25)MMP (179)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (100)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (403)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (271)
Pyroptosis (993)
Caspase (170)Cathepsin (98)IL (172)MyD88 (6)NF-κB (419)TLR (163)
Stem Cells (1527)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (126)Hedgehog (32)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (90)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (458)
Bcr-Abl (105)PKC (157)ROCK (90)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (74)IRAK (71)IRF3 (1)JNK (79)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (587)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (193)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2371)
AP-1 (14)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (126)JNK (79)MMP (179)NF-κB (419)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (157)PKG (10)Rho (14)ROCK (90)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3218)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (126)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (30)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (33)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (15)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (8)Dehydrogenase (156)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1247)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (60)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (24)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (5)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (248)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (4)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (61)VPS (3)XOR (1)α-amylase (15)Others (2611)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (133)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (62)Cell Culture Antibiotic (2)Insect Repellent (42)Plant Tissue Culture Antibiotic (2)Preservative and Disinfectant (20)
Structure (8762)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (2)Cephalosporin (7)Chloramphenicol (1)Imidazole (6042)Macrolide (8)Nucleoside (5)Penicillin (3)Pyridine / Pyrimidine (6)Quinolone (19)Sulfonamide (17)Tetracycline (6)β-Lactam (4)Other Antibiotics (35)Others (2611)
Biochemical Reagents
Amino Acids (799)
Amino Acid Amide (17)Biologically Modified Amino Acid (29)C-protective Amino Acid (194)N-protective Amino Acid (438)Non-protein Amino Acid (115)Protein Amino Acid (55)Side Chain Protected Amino Acid (25)
Biological Buffers (2643)
Good's Buffer (19)Other Buffers (13)Others (2611)
Cross-Linking Agents (33)
Amino-amino Crosslinker (7)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (219)
Aliphatic Acyl (210)Glycerol Lipid (7)Sphingolipid (2)
Polypeptides (39)
Dipeptide and Tripeptide (36)Oligopeptide (3)
Steroids (2675)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2611)
Sugar and Derivatives (151)
Sugar (137)Sugar Alcohol (15)
Sweeteners (For Research Experiments) (18)
Artificial sweetener (6)Natural sweetener (12)
Cancer
Cancer Stem Cells (2475)
Cathepsin (98)CXCR (112)Hedgehog (32)IL (172)IL Receptor (9)Integrin (134)MIF (18)MMP (179)NF-κB (419)NOS (186)Notch (26)PDGFR (127)PPAR (193)STAT (160)TGF-beta/Smad (381)VEGFR (271)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1825)
ALK (86)AP-1 (14)CAR (5)CCR (89)Complement System (45)COX (344)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (188)GSK-3 (126)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (98)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2861)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (43)DNA/RNA Synthesis (620)Epigenetic Reader Domain (396)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)RNA polymerase 1 (2)Sirtuin (129)TET (8)Topoisomerase (271)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (207)Aurora Kinase (87)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (403)ERK (166)HER2 (31)MEK (99)MLKL (4)mTOR (187)p53 (41)PI3K (340)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (21)
Tumor Metabolism (1274)
ACC (22)ALDH (30)AMPK (105)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (156)FBPase (4)FTO (15)GLUT (32)Glutaminase (25)Hexokinase (8)IDH (37)IDO (70)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (398)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1419)
Apoptosis Inducer (1407)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (292)
Additive and Auxiliary Reagent (130)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (90)Stem Cell Induction (83)
Enzymology
Enzyme Inhibitors (206)
Acetaldehyde Dehydrogenase Inhibitor (1)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (47)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (20)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (2)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (63)
Cyclooxygenase (COX) (46)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (61)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (2)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (4)Mitochondrial Dyes (5)NOS Dyes (6)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (18)ROS Dyes (27)
Fluorescence Labeling Reagents (2848)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (7)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (213)Others (2611)
Fluorescent Dyes (2797)
Acridine Dye (8)Blood Dyes (2)Cancer Analysis Dyes (8)Coumarine Dye (57)Cyanine Dye (25)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2611)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (5)
Hybridization Reagent (3)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (3)Oplopanax (1)Panax (53)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (15)
Aristolochia (11)Asarum (3)Holostylis (1)
Asclepiadaceae (19)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (4)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (228)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (25)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (11)
Boswellia (3)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5433)
Alkaloids (149)Coumarins (21)Lignans (36)Phenols (1786)Phenylpropanane (54)Quinones (35)Natural Products-Other Structure (3377)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (16)
Celastrus (3)Euonymus (2)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (2)
Cornus (2)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (41)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pterolobium (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (129)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Cuminum (1)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (7)
Illicium (7)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (5)Salvia (45)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (22)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (3)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (78)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (3)Liriope (3)Ophiopogon (28)Paris (8)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (33)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Solanum (6)Withania (1)
Nyssaceae (52)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (38)
Oleaceae (37)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Olax (1)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (1)
Pittosporum (1)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (14)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (2)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (7)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (3)Sanguisorba (1)Sorbus (1)Spiraea (1)
Rubiaceae (69)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (11)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (14)Uncaria (6)
Rutaceae (162)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (20)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (18)
Kadsura (5)Schisandra (13)
Scrophulariaceae (33)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (4)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (61)
Cardiovascular System (20)Diabete (30)Digestive System (11)
Drug Analysis (663)
Drug Standard (208)Plant Standard (457)
Drug Delivery (560)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (27)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (14)
Small Molecule Positive Drugs (2843)
Anti-allergy (5)Anti-inflammation (30)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (62)Depressurization (18)Diabete (30)Neurotransmitter (32)Reduce Blood Lipid (6)Other Compounds (66)Others (2611)
PROTACS
E3 Ligand-Linker Conjugate (166)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (49)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2591)
ApoE (1)ARF (2)Calcium Channel (269)Ceramidase (4)FGF (2)HBV (151)HIV (447)HSP (161)HSV (75)Integrin (134)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (32)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5789)
Akt (207)AMPAR (54)Apoptosis (2143)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (50)GPCR (203)GSK-3 (126)IL (172)JAK (245)JNK (79)LRRK2 (32)MyD88 (6)NF-κB (419)Notch (26)p53 (41)PI3K (340)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (90)ROS (398)Secretase (112)STAT (160)STING (98)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (100)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (103)
Fungicide (60)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Inhibitors/Agonists
/
Anti-Infection
/
Antibacterial
/
Lactitol
/
Inhibitors/Agonists
/
Anti-Infection
/
Antibacterial
/
Chemical Structure| 585-86-4 Chemical Structure| 585-86-4

Structure of Lactitol
CAS No.: 585-86-4

Chemical Structure| 585-86-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lactitol is a gastrointestinal agent.

Synonyms: D-Lactitol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of Lactitol Purity: 95% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lactitol

CAS No. :585-86-4
Formula : C12H24O11
M.W : 344.31
SMILES Code : OC[C@H](O)[C@@H](O)[C@H](O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)[C@H](O)CO
Synonyms :
D-Lactitol
MDL No. :MFCD00079407

Safety of Lactitol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00297817 Meningococcal Disease Phase 2 Completed - United States, California ... More >> Encinitas, California, United States, 92024 United States, Georgia Atlanta, Georgia, United States, 30322 United States, Missouri St. Louis, Missouri, United States, 63110 United States, Ohio Cleveland, Ohio, United States, 44118 United States, Texas Galveston, Texas, United States, 77555 United States, Utah Layton, Utah, United States, 84123 Salt Lake City, Utah, United States, 84121 United States, Washington Seattle, Washington, United States, 98101 Less <<
NCT00239863 Renal Transplantation Phase 3 Completed - -
NCT00239798 Renal Transplantation Phase 2 Completed - -
NCT00239785 Renal Transplantation Phase 3 Completed - -
NCT00620815 Influenza Phase 2 Completed - Germany ... More >> ATRIUM Gesundheitszentrum; Holzkirchen, Germany, 83607 International Medicine & Public Health Dept. of Infect. Diseases Munich, Germany, 80799 Less <<
NCT00239811 Renal Transplantation Phase 3 Completed - -
NCT00951847 Healthy Not Applicable Completed - India ... More >> Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited Noida, Uttar Pradesh, India Less <<
NCT00620815 - Completed - -
NCT02107807 Influenza, Human ... More >> Flu, Human Flu, Avian Influenza Influenza A Virus, H5N1 Subtype Less << Phase 3 Completed - Australia, New South Wales ... More >> 102, Novartis Investigational Site Darlinghurst, New South Wales, Australia, 2010 103, Novartis Investigational Site Darlinghurst, New South Wales, Australia, 2010 101, Novartis Investigational Site Merewether, New South Wales, Australia, 2291 Germany 303, Novartis Investiagtional Site Würzburg, Bayern, Germany, 97070 304, Novartis Investigational Site Rostock, Mecklenburg-Vorpommern, Germany, 18057 301, Novartis Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39120 302, Novartis Investigational Site Hamburg, Germany, 39120 Italy 082, Novartis Investigational Site Fossacesia, Chieti, Italy, 66022 081, Novartis Investigational Site Lanciano, Chieti, Italy, 66034 003, Novartis Investigational Site Monza, Milan, Italy, 20052 007, Novartis Investigational Site Aviano, Padova, Italy, 33080 006, Novartis Investigational Site San Daniele del Friuli, Udine, Italy, 33038 005, Novartis Investigational Site Chieti, Italy, 66013 008, Novartis Investigational Site Chieti, Italy, 66013 001, Novartis Investigational Site Milan, Italy, 20127 002, Novartis Investigational Site Milan, Italy, 20157 004, Novartis Investigational Site Parma, Italy, 43100 Less <<
NCT03006380 Postpartum Hemorrhage Phase 2 Recruiting September 2017 Egypt ... More >> Ain Shams University Maternity Hospital Recruiting Cairo, Egypt Contact: Amr Yehia, MD Less <<
NCT00951600 Healthy Not Applicable Completed - India ... More >> Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited Noida, Uttar Pradesh, India Less <<
NCT00463801 Staphylococcal Skin Infections Phase 4 Terminated(Because of inadequa... More >>te accrual.) Less << - Italy ... More >> Novartis Italy Novartis Italy, Italy Novartis Italy Saronno, Italy Less <<
NCT00463801 - Terminated(Because of inadequa... More >>te accrual.) Less << - -
NCT00239902 Renal Transplantation Phase 2 Completed - -
NCT01823536 Meningococcal Disease Phase 4 Completed - United States, Arkansas ... More >> 82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300 Bentonville, Arkansas, United States, 72712 83 AR Pediatric Clinical Research 500 South University, Ste. 200 Little Rock, Arkansas, United States, 72205 United States, California 32 Prem Health Research Center 9317 Firestone Blvd. Downey, California, United States, 90241 United States, Kentucky 27 KY Pediatric Adult Research 201 South 5th Street, Suite 102 Bardstown, Kentucky, United States, 40004 United States, Nebraska 36 Meridian Clinical Research 3319 N. 107th Street Omaha, Nebraska, United States, 68134 United States, Ohio 33 Dr. Sender's and Associates 2054 South Green Road Cleveland, Ohio, United States, 44121 United States, Texas 31 Benchmark Research, Fort Worth 4504 Boat Club Rd., Suite 400A Ft. Worth, Texas, United States, 76135 25 Benchmark Research, San Angelo 3555 Knickerbocker Rd. San Angelo, Texas, United States, 76904 United States, Utah 65 Westside Medical 1477 N 2000 W, Suite C Clinton, Utah, United States, 84015 29 J. Lewis Research, Inc. 6360 South 3000 East, Ste. 100 Salt Lake City, Utah, United States, 84121 30 J. Lewis Research, Inc. 6360 South 3000 East, Ste. 100 Salt Lake City, Utah, United States, 84121 37 Copperview Medical Associates 3556 West 9800 South South Jordan, Utah, United States, 84095 47 Wee Care Pediatrics 1792 W. 1700 S. Syracuse, Utah, United States, 84075 United States, Washington 34 Rockwood Clinic P S 400 East Fifth Avenue Spokane, Washington, United States, 99202 35 Rockwood Clinic-North Pediatrics 9001 N Country Homes Blvd Spokane, Washington, United States, 99218 Ukraine 26 Benchmark Research 3800 Houma Blvd., Suite 345 Metairie, LA, Ukraine, 70006 Less <<
NCT00736476 - Completed - -
NCT01823536 - Completed - -
NCT01717638 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 3 Completed - Czech Republic ... More >> Ordinace praktickeho lekare pro deti a dorost Jaromer, Alšova 466, Czech Republic, 55101 Ordinace praktickeho lekare pro deti a dorost Jaromer, Dr. E.Beneše 191, Czech Republic, 55101 Ordinace praktickeho lekare pro deti a dorost Sezemice, Havlickova 168, Czech Republic, 53304 Ordinace praktickeho lekare pro deti a dorost Hronov, Hostovského 485, Czech Republic, 54931 Ordinace praktickeho lekare pro deti a dorost Ceska Skalice, Husovo namesti 36, Czech Republic, 55203 Ordinace praktickeho lekare pro deti a dorost Pardubice, L.Male 656, Czech Republic, 53012 Ordinace praktickeho lekare pro deti a dorost Hradec Králové, Manesova 646, Czech Republic, 50002 Ordinace praktickeho lekare pro deti a dorost Hronov, Palackeho 517, Czech Republic, 54931 Ordinace praktickeho lekare pro deti a dorost Hradec Králové, Pardubicka 752, Czech Republic, 50004 Ordinace praktickeho lekare pro deti a dorost Chlumec nad Cidlinou, Pernstynska 127/I, Czech Republic, 50351 Nemocnice Náchod Nachod, Purkynova 446, Czech Republic, 54701 Ordinace praktickeho lekare pro deti a dorost Jindrichuv Hradec, Ruských legií 352, Czech Republic, 37701 Ordinace praktickeho lekare pro deti a dorost Pardubice, Sladkovskeho 2617, Czech Republic, 53002 Ordinace praktickeho lekare pro deti a dorost Jindrichuv Hradec, Sídliste Vajgar 724/III, Czech Republic, 37701 Fakulta vojenskeho zdravotnictvi UO Hradec Kralove, Trebesska 1575, Czech Republic, 50001 Ordinace praktickeho lekare pro deti a dorost Holice, U kaplicky 1042, Czech Republic, 53401 Ordinace praktickeho lekare pro deti a dorost Jindrichuv Hradec, U nemocnice380/III, Czech Republic, 37701 Italy Universita di Firenze -Pediatria Florence, Italy, 50139 IRCCS Cà Granda Milan, Italy, 20122 Ospedale Maggiore della Carita Novara, Italy, 28100 Dip Pediatria AO Padova Padova, Italy, 35128 Spain Hospital Clinico Universitario de Santiago de Compostela Santiago de Compostela A Coruña, Spain, 15706 Hospital Universitario Dr. Peset Valencia, Spain, 46017 Centro Superior de Investigacion en Salud Publica/Clinica Universitaria San Vicente Martir Valencia, Spain, 46020/46001 Complexo Hospitalario Xeral Cies Vigo Pontevedra, Spain, 36204 United Kingdom Oxford Vaccine Group - Centre for Clinical Vaccinology and Tropical Medicine Churchill Hospital Oxford, Headington, United Kingdom, OX3 7LJ North Bristol NHS Trust Bristol, United Kingdom, BS1 3NU Royal Devon and Exeter NHS Foundation Trust Exeter, United Kingdom, EX2 5DW St Georges Hospital London, United Kingdom, SW17 0RE Less <<
NCT00529451 Hypertension Phase 3 Completed - China ... More >> Novartis Investigative Sites China, China India Novartis Investigative Sites India, India Thailand Novartis Investigative Sites Thailand, Thailand Less <<
NCT00428792 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Freiburg, Germany Less <<
NCT01717638 - Completed - -
NCT00529451 - Completed - -
NCT00428792 - Completed - -
NCT00561392 Alzheimer's Disease Phase 4 Completed - Germany ... More >> Novartis Investigative Site Munich, Germany Less <<
NCT01956669 Solid Tumours Phase 2 Recruiting April 1, 2021 -
NCT00275821 Age Related Macular Degenerati... More >>on Less << Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland, 4002 Less <<
NCT00736476 Helicobacter Pylori Infection Phase 1 Completed - Germany ... More >> Otto von Guericke Universität Magdeburg Magdeburg, Germany, 39120 Less <<
NCT02078609 AML and High Risk MDS Phase 1 Recruiting September 3, 2019 United States, Michigan ... More >> Novartis Investigative Site Recruiting Ann Arbor, Michigan, United States, +1 48109 0944 Contact: Sabrina Pelton Hargrove    +1 734 936 8538    sgomes@med.umich.edu    Principal Investigator: Dale Bixby          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Recruiting Prahran, Victoria, Australia, 3181 France Novartis Investigative Site Completed Marseille, France, 13273 Germany Novartis Investigative Site Completed Ulm, Germany, 89081 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20132 Novartis Investigative Site Recruiting Milano, MI, Italy, 20162 Novartis Investigative Site Recruiting Roma, RM, Italy, 00133 Japan Novartis Investigative Site Recruiting Shinagawa-ku, Tokyo, Japan, 141 8625 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1081 HV Less <<
NCT02124772 Cancer Phase 1 Recruiting October 15, 2020 United States, Arizona ... More >> Novartis Investigative Site Recruiting Phoenix, Arizona, United States, 85016-7710 United States, California Novartis Investigative Site Recruiting San Francisco, California, United States United States, Maryland Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287 United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02115 United States, Minnesota Novartis Investigative Site Recruiting Minneapolis, Minnesota, United States, 55455 United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10065 United States, Ohio Novartis Investigative Site Recruiting Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Novartis Investigative Site Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Recruiting Memphis, Tennessee, United States, 38105-3678 United States, Washington Novartis Investigative Site Recruiting DC, Washington, United States, DC 20010 Australia, New South Wales Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 1X8 France Novartis Investigative Site Recruiting Paris Cedex 05, France, 75248 Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 United Kingdom Novartis Investigative Site Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Recruiting London, United Kingdom, WC1N 3JH Less <<
NCT00477217 Osteonecrosis Phase 2 Withdrawn - Australia ... More >> Novartis Investigative Site Gordon, Australia, NSW,2072 Less <<
NCT00561392 - Completed - -
NCT00567476 Asthma Phase 4 Completed - Brazil ... More >> Novartis Investigator Site São Paulo, Brazil Less <<
NCT00925730 Atopic Dermatitis Phase 4 Completed - Germany ... More >> Novartis Investigative Site Bonn, Germany Novartis Investigative Site Frankfurt am Main, Germany Less <<
NCT00275821 - Completed - -
NCT03492541 Dry Eye Disease Not Applicable Recruiting May 9, 2019 United States, Missouri ... More >> Novartis Investigative Site Recruiting Kansas City, Missouri, United States, 64133 Novartis Investigative Site Recruiting Kansas City, Missouri, United States, 64155 Less <<
NCT02565511 Alzheimer's Disease Phase 2 Phase 3 Recruiting September 2, 2024 -
NCT03650114 Relapsing Multiple Sclerosis Phase 3 Not yet recruiting June 4, 2025 -
NCT00284050 Diabetic Macular Edema Phase 2 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00284050 - Completed - -
NCT00154245 Kidney Transplantation Phase 4 Completed - -
NCT02323126 Non Small Cell Lung Cancer Phase 2 Recruiting April 11, 2022 United States, Alabama ... More >> Novartis Investigative Site Completed Birmingham, Alabama, United States, 35294 United States, Massachusetts Novartis Investigative Site Completed Boston, Massachusetts, United States, 02114 United States, North Carolina Novartis Investigative Site Completed Charlotte, North Carolina, United States, 28203 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Justina M. Price    713-794-5325    jusprice@mdanderson.org    Principal Investigator: Vassiliki A Papadimitrakopoulou          Australia, New South Wales Novartis Investigative Site Recruiting Camperdown, New South Wales, Australia, 2050 Australia, Queensland Novartis Investigative Site Recruiting Chermside, Queensland, Australia, 4032 Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 France Novartis Investigative Site Recruiting Caen Cedex, France, 14021 Novartis Investigative Site Recruiting La Tronche, France, 38700 Germany Novartis Investigative Site Recruiting Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Recruiting Wurzburg, Germany, 97080 Italy Novartis Investigative Site Recruiting Perugia, PG, Italy, 06129 Novartis Investigative Site Recruiting Pisa, PI, Italy, 56124 Novartis Investigative Site Recruiting Aviano, PN, Italy, 33081 Netherlands NKI-AVL, Department of Thoracic-Oncology Recruiting Amsterdam, Netherlands, 1066 CX Contact: E.F. Smit, Prof.    0031-20-5122958    e.smit@nki.nl    Principal Investigator: E.F. Smit, Prof.          Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Alicante, Comunidad Valenciana, Spain, 03010 Novartis Investigative Site Recruiting Madrid, Spain, 28040 Switzerland Novartis Investigative Site Recruiting Chur, Switzerland, 7000 Novartis Investigative Site Recruiting Geneve, Switzerland, 1211 Less <<
NCT00171392 Prevention of Acute Rejection ... More >>After Kidney Transplantation Less << Phase 3 Completed - -
NCT00567476 - Completed - -
NCT00568503 COPD Phase 1 Completed - Denmark ... More >> Novartis Investigator Site Birkeroed, Denmark Less <<
NCT02452268 Metastatic and Advanced Solid ... More >>Tumors Less << Phase 1 Recruiting December 31, 2019 United States, Maryland ... More >> Novartis Investigative Site Recruiting Bethesda, Maryland, United States, 20892 Contact    +1 301 402 29 13       Principal Investigator: Kevin Conlon          United States, Missouri Novartis Investigative Site Recruiting Saint Louis, Missouri, United States, 63110 United States, Ohio Novartis Investigative Site Recruiting Columbus, Ohio, United States, 43212 United States, Oregon Novartis Investigative Site Recruiting Portland, Oregon, United States, 97123 United States, Utah Novartis Investigative Site Recruiting Salt Lake City, Utah, United States, 84112 Contact: Keisa Hales    801-585-3453    keisa.hales@hci.utah.edu    Principal Investigator: Sunil Sharma          United States, Washington Novartis Investigative Site Recruiting Seattle, Washington, United States, 98105 Contact: Erin Shaw    206-288-2056    eshaw@seattlecca.org    Principal Investigator: John Thompson          United States, Wisconsin Novartis Investigative Site Recruiting Madison, Wisconsin, United States, 53792 Contact: Monika Stankiewicz       monika.stankiewicz@wisc.edu    Principal Investigator: Douglas McNeel Less <<
NCT00829673 Healthy Phase 1 Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Less <<
NCT00829673 - Completed - -
NCT00171379 Prevention of Acute Rejection ... More >>After Kidney Transplantation Less << Phase 3 Completed - -
NCT02607813 NSCLC Ovarian... More >> Cancer Melanoma Other Solid Tumors Less << Phase 1 Recruiting December 16, 2019 United States, Massachusetts ... More >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02114 United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10021 Contact: Alida Beck       becka@mskcc.org    Principal Investigator: Gopakumar Iyer          United States, Texas UT M.D Anderson Cancer Center SC - LXH254X2101 Recruiting Houston, Texas, United States, 77030 Contact: Zehra Maloo    713-563-4426    zmaloo@mdanderson.org    Principal Investigator: Filip Janku          Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M6G 1Z5 France Novartis Investigative Site Recruiting Paris, France, 75010 Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Recruiting Essen, Germany, 45147 Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Japan Novartis Investigative Site Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Korea, Republic of, 03080 Netherlands Novartis Investigative Site Recruiting Groningen, Netherlands, 9713 GZ Contact: Department of Pulmonary Diseases University Medical Center Groningen    +31 503611546    h.j.m.groen@umcg.nl    Principal Investigator: H.J.M. Groen, M.D.          Medical Oncology, Erasmus MC Recruiting Rotterdam, Netherlands, 3075 CE Contact       m.dejonge@erasmusmc.nl    Principal Investigator: M. de Jonge, M.D.          Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Switzerland Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 Less <<
NCT02568943 - - - -
NCT00797316 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00836576 Healthy Phase 1 Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Less <<
NCT02712983 Non-cystic Fibrosis Bronchiect... More >>asis Less << Phase 2 Recruiting October 16, 2019 -
NCT00797316 - Completed - -
NCT00731523 Renal Insufficiency Phase 1 Completed - Russian Federation ... More >> Novartis Investigator Site Moscow, Russian Federation Less <<
NCT02460224 Advanced Solid Tumors Phase 1 Phase 2 Recruiting July 24, 2019 -
NCT03114319 Advanced EGFRmutant NonSmallSe... More >>llLungCancer (NSCLC),KRAS G12C NSCLC,CRC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,RAS/RAF Wild-type Other Solid Tumor Less << Phase 1 Recruiting August 3, 2020 United States, Massachusetts ... More >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02215 Contact: Beth Meyers    617-643-1820    Betha_meyers@dfci.harvard.edu    Principal Investigator: Geoffrey Shapiro          United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10065 Contact: Murielle Georges    656-888-4563    georgesm@mskcc.org    Principal Investigator: Helena Yu          Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 1Z5 Japan Novartis Investigative Site Recruiting Kobe-shi, Hyogo, Japan, 650-0017 Netherlands Novartis Investigative Site Recruiting Rotterdam, Netherlands, 3075 EA Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Less <<
NCT02608268 Advanced Malignancies Phase 1 Phase 2 Recruiting March 8, 2019 United States, Maryland ... More >> Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21231 Contact: Bhavika Patel       bpatel5@jhmi.edu    Principal Investigator: Patrick Forde          United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02215 Contact: Natasha Isaac    617-582-7116    Nisaac1@partners.org    Principal Investigator: F Stephen Hodi          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Lacey McQuinn    713-563-9033    lmcquinn@mdanderson.org    Principal Investigator: Aung Naing          Novartis Investigative Site Recruiting San Antonio, Texas, United States, 78229 Contact: Kathleen Rodriguez    210-450-3838    rodriguezk3@uthscsa.edu    Principal Investigator: John Sarantopoulos          Canada, Ontario Novartis Investigative Site Active, not recruiting Toronto, Ontario, Canada, M6G 1Z5 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Recruiting Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03080 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Recruiting Leiden, Netherlands, 2300 RC Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Switzerland Novartis Investigative Site Recruiting Geneve 14, Switzerland, CH-1211 Taiwan Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Less <<
NCT00732771 Primary Hyperaldosteronism Phase 2 Completed - France ... More >> Novartis Investigator Site France, France Less <<
NCT02640664 Retinopathy of Prematurity Phase 3 Recruiting October 31, 2022 -
NCT02734615 Advanced or Metastatic ER+ Bre... More >>ast Cancer Less << Phase 1 Recruiting October 30, 2020 United States, Maryland ... More >> Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Dejan Juric, MD    617-726-6500    Juric.Dejan@mgh.harvard.edu    Contact: Meghan Miles    617-726-6500    MEMILES@mgh.harvard.edu    Principal Investigator: Dejan Juric, MD          United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10021 Contact: Alexandra Burleigh    646-422-4394    burleiga@mskcc.org    Principal Investigator: Komal Jhaveri          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Daniela Westerhold       diwesterhold@mdanderson.org    Principal Investigator: Rachel M Layman          Belgium Novartis Investigative Site Recruiting Bruxelles, Belgium, 1200 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Lyon Cedex, France, 69373 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Japan Novartis Investigative Site Recruiting Koto-ku, Tokyo, Japan, 135 8550 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Less <<
NCT02740270 Solid Tumors ... More >>Lymphomas Less << Phase 1 Recruiting December 5, 2019 United States, Illinois ... More >> Novartis Investigative Site Recruiting Chicago, Illinois, United States, 60637 Contact: Michelle Rainer    773-702-8582    mrainer@bsd.uchicago.edu    Principal Investigator: Jason Luke          United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02215 Contact: Natasha Isaac    617-632-4272    Nisaac1@partners.org    Principal Investigator: Osama Rahma          United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10017 Contact: Deepika Cattry    646-227-2178    cattryd@mskcc.org    Principal Investigator: Alexander Lesokhin          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Rabia Khan    713-563-4667    RKhan@mdanderson.org    Principal Investigator: Sarina Piha-Paul          Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Israel Novartis Investigative Site Recruiting Tel Aviv, Israel, 64239 Japan Novartis Investigative Site Recruiting Kashiwa, Chiba, Japan, 277-8577 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Less <<
NCT02795429 Advanced Hepatocellular Carcin... More >>oma Less << Phase 1 Phase 2 Recruiting December 24, 2019 United States, Illinois ... More >> Novartis Investigative Site Recruiting Chicago, Illinois, United States, 60637 Contact: Tamika Harris    773-834-7188    tharris@medicine.bsd.uchicago.edu    Principal Investigator: Manish Sharma          Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Recruiting Montpellier cedex 5, Herault, France, 34059 Novartis Investigative Site Recruiting Lille Cedex, France, 59037 Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Recruiting Wurzburg, Germany, 97080 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20132 Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Novartis Investigative Site Recruiting Modena, MO, Italy, 41124 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03080 Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03722 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Less <<
NCT02696967 Stable Heart Failure Phase 2 Recruiting December 11, 2018 United States, Illinois ... More >> Novartis Investigative Site Recruiting Chicago, Illinois, United States, 60611 United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02115 United States, Michigan Novartis Investigative Site Recruiting Detroit, Michigan, United States, 48202 United States, Missouri Novartis Investigative Site Recruiting Saint Louis, Missouri, United States, 63110 United States, Ohio Novartis Investigative Site Recruiting Cleveland, Ohio, United States, 44195 United States, Pennsylvania Novartis Investigative Site Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 United States, Washington Novartis Investigative Site Recruiting Tacoma, Washington, United States, 98405 Belgium Novartis Investigative Site Recruiting Gent, Belgium, 9000 Germany Novartis Investigative Site Recruiting Greifswald, Germany, 17475 Novartis Investigative Site Recruiting Hamburg, Germany, 20246 Novartis Investigative Site Recruiting Regensburg, Germany, 93053 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169609 Less <<
NCT02807844 Triple Negative Breast Cancer ... More >> Pancreatic Carcinoma Melanoma Endometrial Carcinoma Less << Phase 1 Phase 2 Recruiting May 15, 2019 United States, Massachusetts ... More >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02215 Contact: Janice Russell    617-643-1820    Janice_Russell@DFCI.Harvard.edu    Principal Investigator: F Stephen Hodi          United States, Missouri Novartis Investigative Site Recruiting Saint Louis, Missouri, United States, 63123 United States, Tennessee Novartis Investigative Site Recruiting Germantown, Tennessee, United States, 38138 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Lacey McQuinn    713-792-0007    lmcquinn@mdanderson.org    Principal Investigator: Aung Naing          Belgium Novartis Investigative Site Recruiting Wilrijk, Belgium, 2610 Finland Novartis Investigative Site Recruiting HUS, Finland, FIN-00029 France Novartis Investigative Site Recruiting Saint Herblain cedex, France, 44805 Germany Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Ulm, Germany, 89081 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Japan Novartis Investigative Site Recruiting Koto-ku, Tokyo, Japan, 135 8550 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03080 Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 05505 Spain Novartis Investigative Site Recruiting Valencia, Comunidad Valenciana, Spain, 46010 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Switzerland Novartis Investigative Site Recruiting Chur, Switzerland, 7000 Novartis Investigative Site Recruiting Geneve 14, Switzerland, CH-1211 Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 Less <<
NCT02829723 Advanced Solid Tumors Phase 1 Phase 2 Recruiting June 19, 2019 United States, Tennessee ... More >> Novartis Investigative Site Recruiting Nashville, Tennessee, United States, 37203 Contact: Jeremy Stewart    615-289-9227    jeremy.stewart@scresearch.net    Principal Investigator: Todd M. Bauer          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Lacey McQuinn    713-563-9033    lmcquinn@mdanderson.org    Principal Investigator: Aung Naing          Novartis Investigative Site Recruiting San Antonio, Texas, United States, 78229 Contact: Kathleen Rodriguez    210-450-3838    rodriguezk3@uthscsa.edu    Principal Investigator: John Sarantopoulos          Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Recruiting Nagoya, Aichi, Japan, 466 8560 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Hospitalet de LLobregat, Catalunya, Spain, 08907 Taiwan Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Less <<
NCT02711345 Ovarian Neoplasms ... More >> Non-Small-Cell Lung Carcinoma Melanoma Other Solid Tumors Less << Phase 1 Recruiting July 17, 2019 United States, New York ... More >> Novartis Investigative Site Recruiting New York, New York, United States, 10021 Contact: Alida Beck       becka@mskcc.org    Principal Investigator: Gopakumar Iyer          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030-4009 Contact: Anjali Raina    713-792-3238    araina@mdanderson.org    Principal Investigator: Filip Janku          Germany Novartis Investigative Site Recruiting Essen, Germany, 45147 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Japan Novartis Investigative Site Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1066 CX Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Recruiting Bellinzona, Switzerland, 6500 Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 Less <<
NCT02892019 Asthma Phase 2 Recruiting April 17, 2018 Belgium ... More >> Novartis Investigative Site Recruiting Brugge, Belgium, 8000 Novartis Investigative Site Recruiting Brussel, Belgium, 1020 Novartis Investigative Site Recruiting Edegem, Belgium, 2650 Germany Novartis Investigative Site Recruiting Hamm, Germany, D-59063 Novartis Investigative Site Recruiting Mannheim, Germany, 68161 Hungary Novartis Investigative Site Recruiting Szeged, Hungary, 6720 Novartis Investigative Site Recruiting Torokbalint, Hungary, 2045 Less <<
NCT00784732 Seasonal Allergic Rhinitis Phase 2 Completed - Canada ... More >> Novartis Investigator Site Toronto, Canada Less <<
NCT03379233 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Recruiting February 28, 2020 Germany ... More >> Novartis Investigative Site Recruiting Berlin, Germany, 12203 Novartis Investigative Site Recruiting Hamburg, Germany, 20354 Novartis Investigative Site Recruiting Leipzig, Germany, 04103 Novartis Investigative Site Recruiting Lubeck, Germany, 23552 Netherlands Novartis Investigative Site Recruiting Heerlen, Netherlands, 6419 PC Novartis Investigative Site Recruiting Helmond, Netherlands, 5707 HA Novartis Investigative Site Recruiting Leeuwarden, Netherlands, 8934 AD Novartis Investigative Site Recruiting Zutphen, Netherlands, 7207 AE Less <<
NCT02900664 Colorectal Cancer, Triple Nega... More >>tive Breast Cancer, NSCLC - Adenocarcinoma Less << Phase 1 Recruiting February 17, 2020 United States, Maryland ... More >> Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287-0013 United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02215 United States, Tennessee Novartis Investigative Site Recruiting Nashville, Tennessee, United States, 37203 Contact: Michael Cain    615-329-7417    Michael.Cain@sarahcannon.com    Principal Investigator: Melissa Johnson          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Munir Yi Chowdury    713-563-9033    MChowdhury@mdanderson.org    Principal Investigator: Siqing Fu          Belgium Novartis Investigative Site Recruiting Brussels, Belgium, BE-B-1200 Novartis Investigative Site Recruiting Wilrijk, Belgium, 2610 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Recruiting Lyon Cedex, France, 69373 Novartis Investigative Site Recruiting Paris, France, 75231 Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Israel Novartis Investigative Site Recruiting Tel Aviv, Israel, 64239 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20132 Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 119228 Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Novartis Investigative Site Recruiting Madrid, Spain, 28050 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taoyuan, Taiwan, 33305 Less <<
NCT02974725 Non-Small Cell Lung Cancer ... More >> Melanoma Less << Phase 1 Recruiting June 29, 2020 United States, Massachusetts ... More >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02114 Contact: Bakhan Barzangy    617-726-1849    bbarzangy@mgh.harvard.edu    Principal Investigator: Rebecca Heist          Australia, Victoria Novartis Investigative Site Recruiting Melbourne, Victoria, Australia, 3000 Belgium Novartis Investigative Site Recruiting Leuven, Belgium, 3000 France Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Koeln, Germany, 50937 Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Less <<
NCT02890069 Colorectal Cancer, Non-small C... More >>ell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Less << Phase 1 Recruiting December 19, 2019 -
NCT02566044 Pulmonary Cystic Fibrosis Phase 1 Phase 2 Recruiting January 1, 2019 United States, New York ... More >> Novartis Investigative Site Completed New York, New York, United States, 10032 United States, Texas Novartis Investigative Site Completed Dallas, Texas, United States, 75390-9034 Germany Novartis Investigative Site Completed Essen, Germany, 45147 Novartis Investigative Site Recruiting Hannover, Germany, 30625 Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Completed Koeln, Germany, 50924 Less <<
NCT01287325 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Phase 2 Completed - Netherlands ... More >> Novartis Investigative Site Zuidlaren, Netherlands United Kingdom Novartis Investigative Site London, United Kingdom Less <<
NCT00149968 Renal Transplantation ... More >> Gastrointestinal Problems Less << Phase 4 Completed - Germany ... More >> Bonn, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT02936102 Advanced Solid Tumors, Non-Sma... More >>ll Cell Lung Carcinoma, Triple Negative Breast Cancer, Endometrial Cancer, Anaplastic Thyroid Cancer Less << Phase 1 Recruiting February 28, 2020 United States, California ... More >> Novartis Investigative Site Recruiting Santa Monica, California, United States, 90404 United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10065 Contact: Afra Yehwalashet    646-888-5341    yehwalaa@mskcc.org    Principal Investigator: Ayca Gucalp          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Anjali Raina    713-563-2632    ARaina@mdanderson.org    Principal Investigator: Filip Janku          Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Recruiting Jena, Germany, 07740 Israel Novartis Investigative Site Recruiting Tel Aviv, Israel, 64239 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Modena, MO, Italy, 41124 Japan Novartis Investigative Site Recruiting Koto-ku, Tokyo, Japan, 135 8550 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 119228 Spain Novartis Investigative Site Recruiting Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Less <<
NCT02232061 Multiple Sclerosis Phase 4 Recruiting July 6, 2020 Belgium ... More >> Novartis Investigative Site Recruiting Gent, Belgium, 9000 Novartis Investigative Site Recruiting Hasselt, Belgium, 3500 Novartis Investigative Site Withdrawn Verviers, Belgium, 4800 Germany Novartis Investigative Site Recruiting Ravensburg, Germany, 88212 Novartis Investigative Site Recruiting Trier, Germany, 54292 Italy Novartis Investigative Site Recruiting Napoli, Italy, 80131 Less <<
NCT02947165 Breast Cancer ... More >> Lung Cancer Hepatocellular Cancer Colorectal Cancer Pancreatic Cancer Renal Cancer Less << Phase 1 Recruiting April 13, 2021 United States, Tennessee ... More >> Novartis Investigative Site Recruiting Nashville, Tennessee, United States, 37203 Contact: Vicky Weikal       Vicky.Weikal@sarahcannon.com    Principal Investigator: Todd M. Bauer          United States, Utah Novartis Investigative Site Recruiting Salt Lake City, Utah, United States, 84112 Contact: Jessica Norton    801-213-4217    Jessica.norton@hci.utah.edu    Principal Investigator: Ignacio Garrido Laguna          Austria Novartis Investigative Site Recruiting Salzburg, Austria, 5020 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M6G 1Z5 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Japan Novartis Investigative Site Recruiting Kashiwa, Chiba, Japan, 277-8577 Taiwan Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Less <<
NCT00170885 Kidney Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT03031782 Juvenile Psoriatic Arthritis ... More >> Enthesitis-related Arthritis Less << Phase 3 Recruiting December 30, 2020 -
NCT03066648 Leukemia Leuk... More >>emia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Bone Marrow Diseases Hematologic Diseases Less << Phase 1 Recruiting April 1, 2020 United States, Massachusetts ... More >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02114 Contact: Meghan Burke    617-726-5131    Mburke19@partners.org    Principal Investigator: Andrew M. Brunner          United States, Oregon Novartis Investigative Site Recruiting Portland, Oregon, United States, 97239 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 Finland Novartis Investigative Site Recruiting Helsinki, Finland, FIN-00290 France Novartis Investigative Site Recruiting Marseille, France, 13273 Germany Novartis Investigative Site Recruiting Jena, Germany, 07740 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1081 HV Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 United Kingdom Novartis Investigative Site Recruiting Cardiff, United Kingdom, CF4 4XN Less <<
NCT03111992 Multiple Myeloma Phase 1 Recruiting May 27, 2020 United States, Arizona ... More >> Novartis Investigative Site Recruiting Phoenix, Arizona, United States, 85054 United States, Tennessee Novartis Investigative Site Recruiting Nashville, Tennessee, United States, 37203 Contact: Kimberly Cox    615-329-7413    Kimberly.Cox3@scresearch.net    Principal Investigator: Jesus G. Berdeja          Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 Germany Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Recruiting Kiel, Germany, 24105 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Spain Novartis Investigative Site Recruiting Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Recruiting Madrid, Spain, 28006 Switzerland Novartis Investigative Site Recruiting Locarno, Switzerland, 6600 Less <<
NCT02998645 Severe Aplastic Anemia Phase 2 Recruiting January 12, 2024 Brazil ... More >> Novartis Investigative Site Recruiting Ribeirao Preto, SP, Brazil, 14048-900 Novartis Investigative Site Recruiting São Paulo, SP, Brazil, 01323-900 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Hungary Novartis Investigative Site Recruiting Debrecen, Hungary, 4032 India Novartis Investigative Site Recruiting Vellore, India Italy Novartis Investigative Site Recruiting Bologna, BO, Italy, 40138 Novartis Investigative Site Recruiting Brescia, BR, Italy, 25123 Novartis Investigative Site Recruiting Milano, MI, Italy, 20122 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 06351 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Recruiting San Sebastian, Pais Vasco, Spain, 20080 Novartis Investigative Site Recruiting Madrid, Spain, 28041 Novartis Investigative Site Recruiting Madrid, Spain, 28222 Thailand Novartis Investigative Site Recruiting Bangkok, Thailand, 10700 Novartis Investigative Site Recruiting Chiang Mai, Thailand, 50200 Turkey Novartis Investigative Site Recruiting Istanbul, Turkey, 34890 Novartis Investigative Site Recruiting Samsun, Turkey, 55139 Less <<
NCT03066804 Heart Failure With Preserved E... More >>jection Fraction Less << Phase 3 Recruiting December 4, 2019 -
NCT03158311 Asthma Phase 3 Recruiting June 28, 2019 Argentina ... More >> Novartis Investigative Site Recruiting Caba, Buenos Aires, Argentina, C1122AAK Novartis Investigative Site Recruiting Caba, Buenos Aires, Argentina, C1414AIF Novartis Investigative Site Recruiting Buenos Aires, Argentina, C1425FVH Germany Novartis Investigative Site Recruiting Peine, Niedersachsen, Germany, 31224 Novartis Investigative Site Recruiting Geesthacht, Schleswig Holstein, Germany, 12502 Novartis Investigative Site Recruiting Arnsberg, Germany, 59755 Novartis Investigative Site Recruiting Aschaffenburg, Germany, 63739 Novartis Investigative Site Recruiting Auerbach, Germany, 08209 Novartis Investigative Site Recruiting Augsburg, Germany, 86150 Novartis Investigative Site Recruiting Berlin, Germany, 10119 Novartis Investigative Site Recruiting Berlin, Germany, 10625 Novartis Investigative Site Recruiting Berlin, Germany, 12157 Novartis Investigative Site Recruiting Berlin, Germany, 12159 Novartis Investigative Site Recruiting Berlin, Germany, 13086 Novartis Investigative Site Recruiting Berlin, Germany, 13156 Novartis Investigative Site Recruiting Berlin, Germany, 13187 Novartis Investigative Site Recruiting Berlin, Germany, 14050 Novartis Investigative Site Recruiting Boehlen, Germany, 04564 Novartis Investigative Site Recruiting Bonn, Germany, 53123 Novartis Investigative Site Recruiting Darmstadt, Germany, 64283 Novartis Investigative Site Recruiting Dortmund, Germany, 44263 Novartis Investigative Site Recruiting Frankfurt, Germany, 60596 Novartis Investigative Site Recruiting Furstenwalde, Germany, 15517 Novartis Investigative Site Recruiting Gifhorn, Germany, 38518 Novartis Investigative Site Recruiting Hannover, Germany, 30173 Novartis Investigative Site Recruiting Leipzig, Germany, 04103 Novartis Investigative Site Recruiting Leipzig, Germany, 04157 Novartis Investigative Site Recruiting Leipzig, Germany, 04275 Novartis Investigative Site Recruiting Leipzig, Germany, 04357 Novartis Investigative Site Recruiting Lubeck, Germany, 23552 Novartis Investigative Site Recruiting Marburg, Germany, 35037 Novartis Investigative Site Recruiting Marburg, Germany, D-35037 Novartis Investigative Site Recruiting Mittweida, Germany, 09648 Novartis Investigative Site Recruiting Potsdam, Germany, 14467 Novartis Investigative Site Recruiting Prien A. Chiemsee, Germany, 83209 Novartis Investigative Site Recruiting Schleswig, Germany, 24837 Novartis Investigative Site Recruiting Witten, Germany, 58452 Turkey Novartis Investigative Site Recruiting Mersin, Turkey, 33343 Less <<
NCT02333344 Prosthetic Fixation After Ceme... More >>ntless Total Hip Arthroplasty Less << Phase 4 Recruiting January 28, 2020 China, Shanghai ... More >> Novartis Investigative Site Recruiting Shanghai, Shanghai, China, 200011 Less <<
NCT00584584 Allergic Rhinitis Phase 2 Completed - Germany ... More >> Novartis Investigator Site Hannover, Germany United Kingdom Novartis Investigator Site London, United Kingdom Less <<
NCT03447769 Non-Small Cell Lung Cancer Phase 3 Recruiting September 15, 2025 -
NCT03131453 Alzheimer's Disease Phase 2 Phase 3 Recruiting March 31, 2025 -
NCT03280030 Acute Myeloid Leukemia Phase 2 Recruiting June 20, 2022 Hong Kong ... More >> Novartis Investigative Site Recruiting Hong Kong, Hong Kong Japan Novartis Investigative Site Recruiting Nagoya-city, Aichi, Japan, 466-8650 Novartis Investigative Site Recruiting Toyoake city, Aichi, Japan, 470 1192 Novartis Investigative Site Recruiting Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Recruiting Matsuyama-city, Ehime, Japan, 790-8524 Novartis Investigative Site Recruiting Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Recruiting Fukuyama city, Hiroshima, Japan, 720-0001 Novartis Investigative Site Recruiting Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Recruiting Kochi city, Kochi, Japan, 781-8555 Novartis Investigative Site Recruiting Nagasaki-city, Nagasaki, Japan, 852-8501 Novartis Investigative Site Recruiting Sayama, Osaka, Japan, 589 8511 Novartis Investigative Site Recruiting Shimotsuke city, Tochigi, Japan, 329-0498 Novartis Investigative Site Recruiting Bunkyo-ku, Tokyo, Japan, 113-8677 Novartis Investigative Site Recruiting Shinagawa-ku, Tokyo, Japan, 141 8625 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03722 Taiwan Novartis Investigative Site Recruiting Putzu City, Chiayi Hsien, Taiwan, 61363 Novartis Investigative Site Recruiting Kaohsiung City, Taiwan, 83301 Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 Novartis Investigative Site Recruiting Taoyuan, Taiwan, 33305 Less <<
NCT03297294 Painful Diabetic Neuropathy Phase 2 Recruiting April 19, 2019 -
NCT03312738 Advanced Breast Cancer Phase 2 Recruiting September 3, 2021 China, Guangdong ... More >> Novartis Investigative Site Recruiting Guangzhou, Guangdong, China, 510000 China, Heilongjiang Novartis Investigative Site Recruiting Harbin, Heilongjiang, China, 150081 China, Hubei Novartis Investigative Site Recruiting Wuhan, Hubei, China, 430022 China, Jiangsu Novartis Investigative Site Recruiting Nanjing, Jiangsu, China, 210009 China, Shanghai Novartis Investigative Site Recruiting Shanghai, Shanghai, China, 200032 China, Sichuan Novartis Investigative Site Recruiting Chengdu, Sichuan, China, 610072 China, Tianjin Novartis Investigative Site Recruiting Tianjin, Tianjin, China, 300060 China, Zhejiang Novartis Investigative Site Recruiting Hangzhou, Zhejiang, China, 310022 China Novartis Investigative Site Recruiting Beijing, China, 100036 Novartis Investigative Site Recruiting Chongqing, China, 400016 Novartis Investigative Site Recruiting Guangzhou, China, 510060 Novartis Investigative Site Recruiting Qingdao, China, 266000 Novartis Investigative Site Recruiting Shanghai, China, 200025 Novartis Investigative Site Recruiting Wuhan, China, 430000 Less <<
NCT03328897 Chronic Spontaneous Urticaria Phase 3 Recruiting September 16, 2019 China, Fujian ... More >> Novartis Investigative Site Recruiting Fuzhou, Fujian, China, 350025 China, Guangxi Novartis Investigative Site Recruiting Nanning, Guangxi, China, 530021 China, Hubei Novartis Investigative Site Recruiting Wuhan, Hubei, China, 430022 Novartis Investigative Site Recruiting Wuhan, Hubei, China, 430030 China, Hunan Novartis Investigative Site Recruiting Changsha, Hunan, China, 410008 China, Jiangsu Novartis Investigative Site Recruiting Nanjing, Jiangsu, China, 210029 Novartis Investigative Site Recruiting Suzhou, Jiangsu, China, 215006 Novartis Investigative Site Recruiting Wuxi, Jiangsu, China China, P. R. China Novartis Investigative Site Recruiting Beijing, P. R. China, China, 1000045 China, Sichuan Novartis Investigative Site Recruiting Chengdu, Sichuan, China, 610041 China, Xinjiang Novartis Investigative Site Recruiting Urumqi, Xinjiang, China, 830001 China, Zhejiang Novartis Investigative Site Recruiting Hangzhou, Zhejiang, China, 310003 Novartis Investigative Site Recruiting Hangzhou, Zhejiang, China, 310006 Novartis Investigative Site Recruiting Hangzhou, Zhejiang, China, 310016 China Novartis Investigative Site Recruiting Beijing, China, 100034 Novartis Investigative Site Recruiting Beijing, China, 100191 Novartis Investigative Site Recruiting Chongqing, China, 400011 Novartis Investigative Site Recruiting Chongqing, China, 400038 Novartis Investigative Site Recruiting Guangzhou, China, 510000 Novartis Investigative Site Recruiting Nanjing, China, 210042 Novartis Investigative Site Recruiting Shanghai, China, 200025 Novartis Investigative Site Recruiting Shanghai, China, 200040 Novartis Investigative Site Recruiting Shanghai, China, 200433 Less <<
NCT03484923 Melanoma Phase 2 Recruiting March 28, 2022 United States, California ... More >> The Angeles Clinic and Research Institute Recruiting Los Angeles, California, United States, 90025 Contact: Jamie Perez    310-231-2122    jperez@theangelesclinic.org    Principal Investigator: Omid Hamid          University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Art Villanueva       avillanueva@mednet.ucla.edu    Principal Investigator: Antoni Ribas          United States, New York NYU Laura and Isaac Perlmutter Cancer Center Perlmutter Cancer Center Recruiting New York, New York, United States, 10016 Contact    212-731-6160       Principal Investigator: Jeffrey S Weber          United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact    412-623-4897       Principal Investigator: John M. Kirkwood          Australia, New South Wales Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Marseille, France, 13009 Novartis Investigative Site Recruiting Paris Cedex 10, France, 75475 Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Dresden, Germany, 01307 Novartis Investigative Site Recruiting Essen, Germany, 45122 Novartis Investigative Site Recruiting Muenchen, Germany, 80336 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Switzerland Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 Less <<
NCT01742286 Anaplastic Lymphoma Kinase Phase 1 Recruiting February 13, 2019 -
NCT01934361 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 1 Completed - United States, Arizona ... More >> Barrow Neurological Insitute St. Joseph's Hospital Phoenix, Arizona, United States, 85013 United States, Arkansas Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 France Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Saint Herblain cedex, France, 44805 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Less <<
NCT03334747 Malaria Phase 2 Recruiting May 14, 2019 Gabon ... More >> Novartis Investigative Site Recruiting Lambarene, Gabon Ghana Novartis Investigative Site Recruiting Kintampo, Ghana Novartis Investigative Site Recruiting Navrango, Ghana Mali Novartis Investigative Site Recruiting Bamako, Mali Novartis Investigative Site Recruiting Sotuba, Mali Rwanda Novartis Investigative Site Recruiting Kigali, Rwanda Uganda Novartis Investigative Site Recruiting Bushenyi, Uganda Novartis Investigative Site Recruiting Kampala, Uganda Novartis Investigative Site Recruiting Tororo, Uganda Less <<
NCT00369161 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00416546 Healthy Phase 1 Completed - Canada, Quebec ... More >> Novartis Investigative Site Dorval, Quebec, Canada Less <<
NCT01784068 Chronic Myelogenous Leukemia Phase 2 Recruiting February 28, 2025 -
NCT03524612 Immune Thrombocytopenic Purpur... More >>a (ITP) Less << Phase 2 Recruiting November 16, 2020 United States, New York ... More >> Hematology Oncology Association of Rockland Drug Shipment Recruiting Nyack, New York, United States, 10960 Contact    845-348-2657       Principal Investigator: Bradley Cohen          Austria Novartis Investigative Site Recruiting A-1090 Vienna, Austria Novartis Investigative Site Recruiting Wien, Austria, 1140 Spain Novartis Investigative Site Recruiting Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site Recruiting Malaga, Spain, 29010 Novartis Investigative Site Recruiting Murcia, Spain, 30008 Less <<
NCT03499899 Triple-negative Breast Cancer Phase 2 Recruiting April 20, 2021 -
NCT03094195 Post-herpetic Neuralgia Phase 2 Recruiting August 28, 2020 -
NCT03481660 Diabetic Macular Edema Phase 3 Recruiting July 22, 2021 -
NCT03512197 Acute Myeloid Leukemia (AML) Phase 3 Recruiting April 28, 2026 -
NCT03481634 Diabetic Macular Edema Phase 3 Recruiting August 13, 2021 -
NCT03578367 CML Chronic M... More >>yelogenous Leukemia Leukemia, Myeloid Chronic Hematologic Diseases Less << Phase 2 Recruiting October 11, 2021 United States, Maryland ... More >> Saint Agnes Healthcare Cancer Institute Recruiting Baltimore, Maryland, United States, 21229 Contact: Chris Hopmann    410-368-2966    chopmann@ascension.org    Principal Investigator: Carole Miller          Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 Czechia Novartis Investigative Site Recruiting Brno - Bohunice, Czechia, 639 01 France Novartis Investigative Site Recruiting Bordeaux, France, 33076 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Spain Novartis Investigative Site Recruiting Sevilla, Andalucia, Spain, 41009 United Kingdom Novartis Investigative Site Recruiting London, United Kingdom, W12 0HS Less <<
NCT00238940 Renal Transplantation Phase 3 Completed - -
NCT03668613 Moderate to Severe Chronic Pla... More >>que-type Psoriasis Less << Phase 3 Recruiting September 15, 2023 United States, California ... More >> Novartis Investigative Site Recruiting California City, California, United States, 92708 United States, Florida Novartis Investigative Site Recruiting Jacksonville, Florida, United States, 32256 United States, Texas Novartis Investigative Site Recruiting San Antonio, Texas, United States, 78218 Belgium Novartis Investigative Site Recruiting Bruxelles, Belgium, 1200 Estonia Novartis Investigative Site Recruiting Tartu, Estonia, 51014 Poland Novartis Investigative Site Recruiting Warszawa, Mazowian, Poland, 02 495 Novartis Investigative Site Recruiting Rzeszow, Poland, 35-055 Russian Federation Novartis Investigative Site Recruiting Kazan, Russian Federation, 420012 Novartis Investigative Site Recruiting Krasnodar, Russian Federation, 350020 Novartis Investigative Site Recruiting Moscow, Russian Federation, 119296 Novartis Investigative Site Recruiting Saint Petersburg, Russian Federation, 191123 Spain Novartis Investigative Site Recruiting Esplugues de Llobregat, Barcelona, Spain, 08950 Novartis Investigative Site Recruiting Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Recruiting Madrid, Spain, 28041 Novartis Investigative Site Recruiting Madrid, Spain, 28046 Less <<
NCT02601378 Uveal Melanoma Phase 1 Recruiting November 1, 2019 United States, New York ... More >> Novartis Investigative Site Recruiting New York, New York, United States, 10032 Australia, New South Wales Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 France Novartis Investigative Site Recruiting Paris, France, 75231 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2300 RC Norway Novartis Investigative Site Recruiting Oslo, Norway, NO-0424 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28050 Less <<
NCT03710564 Age-Related Macular Degenerati... More >>on Less << Phase 3 Recruiting June 9, 2020 United States, Florida ... More >> Novartis Investigative Site Recruiting Deerfield Beach, Florida, United States, 33064 United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02114 United States, Nevada Novartis Investigative Site Recruiting Las Vegas, Nevada, United States, 89144 Novartis Investigative Site Recruiting Reno, Nevada, United States, 89502 United States, New York Novartis Investigative Site Recruiting Syracuse, New York, United States, 13224 United States, Pennsylvania Novartis Investigative Site Recruiting Kingston, Pennsylvania, United States, 95403 United States, Texas Novartis Investigative Site Recruiting Abilene, Texas, United States, 79606 Novartis Investigative Site Recruiting Austin, Texas, United States, 78793 Novartis Investigative Site Recruiting Fort Worth, Texas, United States, 76104 Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Less <<
NCT03610516 Lupus Nephritis Phase 2 Recruiting December 17, 2020 Argentina ... More >> Novartis Investigative Site Recruiting Ciudad Autonoma de Bs As, Argentina, C1015ABO Novartis Investigative Site Recruiting Cordoba, Argentina, X5016KEH Germany Novartis Investigative Site Recruiting Kirchheim, Germany, 73230 Hong Kong Novartis Investigative Site Recruiting HongKong, Hong Kong Hungary Novartis Investigative Site Recruiting Debrecen, Hungary, 4032 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03080 Russian Federation Novartis Investigative Site Recruiting Ekaterinburg, Russian Federation, 620028 Novartis Investigative Site Recruiting Moscow, Russian Federation, 115522 Taiwan Novartis Investigative Site Recruiting Taichung, Taiwan, 40447 Novartis Investigative Site Recruiting Taichung, Taiwan, 40705 Turkey Novartis Investigative Site Recruiting Ankara, Turkey, 06230 Novartis Investigative Site Recruiting Kocaeli, Turkey, 41380 Less <<
NCT00262028 Prevention of Meningococcal Di... More >>sease Less << Phase 2 Completed - United States, California ... More >> Kaiser Permanente Vaccine Study Center Oakland, California, United States, 94612 Less <<
NCT01947608 - - - Argentina ... More >> Novartis Investigative Site Caba, Buenos Aires, Argentina, C1426ANZ Novartis Investigative Site Buenos Aires, Caba, Argentina, C1431FWO Novartis Investigative Site Córdoba, Cordoba, Argentina, 5000 Colombia Novartis Investigative Site Cali, Valle Del Cauca, Colombia Novartis Investigative Site Monteria, Colombia Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site Kowloon, Hong Kong India Novartis Investigative Site Delhi, India, 110 085 Jordan Novartis Investigative Site Amman, Jordan, 11941 Korea, Republic of Novartis Investigative Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Novartis Investigative Site Gyeonggi-do, Korea, Korea, Republic of, 10408 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Seocho-gu, Korea, Republic of, 06591 Novartis Investigative Site Seoul, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Mexico Novartis Investigative Site Ciudad De Mexico, Distrito Federal, Mexico, 14080 Novartis Investigative Site Mexico D F, Distrito Federal, Mexico, 06760 Novartis Investigative Site Mexico, Distrito Federal, Mexico, 14080 Philippines Novartis Investigative Site Taguig City, Metro Manila, Philippines, 1634 Novartis Investigative Site Quezon City, Philippines Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Bangkok, Thailand, 10700 Less <<
NCT02081378 Chronic Myelogenous Leukemia ... More >> Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting December 20, 2022 United States, Massachusetts ... More >> Dana Farber Cancer Institute Hematology / Oncology Recruiting Boston, Massachusetts, United States, 02215 Contact: Shannon Milillo    617-632-6840    shannon_milillo@dfci.harvard.edu    Principal Investigator: Daniel J. DeAngelo          United States, Michigan University of Michigan Comprehensive Cancer Center SC Recruiting Ann Arbor, Michigan, United States, +1 48109 0944 Contact: Shelagh L. Elliott    734-232-0759    shelagh@med.umich.edu    Principal Investigator: Moshe Talpaz          United States, New York Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Recruiting New York, New York, United States, 10065 Contact: Michael Mauro J. Mauro, MD    212-639-3107    maurom@mskcc.org    Principal Investigator: Michael J. Mauro          United States, Oregon Oregon Health and Science University SC-6 Recruiting Portland, Oregon, United States, 97239 Contact: Bianca Gille    503-494-4603    gille@ohsu.edu    Principal Investigator: Michael J. Heinrich          United States, Texas University of Texas/MD Anderson Cancer Center UT MD Anderson Recruiting Houston, Texas, United States, 77030-4009 Contact: Jorge E Cortes, MD    713-794-5783    Jcortes@mdanderson.org    Principal Investigator: Jorge E. Cortes          United States, Utah Huntsman Cancer Institute SC Recruiting Salt Lake City, Utah, United States, 84112 Contact: Aaron Ernst       aaron.ernst@hci.utah.edu    Principal Investigator: Michael W. Deininger          Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 France Novartis Investigative Site Recruiting Paris Cedex 10, Cedex 10, France, 75475 Novartis Investigative Site Recruiting Bordeaux, France, 33076 Germany Novartis Investigative Site Recruiting Berlin, Germany, 13353 Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Jena, Germany, 07740 Italy Novartis Investigative Site Recruiting Roma, RM, Italy, 00161 Japan Novartis Investigative Site Recruiting Kobe-shi, Hyogo, Japan, 650-0017 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Seocho-gu, Korea, Republic of, 06591 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1081 HV Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169608 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28006 Less <<
NCT03333109 Migraine Phase 3 Recruiting February 7, 2020 -
NCT01647789 Prostatic Neoplasms Phase 1 Terminated - United States, California ... More >> UCSF Medical Center Dept of Oncology San Francisco, California, United States, 94143 United States, Texas Cancer Therapy & Research Center UT Health Science Center InstituteForDrugDevelopment(2) San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Dept. of SCCA Seattle, Washington, United States, 98105 United States, Wisconsin University of Wisconsin Univ Wisc Madison, Wisconsin, United States, 53792 Belgium Novartis Investigative Site Bouge, Belgium, 5004 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT02272777 Leukemia Phase 3 Completed - China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 51000 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430022 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210008 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300020 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Fuzhou, China, 350001 Novartis Investigative Site Jinan, China, 250012 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China, 200433 Less <<
NCT00149864 Renal Transplant Phase 3 Completed - -
NCT00150085 Tacrolimus-associated Abnormal... More >> Glucose Metabolism in Kidney and Liver Transplant Recipients Less << Phase 4 Terminated - -
NCT00369161 - Completed - -
NCT00154284 - Completed - -
NCT00228020 Pediatric Kidney Transplantati... More >>on Less << Phase 3 Completed - -
NCT00262028 - Completed - -
NCT00149929 Renal Transplant Phase 3 Completed - -
NCT00239070 Renal Transplantation Phase 3 Completed - -
NCT00650520 Healthy Phase 1 Completed - Canada, Quebec ... More >> MDS Pharma Services Montreal, Quebec, Canada, H4R 2N6 Less <<
NCT00154284 Organ Transplantation, Renal T... More >>ransplantation Less << Phase 3 Completed - -
NCT00649168 Healthy Phase 1 Completed - Canada, Quebec ... More >> MDS Pharma Services Montreal, Quebec, Canada, H4R 2N6 Less <<
NCT00721396 Meningococcal Infections Phase 2 Completed - -
NCT00937521 Meningococcal Meningitis ... More >> Meningococcal Infections Less << Phase 2 Completed - Argentina ... More >> Hospital Privado de Córdoba CMC SA Naciones Unidas 346, Cordoba, Argentina, X5016KHE Chile Universidad de Chile, Av Independencia 1027 Comuna de Independencia, Santiago, Chile Consultorio Manuel Bustos Lo Cruzat 486, Quilicura, Santiago, Chile Czech Republic Samostatna ordinace praktickeho lekare pro deti a dorost O. Kubina 17, Boskovice, Czech Republic, 680 01 Samostatna ordinace praktickeho lekare pro deti a dorost Neklez 3, Brno, Czech Republic, 628 00 Samostatna ordinace praktickeho lekare pro deti a dorost Pernštýnská 127/l, Chlumec nad Cidlinou, Czech Republic, 503 51 Zdravotní středisko Vaclavska 4186, Chomutov, Czech Republic, 430 03 Nemocnice Decin, Detske oddělení U nemocnice 1, Děčín, Czech Republic, 405 01 Fakulta vojenskeho zdravotnictvi UO Trebešská 1575, Hradec Králové, Czech Republic, 50001 Samostatna ordinace praktickeho lekare pro deti a dorost Masarykova 389, Humpolec, Czech Republic, 396 01 Samostatna ordinace praktickeho lekare pro deti a dorost Ruských legii 352, Jindřichův Hradec, Czech Republic, 377 01 Samostatna ordinace praktickeho lekare pro deti a dorost Hrnčířská 1401, Lipník nad Bečvou, Czech Republic, 751 31 Oblastni nemocnice Nachod, Destske oddělení Purkyňova 446, Náchod, Czech Republic, 547 01 Samostatna ordinace praktickeho lekare pro deti a dorost U lékárny 306, Odolena Voda, Czech Republic, 250 70 Prakticky lekar pro deti a dorost Dvouletky 54, Ostrava, Czech Republic, 700 30 KHS Ostrava, Protiepidemické oddělení Na Bělidle 7, Ostrava, Czech Republic, 702 00 Nemocnice Pardubice, Destske odděleni Kyjevská 44, Pardubice, Czech Republic, 532 03 Fakultni nemocnice Bory E. Beneše 13, Plzeň, Czech Republic, 305 99 Samostatna ordinace praktickeho lekare pro deti a dorost Chrudimska 2a, Praha 3, Czech Republic, 130 00 Samostatna ordinace praktickeho lekare pro deti a dorost Kladenská 53, Praha 6, Czech Republic, 160 00 Samostatna ordinace praktickeho lekare pro deti a dorost Velka Michalska 22, Znojmo, Czech Republic, 669 00 Hungary Házi Gyermekorvosi szolgálat Honvéd u.2., Bordány, Hungary, 6795 Medszolg 2000 Bt, 6723, Szeged, Dandár u.4 Ányos u.4., Budapest, Hungary, 1031 Erzsébet Kórház Gyermekosztály Hodmezovasarhely, dr. Imre József u.2., Hungary Baby Box Bt,, 6724, Szeged, Kossuth Lajos sgt.109 Szeged, Kossuth Lajos sgt.109, Hungary Dr. Bán Mariann és Társa Bt. Kando Kalman u.1, Miskolc, Hungary, 3534 Futurnest Kft Selyemrét u.1., Miskolc, Hungary, 3527 Ped-Med Kft. , 3434 Mályi, Fő u.12. Fő u.12., Mályi, Hungary, 3434 S.K. Sipka és Kovács Eü. Bt. Csongrádi sgt. 63., Szeged, Hungary, 6723 Oszila Kft. 6723, Szeged, Debreceni u.10-14. Debreceni u.10-14., Szeged, Hungary, 6723 Győriné dr. Bari Eszter egyéni vállalkozó Csongrad, Szentháromság tér 10, Hungary Vas Megyei Markusovszky Kórház, Gyermekosztály Markusovszky u. 1-3, Szombathely, Hungary, 9700 Italy Dipartimento di Neonatologia e Terapia Intensiva Neonatale, "Ospedale dei Bambini", Presidio Ospedaliero dell'Azienda Ospedaliera Spedali Civili di Brescia P.le Spedali di Brescia,1, Brescia, Italy, 25125 Dipartimento di Pediatria dell'Università degli Studi di Firenze Viale Pieraccini n. 24, Firenze, Italy, 50139 Università degli Studi di Messina, Pad. NI - A.O.U. Policlinico G.Martino Via Consolare Valeria, 1, Messina, Italy, 98125 Fondazione IRCCS dell'Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena di Milano Via Commenda, 9, Milano, Italy, 20122 Pediatria dell'Ospedale Sacco di Milano Via G.B.Grossi 74, Milano, Italy, 20157 Dipartimento di Pediatria Azienda Ospedaliera di Padova Via Giustiniani, 3, Padova, Italy, 35128 Less <<
NCT00721396 - Completed - -
NCT02140762 - Completed - -
NCT00239018 De Novo Kidney Transplantation Phase 4 Completed - -
NCT02091908 Influenza, Human Phase 3 Completed - Germany ... More >> 001, Novartis Investigational Site Berlin, Germany, 10117 003, Novartis Investigational Site Dresden, Germany, 01307 005, Novartis Investigational Site Hamburg, Germany, 20359 006, Novartis Investigational Site Magdeburg, Germany, 39120 004, Novartis Investigational Site Rostock, Germany, 18055 002, Novartis Investigational Site Wuerzburg, Germany, 97070 Less <<
NCT00367393 Atopic Dermatitis Phase 4 Completed - Germany ... More >> Novartis Novartis, Germany Less <<
NCT02140762 Meningococcal Disease Phase 2 Completed - United States, Alabama ... More >> Accelovance, Inc Huntsville, Alabama, United States, 35802 United States, Arkansas The Children's Clinic of Jonesboro, P.A. Jonesboro, Arkansas, United States, 72401 United States, Florida Accelovance, Inc Melbourne, Florida, United States, 32935 United States, Kansas Heartland Research Associates LLC Newton, Kansas, United States, 67114 Heartland Research Associates, LLC Wichita, Kansas, United States, 67207 United States, Kentucky Bluegrass Clinical Research, Inc. Louisville, Kentucky, United States, 40291 United States, Nebraska Meridian Clinical Research Omaha, Nebraska, United States, 68134 United States, Ohio Senders Pediatrics Cleveland, Ohio, United States, 44121 Less <<
NCT01699685 Chronic Obstructive Pulmonary ... More >>Disease: COPD Less << Phase 3 Completed - Switzerland ... More >> Novartis Investigative Site Faltigberg-Wald, ZH, Switzerland, 8639 Novartis Investigative Site Barmelweid, Switzerland, 5017 Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site Bern, Switzerland, 3010 Novartis Investigative Site Bern, Switzerland, 3013 Novartis Investigative Site Crans-Montana, Switzerland, 3963 Novartis Investigative Site Lausanne, Switzerland, 1011 Novartis Investigative Site Locarno, Switzerland, 6600 Novartis Investigative Site Lugano, Switzerland, 6900 Novartis Investigative Site St. Gallen, Switzerland, 9007 Novartis Investigative Site Walenstadtberg, Switzerland, 8881 Less <<
NCT02465203 Hepatitis C, Chronic Phase 3 Terminated(Study was premature... More >>ly terminated.) Less << - -
NCT01699685 - Completed - -
NCT00937521 - Completed - -
NCT02465203 - Terminated(Study was premature... More >>ly terminated.) Less << - -
NCT00381615 Healthy Phase 2 Completed - United Kingdom ... More >> Gloucester, United Kingdom, GLI 3NN London, United Kingdom, NW9 5EQ Oxford, United Kingdom, OX3 7LJ Less <<
NCT02934568 Continued Access to Study Trea... More >>tment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies Less << Phase 2 Active, not recruiting January 21, 2019 United States, Alabama ... More >> Novartis Investigative Site Birmingham, Alabama, United States, 35294-3300 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Michigan Novartis Investigative Site Ann Arbor, Michigan, United States, 48109-5930 United States, New York Novartis Investigative Site Johnson City, New York, United States, 13790 United States, Tennessee Novartis Investigative Site Memphis, Tennessee, United States, 38105 France Novartis Investigative Site Villejuif Cedex, France, 94805 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain, 28050 Taiwan Novartis Investigative Site Tainan, Taiwan, 70421 Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT00381615 - Completed - -
NCT00624663 Rivastigmine Toxicity Not Applicable Completed - Israel ... More >> Tel Aviv Sourasky Medical Center Tel Aviv, Israel Tasmc Clinical Research Center Tel-Aviv, Israel, 64239 Less <<
NCT00106340 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers Nurnberg, Germany Less <<
NCT02336451 ALK-positive Non-small Cell Lu... More >>ng Cancer Less << Phase 2 Recruiting November 22, 2018 -
NCT01782326 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01033747 Liver Iron Overload Phase 2 Phase 3 Completed - Italy ... More >> Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Genova, Italy Novartis Investigative Site Milan, Italy Novartis Investigative Site Torino, Italy Less <<
NCT00476593 Uveitis Iriti... More >>s Iridocyclitis Anterior Uveitis Macular Edema Less << Not Applicable Completed - Norway ... More >> Department of Ophthalmology, St Olavs University Hospital Trondheim, Norway, 7006 Department of Neuroscience, Norwegian University of Science and Technology Trondheim, Norway, 7491 Less <<
NCT01782326 - Completed - -
NCT00674323 Polypoidal Choroidal Vasculopa... More >>thy Less << Phase 4 Completed - Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Singapore Novartis Investigative Site Singapore, Singapore Taiwan Novartis Investigative Site Taipei, Taiwan Thailand Novartis Investigative Site Bangkok, Thailand Less <<
NCT01428297 Healthy Volunteers ... More >> Atopic Dermatitis Netherton Syndrome Less << Phase 1 Completed - United States, Connecticut ... More >> Novartis Investigative Site New Haven, Connecticut, United States, 06519 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63104 United States, North Dakota Novartis Investigative Site Fargo, North Dakota, United States, 58104 Netherlands Novartis Investigative Site Utrecht, the Netherlands, Netherlands, 3508 GA Less <<
NCT00674323 - Completed - -
NCT01033747 - Completed - -
NCT00396071 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Diabetes Zentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT03265899 Healthy Volunteers Phase 1 Completed - -
NCT00476593 - Completed - -
NCT01043744 Malaria Non-m... More >>alarial Febrile Illness Less << Not Applicable Completed - Tanzania ... More >> Miono Health Center Miono, Bagamoyo District, Tanzania Msata Dispensary Msata, Tanzania Less <<
NCT02223637 - Completed - United States, North Carolina ... More >> GSK Investigational Site Wilmington, North Carolina, United States, 28401-3331 Less <<
NCT00371670 Knee Osteoarthritis Phase 2 Completed - United States, Alabama ... More >> Pinnacle Research Group Anniston, Alabama, United States, 36207 Germany Novartis Nuernberg, Germany Less <<
NCT00794157 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01727141 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00172029 Breast Cancer With Metastatic ... More >>Bone Disease Less << Phase 4 Completed - Turkey ... More >> Novartis Investigative Site Ankara, Turkey Novartis Investigative Site Antalya, Turkey Novartis Investigative Site Bursa, Turkey Novartis Investigative Site Istanbul, Turkey Novartis Investigative Site Izmir, Turkey Novartis Investigative Site Kayseri, Turkey Novartis Investigative Site Trabzon, Turkey Less <<
NCT00622635 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - United States, Illinois ... More >> Novartis Investigator Site Normal, Illinois, United States United States, Kansas Novartis Investigator Site Shawnee Mission, Kansas, United States United States, Louisiana Novartis Investigator Site Lafayette, Louisiana, United States United States, North Carolina Novartis Investigator Site Charlotte, North Carolina, United States Novartis Investigator Site Raleigh, North Carolina, United States United States, Ohio Novartis Investigator site Cincinnati, Ohio, United States United States, South Carolina Novartis Investigator Site Spartanburg, South Carolina, United States Belgium Novartis Investigator Site Genk, Belgium Novartis Investigator Site Hasselt, Belgium Novartis Investigator Site Herentals, Belgium Spain Novartis Investigator Site Alicante, Spain Novartis Investigator site Alzira, Spain Novartis Investigator Site Madrid, Spain Novartis Investigator site Mataro, Spain Less <<
NCT00423098 - Completed - -
NCT00772577 Hypertension Phase 4 Completed - United States, California ... More >> Investigative Site Beverly Hills, California, United States Investigative Site Santa Ana, California, United States United States, Georgia Investigative Site Conyers, Georgia, United States United States, Kentucky Investigative Site Lexington, Kentucky, United States United States, South Carolina Investigative Site Columbia, South Carolina, United States United States, Texas Investigative Site Houston, Texas, United States Less <<
NCT00772577 - Completed - -
NCT00777946 - Completed - -
NCT00423098 Lupus Nephritis Phase 2 Completed - Colombia ... More >> Novartis Bogota, Colombia France Novartis Creteil, France Novartis Nantes, France Novartis Investigative Site Paris, France Germany Novartis Berlin, Germany Novartis Tubingen, Germany Greece Novartis Athens, Greece Hungary Novartis Budapest, Hungary Novartis Debrecen, Hungary Italy Novartis Brescia, Italy Novartis Ferrara, Italy Novartis Milano, Italy Novartis Padova, Italy Spain Novartis Barcelona, Spain Novartis Madrid, Spain Taiwan Novartis Taichung, Taiwan United Kingdom Novartis Cambridge, United Kingdom Less <<
NCT00787605 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT00622635 - Completed - -
NCT00777946 Hypertension Phase 3 Completed - Estonia ... More >> Investigative site Estonia, Estonia France Investigative site France, France Iceland Investigative Site Iceland, Iceland India Investigative Site India, India Italy Investigative site Italy, Italy Korea, Republic of Investigative Site Republic of Korea, Korea, Republic of Lithuania Investigative Site Lithuania, Lithuania Spain Investigative Site Spain, Spain Venezuela Investigative Site Venezuela, Venezuela Less <<
NCT00810862 Atopic Dermatitis Phase 4 Terminated(Lack of subject enr... More >>ollment over the past two years.) Less << - -
NCT00787605 - Completed - -
NCT00809926 Stage 2 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT00809926 - Completed - -
NCT01505998 Fed Phase 1 Completed - India ... More >> Vimta Labs Ltd. Hyderabad, A.P, India, 500 051 Less <<
NCT00841672 Moderate to Severe Hypertensio... More >>n Less << Phase 3 Completed - Germany ... More >> Investigative Site Berlin, Germany Philippines Investigative Site Manilla, Philippines Romania Investigative Site Bucharest, Romania Russian Federation Investigative Site Moscow, Russian Federation Singapore Investigative Site Singapore, Singapore Spain Investigative Site Madrid, Spain Less <<
NCT00834041 - Completed - -
NCT00841672 - Completed - -
NCT00865020 - Completed - -
NCT00867490 Hypertension Phase 3 Completed - Germany ... More >> Investigative Site Chemnitz, Germany Less <<
NCT00834041 Hypertension Phase 1 Phase 2 Completed - United States, Kentucky ... More >> Investigative Site Louisville, Kentucky, United States Belgium Investigative Site Brussels, Belgium Brazil Investigative Site Brasilia, Brazil Hungary Investigative Site Budapest, Hungary Poland Investigative Site Warsaw, Poland Less <<
NCT00857259 - Terminated - -
NCT02603393 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 4 Completed - -
NCT00865020 Hypertension Phase 4 Completed - Brazil ... More >> Investigative Site Sorocaba, Brazil Canada Investigative Site Gatineau, Canada Ecuador Investigative Site Guayaquil, Ecuador Germany Investigative Site Erfurt, Germany Hungary Invesitagtive Site Budapest, Hungary Korea, Republic of Investigative Site Cheongju, Korea, Republic of Malaysia Investigative Site Kuala Lumpur, Malaysia Mexico Investigative Site Mexico City, Mexico Panama Investigative Site Panama City, Panama Philippines Investigative Site Manila, Philippines Singapore Investigative Site Singapore, Singapore Slovakia Investigative Site Bratislava, Slovakia Spain Investigative Site Sevilla, Spain Turkey Investigative Site Istanbul, Turkey United Kingdom Investigative Site Westbury, United Kingdom Venezuela Investigative Site Caracas, Venezuela Less <<
NCT00792805 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Australia ... More >> Novartis Investigative Site Adelaide, Australia Novartis Investigative Site Clayton, Australia Novartis Investigative Site Daw Park, Australia China Novartis Investigative Site Beijing, China Novartis Investigative Site Changsha, China Novartis Investigative Site Chongqing, China Novartis Investigator Site Fuzhou, China Novartis Investigative Site Guang Zhou, China Novartis Investigative Site Shandong, China Novartis Investigative Site Shanghai, China Novartis Investigative Site Shenyang, China Novartis Investigative Site Shijiazhuang, China Novartis Investigative Site Xi'an, China India Novartis Investigative Site Bangalore, India Novartis Investigative Site Trivandrum, India Less <<
NCT00794157 - Completed - -
NCT00857259 Choroidal Neo-Vascular Age-ons... More >>et Macular Degeneration Age-related Macular Degeneration Less << Phase 2 Terminated - United States, California ... More >> Retina-Vitreous Associates Medical Group Beverley Hills, California, United States, 90211 Retinal Consultants Medical Group, Inc. Sacramento, California, United States United States, Colorado Porter Adventist Hospital, Diagnostic Eye Laboratory Denver, Colorado, United States, 80210 United States, Missouri Discover Vision Center Independence, Missouri, United States, 64055 United Kingdom Novartis Investigative Site Bristol, United Kingdom Novartis Investigative Site Frimley, United Kingdom Novartis Investigative Site Liverpool, United Kingdom Novartis Investigative Site London, United Kingdom Novartis Investigative Site Oxford, United Kingdom Novartis Investigative site Portsmouth, United Kingdom Novartis Investigative Site Southampton, United Kingdom Novartis Investigator Site Wolverhampton, United Kingdom Less <<
NCT00821093 - Completed - -
NCT00867490 - Completed - -
NCT00846586 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00846586 - Completed - -
NCT00907998 Coronary Heart Disease Phase 1 Completed - United States, Alabama ... More >> Pinnacle Research Group Anniston, Alabama, United States, AL36207 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States United States, Texas Icon Clinical Research San Antonio, Texas, United States, 78230 Denmark Novartis Investigator Site Copenhagen, Denmark Germany Novartis Investigator Site Mainz, Germany Novartis Investigator Site Mannheim, Germany Novartis Investigator Site Neuss, Germany Israel Novartis Investigator Site Rehovot, Israel Novartis Investigator Site Tel Aviv, Israel Novartis Investigator Site Zrifin, Israel Netherlands Novartis Investigator Site Amsterdam, Netherlands Less <<
NCT00792805 - Completed - -
NCT00900731 - Completed - -
NCT00377962 Disorder Related to Cardiac Tr... More >>ansplantation Less << Phase 4 Completed - Denmark ... More >> Novartis Investigative Site Arhus, Denmark, DK-8200 Novartis Investigative Site Copenhagen, Denmark, 2100 Norway Novartis Investigative Site Oslo, Norway Sweden Novartis Investigative Site Goteborg, Sweden, 413 45 Novartis Investigative Site Linkoping, Sweden, 581 85 Novartis Investigative Site Lund, Sweden, 22185 Less <<
NCT00821093 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00940563 Advanced Gastrointestinal Stro... More >>mal Tumors Less << Phase 2 Completed - Italy ... More >> Novartis Investigative Site Ancona, Italy Novartis Investigative Site Aviano, Italy Novartis Investigative Site Bari, Italy Novartis Investigative Site Bergamo, Italy Novartis Investigative Site Bologna, Italy Novartis Investigative Site Candiolo, Italy Novartis Investigative Site Ferrara, Italy Novartis Investigative Site Firenze, Italy Novartis Investigative Site Genova, Italy Novartis Investigative Site Livorno, Italy Novartis Investigative Site Meldola, Italy Novartis Investigative Site Messina, Italy Novartis Investigative Site Milano, Italy Novartis Investigative Site Monserrato, Italy Novartis Investigative Site Napoli, Italy Novartis Investigative Site Nola, Italy Novartis Investigative Site Padova, Italy Novartis Investigative Site Palermo, Italy Novartis Investigative Site Perugia, Italy Novartis Investigative Site Pisa, Italy Novartis Investigative Site Ravenna, Italy Novartis Investigative Site Roma, Italy Novartis Investigative Site Rozzano, Italy Novartis Investigative Site Sassari, Italy Novartis Investigative Site Torino, Italy Novartis Investigative Site Verona, Italy Less <<
NCT01090323 Sickle Cell Disease Phase 2 Completed - -
NCT00900731 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00170950 Hypertension Phase 3 Terminated(The study was termi... More >>nated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.) Less << - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Denmark sites in Denmark Denmark, Denmark Finland sites in Finland Finland, Finland Norway sites in Norway Norway, Norway Sweden sites in Sweden Sweden, Sweden Less <<
NCT01089127 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00377962 - Completed - -
NCT00170950 - Terminated(The study was termi... More >>nated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.) Less << - -
NCT01090323 - Completed - -
NCT00138632 Wet Age-Related Macular Degene... More >>ration Less << Phase 1 Phase 2 Completed - United States, California ... More >> Retina-Vitreous Associates Medical Group Beverly Hills, California, United States, 90211 United States, Colorado Porter Adventist Hospital, Eye Lab Denver, Colorado, United States, 80210 United States, Florida USF Eye Institute Tampa, Florida, United States, 33612-4742 United States, Illinois Springfield Clinic, LLP Springfield, Illinois, United States, 62701 United States, Maryland Wilmer Eye Institute Baltimore, Maryland, United States, 21287 United States, Massachusetts Lahey Clinic Medical Center, Eye institute Peabody, Massachusetts, United States, 01960 United States, South Dakota Black Hills Regional Eye Institute Rapid City, South Dakota, United States, 05770 Australia, New South Wales Novartis Investigative Site Parramatta, New South Wales, Australia, 2150 Novartis Investigational Site Sydney, New South Wales, Australia, 2000 Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site East Melbourne, Victoria, Australia, 3002 Less <<
NCT01079130 Asthma Phase 3 Completed - -
NCT01079130 - Completed - -
NCT01156844 Persistent Asthma Phase 2 Completed - -
NCT01193907 Typhoid Fever Phase 2 Completed - Belgium ... More >> Center for the Evaluation of Vaccination (CEV) Antwerp, Wilrijk (Antwerp), Belgium, 2610 Less <<
NCT01089127 - Completed - -
NCT01278342 Acromegaly Phase 4 Completed - France ... More >> Novartis Investigative Site Brest Cedex, France, 29609 Novartis Investigative Site Bron Cedex, France, 69677 Novartis Investigative Site Kremlin-Bicetre, France, 94275 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Nimes, France, 30029 Novartis Investigative Site Pessac, France, 33604 Novartis Investigative Site Toulouse, France, 31059 Italy Novartis Investigative Site Genova, Italy, 16132 Novarts Investigative Site Naples, Italy Novartis Investigative Site Napoli, Italy, 80131 Novartis Investigative Site Padova, Italy Novartis Investigative Site Perugia, Italy, 06126 Novartis Investigative Site Pisa, Italy, 56124 Novartis Investigative Site Torino, Italy, 10126 Poland Novartis Investigative Site Lodz, Poland, 91-425 Novartis Investigative Site Warszawa, Poland Novartis Investigative Site Wroclaw, Poland Novartis Investigative Site Zabrze, Poland, 41-800 Portugal Novartis Investigative Site Porto, Portugal, 4200-319 Switzerland Novartis Investigative Site Lausanne, Switzerland, CH-1011 Less <<
NCT01193907 - Completed - -
NCT01278342 - Completed - -
NCT00745485 Osteoporosis Phase 4 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Blacktown, New South Wales, Australia, 2148 Novartis Investigative Site Georgetown, New South Wales, Australia, 2298 Novartis Investigative Site Leichhardt, New South Wales, Australia, 2040 Novartis Investigative Site Manly, New South Wales, Australia, 2095 Novartis Investigative Site North Parramatta, New South Wales, Australia, 2150 Novartis Investigative Site Wentworthville, New South Wales, Australia, 2150 Australia, Queensland Novartis Investigative Site Caloundra, Queensland, Australia, 4551 Novartis Investigative Site Southport, Queensland, Australia, 4215 Australia, South Australia Novartis Investigative Site Ashford, South Australia, Australia, 5035 Novartis Investigative Site Norwood, South Australia, Australia, 5067 Australia, Victoria Novartis Investigative Site Footscray, Victoria, Australia, 3011 Novartis Investigative Site Ringwood, Victoria, Australia, 3134 Australia Novartis Investigative Site Nedlands Perth, Australia, 6009 Novartis Investigative Site Nedlands, Australia, WA 6009 Less <<
NCT00219141 - Completed - -
NCT01712516 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00826371 Age Related Macular Degenerati... More >>on Less << Phase 3 Completed - China ... More >> Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100730 Novartis Investigational Site Chengdu, China, 610041 Novartis Investigative Site Guangzhou, China, 510060 Novartis Investigative Site Shanghai, China, 200031 Novartis Investigative Site Shanghai, China, 200080 Less <<
NCT01727141 - Completed - -
NCT01156844 - Completed - -
NCT00239057 Maintenance Renal Transplantat... More >>ion Less << Phase 3 Completed - -
NCT00522236 Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento Chieti, Italy Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto, Via S. Spaventa, 37 Lanciano, Italy, 66034 Less <<
NCT00239005 - Completed - -
NCT00814216 Asthma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Novartis Investigative Site Munich, Germany Novartis Investigative Site Wiesbaden, Germany India Novartis Investigative Site Ahmedabad, India Novartis Investigative Site Mumbai, India Novartis Investigative Site Mysore, India Novartis Investigative SIte Nagpur, India Less <<
NCT01712516 - Completed - -
NCT02294786 Cancer Phase 2 Terminated(study was stopped d... More >>ue to futility by the DMC in September 2016) Less << - -
NCT01068600 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01206764 Renal Cell Carcinoma Phase 4 Recruiting March 30, 2017 Algeria ... More >> Novartis Investigative Site Completed Alger, Algeria, 016000 Novartis Investigative Site Completed Oran, Algeria Egypt Novartis Investigative Site Recruiting Alexandria, Egypt, 21131 Novartis Investigative Site Recruiting Cairo, Egypt Novartis Investigative Site Recruiting Mansoura, Egypt India Novartis Investigative Site Completed Indore, Madhya Pradesh, India, 452 008 Novartis Investigative Site Completed Pune, Maharashtra, India, 411013 Jordan Novartis Investigative Site Recruiting Amman, Jordan, 11941 Lebanon Novartis Investigative Site Completed Beirut, Lebanon, 166830 Russian Federation Novartis Investigative Site Completed Moscow, Russian Federation, 115478 Novartis Investigative Site Completed Samara, Russian Federation, 443031 Saudi Arabia Novartis Investigative Site Recruiting Riyadh, Saudi Arabia, 11211 South Africa Novartis Investigative Site Completed Cape Town, South Africa, 7500 Novartis Investigative Site Completed Cape Town, South Africa, 7925 Novartis Investigative Site Completed Durban, South Africa, 4001 Novartis Investigative Site Completed Parktown, South Africa, 2193 Thailand Novartis Investigative Site Recruiting Bangkok, Thailand, 10400 Novartis Investigative Site Recruiting Chiang Mai, Thailand, 50200 Novartis Investigative Site Recruiting Songkla, Thailand, 90110 Tunisia Novartis Investigative Site Recruiting Ariana, Tunisia, 2080 Less <<
NCT01072448 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00239005 Renal Transplant Phase 4 Completed - United Kingdom ... More >> Novartis Investigative Site Nottingham, United Kingdom Less <<
NCT01068600 - Completed - -
NCT01072448 - Completed - -
NCT00567996 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01285479 - Recruiting December 13, 2030 -
NCT00219141 Hypertension ... More >>Left Ventricular Hypertrophy Overweight Less << Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Argentina sites in Argentina Argentina, Argentina Colombia sites in Colombia Colombia, Colombia Finland sites in Finland Finland, Finland Germany sites in Germany Germany, Germany Italy sites in Italy Italy, Italy Russian Federation sites in Russia Russia, Russian Federation Spain sites in Spain Spain, Spain Sweden sites in Sweden Sweden, Sweden Less <<
NCT00463567 Pulmonary Disease, Chronic Obs... More >>tructive COPD Lung Diseases, Obstructive Less << Phase 2 Phase 3 Completed - -
NCT01069692 Hyperphosphatemia ... More >> Chronic Kidney Disease Less << Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Jette, Belgium, 1090 Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Roeselare, Belgium, 8800 Italy Novartis Investigative Site Brescia, Italy, 25123 Novartis Investigative Site Lecco, Italy, 23900 Novartis Investigator Site Lucca, Italy, 55100 Novartis Investigative Site Napoli, Italy, 80131 Novartis Investigative Site Pavia, Italy, 27100 Novartis Investigative Site Siena, Italy, 53100 Less <<
NCT00463567 - Completed - -
NCT00624286 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00624286 - Completed - -
NCT00567996 - Completed - -
NCT00403845 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - Japan ... More >> Novartis Investigative site Kasukabe, Japan Novartis Investigator Site Kishiwada, Japan Novartis Investigative Site Kurume, Japan Novartis Investigative Site Obihiro, Japan Novartis Investigative Site Sagamihara, Japan Novartis Investigative Site Sapporo, Japan Novartis Investigator Site Tokyo, Japan Novartis Investigative Site Wakayama, Japan Less <<
NCT00403845 - Completed - -
NCT01442194 - Recruiting December 26, 2022 -
NCT00677807 - Completed - -
NCT00759200 Chronic Hepatitis C Phase 2 Completed - -
NCT00677807 COPD Phase 3 Completed - -
NCT00134979 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Switzerland ... More >> Novartis Pharma AG, Switzerland Less <<
NCT00134940 - Completed - Austria ... More >> Novarits Graz, Austria Novartis Investigative Site Innsbruck, Austria Novartis Wein, Austria Germany Novartis Bad Oeynhausen, Germany Novartis Investigative Site Berlin, Germany Novartis Erlangen, Germany Less <<
NCT00615459 - Completed - -
NCT00620022 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - United States, California ... More >> Novartis Investigator Site Torrance, California, United States United States, New Hampshire Novartis Investigator Site Lebanon, New Hampshire, United States Belgium Novartis Investigator Site Bruxelles, Belgium Novartis Investigator Site Gembloux, Belgium Novartis Investigator Site Jette, Belgium Novartis Investigator Site Liege, Belgium Canada Novartis Investigator Site Edmonton, Canada Novartis Investigator Site Kingston, Canada Denmark Novartis Investigator Site Aarhus, Denmark Novartis Investigative Site Hellerup, Denmark Novartis Investigator Site Hvidovre, Denmark Novartis Investigative site Odense, Denmark Italy Novartis Investigator Site Genova, Italy Novartis Investigator Site Pisa, Italy Novartis Investigator Site Verona, Italy Spain Novartis Investigator Site Alicante, Spain Novartis Investigator Site Barcelona, Spain Novartis Investigative Site Madrid, Spain Novartis Investigative site Seville, Spain Novartis Investigator Site Zaragoza, Spain Less <<
NCT00620022 - Completed - -
NCT00393458 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01423825 HIV Infections Phase 1 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States, 02115-6110 Fenway Health (FH) CRS Boston, Massachusetts, United States, 02215-4302 South Africa Soweto HVTN CRS Johannesburg, Gauteng, South Africa, 1864 Emavundleni CRS Cape Town, Western Cape Province, South Africa, 7750 Less <<
NCT00238901 Liver Transplant Phase 3 Completed - -
NCT00393458 - Completed - -
NCT00809614 Psoriatic Arthritis Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Hamburg, Germany, 22081 Novartis Investigative Site Hamburg, Germany, 22415 Novartis Investigative Site Herne, Germany, 44649 Novartis Investigative Site Muenchen, Germany, 80336 Netherlands Novartis Investigative Site Amsterdamn, DE, Netherlands, 1100 Novartis Investigative Site Meerssen, KR, Netherlands, 6231 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G12 8TA Novartis Investigative Site Leeds, United Kingdom, LS7 4SA Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE2 4HH Less <<
NCT00809614 - Completed - -
NCT01912872 Severe IgE-mediated Asthma Phase 4 Unknown November 2016 Mexico ... More >> Novartis Investigative Site Completed Tuxtla Gutierrez, Chiapas, Mexico, 29030 Novartis Investigative Site Terminated Mexico City, Distrito Federal, Mexico, 14000 Novartis Investigative Site Completed Mexico, Distrito Federal, Mexico, 03020 Novartis Investigative Site Recruiting Mexico, Distrito Federal, Mexico, 03100 Novartis Investigative Site Recruiting Mexico, Distrito Federal, Mexico, 04700 Novartis Investigative Site Recruiting Mexico, Distrito Federal, Mexico, 04980 Novartis Investigative Site Completed Mexico, Distrito Federal, Mexico, 06090 Novartis Investigative Site Completed Mexico, Distrito Federal, Mexico, 06760 Novartis Investigative Site Withdrawn Mexico, Distrito Federal, Mexico, 10700 Novartis Investigative Site Completed Mexico, Distrito Federal, Mexico, 14050 Novartis Investigative Site Terminated Mexico, Edo. de México, Mexico, 53910 Novartis Investigative Site Completed Nezahualcoyotl, Estado de Mexico, Mexico, 57730 Novartis Investigative Site Active, not recruiting Pachuca de Soto, Hidalgo, Mexico, 42090 Novartis Investigative Site Completed Guadalajara, Jalisco, Mexico, 44600 Novartis Investigative Site Completed Guadalajara, Jalisco, Mexico, 44620 Novartis Investigative Site Completed Guadalajara, Jalisco, Mexico, 44690 Novartis Investigative Site Completed Guadaljara, Jalisco, Mexico, 44500 Novartis Investigative Site Recruiting Tepic, Nayarit, Mexico, 63000 Novartis Investigative Site Recruiting Monterrey, Nuevo León, Mexico, 64020 Novartis Investigative Site Terminated Monterrey, Nuevo León, Mexico, 64718 Novartis Investigative Site Completed Mérida, Yucatán, Mexico, 97070 Less <<
NCT01743989 Leukemia, Myeloid, Ph1-Positiv... More >>e Less << Phase 3 Recruiting May 28, 2020 -
NCT00581945 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigator Site Anaheim, California, United States, 92801 Novartis Investigator Site Los Angeles, California, United States, 90095 United States, Florida Novartis Investigator Site Panama City, Florida, United States, 32405 United States, Georgia Novartis Investigator Site Marietta, Georgia, United States, 300060 United States, Maryland Novartis Investigator Site Baltimore, Maryland, United States, 21224 United States, Michigan Novartis Investigator Site Livonia, Michigan, United States, 48152 United States, Minnesota Novartis Investigator Site Minneapolis, Minnesota, United States, 55402 United States, Nebraska Novartis Investigator Site Omaha, Nebraska, United States, 68198-5885 United States, New York Novartis Investigator Site Buffalo, New York, United States, 14215 United States, South Carolina Novartis Investigator Site Spartanburg, South Carolina, United States, 29303 United States, Virginia Novartis Investigator Site Richmond, Virginia, United States, 23225 Less <<
NCT00581945 - Completed - -
NCT01786720 - Unknown April 2014 United Kingdom ... More >> Research in Real Life Ltf Cambridge, United Kingdom, CB24 3BA Less <<
NCT00433017 Macular Degeneration ... More >> Choroidal Neovascularization Less << Phase 2 Phase 3 Terminated(Study was terminate... More >>d based on the results of analyses performed as planned at Month 12.) Less << - Austria ... More >> Novartis Investigative site Wien, Austria Belgium Novartis Investigative site Antwerpen, Belgium Denmark Novartis Investigative site Aalborg, Denmark France Novartis Investigative site Creteil, France Germany Novartis Investigative site Regensburg, Germany Hungary Novartis Investigative site Budapest, Hungary Italy Novartis Investigative site Firenze, Italy Netherlands Novartis Investigative site Rotterdam, Netherlands Poland Novartis Investigative site Warszawa, Poland Spain Novartis Investigative site Madrid, Spain Switzerland Novartis Investigative site Geneve, Switzerland United Kingdom Novartis Investigative site Manchester, United Kingdom Less <<
NCT00933920 Hypertension Phase 1 Completed - India ... More >> Novartis Investigator Site Coimbatore, India Novartis Investigative Site Hyderabaad, India Novartis Investigator Site Hyderabaad, India Novartis Investigator Site Mangalore, India Novartis Investigative Site New Delhi, India Less <<
NCT02115113 Liver Transplantation Phase 3 Unknown August 2017 Italy ... More >> Novartis Investigative Site Recruiting Ancona, AN, Italy, 60126 Novartis Investigative Site Recruiting Bari, BA, Italy, 70124 Novartis Investigative Site Recruiting Bergamo, BG, Italy, 24128 Novartis Investigative Site Recruiting Bologna, BO, Italy, 40138 Novartis Investigative Site Recruiting Cagliari, CA, Italy, 09134 Novartis Investigative Site Withdrawn Cagliari, CA, Italy, 09134 Novartis Investigative Site Recruiting Milano, MI, Italy, 20122 Novartis Investigative Site Recruiting Milano, MI, Italy, 20162 Novartis Investigative Site Recruiting Modena, MO, Italy, 41100 Novartis Investigative Site Recruiting Padova, PD, Italy, 35128 Novartis Investigative Site Recruiting Pisa, PI, Italy, 56124 Novartis Investigative Site Recruiting Roma, RM, Italy, 00144 Novartis Investigative Site Recruiting Roma, RM, Italy, 00152 Novartis Investigative Site Not yet recruiting Roma, RM, Italy, 00161 Novartis Investigative Site Recruiting Roma, RM, Italy, 00168 Novartis Investigative Site Recruiting Torino, TO, Italy, 10126 Novartis Investigative Site Recruiting Udine, UD, Italy, 33100 Novartis Investigative Site Recruiting Verona, VR, Italy, 37126 Novartis Investigative Site Recruiting Napoli, Italy, 80132 Less <<
NCT00615459 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Australia ... More >> Novartis Investigative site Camperdown, Australia Germany Novartis Investigator Site Gauting, Germany Novartis Investigator Site Grosshansdorf, Germany Novartis Investigator Site Mainz, Germany Novartis Investigator site Marburg, Germany Novartis Investigator Site Wiesbaden, Germany Netherlands Novartis Investigator Site Almelo, Netherlands Novartis Investigator Site Breda, Netherlands Novartis Investigator Site Eindhoven, Netherlands Novartis Investigator Site Harderwijk, Netherlands Novartis Investigator Site Helmond, Netherlands New Zealand Novartis Investigator Site Wellington, New Zealand Poland Novartis Investigator Site Katowice, Poland Novartis Investigator Site Warsaw, Poland South Africa Novartis Investigator Site Durban, South Africa Spain Novartis Investigative site Alicante, Spain Novartis Investigative Site Cacenes, Spain Novartis Investigator Site La Coruna, Spain Novartis Investigative Site Madrid, Spain Novartis Investigator Site Orense, Spain Less <<
NCT00433017 - Terminated(Study was terminate... More >>d based on the results of analyses performed as planned at Month 12.) Less << - -
NCT00219050 Hypertension Phase 3 Completed - Germany ... More >> Investigative Site Berlin, Germany Hungary Investigative Site Budapest, Hungary Spain Investigative Site Madrid, Spain Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT02310269 - Recruiting September 27, 2023 -
NCT00584298 Irritable Bowel Syndrome (IBS) Phase 1 Completed - United States, Massachusetts ... More >> Novartis Investigator Site Boston, Massachusetts, United States, 02215 United States, Minnesota Novartis Investigator Site Rochester, Minnesota, United States, 55905 Canada Novartis Investigator Site Hamilton, Canada Sweden Novartis Investigator Site Gothenburg, Sweden United Kingdom Novartis Investigator Site London, United Kingdom Novartis Investigator Site Manchester, United Kingdom Novartis Investigator Site Nottingham, United Kingdom Less <<
NCT00644540 FLU Phase 2 Completed - Finland ... More >> University of Tampere Medical School Tampere, Finland, 33014 Less <<
NCT02619617 Cluster Headache - Episodic an... More >>d Chronic Less << Phase 2 Recruiting December 3, 2018 United States, California ... More >> Novartis Investigative Site Recruiting Culver City, California, United States, 90230 United States, Pennsylvania Novartis Investigative Site Recruiting Philadelphia, Pennsylvania, United States, 19107 Germany Novartis Investigative Site Completed Königstein im Taunus, Taunus, Germany, 61462 Novartis Investigative Site Withdrawn Berlin, Germany, 10117 Novartis Investigative Site Withdrawn Essen, Germany, 45147 Novartis Investigative Site Withdrawn Hamburg, Germany, 20246 Novartis Investigative Site Withdrawn Munchen, Germany, 81377 United Kingdom Novartis Investigative Site Completed London, United Kingdom, SE5 9RS Less <<
NCT02471144 Chronic Severe Plaque-type Pso... More >>riasis Less << Phase 3 Recruiting July 20, 2023 -
NCT00006475 Leukemia Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT00247650 Breast Cancer Phase 2 Completed - Canada, Alberta ... More >> Novartis Investigative Site Edmonton, Alberta, Canada Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada Novartis Investigative Site Victoria, British Columbia, Canada Canada, Ontario Novartis Investigative Site London, Ontario, Canada Novartis Investigative Site Toronto, Ontario, Canada Novartis Investigative Site Windsor, Ontario, Canada Canada, Quebec Novartis Investigative Site Granby, Quebec, Canada Novartis Investigative Site Montreal, Quebec, Canada Novartis Investigative Site Victoriaville, Quebec, Canada Canada Novartis Investigative Site Quebec, Canada Less <<
NCT02445222 Safety LTFU, Pts Receiving CD1... More >>9 Directed CAR T-Cell Therapy Less << Not Applicable Recruiting May 17, 2035 -
NCT02299505 Non-Small Cell Lung Cancer Phase 1 Recruiting October 22, 2019 -
NCT02874794 Heart Failure and Reduced Ejec... More >>tion Fraction Less << Phase 4 Recruiting March 7, 2019 -
NCT02446496 - Completed - -
NCT02446496 Infections, Urinary Tract Phase 4 Completed - Egypt ... More >> GSK Investigational Site Cairo, Egypt Less <<
NCT00436553 Macular Degeneration ... More >> Choroidal Neovascularization Less << Phase 3 Completed - -
NCT02884206 Chronic Heart Failure (CHF) Phase 3 Recruiting May 23, 2022 -
NCT00436553 - Completed - -
NCT03742349 Triple Negative Breast Cancer ... More >>(TNBC) Less << Phase 1 Not yet recruiting August 3, 2020 -
NCT00459537 Onychomycosis Phase 3 Completed - Finland ... More >> Novartis Investigative Site Various Cities, Finland France Novartis Investigative Site Various Cities, France Germany Novartis Investigative Site Various Cities, Germany Hungary Novartis Investigative Site Various Cities, Hungary Iceland Novartis Investigative Site Various Cities, Iceland Norway Novartis Investigative Site Various Cities, Norway Poland Novartis Investigative Site Various Cities, Poland Russian Federation Novartis Investigative Site Various Cities, Russian Federation Spain Novartis Investigative Site Various Cities, Spain Turkey Novartis Investigative Site Various Cities, Turkey Less <<
NCT00441064 Hypertension Phase 4 Completed - United States, California ... More >> Novartis US Orangevale, California, United States United States, Minnesota Novartis US Brooklyn Center, Minnesota, United States United States, Montana Novartis US Butte, Montana, United States Novartis US Missoula, Montana, United States United States, Nebraska Novartis US Lincoln, Nebraska, United States United States, New York Novartis US Johnson City, New York, United States United States, North Carolina Novartis US Asheboro, North Carolina, United States Novartis US Shelby, North Carolina, United States United States, Ohio Novartis US Cincinnati, Ohio, United States Novartis US Kettering, Ohio, United States United States, Pennsylvania Novartis US Downington, Pennsylvania, United States Novartis US Erie, Pennsylvania, United States Novartis US Pittsburg, Pennsylvania, United States United States, Texas Novartis US Dallas, Texas, United States Novartis US Kingsport, Texas, United States United States, Utah Novartis US Bountiful, Utah, United States Novartis US Salt Lake City, Utah, United States United States, Washington Novartis US Port Orchard, Washington, United States United States, Wisconsin Novartis US Madison, Wisconsin, United States Less <<
NCT00171704 Hormone Sensitive Resected Pri... More >>mary Breast Cancer in Postmenopausal Women Less << Phase 3 Completed - Denmark ... More >> Novartis Investigative Site Aalborg, Denmark Novartis Investigative Site Arhus, Denmark Novartis Investigative Site Copenhagen, Denmark Novartis Investigative Site Esbjerg, Denmark Novartis Investigative Site Herlev, Denmark Novartis Investigative Site Herning, Denmark Novartis Investigative Site Hillerod, Denmark Novartis Investigative Site Kløvervænget, Denmark Novartis Investigative Site Roskilde, Denmark Novartis Investigative Site Sonderborg, Denmark Novartis Investigative Site Vejle, Denmark Novartis Investigative Site Viborg, Denmark United Kingdom Novartis Investigative Site Sheffield, United Kingdom Less <<
NCT00172068 Primary Breast Cancer Phase 2 Terminated - Germany ... More >> Novartis Invstigative Site Bielefeld, Germany Novartis Investigative Site Hannover, Germany Novartis Investigative Site München, Germany Novartis Investigative Site Tuebingen, Germany Less <<
NCT00459537 - Completed - -
NCT02555683 Asthma Phase 3 Recruiting December 20, 2019 -
NCT01610037 - Completed - -
NCT00441064 - Completed - -
NCT02792231 Relapsing Multiple Scelrosis Phase 3 Recruiting May 15, 2019 -
NCT01697696 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01610037 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01082705 P. Falciparum Malaria Phase 3 Completed - Tanzania ... More >> Miono Health Center Bagamoyo, Tanzania Less <<
NCT00997477 Asthma Phase 4 Withdrawn - Turkey ... More >> Novartis Investigator Site Ankara, Turkey Novarits Investigator Site Istanbul, Turkey Novartis Investigator Site Istanbul, Turkey Novartis Investigator Site Izmir, Turkey Less <<
NCT02294227 Arthritis, Psoriatic Phase 3 Completed - -
NCT01555138 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - -
NCT01555138 - Completed - -
NCT00649883 Influenza Phase 2 Completed - Guatemala ... More >> Centro Clínico La Quinta Guatemala City, Guatemala Clínicas Dr. Rafael Montiel Guatemala City, Guatemala Dr. Carlos Fernando Grazioso Aragón Guatemala City, Guatemala Fundación Pediátrica Guatemalteca Guatemala City, Guatemala Hospital Infantil de Infectologia y rehabilitacion Guatemala City, Guatemala Less <<
NCT00171704 - Completed - -
NCT00582673 Parkinson's Disease Phase 2 Completed - Germany ... More >> Novartis Investigator Site Dresden, Germany Novartis Investigator Site Kassel, Germany Novartis Investigator Site Leun, Germany Novartis Investigator Site Marburg, Germany Novartis Investigator Site Tuebingen, Germany Less <<
NCT00466466 Small-Cell Lung Cancer Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Cancer Therapy and Research Center at UTHSCSA San Antonio, Texas, United States, 78229 France Novartis Investigative Site Paris, France Less <<
NCT00434174 Non Small Cell Lung Cancer Phase 1 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Camperdown, New South Wales, Australia, 2050 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3002 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koeln, Germany, 50924 Less <<
NCT01697696 - Completed - -
NCT00548067 Hypertension Phase 3 Completed - India ... More >> Novartis Investigative Site Ahmedabad, India Novartis investigative site Bangalore, India Novartis Investigative site Hyderabad, India Novartis Investigative site Mangalore, India Novartis investigative site Mehasana, India Less <<
NCT01224717 Post-menopausal Osteoporosis Phase 1 Completed - Denmark ... More >> Novartis Investigative Site Aalborg, Denmark Novartis Investigative Site Ballerup, Denmark Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Munich, Germany Less <<
NCT01626222 Metastatic Breast Cancer Phase 3 Completed - -
NCT01061177 CML in Chronic Phase Phase 4 Completed - -
NCT01613677 Treatment for Metastatic or Lo... More >>cally Advanced Cervical Cancer Less << Phase 2 Withdrawn September 2017 Brazil ... More >> Novartis Investigative Site Rio de Janiero, RJ, Brazil, 20231-050 Less <<
NCT01061177 - Completed - -
NCT00093600 Acute Myeloid Leukemia (AML) Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201-2014 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Germany Novartis Investigative Site Dresden, Germany Novartis Investigative Site Mainz, Germany Less <<
NCT00940160 Asthma Phase 1 Phase 2 Completed - Russian Federation ... More >> Novartis Investigator Site Moscow, Russian Federation Novartis Investigator Site St. Petersburg, Russian Federation United Kingdom Novartis Investigator Site Manchester, United Kingdom Less <<
NCT00546143 Asthma Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Novartis Investigative site Hamburg, Germany Novartis investigative site Hannover, Germany Novartis investigative site Mainz, Germany South Africa Novartis Investigative site Bloemfontein, South Africa Less <<
NCT03264989 Sickle Cell Disease Phase 2 Recruiting November 9, 2020 United States, Florida ... More >> University of Miami Patient Treatment Recruiting Miami, Florida, United States, 33136 Contact: Vanessa Cumming    305-243-9431    v.cumming@med.miami.edu    Principal Investigator: Ofelia Alvarez          Florida Cancer Affiliates of Ocala Recruiting Ocala, Florida, United States, 34471 Contact: Stacy McCombs    352-732-4032    stacy.mccombs@usoncology.com    Principal Investigator: Rama Balaraman          Mid Florida Hematology and Oncology Center Recruiting Orange City, Florida, United States, 32763 Contact: Kiran Kumar Penta    386-774-1223    kiran@clorene.org    Principal Investigator: Santosh Nair          Tampa General Hospital Recruiting Tampa, Florida, United States, 33606 Contact: Stephenie Yapchanyk    (813) 541-0254    syapchanyk@tgh.org    Principal Investigator: Juan Felipe Rico          United States, Georgia Childrens Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30342 Contact: Katherine Garrett    407-785-2025    Katherine.garrett@choa.org    Principal Investigator: Robert Clark Brown          Augusta University Georgia Cancer Center Pharmacy Patient Treatment Recruiting Augusta, Georgia, United States, 30912 Contact: Leigh G. Wells    706-721-2171    lwells@augusta.edu    Principal Investigator: Abdullah Kutlar          United States, Maryland University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Carolynn Harris    420-438-8199    charris@umm.edu    Principal Investigator: Jennie Law          United States, New Jersey Regional Cancer Care Associates RCCA MD LLC Recruiting Cherry Hill, New Jersey, United States, 08003 Contact: Jennifer Cipriano    301-571-2016    jcipriano@ccbdmd.com    Principal Investigator: Ralph V Boccia          Rutgers Robert Wood Johnson Medical School Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Kim White    732-235-7678    kim.a.white@rutgers.edu    Principal Investigator: Amanda Kaveney          United States, New York Children's Hospital at Montefiore Recruiting Bronx, New York, United States, 10467 Contact: Jill Fillipelli    718-741-2384    jfilipelli@brany.com    Principal Investigator: Deepa Manwani          United States, North Carolina Duke University Medical Center Patient Treatment Recruiting Durham, North Carolina, United States, 27710 Contact: Elizabeth Thames    919-668-5178    elizabeth.thames@dm.duke.edu    Principal Investigator: Nirmish Shah          East Carolina University East Carolina University Recruiting Greenville, North Carolina, United States, 27858 Contact: Sue Ann Joyner    +1 252 744 0456    joynersu@ecu.edu    Principal Investigator: Darla K. Liles          United States, Pennsylvania Children's Hospital of Philadelphia Patient Treatment Recruiting Philadelphia, Pennsylvania, United States, 19104-4399 Contact: Courtney Babb    267-426-9338    babbc@email.chop.edu    Principal Investigator: Kim Smith Whitley          United States, South Carolina Medical University of South Carolina Medical Univ of SC Recruiting Charleston, South Carolina, United States, 29425 Contact: Joannie Hayes    843-876-8614    hayesj@musc.edu    Principal Investigator: Julie Kanter-Washko          M Francisco Gonzalez MD PA Recruiting Columbia, South Carolina, United States, 29203 Contact: Sharon Goff    803-840-8890    skgoff2002@yahoo.com    Principal Investigator: M. Francisco Gonzalez          Carolina Blood and Cancer Care of South Carolina Recruiting Rock Hill, South Carolina, United States, 29732 Contact: Dhwani Mehta    803-329-7772    dmehta@cbcca.net    Principal Investigator: Niyati Nathwani Less <<
NCT03050398 Breast Cancer Phase 3 Recruiting May 14, 2021 United States, California ... More >> Beverly Hills Cancer Center Recruiting Beverly Hills, California, United States, 90211 Contact    310-432-8900       Principal Investigator: Linnea Chap Less <<
NCT03610724 Non-Hodgkin Lymphoma Phase 2 Not yet recruiting October 31, 2022 -
NCT01826214 Acute Leukemias Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center SC-5 Durham, North Carolina, United States, 27710 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 Austria Novartis Investigative Site Salzburg, Austria, 5020 Novartis Investigative Site Wien, Austria, 1090 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Novartis Investigative Site Yvoir, Belgium, 5530 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 2M4 Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Ulm, Germany, 89081 Hungary Novartis Investigative Site Debrecen, Hungary, 4032 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Nijmegen, Netherlands, 6525 GA Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Norway Novartis Investigative Site Bergen, Norway, NO-5021 Novartis Investigative Site Trondheim, Norway, 7006 Spain Novartis Investigative Site Salamanca, Castilla y Leon, Spain, 37007 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 United Kingdom Novartis Investigative Site London, United Kingdom, WC1E 6HX Less <<
NCT01826214 - Completed - -
NCT02343679 Hematologic Malignancies Phase 2 Withdrawn(No accrual due to ra... More >>rity of disease.) Less << October 2022 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00242580 Macular Degeneration ... More >> Choroidal Neovascularization Less << Phase 3 Completed - United States, Texas ... More >> Novartis Investigational Site Austin, Texas, United States, 78793 Less <<
NCT00154375 Glioblastoma Multiforme ... More >> Astrocytoma Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Duelmen, Germany Less <<
NCT00154375 - Completed - -
NCT00418756 Healthy Phase 1 Completed - -
NCT00242580 - Completed - -
NCT00426582 Advanced Solid Tumors Phase 1 Completed - United States, Connecticut ... More >> Norwalk Hospital Norwalk, Connecticut, United States, 06856 United States, Maryland Associates in Oncology Rockville, Maryland, United States, 20850 United States, Michigan Wertz Clinical Cancer Center (Wayne State University) Detroit, Michigan, United States, 48201 United States, Missouri Siteman Cancer Center (Washington University School of Medicine) St. Louis, Missouri, United States, 63110-1093 United States, New Mexico Cancer Research and Treatment Center (University of New Mexico) Albuquerque, New Mexico, United States, 87131 Less <<
NCT03365791 Small Cell Lung Cancer ... More >> Gastric Adenocarcinoma Esophageal Adenocarcinoma Castration Resistant Prostate Adenocarcinoma Soft Tissue Sarcoma Ovarian Adenocarcinoma Advanced Well-differentiated Neuroendocrine Tumors Diffuse Large B Cell Lymphoma Less << Phase 2 Recruiting February 1, 2021 -
NCT00433836 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Belgium Sites in Belgium Sites in Belgium, Belgium France Sites in France Sites in France, France Germany Sites in Germany Sites in Germany, Germany Hungary Sites in Hungary Hungary, Hungary India Sites in India Sites in India, India Italy Sites in Italy Sites in Italy, Italy Poland Sites in Poland Poland, Poland Slovakia Sites in Slovakia Slovakia, Slovakia Sweden Sites in Sweden Sites in Sweden, Sweden, 00000 Turkey Sites in Turkey Turkey, Turkey Less <<
NCT00171847 Metastatic Breast Cancer Phase 4 Terminated - Germany ... More >> Novartis Investigative Site Tuebingen, Germany Less <<
NCT00433836 - Completed - -
NCT00437645 Essential Hypertension Phase 3 Completed - Argentina ... More >> sites in Argentina Agentina, Argentina Chile sites in Chile Chile, Chile Ecuador sites in Ecuador Ecuador, Ecuador Finland sites in Finland Finland, Finland France sites in France France, France Germany sites in Germany Germany, Germany Italy sites in Italy Italy, Italy Norway sites in Norway Norway, Norway Spain sites in Spain Spain, Spain Sweden sites in Sweden Sweden, Sweden Switzerland sites in Switzerland Switzerland, Switzerland Turkey sites in Turkey Turkey, Turkey Less <<
NCT00419536 Hormone Refractory Prostate Ca... More >>ncer Disease Less << Phase 1 Terminated - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115-6084 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63119 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00439738 - Completed - -
NCT00446511 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Belgium Sites in Belgium Belgium, Belgium France Sites in France France, France Germany Sites in Germany Germany, Germany Hungary Sites in Hungary Hungary, Hungary India Sites in India India, India Italy Sites in Italy Italy, Italy Poland Sites in Poland Poland, Poland Turkey Sites in Turkey Turkey, Turkey Less <<
NCT00426140 Advanced Malignancies ... More >> Solid Tumors Less << Phase 1 Completed - United States, Texas ... More >> Cancer Therapy and Research Center, Institution for Drug Development San Antonio, Texas, United States, 78229 Less <<
NCT00448396 Advanced Malignancies Phase 1 Completed - United States, Texas ... More >> San Antonio, Texas, United States Less <<
NCT02099149 - Withdrawn August 2015 South Africa ... More >> Respiratory and Meningeal Pathogen Research Unit Soweto, Gauteng, South Africa, 2013 Less <<
NCT01080560 Healthy Volunteers Not Applicable Completed - India ... More >> Accutest Research Laboratories (I) Pvt Ltd. Ahmedabad, Gujrat, India, 380015 Less <<
NCT00439738 Hypertension Phase 4 Completed - United States, Alabama ... More >> Terence T. Hart, MD Muscle Shoals, Alabama, United States, 35662 United States, California Westlake Medical Research Westlake Village, California, United States, 91361 United States, Oklahoma Oklahoma Cardiovascular & Hypertension Oklahoma City, Oklahoma, United States, 73132 United States, Texas Northeast Tarrant Internal Medicine Assoc Euless, Texas, United States, 76040 United States, Washington Frandsen Family Medicine Port Orchard, Washington, United States, 98366 Less <<
NCT00489424 Osteoporosis Phase 4 Completed - United States, New Jersey ... More >> Refer to the E-portal link for ZOL446HUS136 Http://www.osteoporosisclinicalresearch.com, New Jersey, United States Less <<
NCT00446511 - Completed - -
NCT01080586 Healthy Volunteers Not Applicable Completed - India ... More >> Accutest Research Laboratories (I) Pvt Ltd. Ahmedabad, Gujrat, India, 380015 Less <<
NCT00489424 - Completed - -
NCT00468260 Advanced Malignancies Phase 1 Terminated(pts. will be captur... More >>ed in core) Less << - United States, Texas ... More >> San Antonio, Texas, United States Less <<
NCT01137682 Acromegaly Phase 3 Completed - -
NCT02177032 Rabies Infection Phase 3 Completed - Philippines ... More >> 4, De La Salle Health Sciences Institute Cavite, Philippines, 4114 1, Research Institute for Tropical Medicine Muntinlupa, Philippines, 1781 2, Asian Hospital and Medical Center Muntinlupa, Philippines, 1781 3, Research Institute for Tropical Medicine Muntinlupa, Philippines Thailand 11, Infectious Diseases Unit, Department of Pediatrics, Phramongkutklao hospital Bangkok, Thailand, 10400 12, Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand, 10400 Less <<
NCT00687973 - Completed - -
NCT02177032 - Completed - -
NCT00170755 Overactive Bladder Syndrome Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-108 Less <<
NCT03172936 Solid Tumors and Lymphomas Phase 1 Recruiting December 29, 2020 United States, California ... More >> Novartis Investigative Site Recruiting Los Angeles, California, United States, 90025 United States, Illinois Novartis Investigative Site Recruiting Chicago, Illinois, United States, 60637 Contact: Matthew Weist    773-702-1835    mweist@medicine.bsd.uchicago.edu    Principal Investigator: Jason Luke          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Nilza Biaggi Labiosa    +1 713 745 4453    NMBiaggi@mdanderson.org    Principal Investigator: Funda Meric-Bernstam          Australia, Victoria Novartis Investigative Site Recruiting Melbourne, Victoria, Australia, 3000 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Germany Novartis Investigative Site Recruiting Essen, Germany, 45147 Japan Novartis Investigative Site Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1066 CX Switzerland Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 Less <<
NCT00437645 - Completed - -
NCT00171145 Overactive Bladder Syndrome Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-108 Less <<
NCT00687973 Hypertension Phase 4 Completed - France ... More >> 2 & 4 rue Lionel Terray BP 308 Rueil-Malmaison, France, 92506 Less <<
NCT00052013 Von Hippel-Lindau Disease ... More >> CNS Hemangioblastoma Retinal Hemangioblastoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00279773 Acute Myeloid Leukemia Phase 1 Terminated(Study was stopped d... More >>ue to time dependent drug accumulation) Less << - United States, Texas ... More >> The University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States, 77020 Less <<
NCT01327664 Uveitis Phase 3 Withdrawn(Study will not be in... More >>itiated as planned.) Less << - -
NCT00464776 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Completed - Denmark ... More >> Novartis Gentofte, Denmark, 2820 Less <<
NCT00232011 Atopic Dermatitis Phase 3 Completed - Japan ... More >> This study is not being conducted in the United States Various Cities, Japan Less <<
NCT01026961 Heart Rate Bl... More >>ood Pressure Arrhythmias Less << Phase 1 Phase 2 Withdrawn(Study is no longer r... More >>equired by Brazil health authority.) Less << - Brazil ... More >> Scentryphar Pesquisa Clinica Ltda. Campinas, São Paulo, Brazil Less <<
NCT01271166 Advanced Colorectal Cancer Phase 1 Terminated - Australia ... More >> Novarts Investigative Site Melbourne, Australia Less <<
NCT00099801 Kidney Transplantation Phase 3 Completed - -
NCT00127270 Urinary Incontinence Phase 4 Completed - -
NCT01137682 - Completed - -
NCT00150059 Atopic Dermatitis Phase 4 Completed - Philippines ... More >> This study is not being conducted in the United States Investigative Site, Philippines Less <<
NCT00226707 Chronic Hand Dermatitis Phase 3 Completed - -
NCT01679574 Polycystic Ovary Syndrome Not Applicable Completed - Egypt ... More >> Assiut University Assiut, Egypt, 11111 Less <<
NCT01761071 Myopes Who Have Undergone PRK. Phase 3 Completed - Korea, Republic of ... More >> Departement of Ophthalmology, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT00098241 Kidney Transplantation Phase 3 Completed - United States, Ohio ... More >> Columbus Children's Hospital Columbus, Ohio, United States, 43205-2696 Belgium Dienst Pediatrie UZ Gasthuisberg, Herestraat 49 Leuven, Belgium, 3000 Less <<
NCT00006053 Leukemia Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT00006343 Leukemia Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT01068860 - Completed - -
NCT00400400 - Completed - -
NCT00117377 Atopic Dermatitis Phase 4 Completed - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States New York University Hospital New York, New York, United States United States, Virginia Virginia Clinical Research, Inc Norfolk, Virginia, United States Less <<
NCT00400400 Renal Transplantation Phase 4 Completed - -
NCT00241059 Renal Transplantation Phase 4 Completed - -
NCT00386607 Hypertension Phase 3 Completed - United States, California ... More >> Investigative Centers San Diego, California, United States Canada Investigative Centers Canada, Canada Germany Investigative Centers Germany, Germany Netherlands Investigative Centers Netherlands, Netherlands Less <<
NCT00231998 Atopic Dermatitis Phase 3 Completed - Japan ... More >> This study is not being conducted in the United States Various Cities, Japan Less <<
NCT00431444 Osteoporosis Phase 4 Completed - United States, Arizona ... More >> Women's Health Research Phoenix, Arizona, United States, 85015 United States, California Associated Pharma Research Center Buena Park, California, United States, 90620 United States, District of Columbia Washington, District of Columbia, United States, 20036 United States, Florida Jacksonville Center for Clinical Research Jacksonville, Florida, United States, 32216 Women's Physicians of Jacksonville Jacksonville, Florida, United States, 32256 Tampa Clinical Research Tampa, Florida, United States, 33624 United States, Illinois Springfield Clinic Springfield, Illinois, United States, 62703 United States, Missouri Consultants in Women's Health Care St Louis, Missouri, United States, 63131 United States, Nebraska Alegent Health Omaha, Nebraska, United States, 68152 United States, Nevada Specialty Medical and Research Center Pahrump, Nevada, United States, 89048 United States, New Jersey UMDNJ-Robert Wood Johnson Medical Center New Brunswick, New Jersey, United States, 08901 United States, New York Columbia University New York, New York, United States, 10032 United States, North Carolina Kernodle Clinic, Inc. Burlington, North Carolina, United States, 27215 United States, Oregon The Portland Clinic Portland, Oregon, United States, 97205 Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Texas Texas Institute for Clinical Research Fort Worth, Texas, United States, 76104 United States, Washington Valley Women's Health Clinic Renton, Washington, United States, 98055 Less <<
NCT00386607 - Completed - -
NCT00121381 Dermatitis, Atopic Phase 4 Completed - United States, California ... More >> Pediatric Care Medical Group, Inc. Huntington Beach, California, United States, 92647 Children's Hospital -San Diego San Diego, California, United States, 92123 United States, Colorado National Jewish Medical and Research Center Denver, Colorado, United States, 80206 United States, Florida Dermatology Associates and Research Coral Gables, Florida, United States, 33134 United States, Georgia Medical College of Georgia - Clinical Investigative Services Augusta, Georgia, United States, 30912 United States, New Hampshire Dartmouth Hitchcock Medical Center Section of Dermatology Lebanon, New Hampshire, United States, 03756 United States, North Carolina Wake Forest University School of Medicine Dept. of Dermatology Winston-Salem, North Carolina, United States, 27157 United States, Oregon Calcagno Research and Development Gresham, Oregon, United States, 97030 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 United States, Tennessee 520 Trinity Creek Cove Cordova, Tennessee, United States, 38018 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 United States, Washington A.S.T.H.M.A., Inc Seattle, Washington, United States, 98105 Less <<
NCT00739973 Hypertension Phase 3 Completed - -
NCT00484003 Atopic Eczema Phase 4 Completed - South Africa ... More >> Investigative Sites Various Cities, South Africa Less <<
NCT01241487 Primary Hypertension Phase 4 Completed - Egypt ... More >> Dr Ahmed Anwar Clinic, Cairo, Egypt Less <<
NCT01068860 Type 2 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Less << Phase 2 Completed - -
NCT01393860 - Completed - United States, Maryland ... More >> MODEL Clinical Research, Research Division of Bay Endocrinology Associates GBMC Physicians pavilion North Baltimore, Maryland, United States, MD 21204 Less <<
NCT00171496 Kidney Transplant Phase 4 Completed - -
NCT00431444 - Completed - -
NCT00642356 - Terminated(slow enrollment) - -
NCT00171717 Maintenance Liver Transplant P... More >>atients With New Onset Diabetes Less << Phase 4 Completed - -
NCT00171743 Liver Transplant Phase 4 Completed - -
NCT00171509 Liver Transplant Phase 4 Completed - -
NCT00739973 - Completed - -
NCT00395629 - Completed - -
NCT00395629 Iron Overload ... More >> Hereditary Hemochromatosis Less << Phase 1 Phase 2 Completed - United States, California ... More >> UC Irvine/Long Beach Long Beach, California, United States, 90822 United States, Connecticut University of Connecticut Health Center Farmington, Connecticut, United States, 06030 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri St. Louis University St. Louis, Missouri, United States, 63110 United States, New York Rochester General Hospital Rochester, New York, United States, 14625 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, South Carolina Three Medical Park Columbia, South Carolina, United States, 29203 Australia Novartis Investigative Site Brisbane, Australia Canada, Ontario Novartis Investigative Site London, Ontario, Canada France Novartis Investigative Site Rennes Cedex, France Germany Novartis Investigative Site Chemnitz, Germany Novartis Investigative Site Heidelberg, Germany Novartis Investigative Site Magdeburg, Germany Novartis Investigative Site Oberhausen, Germany Italy Novartis Investigative Site Modena, Italy Novartis Investigative Site Monza, Italy Less <<
NCT01058369 Myelodysplastic Syndromes Phase 2 Terminated(Insufficient patien... More >>t recruitment (only 2 patients)) Less << - Germany ... More >> Medizinische Klinik 5, Universitätsklinikum Erlangen Erlangen, Bavaria, Germany, 91054 Less <<
NCT00642356 Parkinson's Disease Phase 4 Terminated(slow enrollment) - United States, Arizona ... More >> Xenoscience, Inc Phoenix, Arizona, United States, 85004 United States, California South Coast Health Center Aliso Viejo, California, United States, 92656 University of California Irvine, California, United States, 92697 Coastal Neurological Medical Group, Inc La Jolla, California, United States, 92037 United States, District of Columbia Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Florida Sunrise Clinical Research, Inc Hollywood, Florida, United States, 33021 Charlotte Neurological Services Port Charlotte, Florida, United States, 33952 United States, Kansas Cotton O'Neil Clinic Topeka, Kansas, United States, 66606 United States, Maryland University of Maryland School of Medicine Baltimore, Maryland, United States, 21201 United States, Missouri Neurology, Inc Columbia, Missouri, United States, 65201 Dr. John's Mercy Medical Center St. Louis, Missouri, United States, 63141 United States, Nebraska Creighton U Medical Center, Dept of Neurology Omaha, Nebraska, United States, 68131 United States, New York Parkinson's Disease & Movement Disorders Commack, New York, United States, 11725 Central New York Research Corporation Syracuse, New York, United States, 13210 Neurological Care of Central NY Syracuse, New York, United States, 13210 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Pennsylvania Neurology Associates Monroeville, Pennsylvania, United States, 15146 University of Pittsburg Pittsburg, Pennsylvania, United States, 15213 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 University of Texas Medical School Houston, Texas, United States, 77030 Scott & White Hospital Temple, Texas, United States, 76508 Less <<
NCT00699192 Hypertension Phase 3 Completed - Czech Republic ... More >> Novartis Investigative site Brno, Czech Republic Investigative site Czech Republic Chrudim, Czech Republic Investigative sites Czech Repbulic Hodonin, Czech Republic Investigative site Czech Repbulic Jicin, Czech Republic Sites in Czech Republic Nachod, Czech Republic Investigative sites Czech Republic Praha, Czech Republic Finland Investigative site Finland Helsinki, Finland Investigative site Finland Joensuu, Finland Investigative site Finland Kerava, Finland Investigative site Finland Tampere, Finland France Investigative site France Paris, France Germany Investigative site Germany Berlin, Germany Hungary Investigative site Hungary Budapest, Hungary Italy Investigative site Italy Rome, Italy Poland Investigative site Poland Warsaw, Poland Slovakia Investigative site Slovakia Bratislava, Slovakia Spain Investigative site Spain Valencia, Spain Sweden Investigative site Sweden Malmo, Sweden Less <<
NCT00542269 Hypertension With Metabolic Sy... More >>ndrome Less << Phase 4 Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - United Kingdom ... More >> Addenbrookes Hospital Cambridge, United Kingdom Less <<
NCT00056459 Colorectal Neoplasms ... More >> Colonic Neoplasms Rectal Neoplasms Less << Phase 3 Completed - -
NCT00699192 - Completed - -
NCT00240955 Renal Transplantation Phase 4 Completed - -
NCT00413920 Renal Transplantation Phase 3 Completed - France ... More >> C.H.U. La Milétrie Poitiers, France Less <<
NCT00542269 - Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - -
NCT00413920 - Completed - -
NCT00427505 Healthy Phase 1 Completed - -
NCT00402103 Hypertension Phase 3 Completed - United States, New Mexico ... More >> Investigative Site Santa Fe, New Mexico, United States Belgium Investigator Site Investigative Site, Belgium Denmark Investigative Center Investigative Center, Denmark Finland Investigative Site Investigative Site, Finland Germany Investigative Center Investigative Center, Germany Iceland Investigative Site Investigative Site, Iceland India Investigative Site Investigative Site, India Switzerland Investigative Site Investigative Site, Switzerland Less <<
NCT00402103 - Completed - -
NCT00446563 - Completed - -
NCT00944034 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 2 Phase 3 Completed - -
NCT00419172 Healthy Phase 1 Completed - -
NCT00739596 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States Less <<
NCT00351052 Atopic Dermatitis Phase 3 Completed - Germany ... More >> Investigational Site, Germany Less <<
NCT00739596 - Completed - -
NCT00446563 Hypertension; Hypertrophy, Lef... More >>t Ventricular Less << Phase 3 Completed - Germany ... More >> 25 centers in Germany Ludwigshafen, Germany Less <<
NCT00709969 Plasmodium Falciparum Malaria Phase 3 Completed - Kenya ... More >> Kemri-Wellcome Trust Programme Kilifi, Kenya Nigeria University College Hospital Malaria Research Laboratories Institute for Advance Medical Research and Training Ibadan, Nigeria Tanzania Muhimbili University College of Health Sciences Department of Parasitology and Medical Entomology, Box 65011 Dar es Salaam, Tanzania Less <<
NCT00733863 Alzheimer Disease Phase 2 Completed - France ... More >> Centre Hospitalier Universitaire Pellegrin Bordeaux, France Sweden Karolinska Universitetssjukhuset Huddinge Stockholm, Sweden Switzerland NeuroPsychologieZentrum Basel, Switzerland United Kingdom Moorgreen Hospital Southampton, United Kingdom Less <<
NCT00797862 Hypertension Phase 3 Completed - Canada ... More >> Investigative Site Toronto, Canada Costa Rica Investigative Site San Jose, Costa Rica France Investigative Site Paris, France Germany Investigative Site Bonn, Germany Greece Investigative Site Athens, Greece Guatemala Investigative Site Guatemala city, Guatemala South Africa Investigative Site Cape Town, South Africa Switzerland Investigative Site Basel, Switzerland United Kingdom Investigative Site London, United Kingdom Venezuela Investigative Site Caracas, Venezuela Less <<
NCT00171587 Tumors Neopla... More >>sm Metastasis Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00819767 Hypertension Phase 2 Completed - Czech Republic ... More >> Investigative Site Pardubice, Czech Republic Investigative Site Prague, Czech Republic Hungary Investigative Site Budapest, Hungary Investigative Site Nyiregyhaza, Hungary Investigative Site Pilisvörösvár, Hungary Investigative Site Szentendre, Hungary Singapore Investigative Site Singapore, Singapore United Kingdom Investigative Site Leicester, United Kingdom Less <<
NCT00219258 Treatment of Bone Metastases Phase 3 Completed - China ... More >> Beijing Beijing, China Less <<
NCT00944034 - Completed - -
NCT02036723 Wet Age-related Macular Degene... More >>ration Less << Phase 3 Withdrawn - Brazil ... More >> Universidade Estadual de Londrina Londrina, Parana, Brazil Hospital dos Olhos do Paraná Curitiba, Paraná, Brazil Universidade Federal de Minas Gerais Hospital das Clínicas Belo Horizonte, Brazil UERJ Hospital Universitário Pedro Ernesto Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro Hospital Clementino Fraga Filho Rio de Janeiro, Brazil Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto São Paulo, Brazil Universidade Federal de São Paulo Hospital São Paulo São Paulo, Brazil Russian Federation Republican Clinical Eye Hospital Kazan, Republic of Tatarstan, Russian Federation Scientific and Research Institute named after Helmholtz Moscow, Russian Federation Regional Clinical Ophthalmic Hospital named TI Yeroshevsky Samara, Russian Federation IRTC "Eye Microsurgery" named after academician SN Fedorov " St. Petersburg, Russian Federation Municipal Advisory and Diagnostic Centre number 1 St. Petersburg, Russian Federation St. Petersburg State Medical University named after academician IP Pavlova St. Petersburg, Russian Federation Less <<
NCT00797862 - Completed - -
NCT00171210 Transfusional Iron Overload in... More >> β-thalassemia Less << Phase 3 Completed - -
NCT00171210 - Completed - -
NCT00819767 - Completed - -
NCT01735968 3rd Line GIST Phase 1 Completed - United States, Oregon ... More >> Oregon Health and Science University Dept. of OHSU (3) Portland, Oregon, United States, 97239 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux, France, 33076 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Essen, Germany, 45122 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Candiolo, TO, Italy, 10060 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site Leeds, United Kingdom, LS9 7TF Less <<
NCT00237120 Chronic Myelogenous Leukemia i... More >>n Chronic Phase Less << Phase 3 Completed - -
NCT00239031 Denovo Renal Transplantation Phase 3 Completed - -
NCT00964665 Chronic Hepatitis B Phase 1 Phase 2 Terminated - China ... More >> Novartis Investigator Site Beijing, China Hong Kong Novartis Investigator Site Sha Tin, Hong Kong Novartis Investigator Site Taipo, Hong Kong Poland Novartis Investigator Site Bialystok, Poland Novartis Investigator Site Lodz, Poland Novartis Investigator Site Warsaw, Poland Taiwan Novartis Investigator Site Kaohsiung, Taiwan Novartis Investigator Site Taipei, Taiwan Novartis Investigator Site Tau-Yuan County, Taiwan Thailand Novartis Investigator Site Bangkok, Thailand Novartis Investigator Site Chiangmai, Thailand Novartis Investigator Site Songkla, Thailand Less <<
NCT01222403 Influenza Phase 4 Completed - Korea, Republic of ... More >> KeeTaek Kim internal medicine Clinic Gimpo, Gyeonggi-do, Korea, Republic of, 415-040 Jiguchon internal medicine Clinic Jeongeup, Jeonrabuk-do, Korea, Republic of, 580-060 21th Century hana internal medicine clinic Mokpo, Jeonranam-do, Korea, Republic of, 530-390 JoongAng family medicine Clinic Suncheon, Jeonranam-do, Korea, Republic of, 540-150 Yonsei Universtity College of Medicine Seodaemun-gu, Seoul, Korea, Republic of, 120-752 Hangajok internal medicine clinic Daejeon, Korea, Republic of, 300-110 Ju Saengmyeong internal medicine Clinic Daejeon, Korea, Republic of, 305-313 Daejeon hospital Daejeon, Korea, Republic of, 306-010 SaeSeoul internal medicine and radiology Clinic Daejeon, Korea, Republic of, 770-160 SeoIncheon catholic clinic Incheon, Korea, Republic of, 404-190 TaeIl Jang internal medicine Clinic Incheon, Korea, Republic of, 405-224 SeokYeon Kim internal medicine clinic Incheon, Korea, Republic of, 407-806 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Yonsei University Severance Hospital Seoul, Korea, Republic of, 120-752 Seoul medical center Seoul, Korea, Republic of, 131-865 Global care internal medicine clinic Seoul, Korea, Republic of, 135-271 Yeonsei Koum internal medicine Clinic Seoul, Korea, Republic of, 138-201 Soon Chun Hyang University Hospital Seoul, Korea, Republic of, 140-887 Gikim internal medicine clinic Seoul, Korea, Republic of, 143-203 Lee internal medicine clinic Seoul, Korea, Republic of, 143-210 Kangnam Sacred Heart Hospital Seoul, Korea, Republic of, 150-950 Korea University Guro Hospital Seoul, Korea, Republic of Yonsei University Severance Hospital Seoul, Korea, Republic of Less <<
NCT00942994 Hypertension Phase 4 Completed - United States, Arkansas ... More >> K and S Research Services Little Rock, Arkansas, United States, 72201 United States, Florida Well Pharma Medical Research South Miami, Florida, United States, 33143 United States, Massachusetts Hyde Park Health Associates Mattapan, Massachusetts, United States, 02126 United States, Virginia Manassas Clinical Research Center Manassas, Virginia, United States, 20110 United States, Washington Scriber Kidney Center Seattle, Washington, United States, 98133 Less <<
NCT00242567 Prostate Cancer Phase 3 Completed - Australia ... More >> Novartis Investigative Site Adelaide, Australia Novartis Investigative Site Brisbane, Australia Novartis Investigative Site Melbourne, Australia Novartis Investigative Site Port Macquarie, Australia Novartis Investigative Site Sydney, Australia Brazil Novartis Investigative Site Porto Alegre, Brazil Novartis Investigative Site Santo Andre, Brazil Novartis Investigative Site Sao Paulo, Brazil China Novartis Investigative Site Beijing, China Novartis Investigative Site Chongqing, China Novartis Investigative Site Shanghai, China Korea, Republic of Novartis Investigative Site Busan, Korea, Republic of Novartis Investigative Site Kyunggi-do, Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Kuwait Novartis Investigative Site Kuwait, Kuwait Lebanon Novartis Investigative Site Beirut, Lebanon New Zealand Novartis Investigative Site Auckland, New Zealand Novartis Investigative Site Christchurch, New Zealand Novartis Investigative Site Hamilton, New Zealand Novartis Investigative Site Tauranga, New Zealand Novartis Investigative Site Wellington, New Zealand Saudi Arabia Novartis Investigative Site Riyadh, Saudi Arabia Taiwan Novartis Investigative Site Taichung, Taiwan Novartis Investigative Site Taipei, Taiwan Novartis Investigative Site Taoyuan, Taiwan Thailand Novartis Investigative Site Bangkok, Thailand Novartis Investigative Site Songkhla, Thailand Less <<
NCT00942994 - Completed - -
NCT00242567 - Completed - -
NCT00171886 Acromegaly Phase 4 Completed - Spain ... More >> Novartis Investigative site Alicante, Spain Novartis Investigative site Barcelona, Spain Novartis Investigative site Burgos, Spain Novartis Investigative site Cordoba, Spain Novartis Investigative site Coruna, Spain Novartis Investigative site Madrid, Spain Novartis Investigative site Malaga, Spain Novartis Investigative site Tarragona, Spain Less <<
NCT00308425 De Novo Renal Transplantation Phase 3 Completed - -
NCT01222403 - Completed - -
NCT00303329 - Completed - -
NCT00306787 - Completed - -
NCT00391950 Prostate Cancer Phase 3 Terminated - United Kingdom ... More >> Derby, United Kingdom Less <<
NCT00306787 Genital Herpes Phase 3 Completed - -
NCT00443820 Onychomycosis Phase 3 Completed - -
NCT00303329 Anemia Hemosi... More >>derosis Less << Phase 2 Completed - United States, California ... More >> Children's Hospital and Research center at Oakland Oakland, California, United States, 94609-1809 Stanford Hospital Stanford, California, United States, 94305 United States, Massachusetts Childres's Hospital Boston Boston, Massachusetts, United States, 02115 United States, New York New York Presbyterian Hospital New York, New York, United States, 10021 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4399 Belgium Novartis Investigative Site Brugge, Belgium Novartis Investigative Site Bruxelles, Belgium Novartis Investigative Site Gent, Belgium Novartis Investigative Site La Louvière, Belgium Novartis Investigative Site Leuven, Belgium Canada Novartis Investigative Site Montreal, Canada Novartis Investigative Site Toronto, Canada France Novartis Investigative Site Creteil, France Novartis Investigative Site Le Kremlin Bicetre, France Novartis Investigative Site Lille, France Novartis Investigative Site Troyes, France Germany Novartis Investigative Site Duesseldorf, Germany Novartis Investigative Site Hannover, Germany Novartis Investigative Site Ulm, Germany Italy Novartis Investigative Site Bologna, Italy Novartis Investigative Site Brindisi, Italy Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Genova, Italy Novartis Investigative Site Milan, Italy Novartis Investigative Site Pavia, Italy Novartis Investigative Site Rome, Italy Novartis Investigative Site Torino, Italy United Kingdom Novartis Investigative Site London, United Kingdom Less <<
NCT00332852 Breast Cancer Phase 3 Completed - -
NCT01468688 3rd Line GIST Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States, 02215 United States, Washington Seattle Cancer Care Alliance Onc Seattle, Washington, United States, 98105 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Villejuif Cedex, France, 94805 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site London, United Kingdom, SW3 6JJ Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT00487058 Advanced Solid Tumors Phase 1 Completed - Japan ... More >> Saitama Prefecture, Japan Less <<
NCT00413270 - - - Canada, Alberta ... More >> Novartis Investigative Site Calgary, Alberta, Canada Novartis Investigative Site Edmonton, Alberta, Canada Canada, British Columbia Novartis Investigative Site Burnaby, British Columbia, Canada Novartis Investigative Site Vancouver, British Columbia, Canada Canada, New Brunswick Novartis Investigative Site Moncton, New Brunswick, Canada Canada, Newfoundland and Labrador Novartis Investigative Site St. John's, Newfoundland and Labrador, Canada Canada, Nova Scotia Novartis Investigative Site Halifax, Nova Scotia, Canada Canada, Ontario Novartis Investigative Site Brampton, Ontario, Canada Novartis Investigative Site Hamilton, Ontario, Canada Novartis Investigative Site London, Ontario, Canada Novartis Investigative Site Oshawa, Ontario, Canada Novartis Investigative Site Ottawa, Ontario, Canada Novartis Investigative Site Toronto, Ontario, Canada, q Novartis Investigative Site Windsor, Ontario, Canada Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada Novartis Investigative Site Sherbrooke, Quebec, Canada Canada, Saskatchewan Novartis Investigative Site Saskatoon, Saskatchewan, Canada Canada Novartis Investigative Site Quebec, Canada Less <<
NCT00006269 Colorectal Cancer ... More >> Diarrhea Less << Phase 3 Terminated - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Theradex Princeton, New Jersey, United States, 08543 Less <<
NCT00443820 - Completed - -
NCT00434447 Bone Neoplasms Phase 4 Completed - Australia, Australian Capital ... More >>Territory Novartis Investigative Site Canberra, Australian Capital Territory, Australia Australia, New South Wales Novartis Investigative Site Concord, New South Wales, Australia Novartis Investigative Site Liverpool, New South Wales, Australia Novartis Investigative Site Wagga Wagga, New South Wales, Australia Australia, Queensland Novartis Investigative Site Redcliffe, Queensland, Australia Novartis Investigative Site Townsville, Queensland, Australia Novartis Investigative Site Woolloongabba, Queensland, Australia Australia, Victoria Novartis Investigative Site Ballarat, Victoria, Australia Novartis Investigative Site Box Hill, Victoria, Australia Novartis Investigative Site Frankston, Victoria, Australia Less <<
NCT00403754 Asthma Phase 2 Completed - Japan ... More >> Novartis Investigative Site Kasukabe, Japan Novartis Investigator Site Kishiwada, Japan Novartis Investigative Site Shimotsuga, Japan Novartis Investigator Site Suita, Japan Novartis Investigative Site Tokyo, Japan Novartis Tokyo, Japan Novartis Investigator Site Wakayama, Japan Novartis Investigator Site Yokohama, Japan Less <<
NCT00403754 - Completed - -
NCT01037452 Heartburn Phase 2 Completed - United States, California ... More >> Anaheim, California, United States Less <<
NCT03207867 NSCLC, Non Small Cell Lung Can... More >>cer RCC, Renal Cell Cancer Pancreatic Cancer Urothelial Cancer Head and Neck Cancer DLBCL, Diffused Large B Cell Lymphoma MSS, Microsatellite Stable Colon Cancer TNBC, Triple Negative Breast Cancer Melanoma Less << Phase 2 Recruiting November 6, 2020 -
NCT00417807 Refractory Desmoplastic Small ... More >>Round Cell Tumors Less << Phase 1 Phase 2 Completed - Italy ... More >> Novartis Investigative Site Ivrea, Italy Novartis Investigative Site Milano, Italy Novartis Investigative Site Napoli, Italy Novartis Investigative Site Padova, Italy Novartis Investigative Site Ravenna, Italy Novartis Investigative Site Rozzano, Italy Novartis Investigative Site Torino, Italy Novartis Investigative Stie Vatania, Italy Less <<
NCT00426452 Healthy Phase 1 Completed - -
NCT00331864 Age Related Macular Degenerati... More >>on Choroidal Neovascularization Less << Phase 3 Completed - Switzerland ... More >> Novartis - 64 sites in 11 countries Basel, Switzerland Less <<
NCT00237224 Breast Cancer Phase 4 Completed - Mexico ... More >> Novartis Investigative Site Guadalajara, Zacatecas, México DF, Mexico Less <<
NCT01506011 Fasting Phase 1 Completed - India ... More >> Vimta Labs Ltd. Hyderabad, A.P, India, 500 051 Less <<
NCT01037452 - Completed - -
NCT03474965 Sickle Cell Disease Phase 2 Recruiting April 28, 2022 United States, South Carolina ... More >> Medical University of South Carolina Medical Uni of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Cynthia M. Brown       browncyn@musc.edu    Principal Investigator: Julie Kanter-Washko Less <<
NCT03570892 Non-Hodgkin Lymphoma Phase 3 Not yet recruiting May 26, 2025 -
NCT00331864 - Completed - -
NCT03626545 Non-Small-Cell Lung Phase 3 Not yet recruiting August 6, 2021 -
NCT03628053 Acute Lymphoblastic Leukemia Phase 3 Not yet recruiting December 22, 2022 -
NCT00258765 Prostate Cancer Phase 2 Terminated(Poor recruitment & ... More >>not feasible to continue) Less << - Australia ... More >> Novartis Investigative Site Sydney, Australia Less <<
NCT03701334 Early Breast Cancer Phase 3 Not yet recruiting December 26, 2025 -
NCT03631199 Non-small Cell Lung Cancer Phase 3 Not yet recruiting October 21, 2022 -
NCT00351377 Autoimmune Disease Phase 3 Completed - Germany ... More >> Novartis Investigational Site Various cities, Germany Less <<
NCT03760445 Leukemia, Myeloid, Acute Phase 1 Phase 2 Not yet recruiting October 13, 2022 -
NCT03774082 Graft vs Host Disease Phase 2 Not yet recruiting June 13, 2025 -
NCT01594957 Hepatic Impairment Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Miami, Florida, United States, 33136 Novartis Investigative Site Orlando, Florida, United States, 32809 Less <<
NCT00640588 Hepatitis B, Chronic Phase 3 Completed - Spain ... More >> Novartis Investigative Site Barcelona, Spain Less <<
NCT00380445 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT00139568 Constipation Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland, 4056 Less <<
NCT00392262 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT02442206 Chronic Obstructive Pulmonary ... More >>Disease, COPD Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Hannover, Germany, 30625 Less <<
NCT02476422 Post Operative Dental Pain Phase 3 Completed - United States, Texas ... More >> Novartis Investigative Site Austin, Texas, United States, 78744 Less <<
NCT02442206 - Completed - -
NCT02482428 External Genital Warts Phase 2 Completed - United States, Illinois ... More >> Novartis Investigative Site Arlington Heights, Illinois, United States, 60005 Less <<
NCT02476422 - Completed - -
NCT02482428 - Completed - -
NCT00367094 Hypertension Phase 3 Completed - China ... More >> Novartis Beijing, China Less <<
NCT03708900 Cushing's Disease Phase 2 Not yet recruiting January 7, 2022 -
NCT00785083 Asthma Phase 2 Completed - United Kingdom ... More >> Novartis Investigator Site Manchester, United Kingdom Less <<
NCT00377806 Superficial Thrombophlebitis o... More >>f the Upper Limb Less << Phase 4 Completed - Germany ... More >> Novartis Nürnberg, Germany Less <<
NCT00280540 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00390520 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT02577107 Age-related Macular Degenerati... More >>on Less << Phase 4 Completed - China, Sichuan ... More >> Novartis Investigative Site Chengdu, Sichuan, China, 610041 Less <<
NCT02577107 - Completed - -
NCT01757691 - Terminated(Discontinuation of ... More >>this study was based on Novartis decision to discontinue development of fingolimod for the treatment of ADON) Less << - -
NCT02675803 Rheumatoid Arthritis Phase 1 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Less <<
NCT00135837 Age-Related Macular Degenerati... More >>on Less << Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT01846468 Chronic Renal Insufficiency Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 Less <<
NCT00503360 Ocular Hypertension Phase 1 Completed - Australia ... More >> Novartis Investigative site, Sydney, Australia Sydney, Australia Less <<
NCT01898845 Advanced Solid Tumors Phase 1 Completed - Japan ... More >> Novartis Investigative Site Kashiwa, Chiba, Japan Novartis Investigative Site Chuo-ku, Tokyo, Japan Less <<
NCT01859455 Hypercholesterolemia ... More >> LDL Cholesterol Less << Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Fort Myers, Florida, United States, 33901-8144 Novartis Investigative Site Miramar, Florida, United States, 33025 Less <<
NCT01911936 Neoplasms Phase 1 Completed - Japan ... More >> Novartis Investigative Site Koto, Tokyo, Japan, 135-8550 Novartis Investigative Site Fukuoka, Japan, 811-1395 Less <<
NCT00351377 - Completed - -
NCT00239889 Forearm Fracture Phase 4 Completed - Germany ... More >> Novartis Nuernberg, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT01757691 Acute Demylelinating Optic Neu... More >>ritis Less << Phase 2 Terminated(Discontinuation of ... More >>this study was based on Novartis decision to discontinue development of fingolimod for the treatment of ADON) Less << - United States, Florida ... More >> Novartis Investigative Site St. Petersburg, Florida, United States, 33713 Spain Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Less <<
NCT01167153 Hypertension Phase 4 Completed - China ... More >> Novartis Pharmaceuticals Beijing, China Less <<
NCT01968915 Neoplasms Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8560 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Less <<
NCT01772212 Mycoses Phase 1 Completed - -
NCT01904214 Renal Impairment Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 Romania Novartis Investigative Site Bucuresti, Romania Less <<
NCT01979601 Hypercholesterolemia Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Miami Gardens, Florida, United States, 33169 United States, North Dakota Novartis Investigative Site Fargo, North Dakota, United States, 58104 Less <<
NCT00154193 Heart and Lung Transplant Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00170820 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00170846 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT01167153 - Completed - -
NCT01474681 Acute Myelocytic Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Chronic Lymphocytic Leukemia Marginal Zone Lymphoma Follicular Lymphomas Large-cell Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma High Grade Lymphomas Mantle-cell Lymphoma Lymphoplasmacytic Lymphoma Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Novartis Investigative Site Minneapolis, Minnesota, United States, 55455 Less <<
NCT00170846 - Completed - -
NCT00414609 Myocardial Infarction Phase 3 Completed - -
NCT00246584 Hypertension Phase 2 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00879242 Beta Thalassemia Transfusion D... More >>ependent Less << Phase 2 Completed - Italy ... More >> Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Orbassano, Italy Less <<
NCT01474681 - Completed - -
NCT01539213 Healthy Psori... More >>asis Less << Phase 1 Completed - Austria ... More >> Novartis Investigative Site Graz, Austria, A-8036 Less <<
NCT00154206 Kidney Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00414609 - Completed - -
NCT01541189 Hypertension Phase 4 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100044 Less <<
NCT00250562 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00905593 - - - Mexico ... More >> Novartis Investigative Site Guadalajara, Jalisco, Mexico Novartis Investigative Site Mexico City, Mexico Less <<
NCT01545726 Asthma Phase 2 Completed - United Kingdom ... More >> Novartis Investigative Site Leicester, United Kingdom, LE3 9QP Less <<
NCT01487460 Dyslipidemia ... More >>Healthy Volunteers Less << Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Miramar, Florida, United States, 33025 Less <<
NCT01594255 Healthy Phase 1 Completed - United States, Texas ... More >> Novartis Investigational Site Austin, Texas, United States, 78744 Less <<
NCT01551173 - Completed - -
NCT01582243 Diabetes Mellitus, Type 2 Phase 4 Completed - Taiwan ... More >> Novartis Investigative Site Changhua, Taiwan, 500 Less <<
NCT01551173 Lipid Metabolism Disorders Phase 4 Completed - China, Hunan ... More >> Novartis Investigative Site Changsha, Hunan, China, 410011 Less <<
NCT01582243 - Completed - -
NCT01596712 Allergy Phase 1 Completed - Japan ... More >> Novartis Investigative Site Sagamihara, Kanagawa, Japan, 228-8520 Less <<
NCT01601470 Mild to Moderate Hypertension Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 14050 Less <<
NCT01613690 Renal Impairment Phase 1 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation Less <<
NCT01601470 - Completed - -
NCT00325429 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT00327145 Hypertension Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01621633 Hepatic Impairment Phase 2 Completed - Germany ... More >> Novartis Investigative Site Grunstadt, Germany, D-67269 Less <<
NCT00333489 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01640964 Compensated Cirrhosis and Port... More >>al Hypertension Less << Phase 2 Completed - United Kingdom ... More >> Novartis Investigative Site Edinburgh, United Kingdom, EH16 4TJ Less <<
NCT01541956 Type 2 Diabetes Phase 4 Completed - China ... More >> Novartis Investigative Site Beijing, China, 100028 Less <<
NCT00325117 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT00343551 Essential Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01621633 - Completed - -
NCT00584740 Crohn's Disease Phase 2 Terminated(The study was termi... More >>nated prematurely after futility criterion was met at planned interim analysis of 41 patients.) Less << - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Stuttgart, Germany, 70376 Less <<
NCT01640964 - Completed - -
NCT01568762 Asthma Phase 1 Completed - United States, North Carolina ... More >> Novartis Investigative Site Raleigh, North Carolina, United States, 27607 Less <<
NCT00584740 - Terminated(The study was termi... More >>nated prematurely after futility criterion was met at planned interim analysis of 41 patients.) Less << - -
NCT00368134 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT01690871 Malignant PEComa (Perivascular... More >> Epithelioid Cell Tumors) Less << Phase 2 Withdrawn January 2015 Spain ... More >> Novartis Investigative Site Barcelona, Cataluña, Spain, 08025 Less <<
NCT00351832 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT00386139 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00389415 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT00138567 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative site Investigative Centers, Germany Less <<
NCT00353912 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT01125514 Heart Failure Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Lithuania Novartis Investigative Site Vilnius, Lithuania Less <<
NCT00385931 Hypertension ... More >>Hypercholesterolemia Dyslipidemia Less << Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01804400 Allergic Rhinitis Phase 2 Completed - Germany ... More >> Novartis Investigative Site Hannover, Germany, 30625 Less <<
NCT01125514 - Completed - -
NCT01064089 Advanced Solid Tumors Phase 1 Terminated - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 466-8560 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Less <<
NCT00464399 De Novo Renal Transplantation Phase 3 Completed - Norway ... More >> Novartis Investigative Site, Oslo, Norway Less <<
NCT01836458 Malaria Phase 2 Completed - Vietnam ... More >> Novartis Investigative Site Ho Chi Minh, Vietnam Less <<
NCT01818726 Aplastic Anemia Phase 4 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation, 125167 Less <<
NCT01875523 Renal Failure, Chronic ... More >> End-Stage Renal Disease Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Grunstadt, Germany, D-67269 Less <<
NCT01836458 - Completed - -
NCT01794780 COPD Not Applicable Completed - China ... More >> Novartis Investigative Site Beijing, China, 100730 Less <<
NCT01195376 Advanced Solid Tumor Phase 1 Completed - Japan ... More >> Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Yufu, Oita, Japan, 879-5593 Less <<
NCT00316628 Influenza Phase 2 Completed - Italy ... More >> G. D'Annunzio University Chieti, Italy, 66100 Office of Hygiene and Public Health, ASL Lanciano Lanciano, Italy Less <<
NCT01132625 Advanced Solid Tumors Phase 1 Completed - Japan ... More >> Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Less <<
NCT01217177 Locally Advanced Cervical Canc... More >>er Less << Phase 1 Completed - Brazil ... More >> Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20230-130 Novartis Investigative Site Rio de Janeiro, Brazil Less <<
NCT01915849 Type 2 Diabetes Mellitus Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Chula Vista, California, United States, 91910 Less <<
NCT01915849 - Completed - -
NCT01283503 Advanced Solid Tumor Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8560 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Less <<
NCT01930162 - Completed - -
NCT00346242 Thalassemia Phase 4 Completed - Greece ... More >> Novartis Investigative Site Athens, Greece Less <<
NCT01302899 Non-diabetic Nephropathy Phase 2 Terminated(In consequence of t... More >>ermination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.) Less << - Netherlands ... More >> Novartis Investigative Site Groningen, Netherlands Novartis Investigative Site Leeuwarden, Netherlands Less <<
NCT01930162 Single Umbilical Cord Blood Tr... More >>ansplantation Non-myeloablative Conditioning Acute Lymphocytic Leukemia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Minnesota ... More >> Novartis Investigative Site Minneapolis, Minnesota, United States, 55455 Less <<
NCT01302899 - Terminated(In consequence of t... More >>ermination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.) Less << - -
NCT03150160 Glaucoma Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site Busan, Korea, Republic of, 49241 Novartis Investigative Site Seoul, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Republic of, 06351 Less <<
NCT00481065 Pandemic Avia... More >>n Influenza Less << Phase 2 Completed - Colombia ... More >> Bogotà, Colombia Less <<
NCT01285453 Advanced or Recurrent Solid Tu... More >>mors Less << Phase 1 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan Novartis Investigative Site Osaka, Japan Less <<
NCT02052687 Healthy Phase 1 Completed - United Kingdom ... More >> Novartis Investigative Site Mid Glamorgan, United Kingdom, CF484DR Less <<
NCT00138606 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT00481065 - Completed - -
NCT02074995 Hypercatabolic Status Related ... More >>to Severe Burn Less << Phase 2 Terminated(The study was prema... More >>turely terminated due to recruitment issues) Less << - United States, North Carolina ... More >> Novartis Investigative Site Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01348100 - Completed - -
NCT01348100 Schizophrenia Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Glendale, California, United States, 91206 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19149 Less <<
NCT00425373 Essential Hypertension Phase 2 Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan, 11111 Less <<
NCT00425373 - Completed - -
NCT01365468 Plexiform Neurofibroma Associa... More >>ted With Neurofibromatosis Type 1 Less << Phase 2 Terminated(Poor patients' accr... More >>ual) Less << - Israel ... More >> Novartis Investigative Site Tel-Aviv, Israel, 6423906 Novartis Investigative Site Tel-Hashomer, Israel, 52621 Less <<
NCT02074995 - Terminated(The study was prema... More >>turely terminated due to recruitment issues) Less << - -
NCT01299701 Advanced Solid Tumors Phase 1 Terminated - New Zealand ... More >> Novartis Investigative Site Grafton, Auckland, New Zealand Less <<
NCT01365468 - Terminated(Poor patients' accr... More >>ual) Less << - -
NCT00170742 Proliferative Diabetic Retinop... More >>athy Less << Phase 3 Terminated(trial stopped on Se... More >>pt 24, 2007) Less << - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT02115386 Philadelphia Positive (Ph+) Ch... More >>ronic Myeloid Leukemia Less << Phase 3 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation, 125167 Less <<
NCT02047656 Part 1 - Healthy Volunteers ... More >> Part 2 - Patients With Hypertension Less << Phase 1 Terminated - United States, Florida ... More >> Novartis Investigative Site Miami, Florida, United States, 33126 Less <<
NCT00342940 Influenza Phase 2 Withdrawn(Lack of Vaccine Supp... More >>lies) Less << - United Kingdom ... More >> Chiltern International Limited , Chiltern Place, Upton Road Slough, United Kingdom, SL1 2AD Less <<
NCT02123199 - Completed - United Kingdom ... More >> Novartis Investigative Site London, United Kingdom Less <<
NCT00366938 Osteoarthritis, Knee Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation E. Hanover, New Jersey, United States, 07936 Less <<
NCT02149420 Primary Sj?gren's Syndrome Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Less <<
NCT00125125 Dyslipidemia Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT02140411 Retinal Vein Occlusion ... More >> Age Related Macular Degeneration Less << Phase 4 Completed - Chile ... More >> Novartis Investigative Site Providencia, Santiago de Chile, Chile, 7510168 Less <<
NCT01433458 Hepatic Impairment Phase 1 Completed - Germany ... More >> Novartis Investigative Site Grunstadt, Germany, D-67269 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 115419 Less <<
NCT01387958 Hepatitis C Phase 2 Terminated(Terminated early du... More >>e to futility) Less << - New Zealand ... More >> Novartis Investigative Site Auckland, New Zealand Novartis Investigative Site Christchurch, New Zealand Less <<
NCT00316615 Influenza Disease Phase 2 Completed - Italy ... More >> G. D'Annunzio University Chieti, Italy, 66100 Office of Hygiene and Public Health, ASL Lanciano Lanciano, Italy Less <<
NCT02194803 - Completed - Germany ... More >> Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT00138528 Metabolic Syndrome Phase 4 Completed - Germany ... More >> Novartis Nürnberg, Germany Less <<
NCT02202616 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Canada, Quebec ... More >> Novartis Investigative Site St-Charles-Borromée, Quebec, Canada, J6E 2B4 Less <<
NCT00171262 Dyslipidemia Phase 4 Completed - Spain ... More >> Novartis Madrid, Spain Less <<
NCT00171275 Coronary Disease ... More >> Myocardial Infarction Less << Phase 4 Completed - Czech Republic ... More >> Novartis Praha, Czech Republic Less <<
NCT01435330 Insulin Resistance Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Chula Vista, California, United States, 91910 United States, Washington Novartis Investigative Site Tacoma, Washington, United States, 98418 Less <<
NCT00171327 Hypertension ... More >>Dyslipidemia Less << Phase 4 Completed - Russian Federation ... More >> Novartis Moscow, Russian Federation Less <<
NCT01447485 Hypertension ... More >>Chronic Kidney Disease Nephrotic Syndrome Less << Phase 1 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan Novartis Investigative Site Tokyo, Japan Less <<
NCT00171288 Dyslipidemia Phase 3 Completed - Spain ... More >> Novartis Madrid, Spain Less <<
NCT01484197 Asthma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Wiesbaden, Germany, 65187 United Kingdom Novartis Investigative Site Machester, United Kingdom, M23 9QZ Less <<
NCT01471548 Advanced Solid Tumors Phase 1 Completed - Japan ... More >> Novartis Investigative Site Takatsuki, Osaka, Japan, 569-8686 Novartis Investigative Site Hidaka, Saitama, Japan, 350-1241 Less <<
NCT02258009 Visual Impairment Due to Diabe... More >>tic Macular Edema Less << Phase 4 Withdrawn October 2016 Germany ... More >> Novartis Investigative Site Chemnitz, Germany, 09113 Less <<
NCT01484197 - Completed - -
NCT00385658 Dyslipidemia Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharma AG Basel, Switzerland Less <<
NCT00565474 Graft Vasculopathy Phase 4 Completed - Spain ... More >> Novartis Investigative Site Barcelona, Spain Less <<
NCT00171236 Heterozygous Familial Hypercho... More >>lesterolemia Mixed Dyslipidemia Less << Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00633997 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Terminated(After analysis of t... More >>he existing data, it was determined that additional skin biopsy samples would not be required to determine study outcome.) Less << - United States, Maryland ... More >> Novartis Investigator Site Baltimore, Maryland, United States, 21225 Less <<
NCT00529269 Renal Transplant Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site Busan, Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Less <<
NCT02276027 Adenocarcinoma Lung Cancer; Sq... More >>uamous Cell Lung Carcinoma Less << Phase 2 Active, not recruiting February 1, 2019 China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 51000 Less <<
NCT01528241 Depression Phase 1 Completed - United States, New York ... More >> Novartis Investigative Site New York, New York, United States United States, Pennsylvania Novartis Investigative Site Pittsburgh, Pennsylvania, United States Less <<
NCT01546428 Advanced Solid Tumor Phase 1 Completed - Japan ... More >> Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Fukuoka, Japan, 811-1395 Less <<
NCT00660309 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Massachusetts ... More >> Novartis Investigator Site Boston, Massachusetts, United States, 02115 Less <<
NCT00294710 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00660309 - Completed - -
NCT01558323 Renal Impairment Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 Less <<
NCT01562041 Atherosclerotic Coronary Vascu... More >>lar Disease Less << Phase 2 Terminated - United States, Florida ... More >> Novartis Investigative Site Jacksonville, Florida, United States, 32216 United States, New York Novartis Investigative Site New York, New York, United States, 10021 Less <<
NCT01578928 Renal Impairment Phase 1 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 14050 South Africa Novartis Investigative Site Bloemfontein, Free State, South Africa, 9300 Less <<
NCT02044848 Type 1 Diabetes Mellitus Phase 2 Terminated(This study was term... More >>inated prematurely by the Sponsor for business reasons only.) Less << - United States, New York ... More >> Novartis Investigative Site New York City, New York, United States, 10032 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98122 Less <<
NCT02044848 - Terminated(This study was term... More >>inated prematurely by the Sponsor for business reasons only.) Less << - -
NCT00262236 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT03131479 Renal Impairment Phase 2 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 Less <<
NCT00556673 - Completed - -
NCT01418235 HIV Seronegativity ... More >> HIV Preventive Vaccine Less << Phase 1 Unknown June 2015 South Africa ... More >> Perinatal HIV Research Unit Johannesburg, Gauteng, South Africa, 1864 Aurum Institute for Health Research Klerksdorp, North-West Province, South Africa, 2570 Desmond Tutu HIV Centre Cape Town, Western Cape, South Africa, 7750 Less <<
NCT00556673 Asthma Phase 2 Completed - France ... More >> Novartis Investigator Site Poitiers, France, 86000 Germany Novartis Investigator Site Berlin, Germany, 14050 Less <<
NCT03198767 - Completed - -
NCT02250443 - Completed - -
NCT02250443 Sporadic Inclusion Body Myosit... More >>is (sIBM) Less << Phase 2 Phase 3 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85013 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 Less <<
NCT03198767 Obesity Phase 2 Completed - United States, Nebraska ... More >> Novartis Investigative Site Lincoln, Nebraska, United States, 68502 Less <<
NCT00532350 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Completed - Germany ... More >> Novartis investigative site Berlin, Germany Novartis Investigative site Mannheim, Germany Novartis Investigative site Wiesbaden, Germany Less <<
NCT00545259 de Novo Liver Transplantation Phase 1 Completed - Germany ... More >> Novartis investigative site Berlin, Germany Italy Novartis Investigative Site Padova, Italy Switzerland Novartis investigative site Zurich, Switzerland Less <<
NCT00219154 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT02201290 Purpura, Thrombocytopenic, Idi... More >>opathic Less << Phase 3 Completed - Russian Federation ... More >> Novartis Investigative Site Krasnodar, Russian Federation, 350007 Novartis Investigative Site Moscow, Russian Federation, 117997 Novartis Investigative Site Saint Petersburg, Russian Federation, 198205 Less <<
NCT00101712 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Investigative Site, Germany Switzerland Novartis Investigative Site Basel, Switzerland Less <<
NCT01001572 Essential Hypertension Phase 3 Completed - -
NCT00310700 Prevention of Meningococcal In... More >>fection Less << Phase 4 Completed - United Kingdom ... More >> Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, Oxon, United Kingdom, OX3 7LJ Less <<
NCT01001572 - Completed - -
NCT00605306 Asthma Phase 2 Completed - France ... More >> Novartis Investigator Site Neuil, France Novartis Investigator Site Paris, France Novartis Investigator Site Poitiers, France Less <<
NCT00537537 Hepatitis B, Chronic Phase 4 Completed - India ... More >> Novartis Investigative Site Hyderabad, India Novartis Investigative Site Mumbai, India Novartis Investigative Site Vellore, India Less <<
NCT02334748 Systemic Juvenile Idiopathic A... More >>rthritis Hereditary Periodic Fevers Less << Phase 3 Active, not recruiting December 24, 2018 France ... More >> Novartis Investigative Site Bron Cedex, France, 69677 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Paris, France, 75015 Less <<
NCT00582738 - Terminated - -
NCT00382096 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00582738 Recurrent Hepatitis C Phase 2 Terminated - Argentina ... More >> Novartis Investigative site Buenos Aires, Argentina Less <<
NCT00402909 Type 2 Diabetes Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07974 Less <<
NCT00654589 Iron Overload Phase 4 Completed - Germany ... More >> Novartis Investigative Site Leipzig, Germany Less <<
NCT00605306 - Completed - -
NCT00417170 - Completed - -
NCT00669097 Advanced Solid Malignancies Phase 1 Completed - Netherlands ... More >> Novartis Investigative Site Amsterdam, Netherlands Less <<
NCT00099944 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00501852 - Completed - -
NCT00501852 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - Belgium ... More >> Novartis Investigator Site Vilvoorde, Belgium France Novartis Investigator Site Rueil-Malmaison,, France Japan Novartis Investigator site Tokyo, Japan Less <<
NCT00423085 Alzheimer's Disease Phase 3 Completed - Japan ... More >> Novartis Investigative Site Hokkaido region, Hokkaido, Japan Less <<
NCT00633295 Gastrointestinal Stromal Tumor... More >>s (GIST) Less << Phase 2 Completed - Israel ... More >> Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Tel Aviv, Israel Novartis Investigative Site Tel Hashomer, Israel Less <<
NCT00670553 Prostate Cancer ... More >> Head & Neck Cancer Esophageal Cancer Less << Phase 1 Completed - Belgium ... More >> Novartis Investigative Site Liege, Belgium Less <<
NCT00396409 - Completed - -
NCT00150046 Heart Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigational Site Germany, Germany Switzerland Basel Novartis Pharma AG Basel, Switzerland Less <<
NCT00237237 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers Nurnberg, Germany Less <<
NCT00396409 Allergic Asthma Phase 3 Completed - Germany ... More >> Novartis Investigator site Nuremberg, Germany Less <<
NCT00927901 Asthma Phase 2 Completed - France ... More >> Novartis Investigative Site Poitiers, France Germany Novartis Investigative Site Wiesbaden, Germany Italy Novartis Investigative Site Verona, Italy Less <<
NCT00739414 Cancer Advanc... More >>ed Solid Tumor Less << Phase 1 Completed - Japan ... More >> Novartis Investigational Site Aichi prefecture, Japan Novartis Investigational Site Hokkaido, Japan Novartis Investigational Site Hyogo prefecture, Japan Less <<
NCT00927901 - Completed - -
NCT02137889 Relapsed or Refractory Chronic... More >> Lymphocytic Leukemia (CLL) Less << Phase 1 Terminated(Study terminated on... More >> 04Oct2013 for business reasons after being on hold for 10 months. Early termination was not due to safety concerns.) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Moffitt Cancer SC Tampa, Florida, United States, 33612 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT00961896 Treatment for Basal Cell Carci... More >>nomas (BCCs) in Gorlin Syndrome Patients Less << Phase 2 Completed - Austria ... More >> Novartis Investigative Site Graz, Austria Novartis Investigator Site Vienna, Austria Switzerland Novartis Investigative Site Zurich, Switzerland Less <<
NCT03594825 Hypertension;Nephropathy Phase 4 Not yet recruiting December 2023 -
NCT00968591 Hepatic Insufficiency Phase 1 Completed - Germany ... More >> Novartis Investigative Site Frankfurt, Germany Russian Federation Novartis Investigative Site Moscow, Russian Federation Singapore Novartis Investigative Site Singapore, Singapore Less <<
NCT00965094 Chronic Renal Failure Phase 4 Completed - Israel ... More >> Novartis Investigative Site Haifa, Israel, 31096 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Tel-Aviv, Israel, 64239 Less <<
NCT00965094 - Completed - -
NCT00376259 Hepatitis B Phase 3 Terminated(The study was not c... More >>ompleted as planned and was terminated early with agreement from the European Medicines Agency (EMEA)) Less << - United States, California ... More >> Novartis San Diego, California, United States San Mateo, California, United States Hong Kong Pok Fu Lam, Hong Kong Korea, Republic of Seoul, Korea, Republic of Taiwan Novarits Kaohsuing, Taiwan Thailand Bangkok, Thailand Less <<
NCT00306527 Influenza Phase 3 Completed - Poland ... More >> Wojewódzki Szpital Dzieci_cy ul. Langiewicza 2, Kielce, Poland, 25-381 Centrum Bada_ Farmakologii Klinicznej ul. Ujastek 3, Krakow, Poland, 30-969 NZOZ Jagiello_skie Centrum Medyczne Sp. z o.o., o_. Jagiello_skie 1, Kraków, Poland, 31-832 NZOZ Praktyka Grupowa Lekarzy Rodzinnych, "Familia" Sp. z o.o. Pl. Sikorskiego 6a, Kraków, Poland, 31-115 Szpital Jana Pawła II, Oddz. Neuroinfekcji ul. Pr_dnicka 80, Kraków, Poland, 31-202 Less <<
NCT00961896 - Completed - -
NCT00879905 Advanced Solid Malignancies Phase 1 Completed - Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Toulouse Cedex 3, France, 31052 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Less <<
NCT00991146 Cryopyrin-associated Periodic ... More >>Syndromes Familial Cold Autoinflammatory Syndrome Muckle-Wells Syndrome Neonatal Onset Multisystem Inflammatory Disease Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 236-0004 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 606-8507 Less <<
NCT01250951 Myelodysplastic Syndrome ... More >> Thalassemia Less << Phase 4 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site Saint-Petersburg, Russian Federation Novartis Investigative Site St. Petersburg, Russian Federation Less <<
NCT00376259 - Terminated(The study was not c... More >>ompleted as planned and was terminated early with agreement from the European Medicines Agency (EMEA)) Less << - -
NCT00434733 Influenza Phase 3 Completed - Poland ... More >> Centrum Badań Farmakologii Klinicznej monipol Kraków, Poland, 30-969 Less <<
NCT00306527 - Completed - -
NCT00523744 Hypertension Phase 3 Completed - Germany ... More >> Novartis Investigative Site, , Germany Schwerin, Germany Less <<
NCT01303380 Mevalonate Kinase Deficiency Phase 2 Completed - Spain ... More >> Novartis Investigative Site Esplugues de Llobregat, Barcelona, Spain, 08950 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Madrid, Spain, 28046 Less <<
NCT01303380 - Completed - -
NCT01368523 Chronic Myelogenous Leukemia Phase 4 Completed - Poland ... More >> Novartis Investigative Site Gdansk, Poland Novartis Investigative Site Poznan, Poland Novartis Investigative Site Warsaw, Poland Less <<
NCT01810042 Exudative Age-related Macular ... More >>Degeneration Less << Phase 4 Completed - Korea, Republic of ... More >> Pusan National University Hospital Busan, Korea, Republic of, 602-739 Haeundae Baik Hospital Busan, Korea, Republic of, 612-896 Less <<
NCT00560820 β-thalassemia ... More >> Transfusional Iron Overload Less << Phase 1 Completed - Italy ... More >> Novartis Investigative Site Cagliari, CA, Italy, 09121 Novartis Investigative Site Genova, GE, Italy, 16128 Novartis Investigative Site Orbassano, Italy, 10043 Less <<
NCT01390519 - Completed - Norway ... More >> Novartis Investigative Site Kristiansand, Norway, 4615 Novartis Investigative Site Tromsø, Norway, 9038 Novartis Investigative Site Trondheim, Norway, 7006 Less <<
NCT01256658 Malaria Phase 4 Completed - Burkina Faso ... More >> Novartis Investigative Site Burkina Faso, Burkina Faso, 2208 Centre National de Recherche et de Formation sur le Paludisme Ouagadougou, Burkina Faso Novartis Investigative site Ouagadougou, Burkina Faso Less <<
NCT01810042 - Completed - -
NCT01456663 Hepatic Impairment Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 Germany Novartis Investigative Site Berlin, Germany, 10117 Hungary Novartis Investigative Site Balatonfured, Hungary, 8230 Less <<
NCT01423110 Sporadic Inclusion Body Myosit... More >>is Less << Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Scottsdale, Arizona, United States United States, Kansas Novartis Investigative Site Kansas City, Kansas, United States United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States Less <<
NCT01471847 Locally Advance Breast Cancer ... More >>(LABC) Metastatic Breast Cancer (MBC) Less << Phase 1 Completed - Spain ... More >> Novartis Investigative Site Madrid, Spain, 28050 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Novartis Investigative Site Manchester, United Kingdom, M20 2BX Less <<
NCT01495247 Inoperable Locally Advanced Br... More >>east Cancer Metastatic Breast Cancer (MBC) Less << Phase 1 Phase 2 Completed - France ... More >> Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Spain Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Less <<
NCT01256658 - Completed - -
NCT01565902 Hepatic Impairment Phase 1 Completed - Hungary ... More >> Novartis Investigative Site Balatonfured, Hungary, 8230 Novartis Investigative Site Budapest, Hungary, 1076 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 115419 Less <<
NCT00523744 - Completed - -
NCT01524341 Malaria Phase 2 Completed - Thailand ... More >> Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Tak Province, Thailand, 63110 Novartis Investigative Site Tak, Thailand, 63110 Less <<
NCT01565902 - Completed - -
NCT01569815 Mild and Moderate Renal Impair... More >>ment Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Neuss, Germany, 41460 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117292 Serbia Novartis Investigative Site Belgrade, Serbia Less <<
NCT00099866 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis investigative Site Investigative Sites, Germany Less <<
NCT00099931 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Investigative Sites, Germany Less <<
NCT01569828 Pharmacokinetics ... More >> Renal Impaired Healthy Volunteer Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Neuss, Germany, 41460 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117292 Serbia Novartis Investigative Site Belgrade, Serbia Less <<
NCT01569828 - Completed - -
NCT01569815 - Completed - -
NCT01610050 Castration-resistant Prostate ... More >>Cancer, Advanced Breast Cancer Less << Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8560 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT01598103 Neurogenic Urinary Bladder ... More >> Neurogenic Bladder Disorder Neurogenic Dysfunction of the Urinary Bladder Neurogenic Bladder, Uninhibited Neurogenic Bladder, Spastic Less << Phase 2 Terminated - Germany ... More >> Novartis Investigative Site Murnau, Germany, D-82419 Netherlands Novartis Investigative Site Nijmegen, Netherlands Switzerland Novartis Investigative Site Zürich, Switzerland, 8008 Less <<
NCT01596062 Renal Transplantation Phase 2 Completed - France ... More >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Tours Cedex, France, 37044 Less <<
NCT01626209 Advanced Breast Cancer, Advanc... More >>ed Carcinomas With Squamous Cell Histology Less << Phase 1 Completed - China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510030 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Guangzhou, China, 510060 Less <<
NCT01624636 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 2 Terminated - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85014 United States, Florida Novartis Investigative Site Winter Haven, Florida, United States, 33880 United States, Ohio Novartis Investigative Site Beachwood/Cleveland, Ohio, United States, 44122 Less <<
NCT01590199 Neuroendocrine Tumors Phase 1 Active, not recruiting May 1, 2020 Germany ... More >> Novartis Investigative Site Bad Berka, Germany, 99438 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT01632358 Dyslipidaemia Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Miramar, Florida, United States, 33025 Jordan Novartis Investigative Site Amman, Jordan, 11941 Taiwan Novartis Investigative Site Taichung, Taiwan, 40447 Less <<
NCT01634763 Tumors Characterized by Geneti... More >>c Alterations in Anaplastic Lymphoma Kinase (ALK) Less << Phase 1 Completed - Japan ... More >> Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Koto, Tokyo, Japan, 135-8550 Novartis Investigative Site Fukuoka, Japan, 811-1395 Less <<
NCT01631864 - Completed - -
NCT01079143 Renal Interstitial Fibrosis Phase 3 Completed - France ... More >> Novartis Investigative Site Caen, Cedex, France, 14033 Novartis Investigative Site Amiens cedex1, France, 80054 Novartis Investigative Site Angers, France, 49 033 Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Lyon, France, 69 437 Novartis Investigative Site Nice Cedex 1, France, 06602 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Paris, France, 75475 Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Pierre Benite Cedex, France, 69495 Novartis Investigative Site Poitiers, France, 86000 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site St Priest en Jarez Cedex, France, 42277 Novartis Investigative Site Strasbourg, France, 67091 Novartis Investigative Site Suresnes, France, 92150 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Novartis Investigative Site Tours Cedex, France, 37044 Novartis Investigative Site Vandoeuvre Les Nancys, France, 54511 Less <<
NCT01631864 Hypertension ... More >>Concurrent Obesity Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Neuss, Germany, 41460 Netherlands Novartis Investigative Site Maastricht, Netherlands, 5800 Less <<
NCT01079143 - Completed - -
NCT00171912 Hypereosinophilic Syndrome ... More >> Systemic Mastocytosis Chronic Myelomonocytic Leukemia Dermatofibrosarcoma Less << Phase 2 Completed - Australia ... More >> Novartis Investigative Site East Melbourne, Australia Less <<
NCT00171899 Chronic Myelogenous Leukemia Phase 4 Completed - Canada ... More >> Novartis Investigative Site Toronto, Canada Less <<
NCT01596062 - Completed - -
NCT00171964 Pain Neoplasm... More >> Metastasis Cancer Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Herne, Germany Less <<
NCT00171925 - Terminated(Recruitment in stud... More >>y could not be reached after 8 yrs of recruiting) Less << - -
NCT00171860 Hypereosinophilic Syndrome Phase 2 Terminated - Belgium ... More >> Novartis Investigative Site Leuven, Belgium Less <<
NCT00172003 Renal Cell Cancer ... More >> Neoplasm Metastasis Less << Phase 4 Completed - Germany ... More >> Novartis investigative Site Offenbach, Germany Less <<
NCT00171977 Gastrointestinal Stromal Tumor... More >>s Less << Phase 4 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT00171925 Multiple Myeloma Stage I Phase 3 Terminated(Recruitment in stud... More >>y could not be reached after 8 yrs of recruiting) Less << - Germany ... More >> Novartis Investigative Site Berlin, Germany Less <<
NCT00237146 Prostate Cancer Phase 4 Completed - Venezuela ... More >> Novartis Investigative Site Caracas, Venezuela Less <<
NCT00219271 Prostate Cancer Phase 4 Completed - Greece ... More >> Novartis Investigative Site Athens, Greece Less <<
NCT01766778 Type-2 Diabetes Mellitus Phase 4 Completed - Hong Kong ... More >> Novartis Investigative Site Hong Kong SAR, Hong Kong Novartis Investigative Site HongKong, Hong Kong Novartis Investigative Site Tuen Mun, Hong Kong Less <<
NCT01652547 Metastatic Melanoma and Merkel... More >> Cell Carcinoma Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Essen, Germany, 45147 Switzerland Novartis Investigative Site Lausanne, Switzerland, 1011 Novartis Investigative Site Zuerich, Switzerland, 8091 Less <<
NCT01831947 Macular Degeneration Phase 4 Completed - Germany ... More >> Dept. of Ophthalmology, University Medical Center Goettingen Goettingen, Germany, 37075 Less <<
NCT00242541 Acromegaly Phase 4 Terminated - Mexico ... More >> Novartis Investigative Site Mexico City, Mexico Less <<
NCT01780935 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 3 Completed - -
NCT01780935 - Completed - -
NCT01727128 Hepatic Impairment Phase 1 Completed - Bulgaria ... More >> Novartis Investigative Site Sofia, Bulgaria, 1618 Germany Novartis Investigative Site Berlin, Germany, 14050 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117198 Less <<
NCT00311012 Hypertension Phase 2 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT01825980 Hepatitis C Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigative Site San Diego, California, United States, 92120 United States, Florida Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78215 Less <<
NCT00099853 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01766778 - Completed - -
NCT00099892 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00394745 Hypertension ... More >>Metabolic Syndrome Less << Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT00101673 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00099957 Diabetes Mellitus, Type 2 Phase 2 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00101803 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00510003 Atopic Dermatitis Phase 4 Completed - Spain ... More >> Novartis Investigative Site Madrid, Spain Less <<
NCT00344110 Hypertension Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Japan, Japan Less <<
NCT00329940 Breast Cancer Phase 3 Completed - France ... More >> Novartis Investigative Site Saint Cloud, France Less <<
NCT00332969 Thymoma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Regensburg, Germany Less <<
NCT00099905 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00332696 - Completed - -
NCT00724776 Chronic Hepatitis C Phase 1 Completed - Japan ... More >> Novartis Pharmaceuticals, Japan Tokyo, Japan Less <<
NCT00334139 Prostate Cancer ... More >> Breast Cancer Bone Metastasis Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Ulm, Germany Less <<
NCT00332696 Peritoneal Neoplasms ... More >> Intestinal Obstruction Carcinomatosis Less << Phase 2 Completed - France ... More >> Novartis Investigative Site Creteil, France Less <<
NCT00110240 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00375427 - Completed - -
NCT00333086 Recurrent and Metastatic Endom... More >>etrial Cancer Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Heidelberg, Germany Less <<
NCT01979614 Coronary Artery Disease Phase 2 Completed - United Kingdom ... More >> Novartis Investigative Site Clydebank, West Dumbartonshire, United Kingdom, G81 4HX Novartis Investigative Site Edinburgh, United Kingdom, EHN 2XU Novartis Investigative Site Leicester, United Kingdom, LE3 9QP Less <<
NCT00264576 - Completed - -
NCT00417170 High Blood Pressure ... More >> Metabolic Syndrome Insulin Resistance Endothelial Dysfunction Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Santa Monica, California, United States, 90404 Less <<
NCT00375427 Breast Cancer With Bone Metast... More >>asis Less << Phase 3 Completed - Italy ... More >> Novartis Investigative Site Forlì, Italy Less <<
NCT00410358 Advanced Solid Tumors Phase 1 Completed - Japan ... More >> Novartis Investigative Site Chiba Prefecture, Japan Less <<
NCT00264576 Influenza Disease; Flu Phase 2 Completed - United States, Kentucky ... More >> Bardstown, Kentucky, United States, 40004 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15241 United States, Utah Salt Lake City, Utah, United States, 84109 Salt Lake City, Utah, United States, 84121 Less <<
NCT00136851 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00432627 Hepatic Impairment Phase 1 Completed - Germany ... More >> Novartis Investigative Site Kiel, Germany Less <<
NCT00384228 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Less << Phase 1 Phase 2 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT00329966 Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell’Invecchiamento Università G. D’AnnunzioVia dei Vestini Chieti, Italy, 66100 Ufficio Igiene e Sanità Pubblica di Lanciano, ASL, Via S. Spaventa, 37 Lanciano, Italy Less <<
NCT00423085 - Completed - -
NCT00428909 Chronic Myeloid Leukemia (CML) Phase 1 Completed - Korea, Republic of ... More >> Novartis Investigative Site Seoul, Korea, Republic of Less <<
NCT00441610 Advanced Solid Tumors Phase 1 Completed - Japan ... More >> Novartis Investigative Site Chiba, Japan Less <<
NCT00545311 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 1 Completed - Denmark ... More >> Novartis Investigative site Copenhagen, Denmark Germany Novartis investigative site Berlin, Germany Novartis investigative site Moenchengladbach, Germany Novartis Investigative Site Munich, Germany Less <<
NCT00329927 Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell’Invecchiamento, Università G. D'Annunzio Via dei Vestini, Chieti, Italy, 66100 Ufficio Igiene e Sanità Pubblica di Lanciano, Via S. Spaventa, 37 Lanciano, Italy Less <<
NCT02091752 - Terminated(The study was termi... More >>nated due to low enrollment.) Less << - -
NCT00260156 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00472368 Cancer Patients With Advanced ... More >>Solid Tumors Including Lymphoma or Chronic Hematological Malignancies Less << Phase 1 Completed - United States, New York ... More >> Novartis Investigative Site Buffalo, New York, United States, 14263 Less <<
NCT00481143 Myelodysplastic Syndromes ... More >> Transfusion Dependent Iron Overload Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 12200 Less <<
NCT00523549 Hypertension ... More >>Diastolic Dysfunction Less << Phase 4 Completed - United States, New Jersey ... More >> Novartis Investigative Sites USA, New Jersey, United States Less <<
NCT02091752 Primary Myelofibrosis Phase 2 Terminated(The study was termi... More >>nated due to low enrollment.) Less << - Germany ... More >> Novartis Investigative Site Leipzig, Germany, 04103 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Spain Novartis Investigative Site Madrid, Spain, 28034 Less <<
NCT00102388 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00367978 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT00003884 Hypercalcemia of Malignancy ... More >> Lung Cancer Metastatic Cancer Pain Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT00260208 Liver Transplant ... More >> Hepatitis C Less << Phase 4 Terminated(Study was premature... More >>ly terminated due to poor recruitment.) Less << - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States Switzerland Novartis Investigational Site Zurich, Switzerland, 8091 Less <<
NCT00354016 Influenza Phase 3 Completed - Germany ... More >> Werksarztzentrum Herborn, Westerwaldstr 36, Herborn, Germany, 35745 Betriebsarztlicher Dienst, Universitat Marburg, Robert-Koch-Str, 5, Marburg, Germany, 35037 Less <<
NCT00099918 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Sites Investigative Centers, Germany Less <<
NCT00260208 - Terminated(Study was premature... More >>ly terminated due to poor recruitment.) Less << - -
NCT02575365 Cognition Bra... More >>in Volume Loss Less << Phase 4 Terminated - Turkey ... More >> Novartis Investigative Site Bursa, Turkey, 16059 Novartis Investigative Site Kocaeli, Turkey, 41380 Novartis Investigative Site Kutahya, Turkey, 43000 Less <<
NCT00818571 Renal Impairment ... More >> Diabetes Less << Phase 1 Phase 2 Completed - Russian Federation ... More >> Novartis Investigator Site Moscow, Russian Federation Less <<
NCT00523549 - Completed - -
NCT02678260 Advanced Malignancies Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 466-8560 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Less <<
NCT00311428 Influenza Phase 4 Completed - Finland ... More >> University of Tampere Medical School Tampere, Finland Less <<
NCT00310674 Prevention of Meningococcal In... More >>fection Less << Phase 3 Completed - Italy ... More >> Istituto di Pediatria, Università degli Studi di Milano Milano, Italy, 20122 Less <<
NCT00299806 Hypertension Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Japan, Japan Less <<
NCT02713256 - Completed - -
NCT00333229 Primary Hormone Receptor Negat... More >>ive Breast Cancer in Premenopausal Women Less << Phase 4 Terminated(Due to rare patient... More >> population, planned number of patients could not be recruited in a reasonable timeframe. Recruitment was stopped prematurely.) Less << - Germany ... More >> Novartis Investigative Site Marburg, Germany, 35043 Less <<
NCT00171990 Recurrent Genital Herpes Phase 3 Completed - Australia ... More >> Novartis Investigative Site North Ryde, Australia Less <<
NCT00333229 - Terminated(Due to rare patient... More >> population, planned number of patients could not be recruited in a reasonable timeframe. Recruitment was stopped prematurely.) Less << - -
NCT00372476 Breast Cancer Phase 4 Completed - Germany ... More >> Novartis Investigative Site Kiel, Germany, 24105 Less <<
NCT00375505 Breast Cancer Phase 3 Completed - Germany ... More >> Novartis Investigative Site Marburg, Germany, 35043 Less <<
NCT02634983 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - United Kingdom ... More >> Novartis Investigative Site Sheffield, South Yorkshire, United Kingdom, S10 2JF Novartis Investigative Site Bradford, West Yorkshire, United Kingdom, BD9 6RJ Novartis Investigative Site Manchester, United Kingdom, M23 9QZ Less <<
NCT02713256 Graves' Disease Phase 2 Completed - United States, Hawaii ... More >> Novartis Investigative Site Honolulu, Hawaii, United States, 96814 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 Germany Novartis Investigative Site Mainz, Germany, 55131 Less <<
NCT00427583 Malignant Peripheral Nerve She... More >>ath Tumors Less << Phase 2 Phase 3 Terminated(stopped due to slow... More >> recruitment and no effect) Less << - Germany ... More >> Novartis Investigative Site Berlin, Germany Novartis Investigative Site Hamburg, Germany Less <<
NCT01018693 Seasonal Allergic Rhinitis Phase 2 Completed - United Kingdom ... More >> Novartis Investigator Site London, United Kingdom Less <<
NCT01066468 Chronic Myeloid Leukemia (CML)... More >> Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN) Less << Phase 1 Terminated - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation, 117997 Less <<
NCT01103050 Allergic Rhinitis Phase 2 Completed - Canada ... More >> Novartis Investigative Site Ontario, Canada Less <<
NCT01146522 Hyperlipoproteinemia Phase 1 Phase 2 Completed - Canada ... More >> Novartis Investigative Site Quebec, Canada Less <<
NCT00375505 - Completed - -
NCT00750295 Chronic Kidney Disease Phase 1 Phase 2 Completed - United States, Colorado ... More >> Novartis Investigator Site Denver, Colorado, United States, 80230 Less <<
NCT00154310 Renal Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigational Sites Nurnberg, Germany Switzerland Novartis Pharma AG Basel, Switzerland Novartis Investigational Sites Bern, Switzerland Less <<
NCT00098046 Chickenpox He... More >>rpes Zoster Less << Phase 3 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Costa Rica Novartis Investigational Site San Jose, Costa Rica Guatemala Novartis Investigational Site Cuidad de Guatemala, Guatemala Panama Novartis Investigational Site Ciudad de Panama, Panama Novartis Investigational Site David, Chiriqui, Panama Less <<
NCT01220648 Chronic Myeloid Leukemia Phase 1 Completed - Germany ... More >> Novartis Investigative Site Leipzig, Germany, 04103 Less <<
NCT00154310 - Completed - -
NCT02947152 Epithelial Ovarian Cancer ... More >> Renal Cell Carcinoma Less << Phase 1 Terminated - United States, Texas ... More >> Novartis Investigative Site Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Japan Novartis Investigative Site Nagoya, Aichi, Japan, 466 8560 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Locarno, Switzerland, 6600 Less <<
NCT01430416 Uveal Melanoma Phase 1 Active, not recruiting October 11, 2018 United States, Massachusetts ... More >> Dana Farber Cancer Institute DFCI - Brookline Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering MSKCC 4 New York, New York, United States, 10017 France Novartis Investigative Site Paris, France, 75231 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC United Kingdom Novartis Investigative Site London, United Kingdom, SW3 6JJ Less <<
NCT01958905 Malaria Sever... More >>e Acute Malnutrition Less << Not Applicable Completed - Mali ... More >> District Hospital Ouelessebougou, Mali Niger CSI Andoumè Maradi city, Niger Less <<
NCT00327587 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation E. Hanover, New Jersey, United States, 07936 Less <<
NCT00758524 Essential Hypertension Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Less <<
NCT01047579 Alzheimer's Disease Phase 4 Completed - Israel ... More >> Novartis Investigative Site Ashkelon, Israel Novartis Investigational Site Haifa, Israel Novartis Investigative Site Holon, Israel Novartis Investigative Site Ramat Gan, Israel Novartis Investigative Site Tel Aviv, Israel Less <<
NCT01033097 Pruritus in Patients With Atop... More >>ic Dermatitis Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Novartis Investigative Site Frankfurt, Germany Novartis Investigator Site Hannover, Germany Novartis Investigative Site Kiel, Germany Novartis Investigative Site Munster, Germany Less <<
NCT01200862 Obese Hypogonadotropic Hypogon... More >>adism Less << Phase 2 Terminated - United States, Arizona ... More >> Novartis Investigative Site Tucson, Arizona, United States, 85712 United States, California Novartis Investigative Site San Diego, California, United States, 92120 United States, Florida Novartis Investigative Site Miramar, Florida, United States, 33025 United States, Utah Novartis Investigative Site West Valley City, Utah, United States, 84120 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3X 2H9 Less <<
NCT01223898 Chronic Myeloid Leukemia Phase 1 Completed - Germany ... More >> Novartis Investigative Site Frankfurt/M, Germany, 60590 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Ulm, Germany, 89081 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G12 0YN Less <<
NCT00470678 Choroidal Neovascularization ... More >> Age-Related Macular Degeneration Less << Phase 3 Completed - Korea, Republic of ... More >> Novartis Investigative Site Daegu, Korea, Republic of Novartis Investigative Site Pusan, Korea, Republic of Novartis Investigative site Seoul, Korea, Republic of Taiwan Novartis Investigative Site Kaohsiung, Taiwan Novartis Investigative Site LinKou, Taiwan Novartis Investigative site Taipei, Taiwan Less <<
NCT02859727 Activated PI3Kdelta Syndrome (... More >>APDS); PASLI Disease Less << Phase 2 Phase 3 Recruiting June 6, 2023 United States, Maryland ... More >> Novartis Investigative Site Recruiting Bethesda, Maryland, United States, 20892 Czechia Novartis Investigative Site Recruiting Prague 5, CZE, Czechia, 15006 Netherlands Novartis Investigative Site Recruiting Rotterdam, Netherlands, 3000 CA Less <<
NCT01406548 Osteopenia Os... More >>teoporosis Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801-2811 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Miami, Florida, United States, 33175 United States, New Jersey Novartis Investigative Site Berlin, New Jersey, United States, 08009 United States, Pennsylvania Novartis Investigative Site Duncansville, Pennsylvania, United States, 16635 Less <<
NCT01379521 Hepatocellular Carcinoma Phase 2 Terminated(The study was termi... More >>nated due to low enrollment. This resulted in the study being underpowered and inconclusive.) Less << - Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Taiwan Novartis Investigative Site Kaohsiung, Taiwan, 807 Novartis Investigative Site Kaohsiung, Taiwan, 83301 Novartis Investigative Site Lin-Kou, Taiwan, 33305 Thailand Novartis Investigative Site Chiang Mai, Thailand, 50200 Less <<
NCT02051751 Neoplasms, Breast Neoplasms, H... More >>ead and Neck Neoplasms Less << Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Indiana Horizon Oncology Center BioAdvance Lafayette, Indiana, United States, 47905 France Novartis Investigative Site Toulouse Cedex 9, France, 31059 Italy Novartis Investigative Site Milano, MI, Italy, 20141 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT00770965 Chronic Plaque Psoriasis Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Santa Monica, California, United States, 90404 United States, Kentucky Novartis Investigative Site Louisville, Kentucky, United States, 40217 United States, North Carolina Novartis Investigative Site High Point, North Carolina, United States, 27262 United States, Pennsylvania Novartis Investigative Site Duncansville, Pennsylvania, United States, 16634 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37215 Less <<
NCT01566630 Pre-eclampsia Phase 2 Terminated(Novartis terminated... More >> this study due to internal, strategic decisions.) Less << - United States, Alabama ... More >> Novartis Investigative Site Mobile, Alabama, United States, 36604 United States, Kentucky Novartis Investigative Site Lexington, Kentucky, United States, 40503 Novartis Investigative Site Louisville, Kentucky, United States, 40202 United States, Texas Novartis Investigative Site Galveston, Texas, United States, 77555-0587 Italy Novartis Investigative Site Modena, MO, Italy, 41100 Less <<
NCT01566630 - Terminated(Novartis terminated... More >> this study due to internal, strategic decisions.) Less << - -
NCT01601600 Skeletal Muscle Phase 2 Completed - United States, Arkansas ... More >> Novartis Investigative Site Hot Springs, Arkansas, United States, 71913 Novartis Investigative Site Little Rock, Arkansas, United States, 72201 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33143 Novartis Investigative Site Miami, Florida, United States, 33169 United States, Massachusetts Novartis Investigative Site Brighton, Massachusetts, United States, 02135 Less <<
NCT03334812 Knee Cartilage Lesion Phase 2 Recruiting May 14, 2019 Austria ... More >> Novartis Investigative Site Recruiting Wien, Austria, 1090 Novartis Investigative Site Recruiting Wien, Austria, 1130 Novartis Investigative Site Recruiting Wien, Austria, 1180 Less <<
NCT03338998 Hemorrhagic Stroke ... More >> Intracerebral Hemorrhage (ICH) Less << Phase 2 Recruiting March 17, 2020 United States, Connecticut ... More >> Novartis Investigative Site Recruiting New Haven, Connecticut, United States, 06520 United States, North Carolina Novartis Investigative Site Recruiting Durham, North Carolina, United States, 27710 United States, Oregon Novartis Investigative Site Recruiting Portland, Oregon, United States, 97239 Less <<
NCT01379521 - Terminated(The study was termi... More >>nated due to low enrollment. This resulted in the study being underpowered and inconclusive.) Less << - -
NCT02477332 Chronic Spontaneous Urticaria Phase 2 Completed - -
NCT01764776 Normal Hepatic Function ... More >> Impaired Hepatic Function Less << Phase 1 Completed - United States, Florida ... More >> University of Miami Div. of Clinical Pharmacology Miami, Florida, United States, 33136 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1612 Germany Novartis Investigative Site Berlin, Germany, 14050 Israel Novartis Investigative Site Tel-Aviv, Israel, 64239 Less <<
NCT02626234 cMET-dysregulated Advanced Sol... More >>id Tumors Less << Phase 1 Completed - United States, Georgia ... More >> Emory University School of Medicine/Winship Cancer Institute Phase 1 Working Group Atlanta, Georgia, United States, 30322 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Austria Novartis Investigative Site Vienna, Austria, A-1090 Belgium Novartis Investigative Site Edegem, Belgium, 2650 Czechia Novartis Investigative Site Brno, Czechia, 65653 Greece Novartis Investigative Site Ioannina, GR, Greece, 455 00 Novartis Investigative Site Athens, Greece, 18547 Italy Novartis Investigative Site Milano, MI, Italy, 20141 Novartis Investigative Site Candiolo, TO, Italy, 10060 Novartis Investigative Site Bologna, Italy, 40138 Novartis Investigative Site Napoli, Italy, 80131 Spain Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site Madrid, Spain, 28034 United Kingdom Novartis Investigative Site London, United Kingdom, W1G 6AD Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT02477332 - Completed - -
NCT00504543 Kidney Transplantation Phase 2 Completed - -
NCT00770965 - Completed - -
NCT01449591 Erythemato-telangiectatic Rosa... More >>cea Less << Phase 2 Completed - United States, Arkansas ... More >> Novartis Investigative Site Hot Springs, Arkansas, United States United States, Michigan Novartis Investigative Site Ann Abor, Michigan, United States United States, New Jersey Novartis Investigative Site Paramus, New Jersey, United States United States, Oregon Novartis Investigative Site Portland, Oregon, United States United States, Texas Novartis Investigative Site Austin, Texas, United States United States, Washington Novartis Investigative Site Spokane, Washington, United States Less <<
NCT01005901 - Completed - -
NCT02515331 - Completed - -
NCT01005901 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00615030 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - France ... More >> Novartis Investigative Site Beuvry, France Novartis Investigative Site Nantes, France Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Mainz, Germany Spain Novartis Investigative Site Barcelona, Spain Less <<
NCT01167335 Partial Onset Seizures Phase 2 Withdrawn - United States, Alabama ... More >> University of South Alabama Mobile, Alabama, United States, 36693 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Wisconsin Epilepsy Care Specialists, S.C. Milwaukee, Wisconsin, United States, 53215 Austria Novartis Investigative Site Salzburg, Austria, A-5020 Novartis Investigative Site Vienna, Austria, 1090 Novartis Investigational Site Wien, Austria, 1130 Belgium Novartis Investigative Site Duffel, Belgium, 2570 Novartis Investigative Site Ottignies, Belgium, 1340 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1113 Canada, Quebec Novartis Investigative Site Greenfield Park, Quebec, Canada, J4V 2J2 Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Estonia Novartis Investigative Site Tallinn, Estonia, 10617 Novartis Investigative Site Tartu, Estonia, 51014 India Novartis Investigative Site Bangalore, Karnataka, India, 560054 Novartis Investigative Site Mumbai, Maharashtra, India, 400012 Novartis Investigative Site Dehli, New Delhi, India, 110002 Novartis Investigative Site Jaipur, India, 302004 Latvia Novartis Investigative Site Riga, Latvia, 1002 Novartis Investigative Site Riga, Latvia, LV-1038 Lithuania Novartis Investigative Site Kaunas, Lithuania, 50009 Romania Novartis Investigative Site Bucharest, Romania, 011635 Novartis Investigative Site Bucharest, Romania, 024092 Spain Novartis Investigative Site Barcelona, Spain, 08036 Less <<
NCT01023815 - Completed - -
NCT02515331 Patients, Resistant Hypertensi... More >>on Less << Phase 2 Completed - United States, Alabama ... More >> Novartis Investigative Site Birmingham, Alabama, United States, 35294 United States, California Novartis Investigative Site North Hollywood, California, United States, 91606 United States, Florida Novartis Investigative Site Atlantis, Florida, United States, 33462 Novartis Investigative Site Daytona Beach, Florida, United States, 32117 Novartis Investigative Site Jacksonville, Florida, United States, 32216 United States, Hawaii Novartis Investigative Site Honolulu, Hawaii, United States, 96814 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 Denmark Novartis Investigative Site Gentofte, Denmark, DK 2820 France Novartis Investigative Site Paris, France, 75015 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Homburg, Germany, 66421 Netherlands Novartis Investigative Site Meibergdreef 9, Netherlands, 1105 AZ Switzerland Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site Lausanne, Switzerland, 1011 Less <<
NCT01037348 Choroidal Neovascularisation Phase 2 Completed - United Kingdom ... More >> Novartis Investigative Site Bristol, United Kingdom, BS1 2LX Novartis Investigational Site City of London, United Kingdom, EC1V 2PD Novartis Investigative Site City of London, United Kingdom, NW1 5YE Novartis Investigative Site City of London, United Kingdom, SE5 9RS Novartis Investigative Site Frimley, United Kingdom, GU16 7UJ Novartis Investigative Site Leeds, United Kingdom, LS9 7TF Novartis Investigative Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Novartis Investigative Site Nottingham, United Kingdom, NG5 1PG Novartis Investigative Site Southampton, United Kingdom, SO16 6YD Novartis Investigative Site Torquay, United Kingdom, TQ2 7AA Novartis Investigative Site Wolverhampton, United Kingdom, WV10 0QP Novartis Investigative Site York, United Kingdom, YO31 8HE Less <<
NCT00600886 Acromegaly Phase 3 Completed - -
NCT01023815 de Novo Kidney Transplant Reci... More >>pients Renal Transplantation Less << Phase 3 Completed - Italy ... More >> Novartis Investigative Site Ancona, Italy, 60100 Novartis Investigative Site Bologna, Italy Novartis Investigative Site Brescia, Italy Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Catania, Italy Novartis Investigative Site Coppito, Italy Novartis Investigative Site Firenze, Italy Novartis Investigative Site Genova, Italy, 16132 Novartis Investigative Site Milano, Italy, 20122 Novartis Investigative Site Modena, Italy, 41100 Novartis Investigative Site Napoli, Italy Novartis Investigative Site Novara, Italy, 28100 Novartis Investigative Site Padova, Italy Novartis Investigative Site Palermo, Italy Novartis Investigative Site Parma, Italy Novartis Investigative Site Perugia, Italy, 06070 Novarits Investigative Site Pisa, Italy Novartis Investigative Site Roma, Italy Novartis Investigative Site Rome, Italy Novartis Investigative Site Salerno, Italy Novartis Investigative Site Sassari, Italy, 07100 Novartis Investigative Site Siena, Italy, 53100 Novartis Investigative Site Torino, Italy, 10126 Novartis Investigative Site Treviso, Italy Novartis InvestigativeSite Udine, Italy Novartis Investigative Site Varese, Italy Novartis Investigative Site Verona, Italy Novartis Investigative Site Vicenza, Italy Less <<
NCT01042392 - Completed - -
NCT01700270 Advanced Solid Tumors, Excludi... More >>ng Breast Cancer Less << Phase 1 Completed - United States, New York ... More >> Montefiore Medical Center Montefiore Medical Center (SC) Bronx, New York, United States, 10467 United States, Texas Cancer Therapy & Research Center / UT Health Science Center SC San Antonio, Texas, United States, 78229 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Switzerland Novartis Investigative Site Chur, Switzerland, 7000 Novartis Investigative Site Genève, Switzerland, 1211 Less <<
NCT02559622 Psoriasis Phase 3 Completed - Germany ... More >> Novartis Investigative Site Augsburg, Germany, 86179 Novartis Investigative Site Berlin, Germany, 10789 Novartis Investigative Site Berlin, Germany, 13187 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Darmstadt, Germany, 64283 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duisburg, Germany, 47166 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79104 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Hamburg, Germany, 20354 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Langenau, Germany, 89129 Novartis Investigative Site Lubeck, Germany, 23538 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Stade, Germany, 21682 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT02573467 Sporadic Inclusion Body Myosit... More >>is Less << Phase 3 Completed - -
NCT02559622 - Completed - -
NCT02573467 - Completed - -
NCT00600886 - Completed - -
NCT01179620 Renal Dialysis Phase 3 Completed - Germany ... More >> Novartis Investigative Site Darmstadt Darmstadt,, Germany Novartis Investigative Site Elsenfeld Elsenfeld, Germany Novartis Investigative Site Flensburg Flensburg, Germany Novartis Investigative Site Heringen Heringen, Germany Novartis Investigative Site Hoyerswerda, Hoyerswerda, Germany Novartis Investigative Site Kronach Kronach, Germany Novartis Investigative Site Magdeburg Magdeburg, Germany Novartis Investigative Site München München, Germany Novartis Investigative Site Münster Münster, Germany Less <<
NCT01103024 Uveitis Phase 3 Terminated(Core study in non-i... More >>nfectious active uveitis was terminated. Patients came only for the planned safety follow-up visit in this extension study.) Less << - United States, Texas ... More >> Texas Retina Associates Arlington, Texas, United States, 76012 Canada, Ontario Novartis Investigative Site London, Ontario, Canada Novartis Investigative Site North York, Ontario, Canada Israel Novartis Investigative Site Ramat Gan, Israel, 52621 Japan Novartis Investigative Site Bunkyo-ku, Japan Novartis Investigative Site Fukuoka, Japan Novartis Investigative Site Fukushima, Japan Novartis Investigational Site Kyoto, Japan, 602-0841 Novartis Investigative Site Sapporo, Japan Novartis Investigative Site Tochigi, Japan Switzerland Novartis Investigative Site Bern, Switzerland Less <<
NCT00554606 Rheumatoid Arthritis Phase 2 Completed - -
NCT02603445 Follicular Lymphoma, Mantle Ce... More >>ll Lymphoma Less << Phase 1 Completed - United States, New York ... More >> Novartis Investigative Site New York, New York, United States, 10017 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Austria Novartis Investigative Site Salzburg, Austria, 5020 France Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Mainz, Germany, 55131 Less <<
NCT01042392 Essential Hypertension Phase 4 Completed - -
NCT02598297 Early Myelofibrosis With High ... More >>Molecular Risk Mutations Less << Phase 3 Completed - -
NCT02625922 - Terminated(In view of outcome ... More >>of RELAX-AHF-2 trial, the entire RLX030A project was decided to be terminated.) Less << - -
NCT00568594 Coronary Heart Disease Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Novartis Investigator Site Philadelphia, Pennsylvania, United States Belgium Novartis Investigator Site Antwerp, Belgium Denmark Novartis Investigator Site Birkeroed, Denmark Israel Novartis Investigator Site Jerusalem, Israel Novartis Investigator Site Tel-Aviv, Israel Novartis Investigator Site Tzrifin, Israel Netherlands Novartis Investigator Site Groningen, Netherlands South Africa Novartis Investigator Site Bloemfontein, South Africa Novartis Investigator Site George, South Africa Novartis Investigator Site Port Elizabeth, South Africa United Kingdom Novartis Investigator Site Harrow, United Kingdom Less <<
NCT01543828 COPD Phase 4 Completed - United States, California ... More >> Novartis Investigative Site Fullerton, California, United States, 92835 United States, Missouri Novartis Investigative Site St. Charles, Missouri, United States, 63301 United States, North Carolina Novartis Investigative Site Charlotte, North Carolina, United States, 28207 Novartis Investigative Site Raleigh, North Carolina, United States, 27607 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43213 United States, Washington Novartis Investigative Site Tacoma, Washington, United States, 98405 Less <<
NCT02941926 Breast Cancer Phase 3 Active, not recruiting November 22, 2019 -
NCT01543828 - Completed - -
NCT02955069 Well-differentiated Non-functi... More >>onal NET of Thoracic Origin Well-differentiated Non-functional NET of Gastrointestinal Origin Well-differentiated Non-functional NET of Pancreatic Origin Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma Less << Phase 2 Active, not recruiting April 3, 2020 -
NCT00514514 Kidney Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt am Main, Germany, 60596 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover Muenden, Germany, 34346 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Lubeck, Germany, 23538 Novartis Investigative Site Munchen, Germany, 81377 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Regensburg, Germany, 93053 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Less <<
NCT01281657 - Completed - -
NCT02661217 Heart Failure With Reduced Eje... More >>ction Fraction Less << Phase 4 Completed - -
NCT02678000 Chronic Kidney Disease (CKD) Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 United States, Colorado Novartis Investigative Site Lakewood, Colorado, United States, 80228 United States, Florida Novartis Investigative Site Miami Lakes, Florida, United States, 33014 Novartis Investigative Site Orlando, Florida, United States, 32810 United States, Louisiana Novartis Investigative Site New Orleans, Louisiana, United States, 70119 United States, Minnesota Novartis Investigative Site Minneapolis, Minnesota, United States, 55404 Novartis Investigative Site Saint Paul, Minnesota, United States, 55114 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Elsterwerda, Germany, 04910 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Hamburg, Germany, 22143 Novartis Investigative Site Mannheim, Germany, 41061 Less <<
NCT00514514 - Completed - -
NCT02690974 Hearth Failure With Reduced Ej... More >>ection Fraction (HFrEF) Less << Phase 4 Completed - Canada, Alberta ... More >> Novartis Investigative Site Edmonton, Alberta, Canada, T5H 3V9 Canada, British Columbia Novartis Investigative Site New Westminster, British Columbia, Canada, V3L 3W4 Novartis Investigative Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Novartis Investigative Site Winnipeg, Manitoba, Canada, R2H 2A6 Canada, New Brunswick Novartis Investigative Site Moncton, New Brunswick, Canada, E1C 2Z3 Novartis Investigative Site Moncton, New Brunswick, Canada, E1G 1A7 Canada, Newfoundland and Labrador Novartis Investigative Site St. John's, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Ontario Novartis Investigative Site Burlington, Ontario, Canada, L7M 4Y1 Novartis Investigative Site Cambridge, Ontario, Canada, N1R 6V6 Novartis Investigative Site London, Ontario, Canada, N6A 5A5 Novartis Investigative Site Mississauga, Ontario, Canada, L5K 2L3 Novartis Investigative Site Newmarket, Ontario, Canada, L3Y 2P6 Novartis Investigative Site Newmarket, Ontario, Canada, L3Y 8C3 Novartis Investigative Site Ottawa, Ontario, Canada, K1Y 4W7 Novartis Investigative Site Peterborough, Ontario, Canada, K9J 0B2 Novartis Investigative Site Sarnia, Ontario, Canada, N7T 4X3 Novartis Investigative Site Scarborough, Ontario, Canada, M1E 5E9 Novartis Investigative Site Scarborough, Ontario, Canada, M1P 2V5 Novartis Investigative Site Sudbury, Ontario, Canada, P3E 3B8 Novartis Investigative Site Sudbury, Ontario, Canada, P3E 5M9 Novartis Investigative Site Toronto, Ontario, Canada, M6R 1B5 Novartis Investigative Site Waterloo, Ontario, Canada, N2T 0C1 Novartis Investigative Site Weston, Ontario, Canada, M9N 1W4 Canada, Quebec Novartis Investigative Site Greenfield Park, Quebec, Canada, J4V 2G8 Novartis Investigative Site Joliette, Quebec, Canada, J6E 6J2 Novartis Investigative Site Montreal, Quebec, Canada, H1T 3Y7 Novartis Investigative Site St-Jean-sur-Richelieu, Quebec, Canada, J3A 1J2 Novartis Investigative Site Terrebonne, Quebec, Canada, J6V 2H2 Canada Novartis Investigative Site Brossard, Canada, J4Z 2K9 Novartis Investigative Site Hamilton, Canada, L8L 0A9 Novartis Investigative Site Quebec, Canada, GIV 4G5 Novartis Investigative Site St-Lambert, Canada, J4P 2J2 Less <<
NCT00555789 Kidney Transplantation Phase 2 Terminated - United States, California ... More >> Novartis Investigative Site San Francisco, California, United States, 94143-0780 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53706 Canada Novartis Investigative Site Halifax, Canada, B3H 1V7 France Novartis Investigative Site Le Kremlin Bicetre, France, 94270 Novartis Investigative Site Nantes, France, 44035 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Toulouse, France, 31403 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Berlin, Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Koeln, Germany Italy Novartis Investigative Site Bologna, Italy, 40138 Novartis Investigative Site Firenze, Italy, 50134 Novartis Investigative Site Padova, Italy, 35128 Spain Novartis Investigative Site Llobregat, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Malaga, Spain, 28041 Novartis Investigative Site Valencia, Spain, 46017 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site Bern, Switzerland, 3010 Novartis Investigative Site Zürich, Switzerland, 8091 United Kingdom Novartis Investigative Site Cardiff, United Kingdom, CF14 4XW Novartis Investigative Site Glasgow, United Kingdom, G11 6NT Novartis Investigative Site London, United Kingdom Novartis Investigative Site Manchester, United Kingdom Less <<
NCT00537862 Kidney Transplant Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site Busan, Korea, Republic of, (614-735) Novartis Investigative Site Daegu, Korea, Republic of, (700-712) Novartis Investigative Site Daegu, Korea, Republic of, (700-721) Novartis Investigative Site Jeollanam-do, Korea, Republic of, (501-757) Novartis Investigative Site Seoul, Korea, Republic of, (110-744) Novartis Investigative Site Seoul, Korea, Republic of, (120-752) Novartis Investigative Site Seoul, Korea, Republic of, (137-701) Novartis Investigative Site Seoul, Korea, Republic of, (138-736) Less <<
NCT01160094 - Completed - Colombia ... More >> Novartis Investigative Site Bogota, Colombia Novartis Investigative Site Bogotá, Colombia Novartis Investigative Site Bucaramanga, Colombia Novartis Investigative Site Medellin, Colombia Novartis Investigative Site Pasto, Colombia Novartis Investigative Site Pereira, Colombia Saudi Arabia Novartis Investigative Site Dammam, Saudi Arabia, Dammam 31444 Novartis Investigative Site Jeddah, Saudi Arabia, 21499 Novartis Investigative Site Jeddah, Saudi Arabia, jEDDAH 21423 Novartis Investigative Site Jeddah, Saudi Arabia Novartis Investigative Site Riyadh, Saudi Arabia Less <<
NCT02703636 Mild to Moderate Alzheimer's D... More >>isease Less << Phase 4 Completed - Japan ... More >> Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 814-001 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 814-0180 Novartis Investigative Site Aizuwakamatsu, Fukushima, Japan, 965-8585 Novartis Investigative Site Tsukuba-city, Ibaraki, Japan, 305-8576 Novartis Investigative Site Kita-gun, Kagawa, Japan, 761-0793 Novartis Investigative Site Sagamihara-city, Kanagawa, Japan, 252-5188 Novartis Investigative Site Kochi-city, Kochi, Japan, 780-0842 Novartis Investigative Site Kurashiki-city, Okayama, Japan, 710-0826 Novartis Investigative Site Osaka-city, Osaka, Japan, 543-8555 Novartis Investigative Site Suita-city, Osaka, Japan, 565 0871 Novartis Investigative Site Kasukabe-city, Saitama, Japan, 344-0036 Novartis Investigative Site Koshigaya-city, Saitama, Japan, 343-0032 Novartis Investigative Site Fuji-city, Shizuoka, Japan Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Hachioji-city, Tokyo, Japan, 193-0944 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Niigata, Japan Novartis Investigative Site Okayama, Japan, 710-0813 Novartis Investigative Site Tokyo, Japan, 168-8535 Less <<
NCT01127750 Relapsing Multiple Sclerosis Phase 3 Completed - -
NCT01610297 - Completed - -
NCT01613976 Myelodysplastic Syndromes (MDS... More >>) Chronic Myelomonocytic Leukemia (CMML) Acute Myeloid Leukemia (AML) Less << Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8650 Novartis Investigative Site Nagoya, Aichi, Japan, 460-0001 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Kyoto, Japan, 602-8566 Less <<
NCT01610297 Iron Overload After Hematopoie... More >>tic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major Less << Phase 4 Completed - Turkey ... More >> Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Ankara, Turkey, 06500 Novartis Investigative Site Antalya, Turkey, 07000 Novartis Investigative Site Antalya, Turkey, 07070 Novartis Investigative Site Istanbul, Turkey Novartis Investigative Site Izmir, Turkey, 35040 Less <<
NCT01619332 Type II Diabetes Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Chula Vista, California, United States, 91910 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45227 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78209 Less <<
NCT02625922 Chronic Heart Failure Phase 2 Terminated(In view of outcome ... More >>of RELAX-AHF-2 trial, the entire RLX030A project was decided to be terminated.) Less << - Germany ... More >> Novartis Investigative Site Greifswald, Mecklenburg Vorpommern, Germany, 17475 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Muenchen, Germany, 80636 Novartis Investigative Site Muenchen, Germany, 81675 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Hull, United Kingdom, HU16 5JQ Novartis Investigative Site London, United Kingdom, SW 6NP Novartis Investigative Site Tyne And Wear, United Kingdom, NE2 4HH Less <<
NCT01199861 Relapsing Multiple Sclerosis Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Aalst, Belgium, 9300 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Wilrijk, Belgium, 2610 Canada, Ontario Novartis Investigative Site Nepean, Ontario, Canada, K2G 6E2 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3A 2B4 Canada Novartis Investigative Site Sherbrooke, Canada, JiH 5N4 Finland Novartis Investigative Site Seinajoki, Finland, 60220 Novartis Investigative Site Turku, Finland, 20100 France Novartis Investigative Site Caen, France, 14033 Novartis Investigative Site Rennes, France, 35043 Novartis Investigative Site St Herblain, France, 44800 Novartis Investigative Site Toulouse, France, 31059 Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Novartis Investigative Site Guatemala City, Guatemala, 01014 Poland Novartis Investigative Site Katowice, Poland, 40-594 Novartis Investigative Site Lodz, Poland, 90-153 Spain Novartis Investigative Site Madrid, Spain, 28029 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Sevilla, Spain, 41009 Novartis Investigative Site Valencia, Spain, 46009 Switzerland Novartis Investigational Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Nottingham, United Kingdom, NG7 2UH Novartis Investigative Site Stoke-on-Trent, United Kingdom, ST4 7LN Less <<
NCT00549757 - Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT01199861 - Completed - -
NCT00549757 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 3 Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT00574743 Heart Transplantation Phase 4 Completed - United States, California ... More >> Novartis Investigative site Los Angeles, California, United States, 90073 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania Novartis Pharmaceuticals Philadelphia, Pennsylvania, United States, 19103 Argentina Argentina Buenos Aires, Argentina, 1107 Site 1: X5000BJH Cordoba, Argentina Australia Novartis Investigative site, Sydney, Australia Sydney, Australia Canada, Alberta Novartis Investigative Edmonton, Alberta, Canada, T6G 2B7 Canada, Ontario Novartis Toronto, Ontario, Canada, M5G 2C4 Canada Novarits Ottawa, Canada, K1H 8L6 Less <<
NCT00570284 Cancer Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States United States, Connecticut Novartis Investigative Site Norwalk, Connecticut, United States United States, Maryland Novartis Investigative Site Rockville, Maryland, United States United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States United States, New Hampshire Novartis Investigative Site Lebanon, New Hampshire, United States United States, New York Novartis Investigative Site New York, New York, United States United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States Sweden Novartis Investigative Site Stokholm, Sweden Switzerland Novartis Investigative Site Zurich, Switzerland Less <<
NCT01998477 Influenza Phase 3 Completed - Italy ... More >> Novartis Investigational Site 022 Firenze, Italy, 50139 Novartis Investigational Site 020 Genova, Italy, 16132 Novartis Investigational Site 021 Milano, Italy, 20157 Novartis Investigational Site 023 Roma, Italy, 165 Spain Novartis Investigational Site 031 Badalona, Barcelona, Spain, 8916 Novartis Investigational Site 017 Burriana, Castellon, Spain, 12530 Novartis Investigational Site 016 Castellon de la Plana, Castellon, Spain, 12004 Novartis Investigational Site 010 Marbella, Malaga, Spain, 29603 Novartis Investigational Site 015 L'Eliana, Valencia, Spain, 46183 Novartis Investigational Site 013 Paiporta, Valencia, Spain, 46200 Novartis Investigational Site 018 Quart de Poblet, Valencia, Spain, 46930 Novartis Investigational Site 030 Madrid, Spain, 28050 Novartis Investigational Site 011 Malaga, Spain, 29011 Novartis Investigational Site 019 Valencia, Spain, 46017 Novartis Investigational Site 014 Valencia, Spain, 46020 Novartis Investigational Site 012 Valencia, Spain, 46024 Less <<
NCT01760525 Solid Tumor With p53 Wild Type... More >> Status Less << Phase 1 Active, not recruiting January 9, 2019 United States, Massachusetts ... More >> Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States, 02215 France Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Essen, Germany, 45147 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 Less <<
NCT01224366 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01998477 - Completed - -
NCT01166178 Osteoporosis ... More >>Multiple Sclerosis Less << Phase 3 Terminated - Germany ... More >> Novartis Investigative Site Bamberg, Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Bochum, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Heidelberg, Germany Novartis Investigative Site Kassel, Germany Novartis investigative site Leipzig, Germany Novartis Investigative Site Leverkusen, Germany Novartis investigative site Ludwigshafen, Germany Novartis investigative site Magdeburg, Germany Novartis investigative site Muenchen, Germany Novartis investigative site Numbrecht, Germany Novartis investigative site Oldenburg, Germany Novartis Investigative Site Siegen, Germany Novartis investigative site Stade, Germany Less <<
NCT01233622 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01238978 Type 2 Diabetes Mellitus ... More >> Elderly Less << Phase 4 Completed - France ... More >> Novartis Investigative Site Armentieres, France, 59208 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Caen, France, 14000 Novartis Investigative Site Creil, France, 60100 Novartis Investigative Site #2 Paris, France, 75012 Novartis Investigative Site Paris, France, 75020 Novartis Investigative Site Pau, France, 64000 Novartis Investigative Site St Jean de la Ruelle, France, 45140 Novartis Investigative Site Strasbourg, France, 67000 Novartis Investigative Site Strasbourg, France Novartis Investigative Site Toulouse, France, 31200 Novartis Investigative Site Tours, France, 37000 Novartis Investigative Site Venissieux, France, 69200 Novartis Investigative Site #2 Venissieux, France Novartis Investigative Site Versailles, France, 78000 Less <<
NCT02925104 cMET Dysegulation Advanced Sol... More >>id Tumors Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Simon Cancer Center SC Indianapolis, Indiana, United States, 46202 Austria Novartis Investigative Site Salzburg, Austria, 5020 Denmark Novartis Investigative Site Herlev, Denmark, 2730 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Mainz, Germany, 55131 Netherlands Novartis Investigative Site Nijmegen, Netherlands, 6500 HB Spain Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Barcelona, Spain, 08041 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Zaragoza, Spain, 50009 Sweden Novartis Investigative Site Goteborg, Sweden, 413 45 Novartis Investigative Site Lund, Sweden, SE-221 85 Novartis Investigative Site Stockholm, Sweden, 171 76 Novartis Investigative Site Uppsala, Sweden, SE-751 85 United Kingdom Novartis Investigative Site London, United Kingdom, W1G 6AD Novartis Investigative Site Manchester, United Kingdom, M20 4BX Less <<
NCT02867735 Macular Edema ... More >> Diabetic Macular Edema Neovascular Age-related Macular Degeneration Retinal Vein Occlusions Less << Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Pasadena, California, United States, 91105-3153 United States, Florida Novartis Investigative Site Fort Myers, Florida, United States, 33901 Novartis Investigative Site Miami, Florida, United States, 33143 Novartis Investigative Site Winter Haven, Florida, United States, 33880 United States, Georgia Novartis Investigative Site Augusta, Georgia, United States, 30909 United States, Pennsylvania Novartis Investigative Site Hagerstown, Pennsylvania, United States, 21740 Puerto Rico Novartis Investigative Site Arecibo, Puerto Rico, 00612 Less <<
NCT02896127 Ankylosing Spondyloarthritis Phase 3 Active, not recruiting March 21, 2019 -
NCT01166178 - Terminated - -
NCT00171301 - Completed - -
NCT00135005 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Completed - United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19111-2497 France Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Berlin, Germany, 13125 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less <<
NCT02953938 Macular Edema Secondary to Bra... More >>nch Retinal Vein Occlusion (BRVO) Less << Phase 4 Active, not recruiting December 27, 2018 Japan ... More >> Novartis Investigative Site Nagakute-city, Aichi, Japan, 480-1195 Novartis Investigative Site Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Kita-gun, Kagawa, Japan, 761-0793 Novartis Investigative Site Tsu-city, Mie, Japan, 514-8507 Novartis Investigative Site Matsumoto-city, Nagano, Japan, 390-8621 Novartis Investigative Site Mitaka-city, Tokyo, Japan, 181-8611 Novartis Investigative Site Hokkaido, Japan, 078-8510 Less <<
NCT02907281 - Completed - -
NCT00251433 Neoplasms, Breast Phase 1 Active, not recruiting December 31, 2019 United States, Tennessee ... More >> Novartis Investigative Site Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Paris Cedex 10, France, 75475 Novartis Investigative Site Paris Cedex 5, France, 75248 Ireland Novartis Investigative Site Dublin, Ireland, 4 Novartis Investigative Site Dublin, Ireland, 8 Less <<
NCT01059318 Lymphangioleiomyomatosis Phase 2 Completed - United States, Massachusetts ... More >> Center for LAM Research and Clinical Care Boston, Massachusetts, United States, 02115 United States, Ohio University of Cincinnati, Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine, Cincinnati, Ohio, United States, 45267 France Novartis Investigative Site Lyon, France Germany Novartis Investigative Site Grosshansdorf, Germany Novartis Investigative Site Leipzig, Germany Italy Novartis Investigative Site Milan, Italy Less <<
NCT01376310 Cancer Phase 2 Completed - -
NCT03100058 Obesity Overw... More >>eight Less << Phase 2 Completed - -
NCT03100500 Asthma Phase 3 Active, not recruiting February 8, 2019 Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 457-8511 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 819-8555 Novartis Investigative Site Chitose-city, Hokkaido, Japan, 066-0021 Novartis Investigative Site Kitahiroshima, Hokkaido, Japan, 061-1121 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 006-0811 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 064-0801 Novartis Investigative Site Takamatsu-city, Kagawa, Japan, 760-0018 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 223-0059 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-8682 Novartis Investigative Site Yokosuka, Kanagawa, Japan, 239-0821 Novartis Investigative Site Chino-city, Nagano, Japan, 391-0011 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0843 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0027 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0014 Less <<
NCT02970669 Heart Failure, Reduced Ejectio... More >>n Fraction Less << Phase 4 Completed - United States, Alabama ... More >> Novartis Investigative Site Fort Payne, Alabama, United States, 35967 United States, California Novartis Investigative Site Beverly Hills, California, United States, 90211 Novartis Investigative Site Stockton, California, United States, 95204 Novartis Investigative Site West Hills, California, United States, 91307 United States, Florida Novartis Investigative Site Doral, Florida, United States, 33126 Novartis Investigative Site Inverness, Florida, United States, 34452 Novartis Investigative Site Ormond Beach, Florida, United States, 32174 Novartis Investigative Site Port Orange, Florida, United States, 32127 United States, Maryland Novartis Investigative Site Lutherville, Maryland, United States, 21093 United States, New Jersey Novartis Investigative Site East Brunswick, New Jersey, United States, 08816 Novartis Investigative Site Ridgewood, New Jersey, United States, 07450 United States, South Carolina Novartis Investigative Site Columbia, South Carolina, United States, 29203 Novartis Investigative Site Greenville, South Carolina, United States, 29615 Novartis Investigative Site Lancaster, South Carolina, United States, 29720 United States, Texas Novartis Investigative Site Allen, Texas, United States, 75002-3688 Novartis Investigative Site McKinney, Texas, United States, 75013 Novartis Investigative Site New Braunfels, Texas, United States, 78130 Novartis Investigative Site San Antonio, Texas, United States, 78229 Novartis Investigative Site San Marcos, Texas, United States, 78666 Novartis Investigative Site Sherman, Texas, United States, 75092 Novartis Investigative Site Tomball, Texas, United States, 77375 United States, Virginia Novartis Investigative Site Midlothian, Virginia, United States, 23114 United States, Washington Novartis Investigative Site Tacoma, Washington, United States, 98405 Less <<
NCT03100825 Asthma Phase 3 Active, not recruiting April 8, 2019 Japan ... More >> Novartis Investigative Site Koga city, Fukuoka, Japan, 811 3195 Novartis Investigative Site Yanagawa-city, Fukuoka, Japan, 832-0059 Novartis Investigative Site Maebashi-shi, Gunma, Japan, 371-0054 Novartis Investigative Site Hiroshima-city, Hiroshima, Japan, 732-0052 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 001-0901 Novartis Investigative Site Tomakomai-city, Hokkaido, Japan, 053-8506 Novartis Investigative Site Takamatsu-city, Kagawa, Japan, 761-8073 Novartis Investigative Site Fujisawa-city, Kanagawa, Japan, 251-0041 Novartis Investigative Site Sagamihara-city, Kanagawa, Japan, 228-8522 Novartis Investigative Site Sagamihara-city, Kanagawa, Japan, 229-1103 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 236 0051 Novartis Investigative Site Yokkaichi-city, Mie, Japan, 510-8561 Novartis Investigative Site Nagaoka-City, Niigata, Japan, 940-2085 Novartis Investigative Site Osaka city, Osaka, Japan, 530 0001 Novartis Investigative Site Sakai-city, Osaka, Japan, 591 8037 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0003 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0027 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0028 Novartis Investigative Site Ota-ku, Tokyo, Japan, 145 0063 Novartis Investigative Site Setagaya-ku, Tokyo, Japan, 158-0097 Novartis Investigative Site Setagaya-ku, Tokyo, Japan, 158-8531 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-8666 Novartis Investigative Site Toshima ku, Tokyo, Japan, 170 0003 Less <<
NCT00487708 NALP3 Mutation Phase 2 Completed - France ... More >> Novartis Investigator Site Lille, France Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Dresden, Germany Novartis Investigator Site Heidelberg, Germany Novartis Investigator Site Marburg, Germany Novartis investigative site Nuernberg, Germany Novartis Investigator Site Tuebingen, Germany India Novartis Investigator Site New Dehli, India Spain Novartis Investigator Site Oviedo, Spain United Kingdom Novartis Investigative site London, United Kingdom Less <<
NCT03096834 Episodic Migraine Phase 3 Active, not recruiting January 19, 2021 -
NCT03152552 Diabetes Type 2 With Heart Fai... More >>lure Less << Phase 2 Completed - -
NCT01428492 Multiple Myeloma Phase 1 Completed - United States, Arizona ... More >> Novartis Investigative Site Scottsdale, Arizona, United States, 85259 United States, California Novartis Investigative Site Duarte, California, United States, 91010 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30322 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60637 United States, New York Novartis Investigative Site New York, New York, United States, 10029 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599-7305 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43210 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53792 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3004 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Ireland Novartis Investigative Site Galway, Ireland Taiwan Novartis Investigative Site Taipei, Taiwan, 100 Less <<
NCT02024932 Spinal and Bulbar Muscular Atr... More >>ophy Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Orange, California, United States, 92868 United States, Maryland National Institutes of Health Bethesda, Maryland, United States, 20892 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43210 Denmark Novartis Investigative Site Copenhagen, Denmark, 2100 Germany Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Padova, PD, Italy, 35128 Less <<
NCT00853827 Coronary Artery Disease (CAD) ... More >> Coronary Atherosclerosis Less << Phase 3 Completed - -
NCT03216915 - Recruiting December 31, 2019 Germany ... More >> University Medical Hospital Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Christoph Heesen, MD    +49 (0) 40 7410 - 52124    heesen@uke.de    Contact: Ruken Özge Akbulak, MD    +49 (0) 40 7410 - 59471    r.akbulak@uke.de Less <<
NCT03070691 Basal Cell Carcinoma Phase 2 Phase 3 Withdrawn - -
NCT03194776 Peripheral Artery Disease (PAD... More >>); Intermittent Claudication Less << Phase 2 Active, not recruiting December 28, 2018 United States, Florida ... More >> Novartis Investigative Site Jacksonville, Florida, United States, 32216 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43215 Germany Novartis Investigative Site Kiel, Schleswig-Holstein, Germany, 24105 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 10787 Novartis Investigative Site Magdeburg, Germany, 39112 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 11217 Less <<
NCT00887588 Chronic Heart Failure Phase 2 Completed - -
NCT00171301 Beta-thalassemia Major ... More >> Hemosiderosis Iron Overload Rare Anemia Less << Phase 4 Completed - Egypt ... More >> Novartis Investigative Site Cairo, Egypt Lebanon Novartis Investigative Site Beirut, Lebanon Oman Novartis Investigative Site Muscat, Oman Saudi Arabia Novartis Investigative Site Riyadh, Saudi Arabia Syrian Arab Republic Novartis Investigative Site Damascus, Syrian Arab Republic Less <<
NCT02024932 - Completed - -
NCT03320941 Obesity Phase 2 Completed - Japan ... More >> Novartis Investigative Site Matsudo city, Chiba, Japan, 271 0077 Novartis Investigative Site Chikushino-city, Fukuoka, Japan, 818-0036 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-0066 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 819-0006 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-0857 Novartis Investigative Site Kakogawa-city, Hyogo, Japan, 675-0101 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-0863 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 860-8039 Novartis Investigative Site Kyoto city, Kyoto, Japan, 600-8898 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-8125 Novartis Investigative Site Nagasaki city, Nagasaki, Japan, 850 0045 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0802 Novartis Investigative Site Higashiosaka-city, Osaka, Japan, 577-0803 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Kawaguchi-sity, Saitama, Japan, 332 0021 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-0042 Novartis Investigative Site Tokorozawa, Saitama, Japan Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0046 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Hyogo, Japan, 674-0081 Less <<
NCT00006052 Leukemia Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States, 07936 Less <<
NCT03333694 Cutaneous Squamous Cell Carcin... More >>oma in Situ (CSCCis) Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85032 United States, California Novartis Investigative Site California City, California, United States, 92708 United States, Florida Novartis Investigative Site Gainesville, Florida, United States, 32606 Australia, Australian Capital Territory Novartis Investigative Site Phillip, Australian Capital Territory, Australia, 2606 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Queensland Novartis Investigative Site Benowa, Queensland, Australia, 4217 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Novartis Investigative Site Liege, Belgium, 4000 Less <<
NCT02014636 Carcinoma, Renal Cell Phase 1 Phase 2 Active, not recruiting April 17, 2019 United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02115 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10065 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 United Kingdom Novartis Investigative Site Manchester, Lancashire, United Kingdom, M20 4BX Novartis Investigative Site London, United Kingdom, W1G 6AD Less <<
NCT03369704 Seasonal Allergic Rhinitis Phase 3 Completed - Japan ... More >> Novartis Investigative Site Chiba-city, Chiba, Japan, 262-0015 Novartis Investigative Site Ichikawa-city, Chiba, Japan, 272-0143 Novartis Investigative Site Kashiwa-city, Chiba, Japan, 2270082 Novartis Investigative Site Matsudo-city, Chiba, Japan, 270-0034 Novartis Investigative Site Matsudo-city, Chiba, Japan, 2710077 Novartis Investigative Site Urayasu city, Chiba, Japan, 279-0012 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 212-0027 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 216 0006 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 216-0002 Novartis Investigative Site Yokohama-city, Kanagawa, Japan Novartis Investigative Site Koshigaya-city, Saitama, Japan, 343-0031 Novartis Investigative Site Arakawa-ku, Tokyo, Japan, 116 0011 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 101-0063 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0027 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 132-0014 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 125-0061 Novartis Investigative Site Nakano-ku, Tokyo, Japan, 164-0012 Novartis Investigative Site Setagaya-ku, Tokyo, Japan, 158-0097 Novartis Investigative Site Shinjuku ku, Tokyo, Japan, 160-0008 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0017 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan Novartis Investigative Site Toshima-Ku, Tokyo, Japan, 170-0005 Less <<
NCT00887588 - Completed - -
NCT00894387 - Completed - -
NCT01479595 Asthma Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 Novartis Investigative Site Riverside, California, United States, 92506 Novartis Investigative Site Rolling Hills Estates, California, United States, 90274 Novartis Investigative Site San Marino, California, United States, 91108 United States, Colorado Novartis Investigative Site Denver, Colorado, United States, 80206 Novartis Investigative Site Denver, Colorado, United States, 80230 United States, Florida Novartis Investigative Site Aventura, Florida, United States, 33180 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, Minnesota Novartis Investigative Site Minneapolis, Minnesota, United States, 55402 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63110 United States, North Carolina Novartis Investigative Site Raleigh, North Carolina, United States, 27607 Novartis Investigative Site Winston-Salem, North Carolina, United States, 27157 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73120 United States, Oregon Novartis Investigative Site Medford, Oregon, United States, 97504-8741 United States, South Carolina Novartis Investigative Site Spartanburg, South Carolina, United States, 29303 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt, Germany, 60596 Novartis Investigative Site Wiesbaden, Germany, 65187 United Kingdom Novartis Investigative Site London, United Kingdom, SE11YR Novartis Investigative Site Manchester, United Kingdom, M23 9QZ Less <<
NCT02089087 Rheumatoid Arthritis Phase 1 Completed - United States, Alabama ... More >> Novartis Investigative Site Anniston, Alabama, United States, 36207-5710 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33136 Novartis Investigative Site South Miami, Florida, United States, 33143 United States, Nebraska Novartis Investigative Site Lincoln, Nebraska, United States, 68502 United States, Pennsylvania Novartis Investigative Site Duncansville, Pennsylvania, United States, 16635 Taiwan Novartis Investigative Site Taipei, Taiwan, 110 Less <<
NCT00894387 Acute Decompensated Heart Fail... More >>ure Congestive Heart Failure Less << Phase 3 Completed - -
NCT01487785 Pancreatic Cancer Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Dept. of Mass General Hospital Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering Cancer Center MSKCC - SC New York, New York, United States, 10021 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman UT Salt Lake City, Utah, United States, 84103 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site Liverpool, United Kingdom, L7 8XP Less <<
NCT00853827 - Completed - -
NCT02005133 - Terminated - United Kingdom ... More >> Novartis Investigative Site Taunton, Somerset, United Kingdom, TA1 5DA Novartis Investigative Site Frimley, Surrey, United Kingdom, GU16 7UJ Novartis Investigative Site Bradford, West Yorkshire, United Kingdom, BD9 6RJ Novartis Investigative Site Leeds, West Yorkshire, United Kingdom, LS9 7TF Novartis Investigative Site Bolton, United Kingdom, BL4 0JR Novartis Investigative Site Bristol, United Kingdom, BS1 2LX Novartis Investigative Site Guildford, Surrey, United Kingdom, GU2 5XX Novartis Investigative Site Kent, United Kingdom, CT1 3NG Novartis Investigative Site Liverpool, United Kingdom, L7 8XP Novartis Investigative Site London, United Kingdom, EC1V 2PD Novartis Investigative Site London, United Kingdom, SE5 9RS Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE1 4LP Novartis Investigative Site Southampton, United Kingdom, SO16 6YD Novartis Investigative Site Southend, United Kingdom, SS0 0RY Novartis Investigative Site Sunderland, United Kingdom, SR2 9HP Novartis Investigative Site Uxbridge, United Kingdom, UB8 3NN Novartis Investigative Site York, United Kingdom, YO31 8HE Less <<
NCT00704483 Hyperphosphatemia Patients Wit... More >>h Chronic Kidney Disease on 3x/Week Replacement Therapy Less << Phase 2 Completed - -
NCT01479595 - Completed - -
NCT00557440 Asthma Phase 2 Completed - Belgium ... More >> Novartis Investigator Site Aalst, Belgium Novartis Investigator site Ghent, Belgium Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Hannover, Germany Novartis Investigator Site Landsberg, Germany Novartis Investigator Site Rostock, Germany Less <<
NCT01545817 Carcinoma, Renal Cell Phase 2 Terminated(Due to changes in t... More >>he RCC treatment landscape, info gained is no longer clinically relevant to patients. Data collected is deemed sufficient to meet objectives.) Less << - Australia, Australian Capital ... More >>Territory Novartis Investigative Site Garran, Australian Capital Territory, Australia, 2606 Australia, New South Wales Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Australia, Queensland Novartis Investigative Site Auchenflower, Queensland, Australia, 4066 Novartis Investigative Site Southport, Queensland, Australia, 4215 Australia, South Australia Novartis Investigative Site Elizabeth Vale, South Australia, Australia, 5112 Novartis Investigative Site Kurralta Park, South Australia, Australia, 5037 Novartis Investigative Site Woodville, South Australia, Australia, 5011 Australia, Victoria Novartis Investigative Site Footscray, Victoria, Australia, 3011 Novartis Investigative Site Frankston, Victoria, Australia, 3199 Australia, Western Australia Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Novartis Investigative Site Perth, Western Australia, Australia, 6001 Korea, Republic of Novartis Investigative Site Gyeonggi-do, Korea, Republic of, 410-769 Novartis Investigative Site Seoul, Korea, Republic of, 110-744 Novartis Investigative Site Seoul, Korea, Republic of, 135-710 Novartis Investigative Site Seoul, Korea, Republic of, 138-736 Less <<
NCT00880308 Advanced Solid Tumor Cancers ... More >> Medulloblastoma Basal Cell Carcinoma Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center SC Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5) San Antonio, Texas, United States, 78229 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Less <<
NCT02257632 Age-Related Macular Degenerati... More >>on Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Koeln, Germany, 50924 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site München, Germany, 80336 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Osnabrück, Germany, 49076 Novartis Investigative Site Regensburg, Germany, 93042 Less <<
NCT00557440 - Completed - -
NCT00560963 Advanced or Metastatic Pancrea... More >>tic Adenocarcinoma Less << Phase 1 Phase 2 Completed - Germany ... More >> Novartis Investigative Site Halle, Germany Novartis Investigative Site Merseburg, Germany Novartis Investigative Site München, Germany Novartis Investigative Site Oberstaufen, Germany Novartis Investigative Site Ulm, Germany Less <<
NCT00564954 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 4 Completed - United States, Arkansas ... More >> Novartis Investigative Site Little Rock, Arkansas, United States, 72205 United States, Florida Novartis Investigative Site Winter Park, Florida, United States, 32792 United States, Nevada Novartis Investigative Site Las Vegas, Nevada, United States, 89128 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77007 Novartis Investigative Site Lubbock, Texas, United States, 79423 Less <<
NCT02267135 - Completed - -
NCT00887861 Seizures Epil... More >>epsy Less << Phase 2 Completed - Germany ... More >> Novartis Investigator Site Berlin, Germany Novartis Investigator Site Bielefeld, Germany Novartis Investigator Site Bonn, Germany Novartis Investigator Site Erlangen, Germany Novartis Investigator Site Freiburg, Germany Novartis Investigator Site Munich, Germany Less <<
NCT00564954 - Completed - -
NCT01890746 Leukaemia, Acute Phase 2 Completed - -
NCT01106508 Advanced Solid Tumors ... More >> Recurrent or Refractory Medulloblastoma Locally Advanced or Metastatic Basal Cell Carcinoma Less << Phase 1 Completed - United States, California ... More >> University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States, 90095 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Netherlands Novartis Investigative Site Utrecht, Netherlands, 3584CX Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 United Kingdom Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Less <<
NCT00467545 Chronic Hepatitis B Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site (705-035) Daegu, Korea, Republic of Novartis Investigative Site , (420-717) Gyeonggi-Do, Korea, Republic of Novartis Investigative Site , (405-760) In Cheon, Korea, Republic of Novartis Investigative Site , (136-705) Seoul, Korea, Republic of Novartis Investigative Site , (150-590) Seoul, Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Less <<
NCT01902992 Allergic Rhinoconjunctivitis Phase 3 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Augsburg, Germany, 86179 Novartis Investigative Site Bad Wildbad, Germany, 75323 Novartis Investigative Site Bad Woerishofen, Germany, 86825 Novartis Investigative Site Bensheim, Germany, 64625 Novartis Investigative Site Berlin, Germany, 13057 Novartis Investigative Site Berlin, Germany, 13187 Novartis Investigative Site Berlin, Germany, 14050 Novartis Investigative Site Bochum, Germany, 44803 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Chemnitz, Germany, 09130 Novartis Investigative Site Delitzsch, Germany, 04509 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duelmen, Germany, 48249 Novartis Investigative Site Duisburg, Germany, 47051 Novartis Investigative Site Frankfurt, Germany, 60389 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Hannover, Germany, 30159 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Leipzig, Germany, 04275 Novartis Investigative Site Leipzig, Germany, 04357 Novartis Investigative Site Luebeck, Germany, 23538 Novartis Investigative Site Lübeck, Germany, 23538 Novartis Investigative Site Muenster, Germany, 48143 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Neunkirchen, Germany, 66538 Novartis Investigative Site Nidderau, Germany, 61130 Novartis Investigative Site Oberhausen, Germany, 46145 Novartis Investigative Site Osnabrück, Germany, 49074 Novartis Investigative Site Rodgau, Germany, 63110 Novartis Investigative Site Wallenhorst, Germany, 49134 Novartis Investigative Site Wiesbaden, Germany, 64191 Novartis Investigative Site Wiesbaden, Germany, 65183 Novartis Investigative Site Witten, Germany, 58452 Less <<
NCT01996124 COPD Hyperinf... More >>lation Right Cardiac Failure Less << Phase 4 Completed - Italy ... More >> Pneumologia Riabilitativa-Fondazione Maugeri-Istituto Scientifico di Milano- IRCCS Milan, Italy, 20142 Less <<
NCT01890746 - Completed - -
NCT00989989 Diabetic Macular Edema Phase 3 Completed - China ... More >> Novartis Investigative Site Beijing, China Novartis Investigative Site Changsha, China Novartis Investigative Site Chengdu, China Novartis Investigative Site Chongqing, China Novartis Investigative Site Guangzhou, China Novartis Investigative Site Hangzhou, China Novartis Investigational Site Shanghai, China Novartis Investigative Site Wenzhou, China Novartis Investigative Site Xi'an, China Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Japan Novartis Investigative Site Chiba, Japan Novartis Investigative Site Chiyoda-ku, Japan Novartis Investigative Site Chuo-ku, Japan Novartis Investigative Site Fukuoka, Japan Novartis Investigative Site Fukushima, Japan Novartis Investigative Site Hirakata, Japan Novartis Investigative Site Kita-gun, Japan Novartis Investigative Site Kobe, Japan Novartis Investigative Site Kyoto, Japan Novartis Investigative Site Mitaka, Japan Novartis Investigative Site Nagoya, Japan Novartis Investigative Site Osaka, Japan Novartis Investigative Site Otsu, Japan Novartis Investigative Site Shimotsuke, Japan Novartis Investigative Site Shinjuku-ku, Japan Novartis Investigative Site Suita, Japan Novartis Investigative Site Toyko, Japan Novartis Investigative Site Urayasu, Japan Novartis Investigative Site Wakayama, Japan Novartis Investigative Site Yamagata, Japan Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Singapore Novartis Investigative Site Singapore, Singapore Taiwan Novartis Investigative Site Kaohsiung, Taiwan Novartis Investigative Site LinKou, Taiwan Novartis Investigative Site Taipei, Taiwan Less <<
NCT00989989 - Completed - -
NCT02409667 Plaque Psoriasis Phase 3 Completed - -
NCT00997399 Advanced Solid Tumors Phase 1 Completed - United States, Utah ... More >> University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States, 84103 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Novartis Investigative Site Utrecht, Netherlands, 3584CX Switzerland Novartis Investigative Site St. Gallen, Switzerland, 9007 United Kingdom Novartis Investigative Site Merseyside, United Kingdom, L63 4JY Less <<
NCT01068483 Breast Cancer ... More >> Colon Cancer Ovarian Cancer Endometrium Cancer Less << Phase 1 Completed - United States, Tennessee ... More >> Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(4) Nashville, Tennessee, United States, 37203 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Spain Novartis Investigative Site Barcelona, Cataluna, Spain, 08035 Less <<
NCT00237185 - Completed - -
NCT00615030 - Completed - -
NCT01649427 Pharmacokinetics Study in de N... More >>ovo Kidney Transplantation Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Bochum, Germany, 44892 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Koeln-Merheim, Germany, 51109 Less <<
NCT01691807 Cancer Phase 1 Completed - United States, Alabama ... More >> Novartis Investigative Site Birmingham, Alabama, United States, 35294-3300 United States, Mississippi Novartis Investigative Site Southaven, Mississippi, United States, 38671 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Novartis Investigative Site San Antonio, Texas, United States, 78229 United States, West Virginia Novartis Investigative Site Morgantown, West Virginia, United States, 26506 Less <<
NCT00698464 Hepatic Cirrhosis ... More >> Alcoholism Less << Phase 1 Completed - United States, Virginia ... More >> McGuire Research Institute VAMC Richmond, Virginia, United States, 23249 Belgium Universite Catholique de Louvain Brussels, Belgium Germany Novartis Investigative site Berlin, Germany South Africa Novartis Investigative Site George, South Africa Less <<
NCT03439839 Patients With Paroxysmal Noctu... More >>rnal Hemoglobinuria (PNH) Less << Phase 2 Recruiting December 12, 2019 France ... More >> Novartis Investigative Site Recruiting Paris, France, 75010 Germany Novartis Investigative Site Recruiting Essen, Germany, 45147 Italy Novartis Investigative Site Recruiting Napoli, Italy, 80131 Less <<
NCT01753323 Malaria Phase 2 Completed - Thailand ... More >> Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Srisaket, Thailand, 33140 Novartis Investigative Site Tak, Thailand, 63110 Novartis Investigative Site Tak, Thailand, 63140 Vietnam Novartis Investigative Site Hanoi, Vietnam, 10000 Less <<
NCT01753323 - Completed - -
NCT02038049 Relapse Remitting Multiple Scl... More >>erosis Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Long Beach, California, United States, 90806 Novartis Investigative Site San Diego, California, United States, 92103 Czechia Novartis Investigative Site Hradec Kralove, Czechia, 501 03 Ukraine Novartis Investigative Site Kharkiv, Ukraine, 61068 Novartis Investigative Site Lviv, Ukraine, 79010 Less <<
NCT00237185 Unresectable or Metastatic Mal... More >>ignant Gastrointestinal Stromal Tumor (GIST) Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Dept of Sarcoma Oncology Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health Sciences University Dept. of Oregon Health Sci. Portland, Oregon, United States, 97201 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Australia, Victoria Novartis Investigative Site Geelong, Victoria, Australia, 3220 Finland Novartis Investigative Site Helsinki, Finland, FIN-00029 Less <<
NCT02267135 Chronic Scalp Psoriasis Phase 3 Completed - United States, California ... More >> Novartis Investigative Site Sacramento, California, United States, 95819 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Connecticut Novartis Investigative Site Trumbull, Connecticut, United States, 06611 United States, Maryland Novartis Investigative Site Rockville, Maryland, United States, 20850 United States, Massachusetts Novartis Investigative Site Andover, Massachusetts, United States, 01810 Novartis Investigative Site Boston, Massachusetts, United States, 02114 United States, Michigan Novartis Investigative Site Troy, Michigan, United States, 48084 United States, New Jersey Novartis Investigative Site East Windsor, New Jersey, United States, 08520 United States, New York Novartis Investigative Site New York, New York, United States, 10025 Novartis Investigative Site New York, New York, United States, 10075 United States, North Carolina Novartis Investigative Site Winston-Salem, North Carolina, United States, 27157 United States, Ohio Novartis Investigative Site Gahanna, Ohio, United States, 43230 United States, Pennsylvania Novartis Investigative Site Hershey, Pennsylvania, United States, 17033 Novartis Investigative Site Pittsburgh, Pennsylvania, United States, 15213-3403 United States, Texas Novartis Investigative Site Arlington, Texas, United States, 76011 United States, Utah Novartis Investigative Site Salt Lake City, Utah, United States, 84132 Novartis Investigative Site West Jordan, Utah, United States, 84088 Less <<
NCT01930175 Pemphigus Vulgaris Phase 2 Active, not recruiting January 31, 2019 United States, North Carolina ... More >> Novartis Investigative Site Chapel Hill, North Carolina, United States, 27516 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 Austria Novartis Investigative Site Vienna, Austria, 1040 Bulgaria Novartis Investigative Site Sofia, BGR, Bulgaria, 1431 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT02177682 Neoplasms, Haematologic Phase 1 Active, not recruiting December 28, 2018 Japan ... More >> Novartis Investigative Site Aichi, Japan, 467-8602 Novartis Investigative Site Fukuoka, Japan, 811-1395 Novartis Investigative Site Miyagi, Japan, 980-8574 Novartis Investigative Site Niigata, Japan, 951-8566 Novartis Investigative Site Tokyo, Japan, 104-0045 Less <<
NCT00888004 Parkinson's Disease ... More >> L-dopa Induced Dyskinesia Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Dresden, Germany Novartis Investigative Site Kassel, Germany Novartis Investigative Site Leun-Biskirchen, Germany Novartis Investigative Site Marburg, Germany Novartis Investigative Site Tubingen, Germany Less <<
NCT03681457 Fatty Liver Phase 1 Recruiting November 25, 2019 United States, Florida ... More >> Novartis Investigative Site Recruiting Orlando, Florida, United States, 32806 Novartis Investigative Site Recruiting Orlando, Florida, United States, 32809 United States, Tennessee Novartis Investigative Site Recruiting Knoxville, Tennessee, United States, 37920 Less <<
NCT02240212 Cancer Phase 1 Completed - Korea, Republic of ... More >> Novartis Investigative Site Seoul, Korea, Republic of, 110-774 Novartis Investigative Site Seoul, Korea, Republic of, 120/752 Novartis Investigative Site Seoul, Korea, Republic of, 135-710 Taiwan Novartis Investigative Site Taipei, Taiwan, 100 Novartis Investigative Site Taipei, Taiwan, 112 Less <<
NCT00505089 Rheumatoid Arthritis Phase 1 Phase 2 Terminated - Belgium ... More >> Novartis Investigative site Antwerp, Belgium Novartis Investigator Site Liege, Belgium Germany Novartis Investigative site Berlin, Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Hannover, Germany Novartis Investigator Site Leipzig, Germany Netherlands Novartis investigative site Leiden, Netherlands Poland Novartis Investigative Site Grodzisk Mazowiecki, Poland Novartis Investigator Site Poznan, Poland Less <<
NCT03337035 Autism Spectrum Disorder Phase 2 Not yet recruiting December 30, 2019 -
NCT02008890 Palmoplantar Pustular Psoriasi... More >>s Less << Phase 3 Completed - -
NCT02008916 Spondylitis, Ankylosing Phase 3 Completed - -
NCT00290771 - Terminated(Lack of efficacy) - -
NCT00290771 Recurrent Glioblastoma Multifo... More >>rme (GBM) Less << Phase 2 Terminated(Lack of efficacy) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00669942 Rheumatoid Arthritis Phase 1 Phase 2 Completed - -
NCT02205398 Squamous Cell Carcinoma of Hea... More >>d and Neck (SCCHN) Metastatic Colorectal Cancer Less << Phase 1 Terminated - United States, Massachusetts ... More >> Massachusetts General Hospital Head & Neck Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering MSKCC NY New York, New York, United States, 10017 United States, Utah University of Utah / Huntsman Cancer Institute Onc Dept Salt Lake City, Utah, United States, 84103 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X6 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Wurzburg, Germany, 97080 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Milano, MI, Italy, 20162 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Less <<
NCT00669942 - Completed - -
NCT01257451 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02015663 - Terminated - -
NCT02034006 Choroidal Neovascularization S... More >>econdary to Pathologic Myopia Less << Phase 3 Completed - Italy ... More >> Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Desenzano del Garda, BS, Italy, 25015 Novartis Investigative Site Bolzano, BZ, Italy, 39100 Novartis Investigative Site Cagliari, CA, Italy, 09124 Novartis Investigative Site Catania, CT, Italy, 95123 Novartis Investigative Site Catanzaro, CZ, Italy, 88100 Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Rapallo, GE, Italy, 16035 Novartis Investigative Site Terracina, LT, Italy, 04019 Novartis Investigative Site Milano, MI, Italy, 20100 Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Palermo, PA, Italy, 90127 Novartis Investigative Site Padova, PD, Italy, 35100 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Perugia, PG, Italy, 06100 Novartis Investigative Site Pisa, PI, Italy, 56124 Novartis Investigative Site Parma, PR, Italy, 43100 Novartis Investigative Site Roma, RM, Italy, 00133 Novartis Investigative Site Roma, RM, Italy, 00161 Novartis Investigative Site Roma, RM, Italy, 00198 Novartis Investigative Site Siena, SI, Italy, 53100 Novartis Investigative Site Torino, TO, Italy, 10122 Novartis Investigative Site Conegliano, TV, Italy, 31015 Novartis Investigative Site Udine, UD, Italy, 33100 Novartis Investigative Site Varese, VA, Italy, 21100 Novartis Investigative Site Negrar, VR, Italy, 37024 Novartis Investigative Site Napoli, Italy, 80131 Novartis Investigative Site Napoli, Italy, 80138 Less <<
NCT02008916 - Completed - -
NCT02032173 Macular Edema ... More >> Macular Degeneration Diabetes Less << Phase 3 Terminated January 2018 France ... More >> Novartis Investigative Site Bobigny, France, 93009 Novartis Investigative Site Bordeaux Cedex, France, F-33076 Novartis Investigative Site Bordeaux, France, 33000 Novartis Investigative Site Créteil, France, 94000 Novartis Investigative Site Le Kremlin Bicetre Cedex, France, 94275 Novartis Investigative Site Lyon, France, 69003 Novartis Investigative Site Nice, France, 6 000 Novartis Investigative Site Paris Cedex 19, France, 75940 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Poitiers, France, 86021 Less <<
NCT02015663 Cystic Fibrosis Phase 4 Terminated - United States, Alabama ... More >> Novartis Investigative Site Mobile, Alabama, United States, 36608-1128 United States, California Novartis Investigative Site Los Angeles, California, United States, 90027 Novartis Investigative Site Sacramento, California, United States, 95819 Novartis Investigative Site Ventura, California, United States, 93003 United States, Florida Novartis Investigative Site Altamonte Springs, Florida, United States, 32701 Novartis Investigative Site Jacksonville, Florida, United States, 32207 Novartis Investigative Site Miami, Florida, United States, 33136 Novartis Investigative Site Orlando, Florida, United States, 32806 Novartis Investigative Site Pensacola, Florida, United States, 32504 United States, Illinois Novartis Investigative Site Glenview, Illinois, United States, 60025 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46202 United States, Iowa Novartis Investigative Site Iowa City, Iowa, United States, 52242 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63104 United States, New York Novartis Investigative Site New Hyde Park, New York, United States, 11040 Novartis Investigative Site New York, New York, United States, 10595 United States, Ohio Novartis Investigative Site Akron, Ohio, United States, 44308 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon Novartis Investigative Site Portland, Oregon, United States, 92772 United States, Pennsylvania Novartis Investigative Site Hershey, Pennsylvania, United States, 17033-8050 United States, Texas Novartis Investigative Site Austin, Texas, United States, 78723 United States, Utah Novartis Investigative Site Salt Lake City, Utah, United States, 84132 Less <<
NCT02034110 Cancer Phase 2 Active, not recruiting June 29, 2020 -
NCT02029274 Active Dermatomyositis Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85028 United States, California Novartis Investigative Site Los Angeles, California, United States, 90095 Novartis Investigative Site Orange, California, United States, 92868 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33136 Novartis Investigative Site Tampa, Florida, United States, 33612 United States, Kansas Novartis Investigative Site Kansas City, Kansas, United States, 66160 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 Czech Republic Novartis Investigative Site Prague 2, Czech Republic, 128 50 Japan Novartis Investigative Site Chiba-city, Chiba, Japan, 260-0801 Novartis Investigative Site Sendai city, Miyagi, Japan, 980-8574 Less <<
NCT02039947 Melanoma and Brain Metastases Phase 2 Completed - -
NCT02278120 Advanced Metastatic Breast Can... More >>cer Less << Phase 3 Active, not recruiting September 27, 2019 -
NCT02049450 Thalassemia Major Phase 2 Completed - Greece ... More >> Novartis Investigative Site Athens, GR, Greece, GR-115 27 Italy Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Palermo, PA, Italy, 90146 Lebanon Novartis Investigative Site Beirut, Lebanon, 1107 2020 Thailand Novartis Investigative Site Bangkok, Thailand, 10700 Turkey Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Izmir, Turkey, 35040 Less <<
NCT02049450 - Completed - -
NCT02040870 Non-Small Cell Lung Cancer Phase 1 Phase 2 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100730 China, Chongqing Novartis Investigative Site Chongqing, Chongqing, China, 400037 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 51000 China, Jilin Novartis Investigative Site Changchun, Jilin, China, 130012 China, Shanghai Novartis Investigative Site Shanghai, Shanghai, China, 200032 Novartis Investigative Site Shanghai, Shanghai, China, 200433 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710038 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Beijing, China, 100036 Novartis Investigative Site Beijing, China, 100039 Novartis Investigative Site Chongqing, China, 400038 Novartis Investigative Site Guang Dong Province, China, 510120 Novartis Investigative Site Guangzhou, China, 510060 Less <<
NCT00687804 Diabetic Macular Edema Phase 3 Completed - Australia ... More >> Novartis Investigative Site Melbourne, Australia Belgium Novartis Investigative Site Leuven, Belgium Canada Novartis Investigative Site Ontario, Canada France Novartis Investigative Site Paris, France Germany Novartis Investigative Site Düsseldorf, Germany Greece Novartis Investigative Site Athens, Greece Hungary Novartis Investigative Site Budapest, Hungary Italy Novartis Investigative Site Firenze, Italy Netherlands Novartis Investigative Site Amsterdam, Netherlands Spain Novartis Investigative Site Barcelona, Spain Switzerland Novartis Investigational Site Zurich, Switzerland Turkey Novartis Investigative Site Ankara, Turkey United Kingdom Novartis Investigative Site Upton, United Kingdom Less <<
NCT02040584 Liver Transplant Phase 3 Completed - Spain ... More >> Novartis Investigative Site Cordoba, Andalucia, Spain, 14004 Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Oviedo, Asturias, Spain, 33011 Novartis Investigative Site Valladolid, Castilla y Leon, Spain, 47012 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site L'Hospitalet de Llobregat, Cataluña, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site La Coruna, Galicia, Spain, 15006 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site El Palmar, Murcia, Spain, 30120 Novartis Investigative Site Pamplona, Navarra, Spain, 31008 Novartis Investigative Site Barakaldo, Pais Vasco, Spain, 48903 Novartis Investigative Site Madrid, Spain, 28007 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Santa Cruz de Tenerife, Spain, 38009 Novartis Investigative Site Zaragoza, Spain, 50009 Less <<
NCT02055352 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Argentina ... More >> Novartis Investigative Site Caba, Buenos Aires, Argentina, C1056ABJ Novartis Investigative Site Florida, Buenos Aires, Argentina, B1602DQD Novartis Investigative Site La Plata, Buenos Aires, Argentina, 1900 Novartis Investigative Site Vicente Lopez, Buenos Aires, Argentina, B1638AAI Novartis Investigative Site Zarate, Buenos Aires, Argentina, 2800 Novartis Investigative Site Santa Rosa, La Pampa, Argentina Novartis Investigative Site Buenos Aires, Argentina, C1125ABE Novartis Investigative Site Ciudad Autonoma de Bs As, Argentina, C1425FVH Novartis Investigative Site Salta, Argentina, 4000 Brazil Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 021941-617 Novartis Investigative Site Porto Alegre, RS, Brazil, 90880-480 Novartis Investigative Site Sao Bernardo do Campo, SP, Brazil, 09750-420 Novartis Investigative Site São Paulo, SP, Brazil, 01244-030 Chile Novartis Investigative Site Santiago, Region Metropolitana, Chile, 8431633 Novartis Investigative Site Rancagua, Chile, 2841959 Dominican Republic Novartis Investigative Site Santo Domingo, Republica Dominicana, Dominican Republic, 10205 Novartis Investigative Site Santo Domingo, Republica Dominicana, Dominican Republic Ecuador Novartis Investigative Site Guayaquil, Guayas, Ecuador, 412 Honduras Novartis Investigative Site San Pedro Sula, Honduras, 21102 Novartis Investigative Site Tegucigalpa, Honduras Mexico Novartis Investigative Site Mexico, Distrito Federal, Mexico, 03310 Novartis Investigative Site Mexico, Distrito Federal, Mexico, 06760 Novartis Investigative Site Mexico, Distrito Federal, Mexico, 14050 Novartis Investigative Site León, Guanajuato, Mexico, 37000 Panama Novartis Investigative Site Panama City, Panamá, Panama Less <<
NCT02055352 - Completed - -
NCT02058381 Pre-menopausal Breast Cancer ... More >> PI3K Pathway Inhibition Less << Phase 1 Completed - Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Korea, Republic of Novartis Investigative Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Novartis Investigative Site Gyeonggi-do, Korea, Korea, Republic of, 10408 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Taiwan Novartis Investigative Site Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan, 33305 Novartis Investigative Site New Taipei City, TWN, Taiwan, 23561 Novartis Investigative Site Kaohsiung City, Taiwan, 83301 Novartis Investigative Site Taichung, Taiwan, 407 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 10449 Novartis Investigative Site Taipei, Taiwan, 112 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Chiang Mai, Thailand, 50200 Less <<
NCT02038036 Polycythemia Vera Phase 3 Active, not recruiting April 8, 2020 -
NCT02059291 Hereditary Periodic Fevers Phase 3 Completed - -
NCT02062645 Essential Hypertension Phase 4 Completed - Turkey ... More >> Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Canakkale, Turkey Novartis Investigative Site Fatih / Istanbul, Turkey, 34098 Novartis Investigative Site Kinikli / Denizli, Turkey, 20070 Novartis Investigative Site Kocaeli, Turkey, 41380 Novartis Investigative Site Malatya, Turkey, 44280 Novartis Investigative Site Mersin, Turkey, 33079 Novartis Investigative Site Talas / Kayseri, Turkey, 38039 Less <<
NCT01128335 Liver Transplantation Phase 2 Completed - -
NCT02058108 Chronic Hepatitis B Phase 3 Active, not recruiting January 31, 2019 Bulgaria ... More >> Novartis Investigative Site Sofia, Sofia-Grad, Bulgaria, 1700 Novartis Investigative Site Pleven, Bulgaria, 5800 Novartis Investigative Site Sofia, Bulgaria, 1407 Novartis Investigative Site Varna, Bulgaria, 9010 Greece Novartis Investigative Site Athens, GR, Greece, GR-115 27 Novartis Investigative Site Haidari Athens, Greece, 12462 Israel Novartis Investigative Site Jerusalem, Israel, 91031 Novartis Investigative Site Jerusalem, Israel, 91120 Novartis Investigative Site Nahariya, Israel, 22100 Novartis Investigative Site Nazareth, Israel, 16100 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Romania Novartis Investigative Site Cluj Napoca, Cluj, Romania, 400177 Novartis Investigative Site Craiova, Dolj, Romania, 200515 Novartis Investigative Site Timisoara, Jud. Timis, Romania, 300011 Novartis Investigative Site Bucharest, Romania, 011743 Novartis Investigative Site Bucharest, Romania, 021105 Novartis Investigative Site Bucharest, Romania, 022328 Novartis Investigative Site Iasi, Romania, 700309 Turkey Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Antalya, Turkey, 07070 Novartis Investigative Site Diyarbakir, Turkey, 21000 Novartis Investigative Site Elazig, Turkey, 23119 Novartis Investigative Site Eskisehir, Turkey, 26040 Novartis Investigative Site Mersin, Turkey, 33343 Ukraine Novartis Investigative Site Dnipropetrovsk, Ukraine, 49006 Novartis Investigative Site Kiev, Ukraine Novartis Investigative Site Kyiv, Ukraine, 04119 Novartis Investigative Site Odesa, Ukraine, 65031 Novartis Investigative Site Vinnytsia, Ukraine, 21029 Less <<
NCT02074982 Chronic Plaque Type Psoriasis Phase 3 Completed - -
NCT02075008 Asthma Phase 2 Terminated(The study was prema... More >>turely terminated after core study CQGE031B2201 failed to meet the primary objective of demonstrating superiority for QGE031 versus placebo.) Less << - -
NCT00687804 - Completed - -
NCT02083354 Cancer Phase 2 Active, not recruiting December 20, 2019 China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510060 China, Yunnan Novartis Investigative Site Kunming, Yunnan, China, 650106 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310022 China Novartis Investigative Site Beijing, China, 100036 Hong Kong Novartis Investigative Site Tuen Mun, Hong Kong Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of, 110-744 Novartis Investigative Site Seoul, Korea, Republic of, 120-752 Taiwan Novartis Investigative Site Kaohsiung, Taiwan, 807 Novartis Investigative Site Taipei, Taiwan, 100 Novartis Investigative Site Taoyuan County, Taiwan, 333 Thailand Novartis Investigative Site Bangkok, Thailand, 10320 Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Songkla, Thailand, 90110 Less <<
NCT02059291 - Completed - -
NCT02062645 - Completed - -
NCT02074982 - Completed - -
NCT02075008 - Terminated(The study was prema... More >>turely terminated after core study CQGE031B2201 failed to meet the primary objective of demonstrating superiority for QGE031 versus placebo.) Less << - -
NCT02064868 Acute Heart Failure (AHF) Phase 3 Terminated(Study was terminate... More >>d based on results from pivotal adult AHF study CRLX030A2301) Less << - -
NCT01148810 Polymyositis ... More >>Dermatomyositis Less << Phase 2 Terminated - United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02115 Czech Republic Novartis Investigative Site Prague 2, Czech Republic, 128 50 Hungary Novartis Investigative Site Budapest, Hungary, 1083 Novartis Investigative Site Debrecen, Hungary, 4032 Sweden Novartis Investigative Site Stockholm, Sweden, 17176 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M6 8HD Less <<
NCT02087059 Primary Myelofibrosis (MF) Phase 3 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 467-8602 Novartis Investigative Site Matsuyama, Ehime, Japan, 790-8524 Novartis Investigative Site Toon-city, Ehime, Japan, 791-0295 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Kurume-city, Fukuoka, Japan, 830-0011 Novartis Investigative Site Maebashi-city, Gunma, Japan, 371-8511 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8543 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0047 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-8556 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 606-8507 Novartis Investigative Site Tsu-city, Mie, Japan, 514-8507 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Miyazaki-city, Miyazaki, Japan, 889-1692 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Hirakata-city, Osaka, Japan, 573-1191 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Shimotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8519 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8603 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8677 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 162-8666 Novartis Investigative Site Chuo-city, Yamanashi, Japan, 409-3898 Novartis Investigative Site Akita, Japan, 010-8543 Novartis Investigative Site Gifu, Japan, 501-1194 Less <<
NCT02087059 - Completed - -
NCT01176032 Hypertension ... More >>Left Ventricle Hypertrophy Less << Phase 4 Completed - Spain ... More >> Novartis Investigative Site Sanlúcar de Barrameda, Andalucia, Spain, 11540 Novartis Investigative Site Sevilla, Andalucia, Spain, 41009 Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Utrera, Andalucia, Spain, 41710 Novartis Investigative Site Burgos, Castilla y Leon, Spain, 09005 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site Girona, Cataluña, Spain, 17007 Novartis Investigative Site L'Hospitalet de Llobregat, Cataluña, Spain, 08907 Novartis Investigative Site Santa Coloma de Gramanet, Cataluña, Spain Novartis Investigative Site Alicante, Comunidad Valenciana, Spain, 03004 Novartis Investigative Site Torrevieja (Alicante), Comunidad Valenciana, Spain, 03186 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46014 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Galdakano, Pais Vasco, Spain, 48960 Novartis Investigative Site Bilbao, País Vasco, Spain, 48013 Novartis Investigative Site Vitoria, País Vasco, Spain Novartis Investigative Site Barcelona, Spain, 08006 Novartis Investigative Site Barcelona, Spain, 08025 Novartis Investigative Site Madrid, Spain, 28009 Novartis Investigative Site Madrid, Spain, 28035 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain, 28046 Novartis Investigative Site Santander, Spain, 39008 Less <<
NCT02103738 - Active, not recruiting July 31, 2019 Canada, Alberta ... More >> Novartis Investigative Site Calgary, Alberta, Canada, T2H0C8 Novartis Investigative Site Edmonton, Alberta, Canada, T5H 0X5 Canada, New Brunswick Novartis Investigative Site Moncton, New Brunswick, Canada, E1C 4B7 Canada, Newfoundland and Labrador Novartis Investigative Site St Johns, Newfoundland and Labrador, Canada, A1A 4A5 Novartis Investigative Site St Johns, Newfoundland and Labrador, Canada, A1B 1S1 Canada, Ontario Novartis Investigative Site Brampton, Ontario, Canada, L6Y 0P6 Novartis Investigative Site Hamilton, Ontario, Canada, L8G 5E4 Novartis Investigative Site London, Ontario, Canada, N6A 4G5 Novartis Investigative Site Missisauga, Ontario, Canada, L5L 1W8 Novartis Investigative Site Ottawa, Ontario, Canada, K1H 8L6 Novartis Investigative Site Timmins, Ontario, Canada, P4N 0A2 Novartis Investigative Site Toronto, Ontario, Canada, M3C 0G9 Novartis Investigative Site Toronto, Ontario, Canada, M4N 3M5 Novartis Investigative Site Toronto, Ontario, Canada, M5C 2T2 Novartis Investigative Site Toronto, Ontario, Canada, M5T 2S8 Novartis Investigative Site Toronto, Ontario, Canada, M5V 1H6 Canada, Quebec Novartis Investigative Site Boisbriand, Quebec, Canada, J7H 1S6 Novartis Investigative Site Drummondville, Quebec, Canada, J2C 2C4 Novartis Investigative Site Montreal, Quebec, Canada, H3Z 1P4 Novartis Investigative Site Montreal, Quebec, Canada, H4P 2S4 Novartis Investigative Site Sherbrooke, Quebec, Canada, J1J 2B8 Novartis Investigative Site Sherbrooke, Quebec, Canada, J1J 2E8 Novartis Investigative Site Ste-Foy, Quebec, Canada, G1V 1T6 Novartis Investigative Site Thetford Mines, Quebec, Canada, G6G 2V2 Less <<
NCT01176032 - Completed - -
NCT02108951 Philidelphia Positive Chronic ... More >>Myeloid Leukaemia Less << Phase 3 Terminated(Study was terminate... More >>d because of slow recruitment) Less << - Australia, Australian Capital ... More >>Territory Novartis Investigative Site Canberra, Australian Capital Territory, Australia, 2605 Australia, New South Wales Novartis Investigative Site Kingswood, New South Wales, Australia, 2747 Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Novartis Investigative Site Liverpool, New South Wales, Australia, 2170 Novartis Investigative Site St. Leonards, New South Wales, Australia, 2065 Australia, Queensland Novartis Investigative Site Douglas, Queensland, Australia, 4810 Novartis Investigative Site Nambour, Queensland, Australia, 4560 Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Novartis Investigative Site Fitzroy, Victoria, Australia, 3065 Novartis Investigative Site Geelong, Victoria, Australia, 3220 Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Australia, Western Australia Novartis Investigative Site Murdoch, Western Australia, Australia, 6150 Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Less <<
NCT00145327 Osteoporosis Phase 3 Completed - -
NCT02125734 - Completed - -
NCT02108951 - Terminated(Study was terminate... More >>d because of slow recruitment) Less << - -
NCT02125734 Chronic Obstructive Pulmonary ... More >>Disease COPD Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Ibbenbüren, Rheinland Pfalz, Germany, 49477 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Berlin, Germany, 13057 Novartis Investigative Site Bonn, Germany, 53119 Novartis Investigative Site Frankfurt, Germany, 60318 Novartis Investigative Site Frankfurt, Germany, 60389 Novartis Investigative Site Garmisch-Partenkirchen, Germany, 82467 Novartis Investigative Site Hannover, Germany, 30173 Novartis Investigative Site Kassel, Germany, 34121 Novartis Investigative Site Leipzig, Germany, 04275 Novartis Investigative Site München, Germany, 80686 Novartis Investigative Site Münster, Germany, 48147 Novartis Investigative Site Neu Isenburg, Germany, 63263 Novartis Investigative Site Rheine, Germany, 48431 Novartis Investigative Site Siegen, Germany, 57072 Novartis Investigative Site Solingen, Germany, 42665 Novartis Investigative Site Sonneberg, Germany, 96515 Novartis Investigative Site Warendorf, Germany, 48231 Less <<
NCT02148133 Cytopaenia Phase 2 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan, 453-8511 Novartis Investigative Site Aichi, Japan, 460-0001 Novartis Investigative Site Hyogo, Japan, 664-8540 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Investigative Site Ishikawa, Japan, 920-8641 Novartis Investigative Site Miyagi, Japan, 981-1293 Novartis Investigative Site Okayama, Japan, 700-0962 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 543-8555 Novartis Investigative Site Osaka, Japan, 565-0871 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 141-8625 Less <<
NCT02150213 Adrenocortical Adenoma ... More >> Endometrial Stromal Sarcomas Less << Phase 2 Completed - United States, Florida ... More >> Novartis Investigative Site Tallahassee, Florida, United States, 32308 United States, Maryland Novartis Investigative Site Baltimore, Maryland, United States, 21287 United States, New Jersey Novartis Investigative Site Monroe Township, New Jersey, United States, 08831 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Germany Novartis Investigative Site Bernau, Germany, 16321 Novartis Investigative Site Bielefeld, Germany, 33617 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Kehl-Kork, Germany, 77694 Novartis Investigative Site Ulm, Germany, 89081 Hungary Novartis Investigative Site Budapest, Hungary, H-1097 Novartis Investigative Site Kecskemet, Hungary, 6000 Novartis Investigative Site Szombathely, Hungary, 9700 Italy Novartis Investigative Site Firenze, FI, Italy, 50143 Novartis Investigative Site Milano, MI, Italy, 20142 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Slovakia Novartis Investigative Site Hlohovec, Slovak Republic, Slovakia, 92001 Novartis Investigative Site Kosice, Slovak Republic, Slovakia, 041 90 Novartis Investigative Site Banska Bystrica, Slovakia, 97517 Less <<
NCT00426530 Breast Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Completed - Belgium ... More >> Novartis Investigative Site Bruxelles, Belgium, 1000 Novartis Investigative Site Liege, Belgium, 4000 France Novartis Investigative Site Paris, France, 75231 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Poland Novartis Investigative Site Warszawa, Poland, 02-781 Sweden Novartis Investigative Site Stockholm, Sweden, SE-171 76 Less <<
NCT02143635 Advanced Solid and Hematologic... More >>al TP53wt Tumors Less << Phase 1 Active, not recruiting July 23, 2019 United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10017 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Paris, France, 75010 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Wuerzburg, Germany, 97080 Japan Novartis Investigative Site Kobe-shi, Hyogo, Japan, 650-0017 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584CX Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Taiwan Novartis Investigative Site Taipei, Taiwan ROC, Taiwan, 10041 Less <<
NCT00145327 - Completed - -
NCT02152761 Muscle Wasting (Atrophy) After... More >> Hip Fracture Surgery Less << Phase 2 Completed - -
NCT02130024 Age-Related Macular Degenerati... More >>on Less << Phase 4 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Albury, New South Wales, Australia, 2640 Novartis Investigative Site Brookvale, New South Wales, Australia, 2100 Novartis Investigative Site Chatswood, New South Wales, Australia, 2067 Novartis Investigative Site Hurtsville, New South Wales, Australia, 2220 Novartis Investigative Site Mona Vale, New South Wales, Australia Novartis Investigative Site Parramatta, New South Wales, Australia, 2150 Novartis Investigative Site Strathfield, New South Wales, Australia, 2035 Novartis Investigative Site Strathfield, New South Wales, Australia, 2135 Novartis Investigative Site Sydney, New South Wales, Australia, 2000 Novartis Investigative Site Sydney, New South Wales, Australia, AUSTRALIA Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Queensland Novartis Investigative Site Caboolture, Queensland, Australia, 4510 Novartis Investigative Site Redcliffe, Queensland, Australia, 4020 Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Novartis Investigative Site Southport, Queensland, Australia, 4215 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Tasmania Novartis Investigative Site South Launceston, Tasmania, Australia, 7249 Australia, Victoria Novartis Investigative Site Clayton, Victoria, Australia, 3168 Novartis Investigative Site Malvern, Victoria, Australia, 3144 Novartis Investigative Site Parkville,, Victoria, Australia, 3065 Australia, Western Australia Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Novartis Investigative Site Subiaco, Western Australia, Australia, 6008 Less <<
NCT02150213 - Completed - -
NCT02151383 Acute Heart Failure Phase 2 Terminated(Study was terminate... More >>d based on results from pivotal adult AHF study CRLX030A2301) Less << - United States, Colorado ... More >> Novartis Investigative Site Denver, Colorado, United States, 80218 United States, Missouri Novartis Investigative Site Saint Louis, Missouri, United States, 63110 United States, New York Novartis Investigative Site Bronx, New York, United States, 10467 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Novartis Investigative Site Charleston, South Carolina, United States, 29425 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Muenchen, Germany, 80636 Switzerland Novartis Investigative Site Genève, Switzerland, 1211 United Kingdom Novartis Investigative Site London, United Kingdom, WC1N 1EH Less <<
NCT02161575 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Bonn, Germany, 53127 Novartis Investigative Site Karlsruhe, Germany, 76135 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muelheim, Germany, 45468 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 80336 United Kingdom Novartis Investigative Site Darlington, Durham, United Kingdom, DL3 6HX Novartis Investigative Site Canterbury, Kent, United Kingdom, CT1 3NG Novartis Investigative Site Aberdeen, Scotland, United Kingdom, AB25 2ZN Novartis Investigative Site Ipswich, Suffolk, United Kingdom, IP4 5PD Novartis Investigative Site Frimley, Surrey, United Kingdom, GU16 7UJ Novartis Investigative Site Guildford, Surrey, United Kingdom, GU2 7XX Novartis Investigative Site Bradford, West Yorkshire, United Kingdom, BD9 6RJ Novartis Investigative Site Ayr, United Kingdom, KA6 6DX Novartis Investigative Site Belfast, United Kingdom, BT12 6BA Novartis Investigative Site East Kilbride, United Kingdom, G75 8RG Novartis Investigative Site Essex, United Kingdom, CM20 1QX Novartis Investigative Site Glasgow - Scotland, United Kingdom, G12 OYN Novartis Investigative Site Great Yarmouth, United Kingdom, NR31 6LA Novartis Investigative Site Harrogate, United Kingdom, HG2 7SX Novartis Investigative Site Liverpool, United Kingdom, L7 8XP Novartis Investigative Site London, United Kingdom, EC1V 2PD Novartis Investigative Site London, United Kingdom, NW1 5QH Novartis Investigative Site London, United Kingdom, SE5 9RS Novartis Investigative Site Manchester, United Kingdom, M13 9WL Novartis Investigative Site Oxford, United Kingdom, OX3 9DU Novartis Investigative Site Southampton, United Kingdom, SO16 6YD Novartis Investigative Site Sunderland, United Kingdom, SR2 9HP Novartis Investigative Site Uxbridge, United Kingdom, UB8 3NN Novartis Investigative Site York, United Kingdom, YO31 8HE Less <<
NCT02158936 Thrombocytopaenia Phase 3 Terminated - -
NCT02422615 - Active, not recruiting - -
NCT02159053 Spondylitis, Ankylosing Phase 3 Completed - -
NCT02158936 - Terminated - -
NCT02435212 Transfusion-dependent Anemia Phase 2 Active, not recruiting January 19, 2024 -
NCT02178540 - Completed - -
NCT02422615 Advanced Breast Cancer Phase 3 Active, not recruiting February 19, 2020 -
NCT02437318 Breast Cancer Phase 3 Active, not recruiting April 15, 2020 -
NCT02435849 Lymphoblastic Leukemia ... More >> Acute Childhood Less << Phase 2 Active, not recruiting November 28, 2022 -
NCT02178540 Cystic Fibrosis Phase 4 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85016 United States, California Novartis Investigative Site Long Beach, California, United States, 90806 Novartis Investigative Site Los Angeles, California, United States, 90027 Novartis Investigative Site Ventura, California, United States, 93003 United States, District of Columbia Novartis Investigative Site Washington, District of Columbia, United States, 20010-2120 United States, Florida Novartis Investigative Site Jacksonville, Florida, United States, 32207 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60611 United States, New York Novartis Investigative Site New York, New York, United States, 10595 United States, Ohio Novartis Investigative Site Toledo, Ohio, United States, 43606 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73104 Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon Novartis Investigative Site Portland, Oregon, United States, 97239 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Less <<
NCT02338609 Growth and Development Phase 4 Active, not recruiting September 25, 2026 United States, California ... More >> University of California at Los Angeles SC Los Angeles, California, United States, 90095 United States, Minnesota Minnesota Epilepsy Group Saint Paul, Minnesota, United States, 55102 United States, Ohio Cincinnati Children's Hospital Medical Center SC Cincinnati, Ohio, United States, 45229-3039 United States, Texas Texas Scottish Rite Hospital for Children SC Dallas, Texas, United States, 75219 Belgium Novartis Investigative Site Brussel, Belgium, 1090 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 127412 Less <<
NCT02217410 Kidney Transplantation Phase 1 Phase 2 Completed - United States, Colorado ... More >> Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Maryland Novartis Investigative Site Baltimore, Maryland, United States, 21201 United States, Michigan Novartis Investigative Site Ann Arbor, Michigan, United States, 48109 Novartis Investigative Site Detroit, Michigan, United States, 48202 United States, New Jersey Novartis Investigative Site Livingston, New Jersey, United States, 07039 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45267-0585 Brazil Novartis Investigative Site São Paulo, SP, Brazil, 04038-002 Germany Novartis Investigative Site Berlin, Germany, D-13353 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 Netherlands Novartis Investigative Site Utrecht, The Netherlands, Netherlands, 3508 GA Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Rotterdam, Netherlands, 3000 CA Less <<
NCT02190604 - Terminated - -
NCT02190604 Cystic Fibrosis Phase 1 Phase 2 Terminated - -
NCT01242813 - Completed - -
NCT02226120 Chronic Heart Failure With Red... More >>uced Ejection Fraction Less << Phase 3 Completed - -
NCT02213042 Neoplasms, Breast Phase 2 Active, not recruiting March 4, 2019 -
NCT01266148 Renal Function and Chronic All... More >>ograft Vasculopathy Less << Phase 4 Completed - Denmark ... More >> Novartis Investigative Site Copenhagen, Denmark, DK-2100 Novartis Investigative Site Århus N, Denmark, DK-8200 Norway Novartis Investigative Site Oslo, Norway, 0424 Sweden Novartis Investigative Site Göteborg, Sweden, 413 45 Novartis Investigative Site Linkoping, Sweden, 581 85 Novartis Investigative Site Lund, Sweden, 221 85 Less <<
NCT02422589 ALK-positive Advanced Tumors Phase 1 Completed - United States, Michigan ... More >> Karmanos Cancer Institute Oncology Department Detroit, Michigan, United States, 48201 Henry Ford Hospital SC Detroit, Michigan, United States, 48202-2689 United States, Texas Cancer Therapy & Research Center UT Health Science Center SC-4 San Antonio, Texas, United States, 78229 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Rozzano, MI, Italy, 20089 Novartis Investigative Site Modena, MO, Italy, 41124 Novartis Investigative Site Padova, PD, Italy, 35100 Spain Novartis Investigative Site La Coruna, Galicia, Spain, 15006 Novartis Investigative Site Madrid, Spain, 28046 Novartis Investigative Site Madrid, Spain, 28050 Less <<
NCT02445248 Diffuse Large B-cell Lymphoma ... More >>(DLBCL) Less << Phase 2 Active, not recruiting February 20, 2023 -
NCT01242813 TNF-receptor Associated Period... More >>ic Syndromes (TRAPS) Less << Phase 2 Completed - Ireland ... More >> Novartis Investigative Site Galway, Ireland Italy Novartis Investigative Site Sciacca, AG, Italy, 92019 Novartis Investigative Site Brescia, BS, Italy, 25123 Novartis Investigative Site Genova, GE, Italy, 16147 Novartis Investigative Site Pavia, PV, Italy, 27100 United Kingdom Novartis Investigative Site London, United Kingdom, NW3 2QG Less <<
NCT01266148 - Completed - -
NCT02262260 Diabetic Macular Edema Phase 3 Completed - Turkey ... More >> Novartis Investigative Site Istanbul, TUR, Turkey, 34098 Novartis Investigative Site Adana, Turkey, 01330 Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Ankara, Turkey, 06490 Novartis Investigative Site Ankara, Turkey, 06500 Novartis Investigative Site Ankara, Turkey, 06590 Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Izmir, Turkey, 35340 Novartis Investigative Site Kocaeli, Turkey, 41380 Less <<
NCT02259088 Diabetic Macular Edema ... More >> Visual Impairment Less << Phase 3 Completed - -
NCT00332839 Renal Transplantation Phase 4 Terminated(The trial was termi... More >>nated early due to slow enrollment. It was determined that the planned sample size of 300 could not be achieved.) Less << - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69115 Novartis Investigative Site Heilbronn, Germany, 74076 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT02381886 Advanced Malignancies That Har... More >>bor IDHR132 Mutations Less << Phase 1 Active, not recruiting April 17, 2019 United States, Massachusetts ... More >> Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States, 02115 United States, New York Columbia University Medical Center- New York Presbyterian Onc Dept. New York, New York, United States, 10032 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3004 Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Germany Novartis Investigative Site Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Jena, Germany, 07740 Netherlands VU Medical Center - Hematology Amsterdam, Netherlands, 1081 HV ErasmusMC Cancer lnstitute, Neuro-Oncology, Rm G3-55 Rotterdam, Netherlands, 3075 EA Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT02292550 Non-small Cell Lung Cancer Phase 1 Completed - United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02114 France Novartis Investigative Site Marseille cedex 05, France, 13385 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Rozzano, MI, Italy, 20089 Korea, Republic of Novartis Investigative Site Seoul, Seocho-gu, Korea, Republic of, 06591 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Taiwan Novartis Investigative Site Tainan, Taiwan ROC, Taiwan, 70421 Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT00332839 - Terminated(The trial was termi... More >>nated early due to slow enrollment. It was determined that the planned sample size of 300 could not be achieved.) Less << - -
NCT02300987 Teratoma Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90033 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46202 United States, Minnesota Mayo Clinic - Rochester Onc Department Rochester, Minnesota, United States, 55905 United States, New Mexico Novartis Investigative Site Albuquerque, New Mexico, United States, 87106 United States, New York Novartis Investigative Site New York, New York, United States, 10017 France Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Spain Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28041 Less <<
NCT02292446 Polycythemia Vera Phase 3 Completed - -
NCT02291029 Primary Sj?gren's Syndrome Phase 2 Completed - United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02111 United States, New York Novartis Investigative Site Mineola, New York, United States, 11501 United States, Pennsylvania Novartis Investigative Site Duncansville, Pennsylvania, United States, 16635 Germany Novartis Investigative Site Berlin, Germany, 10117 Hungary Novartis Investigative Site Debrecen, Hungary, 4032 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Edgbaston, Birmingham, United Kingdom, B15 2WB Novartis Investigative Site London, United Kingdom, EC14 7BE Novartis Investigative Site London, United Kingdom, WC1E 6HX Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE2 4HH Less <<
NCT00446082 Carcinoid Tumor ... More >> Acromegaly Less << Phase 1 Completed - United States, California ... More >> Cedars Sinai Medical Center SC - 4 Los Angeles, California, United States, 90048 Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States, 94304 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Dept.of H.LeeMoffittCC&RI(1) Tampa, Florida, United States, 33612 United States, Texas University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States, 77030-4009 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 Novartis Investigative Site Liege, Belgium, 4000 Canada, Ontario Novartis Investigative Site London, Ontario, Canada, N6A 4L6 Novartis Investigative Site Toronto, Ontario, Canada, M5G1X5 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Leipzig, Germany, 04317 Novartis Investigative Site Muenchen, Germany, 80336 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Norway Novartis Investigative Site Oslo, Norway, NO-0379 Less <<
NCT02307838 Multiple Sclerosis, Relapsing ... More >>Forms of Multiple Sclerosis Less << Phase 4 Completed - Canada, Ontario ... More >> Novartis Investigative Site Ottawa, Ontario, Canada, K1H 8L6 Novartis Investigative Site Toronto, Ontario, Canada, M5B 1N9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Novartis Investigative Site Montreal, Quebec, Canada, H3A 2B4 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 Novartis Investigative Site Glostrup, Denmark, DK-2600 France Novartis Investigative Site Lille, France, 59037 Novartis Investigative Site Marseille, France, 13385 Germany Novartis Investigative Site Würzburg, Germany, 97080 Italy Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Roma, RM, Italy, 00189 Novartis Investigative Site Gallarate, VA, Italy, 21013 Poland Novartis Investigative Site Warszawa, Poland, 02-097 Novartis Investigative Site Warszawa, Poland, 02-957 Portugal Novartis Investigative Site Coimbra, Portugal, 3000-075 Novartis Investigative Site Lisboa, Portugal, 1150-314 Spain Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Sevilla, Andalucia, Spain, 41009 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site L'Hospitalet de Llobregat, Catalunya, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Madrid, Spain, 28040 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site Zuerich, Switzerland, 8091 United Kingdom Novartis Investigative Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Less <<
NCT02307838 - Completed - -
NCT02333370 Hormone Receptor Positive, HER... More >>2-negative, Advanced Breast Cancer Less << Phase 1 Active, not recruiting October 26, 2020 Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Japan Novartis Investigative Site Nagoya-city, Aichi, Japan, 467-8602 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 003-0804 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 241-8515 Novartis Investigative Site Osaka-city, Osaka, Japan, 540-0006 Novartis Investigative Site Suita-city, Osaka, Japan, 565 0871 Novartis Investigative Site Hidaka-city, Saitama, Japan, 350-1298 Novartis Investigative Site Kitaadachi-gun, Saitama, Japan, 362-0806 Novartis Investigative Site Sunto Gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8677 Novartis Investigative Site Koto-ku, Tokyo, Japan, 135 8550 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-8666 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Less <<
NCT02325739 HCC Phase 1 Phase 2 Active, not recruiting July 15, 2020 -
NCT02343172 Liposarcoma Phase 1 Phase 2 Active, not recruiting December 19, 2018 Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Ulm, Germany, 89081 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28222 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT02296424 Systemic Juvenile Idiopathic A... More >>rthritis (SJIA) Less << Phase 3 Completed - -
NCT02335892 - Completed - United Kingdom ... More >> Novartis Investigative Site Truro, Cornwall, United Kingdom, TR1 3LJ Novartis Investigative Site Swansea, England, United Kingdom, SA6 6NL Novartis Investigative Site Romford, Essex, United Kingdom, RM7 0AG Novartis Investigative Site Basingstoke, Hampshire, United Kingdom, RG24 9NA Novartis Investigative Site Edinburgh, United Kingdom, EH16 4SA Novartis Investigative Site Glasgow, United Kingdom, G51 4TF Novartis Investigative Site Leicester, United Kingdom, LE5 4PW Novartis Investigative Site Liverpool, United Kingdom, L9 7LT Novartis Investigative Site London, United Kingdom, E1 1BB Novartis Investigative Site London, United Kingdom, SW17 0QT Novartis Investigative Site London, United Kingdom, W6 8RF Novartis Investigative Site London, United Kingdom, WC1N 3BG Novartis Investigative Site Norwich, United Kingdom, NR4 7UY Novartis Investigative Site Nottingham, United Kingdom, NG5 1PB Less <<
NCT01359943 Rheumatoid Arthritis Phase 2 Completed - -
NCT01377597 Retinal Vein Occlusion Phase 3 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 466-8560 Novartis Investigative Site Nagoya, Aichi, Japan, 467-8602 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Kita-gun, Kagawa, Japan, 761-0793 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Ohtsu, Shiga, Japan, 520-2192 Novartis Investigative Site Kyoto, Japan, 606-8507 Novartis Investigative Site Osaka, Japan, 545-8586 Less <<
NCT02354508 Acromegaly Phase 3 Completed - -
NCT02366468 Diabetic Retinopathy Phase 4 Completed - Germany ... More >> Novartis Investigative Site Ahaus, Germany, 48683 Novartis Investigative Site Bayreuth, Germany, 95444 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Berlin, Germany, 14169 Novartis Investigative Site Bonn, Germany, 53127 Novartis Investigative Site Dresden, Germany, 01067 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Düsseldorf, Germany, 40212 Novartis Investigative Site Freiburg i. Br, Germany, 79106 Novartis Investigative Site Gottingen, Germany, 37075 Novartis Investigative Site Greifswald, Germany, 17475 Novartis Investigative Site Halle, Germany, 06114 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hösbach, Germany, 63768 Novartis Investigative Site Kempten, Germany, 87435 Novartis Investigative Site Koeln, Germany, 50924 Novartis Investigative Site Koeln, Germany, 50935 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Ludwigshafen, Germany, 67063 Novartis Investigative Site Lübeck, Germany, 23538 Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenster, Germany, 48145 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 80333 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Stuttgart, Germany, 70174 Novartis Investigative Site Tübingen, Germany, 72076 Novartis Investigative Site Ulm, Germany, 89075 Novartis Investigative Site Wurzburg, Germany, 97080 Less <<
NCT02404441 Melanoma NSCL... More >>C Triple Negative Breast Cancer Anaplastic Thyroid Cancer Other Solid Tumors Less << Phase 1 Phase 2 Active, not recruiting May 20, 2020 -
NCT02375958 Triple Negative Breast Cancer,... More >> Head & Neck Cancer, Esophageal Cancer Less << Phase 1 Completed - United States, Texas ... More >> Novartis Investigative Site Houston, Texas, United States, 77030 Novartis Investigative Site San Antonio, Texas, United States, 78229 France Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Japan Novartis Investigative Site Koto-ku, Tokyo, Japan, 135 8550 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Madrid, Spain, 28007 Less <<
NCT01332097 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - Bulgaria ... More >> Novartis Investigative Site Plovdiv, Bulgaria, 4000 Novartis Investigative Site Russe, Bulgaria, 7002 Romania Novartis Investigative Site Bucuresti, Romania, 50159 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 107014 Novartis Investigative Site Moscow, Russian Federation, 117292 Novartis Investigative Site St. Petersburg, Russian Federation, 191015 Less <<
NCT01350115 Basal Cell Carcinoma ... More >> Gorlin Syndrome Nevoid Basal Cell Carcinoma Syndrome Less << Phase 2 Completed - Austria ... More >> Novartis Investigative Site Wien, Austria, A-1090 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Markham, Ontario, Canada, L3P 1A8 Novartis Investigative Site Waterloo, Ontario, Canada, N2J 1C4 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2K 4L5 Germany Novartis Investigative Site Kiel, Germany, 24105 Less <<
NCT02520752 cMET-dysregulated Advanced Sol... More >>id Tumors Less << Phase 1 Completed - United States, Georgia ... More >> Emory University School of Medicine/Winship Cancer Institute SC-2 Atlanta, Georgia, United States, 30322 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1756 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Dijon Cedex, Cote D Or, France, 21034 Novartis Investigative Site Pierre Benite, France, 69310 Italy Novartis Investigative Site Rozzano, MI, Italy, 20089 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 United Kingdom Novartis Investigative Site London, United Kingdom, W12 0HS Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT02375971 Retinopathy of Prematurity Phase 3 Completed - -
NCT01365455 - Completed - -
NCT01359943 - Completed - -
NCT01365455 Moderate to Severe Plaque-type... More >> Psoriasis Less << Phase 3 Completed - -
NCT01355614 Crohn's Disease Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Muenchen, Germany, 93053 Switzerland Novartis Investigative Site Zuerich, Switzerland, 8091 Less <<
NCT02375971 - Completed - -
NCT01350115 - Completed - -
NCT00605475 Type 2 Diabetes Mellitus Phase 2 Completed - United States, Arkansas ... More >> Arkansas Research Medical Testing Little Rock, Arkansas, United States, 72202 United States, Florida Allied Research International - Cetero Research Miami Miami, Florida, United States, 33169 Elite Research Institute Miami Miami, Florida, United States, 33169 United States, Maryland International Research Center Towson MD, Maryland, United States, 21286 United States, Oregon Covance Clinical Research Unit Inc Portland, Oregon, United States, 97239 United States, Washington Charles River Clinical Services NW Tacoma, Washington, United States, 98418 Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Kiel, Germany Novartis Investigator Site Moenchengladbach, Germany Novartis Investigator Site Munich, Germany Novartis Investigative Site Neuss, Germany Russian Federation Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site St. Petersberg, Russian Federation Less <<
NCT00929110 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT02396212 Systemic Juvenile Idiopathic A... More >>rthritis Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Obu-city, Aichi, Japan, 474-8710 Novartis Investigative Site Chiba-city, Chiba, Japan, 266-0007 Novartis Investigative Site Kanazawa-city, Ishikawa, Japan, 920-8641 Novartis Investigative Site Kagoshima city, Kagoshima, Japan, 890 8520 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 232-8555 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 236-0004 Novartis Investigative Site Sendai-city, Miyagi, Japan, 989-3126 Less <<
NCT01364389 Polymyalgia Rheumatica ... More >> Inflammatory Diseases Less << Phase 2 Terminated(Data did not show t... More >>hat the two biologic treatments impacted PMR disease activity to the same degree as steroid treatment within a 2-week treatment period.) Less << - United States, Minnesota ... More >> Novartis Investigative Site Rochester, Minnesota, United States, 55905 Germany Novartis Investigative Site Berlin, Germany, 13125 Italy Novartis Investigative Site Reggio Emilia, RE, Italy, 42123 Novartis Investigative Site Siena, SI, Italy, 53100 United Kingdom Novartis Investigative Site Basildon, Essex, United Kingdom, SS16 5NL Novartis Investigative Site Westcliff-on-Sea, Essex, United Kingdom, SS0 0RY Less <<
NCT00929110 - Completed - -
NCT01364389 - Terminated(Data did not show t... More >>hat the two biologic treatments impacted PMR disease activity to the same degree as steroid treatment within a 2-week treatment period.) Less << - -
NCT02404025 Cytopaenia Phase 2 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan, 453-8511 Novartis Investigative Site Aichi, Japan, 460-0001 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Investigative Site Ishikawa, Japan, 920-8641 Novartis Investigative Site Miyagi, Japan, 981-1293 Novartis Investigative Site Okayama, Japan, 700-0962 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 543-8555 Novartis Investigative Site Osaka, Japan, 565-0871 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 141-8625 Less <<
NCT02404389 - Completed - -
NCT02435680 Advanced Triple Negative Breas... More >>t Cancer (TNBC) With High TAMs Less << Phase 2 Active, not recruiting December 19, 2018 -
NCT00605475 - Completed - -
NCT01147003 Partial Onset Seizures Phase 2 Completed - -
NCT02449018 Chronic Obstructive Pulmonary ... More >>Disease, COPD Less << Phase 2 Completed - United States, Alabama ... More >> Novartis Investigative Site Birmingham, Alabama, United States, 35294 United States, California Novartis Investigative Site Fullerton, California, United States, 92835 United States, Connecticut Novartis Investigative Site Waterbury, Connecticut, United States, 06708 United States, Florida Novartis Investigative Site Clearwater, Florida, United States, 33765 Novartis Investigative Site Port Orange, Florida, United States, 32127 Novartis Investigative Site Tampa, Florida, United States, 33603 United States, Illinois Novartis Investigative Site Normal, Illinois, United States, 61761 United States, Missouri Novartis Investigative Site Saint Louis, Missouri, United States, 63141 United States, North Carolina Novartis Investigative Site Huntersville, North Carolina, United States, 28078 Novartis Investigative Site Shelby, North Carolina, United States, 28152 United States, Oregon Novartis Investigative Site Medford, Oregon, United States, 97504 United States, South Carolina Novartis Investigative Site Simpsonville, South Carolina, United States, 29681 Novartis Investigative Site Spartanburg, South Carolina, United States, 29303 Novartis Investigative Site Union, South Carolina, United States, 29379 Poland Novartis Investigative Site Lodz, Poland, 90-153 Novartis Investigative Site Sobotka, Poland, 55-050 Less <<
NCT02404389 Actinic Keratosis Phase 2 Completed - Austria ... More >> Novartis Investigative Site Vienna, Austria, 1040 Denmark Novartis Investigative Site Copenhagen NV, Denmark, DK-2400 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Bonn, Germany, 53111 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hamburg, Germany, 20354 Iceland Novartis Investigative Site Kopavogur, Iceland, 201 United Kingdom Novartis Investigative Site London, United Kingdom, E1 1BB Less <<
NCT02449031 - Active, not recruiting July 31, 2023 -
NCT02449018 - Completed - -
NCT02450903 Non-Small-Cell Lung Cancer Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 811-1395 Novartis Investigative Site Akashi, Hyogo, Japan, 673-8558 Novartis Investigative Site Sakyo-ku, Kyoto, Japan, 606 8507 Novartis Investigative Site Natori, Miyagi, Japan, 981-1293 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Sayama, Osaka, Japan, 589-8511 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Koto-ku, Tokyo, Japan, 135 8550 Less <<
NCT00901186 Diabetic Macular Edema ... More >> Visual Impairment Less << Phase 2 Completed - Spain ... More >> Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Almería, Andalucía, Spain, 04009 Novartis Investigative Site Cadiz, Andalucía, Spain, 11009 Novartis Investigative Site Hospitalet de Llobregat, Barcelona, Spain, 08907 Novartis Investigative Site Valladolid, Castilla y Leon, Spain, 47011 Novartis Investigative Site Terrassa, Cataluña, Spain, 08221 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Mallorca, Islas Baleares, Spain, 07198 Novartis Investigative Site La Laguna, Las Palmas de Gran Canaria, Spain, 38320 Novartis Investigative Site Pamplona, Navarra, Spain, 31080 Novartis Investigative Site Barakaldo, Pais Vasco, Spain, 48903 Novartis Investigative Site Barcelona, Spain, 08021 Novartis Investigative Site Barcelona, Spain, 08025 Novartis Investigative Site Las Palmas de Gran Canaria, Spain, 35016 Novartis Investigative Site Madrid, Spain, 28002 Novartis Investigative Site Madrid, Spain, 28035 Novartis Investigative Site Madrid, Spain Less <<
NCT01417091 Osteogenesis Imperfecta Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 United States, Florida Novartis Investigative Site Miramar, Florida, United States, 33025 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Gent, Belgium, 9000 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3GIA6 Germany Novartis Investigative Site Wuerzburg, Germany, 97074 Less <<
NCT00901186 - Completed - -
NCT00264160 Leukemia, Myeloid, Chronic Phase 2 Phase 3 Completed - Israel ... More >> Novartis Investigative Site Haifa, Israel Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Petach Tikva, Israel Novartis Investigative Site Tel Hashomer, Israel Less <<
NCT00379483 Transfusional Iron Overload Phase 2 Completed - Italy ... More >> Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Genova, Italy Novartis Investigative Site Milan, Italy Novartis Investigative Site Torino, Italy Less <<
NCT01299415 Solid Tumors Phase 1 Terminated - United States, Indiana ... More >> Univ. of Indiana School of Medicine/Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Minnesota Masonic Cancer Center/ Clinical Trials Office Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University School of Medicine/Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Texas Cancer Therapy & Research Center San Antonio, Texas, United States, 78229 Less <<
NCT02596009 - Completed - -
NCT02370706 Myelofibrosis Phase 1 Active, not recruiting December 31, 2018 Australia, Melbourne ... More >> Novartis Investigative Site VIC, Melbourne, Australia, 3004 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Singapore Novartis Investigative Site Singapore, Singapore, 119228 United Kingdom Novartis Investigative Site London, United Kingdom, SE1 9RT Less <<
NCT00411580 Alzheimer's Disease Phase 1 Completed - Sweden ... More >> Novartis Investigative Site Malmo, Sweden, 204 02 Novartis Investigative Site Stockholm, Sweden, 141 86 Novartis Investigative Site Stockholm, Sweden Less <<
NCT01192997 Meningococcal Meningitis Phase 2 Phase 3 Completed - United Kingdom ... More >> Multiple General Practice surgeries Gloucestershire, United Kingdom Multiple General Practice surgeries Hertfordshire, United Kingdom Health Protection Agency, Immunisation Department, Colindale London, United Kingdom, NW9 5EQ Less <<
NCT02596009 Pulmonary Disease, Chronic Obs... More >>tructive (COPD) Less << Phase 4 Completed - Argentina ... More >> Novartis Investigative Site Caba, Buenos Aires, Argentina, C1426ABP Novartis Investigative Site Florida, Buenos Aires, Argentina, B1602DQD Novartis Investigative Site La Plata, Buenos Aires, Argentina, 1900 Novartis Investigative Site Mar del Plata, Buenos Aires, Argentina, 7600 Novartis Investigative Site Ciudad Autonoma de Bs As, Argentina, C1425FVH Less <<
NCT00564941 Myelodysplastic Syndromes ... More >> Beta-Thalassemia Less << Phase 4 Completed - Hungary ... More >> Novartis Investigative Site Budapest, Hungary Novartis Investigative Site Debrecen, Hungary Novartis Investigative Site Pecs, Hungary Novartis Investigative Site Szeged, Hungary Less <<
NCT01278849 Histologically-proven and Radi... More >>ologically-confirmed Solid Tumors Less << Phase 1 Terminated - Italy ... More >> Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Milano, Italy, 2104 New Zealand Novarts Investigative Site Auckland, New Zealand Novartis Investigative Site Wellington, New Zealand Less <<
NCT01012739 Asthma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Netherlands Novartis Investigative Site Groningen, Netherlands United Kingdom Novartis Investigative Site Belfast, United Kingdom Novartis Investigative Site Manchester, United Kingdom Less <<
NCT00986414 Parkinson Disease ... More >> Dyskinesias Less << Phase 2 Completed - -
NCT00774020 Paget's Disease of Bone Phase 4 Completed - China ... More >> Novartis Investigative Site Beijing, China Novartis Investigative site Guangzhou, China Novartis Investigative site Nanjing, China Novartis Investigative site Shanghai, China Less <<
NCT00674102 Non-small Cell Lung Cancer Phase 1 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan Novartis Investigative Site Osaka, Japan Novartis Investigative Site Shizuoka, Japan Novartis Investigative Site Tokyo, Japan Less <<
NCT02418468 - Completed - -
NCT01033019 Sporadic Superficial and Nodul... More >>ar Skin Basal Cell Carcinomas Less << Phase 2 Terminated(The data from parti... More >>cipants with sBCCs showed insufficient efficacy with current formulation and treatment conditions.) Less << - Australia, Queensland ... More >> Novartis Investigative Site Benowa, Queensland, Australia, 4217 Novartis Investigative Site Woolloongabba, Queensland, Australia, 4102 Austria Novartis Investigative Site Graz, Austria, A-8036 Novartis Investigative Site Wien, Austria, 1090 Less <<
NCT01033019 - Terminated(The data from parti... More >>cipants with sBCCs showed insufficient efficacy with current formulation and treatment conditions.) Less << - -
NCT01723072 Chronic Spontaneous Urticaria ... More >> Angioedema Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Augsburg, Germany, 86156 Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Darmstadt, Germany, 64283 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Düsseldorf, Germany, 40225 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Halle/Saale, Germany, 06120 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Köln, Germany, 50937 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 80336 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Oldenburg, Germany, 26133 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Selters, Germany, 56242 Novartis Investigative Site Wiesbaden, Germany, 64191 Less <<
NCT02418468 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Less <<
NCT01012739 - Completed - -
NCT01727024 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 4 Completed - Brazil ... More >> Novartis Investigative Site Goiania, GO, Brazil, 74110-030 Novartis Investigative Site Belo Horizonte, MG, Brazil, 30130-100 Novartis Investigative Site Belo Horizonte, MG, Brazil, 30150-281 Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20551-030 Novartis Investigative Site Porto Alegre, RS, Brazil, 90020-090 Novartis Investigative Site Porto Alegre, RS, Brazil, 90610-000 Novartis Investigative Site Florianopolis, SC, Brazil, 88040-970 Novartis Investigative Site Ribeirao Preto, SP, Brazil, 14048-900 Novartis Investigative Site Sao Paulo, SP, Brazil, 04039-004 Novartis Investigative Site São Paulo, SP, Brazil, 01224-000 Less <<
NCT03300427 Heart Failure Phase 4 Recruiting September 2, 2019 Finland ... More >> Novartis Investigative Site Recruiting Turku, Finland Less <<
NCT01727024 - Completed - -
NCT01731990 Peripheral Artery Disease Phase 2 Terminated(The study got termi... More >>nated based on result from primary endpoint analysis) Less << - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85302 United States, Florida Novartis Investigative Site Jacksonville, Florida, United States, 32207 Novartis Investigative Site Jacksonville, Florida, United States, 32216 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60611 United States, Maryland Novartis Investigative Site Lutherville, Maryland, United States, 21093 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43215 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 United States, Virginia Novartis Investigative Site Richmond, Virginia, United States, 23294 Germany Novartis Investigative Site Hamburg, Germany, 20099 Novartis Investigative Site Hamburg, Germany, 22559 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Mainz, Germany, 55116 Novartis Investigative Site München, Germany, 80336 Jordan Novartis Investigative Site Amman, Jordan, 11941 Less <<
NCT00634192 Pseudomonas Infections Phase 3 Completed - Germany ... More >> Novartis Investigator Site Berlin, Germany Novartis Investigator Site Frankfurt, Germany Novartis Investigator site Halle/Saale, Germany Novartis Investigator Site Hamburg, Germany Novartis Investigator Site Hannover, Germany Novartis Investigator Site Heidelberg, Germany Novartis Investigator Site Koeln, Germany Novartis Investigator Site Munich, Germany Less <<
NCT01730768 Schizophrenia Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Garden Grove, California, United States, 92845 Novartis Investigative Site Glendale, California, United States, 91206 Novartis Investigative Site National City, California, United States, 91950 Novartis Investigative Site Oakland, California, United States, 94612 Novartis Investigative Site Pico Rivera, California, United States, 90660 Novartis Investigative Site San Diego, California, United States, 92102 United States, Florida Novartis Investigative Site Miramar, Florida, United States, 33025 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30308 United States, New Jersey Novartis Investigative Site Marlton, New Jersey, United States, 08053 United States, New York Novartis Investigative Site Staten Island, New York, United States, 10305 Novartis Investigative Site Staten Island, New York, United States, 10312 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19131 United States, Texas Novartis Investigative Site Irving, Texas, United States, 75062 Less <<
NCT01736540 Thalassemia, Non-transfusional... More >>-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia Less << Phase 4 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Camperdown, New South Wales, Australia, 2050 Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Novartis Investigative Site Liverpool, New South Wales, Australia, 2170 Novartis Investigative Site St Leonards, New South Wales, Australia, 2065 Novartis Investigative Site Wollongong, New South Wales, Australia, 2500 Australia, Queensland Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Novartis Investigative Site Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Novartis Investigative Site Bedford Park, South Australia, Australia, 5042 Australia, Tasmania Novartis Investigative Site Hobart, Tasmania, Australia, 7000 Australia, Victoria Novartis Investigative Site East Bentleigh, Victoria, Australia, 3165 Australia, Western Australia Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Novartis Investigative Site Perth, Western Australia, Australia, 6000 Less <<
NCT01736540 - Completed - -
NCT01730248 Myelofibrosis Phase 1 Completed - Australia, Queensland ... More >> Novartis Investigative Site Herston, Queensland, Australia, 4029 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Austria Novartis Investigative Site Vienna, Austria, A-1090 France Novartis Investigative Site Paris, France, 75010 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Rostock, Germany, 18057 Israel Novartis Investigative Site Jerusalem, Israel, 91120 Novartis Investigative Site Ramat Gan, Israel, 5265601 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Varese, VA, Italy, 21100 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Spain Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Edgbaston, Birmingham, United Kingdom, B15 2WB Novartis Investigative Site London, United Kingdom, NW1 2BU Novartis Investigative Site London, United Kingdom, SE1 9RT Less <<
NCT01743560 Oestrogen Receptor Positive Ad... More >>vanced Breast Cancer Less << Phase 4 Completed - United Kingdom ... More >> Novartis Investigative Site Epping, Essex, United Kingdom, CM16 6TN Novartis Investigative Site Ipswich, Suffolk, United Kingdom, IP4 5PD Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Cardiff, United Kingdom, CF14 2TL Novartis Investigative Site Denbighshire, United Kingdom, LL18 5UJ Novartis Investigative Site East Kilbride, United Kingdom, G75 8RG Novartis Investigative Site East Yorkshire, United Kingdom, HU16 5JQ Novartis Investigative Site Edinburgh, United Kingdom, EH4 2XU Novartis Investigative Site Inverness, United Kingdom, IV2 3UJ Novartis Investigative Site London, United Kingdom, SW3 6JJ Novartis Investigative Site Portsmouth, United Kingdom, PO6 3LY Less <<
NCT01958021 - Active, not recruiting - -
NCT01731990 - Terminated(The study got termi... More >>nated based on result from primary endpoint analysis) Less << - -
NCT01744028 Remote Patient Monitoring in C... More >>OPD Patients Less << Phase 1 Completed - Spain ... More >> Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Barcelona, Cataluña, Spain, 08025 Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Novartis Investigative Site Girona, Cataluña, Spain, 17007 Novartis Investigative Site L'Hospitalet de Llobregat, Cataluña, Spain, 08907 Novartis Investigative Site Lerida, Cataluña, Spain, 25198 Novartis Investigative Site Sant Boi de Llobregat, Cataluña, Spain, 08830 Novartis Investigative Site Sant Cugat, Cataluña, Spain, 08190 Novartis Investigative Site Sant Joan Despí, Cataluña, Spain, 08970 Novartis Investigative Site Majadanonda, Madrid, Spain, 28220 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Torremolinos, Spain, 29620 Sweden Novartis Investigative Site Gagnef, Sweden, 785 21 Novartis Investigative Site Göteborg, Sweden Novartis Investigative Site Kungshamn, Sweden, 456 31 Novartis Investigative Site Lund, Sweden, 222 22 Novartis Investigative Site Lund, Sweden, SE-221 85 Novartis Investigative Site Stockholm, Sweden, 113 61 Novartis Investigative Site Östersund, Sweden, 831 83 Less <<
NCT01737827 Advanced Hepatocellular Carcin... More >>oma With c-MET Dysregulation Less << Phase 2 Active, not recruiting March 29, 2019 China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510515 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Shanghai Novartis Investigative Site Shanghai, Shanghai, China, 200032 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310016 China Novartis Investigative Site Beijing, China, 100039 Novartis Investigative Site Guangzhou, China, 510060 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Singapore Novartis Investigative Site Singapore, Singapore, 169610 Taiwan Novartis Investigative Site Tainan, Taiwan ROC, Taiwan, 70421 Novartis Investigative Site Taipei, Taiwan, 10002 Thailand Novartis Investigative Site Khon Kaen, THA, Thailand, 40002 Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Less <<
NCT01752634 Psoriatic Arthritis Phase 3 Active, not recruiting January 18, 2019 -
NCT00463242 Major Depressive Disorder Phase 3 Completed - -
NCT01958021 Advanced, Metastatic Breast Ca... More >>ncer Less << Phase 3 Active, not recruiting July 26, 2019 -
NCT00623103 Parkinson's Disease Dementia Phase 3 Completed - -
NCT01762761 Purpura, Thrombocytopenic, Idi... More >>opathic and Hepatitis C Less << Phase 3 Active, not recruiting November 15, 2018 China, Fujian ... More >> Novartis Investigative Site Fuzhou, Fujian, China, 350001 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510080 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 Novartis Investigative Site Zhongshan, Guangdong, China, 528403 China, Hunan Novartis Investigative Site Changsha, Hunan, China, 410013 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210029 China, Jiangxi Novartis Investigative Site Nanchang, Jiangxi, China, 330006 China, Shandong Novartis Investigative Site Jianan, Shandong, China, 250012 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100034 Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100083 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Chengdu, China, 610041 Novartis Investigative Site Jiang Su Province, China, 215006 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China Novartis Investigative Site Tianjin, China, 300020 Less <<
NCT01750918 Cancer Phase 2 Active, not recruiting April 30, 2019 United States, Arizona ... More >> Novartis Investigative Site Scottsdale, Arizona, United States, 85259 United States, California Novartis Investigative Site San Francisco, California, United States, 94115 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10065 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris cedex 12, France, 75571 Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, Lombardia, Italy, 20162 Novartis Investigative Site Candiolo (TO), Piemonte, Italy, 10060 Japan Novartis Investigative Site Aichi, Japan, 464-8681 Novartis Investigative Site Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584 CX Spain Novartis Investigative Site Barcelona, Spain, 08035 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TH Less <<
NCT01770379 Rheumatoid Arthritis Phase 3 Terminated - -
NCT00623103 - Completed - -
NCT00481676 Chronic Urticaria Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Novartis Investigative Site Bonn, Germany Novartis Investigative Site Dresden, Germany Novartis Investigative Site Giessen, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Hannover, Germany Novartis Investigative Site Koeln, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Luebeck, Germany Novartis Investigative Site Mainz, Germany Novartis Investigative Site Munich, Germany Less <<
NCT01775124 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 4 Completed - -
NCT01762761 - Active, not recruiting - -
NCT01775124 - Completed - -
NCT01770379 - Terminated - -
NCT01775137 - Completed - -
NCT01785602 Atopic Dermatitis Phase 2 Completed - Australia, Australian Capital ... More >>Territory Novartis Investigative Site Phillip, Australian Capital Territory, Australia, 2606 Australia, Queensland Novartis Investigative Site Benowa, Queensland, Australia, 4217 Novartis Investigative Site Woolloongabba, Queensland, Australia, 4102 Austria Novartis Investigative Site Vienna, Austria Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 Novartis Investigative Site Liège, Belgium, 4000 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1612 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Muenster, Germany, 48149 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1105 AZ Novartis Investigative Site Groningen, Netherlands Novartis Investigative Site Utrecht, Netherlands, 3508 GA Romania Novartis Investigative Site Bucharest, Romania, 011461 South Africa Novartis Investigative Site Durban, South Africa, 4001 Less <<
NCT01785472 - Completed - -
NCT00481676 - Completed - -
NCT01785602 - Completed - -
NCT01785472 Essential Hypertension Phase 3 Completed - -
NCT00909961 Postmenopausal Osteoporosis Phase 3 Completed - Turkey ... More >> Novartis Investigational site Ankara, Turkey Novartis Investigative site Antalya, Turkey Novartis Investigational site Istanbul, Turkey Novartis Investigative site Izmir, Turkey Novartis Investigative site Kayseri, Turkey Novartis Investigative site Konya, Turkey Less <<
NCT01915303 Cushing's Disease Phase 2 Active, not recruiting December 31, 2019 -
NCT01775137 Long-term Safety of TIP Phase 4 Completed - United States, Ohio ... More >> Novartis Investigative Site Akron, Ohio, United States, 44308 United States, South Carolina Novartis Investigative Site Charleston, South Carolina, United States, 29425 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Novartis Investigative Site Houston, Texas, United States, 77030 Argentina Novartis Investigative Site Caba, Buenos Aires, Argentina, C1425DTG Novartis Investigative Site Capital Federal, Buenos Aires, Argentina, C1425EFD Novartis Investigative Site Córdoba, Cordoba, Argentina, X5014AKN Australia, New South Wales Novartis Investigative Site New Lambton Heights, New South Wales, Australia, 2305 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3052 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T1C5 Germany Novartis Investigative Site Essen, Germany, 45147 Hungary Novartis Investigative Site Budapest, Hungary, 1121 Italy Novartis Investigative Site Firenze, FI, Italy, 50139 Novartis Investigative Site Messina, ME, Italy, 98125 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Palermo, Italy, 90100 Novartis Investigative Site Roma, Italy, 00161 Mexico Novartis Investigative Site Mexico, Distrito Federal, Mexico, 06720 Novartis Investigative Site Monterrey, Nuevo León, Mexico, 64020 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Less <<
NCT01806597 Moderate to Severe Palmoplanta... More >>r Psoriasis Less << Phase 3 Completed - -
NCT01801917 - Terminated - -
NCT01807520 Moderate to Severe Nail Psoria... More >>sis Less << Phase 3 Completed - -
NCT01807520 - Completed - -
NCT01787552 Primary Myelofibrosis ... More >> Thrombocythemia, Essential Thrombocytosis Myeloproliferative Disorders Bone Marrow Diseases Hematologic Diseases Blood Coagulation Disorders Blood Platelet Disorders Hemorrhagic Disorders Less << Phase 1 Phase 2 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Camperdown, New South Wales, Australia, NSW Australia, Queensland Novartis Investigative Site Woolloongabba, Queensland, Australia, 4102 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 Denmark Novartis Investigative Site Roskilde, Denmark, 4000 France Novartis Investigative Site Marseille, France, 13273 Germany Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Magdeburg, Germany, 39120 Ireland Novartis Investigative Site Galway, Ireland Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Reggio Calabria, RC, Italy, 89124 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Rotterdam, Netherlands, 3015 GD Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28034 United Kingdom Novartis Investigative Site Glasgow, Scotland, United Kingdom, G12 0YN Novartis Investigative Site London, United Kingdom, SE1 9RT Less <<
NCT01811472 Non-alcoholic Fatty Liver Dise... More >>ase (NAFLD) Less << Phase 2 Completed - United States, Alabama ... More >> Novartis Investigative Site Mobile, Alabama, United States, 36608 United States, California Novartis Investigative Site San Diego, California, United States, 92114 United States, Florida Novartis Investigative Site Gainesville, Florida, United States, 32610-0277 Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Tamarac, Florida, United States, 33319 United States, Hawaii Novartis Investigative Site Honolulu, Hawaii, United States, 96814 United States, Kentucky Novartis Investigative Site Louisville, Kentucky, United States, 40213 United States, Mississippi Novartis Investigative Site Tupelo, Mississippi, United States, 38801 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Novartis Investigative Site Plano, Texas, United States, 75093 United States, Virginia Novartis Investigative Site Richmond, Virginia, United States, 23298 Less <<
NCT01801917 Polymyositis Phase 2 Terminated - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85013 Canada, Ontario Novartis Investigative Site Torono, Ontario, Canada, M5G 2C4 Czechia Novartis Investigative Site Prague 2, Czechia, 128 50 Hungary Novartis Investigative Site Budapest, Hungary, 1083 Novartis Investigative Site Debrecen, Hungary, 4032 Poland Novartis Investigative Site Bydgoszcz, Poland, 85-168 Taiwan Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taichung, Taiwan, 40705 Less <<
NCT01811485 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Investigative Site Chikushino-city, Fukuoka, Japan, 818-0083 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-0014 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 819-0006 Novartis Investigative Site Iizuka-city, Fukuoka, Japan, 820-8505 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 800-0296 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-0857 Novartis Investigative Site Koga-city, Ibaraki, Japan, 306-0232 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 221-0802 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Yatsushiro-city, Kumamoto, Japan, 866-8533 Novartis Investigative Site Yatsushiro-city, Kumamoto, Japan, 866-8660 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 607-8062 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-0035 Novartis Investigative Site Sakai-city, Osaka, Japan, 590-0064 Novartis Investigative Site Takatsuki-city, Osaka, Japan, 569-1096 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-1161 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 134-0084 Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0918 Novartis Investigative Site Hachioji, Tokyo, Japan, 192-0046 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 124-0024 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0051 Novartis Investigative Site Shibuya-ku, Tokyo, Japan, 150-0002 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Less <<
NCT01007968 Advanced Solid Tumors Phase 1 Completed - United States, Utah ... More >> University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States, 84103 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Sweden Novartis Investigative Site Lund, Sweden, SE-221 85 Novartis Investigative Site Stockholm, Sweden, SE-171 76 Switzerland Novartis Investigative Site St. Gallen, Switzerland, 9007 United Kingdom Novartis Investigative Site Edinburgh, United Kingdom, EH4 2XR Less <<
NCT01811485 - Completed - -
NCT01813019 - Terminated(Study was premature... More >>ly terminated at the time of the first Interim Analysis (IA) as the study did not meet its primary efficacy objective.) Less << - -
NCT01806597 - Completed - -
NCT00510510 - Completed - -
NCT01811472 - Completed - -
NCT01816594 HER2-positive, Newly Diagnosed... More >>, Primary Breast Cancer, Neoadjuvant Therapy, Trastuzumab Less << Phase 2 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Concord NSW, New South Wales, Australia, 2139 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Austria Novartis Investigative Site Salzburg, Austria, 5020 Germany Novartis Investigative Site Düsseldorf, Nordrhein Westfalen, Germany, 40235 Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45043 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Lübeck, Germany, 23538 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Offenbach, Germany, 63069 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 4103 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site Reus, Tarragona, Spain, 43204 Less <<
NCT01830010 Hematological Malignancies Phase 1 Completed - France ... More >> Novartis Investigative Site Paris, France, 75010 Germany Novartis Investigative Site Regensburg, Bavaria, Germany, 93053 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Koeln, Germany, 50937 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site Zürich, Switzerland, 8091 Less <<
NCT01813019 Patient Diagnosed With OCD and... More >> Resistant to SSRI Treatment Failed SSRI Over 12 Weeks at Appropriate Doses Less << Phase 2 Terminated(Study was premature... More >>ly terminated at the time of the first Interim Analysis (IA) as the study did not meet its primary efficacy objective.) Less << - United States, California ... More >> Novartis Investigative Site San Diego, California, United States, 92103 United States, Massachusetts Novartis Investigative Site Watertown, Massachusetts, United States, 02472 United States, New York Novartis Investigative Site Brooklyn, New York, United States, 11229 Bulgaria Novartis Investigative Site Burgas, Bulgaria, 8000 Novartis Investigative Site Pazardzhik, Bulgaria, 4400 Novartis Investigative Site Sofia, Bulgaria, 1431 Novartis Investigative Site Sofia, Bulgaria, 1632 Novartis Investigative Site Varna, Bulgaria, 9020 Czech Republic Novartis Investigative Site Strakonice, Czech Republic, 386 29 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Muenchen, Germany, 80336 Novartis Investigative Site Nürnberg, Germany, 90419 Novartis Investigative Site Ulm, Germany, 89081 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Less <<
NCT01828086 Chronic Plaque-type Psoriasis Phase 1 Completed - United States, Alabama ... More >> Novartis Investigative Site Anniston, Alabama, United States, 36207 United States, California Novartis Investigative Site Anaheim, California, United States, 92801 Novartis Investigative Site Encino, California, United States, 91436 Novartis Investigative Site North Hollywood, California, United States, 91606 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33136 Novartis Investigative Site Miami, Florida, United States, 33175 Novartis Investigative Site Orlando, Florida, United States, 32809 Novartis Investigative Site Tampa, Florida, United States, 33609 United States, Illinois Novartis Investigative Site Normal, Illinois, United States, 61761 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46256 United States, Kansas Novartis Investigative Site Overland Park, Kansas, United States, 66211 United States, Louisiana Novartis Investigative Site Crowley, Louisiana, United States, 70526 United States, North Carolina Novartis Investigative Site Raleigh, North Carolina, United States, 27612 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45255 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19103 United States, Texas Novartis Investigative Site Austin, Texas, United States, 78759 Novartis Investigative Site San Antonio, Texas, United States, 78229 Less <<
NCT00510510 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - -
NCT01840410 Choroidal Neovascularization (... More >>CNV) Less << Phase 3 Completed - -
NCT01828099 - Active, not recruiting - -
NCT02060383 Cushing's Disease ... More >> Acromegaly Less << Phase 4 Completed - -
NCT01843348 Kidney Transplantation ... More >> Renal Transplantation Less << Phase 3 Completed - France ... More >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Dijon, France, 21079 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Nantes, France, 44035 Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Poitiers, France, 86000 Novartis Investigative Site St Priest en Jarez Cedex, France, 42277 Novartis Investigative Site Strasbourg, France, 67091 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Germany Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bochum, Germany, 44892 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT01834885 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Withdrawn September 2014 Austria ... More >> Novartis Investigative Site Feldkirch, Austria, 6800 Novartis Investigative Site Grieskirchen, Austria, 4710 Novartis Investigative Site Hallein, Austria, 5400 Novartis Investigative Site Linz, Austria, 4020 Novartis Investigative Site Thalheim bei Wels, Austria, 4600 Novartis Investigative Site Wels, Austria, 4600 Germany Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Bad Woerishofen, Germany, 86825 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 10119 Novartis Investigative Site Berlin, Germany, 10717 Novartis Investigative Site Berlin, Germany, 10789 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Berlin, Germany, 12687 Novartis Investigative Site Berlin, Germany, 13156 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Frankfurt, Germany, 60389 Novartis Investigative Site Frankfurt, Germany, 60596 Novartis Investigative Site Grosshansdorf, Germany, 22947 Novartis Investigative Site Hamburg, Germany, 20253 Novartis Investigative Site Hamburg, Germany, 20354 Novartis Investigative Site Hamburg, Germany, 22335 Novartis Investigative Site Hannover, Germany, 30317 Novartis Investigative Site Leipzig, Germany, 04207 Novartis Investigative Site Leipzig, Germany, 04357 Novartis Investigative Site Lübeck, Germany, 23552 Novartis Investigative Site Münster, Germany, 48145 Novartis Investigative Site Potsdam, Germany, 14467 Novartis Investigative Site Rheine, Germany, 48431 Less <<
NCT01844778 Cystic Fibrosis Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site München, Germany, 81241 Novartis Investigative Site Tübingen, Germany, 72076 Ireland Novartis Investigative Site Galway, Ireland Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 Novartis Investigative Site Madrid, Spain, 28046 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site St. Gallen, Switzerland, 9007 Novartis Investigative Site Zürich, Switzerland, 8032 United Kingdom Novartis Investigative Site Southampton, Hampshire, United Kingdom, SO16 6YD Novartis Investigative Site Penarth, Vale of Glamorgan, United Kingdom, CF64 2XX Novartis Investigative Site Birmingham, West Midlands, United Kingdom, b9 5ss Novartis Investigative Site Bristol, United Kingdom, BS1 3NU Novartis Investigative Site East Yorkshire, United Kingdom, HU16 5JQ Novartis Investigative Site Exeter, United Kingdom, EX2 5DW Novartis Investigative Site Liverpool, United Kingdom, L14 3PE Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT01843348 - Completed - -
NCT01846299 Macular Edema (ME) Phase 3 Completed - -
NCT01840410 - Completed - -
NCT01846273 Age-related Macular Degenerati... More >>on Polypoidal Choroidal Vasculopathy PCV Less << Phase 4 Completed - -
NCT01964235 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Withdrawn(Study was cancelled ... More >>by Sponsor.) Less << July 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Mass General Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Research Medical Center Onc Dept Kansas City, Missouri, United States, 64132 Australia, New South Wales Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 France Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site LILLE Cedex, France, 59037 Novartis Investigative Site Montpellier Cedex 5, France, 34298 Novartis Investigative Site Nice Cedex 3, France, 06202 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Würzburg, Germany, 97080 Hong Kong Novartis Investigative Site Hong Kong SAR, Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Spain Novartis Investigative Site Cordoba, Andalucia, Spain, 14004 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Novartis Investigative Site Genève, Switzerland, 1211 Less <<
NCT01828099 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting April 11, 2022 -
NCT01846299 - Completed - -
NCT01863732 Spondylitis, Ankylosing Phase 3 Completed - -
NCT01844778 - Completed - -
NCT01862263 Type 2 Diabetes Mellitus Phase 4 Completed - Mexico ... More >> Novartis Investigative Site Mexico, Distrito Federal, Mexico, 06700 Novartis Investigative Site Mexico, Distrito Federal, Mexico, 07300 Novartis Investigative Site Mexico, Distrito Federal, Mexico, 14050 Novartis Investigative Site Metepec, Estado de México, Mexico, 52140 Novartis Investigative Site Celaya, Guanajuato, Mexico, 38000 Novartis Investigative Site Guadalajara, Jalisco, Mexico, 44150 Novartis Investigative Site Guadalajara, Jalisco, Mexico, 44600 Novartis Investigative Site Guadalajara, Jalisco, Mexico, 44670 Novartis Investigative Site Monterrey, Nuevo Leon, Mexico, 64710 Novartis Investigative Site Monterrey, Nuevo León, Mexico, 64020 Novartis Investigative Site Cancun, Quintana Roo, Mexico, 77500 Novartis Investigative Site Culiacán, Sinaloa, Mexico, 80000 Novartis Investigative Site Puebla, Mexico, 72190 Less <<
NCT01868477 Low and Int 1-risk Myelodyspla... More >>stic Syndrome Less << Phase 2 Completed - -
NCT01870778 Acute Heart Failure Phase 3 Completed - -
NCT02189174 Advanced Solid Tumor Phase 1 Terminated - United States, Massachusetts ... More >> Massachusetts General Hospital SC-9 Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering SC-4 New York, New York, United States, 10017 United States, Tennessee Tennessee Oncology SC Nashville, Tennessee, United States, 37203 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X6 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT01868477 - Completed - -
NCT01874340 Multiple Sclerosis Phase 2 Terminated(Study terminated ea... More >>rly based upon development of another anti-IL17 fully human monoclonal antibody with better potential for treating MS patients) Less << - Belgium ... More >> Novartis Investigative Site Brugge, Belgium, 8000 Czech Republic Novartis Investigative Site JIhlava, Czech Republic, 586 33 France Novartis Investigative Site St Herblain, France, 44800 Italy Novartis Investigative Site Roma, RM, Italy, 00133 Japan Novartis Investigative Site Osaka-city, Osaka, Japan, 556-0016 Poland Novartis Investigative Site Lodz, Poland, 93-121 Novartis Investigative Site Poznan, Poland, 60-355 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 127018 Novartis Investigative Site Saint-Petersburg, Russian Federation, 194044 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Bilbao, Pais Vasco, Spain, 48013 Sweden Novartis Investigative Site Stockholm, Sweden, 17176 Turkey Novartis Investigative Site Atakum / Samsun, Turkey, 55139 Less <<
NCT01870778 - Completed - -
NCT01871558 - Completed - -
NCT01874340 - Terminated(Study terminated ea... More >>rly based upon development of another anti-IL17 fully human monoclonal antibody with better potential for treating MS patients) Less << - -
NCT01871558 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 3 Completed - France ... More >> Novartis Investigative Site Antibes, France, 06600 Novartis Investigative Site Auxerre, France, 89000 Novartis Investigative Site Bar le Duc, France, 55012 Novartis Investigative Site Bondy, France, 93143 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Caen, France, 14000 Novartis Investigative Site Corbeil Essonnes, France, 91100 Novartis Investigative Site Fleury sur Orne, France, 14123 Novartis Investigative Site Maisons Laffitte, France, 78600 Novartis Investigative Site Menton, France, 06500 Novartis Investigative Site Montpellier, France, 34090 Novartis Investigative Site Paris, France, 75010 Novartis Investigative Site Rennes, France, 35203 Novartis Investigative Site Saint Nazaire, France, 44600 Novartis Investigative Site Sanary Sur Mer, France, 83110 Novartis Investigative Site Strsbourg, France, 67000 Novartis Investigative Site Toulouse, France, 31300 Novartis Investigative Site Valence, France, 26000 Novartis Investigative Site Valenciennes, France, 59300 Less <<
NCT01860066 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Withdrawn September 2014 Argentina ... More >> Novartis Investigative Site San Miguel de Tucuman, Tucuman, Argentina, 4000 Novartis Investigative Site Buenos Aires, Argentina, 1425 Novartis Investigative Site Buenos Aires, Argentina, C1115AAB Novartis Investigative Site Buenos Aires, Argentina, C1122AAK Novartis Investigative Site Buenos Aires, Argentina Novartis Investigative Site Mendoza, Argentina, 5500 Novartis Investigative Site Mendoza, Argentina, M5500CBA Belgium Novartis Investigative Site Antwerpen, Belgium, 2060 Novartis Investigative Site Bruxelles, Belgium, 1000 Novartis Investigative Site Genk, Belgium, 3600 Novartis Investigative Site Gilly, Belgium, 6060 Novartis Investigative Site Hasselt, Belgium, 3500 Novartis Investigative Site Jambes, Belgium, 5100 Colombia Novartis Investigative Site Barranquilla, Colombia Novartis Investigative Site Florida Blanca, Colombia Novartis Investigative Site Medellín, Colombia Czech Republic Novartis Investigative Site Kyjov, CZE, Czech Republic, 697 70 Novartis Investigative Site Cvikov, Czech Republic, 471 54 Novartis Investigative Site Jindrichuv Hradec, Czech Republic, 377 01 Novartis Investigative Site Karlovy Vary, Czech Republic, 360 66 Novartis Investigative Site Kurim, Czech Republic, 664 34 Novartis Investigative Site Pardubice, Czech Republic, 530 09 Novartis Investigative Site Teplice, Czech Republic, 415 01 India Novartis Investigative Site Guntur, Andhra Pradesh, India, 522 001 Novartis Investigative Site Ahmedabad, Gujarat, India, 380 008 Novartis Investigative Site Faridabad, Haryana, India, 121 001 Novartis Investigative Site Bangalore, Karnataka, India, 560 002 Novartis Investigative Site Nagpur, Maharashtra, India, 400 012 Novartis Investigative Site Pune, Maharashtra, India, 411004 Novartis Investigative Site Jaipur, Rajasthan, India, 302004 Novartis Investigative Site Karamsad, India, 388225 Less <<
NCT01876368 - Completed - -
NCT01888432 - Completed - -
NCT01876368 Hypertension Phase 3 Completed - -
NCT00171730 Acromegaly Phase 2 Completed - United States, California ... More >> Cedars Sinai Medical Center Dept. of Pituitary Ctr. Los Angeles, California, United States, 90048 United States, Michigan University of Michigan Health System StudyCoordinatorCSOM230B2201E1 Ann Arbor, Michigan, United States, 48109 United States, New York NYU / VA Medical Center New York, New York, United States, 10010 Australia, Queensland Novartis Investigative Site Woolloongabba, Queensland, Australia, 4102 Belgium Novartis Investigative Site Edegem, Belgium, 2650 France Novartis Investigative Site Toulouse Cédex 4, France, 31043 Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Muenchen, Germany, 80336 Italy Novartis Investigative Site Napoli, Italy, 80131 Switzerland Novartis Investigative Site Lausanne, Switzerland, 1011 Less <<
NCT02125877 - Completed - -
NCT01892722 Multiple Sclerosis Phase 3 Active, not recruiting March 15, 2023 -
NCT02125877 Chronic Iron Overload Due to T... More >>ransfusion-dependant Anemias Less << Phase 2 Completed - -
NCT01892722 - Active, not recruiting - -
NCT01271920 Advanced HER2-positive Breast ... More >>Cancer Less << Phase 2 Completed - United States, Arkansas ... More >> Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 France Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Tuebingen, Germany, 72076 Italy Novartis Investigative Site Prato, PO, Italy, 59100 Novartis Investigative Site Candiolo, TO, Italy, 10060 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Madrid, Spain, 28009 Sweden Novartis Investigative Site Stockholm, Sweden, SE-171 76 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TT Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Novartis Investigative Site Manchester, United Kingdom, M20 2BX Novartis Investigative Site Oxford, United Kingdom, OX2 6HE Less <<
NCT01888432 Liver Transplantation Phase 3 Completed - -
NCT01159249 Type 2 Diabetes Phase 3 Completed - Japan ... More >> Novartis Investigative Site Hunabashi, Chiba, Japan, 274-0805 Novartis Investigative Site Chikushino, Fukuoka, Japan, 818-0036 Novartis Investigative Site Itoshima-shi, Fukuoka, Japan, 819-1102 Novartis Investigative Site Koriyama, Fukushima, Japan, 963-8851 Novartis Investigative Site Kobe, Hyogo, Japan, 658-0064 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 212-0024 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 221-0077 Novartis Investigative Site Yokohama, Kanagawa, Japan, 221-0065 Novartis Investigative Site Izumisano, Osaka, Japan, 598-0048 Novartis Investigative Site Hannou, Saitama, Japan, 357-0024 Novartis Investigative Site Hiki-Gun, Saitama, Japan, 355-0328 Novartis Investigative Site Kawaguchi, Saitama, Japan, 332-0012 Novartis Investigative Site Koshigaya city, Saitama, Japan, 343-0826 Novartis Investigative Site Tokorozawa, Saitama, Japan, 359-1161 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 134-0084 Novartis Investigative Site Hachioji, Tokyo, Japan, 192-0046 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 125-0041 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Fukuoka, Japan, 807-0857 Novartis Investigative Site Fukuoka, Japan, 816-0094 Novartis Investigative Site Fukuoka, Japan, 819-0168 Less <<
NCT02088684 Breast Cancer Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham/ Kirklin Clinic Dept Onc Birmingham, Alabama, United States, 35294-0006 United States, Massachusetts Dana Farber Cancer Institute Onc. Dept. Boston, Massachusetts, United States, 02215 United States, Tennessee Sarah Cannon Research Institute Onc Dept Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Lyon Cedex, France, 69373 Italy Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Modena, MO, Italy, 41124 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Madrid, Spain, 28050 Taiwan Novartis Investigative Site Taipei, Taiwan ROC, Taiwan, 10041 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Less <<
NCT01908816 Choroidal Neovascularization ... More >> Macular Edema Glaucoma, Neovascular Diabetic Retinopathy Less << Phase 3 Completed - France ... More >> Novartis Investigative Site Amiens Cedex 1, France, 80054 Novartis Investigative Site Angers, France, 49044 Novartis Investigative Site Bobigny, France, 93009 Novartis Investigative Site Bordeaux, France, 33000 Novartis Investigative Site Bordeaux, France, 33100 Novartis Investigative Site Caen, France, 14050 Novartis Investigative Site Créteil, France, 94000 Novartis Investigative Site Ecully, France Novartis Investigative Site Grenoble, France, 38000 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Lille, France, 59000 Novartis Investigative Site Lyon Cedex 04, France, 69317 Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Mantes la jolie, France, 78201 Novartis Investigative Site Marseille Cedex 8, France, 13008 Novartis Investigative Site Marseille, France, F-13008 Novartis Investigative Site Melun, France, 77000 Novartis Investigative Site Montauban, France, 82000 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Mulhouse cedex, France, 68070 Novartis Investigative Site Nantes Cedex 1, France, 44093 Novartis Investigative Site Nice, France, 06000 Novartis Investigative Site Paris cedex 10, France, 75010 Novartis Investigative Site Paris Cedex 19, France, 75940 Novartis Investigative Site Paris, Cedex 12, France, F-75571 Novartis Investigative Site Paris, France, 75006 Novartis Investigative Site Paris, France, 75007 Novartis Investigative Site Paris, France, 75013 Novartis Investigative Site Paris, France, 75014 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Rouen, France, 76100 Novartis Investigative Site Saint-Jean, France, 31240 Novartis Investigative Site Saitnt Herblain, France, 44819 Novartis Investigative Site St-Priest-en-Jarez, France, 42270 Novartis Investigative Site Strasbourg Cedex, France, 67091 Novartis Investigative Site Toulouse, France, 31077 Novartis Investigative Site Tours, France, 37000 Novartis Investigative Site Tours, France, 37044 Novartis Investigative Site Vannes, France, 56000 Less <<
NCT02144038 Relapsed and Refractory Multip... More >>le Myeloma Less << Phase 1 Completed - United States, Texas ... More >> University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(SC) Houston, Texas, United States, 77030-4009 United States, Washington Seattle Cancer Care Alliance Oncology Dept Seattle, Washington, United States, 98105 United States, Wisconsin University of Wisconsin / Paul P. Carbone Comp Cancer Center Dept of Onc. Madison, Wisconsin, United States, 53792-6164 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 Germany Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Less <<
NCT01920477 Pemphigus Phase 3 Completed - -
NCT01922102 Visual Impairment Due to Choro... More >>idal Neovascularization Secondary to Pathologic Myopia Less << Phase 3 Completed - -
NCT01922089 - Completed - -
NCT01922089 Heart Failure With Reduced Eje... More >>ction Fraction Less << Phase 2 Completed - -
NCT01922271 - Completed - -
NCT01925209 Sporadic Inclusion Body Myosit... More >>is Less << Phase 2 Phase 3 Completed - -
NCT01922271 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 12043 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Berlin, Germany, 12687 Novartis Investigative Site Berlin, Germany, 13086 Novartis Investigative Site Frankfurt, Germany, 60596 Novartis Investigative Site Gelsenkirchen, Germany, 45879 Novartis Investigative Site Grosshansdorf, Germany, 22947 Novartis Investigative Site Gummersbach, Germany, 51643 Novartis Investigative Site Hamburg, Germany, 20354 Novartis Investigative Site Kassel, Germany, 34121 Novartis Investigative Site Leipzig, Germany, 04207 Novartis Investigative Site Lübeck, Germany, 23552 Novartis Investigative Site Rüdersdorf, Germany, 15562 Novartis Investigative Site Sonneberg, Germany, 96515 Less <<
NCT02180217 Cushing's Disease Phase 3 Active, not recruiting December 9, 2019 -
NCT02077933 Neoplasms Bre... More >>ast Neoplasms Kidney Neoplasms Pancreatic Neuroendocine Neoplasms Less << Phase 1 Active, not recruiting November 30, 2018 United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, New York Memorial Sloan Kettering Cancer Center SC - BYL719Z2102 New York, New York, United States, 10065 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Essen, Germany, 45136 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hannover, Germany, 30625 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Hungary Novartis Investigative Site Budapest, Hungary, H-1077 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Milano, MI, Italy, 20141 Novartis Investigative Site Modena, MO, Italy, 41124 Novartis Investigative Site Verona, VR, Italy, 37126 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584CX Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28007 Novartis Investigative Site Madrid, Spain, 28034 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 4BX Less <<
NCT01920711 Heart Failure With Preserved E... More >>jection Fraction Less << Phase 3 Active, not recruiting May 31, 2019 -
NCT01948830 Age-related Macular Degenerati... More >>on Choroidal Neovascularization Less << Phase 3 Completed - -
NCT01950819 End Stage Renal Disease (ESRD)... More >> Chronic Kidney Disease (CKD) Hemodialysis Renal Replacement Therapy Renal Transplantation Less << Phase 4 Completed - -
NCT01948830 - Completed - -
NCT01975701 Recurrent Glioblastoma or Othe... More >>r Glioma Subtypes Less << Phase 2 Active, not recruiting January 25, 2019 United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90095 University of California San Francisco Dept of Onc. San Francisco, California, United States, 94101 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60611 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10032 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43221 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75246 Novartis Investigative Site Dallas, Texas, United States, 75251 Novartis Investigative Site Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Netherlands University Medical Center Utrecht Utrecht, The Netherlands, Netherlands, 3508 GA Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain, 28050 Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 Less <<
NCT01892436 Psoriatic Arthritis Phase 3 Completed - -
NCT01957176 Thrombocytopaenia Phase 4 Active, not recruiting January 1, 2024 Argentina ... More >> Novartis Investigative Site La Plata, Buenos Aires, Argentina, B1900AXI Belgium Novartis Investigative Site Leuven, Belgium, 3000 China Novartis Investigative Site Shanghai, China, 200025 France Novartis Investigative Site Paris Cedex 12, France, 75571 Greece Novartis Investigative Site Athens, Greece, 11527 Novartis Investigative Site Heraklion, Crete, Greece, 71201 Hong Kong Novartis Investigative Site Shatin, Hong Kong Hungary Novartis Investigative Site Debrecen, Hungary, 4012 Ireland Novartis Investigative Site Tullamore, Ireland Israel Novartis Investigative Site Tel Aviv, Israel, 64239 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of, 136-705 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Peru Novartis Investigative Site San Isidro, Lima, Peru, Lima 27 Poland Novartis Investigative Site Chorzow, Poland, 41-500 Romania Novartis Investigative Site Bucharest, Romania, 022328 Tunisia Novartis Investigative Site Montfleury, Tunisia, 1008 Novartis Investigative Site Sousse, Tunisia, 4000 Less <<
NCT01952015 Psoriasis Phase 3 Completed - Japan ... More >> Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 814-0180 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 800-0296 Novartis Investigative Site Asahikawa-city, Hokkaido, Japan, 078-8510 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-0063 Novartis Investigative Site Inashiki-gun, Ibaraki, Japan, 300-0395 Novartis Investigative Site Shimotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 102-8798 Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0032 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Kofu-city, Yamanashi, Japan, 400-8506 Less <<
NCT01959412 Asthma Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Huntington Beach, California, United States, 92647 Novartis Investigative Site Los Angeles, California, United States, 90048 Novartis Investigative Site Mission Viejo, California, United States, 92691 United States, Colorado Novartis Investigative Site Centennial, Colorado, United States, 80112 United States, Massachusetts Novartis Investigative Site North Dartmouth, Massachusetts, United States, 02747 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63141 United States, New Jersey Novartis Investigative Site Skillman, New Jersey, United States, 08558 United States, North Carolina Novartis Investigative Site Raleigh, North Carolina, United States, 27607 United States, Oregon Novartis Investigative Site Medford, Oregon, United States, 97504-8741 Novartis Investigative Site Portland, Oregon, United States, 97213 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75231 Novartis Investigative Site El Paso, Texas, United States, 79902 Less <<
NCT01959516 COPD Phase 4 Completed - Germany ... More >> Novartis Investigative Site Geesthacht, Schleswig Holstein, Germany, 12502 Novartis Investigative Site Berlin, Germany, 10119 Novartis Investigative Site Berlin, Germany, 12099 Novartis Investigative Site Berlin, Germany, 13156 Novartis Investigative Site Halle, Germany, 06108 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Leipzig, Germany, 04275 Novartis Investigative Site Potsdam, Germany, 14467 Novartis Investigative Site Wiesbaden, Germany, 65187 Italy Novartis Investigative Site Firenze, FI, Italy, 50122 Novartis Investigative Site Milano, MI, Italy, 20138 Novartis Investigative Site Orbassano, TO, Italy, 10043 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08026 Novartis Investigative Site Lugo, Galicia, Spain, 27003 Novartis Investigative Site Zaragoza, Spain, 50009 United Kingdom Novartis Investigative Site Blackpool, United Kingdom, FY3 7EN Novartis Investigative Site Bradford, United Kingdom, BD9 6RJ Novartis Investigative Site Cambridge, United Kingdom, CB7 5JD Novartis Investigative Site Cardiff, United Kingdom, CF5 4AD Novartis Investigative Site Watford, United Kingdom, WD25 7NL Novartis Investigative Site Wishaw, United Kingdom, ML2 0DP Less <<
NCT01925209 - Completed - -
NCT01958918 Visual Impairment Due to Neova... More >>scular AMD Less << Phase 4 Completed - -
NCT01961609 Psoriasis Phase 3 Completed - -
NCT01959412 - Completed - -
NCT02108964 Advanced Non-small Cell Lung C... More >>ancer Less << Phase 1 Phase 2 Active, not recruiting September 20, 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Mass General Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering Oncology Department New York, New York, United States, 10017 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Germany Novartis Investigative Site Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Berlin, Germany, 13125 Japan Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 811-1395 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28041 Taiwan Novartis Investigative Site Taipei, Taiwan ROC, Taiwan, 10041 Less <<
NCT01972776 - Terminated(Part 1 was complete... More >>d. Part 2 was terminated for safety reasons.) Less << - -
NCT01972789 Subfoveal Choroidal Neovascula... More >>rization CNV Secondary to Wet Age-related Macular Degeneration AMD Less << Phase 4 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Albury, New South Wales, Australia, 2640 Novartis Investigative Site Chatswood, New South Wales, Australia, 2067 Novartis Investigative Site Eastwood, New South Wales, Australia, 2122 Novartis Investigative Site Hurtsville, New South Wales, Australia, 2220 Novartis Investigative Site Liverpool, New South Wales, Australia, 2170 Novartis Investigative Site North Ryde, New South Wales, Australia, 2109 Novartis Investigative Site Parramatta, New South Wales, Australia, 2150 Novartis Investigative Site Strathfield, New South Wales, Australia, 2135 Novartis Investigative Site Sydney, New South Wales, Australia, 2000 Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Tasmania Novartis Investigative Site Hobart, Tasmania, Australia, 7000 Novartis Investigative Site South Launceston, Tasmania, Australia, 7249 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Novartis Investigative Site Melbourne, Victoria, Australia, 3002 Australia, Western Australia Novartis Investigative Site Nedlands, Western Australia, Australia, 6009 Less <<
NCT01959516 - Completed - -
NCT01055483 Acute Myeloid Leukemia Phase 1 Completed - France ... More >> Novartis Investigative Site Paris Cedex 4, France, 75181 Novartis Investigative Site Paris, France, 75475 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT01064791 Renal Transplantation Phase 2 Completed - -
NCT01976338 Macular Edema Secondary to Bra... More >>nch Retinal Vein Occlusion Less << Phase 3 Completed - -
NCT01976312 - Completed - -
NCT01972776 COPD Phase 2 Terminated(Part 1 was complete... More >>d. Part 2 was terminated for safety reasons.) Less << - United States, Virginia ... More >> Novartis Investigative Site Richmond, Virginia, United States, 23225 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt, Germany, 60596 Novartis Investigative Site Grosshansdorf, Germany, 22947 Novartis Investigative Site Hannover, Germany, 30625 Romania Novartis Investigative Site Bucharest, Romania, Sector 5 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M23 9QZ Less <<
NCT01982292 - Completed - -
NCT01985334 COPD Phase 4 Completed - -
NCT01976312 Central Retinal Vein Occlusion Phase 3 Completed - -
NCT01982292 Chronic Heart Failure Phase 2 Completed - -
NCT01988662 Neovacular Age-related Macular... More >> Degeneration Less << Phase 4 Completed - Israel ... More >> Novartis Investigative Site Be'er Sheva, Israel, 84101 Novartis Investigative Site Haifa, Israel, 3436212 Novartis Investigative Site Haifa, Israel, 3525408 Novartis Investigative Site Kfar-Saba, Israel, 4428164 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Rehovot, Israel, 7610001 Novartis Investigative Site Tel Aviv, Israel, 6423906 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Daegu, Korea, Republic of, 705-703 Novartis Investigative Site Seoul, Korea, Republic of, 06273 Novartis Investigative Site Seoul, Korea, Republic of, 150-950 Malaysia Novartis Investigative Site Petaling Jaya, Selangor Darul Ehsan, Malaysia, 46200 Novartis Investigative Site Kuala Lumpur, Malaysia, 59200 Philippines Novartis Investigative Site Makati City, Philippines, 1209 Novartis Investigative Site Pasig City, Philippines, 1605 Novartis Investigative Site Quezon City, Philippines, 1102 Singapore Novartis Investigative Site Singapore, Singapore, 117549 Novartis Investigative Site Singapore, Singapore, 574623 Taiwan Novartis Investigative Site Lin-Kou, Taiwan, 33305 Novartis Investigative Site Taipei, Taiwan, 10002 Thailand Novartis Investigative Site Bangkok, Bangkoknoi, Thailand, 10700 Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10400 Less <<
NCT01988662 - Completed - -
NCT01996319 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Koblenz, NRW, Germany, 56068 Novartis Investigative Site Cottbus, Sachsen, Germany, 03050 Novartis Investigative Site Geesthacht, Schleswig Holstein, Germany, 12502 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Berlin, Germany, 10119 Novartis Investigative Site Berlin, Germany, 10629 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Dueren, Germany, 52349 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Euskirchen, Germany, 53879 Novartis Investigative Site Grosshansdorf, Germany, 22947 Novartis Investigative Site Hamburg, Germany, 20354 Novartis Investigative Site Heidelberg, Germany, 69117 Novartis Investigative Site Höchstadt, Germany, 91315 Novartis Investigative Site Kassel, Germany, 34121 Novartis Investigative Site Köln, Germany, 51605 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Leipzig, Germany, 04207 Novartis Investigative Site Lübeck, Germany, 23552 Novartis Investigative Site Lübeck, Germany, 23558 Novartis Investigative Site Marburg, Germany, 35037 Novartis Investigative Site Münster, Germany, 48145 Novartis Investigative Site Neunkirchen, Germany, 66539 Novartis Investigative Site Potsdam, Germany, 14467 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Rheine, Germany, 48431 Novartis Investigative Site Rüdersdorf, Germany, 15562 Novartis Investigative Site Saarbruecken, Germany, 66111 Novartis Investigative Site Teterow, Germany, 17166 Novartis Investigative Site Wiesloch, Germany, 69168 Less <<
NCT01989468 Psoriatic Arthritis Phase 3 Completed - -
NCT02002221 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Completed - Japan ... More >> Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-8798 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 815-0071 Novartis Investigative Site Fukutsu-city, Fukuoka, Japan, 811-3217 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 800-0295 Novartis Investigative Site Koriyama-city, Fukushima, Japan, 963-8851 Novartis Investigative Site Mito-city, Ibaraki, Japan, 311-4153 Novartis Investigative Site Ibusuki-city, Kagoshima, Japan, 891-0401 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 221-0802 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 861-8039 Novartis Investigative Site Kumamoto-city, Kumamoto, Japan, 861-8520 Novartis Investigative Site Yatsushiro-city, Kumamoto, Japan, 866-8533 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-0035 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-0021 Novartis Investigative Site Hirakata-City, Osaka, Japan, 573-0153 Novartis Investigative Site Izumisano-city, Osaka, Japan, 598-8577 Novartis Investigative Site Osaka-city, Osaka, Japan, 530-0001 Novartis Investigative Site Osaka-city, Osaka, Japan, 534-0021 Novartis Investigative Site Takatsuki-city, Osaka, Japan, 569-1096 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Saitama-city, Saitama, Japan, 336-0963 Novartis Investigative Site Sayama-city, Saitama, Japan, 350-1305 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-1161 Novartis Investigative Site Adachi-ku, Tokyo, Japan, 123-0845 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 101-0024 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0027 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0028 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0061 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0041 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0051 Novartis Investigative Site Ota-ku, Tokyo, Japan, 144-0051 Novartis Investigative Site Suginami-ku, Tokyo, Japan, 166-0004 Less <<
NCT01986907 Wet Age Related Macular Degene... More >>ration Less << Phase 4 Completed - -
NCT01976338 - Completed - -
NCT02007278 Type 2 Diabetes ... More >> Hypoglycemia Less << Phase 4 Completed - Colombia ... More >> Novartis Investigative Site Medellín, Antioquia, Colombia Novartis Investigative Site Manizales, Caldas, Colombia, 1700 Novartis Investigative Site Bogotá, Cundinamarca, Colombia Novartis Investigative Site Chía, Cundinamarca, Colombia, 11001000 Novartis Investigative Site Cali, Valle del Cauca, Colombia, 760001 Novartis Investigative Site Bogotá, Colombia, 00000 Novartis Investigative Site Cali, Colombia Novartis Investigative Site Monteria, Colombia Less <<
NCT02002221 - Completed - -
NCT02002702 Acute Heart Failure Phase 2 Completed - Japan ... More >> Novartis Investigative Site Seto-city, Aichi, Japan, 489-8642 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 810-0001 Novartis Investigative Site Iizuka-city, Fukuoka, Japan, 820-8505 Novartis Investigative Site Hiroshima-city, Hiroshima, Japan, 730-8518 Novartis Investigative Site Amagasaki-city, Hyogo, Japan, 660-8550 Novartis Investigative Site Higashiibaraki-gun, Ibaraki, Japan, 311-3193 Novartis Investigative Site Kanazawa, Ishikawa, Japan, 920-8650 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 211-8533 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-8682 Novartis Investigative Site Sendai-city, Miyagi, Japan, 981-3107 Novartis Investigative Site Ueda-city, Nagano, Japan, 386-8610 Novartis Investigative Site Osaka-city, Osaka, Japan, 534-0021 Novartis Investigative Site Sayama-city, Saitama, Japan, 350-1323 Novartis Investigative Site Komatsushima-city, Tokushima, Japan, 773-8502 Novartis Investigative Site Itabashi-ku, Tokyo, Japan, 173-8610 Less <<
NCT01996319 - Completed - -
NCT02002702 - Completed - -
NCT02007278 - Completed - -
NCT00662649 Multiple Sclerosis Phase 3 Completed - -
NCT00662649 - Completed - -
NCT02007252 - Terminated(The results of a th... More >>ird interim analysis (ad hoc) indicated a lack of efficacy and futility in continuing the trial.) Less << - -
NCT03354754 Intra-abdominal Infections Phase 2 Recruiting August 29, 2019 United States, New Jersey ... More >> Novartis Investigative Site Recruiting Somers Point, New Jersey, United States, 08230 Less <<
NCT02007252 Abdominal Aortic Aneurysm (AAA... More >>) Less << Phase 2 Terminated(The results of a th... More >>ird interim analysis (ad hoc) indicated a lack of efficacy and futility in continuing the trial.) Less << - United States, Virginia ... More >> Novartis Investigative Site Charlottesville, Virginia, United States, 22903 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 Novartis Investigative Site Kolding, Denmark, 6000 Novartis Investigative Site Odense C, Denmark, DK-5000 Netherlands Novartis Investigative Site Amsterdam, Netherlands Novartis Investigative Site Eindhoven, Netherlands, 5623EJ Sweden Novartis Investigative Site Orebro, Sweden, 701 16 Novartis Investigative Site Stockholm, Sweden, 171 76 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M23 9LT Less <<
NCT01110668 Gastrointestinal Stromal Tumor Phase 2 Completed - Turkey ... More >> Novartis Investigative Site Adana, Turkey Novartis Investigative Site Ankara, Turkey Novartis Investigative Site Istanbul, Turkey Novartis Investigative Site Izmir, Turkey Less <<
NCT02713243 Primary Bile Acid Diarrhea Phase 2 Completed - United States, Minnesota ... More >> Novartis Investigative Site Rochester, Minnesota, United States, 55905 United Kingdom Novartis Investigative Site Harrow, Middlesex, United Kingdom, HA1 3UJ Novartis Investigative Site London, United Kingdom, W2 1PG Novartis Investigative Site Sheffield, United Kingdom, S10 2JF Less <<
NCT03525834 Renal Angiomyolipoma Phase 4 Recruiting December 29, 2021 China, Hubei ... More >> Novartis Investigative Site Recruiting Wuhan, Hubei, China, 430030 Less <<
NCT02007720 Acute Heart Failure Phase 3 Terminated(Study was terminate... More >>d based on results from pivotal adult AHF study CRLX030A2301) Less << - -
NCT03355196 Patients With Moderate Knee Os... More >>teoarthritis (30 - 65 Years) Less << Phase 1 Recruiting March 27, 2019 Netherlands ... More >> Novartis Investigative Site Recruiting Leiden, Netherlands, 2333 CL Less <<
NCT01240642 Metastatic Cancer With Impaire... More >>d Renal Function Metastatic Cancer With Normal Renal Function Less << Phase 1 Terminated - Belgium ... More >> Novartis Investigative Site Charleroi, Belgium Novartis Investigative Site Jette, Belgium Novartis Investigative Site Lambert, Belgium Novartis Investigative Site Wilrijk, Belgium Less <<
NCT01208831 Advanced Solid Tumor Cancers ... More >> Medulloblastoma Basal Cell Carcinoma Less << Phase 1 Completed - Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Japan Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8560 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Taiwan Novartis Investigative Site Taipei, Taiwan, 10048 Less <<
NCT03502070 Cystic Fibrosis Phase 4 Recruiting June 27, 2019 United States, Oklahoma ... More >> Novartis Investigative Site Recruiting Oklahoma City, Oklahoma, United States, 73112 Less <<
NCT00784212 Photosensitive Epilepsy Phase 2 Completed - Germany ... More >> Novartis Investigator Site Bielefeld, Germany Novartis Investigator Site Kehl-Kork, Germany Novartis Investigator Site Kiel, Germany Novartis Investigator Site Radeberg, Germany Less <<
NCT01302873 Chronic Subjective Tinnitus Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Lepzig, Germany Netherlands Novartis Investigative Site Groningen, Netherlands, 9700 Less <<
NCT00443482 Asthma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Novartis Investigative Site Bovenden--Lengler, Germany Novartis Investigative Site Marburg, Germany Novartis Investigative Site Wiesbaden, Germany Less <<
NCT01263353 Gastroenteropancreatic Neuroen... More >>docrine Tumor of the Pulmonary ot Gastroenteropancreatic System Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Bad Berka, Germany, 99438 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT01459250 Renal Impairment Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Miami, Florida, United States, 33136 Novartis Investigative Site Orlando, Florida, United States, 32809-3017 United States, Minnesota Novartis Investigative Site Minneapolis, Minnesota, United States, 55404 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 Less <<
NCT01482143 Fragile X Syndrome Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Sacramento, California, United States, 95817 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60612 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37232-7548 Spain Novartis Investigative Site Sant Cugat, Catalunya, Spain, 08190 Less <<
NCT01387321 Advanced Solid Tumor Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 460-0001 Novartis Investigative Site Nagoya, Aichi, Japan, 466 8560 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Koto-ku, Tokyo, Japan, 135 8550 Less <<
NCT01529294 Hepatic Impairment Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33169 Novartis Investigative Site Orlando, Florida, United States, 32809 Novartis Investigative Site South Miami, Florida, United States, 33143 Less <<
NCT01552629 Atopic Dermatitis Phase 2 Completed - Austria ... More >> Novartis Investigative Site Vienna, Austria France Novartis Investigative Site Nice Cedex 3, France, 06202 Germany Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Kiel, Germany, 24105 Less <<
NCT01446289 - Completed - -
NCT01459718 Transfusion-dependent β-thalas... More >>semia Patients Cardiac Iron Overload Less << Phase 2 Completed - Greece ... More >> Novartis Investigative Site Athens, GR, Greece, 115 27 Novartis Investigative Site Athens, GR, Greece, GR-115 27 Novartis Investigative Site Athens, Greece, GR Novartis Investigative Site Patras, Greece, 26500 Less <<
NCT00332709 Osteoporosis ... More >>Postmenopausal Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Deggendorf, Germany Novartis Investigative Site Frankfurt/Main, Germany Novartis Investigative Site Freiburg, Germany Novartis Investigative Site Georgsmarienhutte, Germany Novartis Investigative Site Gottingen, Germany Novartis Investigative Site Halle, Germany Novaertis Investigative Site Hamein, Germany Novartis Investigative Site Hannover, Germany Novartis Investigative Site Hoxter, Germany Novartis Investigative Site Ilsede, Germany Novartis Investigative Site Jena, Germany Novartis Investigative Site Karlsruhe, Germany Novartis Investigative Site Koln, Germany Novartis Investigative Site Leer, Germany Novartis Investigative Site Lubeck, Germany Novartis Investigative Site Mannheim, Germany Novartis Investigative Site Munster, Germany Novartis Investigative Site Rostock, Germany Novartis Investigative Site Salzgitter, Germany Novartis Investigative Site Schwenningen, Germany Novartis Investigative Site Stendal, Germany Novartis Investigative Site Volklingen, Germany Novartis Investigative Site Witten, Germany Less <<
NCT01844765 Leukemia Leuk... More >>emia,Pediatric Leukemia, Myleiod Leukemia, Mylegenous, Chronic Leukemia, Mylegenous, Accelerated BCR-ABL Positive Myeloproliferative Disorder Bone Marrow Disease Hematologic Diseases Neoplastic Processes Imatinib Dasatinib Enzyme Inhibitor Protein Kinase Inhibitor Less << Phase 2 Active, not recruiting October 7, 2020 -
NCT01446289 Streptococcal Infection ... More >> Gram-positive Bacterial Infection Bacterial Infection Less << Phase 2 Completed - Belgium ... More >> UZ Leuven Herestraat, Leuven, Belgium, 49-B-3000 Regionaal Ziekenhuis Heilig Hart, Gasthuismolenstraat 31, Tienen, Belgium, 3300 Canada, British Columbia University of British Columbia, Rm B3 25 B, 4500 Oak Street, Vancouver, British Columbia, Canada, V6H3N1 Canada, Nova Scotia Dalhousie University, IWK Health Centre, 5850/5980 University Avenue, Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Quebec Centre hospitalier universitaire de Quebec (CHUQ)- hospital CHUL, Centre de recherche en infectiologie, 2705, Boulevard laurier, S-745, Quebec, Canada, G1V 4G2 Less <<
NCT01526889 Non-infectious Intermediate Uv... More >>eitis Non-infectious Posterior Uveitis Non-infectious Panuveitis Less << Phase 2 Completed - United States, Colorado ... More >> Novartis Investigative Site Golden, Colorado, United States, 80401 United States, Georgia Novartis Investigative Site Marietta, Georgia, United States, 30060 United States, Massachusetts Novartis Investigative Site Cambridge, Massachusetts, United States, 02142 United States, Nebraska Novartis Investigative Site Omaha, Nebraska, United States, 68198-5540 United States, New Jersey Novartis Investigative Site Teaneck, New Jersey, United States, 07666 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 United Kingdom Novartis Investigative Site Bristol, United Kingdom, BS1 2LX Novartis Investigative Site London, United Kingdom, EC1V 2PD Less <<
NCT00332709 - Completed - -
NCT01585272 Alzheimer's Dementia Phase 4 Completed - Taiwan ... More >> Novartis Investigative Site Taichung, Taiwan ROC, Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT01527500 Geographic Atrophy ... More >> Age-related Macular Degeneration Less << Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85014 Novartis Investigative Site Phoenix, Arizona, United States, 85020 Novartis Investigative Site Tucson, Arizona, United States, 85704-5614 United States, California Novartis Investigative Site Beverly Hills, California, United States, 90211 Novartis Investigative Site Pasadena, California, United States, 91105-3153 Novartis Investigative Site Sacramento, California, United States, 95841 United States, Colorado Novartis Investigative Site Colorado Springs, Colorado, United States, 80909 United States, Florida Novartis Investigative Site Fort Myers, Florida, United States, 33912-7125 Novartis Investigative Site Miami, Florida, United States, 33143 Novartis Investigative Site Winter Haven, Florida, United States, 33880 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30342 United States, Kansas Novartis Investigative Site Leawood, Kansas, United States, 66211 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 United States, Michigan Novartis Investigative Site Grand Rapids, Michigan, United States, 49546 Novartis Investigative Site Jackson, Michigan, United States, 49202 United States, North Carolina Novartis Investigative Site Charlotte, North Carolina, United States, 28210 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45242 Novartis Investigative Site Cleveland, Ohio, United States, 44122 United States, Washington Novartis Investigative Site Silverdale, Washington, United States, 98383 Less <<
NCT01747876 Malignant Rhabdoid Tumors (MRT... More >>), Neuroblastoma Less << Phase 1 Completed - United States, California ... More >> University of California San Francisco Dept of Pediatic Oncology San Francisco, California, United States, 94101 United States, Georgia Children's Healthcare of Atlanta Dept of Oncology Atlanta, Georgia, United States, 30342 United States, Massachusetts Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center Dept of Onc New York, New York, United States, 10065 United States, Ohio Cincinnati Children's Hospital Medical Center Dept of Oncology Cincinnati, Ohio, United States, 45229-3039 United States, Tennessee St. Jude's Children's Research Hospital Dept of Oncology Memphis, Tennessee, United States, 38105-2794 Australia, Western Australia Novartis Investigative Site Perth, Western Australia, Australia, 6840 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Paris, France, 75231 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Augsburg, Germany, 86156 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00434317 Neoplasm Metastasis Phase 4 Completed - Hungary ... More >> Novartis Investigative Site Budapest, Hungary Novartis Investigative Site Pecs, Hungary Novartis Investigative Site Szeged, Hungary Novartis Investigative Site Szekesfehervar, Hungary Less <<
NCT01528254 Type 2 Diabetes Mellitus Phase 4 Active, not recruiting April 18, 2019 -
NCT01531894 Cancer Phase 2 Completed - United States, Maryland ... More >> Novartis Investigative Site Baltimore, Maryland, United States, 21231 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, New York Novartis Investigative Site New York, New York, United States, 10029 Novartis Investigative Site New York, New York, United States, 10065 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3004 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Ireland Novartis Investigative Site Galway, Ireland Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of, 110-744 Less <<
NCT01529632 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Austria ... More >> Novartis Investigative Site Feldbach, Austria, 8330 Novartis Investigative Site Grieskirchen, Austria, 4710 Novartis Investigative Site Linz, Austria, 4020 Novartis Investigative Site Wels, Austria, 4600 Denmark Novartis Investigative Site Aalborg, Denmark, DK-9100 Novartis Investigative Site Copenhagen NV, Denmark, DK-2400 Novartis Investigative Site Hvidovre, Denmark, DK-2650 Novartis Investigative Site Odense C, Denmark, DK-5000 Novartis Investigative Site Århus, Denmark, DK-8000 Netherlands Novartis Investigative Site Almelo, Netherlands, 7609 PP Novartis Investigative Site Eindhoven, Netherlands, 5623 EJ Novartis Investigative Site Harderwijk, Netherlands, 3840 AC Novartis Investigative Site Heerlen, Netherlands, 6419 PC Novartis Investigative Site Hengelo, Netherlands, 7555 DL Novartis Investigative Site Sittard-Geleen, Netherlands, 6162 BG Novartis Investigative Site Tubbergen, Netherlands, 7651 JH Novartis Investigative Site Veldhoven, Netherlands, 5504 DB Norway Novartis Investigative Site Kløfta, Norway, 2040 Novartis Investigative Site Kongsvinger, Norway, 2212 Novartis Investigative Site Skedsmokorset, Norway, 2020 Novartis Investigative Site Stavanger, Norway, 4005 Novartis Investigative Site Trondheim, Norway, 7006 Sweden Novartis Investigative Site Göteborg, Sweden, 412 63 Novartis Investigative Site Stockholm, Sweden, 111 57 Novartis Investigative Site Stockholm, Sweden, S-171 76 Novartis Investigative Site Uddevalla, Sweden, 451 50 Less <<
NCT01526889 - Completed - -
NCT01529619 Alzheimer's Disease Phase 4 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 467-8602 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 814-0180 Novartis Investigative Site Miyoshi-city, Hiroshima, Japan, 728-0013 Novartis Investigative Site Ohtake, Hiroshima, Japan, 739-0696 Novartis Investigative Site Kita-gun, Kagawa, Japan, 761-0793 Novartis Investigative Site Kamakura-city, Kanagawa, Japan, 247-8533 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 216-8511 Novartis Investigative Site Yokohama, Kanagawa, Japan, 241-0811 Novartis Investigative Site Koshi-city, Kumamoto, Japan, 861-1116 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 600-8558 Novartis Investigative Site Kyoto, Japan, 606-0851 Less <<
NCT01529632 - Completed - -
NCT01534182 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Russian Federation ... More >> Novartis Investigative Site Arkhangelsk, Russia, Russian Federation, 163045 Novartis Investigative Site Barnaul, Russian Federation, 656024 Novartis Investigative Site Belgorod, Russian Federation, 308007 Novartis Investigative Site Kazan, Russian Federation, 420021 Novartis Investigative Site Kemerovo, Russian Federation, 650066 Novartis Investigative Site Khanty-Mansiysk, Russian Federation, 628012 Novartis Investigative Site Kirov, Russian Federation, 610014 Novartis Investigative Site Krasnodar, Russian Federation, 350086 Novartis Investigative Site Kursk, Russian Federation, 305007 Novartis Investigative Site Moscow, Russian Federation, 119992 Novartis Investigative Site Moscow, Russian Federation, 127018 Novartis Investigative Site N.Novgorod, Russian Federation, 603126 Novartis Investigative Site Nizhniy Novgorod, Russian Federation, 603076 Novartis Investigative Site Nizhny Novgorod, Russian Federation, 603155 Novartis Investigative Site Novosibirsk, Russian Federation, 630087 Novartis Investigative Site Perm, Russian Federation, 614990 Novartis Investigative Site Saransk, Russian Federation, 430032 Novartis Investigative Site Saratov, Russian Federation, 410030 Novartis Investigative Site Smolensk, Russian Federation, 214019 Novartis Investigative Site St. Petersburg, Russian Federation, 197376 Novartis Investigative Site Tomsk, Russian Federation, 634050 Novartis Investigative Site Tumen, Russian Federation, 625048 Novartis Investigative Site Tver, Russian Federation, 170036 Novartis Investigative Site Ufa, Russian Federation, 450000 Novartis Investigative Site Ulyanovsk, Russian Federation, 432063 Novartis Investigative Site Yaroslavl, Russian Federation, 150030 Less <<
NCT00338247 - - - -
NCT01535261 Macular Edema ... More >> Central Retinal Vein Occlusion Less << Phase 3 Completed - -
NCT01535950 Neovascular Age-elated Macular... More >> Degeneration (Wet AMD) Exudative Macular Degeneration Less << Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Tuscon, Arizona, United States, 85704-5614 United States, California Novartis Investigative Site Torrance, California, United States, 90503 United States, Florida Novartis Investigative Site Fort Myers, Florida, United States, 33912-7125 United States, Maryland Novartis Investigative Site Baltimore, Maryland, United States, 21237-4350 United States, South Carolina Novartis Investigative Site West Columbia, South Carolina, United States, 29169 United States, Texas Novartis Investigative Site Abilene, Texas, United States, 79606 Novartis Investigative Site Forth Worth, Texas, United States, 76104 Less <<
NCT01535261 - Completed - -
NCT01537432 Psoriasis, Plaque-type Psorias... More >>is Less << Phase 2 Completed - United States, Alabama ... More >> Novartis Investigative Site Birmingham, Alabama, United States, 35205 United States, California Novartis Investigative Site Pasadena, California, United States, 91105 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46256 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63117 United States, New Jersey Novartis Investigative Site East Windsor, New Jersey, United States, 08520 Novartis Investigative Site Verona, New Jersey, United States, 07044 United States, New York Novartis Investigative Site New York, New York, United States, 10065 Novartis Investigative Site Rochester, New York, United States, 14623 United States, North Carolina Novartis Investigative Site High Point, North Carolina, United States, 27262 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Novartis Investigative Site Houston, Texas, United States, 77030 United States, Virginia Novartis Investigative Site Norfolk, Virginia, United States, 23507 Less <<
NCT01546415 Iron Overload Phase 4 Completed - China, Shanghai ... More >> Novartis Investigative Site Shanghai, Shanghai, China, 200437 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300020 China Novartis Investigative Site Beijing, China Novartis Investigative Site Chengdu, China Novartis Investigative Site Shanghai, China Novartis Investigative Site Tianjin, China Less <<
NCT01537432 - Completed - -
NCT01534182 - Completed - -
NCT01544595 Moderate to Severe Plaque-type... More >> Psoriasis Less << Phase 3 Completed - -
NCT01544491 Prevention of Acute Rejection ... More >>in Paediatric Recipients of a Renal Transplant Less << Phase 3 Completed - -
NCT01543854 Acute Heart Failure Phase 2 Completed - Argentina ... More >> Novartis Investigative Site Caba, Buenos Aires, Argentina, C1180AAX Novartis Investigative Site Buenos Aires, Argentina, B1846BMF Germany Novartis Investigative Site Bad Nauheim, Germany, 61231 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Erfurt, Germany, 99089 Novartis Investigative Site Greifswald, Germany, 17475 Novartis Investigative Site Halle/'Saale, Germany, 06120 Italy Novartis Investigative Site Brescia, BS, Italy, 25123 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Poland Novartis Investigative Site Warszawa, Poland, 04-628 Novartis Investigative Site Wroclaw, Poland, 50-981 Russian Federation Novartis Investigative Site Kemerovo, Russian Federation, 650002 Novartis Investigative Site Moscow, Russian Federation, 121552 Novartis Investigative Site Moscow, Russian Federation, 127644 Novartis Investigative Site S.-Petersburg, Russian Federation, 198205 Novartis Investigative Site Saint Petersburg, Russian Federation, 199106 Novartis Investigative Site St-Petersburg, Russian Federation, 198013 Novartis Investigative Site St. Petersburg, Russian Federation, 192242 Novartis Investigative Site Tomsk, Russian Federation, 634012 Less <<
NCT01551212 Liver Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Munchen, Germany, 81377 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT01546532 Chronic Heart Failure (CHF) Phase 2 Completed - United States, Maryland ... More >> Novartis Investigative Site Baltimore, Maryland, United States Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Goettingen, Germany, 37075 Novartis Investigative Site Hamburg, Germany, 20246 Netherlands Novartis Investigative Site Deventer, Netherlands, 7416 SE Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Sneek, Netherlands, 8601 ZR Poland Novartis Investigative Site Grodzisk Mazowiecki, Poland, 05-825 Novartis Investigative Site Katowice, Poland, 40-637 Novartis Investigative Site Krakow, Poland, 31-202 Novartis Investigative Site Kraków, Poland, 31-501 Novartis Investigative Site Lublin, Poland, 20-954 Novartis Investigative Site Walbrzych, Poland, 58-309 Novartis Investigative Site Warszawa, Poland, 04-628 Less <<
NCT01555151 Asthma Phase 2 Completed - -
NCT01527500 - Completed - -
NCT01563354 Neuroendocrine Carcinoma of th... More >>e Lung and Thymus Less << Phase 2 Active, not recruiting June 28, 2019 -
NCT01566604 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01555125 - Completed - -
NCT01570686 Hypertension Phase 4 Completed - -
NCT01566604 - Completed - -
NCT01783444 Breast Cancer Phase 2 Completed - -
NCT01570686 - Completed - -
NCT01576380 Adenocarcinoma, Scirrhous ... More >> Linitis Plastica Stomach Neoplasms Stomach Diseases Neoplasms by Site Neoplasms Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Matsuyama, Ehime, Japan, 791-0280 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-8686 Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Koto, Tokyo, Japan, 135-8550 Less <<
NCT01574651 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01576367 Cryopyrin-associated Periodic ... More >>Syndromes Familial Cold Autoinflammatory Syndrome Muckle-Wells Syndrome Neonatal Onset Multisystem Inflammatory Disease Less << Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Laeken, Belgium, 1020 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 France Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Saint Augustin, Germany, 53757 Novartis Investigative Site Tübingen, Germany, 72076 Spain Novartis Investigative Site Granada, Andalucia, Spain, 18012 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Switzerland Novartis Investigative Site Lausanne, Switzerland, 1011 United Kingdom Novartis Investigative Site London, United Kingdom, WC1N 1EH Less <<
NCT01574651 - Completed - -
NCT01578330 - Completed - -
NCT01576367 - Completed - -
NCT01580020 Retinal Vein Occlusion Phase 4 Completed - Germany ... More >> Novartis Investigative Site Augsburg, Germany, 85155 Novartis Investigative Site Bad Rothenfelde, Germany, 49214 Novartis Investigative Site Berlin, Germany, 10713 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bonn, Germany, 53127 Novartis Investigative Site Bremen, Germany, 28209 Novartis Investigative Site Chemnitz, Germany, 09113 Novartis Investigative Site Darmstadt, Germany, 64297 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Düsseldorf, Germany, 40212 Novartis Investigative Site Frankfurt, Germany, 60318 Novartis Investigative Site Freiburg i. Br, Germany, 79106 Novartis Investigative Site Glauchau, Germany, 08371 Novartis Investigative Site Göttingen, Germany, 37075 Novartis Investigative Site Halle, Germany, 06114 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Ingolstadt, Germany, 85049 Novartis Investigative Site Karlsruhe, Germany, 76133 Novartis Investigative Site Karlsruhe, Germany, 76199 Novartis Investigative Site Koeln, Germany, 50935 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Ludwigshafen, Germany, 67063 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Minden, Germany, 32427 Novartis Investigative Site Muelheim, Germany, 45468 Novartis Investigative Site Muenster, Germany, 48145 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 80336 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Recklinghausen, Germany, 45657 Novartis Investigative Site Regensburg, Germany, 93042 Novartis Investigative Site Sulzbach, Germany, 66280 Novartis Investigative Site Tübingen, Germany, 72076 Novartis Investigative Site Ulm, Germany, 89075 Novartis Investigative Site Wolfsburg, Germany, 38442 Novartis Investigative Site Wuerzburg, Germany, 97080 Less <<
NCT01555151 - Completed - -
NCT01582230 Type 2 Diabetes Mellitus Phase 3 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100730 China, Hunan Novartis Investigative Site Changsha City, Hunan, China, 410011 Novartis Investigative Site Changsha, Hunan, China, 410003 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210006 Novartis Investigative Site Wu Xi, Jiangsu, China, 214023 China, Jiangxi Novartis Investigative Site Nanchang, Jiangxi, China, 330006 China, Liaoning Novartis Investigative Site Shenyang, Liaoning, China, 110003 China, Shandong Novartis Investigative Site Jinan, Shandong, China, 250031 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610072 China Novartis Investigative Site Beijing, China Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Tianjin, China, 300052 Philippines Novartis Investigative Site Metro Manila, Philippines, 1500 Novartis Investigative Site Pasay City, Philippines, 1300 Novartis Investigative Site Quezon City, Philippines, 1102 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Novartis Investigative Site Singapore, Singapore, 768825 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Khon Kaen, Thailand, 40002 Less <<
NCT01580020 - Completed - -
NCT01584648 Melanoma Phase 3 Active, not recruiting October 15, 2018 -
NCT01585298 Multiple Sclerosis Phase 4 Completed - -
NCT01584648 - Active, not recruiting - -
NCT01578330 Multiple Sclerosis ... More >> Relapsing-Remitting Less << Phase 4 Completed - Turkey ... More >> Novartis Investigative Site Altunizade, Turkey, 34662 Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Ankara, Turkey, 06500 Novartis Investigative Site Atakum / Samsun, Turkey, 55139 Novartis Investigative Site Bursa, Turkey, 16059 Novartis Investigative Site Fatih / Istanbul, Turkey, 34098 Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Kocaeli, Turkey, 41380 Novartis Investigative Site Mecidiyekoy/Istanbul, Turkey, 34394 Novartis Investigative Site Trabzon, Turkey, 61080 Novartis Investigative Site Uskudar / Istanbul, Turkey, 34668 Less <<
NCT01593787 Hypertension With Renal Dysfun... More >>ction Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 063-0842 Novartis Investigative Site Sapporo, Hokkaido, Japan, 003-0026 Novartis Investigative Site Sapporo, Hokkaido, Japan, 003-0825 Novartis Investigative Site Aira-city, Kagoshima, Japan, 899-5431 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Kurashiki, Okayama, Japan, 701-0192 Novartis Investigative Site Fujimino, Saitama, Japan, 356-0053 Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0918 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Osaka, Japan, 536-0008 Less <<
NCT01589237 - Terminated(Interim analysis su... More >>ggested that size of benefit anticipated from continued participation of patients in Part B no longer supported trial extension beyond Part A) Less << - -
NCT01555125 Moderate to Severe Plaque-type... More >> Psoriasis Less << Phase 3 Completed - -
NCT01595009 Neuroendocrine Tumors Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Chemnitz, Germany, 09113 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Kassel, Germany, 34125 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Osnabrück, Germany, 49076 Novartis Investigative Site Weiden, Germany, 92637 Less <<
NCT01593787 - Completed - -
NCT01594281 Proliferative Diabetic Retinop... More >>athy (PDR) Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Augsburg, Germany, 86156 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Darmstadt, Germany, 64297 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Freiburg I. Br, Germany, 79106 Novartis Investigative Site Glauchau, Germany, 08371 Novartis Investigative Site Gottingen, Germany, 37075 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hösbach, Germany, 63768 Novartis Investigative Site Karlsruhe, Germany, 76133 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenster, Germany, 48145 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 80336 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Regensburg, Germany, 93042 Novartis Investigative Site Tübingen, Germany, 72076 Novartis Investigative Site Ulm, Germany, 89075 Less <<
NCT01589237 Familial Chylomicronemia Syndr... More >>ome (FCS) (HLP Type I) Less << Phase 3 Terminated(Interim analysis su... More >>ggested that size of benefit anticipated from continued participation of patients in Part B no longer supported trial extension beyond Part A) Less << - United States, Washington ... More >> Novartis Investigative Site Seatlle, Washington, United States, 98104 Canada, Quebec Novartis Investigative Site Chicoutimi, Quebec, Canada, G7H 7P2 Novartis Investigative Site Ste-Foy, Quebec, Canada, G1V4M6 Canada Novartis Investigative Site Ouest-Montreal, Canada, H2W1R7 France Novartis Investigative Site Nantes, France, 44093 Novartis Investigative Site Paris Cedex 13, France, 75651 Germany Novartis Investigative Site Hamburg, Germany, 20246 Netherlands Novartis Investigative Site Meibergdreef 9, Netherlands, 1105 AZ South Africa Novartis Investigative Site Cape Town, South Africa, 7925 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M13 9NT Less <<
NCT01594983 Non Familial Chylocmicronemia ... More >>Syndrome (Non-FCS) Less << Phase 2 Completed - -
NCT01643850 Pigmented Villonodular Synovit... More >>is PVNS Giant Cell Tumor of the Tendon Sheath GCCTS Tenosynovial Giant Cell Tumor Localized or Diffused Type GCTS Less << Phase 2 Active, not recruiting November 27, 2018 United States, California ... More >> Novartis Investigational Site - UCSD San Diego, California, United States, 92103-8894 Novartis Investigative Site San Diego, California, United States, 92103-8894 United States, Colorado Novartis Investigative Site Denver, Colorado, United States, 80237 United States, District of Columbia Novartis investigational Site Washington, District of Columbia, United States, 20011 Novartis Investigative Site Washington, District of Columbia, United States, 20011 United States, Florida Novartis Investigative Site - Sylvester Cancer Center Miami, Florida, United States, 33136 Novartis Investigative Site Miami, Florida, United States, 33136 United States, Illinois Novartis Investigational Site - Rush University Medical Center Chicago, Illinois, United States, 60612 Novartis Investigative Site Chicago, Illinois, United States, 60612 United States, Minnesota Novartis Investigational Site at University of Minnesota, Department of Orthopaedic Surgery Minneapolis, Minnesota, United States, 55455 Novartis Investigative Site Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19107 Switzerland Novartis Investigative Site Basel, Switzerland, 4056 Less <<
NCT01597908 - Active, not recruiting - -
NCT01598987 Renal Function ... More >> Liver Transplant Less << Phase 3 Completed - -
NCT01598987 - Completed - -
NCT01595009 - Completed - -
NCT01599104 Essential Hypertension Phase 3 Completed - -
NCT01597908 Melanoma Phase 3 Active, not recruiting March 18, 2019 -
NCT01599650 Branch Retinal Vein Occlusion Phase 3 Completed - -
NCT01599104 - Completed - -
NCT01602315 Recurrent Head and Neck Squamo... More >>us Cell Carcinoma Metastatic Head and Neck Squamous Cell Carcinoma Less << Phase 1 Phase 2 Terminated(early termination d... More >>ue to Sponsor decision (slow recruitment)) Less << - -
NCT01599650 - Completed - -
NCT01604278 - Completed - -
NCT01602315 - Terminated(early termination d... More >>ue to Sponsor decision (slow recruitment)) Less << - -
NCT01610336 Non-small Cell Lung Cancer Phase 2 Active, not recruiting February 7, 2019 -
NCT01857193 Breast Cancer Phase 1 Active, not recruiting September 16, 2019 United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Florida Sylvester Comprehensive Cancer Center Main Center Miami, Florida, United States, 33136 United States, Illinois Oncology Specialists, SC Dept.of Oncology Specialists Park Ridge, Illinois, United States, 60068-0736 United States, Massachusetts Massachusetts General Hospital Onc Dept Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States, 48201 United States, Missouri St. Luke's Cancer Institute Kansas City, Missouri, United States, 64111 United States, New York Memorial Sloan Kettering Oncology Dept. New York, New York, United States, 10017 United States, Oregon Oregon Health and Science University SC-5 Portland, Oregon, United States, 97239 United States, Texas University of Texas MD Anderson Cancer Center Onc Dept Houston, Texas, United States, 77030 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Saint Herblain cedex, France, 44805 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Less <<
NCT01609478 - Completed - -
NCT01604278 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01619878 Acute Uncomplicated Falciparum... More >> Malaria Less << Phase 2 Phase 3 Completed - Benin ... More >> Novartis Investigative Site Cotonou, Benin, 01 BP 107 Novartis investigative site Cotonou, Benin Burkina Faso Novartis Investigative Site Burkina Faso, Burkina Faso, 2208 Novartis investigative site Ouagadougou, Burkina Faso Congo Novartis investigative site Kinshasa, Congo Nigeria Novartis investigative site Calabar, Nigeria Togo Novartis investigative site Lome, Togo Less <<
NCT01609478 Asthma Phase 2 Completed - -
NCT01602406 Advanced HER2-positive Breast ... More >>Cancer or Gastric Cancer Less << Phase 1 Completed - United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02114 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19111 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Saint Herblain cedex, France, 44805 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Spain Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 United Kingdom Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Less <<
NCT01613326 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01619878 - Completed - -
NCT01613326 - Completed - -
NCT01614886 Alzheimer's Disease Phase 3 Completed - -
NCT01828112 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting February 15, 2021 -
NCT01614886 - Completed - -
NCT01617681 Pediatric Hypertension With or... More >> Without CKD Less << Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Antwerpen, Belgium, 2020 Novartis Investigative Site Liege, Belgium, 4000 Brazil Novartis Investigative Site Curitibia, Parana, Brazil, 80250-060 Novartis Investigative Site Campinas, Brazil, 13087-567 Novartis Investigative Site Caxias do Sul, Brazil, 95070-561 Novartis Investigative Site Porto Alegre, Brazil, 90610-000 France Novartis Investigative Site Montpellier, France, 34059 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Marburg, Germany, 35039 Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Novartis Investigative Site Guatemala, Guatemala, 01001 Novartis Investigative Site Guatemala, Guatemala, 1010 Hungary Novartis Investigative Site Budapest, Hungary, H 1096 Novartis Investigative Site Budapest, Hungary, H-1083 Novartis Investigative Site Szeged, Hungary, 6725 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site San Donato Milanese, MI, Italy, 20097 Novartis Investigative Site Palermo, Italy, 90134 Lithuania Novartis Investigative Site Vinius, Lithuania, 08406 Poland Novartis Investigative Site Bialystok, Poland, 15-274 Novartis Investigative Site Gdansk, Poland, 80-952 Novartis Investigative Site Krakow, Poland, 30-663 Novartis Investigative Site Lodz, Poland, 93-338 Novartis Investigative Site Lublin, Poland, 20-093 Novartis Investigative Site Poznan, Poland, 61-825 Novartis Investigative Site Szczecin, Poland, 71-252 Novartis Investigative Site Warszawa, Poland, 04-154 Less <<
NCT01617681 - Completed - -
NCT01828112 - Active, not recruiting - -
NCT01625182 Chronic Inflammatory Demyelina... More >>ting Polyradiculoneuropathy Less << Phase 3 Completed - -
NCT01623596 - Completed - -
NCT01615198 - Completed - -
NCT01625377 Liver Transplantation Phase 3 Completed - France ... More >> Novartis Investigative Site Besancon cedex, France, 25030 Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Chambray les Tours, France, 37044 Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Marseille, France, 13385 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Rennes Cedex, France, 35033 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Novartis Investigative Site Villejuif, France, 94800 Less <<
NCT01625182 - Completed - -
NCT01623596 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - -
NCT00767819 Progressive Sarcoma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Saarow, Germany, 15526 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less <<
NCT01844765 - Active, not recruiting - -
NCT01615198 Essential Hypertension Phase 3 Completed - -
NCT01636076 COPD Phase 2 Completed - -
NCT01633112 Relapsing-remitting Multiple S... More >>clerosis (RRMS) Less << Phase 4 Completed - -
NCT01636076 - Completed - -
NCT01852292 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Terminated - -
NCT01625377 - Completed - -
NCT01852292 - Terminated - -
NCT01640951 Moderate to Severe Chronic Pla... More >>que-Type Psoriasis Less << Phase 3 Completed - -
NCT01646671 Severe Hypertension Phase 3 Completed - Japan ... More >> Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 606-8507 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Hachioji-city, Tokyo, Japan, 192-0918 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shibuya-ku, Tokyo, Japan, 150-0002 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Less <<
NCT01636687 Plaque-type Psoriasis Phase 3 Completed - -
NCT01646671 - Completed - -
NCT01636687 - Completed - -
NCT00406016 Acute Spinal Cord Injury Phase 1 Completed - Canada ... More >> Novartis Investigative site Calgary, Canada Novartis Investigative site Montreal, Canada Novartis Investigative site Toronto, Canada Novartis Investigative site Vancouver, Canada Germany Novartis Investigative site Bad Wildungen, Germany, 34537 Novartis Investigative site Bayreuth, Germany, 09445 Novartis Investigative site Bochum, Germany, 44789 Novartis Investigative site Hamburg, Germany, 21033 Novartis Investigative site Heidelberg, Germany, 69118 Novartis Investigative site Karlsbad-Lagensteinbach, Germany, 76307 Novartis Investigative site Murnau, Germany, 82418 Novartis Investigative site Tuebingen, Germany, 72076 Novartis Investigative site Ulm, Germany, 89081 Switzerland Novartis Investigative Site Zuerich, Switzerland, 8008 Novartis Investigative site Zurich, Switzerland, 8008 Less <<
NCT01870726 c-MET Inhibitor; PI3K Inhibito... More >>r, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM Less << Phase 1 Phase 2 Terminated - United States, Massachusetts ... More >> Dana Farber Cancer Institute SC Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center- New York Presbyterian Dept of Oncology New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Neurology New York, New York, United States, 90033 United States, North Carolina Duke University Medical Center Duke - Baker Durham, North Carolina, United States, 27710 United States, Texas University of Texas MD Anderson Cancer Center SC-3 Houston, Texas, United States, 77030 Germany Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Tübingen, Germany, 72076 Netherlands ErasmusMC Cancer Institute - Neurooncology, RM G3-55 Rotterdam, Netherlands, 3075EA University Medical Center Utrecht, Rm Q05.4.300, P.O. Box 85500 Utrecht, Netherlands, 3508 GA Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28041 Switzerland Novartis Investigative Site St. Gallen, Switzerland, 9007 Less <<
NCT01697605 Tumor With Alterations of the ... More >>FGF-R Less << Phase 1 Active, not recruiting December 7, 2018 China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 51000 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China Novartis Investigative Site Guangzhou, China, 510060 Japan Nagoya University Hospital Nagoya-city, Aichi, Japan, 466-8560 National Cancer Center Hospital East (NCEE) Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Kobe-shi, Hyogo, Japan, 650-0017 Novartis Investigative Site Sayama, Osaka, Japan, 589-8511 Shizuoka Cancer Center Sunto-gun, Shizuoka, Japan, 411-8777 Less <<
NCT01649375 Anklyosing Spondylitis Phase 3 Completed - -
NCT01640951 - Completed - -
NCT01649466 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01649778 - Completed - -
NCT00558285 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - -
NCT00557466 - Completed - -
NCT01870726 - Terminated - -
NCT00558285 - Completed - -
NCT00411242 Major Depressive Disorder (MDD... More >>) Less << Phase 3 Completed - -
NCT01872260 Breast Cancer Phase 1 Active, not recruiting December 31, 2019 -
NCT00411099 Major Depressive Disorder Phase 3 Completed - -
NCT01820325 Non-Small Cell Lunch Cancer Phase 1 Terminated(Due to DLTs/AEs saf... More >>ety profile considered challenging.) Less << - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Oregon Northwest Cancer Specialists Compass Oncology -BKM Portland, Oregon, United States, 97210 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Germany Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Napoli, Italy, 80131 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28046 Less <<
NCT01663233 - Completed - -
NCT01669174 Chronic Obstructive Pulmonary ... More >>Disease (COPD) With Cachexia Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Torrance, California, United States, 90502 United States, Georgia Novartis Investigative Site Savannah, Georgia, United States, 31419 United States, Illinois Novartis Investigative Site Normal, Illinois, United States, 61761 United States, Montana Novartis Investigative Site Missoula, Montana, United States, 59808 United States, South Carolina Novartis Investigative Site Spartanburg, South Carolina, United States, 29303 Netherlands Novartis Investigative Site Maastricht, Netherlands, 6211 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Novartis Investigative Site London, United Kingdom, SW 6NP Novartis Investigative Site Machester, United Kingdom, M23 9QZ Less <<
NCT00557466 COPD Phase 2 Completed - -
NCT01669174 - Completed - -
NCT01822613 Esophageal Squamous Cell Carci... More >>noma Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Medical Center Dept of Onc Chicago, Illinois, United States, 60637 United States, Michigan Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States, 48201 United States, Texas University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States, 77030-4009 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Taiwan Novartis Investigative Site Tainan, Taiwan ROC, Taiwan, 70421 Novartis Investigative Site Taipei, Taiwan, 10048 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 2BX Less <<
NCT01665144 - Active, not recruiting - -
NCT01673646 Acromegaly, Pituitary Gigantis... More >>m Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 466-8560 Novartis Investigative Site Toyoake-city, Aichi, Japan, 470-1192 Novartis Investigative Site Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-8556 Novartis Investigative Site Fukushima-city, Fukushima, Japan, 960-1295 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Morioka-city, Iwate, Japan, 020-8505 Novartis Investigative Site Kagoshima-city, Kagoshima, Japan, 890-8520 Novartis Investigative Site Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 211-8510 Novartis Investigative Site Yokohama, Kanagawa, Japan, 222-0036 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 612-8555 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Osaka-city, Osaka, Japan, 530-8480 Novartis Investigative Site Osaka-city, Osaka, Japan, 534-0021 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-8513 Novartis Investigative Site Shizuoka-city, Shizuoka, Japan, 420-8527 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8603 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Itabashi-ku, Tokyo, Japan, 173-8610 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-8470 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 162-8666 Novartis Investigative Site Chiba, Japan, 260-8677 Novartis Investigative Site Yamagata, Japan, 990-9585 Less <<
NCT00892203 Migraine Phase 2 Completed - United States, California ... More >> California Clinical Trials, 1560 Chevy Chase Drive, Suite 140 Glendale, California, United States, 91206 California Clinical Trials, 15625 Lakewood Boulevard Paramount, California, United States, 90723 Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Essen, Germany Novartis Investigative Site Goettingen, Germany Novartis Investigator Site Hamburg, Germany Novartis Investigative Site Kiel, Germany Novartis Investigative Site Koenigstein, Germany Novartis Investigative Site Muenster, Germany Novartis Investigative Site Munich, Germany Novartis Investigator Site Munich, Germany Novartis Investigative Site Wurzburg, Germany Spain Novartis Investigative Site Barcelona, Spain Less <<
NCT01681576 Salt-sensitive Hypertension Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 Novartis Investigative Site Cypress, California, United States, 90630 Novartis Investigative Site Glendale, California, United States, 91206 Hong Kong Novartis Investigative Site Hong Kong, Shatin, NT, Hong Kong Korea, Republic of Novartis Investigative Site Bucheon, Gyeonggi-do, Korea, Republic of, 424-717 Novartis Investigative Site Koyang-si, Gyeonggi-do, Korea, Republic of, 410-773 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 152-703 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Novartis Investigative Site Singapore, Singapore, 169609 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 114 Less <<
NCT01682083 Melanoma Phase 3 Active, not recruiting November 30, 2030 -
NCT01663233 Essential Hypertension Phase 3 Completed - China, Hebei ... More >> Novartis Investigative Site Shijiazhuang, Hebei, China, 050000 China Novartis Investigative Site Chongqing, China, 400042 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Tianjin, China, 300142 Japan Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 133-0061 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 124-0024 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Kunitachi, Tokyo, Japan, 186-0001 Novartis Investigative Site Shibuya-ku, Tokyo, Japan, 150-0002 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-0063 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Korea, Republic of Novartis Investigative Site Wonju, Gangwon-Do, Korea, Republic of, 220-701 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Busan, Korea, Republic of, 602-739 Novartis Investigative Site Daegu, Korea, Republic of, 705-703 Novartis Investigative Site Daegu, Korea, Republic of, 705-718 Novartis Investigative Site Seoul, Korea, Republic of, 150-713 Malaysia Novartis Investigative Site Kuching, Sarawak, Malaysia, 94300 Novartis Investigative Site Kuala Lumpur, Malaysia, 56000 Philippines Novartis Investigative Site Quezon City, Manila, Philippines, 1100 Novartis Investigative Site Manila, Metro Manila, Philippines, 1000 Novartis Investigative Site Quezon City, Philippines, 1100 Novartis Investigative Site Quezon City, Philippines, 1102 Novartis Investigative Site Valenzuela City, Philippines, 1441 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 114 Less <<
NCT01686932 - Completed - -
NCT01682083 - Active, not recruiting - -
NCT01688882 Bullous Pemphigoid Phase 2 Terminated(This study was stop... More >>ped after Part 1 completed and was terminated because the predefined criteria of efficacy was not reached ( >50% better then placebo)) Less << - United States, Iowa ... More >> Novartis Investigative Site Iowa City, Iowa, United States, 52242 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 Austria Novartis Investigative Site Vienna, Austria, A 1040 France Novartis Investigative Site Rouen, Cedex, France, 76031 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Freiburg, Germany, 79104 Novartis Investigative Site Marburg, Germany, 35039 Japan Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-8582 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT01688882 - Terminated(This study was stop... More >>ped after Part 1 completed and was terminated because the predefined criteria of efficacy was not reached ( >50% better then placebo)) Less << - -
NCT01692301 Hypertension Phase 2 Completed - -
NCT01686932 Diabetes Mellitus Type 2 Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10115 Novartis Investigative Site Berlin, Germany, 13055 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Elsterwerda, Germany, 04910 Novartis Investigative Site Falkensee, Germany, 14612 Novartis Investigative Site Magdeburg, Germany, 39112 Novartis Investigative Site Neuss, Germany, 41460 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Sulzbach-Rosenberg, Germany, 92237 Novartis Investigative Site Wallerfing, Germany, 94574 Less <<
NCT01854606 CD79 Mutant or ABC-subtype Dif... More >>fuse Large B-Cell Lymphoma Less << Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Dept of Oncology. Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center Onc. Dept. New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Dept of Onc Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Rouen Cedex 1, France, 76038 Germany Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenchen, Germany, 81377 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site New Territories, Hong Kong Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT01692301 - Completed - -
NCT01705236 Relapsing Remitting Multiple S... More >>clerosis RRMS Less << Phase 4 Active, not recruiting January 28, 2019 Germany ... More >> Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Hannover, Germany, 30623 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Rostock, Germany, 18057 Novartis Investigative Site Ulm, Germany, 89081 Switzerland Novartis Investigative Site Zuerich, Switzerland, 8091 Less <<
NCT01665144 Secondary Progressive Multiple... More >> Sclerosis Less << Phase 3 Active, not recruiting September 22, 2023 -
NCT01923168 Breast Cancer Phase 2 Completed - -
NCT01708161 PIK3CA Mutated Advanced Solid ... More >>Tumors PIK3CA Amplified Advanced Solid Tumors Less << Phase 1 Phase 2 Terminated - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90095 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 United States, New York Novartis Investigative Site New York, New York, United States, 10017 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28033 Novartis Investigative Site Madrid, Spain, 28041 Less <<
NCT01923168 - Completed - -
NCT01709864 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01708161 - Terminated - -
NCT01709864 - Completed - -
NCT01928459 Advanced Solid Tumors ... More >> Metastatic Solid Tumors Less << Phase 1 Completed - -
NCT01715298 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01716754 Asthma Phase 2 Completed - -
NCT01709838 Non-transfusion Dependent Thal... More >>assemia Less << Phase 4 Active, not recruiting January 17, 2019 China, Guangxi ... More >> Novartis Investigative Site Nanning, Guangxi, China, 530021 Greece Novartis Investigative Site Athens, GR, Greece, GR-115 27 Italy Novartis Investigative Site Cagliari, CA, Italy, 09121 Novartis Investigative Site Milano, MI, Italy, 20122 Lebanon Novartis Investigative Site Hazmiyeh, Beirut, Lebanon, PO BOX 213 Thailand Novartis Investigative Site Bangkok, Thailand, 10700 Tunisia Novartis Investigative Site Tunis, Tunisia, 1006 Turkey Novartis Investigative Site Adana, Turkey, 01330 Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Izmir, Turkey, 35040 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Novartis Investigative Site London, United Kingdom, NW1 2PJ Less <<
NCT01715298 - Completed - -
NCT01716754 - Completed - -
NCT01703312 Allergic Asthma Phase 1 Phase 2 Completed - Canada, Alberta ... More >> Novartis Investigative Site Calgary, Alberta, Canada, T2N 4N1 Novartis Investigative Site Edmonton, Alberta, Canada, T6G 2B7 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Novartis Investigative Site Ste-Foy, Quebec, Canada, G1V 4G5 Canada, Saskatchewan Novartis Investigative Site Saskatoon, Saskatchewan, Canada, S7N 0W8 Canada Novartis Investigative Site Vancouver, Canada Sweden Novartis Investigative Site Stockholm, Sweden, S-171 76 Less <<
NCT01594268 Kidney Transplant Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site Seoul, Korea, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 135-720 Novartis Investigative Site Seoul, Korea, Republic of, 738-736 Novartis Investigative Site Suwon, Korea, Republic of, 442-721 Less <<
NCT01911325 Squamous Non-small Cell Lung C... More >>ancer Less << Phase 1 Terminated(Review of safety an... More >>d preliminary efficacy data showed marginal anti-tumor activity.) Less << - United States, Arkansas ... More >> Highlands Oncology Group SC-1 Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt Tampa, Florida, United States, 33612 United States, Massachusetts Reliant Medical Group Reliant Medical Group Worcester, Massachusetts, United States, 01608 United States, Virginia Virginia Oncology Associates Virginia Oncology Assoc. (2) Norfolk, Virginia, United States, 23502 Belgium Novartis Investigative Site Charleroi, Belgium, 6000 Novartis Investigative Site Mons, Belgium, 7000 France Novartis Investigative Site Creteil, France, 94000 Novartis Investigative Site Saint Herblain cedex, France, 44805 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Mainz, Germany, 55131 Italy Novartis Investigative Site Monza, MB, Italy, 20900 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Sweden Novartis Investigative Site Stockholm, Sweden, 171 76 Less <<
NCT01599637 Chronic Idiopathic Urticaria Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48149 Less <<
NCT01585272 - Completed - -
NCT00170898 Musculoskeletal Pain Phase 4 Completed - United Kingdom ... More >> For site information contact, Novartis Pharmaceuticals UK Limited Frimley, United Kingdom Less <<
NCT00050934 Epilepsy Epil... More >>epsies, Partial Less << Phase 3 Completed - -
NCT01646684 Castration Resistant Prostate ... More >>Cancer Less << Phase 1 Phase 2 Active, not recruiting September 30, 2018 Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT01681576 - Completed - -
NCT00102466 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Investigative Centers Nurnberg, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00310648 Influenza Phase 3 Completed - China ... More >> Nanning Guangxi, China, 530021 Less <<
NCT00050947 Epilepsy Phase 3 Completed - -
NCT01599637 - Completed - -
NCT01860989 Cure Rate Phase 2 Completed - Thailand ... More >> Novartis Investigative Site Ratchabari, Thailand, 70180 Novartis Investigative Site Srisaket, Thailand, 33140 Novartis Investigative Site Tak, Thailand, 63140 Vietnam Novartis Investigative Site Hanoi, Vietnam, 10000 Less <<
NCT01860989 - Completed - -
NCT01870739 Hypertension Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Erlangen, Germany, 91054 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Glasgow, Scotland, United Kingdom, G12 8TA Less <<
NCT01870739 - Completed - -
NCT01497522 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 800-0296 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-8543 Novartis Investigative Site Ohkawa-city, Fukuoka, Japan, 831-0016 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 210-0014 Novartis Investigative Site Yokohama, Kanagawa, Japan, 221-0802 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 615-0035 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1096 Novartis Investigative Site Ageo-city, Saitama, Japan, 362-8588 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 134-0084 Novartis Investigative Site Hachioji, Tokyo, Japan, 192-0046 Novartis Investigative Site Kiyose, Tokyo, Japan, 204-0021 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Nerima-ku, Tokyo, Japan, 177-0051 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Novartis Investigative Site Fukuoka, Japan, 810-0001 Novartis Investigative Site Fukuoka, Japan, 819-0168 Novartis Investigative Site Kyoto, Japan, 607-8062 Less <<
NCT02431481 Normal Renal Function ... More >> Impaired Renal Function Less << Phase 1 Completed - United States, Minnesota ... More >> DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1612 Czechia Novartis Investigative Site Praha 4, Czech Republic, Czechia, 140 59 Germany Novartis Investigative Site Berlin, Germany, 14050 Less <<
NCT01326845 Myelodysplastic Syndrome ... More >> Transfusional Iron Overload Less << Phase 4 Terminated(The trial was termi... More >>nated due to insufficient enrollment.) Less << - France ... More >> Novartis Investigative Site Caen, Cedex, France, 14033 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Limoges cedex, France, 87042 Novartis Investigative Site Pessac Cedex, France, 33604 Novartis Investigative Site Vandoeuvre les Nancy, France, 54511 Italy Novartis Investigative Site Alessandria, AL, Italy, 15100 Novartis Investigative Site Torino, TO, Italy, 10126 Novartis Investigative Site Roma, Italy, 00133 South Africa Novartis Investigative Site Bloemfontein, South Africa, 901 Spain Novartis Investigative Site Madrid, Spain, 28033 Less <<
NCT01328886 Allergic Asthma Phase 3 Completed - Japan ... More >> Novartis Investigative Site Ohbu, Aichi, Japan, 474-0031 Novartis Investigative Site Sagamihara-city, Kanagawa, Japan, 228-8522 Novartis Investigative Site Yokohama, Kanagawa, Japan, 232-8555 Novartis Investigative Site Yokohama, Kanagawa, Japan, 245-8575 Novartis Investigative Site Tsu, Mie, Japan, 514-0125 Novartis Investigative Site Tenri, Nara, Japan, 632-8552 Novartis Investigative Site Habikino city, Osaka, Japan, 583-8588 Novartis Investigative Site Shimotsuka-gun, Tochigi, Japan, 321-0293 Novartis Investigative Site Fuchu, Tokyo, Japan, 183-8561 Novartis Investigative Site Komae, Tokyo, Japan, 201-8601 Novartis Investigative Site Setagaya-ku, Tokyo, Japan, 158-0097 Novartis Investigative Site Sumida-ku, Tokyo, Japan, 130-8587 Novartis Investigative Site Chiba, Japan, 266-0007 Novartis Investigative Site Fukuoka, Japan, 811-1394 Novartis Investigative Site Gifu, Japan, 501-1194 Less <<
NCT01318941 - Completed - -
NCT01528345 Metastatic Breast Cancer Phase 2 Terminated(Slow and low enroll... More >>ment) Less << - -
NCT01524783 - Active, not recruiting - -
NCT01482156 Advanced Solid Tumors ... More >> Metastatic Breast Cancer Metastatic Renal Cell Carcinoma Less << Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Missouri Washington University School of Medicine Washington University (16) St. Louis, Missouri, United States, 63110 United States, South Carolina Medical University of South Carolina SC Charleston, South Carolina, United States, 29425 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Montellier cedex 5, France, 34298 Italy Novartis Investigative Site Verona, VR, Italy, 37126 New Zealand Novartis Investigative Site Auckland, New Zealand Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site High Heaton, Newcastle Upon Tyne, United Kingdom, NE7 7DN Less <<
NCT01335035 Iron Overload Phase 4 Completed - Spain ... More >> Novartis Investigative Site Andalucia, Spain Novartis Investigative Site Asturias, Spain Novartis Investigative Site Canarias, Spain Novartis Investigative Site Castilla y Leon, Spain Novartis Investigative Site Cataluna, Spain Novartis Investigative Site Comunidad Valenciana, Spain Novartis Investigative Site Islas baleares, Spain Novartis Investigative Site Madrid, Spain Novartis Investigative Site Murcia, Spain Less <<
NCT01327846 Atherosclerosis Phase 3 Active, not recruiting April 1, 2020 -
NCT01524783 Advanced NET of GI Origin ... More >> Advanced NET of Lung Origin Neuroendocrine Tumors Less << Phase 3 Active, not recruiting July 28, 2020 -
NCT01333501 Multiple Sclerosis Phase 4 Completed - Germany ... More >> Novartis Investigative Site Alzenau, Germany, 63755 Novartis Investigative Site Bamberg, Germany, 96049 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Würzburg, Germany, 97080 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bergamo, BG, Italy, 24128 Novartis Investigative Site Montichiari, BS, Italy, 25018 Novartis Investigative Site Chieti, CH, Italy, 66100 Novartis Investigative Site Catania, CT, Italy, 95122 Novartis Investigative Site Catania, CT, Italy, 95123 Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Pozzilli, IS, Italy, 86077 Novartis Investigative Site Messina, ME, Italy, 98121 Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Cefalù, PA, Italy, 90015 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Roma, RM, Italy, 00133 Novartis Investigative Site Roma, RM, Italy, 00161 Novartis Investigative Site Roma, RM, Italy, 00179 Novartis Investigative Site Roma, RM, Italy, 00189 Novartis Investigative Site Gallarate, VA, Italy, 21013 Novartis Investigative Site Napoli, Italy, 80131 Novartis Investigative Site Napoli, Italy, 80138 Less <<
NCT01326845 - Terminated(The trial was termi... More >>nated due to insufficient enrollment.) Less << - -
NCT01336634 Cancer Phase 2 Active, not recruiting December 1, 2020 -
NCT01528345 - Terminated(Slow and low enroll... More >>ment) Less << - -
NCT01338805 Partial Onset Seizures Phase 2 Completed - United States, Florida ... More >> Novartis Investigative Site Tallahassee, Florida, United States, 32308 United States, New Jersey Novartis Investigative Site Hamilton, New Jersey, United States, 08619 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Germany Novartis Investigative Site Bernau, Germany, 16321 Novartis Investigative Site Bielefeld, Germany, 33617 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Kehl-Kork, Germany, 77694 Novartis Investigative Site Ulm, Germany, 89081 Hungary Novartis Investigative Site Budapest, Hungary, 1096 Novartis Investigative Site Kecskemet, Hungary, 6000 Novartis Investigative Site Szombathely, Hungary, 9700 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 135-710 Poland Novartis Investigative Site Warsaw, Poland, 02-957 Slovakia Novartis Investigative Site Banska Bystrica, Slovakia, 97517 Novartis Investigative Site Kosice, Slovakia, 041 90 Less <<
NCT01336634 - Active, not recruiting - -
NCT01338818 - Completed - -
NCT01348087 Fragile X Syndrome Phase 2 Terminated(Study treatment AFQ... More >>056 failed to demonstrate efficacy in the adult patient with Fragile X Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)) Less << - -
NCT01333501 - Completed - -
NCT01348087 - Terminated(Study treatment AFQ... More >>056 failed to demonstrate efficacy in the adult patient with Fragile X Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)) Less << - -
NCT01598077 HER2 + Breast Cancer, HER2 + G... More >>astric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma HER2 + Breast Cancer HER2 + Gastric Cancer Squamous Cell Carcinoma of Head and Neck Esophageal Squamous Cell Carcinoma Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Medical Center University of Chicago (16) Chicago, Illinois, United States, 60546 United States, Massachusetts Massachusetts General Hospital SC-5 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center UT MD Houston, Texas, United States, 77030-4009 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States, 84103 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT00787917 Cystic Fibrosis ... More >> Allergic Bronchopulmonary Aspergillosis Less << Phase 4 Terminated - Belgium ... More >> Novartis Investigator Site Leuven, Belgium Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Bonn, Germany Novartis Investigator Site Munich, Germany Italy Novartis Investigator Site Milan, Italy Novartis Investigator Site Rome, Italy Netherlands Novartis Investigator Site Nijmegen, Netherlands Novartis Investigator Site Utrecht, Netherlands United Kingdom Novartis Investigator Site Cambridge, United Kingdom Novartis Investigator Site London, United Kingdom Less <<
NCT01082367 - Completed - -
NCT01082367 Treatment of Early Pulmonary I... More >>nfections With P. Aeruginosa in Cystic Fibrosis Patients Less << Phase 3 Completed - Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T1C5 Egypt Novartis Investigative Site Alexandria, Egypt, 21131 France Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Paris, France, 75019 Germany Novartis Investigative Site Dresden, Germany, 01307 Greece Novartis Investigative Site Thessaloniki, GR, Greece, 546 29 Novartis Investigative Site Thessaloniki, GR, Greece, 546 42 Novartis Investigative Site Patras, Greece, 265 00 Hungary Novartis Investigative Site Debrecen, Hungary, 4032 Novartis Investigative Site Debrecen, Hungary, 4043 Novartis Investigative Site Kaposvar, Hungary, 7400 Novartis Investigative Site Szeged, Hungary, 6725 Italy Novartis Investigative Site Milano, MI, Italy, 20122 Romania Novartis Investigative Site Bucuresti, Romania, 20395 Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420012 Novartis Investigative Site Voronezh, Russian Federation, 394036 Novartis Investigative Site Yaroslavl, Russian Federation, 150003 Switzerland Novartis Investigative Site Zürich, Switzerland, 8032 Less <<
NCT01090310 - Terminated - -
NCT01275222 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York College of Physicians & Surgeons of Columbia University New York, New York, United States, 10032 United States, Pennsylvania Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Belgium Novarts Investigative Site Edegem, Belgium, 2650 Novarts Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Lille Cedex, France, 59020 Novartis Investigative Site Lyon Cedex 08, France, 69373 Novartis Investigative Site Marseille, France, 13005 Novartis Investigative Site Villejuif, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koln, Germany, 50973 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Tubingen, Germany, 72076 Less <<
NCT01090310 Non-infectious Uveitis Phase 3 Terminated - -
NCT01093846 - Terminated(Core Study in Behce... More >>t's disease with mostly active uveitis did not meet its primary endpoint) Less << - -
NCT01095250 Uveitis Phase 3 Terminated(Terminated Study in... More >> Behcet's disease with mostly active uveitis did not meet its primary endpoint.) Less << - -
NCT01283516 - Completed - -
NCT01283516 Tumors Characterized by Geneti... More >>c Abnormalities of ALK Less << Phase 1 Completed - -
NCT01095250 - Terminated(Terminated Study in... More >> Behcet's disease with mostly active uveitis did not meet its primary endpoint.) Less << - -
NCT01093846 Uveitis Phase 3 Terminated(Core Study in Behce... More >>t's disease with mostly active uveitis did not meet its primary endpoint) Less << - -
NCT01338818 Attention Deficit/Hyperactivit... More >>y Disorder Less << Phase 3 Completed - -
NCT01289041 Advanced Endometrial Cancer Phase 2 Completed - -
NCT01097096 Alzheimer's Disease Phase 2 Completed - -
NCT01154127 - Completed - -
NCT01290406 Endometrial Cancer Phase 2 Withdrawn December 2017 -
NCT01275209 Follicular Lymphoma Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States, 02115 United States, Michigan Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States, 48201 United States, North Carolina Duke University Medical Center Duke Hem & Onc Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute SC - 2 Chattanooga, Tennessee, United States, 37404 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 Belgium Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Paris, France, 75475 Italy Novartis Investigative Site Torino, TO, Italy, 10126 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28046 Less <<
NCT01154127 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - United States, South Carolina ... More >> Spartanburg Medical Research, 485 Simuel Road Spartanburg, South Carolina, United States, 29303 Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Mainz, Germany Novartis Investigative Site Mannheim, Germany Novartis Investigative Site Wiesbaden, Germany Novartis Investigative Site Woehrendamm, Germany Italy Novartis Investigative Site Verona, Italy Romania Novartis Investigative Site Bucharest, Romania United Kingdom Novartis Investigative Site Manchester, United Kingdom Less <<
NCT01109940 Ankylosing Spondylitis Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Paradise Valley, Arizona, United States, 85253 United States, Illinois Novartis Investigative Site Springfield, Illinois, United States, 62703 Novartis Investigative Site Springfield, Illinois, United States, 62704 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Novartis Investigative Site Duncansville, Pennsylvania, United States, 16635 United States, Tennessee Novartis Investigative Site Jackson, Tennessee, United States, 38305 Novartis Investigative Site Knoxville, Tennessee, United States, 37909 United States, Texas Novartis Investigative Site Benbrook, Texas, United States, 76126 United States, Washington Novartis Investigative Site Spokane, Washington, United States, 99204 Germany Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Hamburg, Germany, 22081 Novartis Investigative Site Herne, Germany, 44625 Novartis Investigative Site Munchen, Germany, D-80639 Netherlands Novartis Investigative Site Amsterdamn, DE, Netherlands, 1100 United Kingdom Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE2 4HH Less <<
NCT01114529 Kidney Transplantation Phase 3 Completed - -
NCT01289041 - Completed - -
NCT00375752 Breast Neoplasms Phase 4 Terminated - Germany ... More >> Novartis Investigative Site Amberg, Germany, 92224 Novartis Investigative Site Berlin, Germany, 10365 Novartis Investigative Site Boeblingen, Germany, 71032 Novartis Investigative Site Celle, Germany, 29223 Novartis Investigative Site Ebersberg, Germany, 85560 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Essen, Germany, 45276 Novartis Investigative Site Esslingen, Germany, 73730 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Fürth, Germany, 90766 Novartis Investigative Site Halle, Germany, 06110 Novartis Investigative Site Hamburg, Germany, 22457 Novartis Investigative Site Hameln, Germany, 31785 Novartis Investigative Site Hanau, Germany, 63450 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heilbronn, Germany, 74064 Novartis Investigative Site Kempten, Germany, 87439 Novartis Investigative Site Koeln, Germany, 50924 Novartis Investigative Site Leipzig, Germany, 04277 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Muenchen, Germany, 81545 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Neunkirchen, Germany, 66538 Novartis Investigative Site Rheinfelden/Baden, Germany, 79618 Novartis Investigative Site Ulm, Germany, 89070 Novartis Investigative Site Ulm, Germany, 89703 Less <<
NCT00375752 - Terminated - -
NCT01297491 - Completed - -
NCT01117987 - Terminated(Novartis discontinu... More >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) Less << - -
NCT01119937 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Iizuka, Fukuoka, Japan, 820-8505 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 802-0083 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 820-0052 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-0011 Novartis Investigative Site Onojo, Fukuoka, Japan, 816-0931 Novartis Investigative Site Yanagawa, Fukuoka, Japan, 832-0059 Novartis Investigative Site Asahikawa, Hokkaido, Japan, 070-8644 Novartis Investigative Site Obihiro, Hokkaido, Japan, 080-0805 Novartis Investigative Site Sapporo, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji-city, Hyogo, Japan, 672-8064 Novartis Investigative Site Takarazuka, Hyogo, Japan, 665-0827 Novartis Investigative Site Yabu, Hyogo, Japan, 667-8555 Novartis Investigative Site Inashiki-gun, Ibaraki, Japan, 300-0395 Novartis Investigative Site Naka-gun, Ibaraki, Japan, 319-1113 Novartis Investigative Site Sashima-gun, Ibaraki, Japan, 306-0433 Novartis Investigative Site Morioka, Iwate, Japan, 020-0055 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama, Kanagawa, Japan, 232-0021 Novartis Investigative Site Yokohama, Kanagawa, Japan, 236-0051 Novartis Investigative Site Uji, Kyoto, Japan, 611-0042 Novartis Investigative Site Matsusaka-city, Mie, Japan, 515-8544 Novartis Investigative Site Sendai, Miyagi, Japan, 981-8563 Novartis Investigative Site Nagaoka-City, Niigata, Japan, 940-2085 Novartis Investigative Site Nagaoka, Niigata, Japan, 940-8653 Novartis Investigative Site Kasaoka, Okayama, Japan, 714-0081 Novartis Investigative Site Tsuyama, Okayama, Japan, 708-0841 Novartis Investigative Site Osakasayama, Osaka, Japan, 589-0022 Novartis Investigative Site Sakai, Osaka, Japan, 591-8555 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1096 Novartis Investigative Site Shimotsuka-gun, Tochigi, Japan, 321-0293 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Nakano-ku, Tokyo, Japan, 164-0012 Novartis Investigative Site Ohta-ku, Tokyo, Japan, 140-0063 Novartis Investigative Site Yamagata city, Yamagata, Japan, 990-8533 Novartis Investigative Site Ube, Yamaguchi, Japan, 755-0241 Novartis Investigative Site Fukuoka, Japan, 812-0033 Novartis Investigative Site Kochi, Japan, 780-8077 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 545-8586 Novartis Investigative Site Saitama, Japan, 337-0012 Less <<
NCT01119950 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - -
NCT01119937 - Completed - -
NCT01114529 - Completed - -
NCT01117987 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Terminated(Novartis discontinu... More >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) Less << - -
NCT01120717 - Completed - -
NCT01120717 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01131585 Visual Impairment Due to Diabe... More >>tic Macular Edema Less << Phase 3 Terminated(European drug appro... More >>val.) Less << - Germany ... More >> Novartis Investigative Site Aschaffenburg, Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Bonn, Germany Novartis Investigative Site Bremen, Germany Novartis Investigative Site Chemnitz, Germany Novartis Investigative Site Darmstadt, Germany Novartis Investigative Site Dessau, Germany Novartis Investigative Site Dortmund, Germany Novartis Investigative Site Dresden, Germany Novartis Investigative Site Eichstaett, Germany Novartis Investigative Site Essen, Germany Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Freiburg, Germany Novartis Investigative Site Giessen, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Heidelberg, Germany Novartis Investigative Site Karlsruhe, Germany Novartis Investigative Site Kiel, Germany Novartis Investigative Site Koeln, Germany Novartis Investigative Site Landshut, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Marburg, Germany Novartis Investigative Site Muenchen, Germany Novartis Investigative Site Muenster, Germany Novartis Investigative Site Mühlheim, Germany Novartis Investigative Site München, Germany Novartis Investigative Site Münster, Germany Novartis Investigative Site Nuernberg, Germany Novartis Investigative Site Postdam, Germany Novartis Investigative Site Recklinghausen, Germany Novartis Investigative Site Regensburg, Germany Novartis Investigative Site Rosenheim, Germany Novartis Investigative Site Siegburg, Germany Novartis Investigative Site Stuttgart, Germany Novartis Investigative Site Ulm, Germany Novartis Investigative Site Würzburg, Germany Less <<
NCT01131585 - Terminated(European drug appro... More >>val.) Less << - -
NCT01132612 Plaque-type Psoriasis Phase 2 Completed - -
NCT01119950 - Completed - -
NCT01297491 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT00613171 Systemic Sclerosis, Scleroderm... More >>a Less << Phase 2 Completed - United States, Illinois ... More >> Novartis Investigator Site Chicago, Illinois, United States, 60611 United States, Maryland Novartis Investigator Site Baltimore, Maryland, United States, 21224 United States, Massachusetts Novartis Investigator Site Boston, Massachusetts, United States, 02118 Germany Novartis Investigator Site Erlangen, Germany Italy Novartis Investigator Site Florence, Italy Switzerland Novartis Investigator Site Zurich, Switzerland United Kingdom Novartis Investigator Site London, United Kingdom Less <<
NCT01327053 Basal Cell Carcinoma Phase 2 Completed - -
NCT01327053 - Completed - -
NCT01130064 Asthma Phase 2 Completed - -
NCT01324479 Solid Tumors Phase 1 Completed - -
NCT01148511 - Completed - -
NCT01857206 Influenza Fev... More >>er Less << Phase 3 Completed - -
NCT01132612 - Completed - -
NCT01857206 - Completed - -
NCT01148511 Age-related Macular Degenerati... More >>on Less << Phase 4 Completed - Turkey ... More >> Novartis Investigative Site Adana, Turkey Novartis Investigational Site Ankara, Turkey Novartis Investigative Site Ankara, Turkey Novartis Investigative Site Bursa, Turkey Novartis Investigative Site Eskişehir, Turkey Novartis Investigative Site İstanbul, Turkey Novartis Investigative Site İzmir, Turkey Novartis Investigative Site Konya, Turkey Less <<
NCT01152801 Metastatic Renal Cell Carcinom... More >>a Less << Phase 1 Completed - China, Hubei ... More >> Novartis Investigative Site Wuhan, Hubei, China, 430030 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China Novartis Investigative Site Beijing, China, 100028 Novartis Investigative Site Beijing, China, 100036 Novartis Investigative Site Guangzhou, China, 510060 Novartis Investigative Site Shanghai, China, 200127 Novartis Investigative Site Shanghai, China, 200433 Less <<
NCT01147822 Carcinoma, Renal Cell Phase 2 Active, not recruiting September 30, 2019 China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510060 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Beijing, China, 100036 Novartis Investigative Site Beijing, China, 100853 Novartis Investigative Site Beijing, China Novartis Investigative Site Shanghai, China, 200032 Novartis Investigative Site Shanghai, China, 200127 Novartis Investigative Site Tianjin, China, 300060 Korea, Republic of Novartis Investigative Site Daejeon, Korea, Republic of, 301-721 Novartis Investigative Site Goyang-si, Gyeonggi-Do, Korea, Republic of, 410-769 Novartis Investigative Site Seoul, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 135-710 Novartis Investigative Site Seoul, Korea, Republic of, 138-736 Taiwan Novartis Investigative Site Kaohsiung Hsien, Taiwan, 833 Novartis Investigative Site Taichung, Taiwan, 40402 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 11217 Novartis Investigative Site Taoyuan County, Taiwan, 333 Less <<
NCT01147822 - Active, not recruiting - -
NCT01150357 Hypertension Phase 3 Completed - -
NCT01150097 Liver Transplant Recipient Phase 3 Completed - -
NCT01151410 Hypertension Phase 3 Completed - -
NCT01155700 Allergic Asthma Phase 3 Completed - Japan ... More >> Novartis Investigative Site Ohbu, Aichi, Japan, 474-0031 Novartis Investigative Site Sagamihara, Kanagawa, Japan, 228-8522 Novartis Investigative Site Yokohama, Kanagawa, Japan, 232-8555 Novartis Investigative Site Yokohama, Kanagawa, Japan, 245-8575 Novartis Investigative Site Tsu, Mie, Japan, 514-0125 Novartis Investigative Site Tenri, Nara, Japan, 632-8552 Novartis Investigative Site Habikino, Osaka, Japan, 583-8588 Novartis Investigative Site Shimotsuka-gun, Tochigi, Japan, 321-0293 Novartis Investigative Site Fuchu, Tokyo, Japan, 183-8561 Novartis Investigative Site Komae, Tokyo, Japan, 201-8601 Novartis Investigative Site Setagaya-ku, Tokyo, Japan, 157-8535 Novartis Investigative Site Setagaya-ku, Tokyo, Japan, 158-0097 Novartis Investigative Site Sumida-ku, Tokyo, Japan, 130-8587 Novartis Investigative Site Chiba, Japan, 266-0007 Novartis Investigative Site Fukuoka, Japan, 811-1394 Novartis Investigative Site Gifu, Japan, 501-1194 Novartis Investigative Site Osaka, Japan, 530-0012 Less <<
NCT01331239 Cushing's Disease Phase 2 Active, not recruiting December 21, 2018 United States, Illinois ... More >> Northwestern University Endo, Metabolism and Molecular Chicago, Illinois, United States, 60611-3308 United States, Massachusetts Massachusetts General Hospital Neuroendocrine Unit Boston, Massachusetts, United States, 02114 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health & Science University SC Portland, Oregon, United States, 97239-3098 France Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Paris, France, 75014 Italy Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Ancona, Italy, l60020 Novartis Investigative Site Napoli, Italy, 80131 Japan Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Chiba, Japan, 260-8677 Less <<
NCT01169701 Renal Transplant Phase 4 Completed - Spain ... More >> Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Hospitalet de Llobregat, Barcelona, Spain, 08907 Novartis Investigative Site Barcelona, Catalunya, Spain, 08025 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Barcelona, Cataluña, Spain, 08003 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain Less <<
NCT01150357 - Completed - -
NCT01169701 - Completed - -
NCT03580239 Prostate Cancer Phase 3 Not yet recruiting December 1, 2023 China, Tianjin ... More >> Tianjin First Center Hospital Tianjin, Tianjin, China, 300000 Tianjin Medical University General Hospital Tianjin, Tianjin, China, 300050 The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, Tianjin, China, 300150 Tianjin Medical Unversity Second Hospital Tianjin, Tianjin, China, 300200 Less <<
NCT01151410 - Completed - -
NCT01169844 Psoriatic Arthritis Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Hamburg, Germany, 22081 Novartis Investigative Site Hamburg, Germany, 22415 Novartis Investigative Site Herne, Germany, 44649 Novartis Investigative Site Muenchen, Germany, 80336 Netherlands Novartis Investigative Site Amsterdamn, DE, Netherlands, 1100 Novartis Investigative Site Meerssen, KR, Netherlands, 6231 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G12 8TA Novartis Investigative Site Leeds, United Kingdom, LS7 4SA Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE2 4HH Less <<
NCT01160211 Neoplasms, Breast Phase 3 Active, not recruiting May 5, 2019 -
NCT01171976 Diabetic Macular Edema Phase 3 Completed - -
NCT01171976 - Completed - -
NCT01179737 Pulmonary Arterial Hypertensio... More >>n Less << Phase 2 Terminated(Study was terminate... More >>d due to serious adverse event (SAE)) Less << - United States, Massachusetts ... More >> Novartis Investigative Site Boston, Massachusetts, United States, 02118 United States, Michigan Novartis Investigative Site Ann Arbor, Michigan, United States, 48109-0391 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Ohio Novartis Investigative Site Cleveland, Ohio, United States, 44195 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37232-2573 Canada, Alberta Novartis Investigative Site Calgary, Alberta, Canada, T6G 2B7 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Marburg, Germany, 35039 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 120-752 Singapore Novartis Investigative Site Singapore, Singapore, 119074 Novartis Investigative Site Singapore, Singapore, 168752 Switzerland Novartis Investigative Site Zurich, Switzerland, 8091 Less <<
NCT01173731 Parkinson Disease ... More >> Dyskinesia, Drug-Induced Levodopa Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Sunnyvale, California, United States, 94089 United States, Colorado Novartis Investigative Site Englewood, Colorado, United States, 80113 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46202 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3081 Novartis Investigative Site Parkville, Victoria, Australia, 3050 Novartis Investigative Site Prahran, Victoria, Australia, 3181 Canada, Ontario Novartis Investigative Site Ottawa, Ontario, Canada, K1G 4G3 Canada, Quebec Novartis Investigative Site Gatineau, Quebec, Canada, J9J 0A5 Novartis Investigative Site Greenfield Park, Quebec, Canada, J4V 2J2 France Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Pessac, France, 33604 Germany Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Kassel, Germany, 34128 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenchen, Germany, 80804 Novartis Investigative Site Stadtroda, Germany, 07646 Novartis Investigative Site Tuebingen, Germany, 72076 Italy Novartis Investigative Site Lido di Camaiore, LU, Italy, 55041 Novartis Investigative Site Roma, RM, Italy, 00163 Novartis Investigative Site Napoli, Italy, 80131 Less <<
NCT01322321 Diabetes Mellitus ... More >> Diabetes Type 1 Less << Phase 2 Withdrawn - United States, Wisconsin ... More >> Aurora St Luke's Medical Center, Endocrine & Diabetes Center Milwaukee, Wisconsin, United States Canada, Ontario LMC Endocrinology Centres (Barrie) Ltd Barrie, Ontario, Canada LMC Endocrinology Centres (Bayview) Ltd Toronto, Ontario, Canada Germany Novartis Investigative Site Dusseldorf, Germany Novartis Investigative Site Hannover, Germany Novartis Investigative Site Neuwied, Germany United Kingdom Novartis Investigative Site Bristol, United Kingdom Novartis Investigative Site Exeter, United Kingdom Novartis Investigative Site Hull, United Kingdom Novartis Investigative Site Liverpool, United Kingdom Less <<
NCT01150097 - Completed - -
NCT01374906 Cushing's Disease Phase 3 Completed - -
NCT01172548 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - -
NCT01374906 - Completed - -
NCT01379534 - Completed - -
NCT01185821 - Completed - -
NCT01185821 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 2 Completed - -
NCT01197300 Osteoporosis Phase 3 Active, not recruiting April 15, 2019 Australia, New South Wales ... More >> Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V6H 3V4 Canada, Ontario Novartis Investigative Site Ottawa, Ontario, Canada, K1H 8L1 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3H 1P3 Novartis Investigative Site Montreal, Quebec, Canada, H3T 1C5 Hungary Novartis Investigative Site Budapest, Hungary, 1085 Russian Federation Novartis Investigative Site Saint-Petersburg, Russian Federation, 195067 South Africa Novartis Investigative Site Soweto, Gauteng, South Africa, 2013 Turkey Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Pendik / Istanbul, Turkey, 34899 United Kingdom Novartis Investigative Site West Midlands, Birmingham, United Kingdom, B4 6NH Less <<
NCT01193101 - Completed - -
NCT00427999 Prostate Cancer Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Reichenhall, Germany, 83435 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hamburg, Germany, 22607 Novartis Investigative Site Kassel, Germany, 34131 Novartis Investigative Site Markkleeberg, Germany, 04416 Novartis Investigative Site Passau, Germany, 94032 Novartis Investigative Site Planegg, Germany, 82152 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT01179737 - Terminated(Study was terminate... More >>d due to serious adverse event (SAE)) Less << - -
NCT01379534 Solid Tumors and Advanced Endo... More >>metrial Cancer Endometrial Cancer Second-line Treatment VEGF Less << Phase 2 Completed - -
NCT01193101 Hypertension Phase 2 Completed - China, Hebei ... More >> Novartis Investigative Site Shijiazhuang, Hebei, China, 050000 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300142 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310009 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Chongqing, China, 400042 Japan Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Shimotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 100-0005 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Kunitachi, Tokyo, Japan, 186-0001 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-0053 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-0063 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Korea, Republic of Novartis Investigative Site Bucheon, Gyeonggi-do, Korea, Republic of, 424-717 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 137-701 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Daegu, Korea, Republic of, 705-703 Novartis Investigative Site Seoul, Korea, Republic of, 150-950 Novartis Investigative Site Seoul, Korea, Republic of, 152-703 Taiwan Novartis Investigative Site Changhua, Taiwan, 500 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 10449 Novartis Investigative Site Taipei, Taiwan, 114 Thailand Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Bangkok, Thailand, 10700 Novartis Investigative Site Chiang Mai, Thailand, 50200 Less <<
NCT01202188 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01201356 Relapsing Forms of Multiple Sc... More >>lerosis Less << Phase 3 Completed - -
NCT01202188 - Completed - -
NCT01202903 Persistent Allergic Asthma Phase 3 Completed - -
NCT01374451 Islet Cell Tumor Phase 2 Terminated(The study was stopp... More >>ed for not meeting the primary endpoint for PFS.) Less << - -
NCT01217944 Pathological Myopia Phase 3 Completed - -
NCT01216072 Relapsing Forms of Multiple Sc... More >>lerosis Less << Phase 4 Completed - -
NCT01216072 - Completed - -
NCT00427999 - Completed - -
NCT01337752 Multiple Myeloma ... More >> Renal Insufficiency Less << Phase 2 Completed - United States, Illinois ... More >> University Chicago Hospital Dept. of Univ of Chicago (2) Chicago, Illinois, United States, 60637 United States, Washington Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Spain Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Madrid, Spain, 28006 United Kingdom Novartis Investigative Site Bournemouth, United Kingdom, BH7 7DW Novartis Investigative Site Manchester, United Kingdom, M13 9WL Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Novartis Investigative Site Southampton, United Kingdom, SO16 6YD Less <<
NCT01232894 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Israel ... More >> Novartis Investigative Site Afula, Israel Novartis Investigative Site Ashkelon, Israel Novartis Investigative Site Holon, Israel Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Kfar Saba, Israel Novartis Investigative Site Petach Tikva, Israel Novartis Investigative Site Rehovot, Israel Novartis Investigative Site Tel Aviv, Israel Less <<
NCT01232894 - Completed - -
NCT00432068 Healthy Cholecystectomized Phase 1 Completed - Belgium ... More >> Novartis Investigative Site Ghent, Belgium Novartis Investigative Site Wavre-Gelgique, Belgium France Novartis Investigative Site Lagord, France Novartis Investigative Site Paris, France Novartis Investigative Site Rennes, France Italy Novartis Investigative Site Verona, Italy Less <<
NCT01217944 - Completed - -
NCT01374451 - Terminated(The study was stopp... More >>ed for not meeting the primary endpoint for PFS.) Less << - -
NCT01231594 Cancer Phase 1 Completed - -
NCT01231659 Postmenopausal Women ... More >> Locally Advanced Metastatic Breast Cancer Metastatic Breast Cancer Less << Phase 4 Completed - Israel ... More >> Novartis Investigative Site Jerusalem, Israel, 91120 Novartis Investigative Site Kfar Saba, Israel, 4428164 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Ramat Gan, Israel, 5265601 Novartis Investigative Site Rehovot, Israel, 76100 Novartis Investigative Site Tel Aviv, Israel, 62439 Novartis Investigative Site Tel Aviv, Israel, 64239 Less <<
NCT01232595 Moderate Clostridium Difficile... More >> Infection Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Palm Desert, California, United States, 92211 United States, Connecticut Novartis Investigative Site Bristol, Connecticut, United States, 06010 United States, Florida Novartis Investigative Site Clearwater, Florida, United States, 33756 United States, Georgia Novartis Investigative Site Decatur, Georgia, United States, 30030 United States, Idaho Novartis Investigative Site Idaho Falls, Idaho, United States, 83404 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60637 United States, Indiana Novartis Investigative Site Michigan City, Indiana, United States, 46360 United States, Kansas Novartis Investigative Site Topeka, Kansas, United States, 66606 United States, Montana Novartis Investigative Site Butte, Montana, United States, 59701 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43215 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, South Carolina Novartis Investigative Site Charleston, South Carolina, United States, 29425 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78212 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec Novartis Investigative Site Chicoutimi, Quebec, Canada, G7H 5H6 Novartis Investigative Site Montreal, Quebec, Canada, H1T 2M4 Novartis Investigative Site Trois-Rivières, Quebec, Canada, G8Z 3R9 Less <<
NCT01202903 - Completed - -
NCT01232296 - Completed - -
NCT01235962 Cancer Phase 3 Active, not recruiting April 15, 2019 -
NCT01184872 - Completed - -
NCT00456833 Non Small Cell Lung Cancer Phase 1 Completed - United States, Georgia ... More >> Novartis Investigative Site Atlanta, Georgia, United States, 30322 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60637-1470 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53792 Canada, British Columbia Novartis Investigative Site Richmond, British Columbia, Canada, V7C 5L9 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Denmark Novartis Investigative Site Herlev, Denmark, DK-2730 France Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Villejuif Cedex, France, 94805 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 115478 Less <<
NCT01232296 Hepatocellular Carcinoma Phase 2 Completed - China, Jiangsu ... More >> Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310016 China Novartis Investigative Site Beijing, China, 100039 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site Shatin, New Territories, Hong Kong Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 232-0024 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 136-705 Singapore Novartis Investigative Site Singapore, Singapore, 308433 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan, 33305 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10048 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Novartis Investigative Site Chiang Mai, Thailand, 50200 Novartis Investigative Site Khon Kaen, Thailand, 40002 Novartis Investigative Site Songkla, Thailand, 90110 Less <<
NCT01253603 Persistent Asthma Phase 2 Completed - -
NCT01184872 Infections Phase 3 Completed - Austria ... More >> Novartis Investigative Site Graz, Austria Novartis Investigative Site Vienna, Austria Germany Novartis Investigative Site Bochum, Germany Novartis Investigative Site Essen, Germany Novartis Investigative Site Homburg, Germany Novartis Investigative Site Magdeburg, Germany Novartis Investigative Site Mannheim, Germany Novartis Investigative Site Muenster, Germany Novartis Investigative Site Tuebingen, Germany Italy Novartis Investigative Site Pisa, Italy Russian Federation Novartis Investigative Site (1) Moscow, Russian Federation Novartis Investigative Site Novosibirsk, Russian Federation Novartis Investigative Site (2) Saint Petersburg, Russian Federation Novartis Investigative Site Yaroslavi, Russian Federation Spain Novartis Investigative Site (1) Madrid, Spain Novartis Investigative Site Santander, Spain Novartis Investigative Site Seville, Spain Less <<
NCT01253629 Fragile X Syndrome Phase 2 Completed - -
NCT01254188 Chronic Myeloid Leukemia Phase 3 Completed - -
NCT01254188 - Completed - -
NCT01237873 Essential Hypertension Phase 3 Completed - Japan ... More >> Novartis Investigative Site Yokohama, Kanagawa, Japan, 231-0023 Novartis Investigative Site Koshigaya city, Saitama, Japan, 343-0826 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 133-0061 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 124-0024 Novartis Investigative Site Kiyose, Tokyo, Japan, 204-0021 Novartis Investigative Site Kunitachi, Tokyo, Japan, 186-0001 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shibuya-ku, Tokyo, Japan, 150-0002 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Tachikawa, Tokyo, Japan, 190-0013 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Less <<
NCT01256411 Essential Hypertension Phase 2 Completed - China, Chongqing ... More >> Novartis Investigative Site Chongqing, Chongqing, China, 400042 China, Hebei Novartis Investigative Site Shijiazhuang, Hebei, China, 050000 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310006 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Tianjin, China, 300142 Japan Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0023 Novartis Investigative Site Shimotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-0031 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 100-0005 Novartis Investigative Site Kiyose-city, Tokyo, Japan, 204-0021 Novartis Investigative Site Kunitachi, Tokyo, Japan, 186-0001 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-0053 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 142-0063 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Korea, Republic of Novartis Investigative Site Bucheon, Gyeonggi-do, Korea, Republic of, 424-717 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 137-701 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Daegu, Korea, Republic of, 705-703 Novartis Investigative Site Seoul, Korea, Republic of, 150-950 Novartis Investigative Site Seoul, Korea, Republic of, 152-703 Taiwan Novartis Investigative Site Changhua, Taiwan, 500 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 10449 Novartis Investigative Site Taipei, Taiwan, 114 Thailand Novartis Investigative Site Bangkok, Thailand, 10400 Novartis Investigative Site Bangkok, Thailand, 10700 Novartis Investigative Site Chiang Mai, Thailand, 50200 Less <<
NCT01257815 Diabetic Retinopathy ... More >> Macular Oedema Less << Phase 4 Completed - United Kingdom ... More >> Novartis Investigative Site Torquay, Devon,, United Kingdom, TQ2 7AA Novartis Investigative Site Ayr, United Kingdom, KA6 6DX Novartis Investigative Site Belfast, United Kingdom, BT12 6BA Novartis Investigative Site Birmingham, United Kingdom, B9 5SS Novartis Investigative Site Cardiff,, United Kingdom, CF14 4XW Novartis Investigative Site Colchester, United Kingdom, CO3 3NB Novartis Investigative Site Fife, United Kingdom, KY12 OSU Novartis Investigative Site Great Yarmouth, United Kingdom, NR31 6LA Novartis Investigative Site Hull, United Kingdom, HU3 2JZ Novartis Investigative Site Liverpool, United Kingdom, L7 8XP Novartis Investigative Site London, United Kingdom, E11 1NR Novartis Investigative Site London, United Kingdom, SE5 9RS Novartis Investigative Site Rugby, United Kingdom, CV22 5PX Novartis Investigative Site Uxbridge, United Kingdom, UB8 3NN Novartis Investigative Site York, United Kingdom, YO31 8HE Less <<
NCT01259492 Attention Deficit/Hyperactivit... More >>y Disorder Less << Phase 3 Completed - -
NCT01254227 Cardiac Iron Overload Phase 2 Completed - Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 2C4 Egypt Novartis Investigative Site Cairo, Egypt Greece Novartis Investigative Site Athens, GR, Greece, GR-115 27 Novartis Investigative Site Patra - RIO, GR, Greece, 265 04 Italy Novartis Investigative Site Cagliari, CA, Italy, 09121 Novartis Investigative Site Genova, GE, Italy, 16128 Novartis Investigative Site Napoli, Italy, 80138 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Turkey Novartis Investigative Site Adana, Turkey, 01330 Novartis Investigative Site Antalya, Turkey, 07070 Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Izmir, Turkey, 35040 United Kingdom Novartis Investigative Site London, United Kingdom, NW1 2BU Less <<
NCT01259297 - Terminated(Terminated early in... More >> agreement with Health Authorities for feasibility reasons) Less << - -
NCT01266135 Idiopathic Pulmonary Fibrosis Phase 2 Terminated - United States, Florida ... More >> Novartis Investigative Site Gainesville, Florida, United States, 32611 Novartis Investigative Site Orlando, Florida, United States, 32803 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Pennsylvania Novartis Investigative Site Pittsburgh, Pennsylvania, United States, 15219 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78229 United Kingdom Novartis Investigative Site Cambridge, United Kingdom, CB2 2QQ Novartis Investigative Site Leicester, United Kingdom, LE3 9QP Novartis Investigative Site London, United Kingdom, SW3 6PH Less <<
NCT01402401 Advanced Gastric Cancer Phase 2 Terminated - United States, California ... More >> University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States, 90095 United States, New York Clinical Research Alliance Lake Success, New York, United States, 11042 United States, Texas University of Texas/MD Anderson Cancer Center UT SC Houston, Texas, United States, 77030-4009 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Nice Cedex 2, France, 06189 Novartis Investigative Site Reims, France, 51092 Germany Novartis Investigative Site Mannheim, Baden-Württemberg, Germany, 68305 Novartis Investigative Site Heilbronn, Germany, 74078 Italy Novartis Investigative Site Modena, MO, Italy, 41100 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 135-710 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Less <<
NCT01259297 Cardiovascular Events Phase 3 Terminated(Terminated early in... More >> agreement with Health Authorities for feasibility reasons) Less << - -
NCT01256411 - Completed - -
NCT01275196 Chronic Myeloid Leukemia Phase 3 Completed - China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510080 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430022 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300020 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Fuzhou, China, 350001 Novartis Investigative Site Jinan, China, 250012 Novartis Investigative Site Nan Jing, China, 210008 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China, 200433 Less <<
NCT01272362 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 4 Completed - -
NCT01274351 Chronic Myelogenous Leukemia Phase 2 Active, not recruiting December 31, 2018 Turkey ... More >> Novartis Investigative Site Istanbul, TUR, Turkey, 34098 Novartis Investigative Site Adana, Turkey, 01330 Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Bursa, Turkey, 16059 Novartis Investigative Site Diyarbakir, Turkey, 21000 Novartis Investigative Site Gaziantep, Turkey, 27310 Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Izmir, Turkey, 35340 Novartis Investigative Site Meselik / Eskisehir, Turkey, 26480 Novartis Investigative Site Okmeydani / Istanbul, Turkey, 34370 Novartis Investigative Site Talas / Kayseri, Turkey, 38039 Novartis Investigative Site Trabzon, Turkey, 61080 Less <<
NCT01283542 Non-functioning Pituitary Aden... More >>oma Less << Phase 2 Completed - Brazil ... More >> Novartis Investigative Site Fortaleza, CE, Brazil, 04636-000 Novartis Investigative Site Curitiba, PR, Brazil, 80030-110 Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 21941-913 Novartis Investigative Site Joinville, SC, Brazil, 89201260 Novartis Investigative Site Botucatu, SP, Brazil, 18618-970 Novartis Investigative Site Sao Paulo, SP, Brazil, 05403 000 Novartis Investigative Site São Paulo, SP, Brazil, 04023-900 Less <<
NCT01281306 Systolic Hypertension Phase 2 Completed - -
NCT00139594 Bipolar Disorder Phase 4 Completed - -
NCT01285492 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Anjo, Aichi, Japan, 446-8602 Novartis Investigative Site Nagoya, Aichi, Japan, 457-8511 Novartis Investigative Site Nishio-city, Aichi, Japan, 445-8510 Novartis Investigative Site Kasuga-city, Fukuoka, Japan, 816-0813 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 820-0052 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-0011 Novartis Investigative Site Yanagawa, Fukuoka, Japan, 832-0059 Novartis Investigative Site Asahikawa, Hokkaido, Japan, 070-8644 Novartis Investigative Site Obihiro, Hokkaido, Japan, 080-0805 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji-city, Hyogo, Japan, 672-8064 Novartis Investigative Site Kanazawa, Ishikawa, Japan, 920-8610 Novartis Investigative Site Takamatsu, Kagawa, Japan, 760-8538 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama, Kanagawa, Japan, 236-0051 Novartis Investigative Site Koshi-city, Kumamoto, Japan, 861-1196 Novartis Investigative Site Matsusaka-city, Mie, Japan, 515-8544 Novartis Investigative Site Ueda, Nagano, Japan, 386-8610 Novartis Investigative Site Osaka-city, Osaka, Japan, 545-8586 Novartis Investigative Site Osakasayama, Osaka, Japan, 589-0022 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1192 Novartis Investigative Site Toyonaka, Osaka, Japan, 560-8552 Novartis Investigative Site Kawaguhi-city, Saitama, Japan, 333-0833 Novartis Investigative Site Hamamatsu, Shizuoka, Japan, 430-8525 Novartis Investigative Site Fuchu, Tokyo, Japan, 183-8524 Novartis Investigative Site Meguro, Tokyo, Japan, 152-8902 Novartis Investigative Site Yamagata city, Yamagata, Japan, 990-8533 Novartis Investigative Site Ube, Yamaguchi, Japan, 755-0241 Novartis Investigative Site Akita, Japan, 010-0933 Novartis Investigative Site Fukuoka, Japan, 811-0213 Novartis Investigative Site Fukuoka, Japan, 812-0033 Novartis Investigative Site Fukuoka, Japan, 815-8588 Novartis Investigative Site Kochi, Japan, 780-8077 Novartis Investigative Site Osaka, Japan, 558-8558 Novartis Investigative Site Wakayama, Japan, 641-8510 Less <<
NCT01275196 - Completed - -
NCT01289028 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Bad Saarow, Germany, 155226 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Halle/'Saale, Germany, 06120 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Taormina, ME, Italy, 98039 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Padova, PD, Italy, 35100 Novartis Investigative Site Aviano, PN, Italy, 33081 Novartis Investigative Site Torino, TO, Italy, 10153 Less <<
NCT01281306 - Completed - -
NCT01289028 - Completed - -
NCT01473901 Glioblastoma Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Highlands Oncology Fayetteville, Arkansas, United States, 72703 United States, Massachusetts Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States, 02215 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson DeGrout Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28040 Less <<
NCT01294774 Subacute Cutaneous Lupus Eryth... More >>ematosus Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Frankfurt am Main, Germany, 60596 Novartis Investigative Site Tuebingen, Germany, 72076 Greece Novartis Investigative Site Athens, GR, Greece, 161 21 Novartis Investigative Site Thessaloniki, GR, Greece, 546 29 Italy Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Siena, SI, Italy, 53100 Less <<
NCT01259492 - Completed - -
NCT01285492 - Completed - -
NCT01294579 Lymphoma, Non-Hodgkin Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Chandler, Arizona, United States, 85224 United States, California Novartis Investigative Site Burbank, California, United States, 91505 Novartis Investigative Site Fresno, California, United States, 93720 Novartis Investigative Site Oxnard, California, United States, 93030 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Florida Novartis Investigative Site Orange Park, Florida, United States, 32073 United States, Massachusetts Novartis Investigative Site Burlington, Massachusetts, United States, 01805 United States, Nebraska Novartis Investigative Site Omaha, Nebraska, United States, 68198-9200 United States, Nevada Novartis Investigative Site Las Vegas, Nevada, United States, 89169 United States, North Carolina Novartis Investigative Site Cary, North Carolina, United States, 27518 Novartis Investigative Site Charlotte, North Carolina, United States, 28204 Novartis Investigative Site Raleigh, North Carolina, United States, 27607 United States, Ohio Novartis Investigative Site Kettering, Ohio, United States, 45429 United States, Oregon Novartis Investigative Site Eugene, Oregon, United States, 97401 United States, South Carolina Novartis Investigative Site Charleston, South Carolina, United States, 29414 Novartis Investigative Site Greenville, South Carolina, United States, 29601 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78229 Novartis Investigative Site Sherman, Texas, United States, 75090 Novartis Investigative Site Tyler, Texas, United States, 75702 Novartis Investigative Site Waco, Texas, United States, 76712 United States, Washington Novartis Investigative Site Vancouver, Washington, United States, 98684 Novartis Investigative Site Yakima, Washington, United States, 98902 Less <<
NCT01294787 COPD Phase 3 Completed - Germany ... More >> Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Grosshansdorf, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Lubeck, Germany Novartis Investigative Site Mainz, Germany Novartis Investigative Site Rudersdorf, Germany Novartis Investigative Site Wiesbaden, Germany Spain Novartis Investigative Site Alicante, Spain Novartis Investigative Site Badalona, Spain Novartis Investigative Site Barakaldo, Spain Novartis Investigative Site Barcelona, Spain Novartis Investigative Site Madrid, Spain Novartis Investigative Site Malaga, Spain Less <<
NCT01294787 - Completed - -
NCT01443481 Solid Tumors ... More >>Hepatic Impairment Less << Phase 1 Completed - United States, California ... More >> University of California at Los Angeles Dept. of UCLA (4) Los Angeles, California, United States, 90095 United States, North Carolina Duke University Medical Center DUMC Durham, North Carolina, United States, 27710 United States, Texas Cancer Therapy & Research Center / UT Health Science Center SC San Antonio, Texas, United States, 78229 Belgium Novartis Investigative Site Gent, Belgium, 9000 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hannover, Germany, 30625 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Rozzano, MI, Italy, 20089 Novartis Investigative Site Verona, VR, Italy, 37126 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Maastricht, Netherlands, 5800 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Less <<
NCT01294579 - Completed - -
NCT01302860 Cryopyrin-associated Periodic ... More >>Syndromes Familial Cold Autoinflammatory Syndrome Muckle-Wells Syndrome Neonatal Onset Multisystem Inflammatory Disease Less << Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Laeken, Belgium, 1020 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 France Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site St. Augustin, Germany, 53757 Novartis Investigative Site Tübingen, Germany, 72076 Spain Novartis Investigative Site Granada, Andalucia, Spain, 18012 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Switzerland Novartis Investigative Site Lausanne, Switzerland, 1011 United Kingdom Novartis Investigative Site London, United Kingdom, WC1N 1EH Less <<
NCT01285466 Metastatic or Locally Advanced... More >> Solid Tumors Less << Phase 1 Completed - Belgium ... More >> Novartis Investigative Site Bruxelles, Belgium, 1000 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Wilrijk, Belgium, 2610 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Köln, Germany, 50937 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Chur, Switzerland, 7000 Novartis Investigative Site St. Gallen, Switzerland, 9007 Less <<
NCT00787917 - Terminated - -
NCT00670592 Non-Hodgkin's Lymphoma ... More >> Hodgkin's Lymphoma Less << Phase 1 Phase 2 Completed - -
NCT01316458 Prostatic Neoplasm ... More >> Genital Neoplasms, Male Neoplasms, Abdominal Urogenital Neoplasms Genital Diseases, Male Prostatic Diseases Antineoplastic Agents Imatinib Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany Novarts Investigative Site Berlin, Germany Novartis Investigative Site Bonn, Germany Novartis Investigative Site Borken, Germany Novartis Investigative Site Darmstadt, Germany Novartis Investigative Site Fürth, Germany Novartis Investigative Site Gardelegen, Germany Novarts Investigative Site Hamburg, Germany Novartis Investigative Site Köln, Germany Novartis Investigative Site Marburg, Germany Novartis Investigative Site Ulm, Germany Novartis Investigative Site Wesel, Germany Novartis Investigative Site Wuppertal, Germany Less <<
NCT01313689 Leukaemia Phase 3 Completed - -
NCT01310166 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 4 Completed - -
NCT01315275 Visual Impairment ... More >> Macular Edema Less << Phase 4 Completed - France ... More >> Novartis Investigative Site Amiens, France, 80054 Novartis Investigative Site Angers, France, 49044 Novartis Investigative Site Besançon cedex, France, 25030 Novartis Investigative Site Bobigny, France, 93009 Novartis Investigative Site Bordeaux, France, 33000 Novartis Investigative Site Bordeaux, France, 33100 Novartis Investigative Site Caen, France, 14050 Novartis Investigative Site Cesson Sevigne, France, 35510 Novartis Investigative Site Clermont-ferrand, France, 63014 Novartis Investigative Site Créteil, France, 94000 Novartis Investigative Site Grenoble, France, 38000 Novartis Investigative Site Lille, France, 59037 Novartis Investigative Site Lyon Cedex 04, France, 69317 Novartis Investigative Site Lyon, France, 69007 Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Mantes la joile, France, 78201 Novartis Investigative Site Marseille cedex 05, France, 13385 Novartis Investigative Site Marseille, France, 13008 Novartis Investigative Site Melun, France, 77000 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nice, France, 06000 Novartis Investigative Site Nimes, France, 30029 Novartis Investigative Site Osny, France, 95520 Novartis Investigative Site Paris Cedex 19, France, 75940 Novartis Investigative Site Paris, Cedex 12, France, F-75571 Novartis Investigative Site Paris, France, 75006 Novartis Investigative Site Paris, France, 75007 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Puilboreau, France, 17138 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rouen, France, 76100 Novartis Investigative Site Saint Brieuc, France, 22015 Novartis Investigative Site Saint Etienne, France, 42000 Novartis Investigative Site Saitnt Herblain, France, 44819 Novartis Investigative Site St Jean, France, 31240 Novartis Investigative Site St-Priest-en-Jarez, France, 42270 Novartis Investigative Site Strasbourg, France, 67000 Novartis Investigative Site Toulouse, France, 31077 Novartis Investigative Site Tours, France, 37044 Novartis Investigative Site Vandoeuvre les Nancy, France, 54511 Novartis Investigative Site Vannes, France, 56000 Less <<
NCT01315249 - Completed - -
NCT01313689 - Completed - -
NCT01317615 - Completed - -
NCT01315249 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT01350804 Rheumatoid Arthritis Phase 3 Completed - -
NCT01302860 - Completed - -
NCT01317615 Carcinoma, Large Cell ... More >> Neuroendocrine Tumors Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Bremen, Germany, 28177 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Gauting, Germany, 82131 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Hemer, Germany, 58675 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Leipzig, Germany, 04177 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT01357239 Fragile X Syndrome Phase 2 Completed - -
NCT01356602 - Completed - -
NCT01356602 Acute Gouty Arthritis Phase 3 Completed - -
NCT01357252 Type 2 Diabetes Mellitus Phase 3 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100088 China, Hebei Novartis Investigative Site Shijiazhuang, Hebei, China, 050051 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430070 China, Hunan Novartis Investigative Site Changsha, Hunan, China, 410003 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210006 Novartis Investigative Site Nanjing, Jiangsu, China, 210008 Novartis Investigative Site Nanjing, Jiangsu, China, 210029 Novartis Investigative Site Zhenjiang, Jiangsu, China, 212001 China, Liaoning Novartis Investigative Site ShenYang, Liaoning, China, 110003 China, Shanghai Novartis Investigative Site Shanghai, Shanghai, China China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300211 China Novartis Investigative Site Beijing, China, 100029 Novartis Investigative Site Beijing, China, 100034 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Beijing, China Novartis Investigative Site Guang zhou, China, 510080 Novartis Investigative Site Shanghai, China, 200040 Novartis Investigative Site Shanghai, China, 200233 Less <<
NCT01358175 Ankylosing Spondylitis Phase 3 Completed - -
NCT01350804 - Completed - -
NCT01358578 Chronic Plaque Psoriasis Phase 3 Completed - -
NCT01357239 - Completed - -
NCT00355134 Multiple Sclerosis Phase 3 Completed - -
NCT01362608 Gouty Arthritis Phase 3 Terminated - Argentina ... More >> Novartis Investigative Site Ciudad Autonoma de Bs As, Argentina, C1015ABO China, Anhui Novartis Investigative Site Hefei, Anhui, China, 230001 Novartis Investigative Site Hefei, Anhui, China, 230022 China, Beijing Novartis Investigative Site Beijing, Beijing, China, 100730 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510080 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210029 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 Novartis Investigative Site Chengdu, Sichuan, China, 610072 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310009 China Novartis Investigative Site Beijing, China, 100029 Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Shanghai, China, 200127 Novartis Investigative Site Shanghai, China, 200433 Novartis Investigative Site Wuhan, China, 430022 Poland Novartis Investigative Site Katowice, Poland, 40-084 Novartis Investigative Site Poznan, Poland, 60-773 Novartis Investigative Site Wroclaw, Poland, 50-349 Singapore Novartis Investigative Site Singapore, Singapore, 119074 Novartis Investigative Site Singapore, Singapore, 529889 Less <<
NCT01358175 - Completed - -
NCT01358578 - Completed - -
NCT01362608 - Terminated - -
NCT00718562 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Niigata-city, Niigata, Japan, 951-8520 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT01365481 - Completed - -
NCT00355134 - Completed - -
NCT01365481 Hypertension ... More >>Chronic Kidney Disease Less << Phase 3 Completed - Colombia ... More >> Novartis Investigative Site Bucaramanga, Santander, Colombia, 0001 Novartis Investigative Site Barranquilla, Colombia Novartis Investigative Site Cali, Colombia Finland Novartis Investigative Site Helsinki, Finland, 00029 Germany Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Cottbus, Germany, 03048 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Rostock, Germany, 18107 Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Philippines Novartis Investigative Site Manila, Philippines, 1000 Novartis Investigative Site Quezon City, Philippines, 1100 Novartis Investigative Site Quezon City, Philippines, 1101 Poland Novartis Investigative Site Warszawa, Poland, 04-154 Romania Novartis Investigative Site Cluj-Napoca, Jud Cluj, Romania Novartis Investigative Site Tg. Mures, jud Mures, Romania, 540104 Novartis Investigative Site Timisoara, jud. Timis, Romania, 300011 Novartis Investigative Site Bucuresti, Romania, 041451 Novartis Investigative Site Bucuresti, Romania, 20395 Novartis Investigative Site Iasi, Romania, 700309 Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420012 Novartis Investigative Site Moscow, Russian Federation, 119991 Novartis Investigative Site Moscow, Russian Federation, 125315 Novartis Investigative Site Moscow, Russian Federation, 127412 Novartis Investigative Site Voronezh, Russian Federation, 394036 Singapore Novartis Investigative Site Singapore, Singapore, 119074 Novartis Investigative Site Singapore, Singapore, 229899 Less <<
NCT00718861 Post-menopausal Osteoporosis Phase 3 Completed - -
NCT00903175 Renal Cell Carcinoma Phase 2 Completed - -
NCT00718861 - Completed - -
NCT00720941 Carcinoma, Renal Cell Phase 3 Active, not recruiting June 30, 2019 -
NCT00731224 Alzheimer's Disease Phase 4 Completed - -
NCT00720941 - Active, not recruiting - -
NCT00731692 Primary Progressive Multiple S... More >>clerosis Less << Phase 3 Terminated(The extension study... More >> was terminated early after the results of the core study showed the study did not meet primary endpoint; confirmed disability progression) Less << - -
NCT00903175 - Completed - -
NCT00873041 Non-transfusion Dependent Thal... More >>assemia Less << Phase 2 Completed - United States, California ... More >> Children's Hospital & Research Center Oakland Oakland, California, United States, 94609-1809 United States, Illinois Children's Memorial Hospital/Division of Hematology/Oncology Chicago, Illinois, United States, 60614-3394 United States, New York New York Presbyterian Hospital/Weill Medical College of Cornell University New York, New York, United States, 10021 Greece Novartis Investigative Site Athens, Greece Novartis Investigative Site Patras, Greece Novartis Investigative Site Thessaloniki, Greece Italy Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Genova, Italy Novartis Investigative Site Milano, Italy Novartis Investigative Site Napoli, Italy Novartis Investigative Site Rome, Italy Lebanon Novartis Investigative Site Beirut, Lebanon Malaysia Novartis Investigative Site Ampang Selangor, Malaysia Novartis Investigative Site Kuala Lumpur, Malaysia Taiwan Novartis Investigative Site Taipei, Taiwan Thailand Novartis Investigative Site Bangkok, Thailand Turkey Novartis Investigative Site Adana, Turkey Novartis Investigative Site Ankara, Turkey Novartis Investigative Site Istanbul, Turkey Novartis Investigative Site Izmir, Turkey United Kingdom Novartis Investigative Site London, United Kingdom Less <<
NCT00731692 - Terminated(The extension study... More >> was terminated early after the results of the core study showed the study did not meet primary endpoint; confirmed disability progression) Less << - -
NCT00873041 - Completed - -
NCT00441155 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 France Novartis Investigative Site Lyon Cedex, France, 69373 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less <<
NCT02154776 Advanced or Metastatic Breast ... More >>Cancer Less << Phase 1 Completed - United States, California ... More >> University of California at Los Angeles UCLA SC Los Angeles, California, United States, 90095 United States, Indiana Horizon Oncology Center SC Lafayette, Indiana, United States, 47905 United States, South Carolina Medical University of South Carolina SC Charleston, South Carolina, United States, 29425 United States, Texas South Texas Accelerated Research Therapeutics SC San Antonio, Texas, United States, 78922 United States, Utah University of Utah / Huntsman Cancer Institute SC-3 Salt Lake City, Utah, United States, 84103 Spain Novartis Investigative Site Madrid, Spain, 28007 Less <<
NCT00748189 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 3 Completed - -
NCT00751036 - Terminated - -
NCT00940602 Myelodysplastic Syndromes Phase 2 Completed - -
NCT00748189 - Completed - -
NCT00756509 Gastrointestinal Stromal Tumor... More >>s Less << Phase 4 Active, not recruiting December 31, 2019 Finland ... More >> Novartis Investigative Site HUS, Finland, FIN-00029 France Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Bad Saarow, Germany, 15526 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Muenchen, Germany, 81377 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Spain Novartis Investigative Site Hospitalet de LLobregat, Cataluña, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46009 Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 Less <<
NCT00760877 CHRONIC MYELOGENOUS LEUKEMIA Phase 3 Completed - -
NCT00946647 Myelodysplastic Syndromes ... More >> Chronic Myelomonocytic Leukemia Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting June 13, 2019 -
NCT00958841 Pancreatic Neoplasm ... More >> Pituitary Neoplasm Nelson Syndrome Ectopic ACTH Syndrome Less << Phase 2 Terminated(Slow recruitment ra... More >>te into this study with rare tumors of neuroendocrine origin (enrollment issues)) Less << - -
NCT00958971 Metastatic Breast Cancer Phase 2 Completed - -
NCT00786812 Chronic Myeloid Leukemia Phase 4 Completed - Brazil ... More >> Novartis Investigative Site Belo Horizonte, MG, Brazil, 30130-100 Novartis Investigative Site Curitiba, PR, Brazil, 80060-900 Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20230-130 Novartis Investigative Site Porto Alegre, RS, Brazil, 90035-903 Novartis Investigative Site Campinas, SP, Brazil, 13083-970 Novartis Investigative Site Jaú, SP, Brazil, 17210-080 Novartis Investigative Site Ribeirao Preto, SP, Brazil, 14048-900 Novartis Investigative Site São Paulo, SP, Brazil, 01401-901 Novartis Investigative Site São Paulo, SP, Brazil, 05403-000 Less <<
NCT00958841 - Terminated(Slow recruitment ra... More >>te into this study with rare tumors of neuroendocrine origin (enrollment issues)) Less << - -
NCT00799266 Osteoporosis Phase 3 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Laeken, Belgium, 1020 Canada, Alberta Novartis Investigative Site Calgary, Alberta, Canada, T3B 6A8 Novartis Investigative Site Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V6H 3V4 Canada, Manitoba Novartis Investigative Site Winnipeg, Manitoba, Canada, R3E 0Z2 Canada, Nova Scotia Novartis Investigative Site Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8N 3Z5 Novartis Investigative Site Ottawa, Ontario, Canada, K1H 8L1 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3H 1P3 Novartis Investigative Site Montreal, Quebec, Canada, H3T 1C5 Finland Novartis Investigative Site Helsinki, Finland, FIN-00029 Hungary Novartis Investigative Site Budapest, Hungary, 1085 Romania Novartis Investigative Site Bucharest, Romania, 011461 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 119991 Novartis Investigative Site Saint-Petersburg, Russian Federation, 195067 South Africa Novartis Investigative Site Soweto, Gauteng, South Africa, 2013 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B4 6NH Novartis Investigative Site Manchester, United Kingdom, M14 0JH Less <<
NCT00790816 Neoplasms, Breast Phase 1 Completed - -
NCT00788931 HER-2 Positive Breast Cancer ... More >> Metastatic Breast Cancer Less << Phase 1 Completed - United States, Alabama ... More >> Novartis Investigative Site Mobile, Alabama, United States, 36688 Australia, South Australia Novartis Investigative Site Woodville, South Australia, Australia, 5011 Belgium Novartis Investigative Site Bruxelles, Belgium, 1000 Novartis Investigative Site Liege, Belgium, 4000 Italy Novartis Investigative Site Macerata, MC, Italy, 62100 Novartis Investigative Site Aviano, PN, Italy, 33081 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Less <<
NCT00983060 Chronic Hepatitis C Genotype-1... More >> Relapse Less << Phase 2 Completed - United States, California ... More >> Research and Education Inc. San Diego, California, United States, 92105 United States, Florida Orlando Clinical Research Center Orlando, Florida, United States, 32809 University Hepatitis Center Sarasota, Florida, United States, 34243 West Wind'r Research & Development LLC Tampa, Florida, United States, 33607 United States, Texas Alamo Medical Research San Antonio, Texas, United States, 78215 Australia, New South Wales Novartis Investigative Site Clayton, New South Wales, Australia Novartis Investigative Site Westmead, New South Wales, Australia Australia, South Australia Novartis Investigative Site Wentworthville, South Australia, Australia Belgium Novartis Investigative Site Brussels, Belgium Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Frankfurt, Germany Puerto Rico Fundacion de Investigacion de Diego San Juan, Puerto Rico, 00909 Spain Novartis Investigative Site Barcelona, Spain Novartis Investigative Site Sevilla, Spain Taiwan Novartis Investigative Site Taipei, ROC, Taiwan Novartis Investigative Site Kaohsiung, Taiwan Less <<
NCT00802841 - Completed - -
NCT00751036 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Terminated - -
NCT00866281 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Terminated(Despite considerabl... More >>e efforts to boost recruitment during the final year of the study, no new patients were enrolled.) Less << - United States, Washington ... More >> Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States, 98105 France Novartis Investigative Site Paris Cedex 19, France, 75935 Italy Novartis Investigative Site Genova, GE, Italy, 16147 Novartis Investigative Site Monza, MB, Italy, 20900 Novartis Investigative Site Roma, RM, Italy, 00165 Novartis Investigative Site Torino, TO, Italy, 10126 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 GJ Sweden Novartis Investigative Site Stockholm, Sweden, SE-171 76 Less <<
NCT00866281 - Terminated(Despite considerabl... More >>e efforts to boost recruitment during the final year of the study, no new patients were enrolled.) Less << - -
NCT00802841 Chronic Myelogenous Leukemia Phase 3 Completed - -
NCT00545272 Asthma Phase 2 Completed - -
NCT00809159 - Completed - -
NCT00760877 - Completed - -
NCT01007942 HER2/Neu Over-expressing Local... More >>ly Advanced Breast Cancer Metastatic Breast Cancer Less << Phase 3 Completed - -
NCT00809159 Ankylosing Spondylitis Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Paradise Valley, Arizona, United States, 85253 United States, Illinois Novartis Investigative Site Springfield, Illinois, United States, 62703 Novartis Investigative Site Springfield, Illinois, United States, 62704 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Novartis Investigative Site Duncansville, Pennsylvania, United States, 16635 United States, South Carolina Novartis Investigative Site North Charleston, South Carolina, United States, 29406 United States, Tennessee Novartis Investigative Site Jackson, Tennessee, United States, 38305 Novartis Investigative Site Knoxville, Tennessee, United States, 37909 United States, Texas Novartis Investigative Site Benbrook, Texas, United States, 76126 United States, Washington Novartis Investigative Site Spokane, Washington, United States, 99204 Germany Novartis Investigative Site Berlin, Germany, 12200 Novartis Investigative Site Hamburg, Germany, 22081 Novartis Investigative Site Herne, Germany, 44649 Novartis Investigative Site Munchen, Germany, D-80639 Netherlands Novartis Investigative Site Meerssen, KR, Netherlands, 6231 Novartis Investigative Site Amstedam, Netherlands, 22700 Novartis Investigative Site Maastricht, Netherlands, 5800 United Kingdom Novartis Investigative Site Leeds, United Kingdom, LS7 4SA Novartis Investigative Site Newcastle upon Tyne, United Kingdom, NE2 4HH Novartis Investigative Site Oxford, United Kingdom, OX3 7LD Less <<
NCT01007942 - Completed - -
NCT00820222 Metastases, Brain Phase 3 Completed - -
NCT00820222 - Completed - -
NCT01237236 Advanced Solid Tumor ... More >> Lymphomas Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States, +1 48109 0944 United States, New York Memorial Sloan Kettering MSKCC (2) New York, New York, United States, 10017 United States, Tennessee Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Villejuif Cedex, France, 94805 Netherlands Novartis Investigative Site Utrecht, Netherlands, 3584CX Less <<
NCT00699166 Irritable Bowel Syndrome Phase 2 Completed - -
NCT00545272 - Completed - -
NCT00824265 - Completed - -
NCT01023308 Multiple Myeloma Phase 3 Completed - -
NCT00820911 Kidney Transplantation Phase 2 Completed - -
NCT01023308 - Completed - -
NCT01028222 - Completed - -
NCT00845728 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00846989 Glaucoma Ocul... More >>ar Hypertension Less << Phase 1 Phase 2 Completed - -
NCT01028222 Melanoma Phase 2 Completed - -
NCT01362621 - Completed - -
NCT01034163 - Completed - -
NCT00845728 - Completed - -
NCT01035229 - Completed - -
NCT01034163 Hodgkin's Lymphoma Phase 3 Completed - -
NCT01302886 Smoldering Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute SC - 3 Tampa, Florida, United States, 33612 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Indiana Univ Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute DFCI (2) Boston, Massachusetts, United States, 02115 United States, Missouri Washington University School of Medicine Dept. of WUSTL St. Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Multiple Myeloma Division Hackensack, New Jersey, United States, 07601 United States, New York Mount Sinai School of Medicine Mt Sinai New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Duke SC Durham, North Carolina, United States, 27710 United States, Washington Fred Hutchinson Cancer Research Center Fred Hutchinson Seattle, Washington, United States, 98109 France Novartis Investigative Site LILLE Cedex, France, 59037 Germany Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Würzburg, Germany, 97080 Less <<
NCT00853658 Chronic Heart Failure Phase 3 Completed - -
NCT00862979 Heart Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigative Site Bad Oeynhausen, Germany, 32545 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Leipzig, Germany, 04289 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 81377 Novartis Investigative Site Regensburg, Germany, 93053 Less <<
NCT01044186 Transfusional Iron Overload Phase 2 Completed - United States, California ... More >> Children's Hospital and Research Center - Oakland Oakland, California, United States, 94609 Children's Hospital of Orange County Orange, California, United States, 92868 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, New York Queens Hospital Center Jamaica, New York, United States, 11432 New York Presbyterian Hospital/Weill Medical College of Cornell University New York, New York, United States, 10021 New York Methodist Hospital New York, New York, United States, 11215 United States, Ohio Cincinnatti Children's Hospital Medical center Cincinnatti, Ohio, United States, 45229 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Greece Novartis investigative Site Athens, Greece Italy Novartis Investigative Site Ancona, Italy Novartis Investigative Site Brindisi, Italy Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Cosenza, Italy Novartis Investigative Site Firenze, Italy Novartis Investigative Site Milano, Italy Novartis Investigative Site Modena, Italy Novartis Investigative Site Napoli, Italy Novartis Investigative Site Torino, Italy Less <<
NCT01035229 Carcinoma Phase 3 Completed - -
NCT01103037 Asthma Phase 2 Terminated(Terminated by spons... More >>or) Less << - United States, California ... More >> West Coast Clinical Trials Cypress, California, United States, 90630 United States, North Carolina American Health Research Charlotte, North Carolina, United States, 28207 North Carolina Clinical Research Raleigh, North Carolina, United States, 27607 Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Wiesbaden, Germany Russian Federation Novartis Investigative Site Moscow, Russian Federation Less <<
NCT00824265 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 3 Completed - -
NCT00866697 Ovarian Cancer Phase 3 Completed - -
NCT00876694 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - Japan ... More >> Novartis Investigator Site Asahikawa, Japan Novartis Investigator Site Bunkyo-ku, Japan Novartis Investigator Site Gifu, Japan Novartis Investigator Site Hamamatsu, Japan Novartis Investigator Site Himeji, Japan Novartis Investigator Site Hiroshima, Japan Novartis Investigator Site Iwata, Japan Novartis Investigator Site Kanazawa, Japan Novartis Investigator Site Kasaoka, Japan Novartis Investigator Site Kawasaki, Japan Novartis Investigator Site Kishiwada, Japan Novartis Investigator Site Kitakyushu, Japan Novartis Investigator Site Kochi, Japan Novartis Investigator Site Koga, Japan Novartis Investigator Site Kurume, Japan Novartis Investigator Site Kyoto, Japan Novartis Investigator Site Maebashi, Japan Novartis Investigator Site Matsusaka-city, Japan Novartis Investigator Site Morioka, Japan Novartis Investigator Site Nagaoka-city, Japan Novartis Investigator Site Nagoya, Japan Novartis Investigator Site Naka-gun, Japan Novartis Investigator Site Noda, Japan Novartis Investigator Site Obihiro, Japan Novartis Investigator Site Sakai, Japan Novartis Investigator site Sapporo, Japan Novartis Investigator Site Sendai, Japan Novartis Investigator Site Setagaya-ku, Japan Novartis Investigator Site Sumida-ku, Japan Novartis Investigator Site Tenri, Japan Novartis Investigator Site Tokyo, Japan Novartis Investigator Site Ube, Japan Novartis Investigator Site Wakayama, Japan Novartis Investigator Site Yabu, Japan Novartis Investigator Site Yanagawa, Japan Novartis Investigator Site Yokkaichi, Japan Novartis Investigator Site Yokohama, Japan Less <<
NCT00862979 - Completed - -
NCT01058434 Relapsed or Refractory Multipl... More >>e Myeloma Less << Phase 2 Completed - -
NCT00881205 Multiple Sclerosis ... More >> Cognitive Impairment Less << Phase 4 Terminated(Termination of stud... More >>y due to low enrollment) Less << - -
NCT00881205 - Terminated(Termination of stud... More >>y due to low enrollment) Less << - -
NCT00894868 Congestive Heart Failure ... More >> Type II Diabetes Mellitus Less << Phase 4 Completed - -
NCT00891046 - Completed - -
NCT00902174 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - -
NCT00853658 - Completed - -
NCT00891046 Systemic Juvenile Idiopathic A... More >>rthritis Less << Phase 3 Completed - -
NCT00876694 - Completed - -
NCT01084330 Advanced Gastric Cancer ... More >> Gastro-esophageal Junction Cancer Less << Phase 2 Completed - -
NCT00902174 - Completed - -
NCT00877383 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00877383 - Completed - -
NCT00866697 - Completed - -
NCT00918957 Cystic Fibrosis Phase 3 Completed - Bulgaria ... More >> Novartis Investigative Site Pleven, Bulgaria Novartis Investigative Site Plovdiv, Bulgaria Novartis Investigative Site Sofia, Bulgaria Novartis Investigative Site Varna, Bulgaria Egypt Novartis Investigative Site Alexandria, Egypt Novartis Investigative Site Giza, Egypt Estonia Novartis Investigative Site Tallin, Estonia Novartis Investigative Site Tartu, Estonia India Novartis Investigative Site Chandigarh, India Novartis Investigative Site Hyderabad, India Novartis Investigative Site New Delhi, India Novartis Investigative Site Vellore, India Latvia Novartis Investigative Site Riga, Latvia Lithuania Novartis Investigative Site Kaunas, Lithuania Novartis Investigative Site Vilnius, Lithuania Romania Novartis Investigative Site Bucuresti, Romania Novartis Investigative Site Timisoara, Romania Russian Federation Novartis Investigative Site Kazan, Russian Federation Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site Saint Petersburg, Russian Federation Novartis Investigative Site Samara, Russian Federation Novartis Investigative Site Voronezh, Russian Federation Novartis Investigator Site Yaroslavi, Russian Federation South Africa Novartis Investigative Site Durban, South Africa Less <<
NCT00923156 Heart Failure Phase 2 Completed - Germany ... More >> Novartis Investigator Site Bad Krozingen, Germany, 79189 Novartis Investigator Site Berlin, Germany, 12207 Novartis Investigator Site Berlin, Germany, 13353 Novartis Investigator Site Göttingen, Germany, 37057 Novartis Investigator Site Jena, Germany, 07747 Novartis Investigator Site München, Germany, 80336 Poland Novartis Investigator Site Krakow, Poland, 31-501 Novartis Investigator Site Lublin, Poland, 20-090 Novartis Investigator Site Poznan, Poland, 61-848 Novartis Investigator Site Warszawa, Poland, 02-507 Novartis Investigator Site Wroclaw, Poland, 50-981 Russian Federation Novartis Investigator Site Moscow, Russian Federation, 117292 Novartis Investigator Site Moscow, Russian Federation, 119620 Novartis Investigator Site Moscow, Russian Federation, 121309 Novartis Investigator Site Moscow, Russian Federation, 121552 Novartis Investigative Site Moscow, Russian Federation Less <<
NCT00918957 - Completed - -
NCT00928512 Rheumatoid Arthritis Phase 2 Completed - -
NCT00907894 Chronic Hepatitis B Phase 1 Completed - Belgium ... More >> Novartis Investigative Site Brussels, Belgium Germany Novartis Investigator Site Frankfurt, Germany Novartis Investigator Site Starnberg, Germany Novartis Investigator Site Wuppertal, Germany Philippines Novartis Investigator Site Manila, Philippines Novartis Investigator Site Quezon City, Philippines United Kingdom Novartis Investigator Site Birmingham, United Kingdom Less <<
NCT00928512 - Completed - -
NCT01160822 - Completed - -
NCT00938860 Hepatitis C L... More >>iver Transplantation Less << Phase 4 Completed - -
NCT00923156 - Completed - -
NCT00938860 - Completed - -
NCT00941031 Chronic Plaque-type Psoriasis Phase 2 Completed - -
NCT00934544 Myelofibrosis Phase 3 Completed - -
NCT00934544 - Completed - -
NCT00941031 - Completed - -
NCT01132664 Metastatic Breast Cancer ... More >> HER2+ Breast Cancer Less << Phase 1 Phase 2 Terminated(Due to the rare pat... More >>ient population and challenges to enroll patients.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI Birmingham, Alabama, United States, 35294-0006 United States, Arkansas Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Michigan Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States, 48201 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr WA Siteman St. Louis, Missouri, United States, 63110 United States, New York Beth Israel Medical Center BIMC New York, New York, United States, 10003 United States, Tennessee Sarah Cannon Research Institute Sarah Cannon Cancer Center SC Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Italy Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Macerata, MC, Italy, 62100 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Terni, TR, Italy, 05100 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 United Kingdom Novartis Investigative Site Brighton, East Sussex, United Kingdom, BN2 5BE Novartis Investigative Site Nottingham, United Kingdom, NG5 1PB Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Less <<
NCT00941798 - Completed - -
NCT00941798 Asthma Phase 2 Completed - -
NCT00956293 - Terminated(The study was termi... More >>nated because the required sample size of 240-260 de novo senior renal transplant patients was not achieved within a reasonable time.) Less << - -
NCT01160822 Osteoarthritis Phase 2 Completed - United States, Alabama ... More >> Pinnacle Research Group, LLC Anniston, Alabama, United States, 36207 United States, Arizona Arizona Arthritis & Rheumatology Research, PLLC Mesa, Arizona, United States, 85202 United States, California San Diego Arthritis & Osteoporosis Medical Clinic San Diego, California, United States, 92108 Westlake Medical Research Westlake Village, California, United States, 91361 United States, Illinois Rush-Presbyterian St. Lukes Medical Center Chicago, Illinois, United States, 60612 United States, Kansas Cotton O'Neil Clinical Research Institute Topeka, Kansas, United States, 66606 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Tennessee Volunteer Research Group Knoxville, Tennessee, United States, 37920 Finland Novartis Investigative site Helsinki, Finland Novartis Investigative site Kuopio, Finland France Novartis Investigative site Creteil, France Germany Novartis Investigative site Berlin, Germany Novartis Investigative site Erlangen, Germany Less <<
NCT00956293 Renal Transplantation Phase 4 Terminated(The study was termi... More >>nated because the required sample size of 240-260 de novo senior renal transplant patients was not achieved within a reasonable time.) Less << - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kaiserslautern, Germany, 67655 Novartis Investigative Site Koeln-Merheim, Germany, 51109 Novartis Investigative Site München, Germany, 81377 Less <<
NCT01125800 Medulloblastoma ... More >> Rhabdomyosarcoma Neuroblastoma Hepatoblastoma Glioma Astrocytoma Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Children's Healthcare of Atlanta Childern Hosp - ATL Atlanta, Georgia, United States, 30342 United States, Maryland Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana Farber Cancer Institute DFCI (3) Boston, Massachusetts, United States, 02115 United States, Washington Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States, 98105 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3052 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Paris, France, 75231 Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Bologna, BO, Italy, 40139 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Roma, RM, Italy, 00168 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Less <<
NCT00968968 Cancer Phase 3 Completed - -
NCT01125800 - Completed - -
NCT00509990 Atopic Dermatitis Phase 4 Completed - Mexico ... More >> Novartis Investigative Site Mexico, Mexico Novartis Investigative Site Monterrey, Mexico Novartis Investigative Site Puebla, Mexico Venezuela Novartis Investigative Site Aragua, Venezuela Novartis Investigative Site, Edo Carabobo, Venezuela Novartis Investigative Site Caracas, Venezuela Less <<
NCT01080131 - Completed - -
NCT00975715 Partial Onset Seizures Phase 2 Phase 3 Completed - Japan ... More >> Novartis Investigative Site Nagoya-shi, Aichi, Japan, 460-0004 Novartis Investigative Site Ohbu, Aichi, Japan, 474-0031 Novartis Investigative Site Matsuyama, Ehime, Japan, 790-8524 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 814-0180 Novartis Investigative Site Kameda-gun, Hokkaido, Japan, 041-1111 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji, Hyogo, Japan, 670-8540 Novartis Investigative Site Kobe, Hyogo, Japan, 658-0032 Novartis Investigative Site Yokohama, Kanagawa, Japan, 244-0842 Novartis Investigative Site Koshi-city, Kumamoto, Japan, 861-1196 Novartis Investigative Site Kashiwazaki, Niigata, Japan, 945-8585 Novartis Investigative Site Yufu, Oita, Japan, 879-5593 Novartis Investigative Site Kurashiki, Okayama, Japan, 710-8522 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Neyagawa, Osaka, Japan, 572-0085 Novartis Investigative Site Higashimatsuyama-shi, Saitama, Japan, 355-0008 Novartis Investigative Site Moriyama-shi, Shiga, Japan, 524-0022 Novartis Investigative Site Shimotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Chuo-city, Yamanashi, Japan, 409-3898 Novartis Investigative Site Gifu, Japan, 502-8558 Novartis Investigative Site Niigata, Japan, 950-2085 Novartis Investigative Site Saitama, Japan, 339-8551 Novartis Investigative Site Shizuoka, Japan, 420-8688 Novartis Investigative Site Yamagata, Japan, 990-0876 Less <<
NCT01132664 - Terminated(Due to the rare pat... More >>ient population and challenges to enroll patients.) Less << - -
NCT00975715 - Completed - -
NCT00995930 Diabetes Mellitus, Type 2 ... More >> Atherosclerosis Prediabetic State Less << Phase 2 Completed - United States, New York ... More >> Novartis Investigative Site New York, New York, United States, 10029 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45219 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 1C8 Germany Novartis Investigative Site Mainz, Germany, 55116 Novartis Investigative Site Neuss, Germany, 41460 Novartis Investigative Site Ulm, Germany, 89081 Israel Novartis Investigative Site Jerusalem, Israel, 91120 United Kingdom Novartis Investigative Site Oxford, UK, United Kingdom, OX2 6HE Novartis Investigative Site London, United Kingdom, EC1M 6BQ Less <<
NCT01080131 Acute Gout Phase 3 Completed - -
NCT01032915 - Terminated(Results of a planne... More >>d interim analysis did not show significant effects for any of the 3 AIN dose regimens versus placebo on any primary or secondary endpoint) Less << - -
NCT00995930 - Completed - -
NCT00995709 Behcet Disease Phase 3 Completed - -
NCT00995709 - Completed - -
NCT00999908 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Italy ... More >> Novartis Investigative Site Bergamo, Italy Novartis Investigative Site Brescia, Italy Novartis Investigative Site Cava De' Tirreni, Italy Novartis Investigative Site Genova, Italy Novartis Investigative Site Milano, Italy Novartis Investigative Site Orbassano, Italy Novartis Investigative Site Pavia, Italy Novartis Investigative Site Reggio Emilia, Italy Novartis Investigative Site Sesto San Giovanni, Italy Novartis Investigative Site Treviso, Italy Novartis Investigative Site Verona, Italy Less <<
NCT01032915 Non-infectious Uveitis Phase 3 Terminated(Results of a planne... More >>d interim analysis did not show significant effects for any of the 3 AIN dose regimens versus placebo on any primary or secondary endpoint) Less << - -
NCT01240655 Solid Tumors Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute SC Boston, Massachusetts, United States, 02215 United States, North Carolina University of North Carolina Lineberger Comp Cancer Ctr Chapel Hill, North Carolina, United States, 27514 United States, Tennessee Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States, 37203 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 1L3 Italy Novartis Investigative Site Modena, MO, Italy, 41100 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Less <<
NCT00999908 - Completed - -
NCT01007149 Asthma Phase 3 Completed - France ... More >> Novartis Investigative Site Arnaud de Villeneuve, France Novartis Investigative Site Bethune, France Novartis Investigative Site Bordeaux, France Novartis Investigative Site Clamart, France Novartis Investigative Site Lyon, France Novartis Investigative Site Nantes, France Novartis Investigative Site Paris, France Novartis Investigative Site Strasbourg, France Novartis Investigative Site Suresnes, France Novartis Investigative Site Toulouse, France Less <<
NCT01007149 - Completed - -
NCT01012765 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Aschaffenburg, Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Dresden, Germany Novartis Investigative Site Erfurt, Germany Novartis Investigative site Frankfurt am Main, Germany Novartis Investigative Site Fulda, Germany Novartis Investigative Site Geesthacht, Germany Novartis Investigative Site Großhansdorf, Germany Novartis Investigative Site Halle, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Kiel, Germany Novartis Investigative Site Koblenz, Germany Novartis Investigative site Leipzig, Germany Novartis Investigative Site Mannheim, Germany Novartis Investigative Site Marburg, Germany Novartis Investigative Site Neumünster, Germany Novartis Investigative Site Potsdam, Germany Novartis Investigative Site Rathenow, Germany Novartis Investigative Site Rüdersdorf, Germany Novartis Investigator Site Witten, Germany Novartis Investigative Site Zerbst, Germany Less <<
NCT01004224 Advanced Solid Tumors With Alt... More >>erations of FGFR1, 2 and or 3 Squamous Lung Cancer With FGFR1 Amplification Bladder Cancer With FGFR3 Mutation or Fusion Advanced Solid Tumors With FGFR1 Amplication Advanced Solid Tumors With FGFR2 Amplication Advanced Solid Tumors With FGFR3 Mutation Less << Phase 1 Completed - -
NCT01155453 Advanced and Selected Solid Tu... More >>mors Less << Phase 1 Completed - United States, California ... More >> University of California at Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States, 90095 United States, Texas University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8) Houston, Texas, United States, 77030-4009 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Bellinzona, Switzerland, 6500 Less <<
NCT01017029 Cardiac Transplantation Phase 4 Completed - Italy ... More >> Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Milano, MI, Italy, 20162 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Roma, RM, Italy, 00152 Novartis Investigative Site Siena, SI, Italy, 53100 Novartis Investigative Site Torino, TO, Italy, 10126 Novartis Investigative Site Udine, UD, Italy, 33100 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Napoli, Italy, 80131 Less <<
NCT01012765 - Completed - -
NCT01242774 Acute Myeloid Leukemia (AML) Phase 1 Completed - United States, California ... More >> Stanford University Medical Center Stanford U Stanford, California, United States, 94304 United States, Massachusetts Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02115 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina -Hollings Cancer Center MUSC/HCC (2) Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3 Nashville, Tennessee, United States, 37212 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Ulm, Germany, 89081 Spain Novartis Investigative Site Salamanca, Castilla y Leon, Spain, 37007 Novartis Investigative Site Barcelona, Spain, 08025 Less <<
NCT01017029 - Completed - -
NCT01019473 Huntington's Disease ... More >> Chorea Less << Phase 2 Terminated - Germany ... More >> Novartis Investigator Site Berlin, Germany Novartis Investigator Site Bochum, Germany Novartis Investigator Site Munster, Germany Novartis Investigator Site Taufkirchen, Germany Novartis Investigator Site Tubingen, Germany Novartis Investigator Site Ulm, Germany United Kingdom Novartis Investigator Site Birmingham, United Kingdom Novartis Investigator Site Cardiff, United Kingdom Novartis Investigator Site Manchester, United Kingdom Novartis Investigator Site Oxford, United Kingdom Less <<
NCT01077544 - Completed - -
NCT01077544 Chronic Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 1 Completed - United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie Chicago, Illinois, United States, 60611 Brazil Novartis Investigative Site Barretos, SP, Brazil, 14784-400 Novartis Investigative Site Sao Paulo, SP, Brazil Novartis Investigative Site São Paulo, SP, Brazil, 08270-070 France Novartis Investigative Site Bordeaux, Aquitaine, France, 33076 Novartis Investigative Site Lille cedex, France, 59037 Novartis Investigative Site Paris, France, 75571 Novartis Investigative Site Poitiers, France, 86021 Italy Novartis Investigative Site Monza, MB, Italy, 20900 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Roma, RM, Italy, 00161 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Rotterdam, Netherlands, 3015 GJ Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117997 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Birmingham, United Kingdom, B4 6NH Novartis Investigative Site Bristol, United Kingdom, BS2 8BJ Less <<
NCT01029652 Acute Gout Phase 3 Completed - -
NCT01025817 - Completed - -
NCT01034657 Myelodysplastic Syndrome (MDS) Phase 2 Terminated(The study was termi... More >>nated due to lack of efficacy of single agent LBH589 in the 4 month open label core phase and due to enrollment difficulties.) Less << - Germany ... More >> Novartis Investigative Site Mannheim, Baden-Württemberg, Germany, 68305 Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Duisburg, Germany, 47166 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Goettingen, Germany, 37075 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Ulm, Germany, 89081 Less <<
NCT01013740 Cancer Phase 2 Completed - -
NCT01034657 - Terminated(The study was termi... More >>nated due to lack of efficacy of single agent LBH589 in the 4 month open label core phase and due to enrollment difficulties.) Less << - -
NCT01029652 - Completed - -
NCT01223027 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT01035255 Heart Failure With Reduced Eje... More >>ction Fraction Less << Phase 3 Terminated(Early termination w... More >>as approved due to compelling efficacy of LCZ696 in patients with HF & reduced EF after final pre-specified interim analysis 28-Mar-2014.) Less << - -
NCT03123939 - - - Austria ... More >> Novartis Investigative Site Vienna, Austria, A-1090 Belgium Novartis Investigative Site Gent, Belgium, 9000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 Spain Novartis Investigative Site Esplugues de Llobregat, Barcelona, Spain, 08950 Less <<
NCT01025817 Kidney Transplant Phase 3 Completed - -
NCT01338831 Castration-resistant Prostate ... More >>Cancer Metastatic Breast Cancer Uterine Leiomyoma Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Mass Gen 3 Boston, Massachusetts, United States, 02114 United States, New Jersey Cancer Institute of New Jersey SC New Brunswick, New Jersey, United States, 08901 United States, Pennsylvania Thomas Jefferson University, Dept. of Phsyciatry & Neurology Thomas Jefferson Philadelphia, Pennsylvania, United States, 19107 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman 3 Salt Lake City, Utah, United States, 84103 United States, Wisconsin University of Wisconsin Clinical Science Center Madison, Wisconsin, United States, 53792 Belgium Novartis Investigative Site Bruxelles, Belgium, 1000 Novartis Investigative Site Bruxelles, Belgium, 1200 Italy Novartis Investigative Site Modena, MO, Italy, 41100 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT01039376 - Completed - -
NCT01035255 - Terminated(Early termination w... More >>as approved due to compelling efficacy of LCZ696 in patients with HF & reduced EF after final pre-specified interim analysis 28-Mar-2014.) Less << - -
NCT01039376 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 3 Completed - -
NCT01051817 Relapsing-remitting Multiple S... More >>clerosis RRMS Less << Phase 2 Completed - Czech Republic ... More >> Novartis Investigative Site Hradec Kralove, Czech Republic, 500 05 Novartis Investigative Site Ostrava-Moravska Ostrava, Czech Republic Novartis Investigative Site Ostrava, Czech Republic Novartis Investigative Site Praha 10, Czech Republic Novartis Investigative Site Praha 2, Czech Republic, 128 08 Novartis Investigative Site Teplice, Czech Republic, 415 29 Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420021 Novartis Investigative Site Moscow, Russian Federation, 129128 Novartis Investigative Site Nizhny Novgorod, Russian Federation, 603155 Novartis Investigative Site Smolensk, Russian Federation, 214019 Ukraine Novartis Investigative Site Kharkiv, Ukraine, 61068 Novartis Investigative Site Kharkiv, Ukraine Novartis Investigative Site Kiev, Ukraine, 03110 Novartis Investigative Site Kiev, Ukraine Novartis Investigative Site Odessa, Ukraine, 65025 Novartis Investigative Site Vinnitsya, Ukraine, 21005 Less <<
NCT01013740 - Completed - -
NCT01051817 - Completed - -
NCT01223027 - Completed - -
NCT01064310 Carcinoma, Renal Cell Phase 3 Completed - -
NCT01056822 Prophilaxis of Acute Rejection... More >> in Patients Receiving a Renal Allograft Less << Phase 4 Completed - Spain ... More >> Novartis Investigative Site Granada, Andalucia, Spain, 18014 Novartis Investigative Site Oviedo, Asturias, Spain, 33006 Novartis Investigative Site Santander, Cantabria, Spain, 39008 Novartis Investigative Site Toledo, Castilla la Mancha, Spain, 45004 Novartis Investigative Site Valladolid, Castilla y Leon, Spain, 47011 Novartis Investigative Site Barcelona, Catalunya, Spain, 08025 Novartis Investigative Site Barcelona, Cataluña, Spain, 08003 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site Alicante, Comunidad Valenciana, Spain, 03010 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46017 Novartis Investigative Site La Coruna, Galicia, Spain, 15006 Novartis Investigative Site Palma de Mallorca, Islas Baleares, Spain, 07014 Novartis Investigative Site La Laguna, Las Palmas de Gran Canaria, Spain, 38320 Novartis Investigative Site Pamplona, Navarra, Spain, 31080 Novartis Investigative Site Barakaldo, Pais Vasco, Spain, 48903 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain Novartis Investigative Site Zaragoza, Spain, 50009 Less <<
NCT01069705 Pulmonary Infections ... More >> Pseudomonas Aeruginosa Less << Phase 3 Completed - Bulgaria ... More >> Novartis Investigative Site Pleven, Bulgaria Novartis Investigative Site Polvdiv, Bulgaria Novartis Investigative Site Sofia, Bulgaria Novartis Investigative Site Varna, Bulgaria Estonia Novartis Investigative Site Tallin, Estonia Novartis Investigative Site Tartu, Estonia Latvia Novartis Investigative Site Riga, Latvia Lithuania Novartis Investigative Site Kaunas, Lithuania Novartis Investigative Site Vilnius, Lithuania Romania Novartis Investigative Site Bucharest, Romania Novartis Investigative Site Timisoara, Romania Russian Federation Novartis Investigative Site Kazan, Russian Federation Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site Saint Petersburg, Russian Federation Novartis Investigative Site Samara, Russian Federation Novartis Investigative Site Yaroslavl, Russian Federation South Africa Novartis Investigative Site Durban, South Africa Less <<
NCT01056822 - Completed - -
NCT01071252 Chronic Plaque-type Psoriasis Phase 2 Completed - United States, California ... More >> Novartis Investigative Site San Diego, California, United States, 92123 United States, Kentucky Novartis Investigative Site Louisville, Kentucky, United States, 40217 United States, New York Novartis Investigative Site Rochester, New York, United States, 14623 United States, Oregon Novartis Investigative Site Lake Oswego, Oregon, United States, 97035 Novartis Investigative Site Portland, Oregon, United States, 97210 Canada, Nova Scotia Novartis Investigative Site Halifax, Nova Scotia, Canada, B3H 1Z2 Canada, Ontario Novartis Investigative Site North Bay, Ontario, Canada, P1B 3Z7 Novartis Investigative Site Waterloo, Ontario, Canada, N2J 1C4 Estonia Novartis Investigative Site Tallinn, Estonia, 10138 Novartis Investigative Site Tallinn, Estonia, 13419 Novartis Investigative Site Tartu, Estonia, 51014 Iceland Novartis Investigative Site Kopavogur, Iceland, IS-201 Japan Novartis Investigative Site Nagoya-city, Aichi, Japan, 467-8602 Novartis Investigative Site Maebashi-city, Gunma, Japan, 371-8511 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-0063 Novartis Investigative Site Saitama-city, Saitama, Japan, 330-0854 Latvia Novartis Investigative Site Riga, Latvia, 1012 Novartis Investigative Site Riga, Latvia, LV-1001 Novartis Investigative Site Riga, Latvia Less <<
NCT01064310 - Completed - -
NCT01213641 - Completed - United States, Arizona ... More >> Little Rock Allergy and Asthma Clinic Little Rock, Arizona, United States, 72205 United States, Georgia Allergy Center at Brookstone Columbus, Georgia, United States, 31904 United States, Illinois Rush Presbyterian - St. Lukes Medical Center Chicago, Illinois, United States, 60612 Austria Novartis Investigative site Bregenz, Austria Novartis Investigative site Vienna, Austria Germany Novartis Investigative site Dresden, Germany Novartis Investigative site Hamburg, Germany Novartis Investigative site Heidelberg, Germany Novartis Investigative site Herne, Germany Novartis Investigative site Kiel, Germany Novartis Investigative site Schweinfurt, Germany Novartis Investigative site Tuebingen, Germany Norway Novartis Investigative site Oslo, Norway Switzerland Novartis Investigative site Aarau, Switzerland Novartis Investigative site Basel, Switzerland Novartis Investigative site Geneve, Switzerland Novartis Investigative site Lausanne, Switzerland Less <<
NCT01077518 Lymphoma, Follicular Phase 3 Active, not recruiting June 1, 2024 -
NCT01072175 Cancer Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90025 Novartis Investigative Site San Francisco, California, United States, 94115 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Connecticut Novartis Investigative Site New Haven, Connecticut, United States, 06520 United States, Florida Novartis Investigative Site Tampa, Florida, United States, 33612 United States, Maryland Novartis Investigative Site Lutherville-Timonium, Maryland, United States, 21093 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Novartis Investigative Site Nashville, Tennessee, United States, 37232 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Less <<
NCT01080768 - Terminated(Publication of data... More >> from a similar study made the current study redundant.) Less << - -
NCT01080768 Hypertension ... More >>Ankle Edema Less << Phase 2 Terminated(Publication of data... More >> from a similar study made the current study redundant.) Less << - Netherlands ... More >> Novartis Investigative Site Beek en Donk, Netherlands Novartis Investigative Site Bosch, Netherlands Novartis Investigative Site Den Haag, Netherlands Novartis Investigative Site Hoogwoud, Netherlands Novartis Investigative Site Lichtenvoorde, Netherlands Novartis Investigative Site Lieshout, Netherlands Novartis Investigative Site Poortvliet, Netherlands Novartis Investigative Site Utrecht, Netherlands Novartis Investigative Site Wildervank, Netherlands Less <<
NCT01368536 Hypertension ... More >>Stage 2 Hypertension Diabetes Less << Phase 4 Terminated(Based on results fr... More >>om an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment) Less << - -
NCT01071252 - Completed - -
NCT01368536 - Terminated(Based on results fr... More >>om an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment) Less << - -
NCT00549770 Hypertension Phase 2 Completed - -
NCT01377012 Rheumatoid Arthritis Phase 3 Completed - -
NCT01572727 - Completed - -
NCT01377012 - Completed - -
NCT01375179 Ulcerative Colitis Phase 2 Terminated - Belgium ... More >> Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Frankfurt am Main, Germany, 60318 Novartis Investigative Site Hamburg, Germany, 20148 Novartis Investigative Site Köln, Germany, 51103 Hungary Novartis Investigative Site Budapest, Hungary, 1083 Novartis Investigative Site Debrecen, Hungary, 4032 Sweden Novartis Investigative Site Stockholm, Sweden, 116 91 Novartis Investigative Site Stockholm, Sweden, SE-141 86 Novartis Investigative Site Uppsala, Sweden, 751 85 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Novartis Investigative Site Zurich, Switzerland, 8091 United Kingdom Novartis Investigative Site Oxford, Oxfordshire, United Kingdom, OX3 9DU Novartis Investigative Site Nottingham, United Kingdom, NG7 2UH Less <<
NCT01582061 Cushing's Disease Phase 3 Completed - -
NCT01582061 - Completed - -
NCT01379508 Chronic Hepatitis B Phase 4 Completed - Austria ... More >> Novartis Investigative Site Innsbruck, Austria, A-6020 Novartis Investigative Site Wien, Austria, 1090 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1407 Novartis Investigative Site Sofia, Bulgaria, 1413 Novartis Investigative Site Sofia, Bulgaria, 1431 Novartis Investigative Site Sofia, Bulgaria, 1527 Novartis Investigative Site Varna, Bulgaria, 9010 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20099 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Herne, Germany, 44623 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Wurzburg, Germany, 97080 Greece Novartis Investigative Site Alexandroupolis, Evros, Greece, 681 00 Novartis Investigative Site Athens, GR, Greece, 115 21 Novartis Investigative Site Thessaloniki, GR, Greece, 546 42 Novartis Investigative Site Athens, Greece, 115 27 Italy Novartis Investigative Site Caserta, CE, Italy, 81100 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 111123 Novartis Investigative Site Moscow, Russian Federation, 119333 Novartis Investigative Site Moscow, Russian Federation, 119992 Novartis Investigative Site Moscow, Russian Federation, 127473 Novartis Investigative Site Moscow, Russian Federation, 129110 Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site Saint-Petersburg, Russian Federation, 194044 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Tarragona, Cataluña, Spain, 43005 Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Turkey Novartis Investigative Site Istanbul, TUR, Turkey, 34098 Novartis Investigative Site Diyarbakir, Turkey, 21280 Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Trabzon, Turkey, 61080 Less <<
NCT01072175 - Completed - -
NCT00250575 Schizophrenia Phase 3 Completed - Japan ... More >> Novartis Investigational Site Chiba, Japan Novartis Investigative Site Fukuoka, Japan Novartis Investigative Site Ishikawa, Japan Novartis Investigative Site Osaka, Japan Novartis Investigative Site Saga, Japan Novartis Investigative Site Tokyo, Japan Novartis Investigative Site Toyama, Japan Novartis Investigative Site Yamanashi, Japan Less <<
NCT00549770 - Completed - -
NCT01572727 Breast Cancer Phase 2 Phase 3 Completed - -
NCT01392495 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Terminated(Novartis discontinu... More >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) Less << - United States, New York ... More >> Novartis Investigative Site Mineola, New York, United States, 11501 Australia, New South Wales Novartis Investigative Site Darlinghurst, New South Wales, Australia, 2010 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Hannover, Germany, 30625 Italy Novartis Investigative Site Roma, RM, Italy, 00161 Lithuania Novartis Investigative Site Vilnius, Lithuania, LT-08661 United Kingdom Novartis Investigative Site London, United Kingdom, NW3 2QG Less <<
NCT01392495 - Terminated(Novartis discontinu... More >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) Less << - -
NCT00532389 Multiple Myeloma Phase 1 Completed - United States, Florida ... More >> Innovative Medical Research of South Florida Dept.ofInnovativeMedResearch Miami Shores, Florida, United States, 33138 United States, Massachusetts Dana Farber Cancer Institute Clinical Research Coordinator Boston, Massachusetts, United States, 02115 United States, New Jersey Hackensack University Medical Center Multiple Myeloma Division Hackensack, New Jersey, United States, 07601 United States, Washington Swedish Medical Center Dept.ofSwedishMedicalCtr. Seattle, Washington, United States Australia, Australian Capital Territory Novartis Investigative Site Canberra, Australian Capital Territory, Australia, 2606 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 2M4 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site München, Germany, 80336 Novartis Investigative Site Wuerzburg, Germany, 97070 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Torino, TO, Italy, 10126 Spain Novartis Investigative Site Salamanca, Castilla y Leon, Spain, 37007 Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Less <<
NCT00171314 Breast Cancer Phase 3 Completed - -
NCT01379508 - Completed - -
NCT00171340 Bone Loss Bre... More >>ast Cancer Less << Phase 3 Completed - -
NCT00171314 - Completed - -
NCT00171821 Transfusion-dependent Iron Ove... More >>rload Less << Phase 3 Completed - -
NCT00172042 - Completed - -
NCT00172055 Cancer Prostate Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Anderlecht, Belgium Novartis Investigative Site Antwerpen, Belgium Novartis Investigative Site Brugge, Belgium Novartis Investigative Site Bruxelles, Belgium Novartis Investigative Site Charleroi, Belgium Novartis Investigative Site Edegem, Belgium Novartis Investigative Site Gent, Belgium Novaris Investigative Site Gosselies, Belgium Novartis Investigative Site Kortrijk, Belgium Novartis Investigative Site Leper, Belgium Novartis Investigative Site Leuven, Belgium Novaris Investigative Site Libramont, Belgium Novartis Investigative Site Mont-Godinne, Belgium Novartis Investigative Site Roeselare, Belgium Novartis Investigative Site Tongeren, Belgium Novartis Investigative Site Tournai, Belgium Novartis Investigative Site Turnhout, Belgium Novartis Investigative Site Wilrijk, Belgium Novartis Investigative Site Woluwe-Saint-Lambert, Belgium Less <<
NCT01146041 Healthy Phase 1 Completed - -
NCT00231166 Multiple Myeloma Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute StudyCoordinator:CHCD122A2102 Boston, Massachusetts, United States, 02115 United States, New York St. Vincent's Comprehensive Cancer Center Dept. of St. Vincent's Cancer New York, New York, United States, 10011 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania--Abramson Cancer Center StudyCoordinator:CHCD122A2102 Philadelphia, Pennsylvania, United States, 19104 United States, Washington Fred Hutchinson Cancer Research Center Dept. of FHCRC Seattle, Washington, United States, 98109 Australia, Queensland Novartis Investigative Site Herston, Queensland, Australia, 4029 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 Less <<
NCT00237133 Locally Advanced Breast Cancer Phase 4 Completed - Brazil ... More >> Novartis Investigative Site Barretos - SP, Brazil Novartis Investigative Site Florianopolis - SC, Brazil Novartis Investigative Site Fortaleza/CE, Brazil Novartis Investigative Site Goiania/GO, Brazil Novartis Investigative Site Jau -SP, Brazil Novartis Investigative Site Porto Alegre/RS, Brazil Novartis Investigative Site Ribeirao - SP, Brazil Novartis Investigative Site Rio de Janeiro, Brazil Novartis Investigative Site Santo Andre, Brazil Novartis Investigative Site Sao Paulo/SP, Brazil Novartis Investigative Site Vitoria/ES, Brazil Less <<
NCT00363051 - Completed - -
NCT00237211 Postmenopausal Women With Adva... More >>nced Breast Cancer Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Matsuyama, Ehime, Japan, 791-0280 Novartis Investigative Site Kooriyama, Fukushima, Japan, 963-8501 Novartis Investigative Site Maebashi, Gunma, Japan, 371-8511 Novartis Investigative Site Kurashiki, Okayama, Japan, 701-0192 Novartis Investigative Site Kitaadachi-gun, Saitama, Japan, 338-8553 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8677 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-8582 Novartis Investigative Site Fukushima, Japan, 960-1295 Novartis Investigative Site Osaka, Japan, 537-8511 Novartis Investigative Site Saitama, Japan, 338-8553 Less <<
NCT00237198 Postmenopausal Women With Adva... More >>nced Breast Cancer Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Nagoya, Aichi, Japan, 465-0024 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Matsuyama, Ehime, Japan, 791-0280 Novartis Investigative Site Kooriyama, Fukushima, Japan, 963-8501 Novartis Investigative Site Maebashi, Gunma, Japan, 371-8511 Novartis Investigative Site Kure, Hiroshima, Japan, 737-0023 Novartis Investigative Site Sapporo, Hokkaido, Japan, 003-0804 Novartis Investigative Site Sapporo, Hokkaido, Japan, 060-0001 Novartis Investigative Site Sapporo, Hokkaido, Japan, 063-0812 Novartis Investigative Site Yokohama, Kanagawa, Japan, 241-0815 Novartis Investigative Site Kurashiki, Okayama, Japan, 701-0192 Novartis Investigative Site Kitaadachi-gun, Saitama, Japan, 338-8553 Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8677 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Cyuo-ku, Tokyo, Japan, 104-8560 Novartis Investigative Site Koto, Tokyo, Japan, 135-8550 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-8582 Novartis Investigative Site Fukuoka, Japan, 811-1395 Novartis Investigative Site Fukushima, Japan, 960-1295 Novartis Investigative Site Niigata, Japan, 951-8566 Novartis Investigative Site Osaka, Japan, 537-8511 Novartis Investigative Site Shizuoka, Japan, 420-0881 Less <<
NCT00247663 Postmenopausal Women With Adva... More >>nced Breast Cancer Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Amagasaki, Hyogo, Japan, 660-8511 Novartis Investigative Site Hamamatsu, Shizuoka, Japan, 430-8558 Novartis Investigative Site Chuo-Ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Cyuo-ku, Tokyo, Japan, 104-8560 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-8582 Novartis Investigative Site Fukuoka, Japan, 811-4395 Novartis Investigative Site Kumamoto, Japan, 862-0909 Novartis Investigative Site Nigata, Japan, 951-8566 Novartis Investigative Site Saitama, Japan, 338-8553 Less <<
NCT00263588 Neoplasms, Breast Phase 2 Completed - -
NCT00273312 Hepatocellular Carcinoma Phase 2 Completed - United States, California ... More >> Novartis Investigative Site San Francisco, California, United States, 94115 Hong Kong Novartis Investigative Site Hong Kong, Shatin, NT, Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 738-736 Taiwan Novartis Investigative Site Taipei, Taiwan ROC, Taiwan, 100 Novartis Investigative Site Tai Chung Municipality, Taiwan Less <<
NCT00171340 - Completed - -
NCT00457119 Non Small Cell Lung Cancer Phase 1 Completed - United States, District of Col... More >>umbia Georgetown University/Lombardi Cancer Center StudyCoordinator:CRAD001C2114 Washington, District of Columbia, United States, 20007-2197 United States, Louisiana LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans, Louisiana, United States, 70115 United States, Texas U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office Dallas, Texas, United States, 75390-9151 MD Anderson Cancer Center/University of Texas Thoractic Head/Neck Med. Onc. Houston, Texas, United States, 77030-4009 Australia, South Australia Novartis Investigative Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Heidelberg, Germany, 69126 Less <<
NCT00272987 - Active, not recruiting - -
NCT00411528 Metastatic Hormone Refractory ... More >>Prostate Cancer Less << Phase 2 Completed - -
NCT00272987 Neoplasms, Breast Phase 3 Active, not recruiting December 31, 2018 -
NCT00281658 Neoplasms, Breast Phase 3 Active, not recruiting December 31, 2020 -
NCT00281658 - Active, not recruiting - -
NCT00412061 Carcinoid Tumor ... More >> Malignant Carcinoid Syndrome Less << Phase 3 Completed - -
NCT00172042 Non-Small-Cell Lung Cancer Phase 3 Completed - -
NCT00445068 Multiple Myeloma Phase 2 Terminated - -
NCT00363051 Islet Cell Carcinoma ... More >> Neuroendocrine Carcinoma Neuroendocrine Tumor Pancreatic Neoplasms Less << Phase 2 Completed - -
NCT00426556 Metastatic Breast Cancer Phase 1 Completed - United States, California ... More >> Wilshire Oncology Medical Group La Verne *see Various Departments*, California, United States Compassionate Cancer Care Medical Group Dept.ofCCCMG Fountain Valley, California, United States, 92708 Loma Linda University Dept.ofLomaLindaCancerCent(3) Loma Linda, California, United States, 92354 University of California at Los Angeles Dept.of UCLA Dept.ofMed. Los Angeles, California, United States, 90095 United States, Florida Florida Cancer Research Institute Davie, Florida, United States, 33328 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) Atlanta, Georgia, United States, 30322 United States, Illinois North Shore University Health System Evanston, Illinois, United States, 60201 United States, Maryland Peninsula Regional Medical Center Deptof Oncology and Hematology Salisbury, Maryland, United States, 21801 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr StudyCoordinator:CRAD001J2101 St. Louis, Missouri, United States, 63110 United States, South Carolina Cancer Centers of the Carolinas CC of C -Eastside Greenville, South Carolina, United States, 29605 United States, Texas Sammons Cancer Center - Texas Oncology Dallas, Texas, United States, 78246 Belgium Novartis Investigative Site Charleroi, Belgium, 6000 Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Turnhout, Belgium, 2300 France Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Novartis Investigative Site Villejuif Cedex, France, 94805 Netherlands Novartis Investigative Site Maastricht, Netherlands, 6229 HX Spain Novartis Investigative Site Lleida, Cataluna, Spain, 25198 Less <<
NCT00412061 - Completed - -
NCT00434148 Cushing's Disease Phase 3 Completed - -
NCT00425555 Cutaneous T-Cell Lymphoma Phase 2 Phase 3 Completed - -
NCT00171184 Overactive Bladder Phase 4 Completed - United States, Texas ... More >> Scott Department of Urology Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00330317 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Novartis Investigative Site Bournemouth, United Kingdom Novartis Investigative Site Brighton, United Kingdom Novartis Investigative Site Bristol, United Kingdom Novartis Investigative Site Crewe, United Kingdom Novartis Investigative Site Dundee, United Kingdom Novartis Investigative Site East Sussex, United Kingdom Novartis Investigative Site Epping, United Kingdom Novartis Investigative Site Farnworth, United Kingdom Novartis Investigative Site Gateshead, United Kingdom Novartis Investigative Site Glasgow, United Kingdom Novartis Investigative Site Hants, United Kingdom Novartis Investigative Site Leicester, United Kingdom Novartis Investigative Site Liverpool, United Kingdom Novartis Investigative Site London, United Kingdom Novartis Investigative Site Luton, United Kingdom Novartis Investigative Site Manchester, United Kingdom Novartis Investigative Site Newcastle, United Kingdom Novartis Investigative Site Poole, United Kingdom Novartis Investigative Site St. Leonards on Sea, United Kingdom Novartis Investigative Site West Smithfield, United Kingdom Less <<
NCT00170768 Healthy Volunteers Phase 2 Completed - United States, District of Col... More >>umbia Washington Neuropsychological Institute LLC Georgetown Washington, District of Columbia, United States, 20016 Less <<
NCT00434148 - Completed - -
NCT00449761 Leukemia, Myeloid, Chronic Phase 2 Phase 3 Completed - -
NCT00333840 Chronic Myelogenous Leukemia Phase 3 Completed - -
NCT00471328 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - -
NCT00333840 - Completed - -
NCT00471497 - Active, not recruiting - -
NCT00471497 Myelogenous Leukemia, Chronic Phase 3 Active, not recruiting November 12, 2018 -
NCT00471328 - Completed - -
NCT00351468 Purpura, Thrombocytopaenic, Id... More >>iopathic Less << Phase 3 Completed - -
NCT00351468 - Completed - -
NCT00376064 Acromegaly Phase 4 Completed - Germany ... More >> Novartis Investigative Site Aachen, Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Bochum, Germany Novartis Investigative Site Erlangen, Germany Novartis Investigative Site Essen, Germany Novartis Investigative Site Greifswald, Germany Novartis Investigative Site Heidelberg, Germany Novartis Investigative Site Koln, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Marburg, Germany Novartis Investigative Site Muenchen, Germany Novartis Investigative Site Oldenburg, Germany Novartis Investigative Site Regensburg, Germany Novartis Investigative Site Tubingen, Germany Novartis Investigative Site Ulm, Germany Novartis Investigative Site Wurzburg, Germany Less <<
NCT00535951 Carcinoma, Non-Small-Cell Lung... More >> Mesothelioma Less << Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Georgia Medical College of Georgia Augusta, Georgia, United States, 30912 United States, Illinois RUSH Medical Center Chicago, Illinois, United States, 60612 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada Novartis Investigative Site Ontario, Canada Less <<
NCT00426556 - Completed - -
NCT00378014 Liver Transplantation Phase 3 Completed - Austria ... More >> Novartis Investigative Site Innsbruck, Austria, A-6020 Novartis Investigative Site Wien, Austria, A-1090 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Tübingen, Germany, 72076 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Switzerland Novartis Investigative Site Genève, Switzerland, 1211 Novartis Investigative Site Zurich, Switzerland, 8091 Less <<
NCT00510068 Advanced Neuroendocrine Tumors... More >> of Pancreatic Origin Less << Phase 3 Completed - -
NCT00378014 - Completed - -
NCT00387205 Carcinoma, Renal Cell Phase 1 Completed - -
NCT00519090 - Terminated(This study was term... More >>inated due to limited enrollment.) Less << - -
NCT00510068 - Completed - -
NCT00410124 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT00420485 Solid Tumors Phase 1 Completed - Canada, British Columbia ... More >> Novartis Investigative Site Vancouver, British Columbia, Canada Canada, Ontario MD Anderson Cancer Center - Orlando Toronto, Ontario, Canada, M5G 2M9 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Paris, France, 75005 Novartis Investigative Site Saint-Herblain Cedex, France, 44805 Novartis Investigative Site Toulouse, France, 31052 Germany Novartis Investigative Site Mainz, Germany, 55101 Novartis Investigative Site Tubingen, Germany, 72076 Netherlands Novartis Investigative Site Enschede, Netherlands Norway Novartis Investigative Site Oslo, Norway, 310 Spain Novartis Investigative Site Madrid, Spain, 28041 Less <<
NCT00410124 - Completed - -
NCT00414440 - Completed - -
NCT00621244 Lymphoma Leuk... More >>emia Multiple Myeloma Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States, 30912 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3002 Novartis Investigative Site Prahran, Victoria, Australia, 3181 Germany Novartis Investigative Site Frankfurt/M, Germany, 60590 Novartis Investigative Site Mainz, Germany, 55131 Less <<
NCT00567879 Breast Cancer Phase 1 Phase 2 Terminated(The study was termi... More >>nated early due to insufficient evidence of clinical benefit.) Less << - United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 United States, Colorado University of Colorado Dept. of Univ. of Colorado Aurora, Colorado, United States, 80045 United States, Connecticut Norwalk Hospital Dept of Norwalk Hospital (2) Norwalk, Connecticut, United States, 06856 United States, Maryland VA Maryland Health Care Dept.of GreenbaumCancerCent(3) Baltimore, Maryland, United States, 21201 United States, Missouri The Center for Cancer Care and Research St. Louis, Missouri, United States, 63141 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital SC Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute Dept of Magee Women's Hospital Pittsburgh, Pennsylvania, United States, 15232 Canada, British Columbia Novartis Investigative Site Kelowna, British Columbia, Canada, V1Y 5L3 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Paris, France, 75231 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Germany Novartis Investigative Site Heidelberg, Germany, 69115 Italy Novartis Investigative Site Meldola, FC, Italy, 47014 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Modena, MO, Italy, 41100 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TH Novartis Investigative Site London, United Kingdom, W12 0HS Novartis Investigative Site Manchester, United Kingdom, M20 4BX Less <<
NCT00444535 Neoplasms, Breast Phase 2 Active, not recruiting December 31, 2019 United States, Arizona ... More >> Novartis Investigative Site Tucson, Arizona, United States, 85724 United States, California Novartis Investigative Site San Francisco, California, United States, 94115 United States, Florida Novartis Investigative Site Hollywood, Florida, United States, 33021 Novartis Investigative Site Tampa, Florida, United States, 33612 United States, New York Novartis Investigative Site Basking Ridge, New York, United States, 07920 Novartis Investigative Site Commack, New York, United States, 11725 Novartis Investigative Site New York, New York, United States, 10065 Novartis Investigative Site Rockville Centre, New York, United States, 11570 Novartis Investigative Site Sleepy Hollow, New York, United States, 10591 Less <<
NCT00567879 - Terminated(The study was termi... More >>nated early due to insufficient evidence of clinical benefit.) Less << - -
NCT00451035 Chronic Myeloid Leukemia in Ch... More >>ronic Phase Less << Phase 2 Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Bruxelles, Belgium Novartis Investigative Site Godinne, Belgium Novartis Investigative Site Leuven, Belgium Germany Novartis Investigative Site Cologne, Germany Novartis Investigative Site Dusseldorf, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Mainz, Germany Novartis Investigative Site Mannheim, Germany Novartis Investigative Site Munich, Germany Less <<
NCT00621244 - Completed - -
NCT00620594 Breast Cancer ... More >> Advanced Solid Tumors Cowden Syndrome Less << Phase 1 Completed - United States, California ... More >> University of California at Los Angeles JonssonComprehensiveCancerCtr Los Angeles, California, United States, 90095 United States, Connecticut Yale University School of Medicine YaleCancerCtr-ClinTrialsOffice New Haven, Connecticut, United States, 06520 United States, Massachusetts Dana Farber Cancer Institute Clinical Trials ProjectManager Boston, Massachusetts, United States, 02215 United States, Nevada Nevada Cancer Institute NVCC - Huntsman Las Vegas, Nevada, United States, 89135 United States, South Carolina Cancer Centers of the Carolinas CCC Faris Greenville, South Carolina, United States, 29605 United States, Tennessee Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(2) Nashville, Tennessee, United States, 37203 United States, Texas Baylor Health Care System/Sammons Cancer Center Baylor- Sammons Dallas, Texas, United States, 75246 University of Texas/MD Anderson Cancer Center Thoractic Head/Neck Med.Onc(2) Houston, Texas, United States, 77030-4009 Tyler Cancer Center TCC Tyler, Texas, United States, 75702 Germany Novartis Investigative Site Essen, Germany, 45147 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46009 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT00414440 Autosomal Dominant Polycystic ... More >>Kidney Disease Less << Phase 4 Completed - Austria ... More >> Novartis Investigative Site Innsbruck, Austria, INNSBRUCK Novartis Investigative Site Linz, Austria, A-4010 Novartis Investigative Site Wien, Austria, 1090 France Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Nantes Cedex, France, 44035 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt am Main, Germany, 60596 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Lübeck, Germany, 23538 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Würzburg, Germany, 97080 Less <<
NCT00457626 Hypertension Phase 3 Completed - -
NCT00741377 Multiple Myeloma Bone Disease Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States, 85259 United States, Arkansas Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Massachusetts Dana Farber Cancer Institute Deptof DanaFarberCancerInst(2) Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (11) Houston, Texas, United States, 77030-4009 Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(4) San Antonio, Texas, United States, 78229 United Kingdom Novartis Investigative Site Bradford, United Kingdom, BD9 6RJ Novartis Investigative Site London, United Kingdom, EC1A 7BE Novartis Investigative Site London, United Kingdom, SE1 9RT Novartis Investigative Site Manchester, United Kingdom, M20 4BX Less <<
NCT00444535 - Active, not recruiting - -
NCT00655252 - - - -
NCT00532675 Multiple Myeloma Phase 1 Completed - United States, California ... More >> UCSF Medical Center UCSF MC at Parnassus (SC) San Francisco, California, United States, 94143 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States, 30322 United States, New York St. Vincent's Comprehensive Cancer Center New York, New York, United States, 10011 Australia, Queensland Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 France Novartis Investigative Site Lille, France, 59037 Novartis Investigative Site Montpellier cedex 5, France, 34295 Novartis Investigative Site Nantes, France, 44035 Spain Novartis Investigative Site Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Less <<
NCT00519090 Myelogenous Leukemia Phase 3 Terminated(This study was term... More >>inated due to limited enrollment.) Less << - -
NCT00662597 Non-Small Cell Lung Cancer Phase 3 Terminated - -
NCT00510354 Progressive Gastrointestinal S... More >>tromal Tumor Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt/M, Germany, 60590 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT00690430 Symptomatic Refractory Resista... More >>nt Carcinoid Disease Less << Phase 3 Completed - -
NCT00490139 - Active, not recruiting - -
NCT00529529 Asthma Phase 3 Completed - -
NCT00690430 - Completed - -
NCT00490139 Neoplasms, Breast Phase 3 Active, not recruiting July 1, 2021 -
NCT00719264 Carcinoma Ade... More >>nocarcinoma Renal Cell Nephroid Carcinoma Hypernephroid Less << Phase 2 Completed - -
NCT00529529 - Completed - -
NCT00508274 - Active, not recruiting - -
NCT00719264 - Completed - -
NCT00508274 Neoplasms, Breast Phase 3 Active, not recruiting April 10, 2020 China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510060 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430030 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210009 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310006 Novartis Investigative Site Hangzhou, Zhejiang, China, 310022 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Beijing, China, 100071 Novartis Investigative Site Shanghai, China, 200032 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site Shatin, Hong Kong Less <<
NCT00519324 Advanced Gastric Cancer Phase 2 Completed - Japan ... More >> Novartis investigative Site Aichi, Japan Novartis investigative Site Chiba, Japan Novartis investigative Site Ehime, Japan Novartis Investigative Site Hokkaido, Japan Novartis investigative Site Osaka, Japan Novartis investigative Site Shizuoka, Japan Novartis Investigative Site Tochigi, Japan Novartis investigative Site Tokyo, Japan Less <<
NCT00738387 Non-Small Cell Lung Cancer Phase 3 Terminated - -
NCT00742027 Classical Hodgkin's Lymphoma (... More >>i.e. Nodular Sclerosing, Mixed-cellularity, Lymphocyte-rich, Lymphocyte-depleted) Less << Phase 2 Completed - -
NCT00553358 - Active, not recruiting - -
NCT00570778 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - United States, Missouri ... More >> Novartis Investigator Site Saint Louis, Missouri, United States United States, North Carolina Novartis Investigator Site Charlotte, North Carolina, United States Novartis Investigator site Raleigh, North Carolina, United States Belgium Novartis Investigator Site Antwerpen, Belgium Novartis Investigator Site Gent, Belgium Novartis Investigator Site Jambes, Belgium Novartis Investigator Site Saint Vith, Belgium Canada Novartis Investigator Site Moncton, Canada Novartis Investigator Site Montreal, Canada Novartis Investigator site Toronto, Canada Germany Novartis Investigator Site Bad Worishofen, Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Frankfurt, Germany Novartis Investigator Site Mainz, Germany Novartis Investigator Site Rudersdorf, Germany Novartis Investigator Site Wiesbaden, Germany Netherlands Novartis Investigator Site Almelo, Netherlands Novartis Investigator Site Breda, Netherlands Novartis Investigator site Eindhoven, Netherlands Novartis investigator site Heerlen, Netherlands Novartis Investigator Site Nijmegen, Netherlands Novartis Investigator Site Veldhoven, Netherlands Less <<
NCT00572585 Ulcerative Colitis Phase 2 Completed - United States, Alabama ... More >> Novartis Investigative Site Mobile, Alabama, United States, 36608 United States, Arizona Novartis Investigative Site Mesa, Arizona, United States, 85213 United States, Kansas Novartis Investigative Site Topeka, Kansas, United States, 66606 United States, Louisiana Novartis Investigative Site Lafayette, Louisiana, United States, 70501 United States, Michigan Novartis Investigative Site Chesterfield Twp, Michigan, United States, 48047 Novartis Investigative Site Troy, Michigan, United States, 48098 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73104 Denmark Novartis Investigative Site Odense C, Denmark, DK-5000 Novartis Investigative Site Århus, Denmark, DK-8000 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Hamburg, Germany, 22559 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Leipzig, Germany, 04105 Novartis Investigative Site Lüneburg, Germany, 21339 Novartis Investigative Site Minden, Germany, 32423 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Stuttgart, Germany, 70376 Poland Novartis Investigative Site Kraków, Poland, 30-307 Novartis Investigative Site Poznan, Poland, 60-539 Less <<
NCT00553358 Neoplasms, Breast Phase 3 Active, not recruiting December 23, 2019 -
NCT00782067 Leukemia Phase 2 Completed - -
NCT00582855 Mild Alzheimer's Disease ... More >> Amnestic Mild Cognitive Impairment Less << Phase 2 Terminated - Canada ... More >> Novartis Investigator Site Halifax, Canada Novartis Investigator Site Montreal, Canada Novartis Investigator Site Toronto, Canada South Africa Novartis Investigator Site Bloemfontein, South Africa Novartis Investigator Site George, South Africa Novartis Investigator Site Port Elizabeth, South Africa United Kingdom Novartis Investigator Site Blackpool, United Kingdom Novartis Investigator Site Epping, United Kingdom Novartis Investigator Site Glasgow, United Kingdom Novartis Investigator Site Manchester, United Kingdom Novartis Investigator Site Southampton, United Kingdom Novartis Investigator Site Swindon, United Kingdom Less <<
NCT00782067 - Completed - -
NCT00708292 Relapsed or Refractory Multipl... More >>e Myeloma Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States, 85259 United States, Texas Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) San Antonio, Texas, United States, 78229 Australia Novartis Investigative Site Melbourne, Australia, 3004 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Wuerzburg, Germany, 97070 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28006 Less <<
NCT00785785 - Completed - -
NCT00570778 - Completed - -
NCT00789828 - Completed - -
NCT00790036 Diffuse Large B-cell Lymphoma Phase 3 Completed - -
NCT00790036 - Completed - -
NCT00790400 Tuberous Sclerosis Complex (TS... More >>C) Lymphangioleiomyomatosis (LAM) Less << Phase 3 Completed - -
NCT00789828 Tuberous Sclerosis ... More >> Subependymal Giant Cell Astrocytoma Less << Phase 3 Completed - -
NCT00600938 Transfusional Iron Overload ... More >> Transfusional Hemosiderosis Less << Phase 2 Completed - Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 China, Guangxi Novartis Investigative Site Nanning, Guangxi, China, 530021 Cyprus Novartis Investigative Site Limassol, Cyprus, 3304 Egypt Novartis Investigative Site Cairo, Egypt Novartis Investigative Site Mansoura, Egypt Italy Novartis Investigative Site Cagliari, CA, Italy, 09121 Novartis Investigative Site Genova, GE, Italy, 16128 Lebanon Novartis Investigative Site Hazmiyeh, Lebanon Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Turkey Novartis Investigative Site Adana, Turkey, 01330 Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Antalya, Turkey, 07070 Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Izmir, Turkey, 35040 United Arab Emirates Novartis Investigative Site Dubai, United Arab Emirates, 9115 United Kingdom Novartis Investigative Site Leeds, West Yorkshire, United Kingdom, LS9 7TF Novartis Investigative Site Leeds, United Kingdom, LS9 7TF Novartis Investigative Site London, United Kingdom, N19 5NF Novartis Investigative Site London, United Kingdom, NW1 2PJ Less <<
NCT00790400 - Completed - -
NCT00785785 Gastrointestinal Stromal Tumor... More >> (GIST) Less << Phase 3 Completed - -
NCT00622258 Non-Hodgkin's Lymphoma Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8650 Novartis Investigative Site Nagoya, Aichi, Japan, 460-0001 Novartis Investigative Site Kashiwa, Chiba, Japan Novartis Investigative Site Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Chuo-ku, Tokyo, Japan Novartis Investigative Site Fukuoka, Japan, 811-1395 Novartis Investigative Site Kyoto, Japan, 602-8566 Less <<
NCT00622869 Liver Transplantation Phase 3 Completed - -
NCT00790426 Urothelial Cancer Phase 2 Completed - -
NCT00927810 Gout Phase 2 Completed - -
NCT00819585 Gout Phase 2 Completed - -
NCT00600938 - Completed - -
NCT00819585 - Completed - -
NCT00518765 Hypertension Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00668200 Paget's Disease of the Bone ... More >> Hypocalcemia Less << Phase 4 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85012 Novartis Investigative Site Tucson, Arizona, United States, 85723-0001 United States, Georgia Novartis Investigative Site Gainesville, Georgia, United States, 30501 United States, Michigan Novartis Investigative Site Detroit, Michigan, United States, 48236 United States, New York Novartis Investigative Site Syracuse, New York, United States, 13210-2306 United States, Rhode Island Novartis Investigative Site Providence, Rhode Island, United States, 02908 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75216 Novartis Investigative Site Waco, Texas, United States, 76708 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53705-3611 Less <<
NCT00634920 - Completed - -
NCT00622869 - Completed - -
NCT00667251 Breast Cancer Phase 3 Active, not recruiting December 31, 2020 -
NCT00634920 Renal Function Phase 4 Completed - Denmark ... More >> Novartis Investigative Site Aarhus N, Denmark, 8200 Novartis Investigative Site Copenhagen, Denmark, DK-2100 Novartis Investigative Site Herlev, Denmark, 2730 Novartis Investigative Site Odense C, Denmark, DK-5000 Norway Novartis Investigative Site Oslo, Norway, 0424 Sweden Novartis Investigative Site Goteborg, Sweden, 413 45 Novartis Investigative Site Malmo, Sweden, 205 02 Novartis Investigative Site Uppsala, Sweden, 751 85 Less <<
NCT00670930 Allergic Asthma Phase 4 Completed - United States, Colorado ... More >> Novartis Investigative Site Denver, Colorado, United States, 80206 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63110 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19140 United States, Texas Novartis Investigative Site Galveston, Texas, United States, 77555-1083 Canada, Alberta Novartis Investigative Site Calgary, Alberta, Canada, T2N 4N1 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2X 2P4 Canada Novartis Investigative Site Quebec, Canada, G1V 4G5 France Novartis Investigative Site Montpellier, France, 34059 Germany Novartis Investigative Site Mainz, Germany, D-55101 Netherlands Novartis Investigative Site Leiden 2333 ZA, Netherlands, 2333 Sweden Novartis Investigative Site Lund, Sweden, SE-221 85 United Kingdom Novartis Investigative Site Glasgow - Scotland, United Kingdom, G12 OYN Novartis Investigative Site Manchester, United Kingdom, M20 8LR Novartis Investigative Site Southampton, United Kingdom, SO16 6YD Less <<
NCT00828594 Hepatocellular Carcinoma Phase 1 Terminated - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 UCLA Department of Medicine Los Angeles, California, United States, 90005 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of Netherlands Novartis Investigative Site Amsterdam, Netherlands Spain Novartis Investigative Site Barcelona, Spain Novartis Invstigative Site Madrid, Spain Taiwan Novartis Investigative Site Tainan, Taiwan Less <<
NCT00668200 - Completed - -
NCT00663832 Prostate Cancer Phase 1 Completed - United States, Maryland ... More >> Novartis Investigative Site Rockville, Maryland, United States, 20850 United States, Michigan Novartis Investigative Site Detroit, Michigan, United States, 48201 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63110 United States, Nevada Novartis Investigative Site Las Vegas, Nevada, United States, 89135 United States, New York Novartis Investigative Site New York, New York, United States, 10021 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Oregon Novartis Investigative Site Portland, Oregon, United States, 97239 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 1L8 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Less <<
NCT00670930 - Completed - -
NCT00680901 Neoplasms, Gastrointestinal Tr... More >>act Less << Phase 3 Active, not recruiting December 31, 2020 -
NCT00667251 - Active, not recruiting - -
NCT00863655 - Completed - -
NCT00688623 Carcinoma Neu... More >>roendocrine Non Functioning Neuroendocrine Tumors/NET Non Syndromic Neuroendocrine Tumors/NET Carcinoids Non Functioning Less << Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Berka, Germany, 99438 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Mainz, Germany, 55131 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Viagrande, CT, Italy, 95029 Novartis Investigative Site Roma, RM, Italy, 00189 Poland Novartis Investigative Site Gdansk, Poland, 80-952 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08907 Novartis Investigative Site Barcelona, Cataluña, Spain United Kingdom Novartis Investigative Site Glasgow - Scotland, United Kingdom, G12 OYN Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT00863655 Breast Cancer Phase 3 Completed - -
NCT00685399 Non-infectious Uveitis Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Beverly Hills, California, United States, 90211 Novartis Investigative Site Los Angeles, California, United States, 90033 Novartis Investigative Site Sacramento, California, United States, 95819 United States, Colorado Novartis Investigative Site Denver, Colorado, United States, 80210 Novartis Investigative Site Golden, Colorado, United States, 80401 Novartis Investigative Site Littleton, Colorado, United States, 80120 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30322 United States, Maryland Novartis Investigative Site Baltimore, Maryland, United States, 21201 Novartis Investigative Site Baltimore, Maryland, United States, 21287 United States, Massachusetts Novartis Investigative Site Cambridge, Massachusetts, United States, 02142 United States, Missouri Novartis Investigative Site Kansas City, Missouri, United States, 64111 United States, New Jersey Novartis Investigative Site Teaneck, New Jersey, United States, 07666 United States, New York Novartis Investigative Site New York, New York, United States, 10022 Novartis Investigative Site Slingerlands, New York, United States, 12159 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Ohio Novartis Investigative Site Cleveland, Ohio, United States, 44195 United States, South Carolina Novartis Investigative Site Spartanburg, South Carolina, United States, 29306 United States, Texas Novartis Investigative Site Arlington, Texas, United States, 76012 Novartis Investigative Site Austin, Texas, United States, 78793 Novartis Investigative Site Houston, Texas, United States, 77030 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Heidelberg, Germany, 691120 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT00685399 - Completed - -
NCT00688753 Carcinoma Ren... More >>al Cell Non Clear Cell Renal Carcinoma Papillary Cell Renal Carcinoma Adenocarcinoma Less << Phase 2 Completed - Belgium ... More >> Novartis Investigative Site Brussels, Belgium, BE-B-1200 Novartis Investigative Site Gent, Belgium, 9000 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Muenster, Germany, 48149 Italy Novartis Investigative Site Arezzo, AR, Italy, 52100 Novartis Investigative Site Cremona, CR, Italy, 26100 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Napoli, Italy, 80132 Poland Novartis Investigative Site Otwock, Poland, 05-400 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Cataluña, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46009 Novartis Investigative Site Barcelona, Spain, 08041 Less <<
NCT00688753 - Completed - -
NCT00876395 Breast Cancer Phase 3 Completed - -
NCT00680901 - Active, not recruiting - -
NCT00980018 Chronic Myelogenous Leukemia Phase 4 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States, 72205 United States, California USC Norris Cancer Center LAC & USC Medical Center Los Angeles, California, United States, 90033 Southwest Cancer Care Murrieta Poway, California, United States, 92064 United States, Colorado Rocky Mountain Cancer Centers RMCC - Aurora Greenwood Village, Colorado, United States United States, Florida Florida Cancer Institute New Port Richey, Florida, United States, 34655 Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 Ocoee, Florida, United States, *see dep* United States, Illinois Stroger Cook County Hospital John H. Stroger Hospital Chicago, Illinois, United States, 60612 United States, Indiana St. Francis Hospital and Health Centers IndianaBlood&MarrowTransplantn Beech Grove, Indiana, United States, 46107 United States, Maryland St. Agnes Hospital Baltimore, Maryland, United States, 21229 United States, Missouri St. Louis University Cancer Center St. Louis, Missouri, United States, 63110 United States, Oregon Northwest Cancer Specialists Salmon Creek Office Portland, Oregon, United States, 97210 Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Tennessee The Jones Clinic Germantown, Tennessee, United States, 38138 United States, Texas Texas Oncology, P.A. Bedford, Texas, United States, 76022 Presbyterian Hospital of Dallas TexasOncology@PresbyterianHosp Dallas, Texas, United States, 75231 Texas Oncology Texas Oncology - Sugar Land Dallas, Texas, United States, 75246 MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77031 Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2) San Antonio, Texas, United States, 78229 Canada, Ontario Novartis Investigative Site Brampton, Ontario, Canada, L6R 3J7 Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 2M4 Novartis Investigative Site Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT00879333 Advanced Gastric Cancer Phase 3 Completed - -
NCT00412750 Hepatitis B Phase 3 Terminated(Enrollment stopped ... More >>for safety issues) Less << - United States, California ... More >> Novartis San Francisco, California, United States, 94115 Less <<
NCT00880269 Refractory Leukemia ... More >> Acute Myelogenous Leukemia Less << Phase 2 Completed - -
NCT00879333 - Completed - -
NCT00879658 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 2 Completed - -
NCT00880269 - Completed - -
NCT00886769 Systemic Juvenile Idiopathic A... More >>rthritis Less << Phase 3 Terminated(recommendation by D... More >>ata Monitoring Committee) Less << - -
NCT00885196 Moderate and Severe Plaque Pso... More >>riasis Less << Phase 2 Completed - -
NCT00412750 - Terminated(Enrollment stopped ... More >>for safety issues) Less << - -
NCT00704678 Chronic Kidney Disease Phase 2 Completed - Japan ... More >> Novartis Investigative Site Koriyama, Fukushima, Japan Novartis Investigative Site Midori, Gunma, Japan Novartis Investigative Site Hitachiomiya, Ibaraki, Japan Novartis Investigative Site Moriya, Ibaraki, Japan Novartis Investigative Site Sashima-gun, Ibaraki, Japan Novartis Investigative Site Takamatsu, Kagawa, Japan Novartis Investigative Site Tsu, Mie, Japan Novartis Investigative Site Okayama City, Okayama, Japan Novartis Investigative Site Sakai, Osaka, Japan Novartis Investigative Site Kasukabe, Saitama, Japan Novartis Investigative Site Nagano, Japan Novartis Investigative Site Shizuoka, Japan Taiwan Novartis Investigative Site Changhua, Taiwan Novartis Investigative Site Kaoshiung, Taiwan Novartis Investigative Site Taipei, Taiwan Less <<
NCT00889863 Systemic Juvenile Idiopathic A... More >>rthritis With Active Flare Less << Phase 3 Completed - -
NCT00886769 - Terminated(recommendation by D... More >>ata Monitoring Committee) Less << - -
NCT00889863 - Completed - -
NCT00715182 Advanced/ Metastatic Renal Cel... More >>l Cancer Less << Phase 1 Completed - United States, California ... More >> Novartis Investigative Site San Francisco, California, United States United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98109-1023 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site München, Germany, 81675 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Spain Novartis Investigative Site Madrid, Spain, 28041 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT00709761 Neoplasms, Breast Phase 2 Completed - United States, California ... More >> Novartis Investigative Site La Verne, California, United States, 91750 Novartis Investigative Site Long Beach, California, United States, 90813 United States, Florida Novartis Investigative Site Fort Myers, Florida, United States, 33916 Novartis Investigative Site Jupiter, Florida, United States, 33458 Novartis Investigative Site Saint Petersburg, Florida, United States, 33705 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30341 United States, Kentucky Novartis Investigative Site Paducah, Kentucky, United States, 42003 United States, New York Novartis Investigative Site New York, New York, United States, 10065 Novartis Investigative Site Rochester, New York, United States, 14623 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45242 Novartis Investigative Site Cleveland, Ohio, United States, 44106 United States, Oregon Novartis Investigative Site Portland, Oregon, United States, 97213 United States, Rhode Island Novartis Investigative Site Woonsocket, Rhode Island, United States, 02895 United States, Tennessee Novartis Investigative Site Chattanooga, Tennessee, United States, 37404 Novartis Investigative Site Nashville, Tennessee, United States, 37203 United States, Texas Novartis Investigative Site Lubbock, Texas, United States, 79410 United States, Virginia Novartis Investigative Site Danville, Virginia, United States, 24541 Novartis Investigative Site Richmond, Virginia, United States, 23230 Novartis Investigative Site Salem, Virginia, United States, 24153 United States, Washington Novartis Investigative Site Everett, Washington, United States, 98201 Novartis Investigative Site Seattle, Washington, United States, 98101 Novartis Investigative Site Spokane, Washington, United States, 99218 Novartis Investigative Site Tacoma, Washington, United States, 98405 Less <<
NCT01392469 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - United States, Florida ... More >> Novartis Investigative Site Tampa, Florida, United States, 33606 Novartis Investigative Site Weston, Florida, United States, 33331 United States, New York Novartis Investigative Site Mineola, New York, United States, 11501 Australia, New South Wales Novartis Investigative Site Darlinghurst, New South Wales, Australia, 2010 Belgium Novartis Investigative Site Bruxelles, Belgium, 1070 Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Berlin, Germany, 12683 Novartis Investigative Site Hannover, Germany, 30625 Italy Novartis Investigative Site Roma, RM, Italy, 00161 Lithuania Novartis Investigative Site Vilnius, Lithuania, LT-08661 United Kingdom Novartis Investigative Site London, United Kingdom, NW3 2PR Less <<
NCT01392326 - Completed - -
NCT01392443 Primary Myelofibrosis (MF) ... More >> Post-Polycythemia Vera (PV) MF Post-Essential Thrombocythemia (ET) MF Less << Phase 2 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100730 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510080 China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430030 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210029 Novartis Investigative Site Suzhou, Jiangsu, China, 215006 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Tianjin Novartis Investigative Site Tianjin, Tianjin, China, 300020 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Jinan, China, 250012 Novartis Investigative Site Shanghai, China, 200025 Japan Novartis Investigative Site Nagoya, Aichi, Japan, 466-8560 Novartis Investigative Site Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Maebashi-city, Gunma, Japan, 371-8511 Novartis Investigative Site Kanazawa-city, Ishikawa, Japan, 920-8641 Novartis Investigative Site Tsu-city, Mie, Japan, 514-8507 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-8582 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Republic of, 06591 Taiwan Novartis Investigative Site Kaohsiung, Taiwan, 833 Novartis Investigative Site Taipei, Taiwan, 10048 Novartis Investigative Site Taoyuan, Taiwan, 333 Less <<
NCT01394029 - Completed - Egypt ... More >> Novartis Investigative Site Cairo, Egypt, 11566 Novartis Investigative Site Cairo, Egypt Jordan Novartis Investigative Site Amman, Jordan, 11195 Spain Novartis Investigative Site Oviedo, Asturias, Spain, 33006 Novartis Investigative Site Barcelona, Cataluña, Spain, 08916 Novartis Investigative Site Barcelona, Cataluña, Spain United Kingdom Novartis Investigative Site West Midlands, Birmingham, United Kingdom, B4 6NH Novartis Investigative Site London, United Kingdom, N18 1QX Novartis Investigative Site London, United Kingdom, N19 5NF Novartis Investigative Site London, United Kingdom, SE5 9RS Less <<
NCT00709761 - Completed - -
NCT01385592 Dyskinesias P... More >>arkinson Disease Movement Disorders Parkinsonian Disorders Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Sunnyvale, California, United States, 94089 United States, Colorado Novartis Investigative Site Englewood, Colorado, United States, 80113 Canada, Ontario Novartis Investigative Site London, Ontario, Canada, N6A 4G5 Canada, Quebec Novartis Investigative Site Gatineau, Quebec, Canada, J9J 0A5 France Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Pessac, France, 33604 Novartis Investigative Site Poitiers, France, 86021 Germany Novartis Investigative Site Beelitz-Heilstaetten, Germany, 14547 Novartis Investigative Site Berlin, Germany, 12163 Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Kassel, Germany, 34128 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Muenchen, Germany, 80804 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Stadtroda, Germany, 07646 Novartis Investigative Site Westerstede/Oldenburg, Germany, 26655 Hungary Novartis Investigative Site Budapest, Hungary, 1085 Novartis Investigative Site Kaposvár, Hungary, 7400 Novartis Investigative Site Szeged, Hungary, H-6725 Italy Novartis Investigative Site Bolzano, BZ, Italy, 39100 Novartis Investigative Site Pisa, PI, Italy, 56126 Novartis Investigative Site Roma, RM, Italy, 00163 Spain Novartis Investigative Site Sant Cugat, Barcelona, Spain, 08190 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28006 Novartis Investigative Site San Sebastian, Spain, 20014 Less <<
NCT01396057 Visual Impairment ... More >> Macular Edema Branch Retinal Vein Occlusion Less << Phase 3 Completed - -
NCT01396057 - Completed - -
NCT01392326 Psoriatic Arthritis Phase 3 Completed - -
NCT01399125 Alzheimer's Disease Phase 3 Completed - China, Fujian ... More >> Novartis Investigative Site Fuzhou, Fujian, China China, Hubei Novartis Investigative Site Wuhan, Hubei, China, 430022 Novartis Investigative Site Wuhan, Hubei, China, 430030 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210029 Novartis Investigative Site Suzhou, Jiangsu, China, 215004 China, Jilin Novartis Investigative Site Changchun, Jilin, China, 130021 China, Shanghai Novartis Investigative Site Shanghai, Shanghai, China, 200080 China, Shanxi Novartis Investigative Site Xi'an, Shanxi, China, 710032 China, Sichuan Novartis Investigative Site Chengdu, Sichuan, China, 610041 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310009 China Novartis Investigative Site Beijing, China, 100028 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Shanghai, China, 200003 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China, 200040 Novartis Investigative Site Shanghai, China, 200127 Less <<
NCT01396083 Visual Impairment ... More >> Macular Edema Central Retinal Vein Occlusion Less << Phase 3 Completed - -
NCT01399125 - Completed - -
NCT01406938 Moderate to Severe Plaque-type... More >> Psoriasis Less << Phase 3 Completed - -
NCT00986882 Postoperative Pain Phase 2 Completed - United States, Utah ... More >> Jean Brown Research Salt Lake City, Utah, United States, 84124 Less <<
NCT01406938 - Completed - -
NCT02518451 Healthy Not Applicable Completed - Indonesia ... More >> PT Equilab International Jakarta, Indonesia, 12430 Less <<
NCT01396083 - Completed - -
NCT02672358 Non-Small-Cell Lung Cancer Phase 2 Withdrawn(Company Decision) December 7, 2020 -
NCT00418626 Healthy Phase 1 Completed - United States, Virginia ... More >> Richmond, Virginia, United States, 23249 Less <<
NCT01610284 Breast Cancer Phase 3 Active, not recruiting December 31, 2018 -
NCT03200717 Advanced Renal Cell Carcinoma ... More >> Metastatic Renal Cell Carcinoma Less << Phase 2 Recruiting August 27, 2021 -
NCT01023685 Alzheimer Disease Phase 2 Completed - United States, California ... More >> ATP Clinical Research, Inc. Costa Mesa, California, United States, 92626 United States, Colorado Alpin Research Center Boulder, Colorado, United States, 80304 United States, Florida Sunrise Clinical Research, Inc. Hollywood, Florida, United States, 33021 United States, Illinois Alexian Brothers Neuroscience Institute Elk Grove Village, Illinois, United States, 60007 United States, Indiana Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Pennsylvania Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19102 United States, Tennessee Volunteer Research Group Knoxville, Tennessee, United States, 37920 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT01410448 - Completed - -
NCT02720510 Multiple Myeloma Phase 2 Terminated(A study was termina... More >>ted due to low enrollment.) Less << - United States, California ... More >> David Geffen School of Medicine at UCLA UCLA Los Angeles, California, United States, 90095 United States, Florida Memorial West Cancer Center Memorial Cancer Institute Pembroke Pines, Florida, United States, 33028 United States, Georgia Northside Hospital Central Research Dept. Atlanta, Georgia, United States, 30342 United States, Nebraska Oncology Hematology West Nebraska Cancer Specialists dbaNebraska Cancer Specialists Omaha, Nebraska, United States, 68124 United States, Texas Brooke Army Medical Center Hematology/Oncology San Antonio, Texas, United States, 78234 Less <<
NCT02720510 - Terminated(A study was termina... More >>ted due to low enrollment.) Less << - -
NCT01056731 High Blood Pressure Phase 4 Completed - Venezuela ... More >> Investigative Site Bolíva, Venezuela Investigative Site Carabobo, Venezuela Investigative Site Caracas, Venezuela Investigative Site Edo Zulia, Venezuela Investigative Site Estado Monagas, Venezuela Investigative Site Falcón, Venezuela Investigative Site Maracaibo Estado Zulia, Venezuela Less <<
NCT01070030 Stage II Hypertension Phase 4 Completed - Thailand ... More >> Investigative Site Bangkok, Thailand Investigative Site Chiang Mai, Thailand Investigative Site Nakhon Ratchasima, Thailand Less <<
NCT01410448 Kidney Transplantation Phase 3 Completed - Italy ... More >> Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Coppito, AQ, Italy, 67100 Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Brescia, BS, Italy, 25123 Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Catania, CT, Italy, 95123 Novartis Investigative Site Firenze, FI, Italy, 50139 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Milano, MI, Italy, 20162 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Palermo, PA, Italy, 90127 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Roma, RM, Italy, 00144 Novartis Investigative Site Roma, RM, Italy, 00152 Novartis Investigative Site Roma, RM, Italy, 00161 Novartis Investigative Site Roma, RM, Italy, 00168 Novartis Investigative Site Salerno, SA, Italy, 84131 Novartis Investigative Site Siena, SI, Italy, 53100 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Novara, Italy, 28100 Less <<
NCT01092065 Parkinson's Disease Phase 2 Completed - United States, California ... More >> The Parkinsons Institute Sunnyvale, California, United States, 94085 United States, Colorado Colorado Neurological Institute Englewood, Colorado, United States, 80113 United States, Indiana Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Kansas University of Kansas Medical Center - Parkinson's Disease and Movement Disorders Center Kansas City, Kansas, United States, 66160 Less <<
NCT02826642 Acute Myeloid Leukemia (AML) Phase 1 Withdrawn November 29, 2016 -
NCT00598104 Asthma Phase 1 Phase 2 Withdrawn(Due to the lack of e... More >>nrolment and complexity of design, this study in asthma was terminated. No subjects have been dosed for this study.) Less << - -
NCT02857868 Hepatic Impairment Phase 1 Completed - United States, Florida ... More >> University of Miami / Clinical Research Services, Inc. Miami, Florida, United States, 33136 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Minnesota DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 Less <<
NCT00615693 Uveitis Poste... More >>rior Uveitis Panuveitis Less << Phase 2 Completed - United States, California ... More >> University of Southern California Doheny Eye Institute Los Angeles, California, United States, 90033 University of California San Francisco, California, United States, 94143 United States, Colorado Colorado Retina Associates Denver, Colorado, United States, 80230 United States, Florida University of Miami Miller School of Medicine; Anne Bates Leach Eye Hosptial;Bascom Palmer Eye Institute Miami, Florida, United States, 33136 University of South Florida, Eye Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland John Hopkins Hospital/Wilmer Eye Institute Baltimore, Maryland, United States, 21287 United States, Massachusetts MERSI Cambridge, Massachusetts, United States, 02142 United States, Minnesota Mayo Clinic Department of Opthalmology Rochester, Minnesota, United States, 55905 United States, New Jersey Cornea and Laser Eye Institute Teaneck, New Jersey, United States, 07666 United States, New York New York Eye and Ear Infirmary, Clinical Research Department New York, New York, United States, 10003 United States, Texas Retina Research Centre Austin, Texas, United States, 78705 Vitreoretinal Consultants Houston, Texas, United States, 77030 Less <<
NCT00424983 Multiple Myeloma ... More >> Breast Cancer Less << Phase 1 Completed - United States, California ... More >> Oncotherapeutics West Hollywood, California, United States, 90069 United States, Colorado Rocky Mountain Cancer Centers RMCC Greenwood Village, Colorado, United States United States, Connecticut Norwalk Hospital Norwalk, Connecticut, United States, 06856 United States, Pennsylvania Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 United States, Utah Huntsman Cancer Institute Univ. of Utah Salt Lake City, Utah, United States, 84112-0550 United States, Vermont University of Vermont Fletcher Allen Health Care Burlington, Vermont, United States, 05404 United States, Virginia Virginia Cancer Institute Virginia Cancer Center Richmond, Virginia, United States, 23230 Less <<
NCT02756663 Multiple Myeloma Phase 2 Withdrawn February 2021 -
NCT01220115 - Completed - -
NCT02878681 Visual Impairment Due to Diabe... More >>tic Macular Edema Less << Phase 4 Withdrawn September 2017 -
NCT00228059 Bipolar I Disorder Phase 3 Completed - United States, California ... More >> Investigational Site Cerritos, California, United States Less <<
NCT02980263 Kawasaki Disease Phase 2 Withdrawn November 30, 2017 -
NCT01237223 Essential Hypertension Phase 3 Completed - Japan ... More >> Investigative Site Aichi, Japan Investigative Site Ehime, Japan Investigative Site Fukuoka, Japan Investigative Site Hokkaido, Japan Investigative Site Hyogo, Japan Investigative Site Kanagawa, Japan Investigative Site Kyoto, Japan Investigative Site Okayama, Japan Investigative Site Osaka, Japan Investigative Site Saitama, Japan Investigative Site Tokyo, Japan Less <<
NCT01237223 - Completed - -
NCT01992536 Meningococcal Disease Phase 2 Completed - United States, Alabama ... More >> Site 23, Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615 Birmingham, Alabama, United States, 35205 United States, California Site 24, Madera Family Medical Group 1111 West 4th Street Madera, California, United States, 93637 Site 25, Center for Clinical Trials LLC 16660 Paramount Blvd, Suite 301 Paramount, California, United States, 90723 United States, Kentucky Site 28, Kentucky Pediatric/Adult Research 201 South 5th Street Bardstown, Kentucky, United States, 40004 Site 21, Bluegrass Clinical Research Inc. 5512 Bardstown Road, Suite 2 Louisville, Kentucky, United States, 40291 United States, Ohio Site 26, Ohio Pediatric Research Association 7200 Poe Ave, Suite 200 Dayton, Ohio, United States, 45414 Site 27, Ohio Pediatric Research Association 1775 Delco Park Drive Kettering, Ohio, United States, 45420 United States, Tennessee Site 22, Focus Research Group 201 Signature Place Lebanon, Tennessee, United States, 37087 Poland Site 15, Specjalistyczna Przychodnia Lekarska Internistyczno-Pediatryczna, Juniperus" s.c. ul.Kościuszki 41, Izabelin, Poland, 05-080 Site 13, Hanna Czajka Indywidualna Specjalistyczna Praktyka Lekarska ul. Braci Kiemliczów 14, Kraków, Poland, 31-223 Site 12, NZOZ PRAKTIMED Sp.zo.o ul.Strzelców 15, Kraków, Poland, 31-422 Site 14, Klinika Pediatrii Centrum Medycznego Kształcenia Podyplomowego,Szpital Bielański ul. Cegłowska 80, Warszawa, Poland, 01-809 Site 11, Katedra i Klinika Pediatrii i Chorób Infekcyjnych ul.O.Bujwida 44, Wrocław, Poland, 50-354 Less <<
NCT01933646 - Completed - China ... More >> Site 12 Changsha, China Site 13 Guangzhou, China Site 14 Guangzhou, China Less <<
NCT03078751 Breast Cancer Phase 2 Active, not recruiting March 25, 2020 -
NCT03081234 Breast Cancer Phase 3 Withdrawn(Withdrawn due to cha... More >>nge in plan for this study and not due to safety reasons.) Less << November 17, 2025 -
NCT01992536 - Completed - -
NCT01150123 Group B Streptococcus Phase 1 Completed - Belgium ... More >> Gent, Belgium Less <<
NCT01332396 - Completed - -
NCT01256294 Renal Transplant Phase 4 Completed - United States, Ohio ... More >> University of Cincinnati Medical Center Cincinnati, Ohio, United States, 45267 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03240393 Carcinoma Non... More >>-Small-Cell Lung Cancer Less << Phase 2 Withdrawn(Company Decision) October 26, 2021 -
NCT01150123 - Completed - -
NCT01478373 - Completed - -
NCT02139228 Meningitis, Epiglottitis, Pneu... More >>monia, Arthritis Caused by Haemophilus Influenzae Type b Less << Phase 3 Completed - China, Hebei ... More >> DingXing Center for Disease Control and Prevention Dingxing, Hebei, China, 050021 Less <<
NCT00420043 Healthy Phase 1 Completed - -
NCT01478373 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Finland ... More >> Novartis Investigative Site HUS, Finland, FIN-00029 France Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Lille Cedex, France, 59020 Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Essen, Germany, 45147 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Roma, RM, Italy, 00168 Novartis Investigative Site Candiolo, TO, Italy, 10060 Novartis Investigative Site Torino, TO, Italy, 10153 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 Novartis Investigative Site Barcelona, Spain, 08041 Less <<
NCT00141089 Chronic Constipation Phase 3 Completed - -
NCT01256294 - Completed - -
NCT00097955 Diabetic Nephropathy Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Canada Investigative Site Quebec, Canada Denmark Investigative Site Hillerod, Denmark France Investigative Site Paris, France Germany Investigative Centers, Germany Greece Investigative Site Athens, Greece Italy Investigative Site Rome, Italy Netherlands Investigative Site Rotterdam, Netherlands Romania Investigative Site Bucharest, Romania Russian Federation Investigative Site Moscow, Russian Federation Spain Investigative Site Madrid, Spain United Kingdom Investigative Site London, United Kingdom Less <<
NCT01715779 - Completed - -
NCT00532233 Idiopathic Pulmonary Fibrosis Phase 2 Completed - United States, Colorado ... More >> Novartis Investigative Site Denver, Colorado, United States, 80206 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30319 United States, Louisiana Novartis Investigative Site New Orleans, Louisiana, United States, 70112 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27704 United States, Pennsylvania Novartis Investigative Site Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01620684 Metabolic Syndrome ... More >> Obesity Insulin Resistance Less << Phase 4 Unknown - Australia, Victoria ... More >> Heart Centre, Alfred Hospital Recruiting Prahran, Melbourne, Victoria, Australia, 3181 Contact: Nora E Straznicky, BPharm PhD MPH    61 3 8532 1371    nora.straznicky@bakeridi.edu.au    Principal Investigator: Nora E Straznicky, PhD MPH Less <<
NCT02139228 - Completed - -
NCT00413790 Healthy Phase 4 Completed - United States, Arizona ... More >> Investigative Site Scottsdale, Arizona, United States, 85251 Investigative Site Tempe, Arizona, United States, 85282 United States, California Investigative Site San Diego, California, United States, 92103 United States, Florida Investigative Site Jacksonville, Florida, United States, 32216 Investigative Site Jupiter, Florida, United States, 33458 United States, Kansas Investigative Site Overland Park, Kansas, United States, 66215 United States, Kentucky Investigative Site Madisonville, Kentucky, United States, 42431 United States, Massachusetts Investigative Site Wellesley Hills, Massachusetts, United States, 02481 United States, New Jersey Investigative Site Hackensack, New Jersey, United States, 07601 United States, New York Investigative Site Buffalo, New York, United States, 14202 United States, Texas Investigative Site Austin, Texas, United States, 78752 Investigative Site Dallas, Texas, United States, 75235 Less <<
NCT00171418 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Completed - United States, Louisiana ... More >> Drug Research Services, Inc Metairie, Louisiana, United States, 70001 United States, Oklahoma The Oklahoma Foundation for Digestive Research Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT03529084 Carcinoma, Non-small Cell Lung Phase 3 Withdrawn(strategic decision b... More >>y company) Less << May 31, 2024 -
NCT00166725 Prostate Cancer Phase 2 Completed - Italy ... More >> Orbassano Orbassano, Italy Less <<
NCT01513499 Eating Behavior Early Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00171470 Dyspepsia Phase 3 Completed - United States, New Jersey ... More >> http://www.novartisclinicaltrials.com/etrials/DiseaseID21/Dyspepsia-clinical-trials.go East Hanover, New Jersey, United States, 07936 Less <<
NCT00171483 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Completed - United States, Florida ... More >> Consultants for Clinical Research of South Florida Boynton Beach, Florida, United States, 33426 Miami Research Associates Miami, Florida, United States, 33173 University Clinical Research Pembroke Pines, Florida, United States, 33024 United States, North Carolina Department of Internal Medicine - Wake Forest University School of Medicine Winston Salem, North Carolina, United States, 27157 United States, Ohio Consultants for Clinical Research Cincinnati, Ohio, United States, 45219 United States, Virginia Metropolitan Research Fairfax, Virginia, United States, 22031 United States, Wisconsin The Wisconsin Center for Advanced Research Milwaukee, Wisconsin, United States, 53207 Less <<
NCT00171457 Heartburn Dys... More >>pepsia Less << Phase 3 Completed - United States, Oklahoma ... More >> Oklahoma Foundation for Digestive Research Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00219219 Prostate Cancer Phase 4 Completed - Italy ... More >> Bologna Bologna, Italy Less <<
NCT00238966 Renal Transplantation Phase 4 Completed - -
NCT00366002 Overactive Bladder (OAB) Phase 4 Completed - -
NCT00312143 De Novo Kidney Transplant Reci... More >>pients Less << Phase 4 Completed - -
NCT00243763 Multiple Myeloma Phase 1 Terminated - United States, Arizona ... More >> Mayo Clinic - Arizona Scottsdale, Arizona, United States, 85259 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic - Minnesota Rochester, Minnesota, United States, 55905 Less <<
NCT00171938 Glioblastoma Phase 2 Terminated - Brazil ... More >> Rio Grande, Brazil Less <<
NCT00333047 Metastatic Breast Cancer Phase 2 Phase 3 Completed - Germany ... More >> Kiel, Germany Less <<
NCT02198508 Beta-thalassemia Major Not Applicable Completed - -
NCT00242528 Multiple Myeloma Phase 4 Withdrawn - -
NCT00372710 Breast Cancer With Bone Metast... More >>asis Less << Phase 3 Terminated - Germany ... More >> Freiburg, Germany Less <<
NCT03625531 Polycystic Ovary Syndrome Phase 3 Not yet recruiting October 7, 2021 -
NCT00171613 Hypothalamic Obesity Phase 4 Completed - -
NCT00931710 Stage 2 Systolic Hypertension Phase 4 Completed - United States, New Jersey ... More >> sites in USA East Hanover, New Jersey, United States Less <<
NCT00728351 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01070043 - Completed - -
NCT01043874 Philadelphia Chromosome Positi... More >>ve Chronic Myelogenous Leukemia in Chronic Phase Less << Phase 4 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 453-8511 Novartis Investigative Site Nagoya-city, Aichi, Japan, 466-8560 Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 807-8556 Novartis Investigative Site Hiroshima-city, Hiroshima, Japan, 734-8551 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-8556 Novartis Investigative Site Sendai-city, Miyagi, Japan, 983-8520 Novartis Investigative Site Nagasaki-city, Nagasaki, Japan, 852-8501 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Osaka-city, Osaka, Japan, 545-8586 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8519 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Aomori, Japan, 030-8553 Novartis Investigative Site Gifu, Japan, 501-1194 Novartis Investigative Site Kyoto, Japan, 602-8566 Novartis Investigative Site Saga, Japan, 849-8501 Less <<
NCT01043874 - Completed - -
NCT00403637 Asthma Phase 2 Phase 3 Completed - United States, Colorado ... More >> Colorado Allergy and Asthma Centres, P.C. Denver, Colorado, United States, 80230 United States, Massachusetts Northeast Medical Research Associates, Inc. North Dartmouth, Massachusetts, United States, 02747 United States, Minnesota Clinical Research Institute Minneapolis, Minnesota, United States, 55402 United States, Missouri The Clinical Research Center St Louis, Missouri, United States, 63141 United States, North Carolina North Carolina Clinical Research Raleigh, North Carolina, United States, 27606 Less <<
NCT00399945 Cystic Fibrosis Phase 1 Completed - United Kingdom ... More >> Stoke on Trent, United Kingdom Less <<
NCT00931710 - Completed - -
NCT01746563 Diabetic Retinopathy ... More >> Retinal Diseases Eye Diseases Diabetic Angiopathies Vascular Diseases Cardiovascular Diseases Less << Phase 1 Phase 2 Completed - Brazil ... More >> Universidade of Sao Paulo Sao Paulo, Brazil, 05403-000 Less <<
NCT00035100 Ovarian Neoplasms ... More >> Peritoneal Neoplasms Fallopian Tube Neoplasms Less << Phase 2 Completed - United States, New Jersey ... More >> Novartis Investigative Site New Brunswick, New Jersey, United States, 08901 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Enschede, Netherlands, 7513 ER Novartis Investigative Site Zwolle, Netherlands, 8025 AB Slovakia Novartis Investigative Site Bratislava, Slovakia, 812 50 Novartis Investigative Site Kosice, Slovakia, 04190 United Kingdom Novartis Investigative Site Surrey, United Kingdom, SM2 5PT Less <<
NCT00600275 Solid Tumors ... More >>Breast Cancer Cowden Syndrome Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Nevada Nevada Cancer Center Las Vegas, Nevada, United States, 89135 United States, Texas Cancer Therapy and Research Center (CTRC) San Antonio, Texas, United States, 78229 Canada Princess Margaret Hospital Toronto, Canada Spain Novartis Investigative Site Barcelona, Spain Less <<
NCT01438996 Typhoid Fever Phase 2 Completed - Belgium ... More >> Centre for the Evaluation of Vaccination (CEV) Antwerp, Wilrijk, Belgium, 2610 Less <<
NCT01070043 Hypertension ... More >>High Blood Pressure Less << Phase 4 Completed - Taiwan ... More >> Taipei, Taiwan, 11217 Less <<
NCT00365820 Constipation Phase 2 Phase 3 Terminated(This study was term... More >>inated early as a result of regulatory action suspending tegaserod use in 2007) Less << - -
NCT00443898 - Completed - -
NCT00304525 Metastatic Melanoma Phase 2 Completed - United States, Colorado ... More >> University of Colorado Univ.ofColoradoCancerCenter Aurora, Colorado, United States, 80045 United States, Georgia Georgia Regents University Cancer Clinical Research Unit Augusta, Georgia, United States, 30912 United States, Maryland Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Dept of Cancer for Melanoma Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Dept.ofBethIsraelDeaconess(3) Boston, Massachusetts, United States, 02215 United States, Pennsylvania University of Pennsylvania Health System Dept of Hospital of UnivofPenn Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Dept of Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Vanderbilt University Medical Center Dept. of Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas University of Texas/MD Anderson Cancer Center Onc. Dept, Houston, Texas, United States, 77030-4009 Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 Less <<
NCT00443898 Onychomycosis Phase 3 Completed - -
NCT00219102 Hypertension ... More >>Diabetes Less << Phase 3 Completed - United States, North Carolina ... More >> Investigative Site Salisbury,, North Carolina, United States, 28144 Belgium Investigative Site Kortrijk, Belgium Romania Investigative Site Bucharest, Romania Spain Investigative Site Madrid, Spain Sweden Investigative Site Stockholm, Sweden Switzerland Novartis Pharmaceuticals Basel, Switzerland Ukraine Investigative Site Kiev, Ukraine Less <<
NCT00667719 Essential Hypertension Phase 3 Completed - United States, Texas ... More >> Investigative Site Houston, Texas, United States Belgium Investigative Site Belgium, Belgium Egypt Investigative Site Egypt, Egypt Germany Investigative Site Germany, Germany Poland Investigative Site Poland, Poland Slovakia Investigative Site Slovakia, Slovakia Spain Investigative Site Spain, Spain Turkey Investigative Site Turkey, Turkey Less <<
NCT00853957 Hypertension Phase 4 Completed - United States, Illinois ... More >> Investigative Site Chicago, Illinois, United States United States, Maryland Investigative Site Baltimore, Maryland, United States Investigative Site Oxon Hill, Maryland, United States United States, Michigan Investigative Site Detroit, Michigan, United States United States, New Jersey Investigative Site Trenton, New Jersey, United States United States, New York Investigative Site Brooklyn, New York, United States Investigative Site Springfield Gardens, New York, United States United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States United States, Wisconsin Investigative Site Milwaukeee, Wisconsin, United States Less <<
NCT00425997 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT00853957 - Completed - -
NCT00073528 Neoplasms, Breast Phase 3 Completed - -
NCT00073528 - Completed - -
NCT00631917 Hypertension Phase 4 Completed - United States, Missouri ... More >> Investigative Site Kansas City, Missouri, United States Argentina Investigative Site Investigative Site, Argentina Colombia Investigative Site Investigative Site, Colombia France Investigative Site Investigative Site, France Germany Investigative Site Investigative Site, Germany India Investigative Site investigative Site, India Spain Investigative Site Investigative Site, Spain Less <<
NCT00631917 - Completed - -
NCT00107016 Breast Neoplasm Phase 2 Completed - -
NCT01438996 - Completed - -
NCT00109707 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Hypereosinophilic Syndrome Systemic Mastocytosis Less << Phase 1 Phase 2 Completed - -
NCT00110266 Myelodysplastic Syndrome ... More >> Iron Overload Less << Phase 2 Completed - -
NCT00927394 - Completed - -
NCT02670928 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Completed - Russian Federation ... More >> Novartis Investigative Site Kazan, Russian Federation, 420012 Novartis Investigative Site Moscow, Russian Federation, 117036 Less <<
NCT00927394 Hypertension Phase 4 Completed - United States, Delaware ... More >> Investigative Site Newark, Delaware, United States, USA United States, Missouri Investigative Site Kansas, Missouri, United States United States, New Jersey Investigative Site Camden, New Jersey, United States United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States Less <<
NCT00107926 Bipolar Disorder Phase 3 Completed - -
NCT00124748 Leukemia, Myeloid, Chronic Pha... More >>se Less << Phase 3 Terminated(This study was prem... More >>aturely discontinued because no improvement was observed in the 800mg dose compared to 400mg dose) Less << - -
NCT00778921 Hypertension Phase 3 Completed - Argentina ... More >> Investigative Site Buenos Aires, Argentina Germany Investigative Site Berlin, Germany Norway Investigative Site Oslo, Norway Poland Investigative Site Warsaw, Poland Slovakia Investigative Site Bratislava, Slovakia Sweden Investigative Site Stockholm, Sweden Turkey Investigative Site Ankara, Turkey Less <<
NCT00778921 - Completed - -
NCT00171951 Cushing Disease Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Oregon Oregon Health & Sciences University Dept.ofOregonHealth&SciencesU. Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States, 19104-6149 France Novartis Investigative Site Paris, France, 75006 Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Muenchen, Germany, 80336 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 United Kingdom Novartis Investigative Site Belfast, United Kingdom, BT12 6BA Less <<
NCT00171249 Philadelphia Positive Chronic ... More >>Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York New York Presbyterian Hospital New York, New York, United States, 10021 United States, Oregon Oregon Health & Sciences University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center, University of Texas Houston, Texas, United States, 77030 France Novartis Investigative Site Pessac, France Novartis Investigative Site Poitiers, France Germany Novartis Investigative Site Frankfurt, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Mainz, Germany Novartis Investigative Site Mannheim, Germany Italy Novartis Investigative Site Monza, Italy United Kingdom Novartis Investigative Site London, United Kingdom Less <<
NCT00768040 Diabetic Macular Edema Phase 2 Terminated(Inadequate enrollme... More >>nt) Less << - United States, Arizona ... More >> Retinal Consultants of Arizona Phoenix, Arizona, United States United States, California Retina-Vitreous Associates Los Angeles, California, United States United States, Florida National Ophthalmic Research Institute Fort Myers, Florida, United States United States, Georgia Georgia Retina Atlanta, Georgia, United States United States, Maryland Elman Retina Group Baltimore, Maryland, United States United States, Massachusetts Joslin Clinic Boston, Massachusetts, United States, MA United States, Michigan Vitreo-Retinal Associates Grand Rapids, Michigan, United States United States, North Carolina Charlotte Eye, Ear, Nose and Throat Associate Charlotte, North Carolina, United States, NC United States, Ohio Retina-Associates of Cleveland, Inc Beachwood, Ohio, United States United States, Texas Retinal Consultants of Houston Houston, Texas, United States, TX Denmark Novartis Investigative Site Arhus, Denmark Novartis Investigative Site Copenhagen, Denmark Less <<
NCT00124748 - Terminated(This study was prem... More >>aturely discontinued because no improvement was observed in the 800mg dose compared to 400mg dose) Less << - -
NCT00768040 - Terminated(Inadequate enrollme... More >>nt) Less << - -
NCT00248170 Breast Cancer Phase 3 Completed - -
NCT00171223 Philadelphia Positive Chronic ... More >>Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Less << Phase 2 Completed - -
NCT00340834 Multiple Sclerosis Phase 3 Completed - -
NCT00171158 Philadelphia Positive Chronic ... More >>Myeloid Leukemia in Myeloid Blast Crisis Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Dana Faber Institute Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 France Novartis Investigative Site Poitiers, France Germany Novartis Investigative Site Frankfurt/Main, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Mannheim, Germany Novartis Investigative Site Muenchen, Germany Italy Novartis Investigative Site Bologna, Italy Novartis Investigative Site Monza, Italy Less <<
NCT00262990 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Neoplasms Less << Phase 3 Completed - -
NCT00340834 - Completed - -
NCT00171808 Endometrial Cancer Phase 2 Completed - Germany ... More >> Ebersberg, Germany Celle, Germany Heidelberg, Germany Ebersberg, Germany Novartis Investigative Site Freiburg, Germany Ebersberg, Germany Hamburg, Germany Novartis Investigative Site Hamburg, Germany Celle, Germany Hannover, Germany Tuebingen, Germany Heidelberg, Germany Novartis Investigative Site Karlsruhe, Germany Muenchen, Germany Kiel, Germany Muenchen, Germany Muenchen, Germany Novartis Investigative Site Muenchen, Germany Novartis Investigative Site Oberaudorf, Germany Novartis Investigative Site Rostock, Germany Novartis Investigative Site Tuebingen, Germany Hannover, Germany Wolfsburg, Germany Less <<
NCT00103740 - Completed - -
NCT00103740 Paget's Disease of Bone Phase 3 Completed - -
NCT00526045 Breast Cancer ... More >> Hematologic Neoplasms Less << Phase 1 Phase 2 Completed - United States, California ... More >> UCLA/ University of California Los Angeles UCLA Los Angeles, California, United States, 90095 United States, Georgia Georgia Health Sciences University Med College of GA Augusta, Georgia, United States, 30912 United States, Massachusetts Dana Farber Cancer Institute StudyCoordinator:CAUY922A2101 Boston, Massachusetts, United States, 02115 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. St. Louis, Missouri, United States, 63110 United States, Nevada Nevada Cancer Institute Clinical Trials Office Las Vegas, Nevada, United States, 89135 United States, Texas MD Anderson Cancer Center/University of Texas Thoractic Head/Neck Med.Onc(2) Houston, Texas, United States, 77030-4009 Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) San Antonio, Texas, United States, 78229 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Switzerland Novartis Investigative Site Bellinzona, Switzerland, 6500 United Kingdom Novartis Investigative Site Sutton, United Kingdom, SM2 5PT Less <<
NCT00302016 - - - -
NCT00150072 Chordoma Phase 2 Completed - Italy ... More >> Novartis Investigative Site Aviano, Italy Novartis Investigative Site Bologna, Italy Novartis Investigative Site Candiolo, Italy Novartis Investigative Site Firenze, Italy Novartis Investigative Site Milano, Italy Novartis Investigative Site Napoli, Italy Novartis Investigative Site Padova, Italy Novartis Investigative Site Pisa, Italy Novartis Investigative Site Roma, Italy Novartis Investigative Site Rozzano, Italy Novartis Investigative Site Torino, Italy Switzerland Novartis Investigative Site Lausanne, Switzerland Less <<
NCT00154336 Rheumatoid Arthritis Phase 2 Completed - Austria ... More >> Novartis Investigative site Graz, Austria, 8036 Novartis Investigative site Vienna, Austria, A-1090 Novartis Investigative site Vienna, Austria, A-1130 Canada, Manitoba Novartis Investigative site Winnipeg, Manitoba, Canada, R3A 1M1 Canada, Ontario Novartis Investigative site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec Novartis Investigative site Montréal, Quebec, Canada, H3Z 2Z3 Novartis Investigative site Sainte-Foy, Quebec, Canada, G1W 4R4 Finland Novartis Investigative site Helsinki, Finland, 00260 Novartis Investigative site Husu, Finland, 00029 United Kingdom Novartis Investigative site Cannock, Staffordshire, United Kingdom, WS11 2XY Novartis Investigative site Colchester, United Kingdom, CO4 5JL Novartis Investigative site Glasgow, United Kingdom, G11 6NT Novartis Investigative site Manchester, United Kingdom, M41 5SL Multiple Sites Multiple Cities, United Kingdom Novartis Investigative site Stoke-on-Trent, United Kingdom, ST6 7AG Less <<
NCT00149981 Organ Transplantation Phase 4 Completed - -
NCT01617668 Breast Cancer Phase 2 Completed - -
NCT01420055 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 4 Completed - France ... More >> Novartis Investigative Site Agen Cedex 9, France, 47923 Novartis Investigative Site Amiens Cedex 1, France, 80054 Novartis Investigative Site Angers Cedex 1, France, 49033 Novartis Investigative Site Auxerre, France, 89000 Novartis Investigative Site Avignon, France, 84000 Novartis Investigative Site Bayonne, France, 64109 Novartis Investigative Site Beziers, France, 34525 Novartis Investigative Site Bobigny Cedex, France, 93009 Novartis Investigative Site Brest, France, 29240 Novartis Investigative Site Calais, France, 62107 Novartis Investigative Site Castelnau-le-Lez, France, 34170 Novartis Investigative Site Chambray les Tours, France, 37175 Novartis Investigative Site Cherbourg, France, 50100 Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Créteil, France, 94010 Novartis Investigative Site Dijon, France, 21034 Novartis Investigative Site Epinal, France, 88021 Novartis Investigative Site Grenoble Cedex 9, France, 38042 Novartis Investigative Site Hagueneau, France, 67500 Novartis Investigative Site La Rochelle cedex 1, France, 17019 Novartis Investigative Site La Seyne sur mer, France, 83500 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Le Mans Cedex 09, France, 72037 Novartis Investigative Site Limoges, France Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Marseille, France, 13008 Novartis Investigative Site Marseille, France, 13012 Novartis Investigative Site Metz, France, 57085 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nimes, France, 32900 Novartis Investigative Site Orsay, France, 91401 Novartis Investigative Site Paris, France, 75005 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Pontoise, France, F-95300 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rennes Cedex, France, 35033 Novartis Investigative Site Roanne, France, 42328 Novartis Investigative Site Saint Aubin sur Scie, France, 76550 Novartis Investigative Site Saint Jean, France, 31243 Novartis Investigative Site Sainte Foy les Lyon, France, 69110 Novartis Investigative Site Saumur, France, 49400 Novartis Investigative Site Strasbourg Cedex, France, 67091 Novartis Investigative Site Talant, France, 21240 Novartis Investigative Site Toulouse, France, 31059 Novartis Investigative Site Tourcoing, France, 59200 Novartis Investigative Site Tours Cedex, France, 37044 Less <<
NCT00248170 - Completed - -
NCT01420068 - Completed - -
NCT01412944 Plaque-type Psoriasis Phase 3 Completed - -
NCT01412944 - Completed - -
NCT00072709 Amyotrophic Lateral Sclerosis Phase 2 Completed - United States, New Jersey ... More >> Novartis USA East Hanover, New Jersey, United States, 07936 Belgium Novartis Belgium Vilvoorde, Belgium Canada, Quebec Novartis CANADA Dorval, Quebec, Canada France Novartis France Rueil-Malmaison, France Germany Novartis Germany Nuernberg, Germany Italy Novartis Italy Saronno, Italy Netherlands Novartis Netherlands Arnhem, Netherlands Switzerland Novartis Switzerland Bern, Switzerland United Kingdom Novartis UK Frimley, United Kingdom Less <<
NCT01426789 Rheumatoid Arthritis Phase 2 Completed - -
NCT01576666 Dose Escalation ... More >> Safety Preliminary Efficacy Advanced Solid Tumors Metastatic Breast Cancer Advanced Pancreatic Adenocarcinoma Metastatic Colorectal Cancer Recurrent Glioblastoma Multiforme Gastric Cancer Gastroesophageal Junction Cancer Triple Negative Metastatic Breast Cancer Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer Less << Phase 1 Completed - -
NCT01426789 - Completed - -
NCT01404325 Lung Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Muenchen, Germany, 81377 Less <<
NCT01617668 - Completed - -
NCT01431638 Acute Gouty Arthritis Phase 3 Completed - -
NCT01433263 Cachexia Phase 2 Completed - United States, Arizona ... More >> Novartis Investigative Site Tucson, Arizona, United States, 85715 United States, Florida Novartis Investigative Site Tampa, Florida, United States, 33647 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60611-3308 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 United States, Ohio Novartis Investigative Site Canton, Ohio, United States, 44718 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78217 Lithuania Novartis Investigative Site Vilnius, Lithuania, LT 08661 Romania Novartis Investigative Site Bucharest, Romania, Sector 5 Switzerland Novartis Investigative Site St. Gallen, Switzerland, 9007 United Kingdom Novartis Investigative Site Edinburgh, United Kingdom, EH10 5HF Less <<
NCT01633060 Metastatic Breast Cancer Phase 3 Completed - -
NCT00056446 Colorectal Neoplasms ... More >> Colonic Neoplasms Rectal Neoplasms Less << Phase 3 Completed - -
NCT01715311 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 4 Withdrawn(withdrawn prior to p... More >>atient recruitment) Less << September 2013 -
NCT01433263 - Completed - -
NCT01724138 β-thalassemia Major Phase 4 Withdrawn October 2014 -
NCT01433250 - Completed - -
NCT01433250 Multiple Sclerosis Phase 2 Completed - Czech Republic ... More >> Novartis Investigative Site Hradec Kralove, Czech Republic, 500 05 Novartis Investigative Site Ostrava-Moravska Ostrava, Czech Republic Novartis Investigative Site Ostrava, Czech Republic Novartis Investigative Site Praha 2, Czech Republic, 128 08 Novartis Investigative Site Teplice, Czech Republic, 415 29 Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420021 Novartis Investigative Site Moscow, Russian Federation, 129128 Novartis Investigative Site Nizhny Novgorod, Russian Federation, 603155 Novartis Investigative Site Smolensk, Russian Federation, 214019 Ukraine Novartis Investigative Site Kharkiv, Ukraine, 61068 Novartis Investigative Site Kharkiv, Ukraine Novartis Investigative Site Kiev, Ukraine Novartis Investigative Site Odessa, Ukraine, 65025 Novartis Investigative Site Vinnitsya, Ukraine, 21005 Less <<
NCT00973700 Novel 2009 Influenza H1N1 Phase 3 Completed - Costa Rica ... More >> Instituto de Atencion Pediatrica, Avenida 0-2 Calle 22, Paseo Colon del Restaurante La, Bastilla 50 metros Sur, Edificio 5. San Jose, Costa Rica Less <<
NCT01744665 CML Phase 2 Active, not recruiting February 1, 2021 -
NCT00992212 Pandemic Influenza Disease Phase 2 Completed - Italy ... More >> 01 Chieti, 66100, Italy 05 Ferrara 44100, Italy 04 Genova 16132, Italy 02 Lanciano,66034, Italy 03 Mira 30034 Pianiga,, Italy Less <<
NCT01709812 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 4 Withdrawn July 2013 -
NCT01757015 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Withdrawn April 2014 -
NCT00380380 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Munich, 81377, Germany Munich, Germany Less <<
NCT01365494 Rabies Phase 4 Completed - India ... More >> Kempegowda Institute of Medical Sciences Hospital (KIMS) Bangalore, KA, India, 560070 Mandya Institute of Medical Sciences Mandya, KA, India, 571401 Padmashree Dr. D.Y Patil Hospital Pune, MS, India, 411018 Less <<
NCT01769768 Advanced Solid Tumor Phase 1 Completed - United States, California ... More >> City of Hope National Medical Center Oncology Duarte, California, United States, 91010 United States, Kansas University of Kansas Medical Center CBYM338B2203 Kansas City, Kansas, United States, 66160 United States, Massachusetts Massachusetts General Hospital Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New Hampshire Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock Med Ctr Lebanon, New Hampshire, United States, 03756 United States, New Jersey Hackensack University Medical Center Dept.of HackensackUniv.MedCtr. Hackensack, New Jersey, United States, 07601 United States, Pennsylvania University of Pennsylvania--Abramson Cancer Center Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 University of Pittsburgh Cancer Institute UPMC Cancer Pavilion Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Medical University of South Carolina Dept.of Neurosciences/MS Ctr. Charleston, South Carolina, United States, 29425 Cancer Centers of the Carolinas SC Greenville, South Carolina, United States, 29605 United States, Texas Utah Health Science Center at San Antonio San Antonio, Texas, United States, 78229 United States, Utah University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00035997 Prostate Cancer Phase 4 Completed - -
NCT00171795 Traumatic Brain Injury Phase 3 Completed - -
NCT00973700 - Completed - -
NCT01365494 - Completed - -
NCT01806610 Chronic-kidney Disease Stage 5... More >>D on Stable Hemodialysis Less << Phase 2 Withdrawn April 2014 -
NCT01791192 Acute Noninfectious Posterior,... More >> Intermediate, or Pan Uveitis Less << Phase 2 Withdrawn October 2014 -
NCT01824264 Type 2 Diabetes Mellitus Phase 2 Withdrawn November 2016 -
NCT01000207 Swine-Origin Influenza A H1N1 ... More >>Virus Less << Phase 2 Phase 3 Completed - Japan ... More >> Sites 1,2,3,4,5 Kagoshima, Japan Less <<
NCT00428389 - Completed - -
NCT00428389 Alzheimer's Disease Phase 3 Completed - -
NCT01831726 Tumor Pathway Activations Inhi... More >>bited by Dovitinib Less << Phase 2 Completed - -
NCT00435162 - Completed - -
NCT01837927 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Withdrawn April 2016 -
NCT00435162 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Sites in USA USA, New Jersey, United States Belgium Sites in Belgium Belgium, Belgium Brazil Sites in Brazil Brazil, Brazil France Sites in France Paris, France Hungary Sites in Hungary Hungary, Hungary India Sites in India India, India Italy sites in Italy Italy, Italy Poland Sites in Poland Poland, Poland South Africa Sites in South Africa South Africa, South Africa Sweden Sites in Sweden Sweden, Sweden Turkey Sites in Turkey Turkey, Turkey Less <<
NCT01833169 PI3K Pathway Activated Tumors Phase 2 Completed - -
NCT01833169 - Completed - -
NCT01845623 Asthma Phase 2 Withdrawn December 2013 -
NCT01865188 Hypertension Phase 3 Withdrawn April 2015 -
NCT01069367 Swine-Origin Influenza A H1N1 ... More >>Virus Less << Phase 4 Completed - Japan ... More >> CPC Clinic, Medipolis Medical Research Institute Kagoshima, Japan Less <<
NCT01868685 Mechanical Ventilation Phase 2 Withdrawn January 2015 -
NCT00084071 Pneumonia Phase 3 Completed - -
NCT01910441 Type 2 Diabetes Mellitus Phase 4 Terminated(The study was termi... More >>nated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.) Less << - -
NCT01910441 - Terminated(The study was termi... More >>nated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.) Less << - -
NCT01900782 Psoriasis Phase 3 Withdrawn June 2015 -
NCT01831726 - Completed - -
NCT00482248 Asthma Phase 3 Completed - -
NCT00482508 Asthma Phase 3 Completed - -
NCT01147081 Seasonal Influenza Phase 3 Completed - Germany ... More >> Universität Rostock/Medizinische Fakultät Ernst-Heydemann Str. 6, Rostock, Germany, 18057 Magdeburg, Sachsen-Anhalt, Germany, 39120 Hamburg, Germany, 20359 Less <<
NCT00468039 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Texas ... More >> Diabetes and Glandular Disease Research Associates San Antonio, Texas, United States, 78229 Less <<
NCT01941004 Multiple Sclerosis (Relapsing ... More >>Remitting) Less << Phase 3 Withdrawn May 2017 -
NCT01148524 - Completed - -
NCT01948817 Focus on Transfusion Dependent... More >> Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD Less << Phase 2 Withdrawn February 2016 -
NCT01922141 Hypertension Phase 4 Withdrawn June 2018 -
NCT01950481 Normal Hepatic Function ... More >> Impaired Hepatic Function Less << Phase 1 Completed - United States, Colorado ... More >> DaVita Clinical Research-Denver Lakewood, Colorado, United States, 80228 United States, Florida Avail. Clinical Research, LLC Deland, Florida, United States, 32720 Clinical Research of Miami, INC CLDK378A2110 Miami, Florida, United States, 33126 Orlando Clinical Research Center Orlando, Florida, United States, 32086 United States, Minnesota DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 Less <<
NCT01162122 Influenza Phase 3 Completed - -
NCT01148524 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 2 Phase 3 Completed - Chile ... More >> Centro de Salud Lo Barnechea Santiago, Chile Centro para vacunas en desarrollo. Hospital de Niños Roberto del Río Santiago, Chile Escuela de Medicina de la Universidad de Valparaíso Santiago, Chile Hospital Luis Calvo Mackenna Santiago, Chile Liceo Jose Victorino Lastarria Santiago, Chile Universidad de Chile. Facultad de Medicina Santiago, Chile Less <<
NCT00087659 Prostate Cancer Not Applicable Completed - United States, Arizona ... More >> Tucson VA Medical Center Tucson, Arizona, United States, 85723 United States, California VA Medical Center - Long Beach Long Beach, California, United States, 90822 United States, District of Columbia Washington VA Medical Center Washington, District of Columbia, United States, 20422 United States, Georgia Veterans Affairs Medical Center Augusta, Georgia, United States, 30904 Atlanta VA Medical Center Decatur, Georgia, United States, 30033 United States, Illinois West Sde Vamc Chicago, Illinois, United States, 60612 Hines VA Medical Center Hines, Illinois, United States, 60141 United States, Kentucky Louisville VAMC Louisville, Kentucky, United States, 40206 United States, Massachusetts West Roxbury VAMC West Roxbury, Massachusetts, United States, 02132 United States, Michigan John D. Dingell VA Medical Center Detroit, Michigan, United States, 48201 United States, Minnesota Department of Veterans Affairs Minneapolis, Minnesota, United States, 55417 United States, Missouri Kansas City VAMC Kansas City, Missouri, United States, 64128 United States, New Jersey Department of Veterans Affairs East Orange, New Jersey, United States, 07018 United States, New York VAWNY, Buffalo Buffalo, New York, United States, 14215 United States, Oregon Portland/Vancouver Portland, Oregon, United States, 97207 United States, South Carolina WJB Dorn Veteran Affairs Medical Center Columbia, South Carolina, United States, 29209 Less <<
NCT00134992 Healthy Phase 4 Completed - Germany ... More >> Kopfklinik der Ruprechts-Karls- Universität Heidelberg, Germany Less <<
NCT01151059 Seasonal Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini Chieti, Italy, 66100 Dipartimento di Medicina Clinica e Sperimentale - Sezione di Igiene e Medicina Preventiva, Via Fossato di Mortara, 64/b Ferrara, Italy, 44100 Dipartimento di Scienze della Salute Università di Genova Via Pastore, 1 Genova, Italy, 16132 Centro Satellite. ASL Lanciano - Vasto, sede legale Via S. Spaventa, 37 Lanciano, Italy, 66034 Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona, 20 Milano, Italy, 20127 Less <<
NCT00098735 Kidney Transplantation Phase 3 Completed - -
NCT01162122 - Completed - -
NCT00099736 Kidney Transplantation Phase 3 Completed - -
NCT00170729 Cataract Surgery Phase 4 Completed - -
NCT02069093 Advanced Breast Cancer Phase 2 Completed - -
NCT02756650 Behcet Disease Phase 2 Recruiting June 25, 2018 Turkey ... More >> Novartis Investigative Site Recruiting Istanbul, Turkey, 34093 Novartis Investigative Site Recruiting Mecidiyekoy/Istanbul, Turkey, 34394 Less <<
NCT01995734 - - - -
NCT02069886 Thalassemia (Transfusion Delen... More >>dent) Less << Phase 4 Withdrawn December 2018 -
NCT01272180 Invasive Meningococcal Disease Phase 2 Completed - United States, Alabama ... More >> Alabama Clinical Therapeutics, 806 St. Vincent's Drive, Suite 615 Birmingham, Alabama, United States, 35205 United States, California Madera Family Medical Group,1111 West 4th Street Madera, California, United States, 93637 Center for Clinical Trials LLC, 16660 Paramount Blvd, Suite 301 Paramount, California, United States, 90723 United States, Kentucky Kentucky Pediatric/Adult Research, 201 south 5th street Bardstown, Kentucky, United States, 40004 Bluegrass Clinical Research Inc.5512 Bardstown Road, Suite 2 Louisville, Kentucky, United States, 40291 United States, Ohio Ohio Pediatric Research Association, 7371 Brandt Pike, Suite C Huber Heights, Ohio, United States, 45424 Ohio Pediatric Research Association, 1775 Delco Park Drive Kettering, Ohio, United States, 45420 United States, Tennessee Focus Research Group,201 Signature Place Lebanon, Tennessee, United States, 37087 Poland Specjalistyczna Przychodnia Lekarska Internistyczno-Pediatryczna,,Juniperus"s.c, ul.Kościuszki 41 Izabelin (Warszawa), Poland, 05-080 NZOZ HIPOKRATES II.sp.zo.o, ul.Pachonskiego 12 Kraków, Poland, 31-223 NZOZ PRAKTIMED Sp.zo.o, ul.Strzelców 15 Kraków, Poland, 31-422 Klinika Pediatrii Centrum Medycznego Kształcenia PodyplomowegoSzpital Bielański, ul. Cegłowska 80 Warszawa, Poland, 01-809 Katedra i Klinika Pediatrii i Chorób Infekcyjnych, ul.O.Bujwida 44 Wrocław, Poland, 50-354 Less <<
NCT02069093 - Completed - -
NCT00705575 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Investigative Site East Hanover, New Jersey, United States, 07936 Argentina Investigative Site Buenos Aires, Argentina Ecuador Investigative Site Quito, Ecuador Germany Investigative Site Berlin, Germany Guatemala Investigative Site Guatemala City, Guatemala Italy Investigative Site Rome, Italy Switzerland Investigative Site Basel, Switzerland Turkey Investigative Site Ankara, Turkey Less <<
NCT01272180 - Completed - -
NCT00099749 Kidney Transplantation Phase 2 Phase 3 Completed - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 SIU School of Medicine Springfield, Illinois, United States, 62781 United States, New Jersey St. Barnabas Medical Center Livingston, New Jersey, United States, 07039 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT00706134 Hypertension Phase 3 Completed - Argentina ... More >> Investigative Site Buenos Aires, Argentina Czech Republic Investigative Site Prague, Czech Republic Germany Investigative Site Berlin, Germany Iceland Investigative Site Reykjavik, Iceland Italy Investigative Site Rome, Italy Netherlands Investigative Site Amsterdam, Netherlands Poland Investigative Site Warsaw, Poland Slovakia Investigative Site Bratislava, Slovakia Less <<
NCT00705575 - Completed - -
NCT01111162 HIV Infections Phase 4 Completed - United States, Pennsylvania ... More >> University of Pennsylvania. Clinical Trials Unit Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02159040 High Risk MDS Phase 2 Terminated - United States, Arkansas ... More >> Hematology Oncology Services of Arkansas HOSA 2 Little Rock, Arkansas, United States, 72205 United States, California City of Hope National Medical Center Oncology Duarte, California, United States, 91010 United States, Maryland University of Maryland Medical Center UM Greenbaum Cancer Ctr (2) Baltimore, Maryland, United States, 21201 United States, New York Rochester General Hospital / Lipson Cancer Center Lipson Cancer Center Rochester, New York, United States, 14621 United States, Tennessee The Jones Clinic Germantown, Tennessee, United States, 38138 United States, Utah Utah Cancer Specialists IHO Corp Salt Lake City, Utah, United States, 84106 Less <<
NCT02127697 Asthma Phase 3 Withdrawn May 2017 -
NCT00108108 Chronic Lymphocytic Leukemia Phase 1 Terminated(Slow enrollment and... More >> minimal preliminary biological and clinical efficacy.) Less << - United States, California ... More >> University of California San Diego StudyCoordinator:CHCD122A2101 La Jolla, California, United States, 92093-0658 United States, Indiana St. Francis Cancer Research Foundation Beech Grove, Indiana, United States, 46107 United States, Maryland The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Div Of HematologicMalignancies Baltimore, Maryland, United States, 21231 United States, Ohio OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 Columbus, Ohio, United States, 43210 United States, Texas MD Anderson Cancer Center/University of Texas Dept of MD Anderson CancerCent Houston, Texas, United States, 77030-4009 Less <<
NCT00706134 - Completed - -
NCT02159040 - Terminated - -
NCT01111162 - Completed - -
NCT00673608 Hemoglobinopathies ... More >> Myelodysplastic Syndromes Other Inherited or Acquired Anaemia MPD Syndrome Diamond-Blackfan Anemia Other Rare Anaemias Transfusional Iron Overload Less << Phase 4 Completed - Australia ... More >> Novarts Investigative Site Adelaide, Australia Novarts Investigative Site Brisbane, Australia Novarts Investigative Site Melbourne, Australia Novarts Investigative Site Sydney, Australia Less <<
NCT01346592 Influenza Disease Phase 3 Completed - Argentina ... More >> 401 Paideia Jeronimo Salguero 2835 Piso 1 Buenos Aires, Argentina 402 Hospital de Ninos Gallo 130 Buenos Aires, Argentina 403 Instituto Medico Rio Cuarto Hipolito Yrigoyen 1020 Cordoba, Argentina 405 Hospital Pediatrico Nino Jesus Castro Barros 650 Cordoba, Argentina 406 Hospital Nostra Senora de la Misericordia Belgrano 1500 Cordoba, Argentina 407 Centro Pediatrico Caballito Directorio 1658 Cuidad Automa de Beunos Aires, Argentina, 1406 409 Centro de Salud 16 Alpatacal y Chile Guaymallen, Argentina 408 Centro de Salud 31 Serpa y Republica del Libano Mendoza, Argentina Australia 206 Vaccine and Immunology Research Trials Unit University Department of Paediatrics 2nd floor Clarence Reiger Bldg Womens and Childrens Hospital Adelaide, Australia, 5006 201 Royal Children Hospital Department of Respiratory Medicine Herston, Australia, 4029 205 Vaccine and Immunisation Research Group Murdoch Childrens Research Institute School Of Population Health Level 5 207 Bouverie St, Australia 202 Sydney Children Hospital Department of Immunology and Infectious Diseases Randwick, Australia, 2031 204 National Centre for Immunisation Research and Surveillance Kids Research Institute The Childrens Hospital at Westmead Westmead, Australia, 2145 Chile 502 Hospital Clinico Pontificia Universidad Catolica de Chile Marcoleta 357 Santiago, Chile 503 Clinica Tabancura Av Tabancura 1185 Santiago, Chile Philippines 111 DLSHI deCastro De La Salle Health Sciences Institute DBB B Dasmarinas Cavite, Philippines, 4114 109 De La Salle Health Sciences Institute Dbbb Dasmarinas Cavite, Philippines, 4114 110 De La Salle Health Sciences Institute Dbbb Dasmarinas Cavite, Philippines, 4114 103 Philippine General Hospital Taft Avenue Manila, Philippines, 1000 107 Philippine General Hospital Taft Avenue Manila, Philippines, 1000 112 PGH Lim Philippine General Hospital Taft Avenue Manila, Philippines, 1000 114 Philippine General Hospital Taft Avenue Manila, Philippines, 1000 105 Mary Chiles General Hospital 667 Gastambide St Sampaloc Manila Manila, Philippines, 1008 106 Research Institute for Tropical Medicine Alabang Muntinlupa Muntinlupa, Philippines 108 RITM Research Institute for Tropical Medicine Department of Health Compound FILINVEST Corporate City Alabang Muntinlupa, Philippines 101 Philippine Childrens Medical Center Quezon Avenue cor Agham Road Quezon City Quezon City, Philippines 104 Philippine Childrens Medical Center Quezon Avenue cor Agham Road Quezon City Quezon City, Philippines 113 Philippine Childrens Medical Center Quezon Avenue cor Agham Road Quezon City Quezon City, Philippines 102 University of the East Ramon Magsaysay Memorial 64 Aurora Boulevard Barangay Dona Imelda Quezon, Philippines South Africa 305 Worthwhile Clinical Trials Lakeview Hospital 1 Mowbray Avenue Benoni, South Africa, 1500 304 Newgate Centre Suite 3 Johannesburg, South Africa, 2113 303 Emmed Research Pretoria, South Africa, 0084 301 Perinatal HIV Research Unit, Baragwanath Hospital Soweto, South Africa 302 Soweto Clinical Research Soweto, South Africa Less <<
NCT00420836 Cystic Fibrosis Phase 1 Completed - -
NCT01288092 Metastatic Breast Cancer Phase 2 Withdrawn - -
NCT02143622 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 1 Phase 2 Withdrawn August 2018 -
NCT01346592 - Completed - -
NCT00703703 Healthy Phase 1 Completed - United States, Arizona ... More >> Investigative Site Phoenix, Arizona, United States Investigative Site Tempe, Arizona, United States United States, Arkansas Investigative Site Little Rock, Arkansas, United States United States, California Investigative Site San Diego, California, United States United States, District of Columbia Investigative Site Washington, District of Columbia, United States United States, Florida Investigative Site Fort Myers, Florida, United States Investigative Site Jacksonville, Florida, United States Investigative Site Jupiter, Florida, United States Investigative Site Miami, Florida, United States Investigative Site Orlando, Florida, United States United States, Kansas Investigative Site Overland Park, Kansas, United States Investigative Site Topeka, Kansas, United States United States, Maryland Investigative Site Riverdale, Maryland, United States United States, Massachusetts Investigative Site Wellesley Hills, Massachusetts, United States United States, Missouri Investigative Site Springfield, Missouri, United States United States, New Jersey Investigative Site Hackensack, New Jersey, United States United States, North Carolina Investigative Site Burlington, North Carolina, United States Investigative Site Greensboro, North Carolina, United States United States, Oklahoma Investigative Site Oklahoma City, Oklahoma, United States United States, Tennessee Investigative Site Knoxville, Tennessee, United States United States, West Virginia Investigative Site Morgantown, West Virginia, United States Less <<
NCT01367158 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 2 Completed - Chile ... More >> CESFAM Gabriela Mistral: Aurora de Chile 9872 - San Ramón, Saniago, Chile Pontificia Universidad Catolica de Chile Marcoleta 350, Santiago, Chile Colombia CAFAM Avenida Carrera 68# 90-88 Piso 4, Bogota, Colombia Centro de Investigacion CafeSalud Medicina Prepagada Carrera 14 No. 94-49 PisoSexto, Bogota, Colombia CAIMED Carrera, Bogotá, Colombia, 42A # 17-50 Panama Indicasat: Clayton, ciudad del Saber Edificio 219, Panama City, Panama Health Research International: Centro Especializado san Fernando Piso numero 5, Consultorio 12; Via Espana, las Sabanas,, Panama city, Panama Less <<
NCT02228096 B-cell Acute Lymphoblastic Leu... More >>kemia Relapsed B-cell Acute Lymphoblastic Leukemia Refractory B-cell Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting December 5, 2022 United States, California ... More >> Childrens Hospital Los Angeles SC Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Georgia Children's Healthcare of Atlanta SC-2 Atlanta, Georgia, United States, 30342 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109-5941 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 United States, Missouri Mercy Children's Kansas University Kansas City, Missouri, United States, 64108 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27708 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45230 United States, Oregon Oregon Health & Science University SC Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas Southwestern Medical Center SC Dallas, Texas, United States, 75390-9034 United States, Utah University of Utah Salt Lake City, Utah, United States, 84113 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53705 Less <<
NCT00149903 Renal Transplant Phase 3 Completed - China ... More >> General Hospital, Friendship Hospital, Beijing, No 1 Hospital Peking University, Beijing China; Shanghai No 1 Hospital, Shanghai China; Changzheng Hospital, Shanghai, China; Shanghai Ruij Beijing, China Less <<
NCT00149916 Renal Transplant Phase 3 Completed - -
NCT00154232 Renal Transplantation Phase 4 Completed - -
NCT00170794 Cardiac Transplantation Phase 3 Completed - -
NCT02204553 - - - -
NCT00170833 Renal Transplantation Phase 3 Completed - -
NCT00171431 Constipation Predominant ... More >> Irritable Bowel Syndrome (IBS-C) Less << Phase 3 Terminated(This study was term... More >>inated early in May 2006 due to low patient enrollment) Less << - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT01412801 Streptococcal Infections ... More >> Gram-Positive Bacterial Infections Bacterial Infections Less << Phase 2 Completed - Malawi ... More >> Limbe Health Center Blantyre, Malawi South Africa Chris Hani Baragwanath Hospital Bertsham, South Africa, 2013 Less <<
NCT00238979 Renal Transplantation Phase 4 Completed - -
NCT01412801 - Completed - -
NCT00238992 Kidney de Novo Transplant Phase 3 Completed - -
NCT00239044 Kidney Transplant Recipients Phase 3 Completed - -
NCT00239876 Renal Transplantation Phase 3 Completed - -
NCT00238446 Patients Successfully Completi... More >>ng the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS Less << Phase 3 Completed - -
NCT00770081 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency Less << Phase 3 Completed - -
NCT00150007 Kidney Maintenance Transplant Phase 4 Completed - -
NCT01452438 - Completed - United States, California ... More >> Kaiser Permanente South California Pasadena, California, United States, 91101 Less <<
NCT02372084 Hepatic Impairment Phase 1 Completed - United States, Florida ... More >> University of Miami / Clinical Research Services, Inc. Boynton Beach Miami, Florida, United States, 33136 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Minnesota DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 Less <<
NCT00241046 Metastatic Breast Cancer Phase 4 Terminated - -
NCT00795418 Alzheimer's Disease Phase 2 Completed - United States, California ... More >> ATP Clinical Research Costa Mesa, California, United States, 92626 United States, Colorado Alpine Clinical Research Center Boulder, Colorado, United States, 80304 United States, Florida Sunrise Clinical Research Hollywood, Florida, United States, 33021 United States, Illinois Alexian Brothers Neuroscience Institute Elk Grove Village, Illinois, United States, 60007 United States, Indiana Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Kansas MidAmerica NeuroScience Research Foundation Lenexa, Kansas, United States, 66214 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Pennsylvania Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19102 United States, Tennessee NOCCR Knoxville Knoxville, Tennessee, United States, 37920 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390-9139 Less <<
NCT02038712 Obesity Binge... More >> Eating Disorder Less << Not Applicable Completed - -
NCT00805480 Chronic Plaque Psoriasis Phase 2 Completed - -
NCT01367158 - Completed - -
NCT00817414 Hypertension Phase 2 Completed - United States, California ... More >> Impact Clinical Trials Beverly Hills, California, United States, 90211 Associated Pharmaceutical Research Center, Inc Buena Park, California, United States, 90620 Innovative Clinical Research, Inc Harbor City, California, United States, 90710 Long Beach Center for Clinical Research Long Beach, California, United States, 90806 United States, Colorado Metro Clinical Research Littleton, Colorado, United States, 80120 United States, North Carolina Clinical Study Center of Asheville, LLC Asheville, North Carolina, United States, 28801 Northstate Clinical Research Lenior, North Carolina, United States, 28645 United States, Pennsylvania Tipton Medical & Diagnostic Center Tipton, Pennsylvania, United States, 16684 United States, Texas Punzi Medical Center Carollton, Texas, United States, 75006 dgd Research, Inc San Antonio, Texas, United States, 78229 Iceland Encode Clinic Reykjavik, SA, Iceland Less <<
NCT00805480 - Completed - -
NCT00817635 Hypertension Phase 2 Completed - -
NCT02388620 Normal Hepatic Function ... More >> Impaired Hepatic Function Less << Phase 1 Completed - United States, California ... More >> Anaheim Clinical Trials Anaheim, California, United States, 92801 United States, Florida University of Miami Coral Gables, Florida, United States, 33124 Orlando Clinical Research Center Orlando, Florida, United States, 32809 Less <<
NCT00540111 Hypertriglyceridemia ... More >> HIV Infections Less << Not Applicable Completed - -
NCT00822211 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> China-Japan Friendship Hospital Beijing, China General Hospital of Beijing Military Region of PLA Beijing, China Peking Union Medical College Hospital Beijing, China Peking University First Hospital Beijing, China The General Hospital of the PLA Beijing, China The General Hospital of the Second Artilleryman of PLA Beijing, China The Affiliated Union Hospital of Fujian Medical University Fuzhou, China The Fuzhou General Hospital of the PLA Nanjing Military Area Fuzhou, China Guangdong Provincial People's Hospital Guangzhou, China Second Affiliated Hospital of Nanchang University Nanchang, China The Jiangxi Provincial People's Hospital Nanchang, China Te Affiliated Drum Tower of Nanjing University Medical School Nanjing, China Tongji Hospital of Tongji University Nanjing, China Shanghai Changzheng Hospital Shanghai, China The Second Affiliated Hospital of China Medical University Shenyang, China The Second Affiliated Hospital of Tianjin Medical University Tianjin, China First Affiliated Hospital of 4th Military Medical University Xi'an, China Less <<
NCT00284921 De Novo Kidney Transplant Phase 3 Terminated - -
NCT00856193 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - United States, South Carolina ... More >> Spartanburg Medical Research Spartanburg, South Carolina, United States, 29303 Germany Harrison Clinical Research Deutschland GmbH Albrechtstrasse 14, Munich, Germany, 80636 Less <<
NCT00477269 Pulmonary Arterial Hypertensio... More >>n Less << Phase 2 Phase 3 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90073 United States, New Jersey Novartis investigative site Newark, New Jersey, United States, 07112 United States, New York Novartis Investigative Site New York, New York, United States, 10032 Austria Novartis Investigative Site Graz, Austria, A-8036 Novartis Investigative site Graz, Austria Germany Novartis Investigative Site Giessen, Germany, 35385 Novartis Investigative site Giessen, Germany Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative site Hannover, Germany United Kingdom Novartis Investigative Site Cambridge, Cambridgeshire, United Kingdom, CB23 3RE Novartis Investigative Site Glasgow, United Kingdom, G11 6NT Novartis Investigative site Glasgow, United Kingdom Novartis Investigative site Papworth, United Kingdom Less <<
NCT00477269 - Completed - -
NCT01317004 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Italy ... More >> Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Ponderano, BI, Italy, 13900 Novartis Investigative Site Caltanissetta, CL, Italy, 93100 Novartis Investigative Site Cuneo, CN, Italy, 12100 Novartis Investigative Site Como, CO, Italy, 22100 Novartis Investigative Site Catania, CT, Italy, 95122 Novartis Investigative Site Foggia, FG, Italy, 71100 Novartis Investigative Site Castelfiorentino, FI, Italy, 50051 Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site San Donato Milanese, MI, Italy, 20097 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Palermo, PA, Italy, 90129 Novartis Investigative Site Palermo, PA, Italy, 90146 Novartis Investigative Site Pisa, PI, Italy, 56126 Novartis Investigative Site Legnago, VR, Italy, 37045 Novartis Investigative Site Novara, Italy, 28100 Less <<
NCT01317004 - Completed - -
NCT00948766 Alzheimer's Disease Phase 4 Completed - -
NCT00300274 - Completed - -
NCT00948766 - Completed - -
NCT02624557 Hepatic Impairment Phase 1 Completed - United States, Colorado ... More >> DaVita Clinical Research-Denver Lakewood, Colorado, United States, 80228 United States, Florida University of Miami / Clinical Research Services, Inc. Miami, Florida, United States, 33136 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Minnesota DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 Less <<
NCT00371826 - Completed - -
NCT01680016 Rabies Phase 3 Completed - China, Guangxi ... More >> Mengshan Center for Disease Prevention and Control (CDC) Mengshan, Guangxi, China, 530028 Less <<
NCT00371826 Renal Transplanted Recipients Phase 4 Completed - Australia ... More >> Royal Prince Alfred Hospital NSW, Australia Westmead Hospital NSW, Australia Princess Alexandra Hospital QLD, Australia Monash Medical Centre Sale, Australia Queen Elizabeth Hospital Sale, Australia Royal Melbourne Hospital VIC, Australia Sir Charles Gairdner Hospital WA, Australia Less <<
NCT00300274 Graft Rejection Phase 3 Completed - -
NCT01680016 - Completed - -
NCT01433354 Fragile X Syndrome Phase 2 Phase 3 Terminated(The study treatment... More >> failed to demonstrate efficacy in target population in two other clinical studies (CAFQ056B2214 and CAFQ056A2212).) Less << - -
NCT01433354 - Terminated(The study treatment... More >> failed to demonstrate efficacy in target population in two other clinical studies (CAFQ056B2214 and CAFQ056A2212).) Less << - -
NCT01637272 Dumping Syndrome Phase 2 Completed - United States, California ... More >> Ximed Center for Weight Management Ximed Research La Jolla, California, United States, 92037 Stanford University Medical Center SC - SOM230X2203 Stanford, California, United States, 94304 United States, Minnesota Mayo Clinic - Rochester Mayo MN Rochester, Minnesota, United States, 55905 United States, New York Montefiore Medical Center CLCZ696B2320 Bronx, New York, United States, 10467 United States, Texas Texas Tech University Health Science Center El Paso, Texas, United States, 79905 United States, Virginia Virginia Endocrinology Research SC Chesapeake, Virginia, United States, 23321 Belgium Novartis Investigative Site Brugge, Belgium, 8310 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Pessac Cedex, France, 33604 Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Würzburg, Germany, 97080 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Utrecht, Netherlands, 3584CX Less <<
NCT01433445 Idiopathic Myelofibrosis ... More >> Post Essential Thrombocythemia Myelofibrosis Post Polycythemia-Vera Myelofibrosis Less << Phase 1 Active, not recruiting December 31, 2018 France ... More >> Novartis Investigative Site Paris, France, 75010 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Mainz, Germany, 55131 Ireland Novartis Investigative Site Dublin, Ireland, DUBLIN 8 Novartis Investigative Site Galway, Ireland Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Reggio Calabria, RC, Italy, 89124 Novartis Investigative Site Varese, VA, Italy, 21100 United Kingdom Novartis Investigative Site London, United Kingdom, SE1 9RT Less <<
NCT01919229 Early Breast Cancer Phase 2 Terminated(Due to low recruitm... More >>ent, it was decided to terminate the study.) Less << - United States, Arkansas ... More >> Highlands Oncology Group SC Fayetteville, Arkansas, United States, 72703 United States, California University of California at Los Angeles UCLA SC Los Angeles, California, United States, 90095 United States, Massachusetts Massachusetts General Hospital SC-9 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8) Houston, Texas, United States, 77030-4009 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT01436643 Depression Re... More >>lapsing-remitting Multiple Sclerosis Less << Phase 4 Terminated(Due to slow enrollm... More >>ent the study was terminated early) Less << - Germany ... More >> Novartis Investigative Site Achim, Germany, 28832 Novartis Investigative Site Altenholz-Stift, Germany, 24161 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Bad Honnef, Germany, 53604 Novartis Investigative Site Baesweiler, Germany, 52499 Novartis Investigative Site Berlin, Germany, 12621 Novartis Investigative Site Bielefeld, Germany, 33602 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44787 Novartis Investigative Site Bremerhaven, Germany, 27574 Novartis Investigative Site Butzbach, Germany, 35510 Novartis Investigative Site Grevenbroich, Germany, 41515 Novartis Investigative Site Heidenheim, Germany, 89518 Novartis Investigative Site Klingenmünster, Germany, 76889 Novartis Investigative Site Leipzig, Germany, 04275 Novartis Investigative Site Merzig, Germany, 66663 Novartis Investigative Site Nienburg, Germany, 31582 Novartis Investigative Site Oberhausen, Germany, 46045 Novartis Investigative Site Oldenburg, Germany, 26122 Novartis Investigative Site Potsdam, Germany, 14471 Novartis Investigative Site Schwalmstadt-Treysa, Germany, 34613 Novartis Investigative Site Stadtroda, Germany, 07646 Novartis Investigative Site Tübingen, Germany, 72076 Novartis Investigative Site Weil am Rhein, Germany, 79576 Novartis Investigative Site Zwickau, Germany, 08060 Less <<
NCT01919229 - Terminated(Due to low recruitm... More >>ent, it was decided to terminate the study.) Less << - -
NCT00856193 - Completed - -
NCT01491672 - Completed - -
NCT01491672 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center NY, New York, United States, 90033 Argentina Novartis Investigative Site Rio Negro, Viedma, Argentina, 8500 Novartis Investigative Site Tucuman, Argentina, T4000 Brazil Novartis Investigative Site Florianopolis, SC, Brazil, 88034-000 Novartis Investigative Site Barretos, SP, Brazil, 14784-400 Novartis Investigative Site São Paulo, SP, Brazil, 01246-000 Novartis Investigative Site São Paulo, SP, Brazil, 01509-900 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1784 China, Beijing Novartis Investigative Site Beijing, Beijing, China, 100730 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Guangzhou, China, 510060 Novartis Investigative Site Shanghai, China, 200032 Russian Federation Novartis Investigative Site Leningrad Region, Russia, Russian Federation, 188663 Novartis Investigative Site Moscow, Russia, Russian Federation, 125284 Novartis Investigative Site Nizhny Novgorod, Russia, Russian Federation, 603001 Novartis Investigative Site Obninsk, Russia, Russian Federation, 249036 Less <<
NCT01437735 Asthma Phase 2 Completed - -
NCT01637272 - Completed - -
NCT01135914 Diabetic Macular Edema Phase 3 Completed - Canada, Alberta ... More >> Calgary Retina Consultants Calgary, Alberta, Canada Canada, British Columbia UBC - Eye Care Center Vancouver, British Columbia, Canada Retina Consultants of Victoria Victoria, British Columbia, Canada Canada, Newfoundland and Labrador Memorial University Health Sciences Centre / Bense Eye Centre St-John's, Newfoundland and Labrador, Canada Canada, Nova Scotia Victoria General Hospital, Department of Ophthalmology Halifax, Nova Scotia, Canada Canada, Ontario Ivey Eye Institute London, Ontario, Canada Canadian Centre for Advanced Eye Therapeutics Mississauga, Ontario, Canada The Ottawa Hospital - General Campus Ottawa, Ontario, Canada St-Michael's Hospital - Dept of Ophthalmology Toronto, Ontario, Canada Sunnybrook Health Sciences Centre Toronto, Ontario, Canada Toronto Western Hospital Toronto, Ontario, Canada Canada, Quebec Clinique ChirurgiVision Drummondville, Quebec, Canada Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada Hôpital Notre Dame (CHUM) Montreal, Quebec, Canada Royal Victoria Hospital Montreal, Quebec, Canada Centre Oculaire de Québec Québec, Quebec, Canada Dr.Michel Giunta Clinique Médicale Sherbrooke, Quebec, Canada Canada, Saskatchewan Saskatoon City Hospital / Spadina Clinic Saskatoon, Saskatchewan, Canada Canada Institut de l'oeil des Laurentides Quebec, Canada Memorial University Health Sciences Centre / Newfoundland Drive Medical Clinic St-John's, Canada Less <<
NCT01436643 - Terminated(Due to slow enrollm... More >>ent the study was terminated early) Less << - -
NCT01605981 Chronic Myeloid Leukemia (CML) Phase 4 Withdrawn January 2017 Brazil ... More >> Novartis Investigative Site Fortaleza, CE, Brazil, 60115-290 Novartis Investigative Site Goiania, GO, Brazil, 74605-020 Novartis Investigative Site Belo Horizonte, MG, Brazil, 30130-100 Novartis Investigative Site Cuiaba, MS, Brazil, 033426-102 Novartis Investigative Site Porto Alegre, Porto Alegre-RS, Brazil Novartis Investigative Site Curitiba, PR, Brazil, 80060-900 Novartis Investigative Site Niterói, RJ, Brazil, 24030210 Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20.211-030 Novartis Investigative Site Porto Alegre, RS, Brazil, 90035-903 Novartis Investigative Site São José, Sao Paulo, Brazil, 15015-110 Novartis Investigative Site Florianopolis, SC, Brazil, 88034-000 Novartis Investigative Site Campinas, SP, Brazil, 13083-970 Novartis Investigative Site Jaú, SP, Brazil, 17210-080 Novartis Investigative Site Santo Andre, SP, Brazil, 09190-615 Novartis Investigative Site Santos, SP, Brazil, 11075-350 Novartis Investigative Site São Paulo, SP, Brazil, 05651-901 Novartis Investigative Site São Paulo, SP, Brazil, 08270-070 Novartis Investigative Site Sao Paulo, Brazil, 03454-000 Less <<
NCT01135914 - Completed - -
NCT01163227 Schizophrenia Disorders Phase 2 Completed - United States, California ... More >> PAREXEL (California Clinical Trials Medical Group), 1560 Chevy Chase Drive, Suite 140, Glendale, California, United States, 91206 United States, New Jersey CRI Worldwide, 1113 Hospital Dr. Suite 202, Willingboro, New Jersey, United States, 08046 Less <<
NCT01440374 Thrombocytopaenia Phase 2 Completed - -
NCT01155713 Neoplasm Canc... More >>er Tumors Less << Phase 1 Completed - United States, Arizona ... More >> Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service Scottsdale, Arizona, United States, 85258 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute Sarah Cannon Research Instit Nashville, Tennessee, United States, 37203 United States, Utah University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01640314 - Completed - -
NCT01636102 - Completed - -
NCT01640327 Human Influen... More >>za Less << Phase 3 Completed - Germany ... More >> University of Rostock, Department Tropical Medicine and Infectious Diseases Rostock, Mecklenburg-Western Pomerania, Germany, 18057 Less <<
NCT01440374 - Completed - -
NCT01651104 Human Influenza Phase 2 Completed - Belgium ... More >> University Hospital Ghent Center for Vaccinology De Pintelaan, BE-9000 Ghent, Belgium, 185 Less <<
NCT01651104 - Completed - -
NCT01636102 Human Influenza Phase 2 Completed - Belgium ... More >> University Hospital Ghent, Center for Vaccinology, Prof.Dr. G Leroux Roels Ghent, Belgium, BC001 Less <<
NCT01662440 Rabies Japane... More >>se Encephalitis Less << Phase 3 Completed - Austria ... More >> Institute of Specific Prophylaxis and Tropical Medicine Center for Pathophysiology, Infectious Diseases and Immunology Medical University of Vienna Kinderspitalgasse 15, Vienna, Austria, A-1090 Germany Bernhard Nocht Institute for Tropical Medicine Bernhard-Nocht-Strasse 74, Hamburg, Germany, D-20359 Switzerland The University of Zurich Rämistrasse 71, Zürich, Switzerland, CH-8006 Less <<
NCT00492063 Influenza Phase 3 Completed - Poland ... More >> Wojewódzki Szpital Dzieciecy ul. Langiewicza 2, Kielce, Poland, 25-381 N ZOZ Jagiellonskie, Centrum Medyczne Sp. z o.o. os. Jagiellonskie 1, Kraków, Poland, 31-832 Praktyka Grupowa Lekarzy POZ "Familia" Pl. Sikorskiego 6a, Kraków, Poland, 31-115 Szpital Jana Pawła II ul. Pradnicka 80, Kraków, Poland, 31-202 Centrum Farmakologii Klinicznej Krakow, Poland, 30-969 Less <<
NCT01640314 Influenza Phase 3 Completed - Germany ... More >> Bernhard Nocht Institute Bernhard-Nocht-Strasse 74, Hamburg, Germany, D-20359 Less <<
NCT00492063 - Completed - -
NCT01227577 Chronic Myelogenous Leukemia i... More >>n Chronic Phase Less << Phase 4 Completed - -
NCT00511914 - Completed - -
NCT01662440 - Completed - -
NCT00518453 Influenza Phase 2 Completed - United Kingdom ... More >> The Health Centre Suffolk, United Kingdom Less <<
NCT00511914 Seasonal Influenza Vaccine Phase 3 Completed - Germany ... More >> Betriebsaerztlicher Dienst, Standort Marburg Baldingerstrasse, Marburg Hessen, Germany, 35033 Z29, Blutspendezentrale, Gebaude Z29, Behringwerke Emil-von-Behring-Str. 76, Marburg, Germany, 35041 Less <<
NCT01228344 - Completed - United States, Georgia ... More >> Centers for Disease Control and Prevention,GA Atlanta, Georgia, United States Less <<
NCT00518726 Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio Via dei Vestini, Chieti, Italy Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto sede legale Via S. Spaventa, 37, Lanciano, Chieti, Italy Presidio Distrettuale No. 8 Azienda Sanitaria USL 7 di Siena Siena, Italy, 53100 Less <<
NCT01640327 - Completed - -
NCT01250171 - Completed - -
NCT01227577 - Completed - -
NCT01255462 Advanced Age-related Macular D... More >>egeneration Less << Phase 1 Completed - United States, Arizona ... More >> Retinal Consultants of Arizona, Phoenix, Arizona, United States, 85014 United States, California Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States, 90211 United States, Florida National Ophthalmic Research Institute Fort Myers, Florida, United States, 33912 Center for Retina and Macular Disease Winter Haven, Florida, United States, 33880 United States, Massachusetts Opthalmic Consultants of Boston Boston, Massachusetts, United States, 02114 United States, North Carolina Charlotte Eye, Ear, Nose and Throat Associates Charlotte, North Carolina, United States, 28210 United States, Texas Texas Retina Associates Dallas, Texas, United States, 75231 Retina Consultants of Houston Houston, Texas, United States, 77030 Less <<
NCT01734434 - Completed - -
NCT00537524 Prophylaxis of Avian Influenza Phase 2 Completed - Finland ... More >> University of Tampere Medical School Tampere, Finland, 33014 Less <<
NCT01250171 Dry Eye Phase 2 Completed - United States, Massachusetts ... More >> Ora Inc, 300 Brickstone Square, Andover, Massachusetts, United States, 01810 Less <<
NCT01257126 Upper Respiratory Tract Infect... More >>ions Less << Phase 4 Withdrawn - -
NCT01734434 - Completed - Dominican Republic ... More >> Centro Sanitario de Santo Domingo Santo Domingo, Dominican Republic Maternidad Nuestra Senora de La Altagracia Santo Domingo, Dominican Republic Mozambique CISM Manhica Health Research Centre Manhiça, Mozambique Panama Policentro Juan Diaz Panama City, Panama Policentro Parque Lefevre Panama City, Panama Policlínica JJ Vallarino Panama City, Panama South Africa Children's Infectious Diseases Clinical Research Unit Cape Town, South Africa, 7500 Setshaba Research Centre Gauteng, South Africa, 0152 Synexus Research Centre Gauteng, South Africa Respiratory and Meningeal Pathogens Research Unit Soweto, Johannesburg, South Africa Less <<
NCT01766921 Pandemic H5N1 Influenza Phase 2 Completed - United States, Arizona ... More >> 1 Tatum Highlands Med Ass PLLC Phoenix, Arizona, United States, 85253 United States, Florida 5 Broward Research Group Pembroke Pines Florida, Florida, United States, 33206 United States, Kansas 7 Heartland Rsrch Ass LLC Wichita, Kansas, United States, 67207 9 Heartland Research Associates Wichita, Kansas, United States, 67207 United States, Missouri 3 Saint Louis University St Louis, Missouri, United States, 63141 2 Mercy Health Research St. Louis, Missouri, United States, 63141 United States, New York 6 Regional Clinical Research Endwell, Endwell, New York, United States, 13760 United States, Texas 4 Benchmark Medical Research Austin, Texas, United States, 78705 12 Tekton Research Georgetown, Texas, United States, 78745 United States, Utah 8 J. Lewis Research Inc. Salt Lake City, Utah, United States, 84121 10 Foothill Family Clinic South Cottonwood Heights, Utah, United States, 84121 11 Jordan River Family Medicine South Jordan, Utah, United States, 84095 Australia, New South Wales 42 Hunter Clinical Research Newcastle, New South Wales, Australia, 2292 Australia, Queensland 44 Wesley Research Institute Clinical Trials Center Auchenflower, Queensland, Australia, 4066 Australia, South Australia 40 CMAX Adelaide, South Australia, Australia, 5000 Australia, Western Australia 41 Linear Clinical Research Nedlands, Western Australia, Australia, 6009 45 Childrens Clin Rsrch Facility Perth, Western Australia, Australia, 6872 New Zealand 50 Southern Clinical Trials Beckenham, Christchurch, New Zealand, 8244 51 Riccarton Clinic Riccarton, Christchurch, New Zealand, 8041 Thailand 72 Faculty of Medicine, Chulalongkorn University - Queen Saovabha Memorial Institute Bangkok, Thailand, 10330 71 Phramongkutklao Hospital Bangkok, Thailand, 10400 73 Siriraj Clinical Research Ctr Bangkok, Thailand, 10700 74 Chiang Mai Uni Hospital Clinical Trial Center Bangkok, Thailand, 50200 Less <<
NCT00560066 Seasonal Influenza ... More >> Vaccine Less << Phase 4 Completed - Germany ... More >> Balve, Germany Duisberg, Germany Garmisch-Partenkirchen, Germany Hannover, Germany Herborn, Germany Illingen, Germany Kiel, Germany Laufach, Germany Marburg, Germany Midlum, Germany Olpe, Germany Potsdam, Germany Regensburg, Germany Unterschleißheim, Germany Wiesbaden, Germany Less <<
NCT01766921 - Completed - -
NCT00348491 Pain Phase 4 Completed - United States, Texas ... More >> Dental Research Clinic Austin, Texas, United States, 78703 Less <<
NCT00561184 Avian Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini Chieti, Italy, 66100 01: Dipartimento di Scienze della Salute, Sezione Igiene e Medicina Preventiva, Università di Genova Genova, Italy, 16129 03: Ufficio di Igiene e Sanità Pubblica di Lanciano, ASL Lanciano -Vasto, Via Spaventa, 37, Lanciano, Italy, 66034 Less <<
NCT01776541 Pandemic H5N1 Influenza Phase 2 Completed - United States, Florida ... More >> 1 Miami Research Associates Miami, Florida, United States, 33143 United States, Missouri 2 Mercy Health Research St. Louis, Missouri, United States, 63141 3 Saint Louis University St. Louis, Missouri, United States, 63141 United States, Texas 4 Benchmark Medical Research Austin, Texas, United States, 78705 Australia, New South Wales 48 Hunter Clinical Research Newcastle, New South Wales, Australia, 2292 Australia, South Australia 46 CMAX Adelaide, South Australia, Australia, 5000 Australia, Western Australia 47 Linear Clinical Research Nedlands, Western Australia, Australia, 6009 Thailand 80 Faculty of Tropical Medicine Bangkok, Thailand, 1040 Less <<
NCT00992433 - Completed - -
NCT01289054 - Completed - United States, North Carolina ... More >> INC Research, LLC Wilmington, North Carolina, United States, 28405 Less <<
NCT00992433 Influenza Phase 2 Completed - United States, Iowa ... More >> University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland Baltimore - Institute of Human Virology Baltimore, Maryland, United States, 21201 United States, Missouri Saint Louis University St. Louis, Missouri, United States, 63104 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington University of Washington Seattle, Washington, United States, 98104 Less <<
NCT00751608 Familial Hypercholesterolemia Phase 2 Withdrawn - -
NCT01776554 - Completed - -
NCT01776554 Pandemic H5N1 Influenza Phase 2 Completed - United States, Florida ... More >> 3 Meridian Clinical Research Miami, Florida, United States, 68005 6 Meridian Clinical Research Miami, Florida, United States, 68134 United States, Kansas 7 Heartland Research Associates Wichita, Kansas, United States, 67114 5 Heartland Research Associates Wichita, Kansas, United States, 67207 9 Heartland Research Associates Wichita, Kansas, United States, 67207 United States, Missouri 1 Saint Louis University St. Louis, Missouri, United States, 63110 United States, Texas 10 Tekton Research Georgetown, Texas, United States, 78745 United States, Utah 4 Foothill Family Clinic South Cottonwood Heights, Utah, United States, 84121 8 Foothill Family Clinic South Cottonwood Heights, Utah, United States, 84121 United States, Washington 2 Rockwood Clinic P S Spokane, Washington, United States, 99204 Thailand 75 Phramongkutklao Hospital Bangkok, Thailand, 10400 76 Faculty of Tropical Medicine Mahidol University Bangkok, Thailand, 10400 Less <<
NCT01320358 Detection Accuracy ... More >> Patient Compliance Less << Phase 2 Completed - Switzerland ... More >> Kantonspital Aarau AG / Nephrologie Aarau, Switzerland, 5001 University Hospital Basel Basel, Switzerland, 4000 Inselspital Bern / Nephrology Bern, Switzerland, 3010 Stadtspital Waid Zurich Zurich, Switzerland, 8037 University Hospital Zurich Zurich, Switzerland, 8091 Less <<
NCT01776541 - Completed - -
NCT01290380 Solid Tumor Malignancies Phase 1 Terminated - United States, Texas ... More >> The University of Texas Science Center at Houston Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin & Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00616811 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00560066 - Completed - -
NCT00972816 Influenza Phase 2 Phase 3 Completed - -
NCT00613665 Helicobacter Pylori ... More >> Gastritis Gastric Cancer Gastroduodenal Ulcers Lymphoma Less << Phase 1 Completed - Germany ... More >> Universitaetsklinikum Charité Berlin, Germany, 10117 Less <<
NCT02786186 - Recruiting December 30, 2024 Argentina ... More >> Novartis Investigative Site Recruiting Caba, Buenos Aires, Argentina, C1024AAO Novartis Investigative Site Completed Caba, Buenos Aires, Argentina, C1055AAO Novartis Investigative Site Completed Caba, Buenos Aires, Argentina, C1062ABK Novartis Investigative Site Recruiting Caba, Buenos Aires, Argentina, C1181ACH Novartis Investigative Site Recruiting Caba, Buenos Aires, Argentina Novartis Investigative Site Completed Caba, Buenos Aires, Argentina Novartis Investigative Site Recruiting Ciudad Autonoma de Bs As, Buenos Aires, Argentina, C1055AAF Novartis Investigative Site Recruiting Ciudad Autonoma de Bs As, Buenos Aires, Argentina, C1425BEA Novartis Investigative Site Recruiting Buenos Aires, Argentina, C1425DKG Novartis Investigative Site Recruiting Ciudad Autonoma de Bs As, Argentina, C1428AAF Brazil Novartis Investigative Site Completed São Paulo, SP, Brazil, 01532000 Canada, Ontario Novartis Investigative Site Recruiting Peterborough, Ontario, Canada, K9J 5K2 Costa Rica Novartis Investigative Site Recruiting San José, San Jose, Costa Rica, Costa Rica Guatemala Novartis Investigative Site Recruiting Guatemala City, Ciudad DE Guatemala, Guatemala, 01010 Novartis Investigative Site Recruiting Guatemala City, Guatemala, 01011 Mexico Novartis Investigative Site Recruiting Mexicali, Baja California, Mexico, 21100 Novartis Investigative Site Recruiting Del Tlalpan, Ciudad De Mexico, Mexico, 14389 Novartis Investigative Site Recruiting Toluca, Estado De Mexico, Mexico, 50120 Novartis Investigative Site Recruiting Guadalajara, Jalisco, Mexico, 44636 Novartis Investigative Site Recruiting San Pedro Garza Garcia, Nuevo Leon, Mexico, 66220 Novartis Investigative Site Recruiting Monterrey, Nuevo León, Mexico, 64460 Novartis Investigative Site Completed Monterrey, Nuevo León, Mexico, 64710 Novartis Investigative Site Recruiting Aguascalientes, Mexico, 20127 Novartis Investigative Site Recruiting Guadalajara Jalisco, Mexico, 44610 Less <<
NCT01855945 Prophylaxis of A/H3N2v Influen... More >>za Less << Phase 1 Completed - United States, California ... More >> 51, Northern California Clinical Research Center Redding, California, United States, 96001 47, Benchmark Research Sacramento, California, United States, 95822 United States, Kansas 46, Johnson County Clinical Trials Lenexa, Kansas, United States, 66213 49, Heartland Research Associates, LLC Wichita, Kansas, United States, 67207 United States, Kentucky 43, Central Kentucky Research Associates Lexington, Kentucky, United States, 40509 United States, Louisiana 41, Benchmark Research Metairie, Louisiana, United States, 70006 United States, New York 44, Rochester Clinical Research Inc. Rochester, New York, United States, 14609 United States, North Carolina 50, PMG Research of Raleigh Raleight, North Carolina, United States, 27609 United States, Rhode Island 45, Omega Medical Research Warwick, Rhode Island, United States, 02886 United States, Texas 42, Research Acros Dallas, Texas, United States, 75234 United States, Utah 48, "J. Lewis Research, Inc. Salt lake City, Utah, United States, 84109 Less <<
NCT01373086 Hypertension Phase 2 Terminated - United States, California ... More >> Advanced Clinical Research Institute-Phase I Anaheim, California, United States, 92801 United States, Florida Comprehensive Phase I Fort Myers, Florida, United States, 333901 Comprehensive Phase One®, Miramar, Florida, United States, 33025 Comprehensive NeuroScience St Petersburg, Florida, United States, 33716 United States, Georgia Clinical Research Atlanta Stockbridge, Georgia, United States, 30281 United States, Nebraska Clinical Research Advantage/ Prairie Fields Family Medicine, PC Fremont, Nebraska, United States, 68025 Internal Medicine Physicians Omaha, Nebraska, United States, 68130 ICON Developmental Solutions Omaha, Nebraska, United States, 68154 United States, Nevada Clinical Research Advantage/ Aloha Medical Las Vegas, Nevada, United States, 89183 United States, Texas ICON Development Solutions, San Antonio, Texas, United States, 78209 United States, Washington Comprehensive Clinical Development NW, Inc. Tacoma, Washington, United States, 98418 Less <<
NCT01879540 - Completed - -
NCT01879553 Human Influenza Phase 2 Completed - Belgium ... More >> Ghent University & Hospital; CEVAC: Center for Vaccinology, Ghent, Belgium, 9000 Less <<
NCT00972816 - Completed - -
NCT01855945 - Completed - -
NCT01364415 Neuroendocrine Tumors Phase 1 Completed - United States, California ... More >> Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States, 90048 United States, Florida H. Lee Moffitt Cancer Center & Research Institute SC-1 Tampa, Florida, United States, 33612 United States, Massachusetts Dana Farber Cancer Institute SC-6 Boston, Massachusetts, United States, 02215 United States, Texas University of Texas/MD Anderson Cancer Center UT MD Anderson Cancer Ctr Houston, Texas, United States, 77030-4009 Less <<
NCT01879553 - Completed - -
NCT01880697 - Completed - -
NCT01377428 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 4 Withdrawn February 2012 -
NCT01880697 Human Influenza Phase 3 Completed - Germany ... More >> Rostock University, Department of Tropical Medicine and Infectious Diseases Ernst Heydemann Strasse 6, Rostock, Germany, 18057 Less <<
NCT00422825 Healthy Phase 1 Completed - -
NCT01879540 Human Influenza Phase 2 Completed - Belgium ... More >> Antwerp University Centre for the Evaluation of Vaccination Antwerpen, Wilrijk, Belgium, 2610 Less <<
NCT00338936 Hypertension Phase 3 Completed - -
NCT01376115 - Completed - Japan ... More >> University of Tsukuba Hospital Tsukuba, Japan Less <<
NCT00430937 Skin Diseases, Infectious ... More >> Soft Tissue Infections Less << Phase 3 Terminated - -
NCT01416311 - Active, not recruiting October 20, 2020 -
NCT00657683 Invasive Group B Streptococcus... More >> (GBS) Disease Less << Phase 1 Completed - Switzerland ... More >> Institute for Pharmacokinetic and Analytical Studies, I.P.A.S. S.A. Ligornetto, Switzerland, 6853 Less <<
NCT00350155 Healthy Volunteers Phase 4 Completed - Germany ... More >> Wiesbaden, Germany United Kingdom Nottingham, United Kingdom Less <<
NCT00430937 - Terminated - -
NCT01928472 - Completed - -
NCT01451450 Peanut Allergy Phase 2 Withdrawn - -
NCT00367939 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Less <<
NCT01928472 H7N9 Influenza Phase 1 Completed - United States, California ... More >> Site 04: Accelovance San Diego, California, United States, 92108 United States, Florida Site 01: Accelovance Melbourne, Florida, United States, 32935 United States, Illinois Site 02: Accelovance Peoria, Illinois, United States, 61602 United States, Maryland Site 03: Accelovance Rockville, Maryland, United States, 20850 United States, Utah Site 05: Janet Lewis Salt Lake City, Utah, United States, 84109 Site 06: Janet Lewis Salt Lake City, Utah, United States, 84121 Less <<
NCT00129831 COPD Phase 2 Completed - United States, California ... More >> Radiant Research Encinitas, California, United States, 92024 United States, Idaho Radiant Research Boise, Idaho, United States, 83704 Less <<
NCT00129818 Genital Herpes Phase 4 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Florida Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Indiana IU Center for Clinical STD Research Indianapolis, Indiana, United States, 46202 United States, North Carolina UNC Clinical Research - Raleigh Raleigh, North Carolina, United States, 27607 United States, Oklahoma Lynne Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Oregon Westover Heights Clinic Portland, Oregon, United States, 97210 United States, Washington University of Washington - Virology Research Clinic Seattle, Washington, United States, 98122 Less <<
NCT01441375 - Completed - United States, Louisiana ... More >> Tulane University New Orleans, Louisiana, United States, 70112 United States, Tennessee Universit of Tennessee Memphis, Tennessee, United States, 38163 Less <<
NCT01460849 - Active, not recruiting - -
NCT01460862 - Active, not recruiting - -
NCT01460836 - Completed - -
NCT00734734 Interpandemic Influenza Phase 2 Completed - Italy ... More >> Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto, sede legale Lanciano, Italy, 66034 Pianiga Distretto n. 2 - Area Sud - Azienda ULSS 13 Mirano -Via Nazionale 48 Pianiga, Italy, 30034 Less <<
NCT00734565 Haemophilus Influenzae Type b Phase 1 Completed - China ... More >> Vaccination site Shijiazhuang, China, 050800 Less <<
NCT00734734 - Completed - -
NCT00136773 Albuminuria Phase 4 Completed - -
NCT00735410 Seasonal Influenza, Vaccine Phase 3 Completed - Germany ... More >> Site 1, 2 and 3 Hessen, Germany, 35033 Less <<
NCT01426802 Type 2 Diabetes Mellitus Phase 4 Completed - Egypt ... More >> Investigative site Cairo, Egypt Less <<
NCT00154271 Hypertension Phase 4 Completed - -
NCT00171405 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Investigative Site East Hanover, New Jersey, United States Belgium Investigative Site Deurne, Belgium Canada Investigative Site Ste-Fov, Canada Germany Investigative Site Krassel, Germany Italy Investigative Site Broni, Italy Netherlands Investigative Site Rotterdam, Netherlands Peru Investigative Site Lima, Peru Russian Federation Investigative Site Moscow, Russian Federation Switzerland Investigative Site Basel, Switzerland United Kingdom Investigative Site London, United Kingdom Less <<
NCT00748150 Influenza Phase 2 Completed - United Kingdom ... More >> The Health Centre Heath Road, Woolpit, Bury St. Edmunds, Suffolk, United Kingdom, IP309QU Less <<
NCT00154258 Schizophrenia Phase 2 Completed - -
NCT00219037 Hypertension Phase 3 Completed - Germany ... More >> Investigative Sites, Germany Less <<
NCT00748813 Seasonal Influenza Phase 2 Completed - Italy ... More >> Site 1 Chieti, Italy, 66100 Site 2 Lanciano, Italy, 66034 Site 3 Pianiga, Italy, 30034 Less <<
NCT00171782 HYPERTENSION Phase 4 Completed - -
NCT00241072 Hypertension ... More >>Impaired Glucose Tolerance Less << Phase 4 Completed - -
NCT00241085 PROTEINURIA H... More >>ypertension Type 2 Diabetes Less << Phase 4 Completed - -
NCT00130351 Asthma Phase 3 Completed - United States, California ... More >> Allergy and Asthma Specialists Medical Group and Research Ct Huntington Beach, California, United States, 92647 Allergy and Asthma Medical Group & Research Center San Diego, California, United States, 92123 Allergy & Asthma Associates of Santa Clara Res. Center San Jose, California, United States, 95117 United States, Colorado Colorado Allergy and Asthma Centers, PC Denver, Colorado, United States, 80230 Colorado Allergy and Asthma Centers, PC Englewood, Colorado, United States, 80112 United States, Massachusetts Northeast Medical Research Associates, Inc. North Dartmouth, Massachusetts, United States, 02747 Northeast Medical Research Associates, Inc North Dartmouth, Massachusetts, United States, 02747 United States, Minnesota Clinical Research Institute Minneapolis, Minnesota, United States, 55402 United States, Missouri The Clinical Research Center St. Louis, Missouri, United States, 63141 United States, Nebraska The Asthma & Allergy Center, PC Papillion, Nebraska, United States, 68046 United States, North Carolina North Carolina Clinical Research Raleigh, North Carolina, United States, 27607 United States, Oregon Allergy Associates Research Center Portland, Oregon, United States, 97213 Less <<
NCT00241150 Hypertension ... More >>Metabolic Syndrome Less << Phase 4 Completed - -
NCT00238498 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT02285777 Meningococcal Disease Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Huntsville, Alabama, United States, 35802 United States, Arkansas GSK Investigational Site Jonesboro, Arkansas, United States, 72401 United States, Florida GSK Investigational Site Melbourne, Florida, United States, 32934 United States, Kansas GSK Investigational Site Newton, Kansas, United States, 67114 GSK Investigational Site Wichita, Kansas, United States, 67207 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40207 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68134 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44121 Less <<
NCT00241137 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Less <<
NCT00241098 Hypertension ... More >>Congestive Heart Failure Less << Phase 4 Completed - -
NCT00241124 Hypertension Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Less <<
NCT01531309 Hepatic Impairment Phase 1 Phase 2 Completed - United States, Florida ... More >> Orlando Clinical Research Center Orlando, Florida, United States, 32809 Less <<
NCT01529307 Advanced Solid Tumors Phase 1 Terminated - United States, Florida ... More >> H. Lee Moffitt Cancer Center/University of South Florida Moffitt SC Tampa, Florida, United States, 33612 United States, Texas South Texas Accelerated Research Therapeutics START San Antonio, Texas, United States, 789229 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman UT Salt Lake City, Utah, United States, 84103 Less <<
NCT00275912 Epilepsy, Partial Seizures Phase 4 Completed - Russian Federation ... More >> Regional Pediatric Clinical Hospital №1 EkaterinburgRegional Pediatric Clinical Hospital №1 Ekaterinburg, Russian Federation Moscow Scientific Research Institute of Pediatrics and Pediatric Surgery Moscow, Russian Federation Russian State Medical University clinically based on Russian Pediatric Clinical Hospital Moscow, Russian Federation Scientific-practical centre of children treatment suffering from craniofacial malformation and congenital pathology of nervous system Moscow, Russian Federation St. Petersburg State Pediatrics Medical Academy St Petersburg, Russian Federation Less <<
NCT00275925 Epilepsy, Partial Seizures Phase 4 Completed - Russian Federation ... More >> Epilepsy Department of the Moscow Research Institute of Psychiatry Moscow, Russian Federation Neurology and Neurosurgery Department of the Moscow State Medico-stomatology University Moscow, Russian Federation Neurology and Neurosurgery Department of the Russian State Medical University Moscow, Russian Federation Neurology Department of I.M. Sechenov Moscow Medical Academy Moscow, Russian Federation Neurology Department of Pediatric faculty of the Russian State Medical University Moscow, Russian Federation Neurology Department of the Moscow region Research Institute named after M.F. Vladimirskiy Moscow, Russian Federation Epilepsy Department of the V.M. Bekhterev Sant-Petersburg Psychoneurology Institute Saint Petersburg, Russian Federation Less <<
NCT02285777 - Completed - -
NCT00264849 - Completed - -
NCT02255279 - Completed - -
NCT00264849 Asthma Phase 4 Completed - -
NCT02255279 Influenza Phase 3 Completed - Mexico ... More >> 03, Centro Médico Universitario Colonia Chamilpa, Cuernavaca, Morelos, Mexico 02, Unidad de Atencion Medica E Investigacion En Salud S.C (Unamis) Mérida, Yucatán, Mexico 04, Medical Care and Research S.A. de C.V. Mérida, Yucatán, Mexico Less <<
NCT00289978 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 3 Completed - -
NCT00825305 Rabies Phase 3 Completed - China, Hebei ... More >> Jizhou City, Hebei, China, 053200 Less <<
NCT00825305 - Completed - -
NCT00841646 Prepandemic Influenza Vaccine Phase 2 Completed - Hungary ... More >> Pestlőrinc-Pestszentimre Egészségügyi Szolgáltató KFT Budapest, Hungary, 1183 Bács-Kiskun Megyei Kórház Tüdőgondozó Intézet Kecskemét, Hungary, 6000 Less <<
NCT00735020 Influenza Phase 1 Completed - Switzerland ... More >> I.P.A.S. Ligornetto, Switzerland, 36 6853 Less <<
NCT00300287 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Investigative Sites, Germany Less <<
NCT00312130 Pre-diabetes Phase 3 Completed - United States, Washington ... More >> University of Washington Seattle, Washington, United States, 98108 Less <<
NCT00289978 - Completed - -
NCT01193920 - Completed - -
NCT01617941 Patients With Migraine Equal o... More >>f /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening Less << Phase 2 Withdrawn November 2016 -
NCT03068949 Influenza Phase 4 Recruiting June 30, 2020 United States, New York ... More >> University of Rochester Medical Center, Vaccine Research Unit Room 3-5000 Recruiting Rochester, New York, United States, 14642 Contact: John J. Treanor, MD    585-275-5871    john_treanor@urmc.rochester.edu    Principal Investigator: John J. Treanor, MD Less <<
NCT01057277 Head and Neck Cancer Phase 1 Terminated(Pharmaceutical co- ... More >>re aligned their specialties- no longer will fund H&N ca) Less << - United States, Rhode Island ... More >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT01596647 Advanced Solid Tumors, Excludi... More >>ng Breast Cancer Less << Phase 1 Completed - United States, Kansas ... More >> University of Kansas Cancer Center Medical Center Kansas City, Kansas, United States, 66160 United States, Michigan Henry Ford Hospital Henry Ford Detroit, Michigan, United States, 48202-2689 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Nevada Comprehensive Cancer Centers Las Vegas, Nevada, United States, 89169 United States, New Jersey Cancer Institute of New Jersey Dept of Cancer Institute of NJ New Brunswick, New Jersey, United States, 08901 Less <<
NCT01649050 Muscle Spasticity Due to Multi... More >>ple Sclerosis Less << Phase 2 Withdrawn March 2018 -
NCT00914771 Pandemic H5N1 Influenza Phase 2 Completed - Poland ... More >> NZOZ Centrum Zdrowia "Blonie" Bydgoszcz, Poland Prakytka Lekarzy Rodzinnych "Salus" Katowice, Poland Szpital Internistyczny Krakow, Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Krakow, Poland Samodyielny Publiczny ZOZ Lubartow, Poland NZOZ Praktyka Lekarza Rodzinnego "Eskulap" Lubin, Poland Turkey Gazi Universitesi Tip Fakultesi Ankara, Turkey Hacettepe Universitesi Tip Fakultesi Ic Hastaliklan Ankara, Turkey T.C.S.B. Ankara Numune Egitim ve Arastirma Ankara, Turkey T.C.S.B.Ataturk Egitim ve Arastirma Hastanesi Ankara, Turkey Osmangazi Universitesi Tip Fakutesi Eskisehir, Turkey Enfeksiyon Hastaliklari ve Klinik Mikeoviyloji Izmir, Turkey Less <<
NCT00918268 Influenza Disease Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini Chieti, Italy, 66100 Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto, sede legale Via S. Spaventa, 37 ----- Satellite sites: (a) Distretto Sanitario di Base, Via Don Minzoni, Lanciano (CH) and (b) Distretto Sanitario di Base, Via Polidoro, Fossacesia (CH)) Lanciano, Italy, 66034 Pianiga Distretto n. 2 - Area Sud - Azienda ULSS 13 Mirano-Via Nazionale 48 Pianiga, Italy, 30030 Less <<
NCT01057277 - Terminated(Pharmaceutical co- ... More >>re aligned their specialties- no longer will fund H&N ca) Less << - -
NCT01193920 Streptococcal Infections Phase 1 Phase 2 Completed - South Africa ... More >> Chris Hani Baragwanath Hospital Chris Hani Rd, Soweto, Johannesburg, South Africa Less <<
NCT01628913 Pancreatic Neuroendocrine Tumo... More >>rs (pNET) Less << Phase 2 Terminated(This trial was term... More >>inated based on an interim analysis as BEZ235 did not demonstrate a progression free survival advantage to everolimus treatment.) Less << - United States, California ... More >> Cedars Sinai Medical Center SC-3 Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Univ Colorado Aurora, Colorado, United States, 80045 United States, Kentucky University of Kentucky Univ Kebtucky Lexington, Kentucky, United States, 40536-0098 United States, New York Montefiore Medical Center SC Bronx, New York, United States, 10467 France Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Montpellier Cedex 5, France, 34298 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Pisa, PI, Italy, 56126 Novartis Investigative Site Roma, RM, Italy, 00189 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1105 AZ Novartis Investigative Site Groningen, Netherlands, 9713 GZ Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420029 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28046 Switzerland Novartis Investigative Site Luzern, Switzerland, 6000 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G11 6NT Novartis Investigative Site London, United Kingdom, NW3 2QG Novartis Investigative Site London, United Kingdom, SE1 9RT Novartis Investigative Site Manchester, United Kingdom, M20 9BX Novartis Investigative Site Sheffield, United Kingdom, S10 2SJ Less <<
NCT01676948 Systemic Juvenile Idiopathic A... More >>rthritis Less << Phase 3 Withdrawn - -
NCT01456689 Multiple Myeloma Phase 1 Active, not recruiting December 27, 2018 United States, Illinois ... More >> Novartis Investigative Site Chicago, Illinois, United States, 60637 United States, Michigan Novartis Investigative Site Ann Arbor, Michigan, United States, +1 48109 0944 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Germany Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Spain Novartis Investigative Site Salamanca, Castilla Y Leon, Spain, 37007 Less <<
NCT01456676 Philadelphia Chromosome Positi... More >>ve Chronic Myelogenous Leukemia Less << Phase 1 Completed - Canada, Ontario ... More >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Marseille, France, 13273 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Roma, RM, Italy, 00161 Spain Novartis Investigative Site Pamplona, Navarra, Spain, 31008 Novartis Investigative Site Madrid, Spain, 28006 Less <<
NCT01621269 Multiple Sclerosis Phase 4 Withdrawn June 2014 -
NCT01470989 Acute Gouty Arthritis Flares Phase 3 Completed - -
NCT00631163 Chronic Anemia ... More >> Transfusional Hemosiderosis Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 453-8511 Novartis Investigative Site Nagoya, Aichi, Japan, 466-8560 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 814-0180 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8543 Novartis Investigative Site Nishinomiya, Hyogo, Japan, 663-8501 Novartis Investigative Site Kahoku-gun, Ishikawa, Japan, 920-0293 Novartis Investigative Site Kanazawa, Ishikawa, Japan, 920-8641 Novartis Investigative Site OsakaSayama, Osaka, Japan, 589-8511 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Shimotsuka-gun, Tochigi, Japan, 321-0293 Novartis Investigative Site Simotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Cyuo-ku, Tokyo, Japan, 104-8560 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-8639 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-8625 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 162-8666 Novartis Investigative Site Hiroshima, Japan, 734-8551 Novartis Investigative Site Kumamoto, Japan, 860-0811 Novartis Investigative Site Kyoto, Japan, 606-8507 Novartis Investigative Site Nagasaki, Japan, 852-8501 Novartis Investigative Site Toyama, Japan, 930-8550 Poland Novartis Investigative Site Warszawa, Poland, 02-097 Novartis Investigative Site Warszawa, Poland, 02-776 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Spain Novartis Investigative Site Salamanca, Castilla y Leon, Spain, 37007 Novartis Investigative Site Valencia, Spain, 46026 Turkey Novartis Investigative Site Adana, Turkey, 01330 Novartis Investigative Site Ankara, Turkey, 06100 Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Izmir, Turkey, 35040 Less <<
NCT01658436 Pancreatic Neuroendocrine Tumo... More >>rs (pNET) Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University SC Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute GastrointestionalCancer Clinic Boston, Massachusetts, United States, 02215 United States, New York Montefiore Medical Center SC-2 Bronx, New York, United States, 10467 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital SC Columbus, Ohio, United States, 43210 Austria Novartis Investigative Site Wien, Austria, A-1090 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Essen, Germany, 45147 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 4BX Less <<
NCT01772797 Anaplastic Lymphoma Kinase (AL... More >>K) Non-small Cell Lung Cancer Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado Dept. of Anschutz Cancer (3) Aurora, Colorado, United States, 80045 United States, Massachusetts Massachusetts General Hospital Mass General Boston, Massachusetts, United States, 02114 United States, Pennsylvania Fox Chase Cancer Center Fox Chase Cancer (2) Philadelphia, Pennsylvania, United States, 19111-2497 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States, 84103 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Italy Novartis Investigative Site Milano, MI, Italy, 20141 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT01628913 - Terminated(This trial was term... More >>inated based on an interim analysis as BEZ235 did not demonstrate a progression free survival advantage to everolimus treatment.) Less << - -
NCT01658436 - Completed - -
NCT01685060 - Completed - -
NCT00301236 ADHD, ADD Phase 3 Completed - -
NCT01478360 - Terminated(Further investigati... More >>ons would require changes in study design; the use of different endpoints, a different IL-17 antibody or a different patient population.) Less << - -
NCT01483014 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Brazil ... More >> Novartis Investigative Site Belo Horizonte, MG, Brazil, 30380-490 Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20230-130 Novartis Investigative Site Florianopolis, SC, Brazil, 88034-000 Novartis Investigative Site São Paulo, SP, Brazil, 01401-901 Novartis Investigative Site São Paulo, SP, Brazil, 01509-900 Novartis Investigative Site São Paulo, SP, Brazil, 05403-000 Novartis Investivative site Belo Horizonte, Brazil Novartis Investivative site Florianopolis, Brazil Novartis Investivative site Porto Alegre, Brazil Novartis Investivative site Rio de Janeiro, Brazil Novartis Investivative site Sao Paulo, Brazil Less <<
NCT01685060 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT01490125 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01478360 Asthma Phase 2 Terminated(Further investigati... More >>ons would require changes in study design; the use of different endpoints, a different IL-17 antibody or a different patient population.) Less << - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt, Germany, 60596 Novartis Investigative Site Grosshansdorf, Germany, 22927 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Wiesbaden, Germany, 65187 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE3 9QP Novartis Investigative Site London, United Kingdom, SE11YR Novartis Investigative Site London, United Kingdom, SW3 6PH Novartis Investigative Site Manchester, United Kingdom, M23 9QZ Less <<
NCT00320710 Breast Cancer Phase 3 Completed - -
NCT01474421 Dyskinesias D... More >>rug-induced Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Sacramento, California, United States, 95817 United States, New York Novartis Investigative Site Manhasset, New York, United States, 11030 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45219 Novartis Investigative Site Cleveland, Ohio, United States, 44195 France Novartis Investigative Site Bron, France, 69677 Novartis Investigative Site Clermont Fd, France, 63003 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Marseille cedex 05, France, 13385 Novartis Investigative Site Montpellier cedex 5, France, 34295 Novartis Investigative Site Nantes Cedex 1, France, 44093 Novartis Investigative Site Paris, France, 75013 Novartis Investigative Site Pessac, France, 33604 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Strasbourg, France, 67098 Novartis Investigative Site Toulouse cedex 9, France, 31059 Germany Novartis Investigative Site Berlin, Germany, 10178 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Gera, Germany, 07551 Novartis Investigative Site Haag, Germany, 83527 Novartis Investigative Site Kassel, Germany, 34128 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenchen, Germany, 80804 Novartis Investigative Site Tübingen, Germany, 72076 Italy Novartis Investigative Site Roma, RM, Italy, 00163 Less <<
NCT00461136 Diabetes Type 2 Phase 1 Phase 2 Completed - Denmark ... More >> Novartis Gentofte, Denmark, 2820 Less <<
NCT00320710 - Completed - -
NCT03063086 Asthma Phase 2 Recruiting August 2, 2018 Bulgaria ... More >> Novartis Investigative Site Recruiting Sofia, Bulgaria, 1612 China, Jilin Novartis Investigative Site Recruiting Changchun, Jilin, China, 130021 China Novartis Investigative Site Recruiting Shanghai, China, 200433 Germany Novartis Investigative Site Recruiting Berlin, Germany, 10117 Novartis Investigative Site Recruiting Frankfurt, Germany, 60596 Novartis Investigative Site Recruiting Grosshansdorf, Germany, 22947 Novartis Investigative Site Recruiting Hannover, Germany, 30625 Novartis Investigative Site Recruiting Wiesbaden, Germany, 65187 Netherlands Novartis Investigative Site Recruiting Groningen, GZ, Netherlands, 9713 United Kingdom Novartis Investigative Site Recruiting Manchester, United Kingdom, M23 9QZ Less <<
NCT00464880 Diabetes Type 2 Phase 1 Phase 2 Completed - Denmark ... More >> Novartis Gentofte, Denmark, 2820 Less <<
NCT03096847 Advanced Metastatic Breast Can... More >>cer Less << Phase 3 Recruiting September 30, 2019 -
NCT03205150 Obese Patients With Non-alcoho... More >>lic Steatohepatitis (NASH) Less << Phase 2 Recruiting October 1, 2019 United States, Florida ... More >> Novartis Investigative Site Recruiting Miami, Florida, United States, 33126 United States, Louisiana Novartis Investigative Site Recruiting Baton Rouge, Louisiana, United States, 70808 Novartis Investigative Site Recruiting New Orleans, Louisiana, United States, 70121 United States, Missouri Novartis Investigative Site Recruiting Saint Louis, Missouri, United States, 63110 United States, Tennessee Novartis Investigative Site Recruiting Knoxville, Tennessee, United States, 37920 United States, Texas Novartis Investigative Site Recruiting Live Oak, Texas, United States, 78233 Argentina Novartis Investigative Site Recruiting Caba, Buenos Aires, Argentina, C1056ABJ Novartis Investigative Site Recruiting Ciudad Autonoma de Bs As, Buenos Aires, Argentina, C1119ACN Novartis Investigative Site Recruiting Buenos Aires, Argentina, C1120AAC Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3P 3P1 Hong Kong Novartis Investigative Site Recruiting Hong Kong Island, Hong Kong Israel Novartis Investigative Site Recruiting Haifa, Israel, 343621 Novartis Investigative Site Recruiting Ramat Gan, Israel Novartis Investigative Site Recruiting Tel Aviv, Israel, 64239 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2333 CL Russian Federation Novartis Investigative Site Recruiting Moscow, Russian Federation, 117198 Taiwan Novartis Investigative Site Recruiting Chia-Yi, Taiwan, 60002 Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Thailand Novartis Investigative Site Recruiting Bangkok, Thailand, 10330 Novartis Investigative Site Recruiting Chiang Mai, Thailand, 50200 Less <<
NCT01698918 Hormone Receptor Positive Brea... More >>st Cancer Less << Phase 2 Active, not recruiting June 4, 2020 -
NCT03215758 Asthma Phase 3 Recruiting November 20, 2019 -
NCT03055494 Plaque Psoriasis Phase 4 Recruiting April 5, 2019 United States, Arkansas ... More >> Novartis Investigative Site Recruiting Hot Springs, Arkansas, United States, 71913 United States, California Novartis Investigative Site Recruiting Los Angeles, California, United States, 90033 Novartis Investigative Site Recruiting Santa Ana, California, United States, 92701 United States, Georgia Novartis Investigative Site Recruiting Atlanta, Georgia, United States, 30342 United States, Indiana Novartis Investigative Site Recruiting Indianapolis, Indiana, United States, 46256 United States, New Jersey Novartis Investigative Site Recruiting East Windsor, New Jersey, United States, 08520 Novartis Investigative Site Recruiting West Orange, New Jersey, United States, 07052 United States, New York Novartis Investigative Site Recruiting Buffalo, New York, United States, 14203 Novartis Investigative Site Active, not recruiting New York, New York, United States, 10025 1737 Novartis Investigative Site Recruiting New York, New York, United States, 10065 United States, Oregon Novartis Investigative Site Recruiting Portland, Oregon, United States, 97223 United States, Pennsylvania Novartis Investigative Site Recruiting Pittsburgh, Pennsylvania, United States, 15213-3403 United States, Texas Novartis Investigative Site Recruiting Webster, Texas, United States, 77004 United States, Utah Novartis Investigative Site Recruiting Murray, Utah, United States, 84107 United States, Virginia Novartis Investigative Site Recruiting Norfolk, Virginia, United States, 23507 United States, Wisconsin Novartis Investigative Site Completed Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00386750 Malaria Falci... More >>parum Less << Phase 4 Terminated - -
NCT03217422 Autoimmune Hepatitis Phase 2 Phase 3 Recruiting November 24, 2022 -
NCT00382187 Influenza Phase 2 Completed - Italy ... More >> Presidio Distrettuale N. 8, Azienda USL 7 di Siena, Via Savina Petrilli, 3 Siena, Italy, 53100 Less <<
NCT03249714 Relapsing Multiple Sclerosis Phase 2 Recruiting October 1, 2020 Japan ... More >> Novartis Investigative Site Recruiting Toon-city, Ehime, Japan, 791-0295 Novartis Investigative Site Recruiting Koriyama-city, Fukushima, Japan, 963-8052 Novartis Investigative Site Recruiting Morioka city, Iwate, Japan, 020 8505 Novartis Investigative Site Recruiting Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Recruiting Sendai-city, Miyagi, Japan, 983-8512 Novartis Investigative Site Recruiting Kawagoe, Saitama, Japan, 350 8550 Novartis Investigative Site Recruiting Kodaira, Tokyo, Japan, 187-8551 Novartis Investigative Site Recruiting Ota-ku, Tokyo, Japan, 145-0065 Novartis Investigative Site Recruiting Shinjuku ku, Tokyo, Japan, 162 8666 Novartis Investigative Site Recruiting Shinjuku-ku, Tokyo, Japan, 160-8582 Novartis Investigative Site Recruiting Toyama-city, Toyama, Japan, 930-0194 Novartis Investigative Site Recruiting Chiba, Japan, 260-8677 Novartis Investigative Site Recruiting Niigata, Japan, 951 8520 Novartis Investigative Site Recruiting Osaka, Japan, 556-0016 Less <<
NCT03226392 Asthma Phase 3 Recruiting November 20, 2019 -
NCT03259074 Ankylosing Spondylitis Phase 3 Recruiting January 20, 2022 -
NCT03287414 Idiopathic Pulmonary Fibrosis Phase 2 Recruiting April 6, 2022 United States, Alabama ... More >> Novartis Investigative Site Recruiting Birmingham, Alabama, United States, 35294-0007 United States, Florida Novartis Investigative Site Recruiting Miami, Florida, United States, 33136 United States, Maryland Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21224 United States, New Hampshire Novartis Investigative Site Recruiting Lebanon, New Hampshire, United States, 03756 Canada Novartis Investigative Site Recruiting Quebec, Canada, GIV 4G5 Ireland Novartis Investigative Site Recruiting Dublin, Ireland, DUBLIN 4 Italy Novartis Investigative Site Recruiting Modena, Italy, 41124 Less <<
NCT00415844 Healthy Phase 1 Completed - Germany ... More >> Novartis Investigative Site Nuernberg, Germany Less <<
NCT00416468 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT00416728 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT00403416 Kidney Transplantation Phase 1 Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143-0780 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106-5048 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-7375 Canada QE II Health Sciences Center Halifax, Canada, B3H 1V7 France Hopital Kremlin Bicetre Le Kremlin Bicetre, France, 94270 Hopital Hotel Dieu Nantes, France, 44035 Hopital Necker Paris, France, 75015 CHU de Rangueil Toulouse, France, 31403 Germany Universitaetsklinik Charite Berlin, Germany, 10117 Klinikum der Humboldt Universitat Charite Berlin, Germany, 13353 Universitaetsklinikum Essen Essen, Germany, 45122 Medizinische Hochschule Hannover Hannover, Germany, 30625 Univ. - Klinikum Heidelberg Heidelberg, Germany, 69120 Staedt. Krankenhaus Koeln-Merheim Koeln, Germany, 51109 Italy Az. Osp. Di Bologna Polici. S. Orsola - Malpighi Bologna, Italy, 40138 Azienda Opedaliera Careggi - Universita degli Studi Firenze, Italy, 50134 Azienda Ospedaliera di Padova - Universita degli Studi Padova, Italy, 35128 Spain Ciutat Santitaria I Univessitaria de Bellvitge Hospitalet de Llobregat, Spain, 08907 Hospital 12 de Octubre Madrid, Spain, 28041 Complejo Hospitalario Carlos Haya Malaga, Spain, 28041 Hospital Doctor Peset Valencia, Spain, 46017 Switzerland Universitatsspital Basel Basel, Switzerland, 4031 Inselspital Bern Bern, Switzerland, 3010 Universitätsspital Zürich Zürich, Switzerland, 8091 United Kingdom University Hospital of Wales Cardiff, United Kingdom, CF14 4XW Western Infirmary Glasgow, United Kingdom, G11 6NT Saint George's University of London London, United Kingdom Manchester Royal Infirmary Manchester, United Kingdom Less <<
NCT03257358 Relapsing Multiple Sclerosis Phase 4 Recruiting July 1, 2019 -
NCT00415883 Healthy Phase 1 Completed - India ... More >> Novartis Investigative Site Mumbai, India Less <<
NCT00416962 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT00415922 Healthy Phase 1 Completed - Germany ... More >> Novartis Investigative Site Nuernberg, Germany Less <<
NCT00416845 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT00418002 Healthy Phase 1 Completed - United Kingdom ... More >> Novartis Investigative Site Horsham, United Kingdom Less <<
NCT00417820 Psoriasis Phase 1 Completed - Austria ... More >> Novartis Investigative Site Vienna, Austria Less <<
NCT00421590 Health Postmenopausal Women Phase 2 Completed - Denmark ... More >> Novartis Investigative site Copenhagen, Denmark Less <<
NCT00424541 Hypertension Phase 1 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan, 160-8618 Less <<
NCT00424671 Healthy Phase 1 Completed - Czech Republic ... More >> Novartis Investigative site Prague, Czech Republic Less <<
NCT00426036 Healthy Phase 1 Completed - Czech Republic ... More >> Novartis Investigative site Prague, Czech Republic Less <<
NCT00839358 Renal Failure ... More >> Hyponatremia Sepsis Hepatic Encephalopathy Gastrointestinal Bleeding Less << Phase 4 Completed - Spain ... More >> Hospital Clinic Villarroel 170, Barcelona, Spain, 08870 Less <<
NCT00925873 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> GOELAMS Tours, France, 37000 Less <<
NCT00421226 Healthy Phase 1 Completed - Japan ... More >> Novartis Investigative site Tokyo, Japan Less <<
NCT00813436 Schizophrenia Phase 2 Unknown January 2010 Israel ... More >> Shalvata Mental Health Center Recruiting Hod Hasharon, Israel Contact: Yechiel Levkovitz, MD    972-9-7478697    ylevk@clalit.org.il    Principal Investigator: Yechiel Levkovitz, MD Less <<
NCT02042872 Disuse Osteoporosis Phase 4 Completed - United States, New Jersey ... More >> Kessler Institute for Rehabilitation West Orange, New Jersey, United States, 07052 Less <<
NCT01446250 - Terminated - -
NCT01191450 Arterial Hypertension Phase 3 Unknown November 2012 Brazil ... More >> Centro de Estudos de Diabetes e Hipertensão Recruiting Fortaleza, Ceará, Brazil Contact: Viviana    55 85 3105-8300    cedh@cedh.med.br    Principal Investigator: Adriana C Forti          CEDOES - Centro de Diagnóstico e Pesquisa de Osteoporose do Espírito Santo Recruiting Vitória, Espirito Santo, Brazil Contact: Ana Carolina    55 27 21250220    pesquisa2@cedoes.com.br    Principal Investigator: Daniela G Barbieri          Liga de Hipertensão Arterial - Universidade Federal de Goiás Recruiting Goiânia, Goiás, Brazil Contact: Ana Paula Souza    55 62 3269-8433    anapauladesouza@hotmail.com    Principal Investigator: Paulo Cesar V Jardim          UPECLIN - Unidade de Pesquisa Clínica da Faculdade de Medicina - UNESP Recruiting Botucatu, São Paulo, Brazil Contact: Mônica    55 14 3811-6574    mapaula@fmb.unesp.br    Sub-Investigator: Roberto Jorge S Franco          Centro de Pesquisa Clínica do IMC - Instituto de Moléstias Cardiovasculares Recruiting São José do Rio Preto, São Paulo, Brazil Contact: Clotilde    55 17 3203-4051    dcimc@imconline.com.br    Principal Investigator: José Carlos A Ayoub          Instituto de Moléstias Cardiovasculares de Tatuí Recruiting Tatuí, São Paulo, Brazil Contact: Lucas Frare    55 15 3305 1260    lucasfrare@yahoo.com.br    Principal Investigator: Fábio José C Fucci          Clínica Paulista de Doenças Cardiovasculares - FGM Recruiting São Paulo, Brazil Contact: Raquel    55 11 3373-7310       Principal Investigator: Fernando Augusto A Costa          Hospital Santa Marcelina Recruiting São Paulo, Brazil Contact: Isabel    55 11 2217-3766    isabelcpchsm@santamarcelina.org    Principal Investigator: Paulo Guilherme O Silva          Hospital São Camilo Recruiting São Paulo, Brazil Contact: Mariana Gonçalves    55 11 3677-4444 ext 5015    pesquisa.iep@saocamilo.com    Principal Investigator: Humberto Freitas          IMA - Instituto de Medicina Avançada Recruiting São Paulo, Brazil Contact: Daniela Fakih    55 11 38639156    daniela.fakih@imabrasil.com.br    Principal Investigator: Marise L Castro Less <<
NCT02042872 - Completed - -
NCT01083602 Relapsed and Bortezomib Refrac... More >>tory Multiple Myeloma Refractory Multiple Myeloma Multiple Myeloma in Relapse Less << Phase 2 Completed - United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 Stanford University Medical Center Division of Hematology Stanford, California, United States, 94305-5826 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States, 30322 Georgia Regents University MedCollege of GA Cancer Ctr 2 Augusta, Georgia, United States, 30912 United States, Illinois Hematology/Oncology of the North Shore Orchard Healthcare Res. Inc. Skokie, Illinois, United States, 60076 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2) Somerset, New Jersey, United States, 08873 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 United States, North Carolina Duke University Medical Center Dept. of DUMC (4) Durham, North Carolina, United States, 27710 United States, Tennessee Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC Nashville, Tennessee, United States, 37212 United States, Texas MD Anderson Cancer Center/University of Texas MD Anderson CC Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00848848 Influenza Phase 1 Completed - Belgium ... More >> Center For Vaccinology Ghent, Belgium, 9000 Less <<
NCT00422552 COPD Phase 1 Phase 2 Completed - United Kingdom ... More >> Novartis Investigative site Horsham, United Kingdom Less <<
NCT01421004 Advanced Solid Tumors ... More >> Excluding Breast Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope National Medical Center SC-2 Duarte, California, United States, 91010-3000 University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States, 90095 University of California San Francisco UCSF (SC) San Francisco, California, United States, 94101 United States, Florida Florida Cancer Specialists Sarasota Office Fort Myers, Florida, United States, 33901 United States, Illinois Rush University Medical Center Rush 3 Chicago, Illinois, United States, 60612 United States, Missouri Washington University School of Medicine SC St. Louis, Missouri, United States, 63110 United States, New York Montefiore Medical Center Montefiore Medical Center (SC) Bronx, New York, United States, 10467 United States, Oklahoma University of Oklahoma Health Sciences Center OUHSC - SC Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232-1305 United States, Tennessee Sarah Cannon Research Institute Sarah Cannon Research (SC) Nashville, Tennessee, United States, 37203 United States, Texas Sammons Cancer Center - Texas Oncology SC-2 Dallas, Texas, United States, 78246 Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5) San Antonio, Texas, United States, 78229 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States, 84112 United States, Wisconsin University of Wisconsin Univ Wisc Madison, Wisconsin, United States, 53792 Less <<
NCT01446250 Hepatitis C Phase 3 Terminated - United States, California ... More >> Novartis Investigational Site Beverly Hills, California, United States, 90211 United States, Maryland Novartis Investigational Site Baltimore, Maryland, United States, 21229 Less <<
NCT01083602 - Completed - -
NCT01752153 Immune Abnormalities Phase 1 Completed - Iran, Islamic Republic of ... More >> Department of Immunology, School of Medicine, Shiraz University of Medical Sciences Shiraz, Fars, Iran, Islamic Republic of Less <<
NCT00514488 Chronic Myeloid Leukemia Phase 3 Completed - Italy ... More >> Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Bologna, Italy Less <<
NCT00504595 Rheumatoid Arthritis Phase 2 Completed - Russian Federation ... More >> Novartis Investigative site Moscow, Russian Federation Spain Novartis investigative site Barcelona, Spain Switzerland Novartis Investigative site Bern, Switzerland Turkey Novartis investigative site Istanbul, Turkey Less <<
NCT01992081 COPD Phase 4 Withdrawn June 2015 -
NCT01567423 Malaria, Falciparum Not Applicable Completed - Congo, The Democratic Republic... More >> of the General reference hospital of Chamfubu Pweto, Katanga, Congo, The Democratic Republic of the Less <<
NCT00006370 Breast Cancer ... More >> Lung Cancer Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00414856 Gastroesophageal Reflux Diseas... More >>e Less << Phase 1 Completed - Belgium ... More >> Novartis Investigative site Brussels, Belgium France Novartis Investigative site Paris, France Germany Novartis Investigative Site Nuernberg, Germany Switzerland Novartis Investigative site Bern, Switzerland Less <<
NCT02126761 Influenza Phase 1 Completed - Germany ... More >> PAREXEL Early Phase Clinical Unit Berlin, Germany, 14050 Less <<
NCT00504595 - Completed - -
NCT01529645 Pertussis Who... More >>oping Cough Tetanus Lockjaw Diphtheria Less << Phase 1 Completed - Belgium ... More >> Center for Vaccinology (CEVAC), Ghent University Hospital De Pintelaan, B-9000 Ghent, Belgium, 185 Less <<
NCT01012557 H1N1v Influenza Not Applicable Completed - Denmark ... More >> COPSAC Gentofte/Copenhagen, Denmark, 2620 Næstved Hospital, Pediatric Department Næstved, Denmark, 4700 Less <<
NCT00093639 Leukemia Phase 1 Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01529645 - Completed - -
NCT00006368 Brain and Central Nervous Syst... More >>em Tumors Breast Cancer Gastrointestinal Carcinoid Tumor Islet Cell Tumor Lung Cancer Lymphoma Melanoma (Skin) Neoplastic Syndrome Less << Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT02299310 Chronic Kidney Disease Phase 4 Unknown December 2015 China, Beijing ... More >> Chinese PLA General Hospital Beijing, Beijing, China, 100853 Less <<
NCT02365519 - Completed - -
NCT02624570 - - - -
NCT03613220 HR+ HER2 Breast Cancer Phase 2 Not yet recruiting December 28, 2018 -
NCT00005073 Prostate Cancer Phase 3 Terminated - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT03437278 Chronic Spontaneous Urticaria Phase 2 Not yet recruiting March 17, 2020 -
NCT03574545 Rheumatoid Arthritis Phase 1 Not yet recruiting September 2, 2021 -
NCT01324960 Myelodysplastic Syndromes Phase 1 Phase 2 Withdrawn December 2014 France ... More >> CHU de Bicêtre Le Kremlin-Bicêtre, Ile de France, France, 94275 CHU Cochin Paris, Ile de France, France, 75679 CHU d'Amiens Amiens, France, 80054 CHU Angers Angers, France, 43033 CH d'Avignon Avignon, France, 84000 Hôpital de la Côte Basque Bayonne, France, 64100 Hopital Avicenne Bobigny, France, 93009 CHU de Caen Caen, France, 14033 CHU de Clermont Ferrand, France, 63058 Centre Hospitalier Sud-Francilien Corbeil-Essonnes, France, 91106 CHU Grenoble Grenoble, France, 38043 Hôpital Versailles Le Chesnay, France, 78157 Hôpital Saint Vincent Lille, France, 59020 CHRU Hurriez Lille, France, 59057 CHRU Limoges Limoges, France, 87046 Hôpital Edouard Heriot, dpt Hématologie Clinique Lyon, France, 69437 Hôpital Paoli-Calmettes Marseille, France, 13273 Hematology Dpt, Hopital de l'Hotel Dieu Nantes, France, 44093 CHU Archet Nice, France, 06202 Hopital Saint Louis Paris, France, 75475 Hôpital Saint Antoine Paris, France, 75571 Centre Hospitalier Joffre Perpignan, France, 66046 Hôpital Jean-Bernard Poitiers, France, 86021 CHRU de Reims Reims, France, 51092 Centre Henri Bequerel Rouen, France, 76038 Centre Hospitalier Universitaire de STRASBOURG Strasbourg, France, 67098 Hopital Purpan Service d'Hématologie Clinique Toulouse, France Hopital Bretonneau Tours, France, 37044 Less <<
NCT03517566 Atopic Dermatitis Phase 2 Not yet recruiting August 15, 2019 -
NCT03629249 Asthma Bronch... More >>ial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Physiological Effects of Drugs Less << Phase 4 Not yet recruiting May 27, 2021 -
NCT03601442 - - - -
NCT02365519 Dry Eye Phase 2 Completed - -
NCT03656562 Systemic Lupus Erythematosus (... More >>SLE) Less << Phase 2 Not yet recruiting January 25, 2024 -
NCT00409643 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Sites in Germany Germany, Germany Less <<
NCT03589885 Plaque Psoriasis Phase 3 Not yet recruiting May 11, 2020 -
NCT03681093 Asthma Nasal ... More >>Polyps Bronchial Diseases Lung Diseases Nose Diseases Respiratory Hypersensitivity Hypersensitivity Less << Phase 3 Not yet recruiting July 6, 2020 -
NCT03696771 NON-breast HER2+ Malignancies Phase 1 Not yet recruiting June 8, 2021 -
NCT03663335 Kidney Transplant Rejection Phase 2 Not yet recruiting September 9, 2022 -
NCT03713619 Hidradenitis Suppurativa Phase 3 Not yet recruiting April 22, 2022 -
NCT03706573 - - - -
NCT03720626 - - - -
NCT03647488 Carcinoma, Non-Small-Cell Lung Phase 2 Not yet recruiting December 22, 2021 -
NCT03751280 Schizophrenia Phase 2 Not yet recruiting October 14, 2019 -
NCT03713632 Hidradenitis Suppurativa Phase 3 Not yet recruiting April 22, 2022 -
NCT03769168 Juvenile Psoriatic Arthritis ... More >> Enthesitis Related Arthritis Less << Phase 3 Not yet recruiting November 27, 2024 -
NCT03765788 Giant Cell Arteritis Phase 2 Not yet recruiting August 30, 2021 -
NCT03718533 Poor Graft Function Phase 2 Not yet recruiting March 1, 2021 Spain ... More >> Hospital de la Santa Creu i Sant Pau Not yet recruiting Barcelona, Spain Hospital Ramón y Cajal Not yet recruiting Madrid, Spain Hospital Carlos Haya Not yet recruiting Málaga, Spain Hospital Son Espases Not yet recruiting Palma de Mallorca, Spain Hospital Universitario de Salamanca Not yet recruiting Salamanca, Spain Hospital Universitario de Donosti Not yet recruiting San Sebastián, Spain, 20014 Hospital Clínico de Valencia Not yet recruiting Valencia, Spain Hospital Alvaro Cunqueiro Not yet recruiting Vigo, Spain Less <<
NCT00452270 Common Cold Phase 3 Completed - United Kingdom ... More >> Novartis Investigative Site Cardiff, Wales, United Kingdom Less <<
NCT00213590 Kidney Transplantation ... More >> Primary Prevention Kidney Failure Less << Phase 3 Completed - -
NCT03756129 Depressive Disorder, Treatment... More >>-Resistant Less << Phase 2 Not yet recruiting March 10, 2020 -
NCT02494206 Breast Cancer ... More >> Upper Extremity Lymphedema Less << Not Applicable Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02253277 Chronic Myeloid Leukemia Phase 1 Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Mannheim, Germany, 68169 Less <<
NCT02989402 Alzheimer's Disease Phase 4 Not yet recruiting February 3, 2020 -
NCT02987660 Myopia Astigm... More >>atism Less << Not Applicable Terminated(management decision... More >> with no risk to patient safety) Less << - France ... More >> Alcon Investigative Site Paris, France, 75008 Less <<
NCT01162824 Endothelial Dysfunction ... More >> Atherosclerosis Inflammation Myocardial Ischemia Less << Not Applicable Unknown December 2011 United Kingdom ... More >> Department of Cardiology, St George's Healthcare NHS Trust Recruiting London, England, United Kingdom, SW17 0RE Contact: Peter E Ong, MD    +44208725 ext 2628    pong@sgul.ac.uk    Sub-Investigator: Peter E Ong, MD Less <<
NCT00416442 Healthy Phase 1 Completed - United Kingdom ... More >> Novartis Investigative Site Horsham, United Kingdom Less <<
NCT00550095 Microalbuminuria ... More >> Proteinuria Less << Phase 4 Completed - Egypt ... More >> Novartis Investigative Site , Cairo, Egypt Less <<
NCT01027481 Retinal Vein Occlusion Phase 4 Completed - Austria ... More >> Vienna General Hospital Vienna, Austria, 1090 Less <<
NCT02494206 - Completed - -
NCT01402440 Diffuse Large B-Cell Lymphoma Phase 1 Terminated(Study terminated du... More >>e to enrolment challenges and availability of other options for DLBCL patients. The termination is not a consequence of any safety concern.) Less << - -
NCT00703079 - Completed - Italy ... More >> Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples Naples, Italy, 80131 Less <<
NCT01561066 Enterocutaneous Fistulas ... More >> Intra-abdominal Infection Less << Phase 1 Completed - China, Jiangsu ... More >> Department of Surgery, Jinling Hospital Nanjing, Jiangsu, China, 210002 Less <<
NCT00254475 Essential Hypertension ... More >> Hypercholesterolemia Less << Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00260923 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT01398592 Diabetes Mellitus Type 2 Phase 4 Completed - Germany ... More >> Novartis Investigative Site Bad Oeynhausen, Germany, 32549 Novartis Investigative Site Berlin, Germany, 12347 Novartis Investigative Site Berlin, Germany, 13597 Novartis Investigative Site Berlin, Germany, 14089 Novartis Investigative Site Celle, Germany, 29221 Novartis Investigative Site Hannover, Germany, 30165 Novartis Investigative Site Hannover, Germany, 30167 Novartis Investigative Site Kassel, Germany, 34117 Novartis Investigative Site Kirchhain, Germany, 35274 Novartis Investigative Site Lehrte, Germany, 31275 Novartis Investigative Site Mülheim, Germany, 45468 Novartis Investigative Site Oberhausen, Germany, 46049 Novartis Investigative Site Osnabrück, Germany, 49080 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Stuttgart, Germany, 70378 Less <<
NCT00311441 Encephalitis, Tick-Borne Phase 4 Completed - Germany ... More >> Weilheim, Germany Less <<
NCT00310687 Prevention of Meningococcal In... More >>fection Less << Phase 4 Completed - United Kingdom ... More >> Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Headington, Oxfordshire, United Kingdom, OX3 9DU Less <<
NCT00133627 Seasonal Allergic Conjunctivit... More >>is Less << Phase 4 Completed - China ... More >> Hospital of Shanghai Medical University Shanghai, China Less <<
NCT01129622 Breast Cancer Phase 2 Completed - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5T 3H7 Less <<
NCT00304226 Hypertension Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00310635 Meningococcal Infection Phase 4 Completed - Germany ... More >> Mainz, Kehl, Traunreut, Mühldorf am Inn, Bad Sobernheim, Bad Kreuznach, Baldham, Speyer, Oppenheim,, Kempten, Germany Less <<
NCT00311740 Hypertension Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Tokyo, Japan Less <<
NCT00351130 Hypertension Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00311480 Pandemic Influenza Disease Phase 2 Completed - Italy ... More >> G. D'Annunzio University Chieti, Italy, 66100 Department of Health Sciences Genoa, Italy, 16129 ASL Lanciano-Vasto Lanciano, Italy, 66034 University Hospital of Siena Siena, Italy, 53100 Less <<
NCT00316654 Prevention of Meningococcal In... More >>fection Less << Phase 4 Completed - Poland ... More >> Olsztyn, Lubartów, Kielce, Kraków, Bydgoszcz, Poland Spain Valencia, Spain Less <<
NCT00409500 Healthy Phase 1 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT01129622 - Completed - -
NCT00311415 Prevention of Meningococcal In... More >>fection Less << Phase 3 Completed - Germany ... More >> Mainz, Kehl, Neumünster, Ettenheim, Germany Poland Kraków, Lubartów, Lublin, Bydgosczcz, Poland Less <<
NCT00310713 Prevention of Meningococcal In... More >>fection Less << Phase 4 Completed - United Kingdom ... More >> Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Old Road Headington, Oxford, United Kingdom, OX3 7LJ Less <<
NCT00273299 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00409851 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Sites in Germany, Germany Less <<
NCT02334449 Healthy Volunteers Phase 1 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 14050 Less <<
NCT00360178 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00131144 Diabetic Retinopathy Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT00345319 Rabies Post-exposure Prophylax... More >>is Less << Phase 3 Completed - China, Jiangsu ... More >> Danyang CDC Danyang, Jiangsu, China Less <<
NCT00738257 Bone Loss Phase 4 Completed - United Kingdom ... More >> Novartis Investigative Site Frimley, United Kingdom Less <<
NCT00050011 Breast Neoplasms ... More >> Osteoporosis Less << Phase 3 Completed - -
NCT02470403 Elevated Body Mass Index Phase 2 Completed - United States, Nebraska ... More >> Novartis Investigative Site Lincoln, Nebraska, United States, 68502 Less <<
NCT00829712 - Completed - -
NCT00829712 Healthy Phase 1 Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Less <<
NCT02470403 - Completed - -
NCT01606462 Healthy Male Volunteers Phase 1 Completed - Germany ... More >> Department of Psychiatry, University of Bonn Bonn, Germany, 53105 Less <<
NCT00050011 - Completed - -
NCT00170781 Acute Gouty Arthritis Phase 4 Completed - Germany ... More >> Novartis Nuernberg, Germany Switzerland For Site Information, contact Novartis Pharma AG Basel, CH, Switzerland, 4002 Less <<
NCT00410228 Healthy Phase 1 Completed - Switzerland ... More >> Novartis Investigative Site Bern, Switzerland Less <<
NCT00411567 Bronchial Asthma Phase 1 Phase 2 Completed - Germany ... More >> Novartis Investigative Site Nuernberg, Germany Less <<
NCT02103322 Chronic Myeloid Leukemia ... More >> Gastrointestinal Stromal Tumor Less << Phase 2 Phase 3 Completed - India ... More >> Kailash Cancer Hospital & Research Centre Vadodara, Gujurat, India, 391760 Srinivasam Cancer Care Hospitals India Pvt. Bangalore, Karnataka, India, 560076 Karnataka Caner Hospital Bengaluru, Karnataka, India, 560096 Lokmaya Hospital Pune, Maharashtra, India, 411044 Dr. G Viswanathan Speciality Hospitals Tiruchirappalli, Tamil Nadu, India, 620 008 Less <<
NCT00409929 Healthy Phase 1 Completed - Switzerland ... More >> Novartis Investigative Site Bern, Switzerland Less <<
NCT00414752 Smoking Abstinence Phase 1 Completed - Germany ... More >> Novartis Investigative Site Nuernberg, Germany Less <<
NCT00414778 Healthy Phase 1 Completed - China ... More >> Novartis Investigative Site Beijing, China Less <<
NCT00413426 Healthy Phase 1 Completed - India ... More >> Novartis Investigative Site Mumbai, India Less <<
NCT00415831 Healthy Phase 1 Completed - Germany ... More >> Novartis Investigative Site Nuernberg, Germany Less <<
NCT00415740 Healthy Phase 1 Completed - Germany ... More >> Novartis Investigative Site Nuernberg, Germany Less <<
NCT01607970 Healthy Male Volunteers Phase 1 Completed - Germany ... More >> Department of Psychiatry, University of Bonn Bonn, Germany, 53105 Less <<
NCT00232063 Severe Atopic Dermatitis Phase 3 Completed - -
NCT00232076 Severe Atopic Dermatitis Phase 3 Completed - -
NCT00426179 Seasonal Allergic Rhinitis Phase 1 Phase 2 Completed - United Kingdom ... More >> Novartis Investigative site Horsham, United Kingdom Less <<
NCT01372982 Healthy Phase 1 Completed - -
NCT00531050 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - Belgium ... More >> Novartis Investigative site Antwerp, Belgium Less <<
NCT01375452 Healthy Phase 1 Completed - -
NCT00035126 Breast Neoplasms Phase 2 Completed - United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States, 08901 Less <<
NCT00035113 Prostatic Neoplasms Phase 2 Completed - United States, California ... More >> Pacific Shores Medical Group Long Beach, California, United States, 90813 California Pacific Medical Center San Francisco, California, United States, 94115 United States, Maryland University of Maryland - Greenbaum Cancer Center Baltimore, Maryland, United States, 21201 United States, New Jersey Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States, 08901 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01701180 Healthy Early Phase 1 Completed - Germany ... More >> Department of Psychiatry, University of Bonn Bonn, North Rhine-Westphalia, Germany, 53105 Less <<
NCT00035243 Kidney Neoplasms Phase 2 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Wayne State University Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, New York Our Lady Of Mercy Medical Center Bronx, New York, United States, 10466 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Washington University of Washington Seattle, Washington, United States, 98109 France Centre L. Berard Lyon, France Institut Gustave Roussy Villejuif, France Less <<
NCT00035165 Melanoma Phase 2 Completed - United States, Colorado ... More >> University of Colorado Aurora, Colorado, United States, 80045 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, New York Comprehensive Cancer Center@ Our Lady if Mercy Medical Center Bronx, New York, United States, 10466-2697 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oklahoma Oklahoma Oncology, Inc. Tulsa, Oklahoma, United States, 74104 United States, Pennsylvania UPMC Health Systems Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00036413 Amyotrophic Lateral Sclerosis Phase 2 Completed - United States, New York ... More >> Neurological Institute New York, New York, United States, 10032 Less <<
NCT00400777 Hypertension Phase 4 Completed - Brazil ... More >> Novartis Rio de Janeiro, Brazil, RJ 20551-030 Less <<
NCT00045942 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 1 Phase 2 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York New York Weill Cornell Medical Center New York, New York, United States, 10021 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00531050 - Completed - -
NCT00045942 - Completed - -
NCT00394823 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT03741101 Neurofibromatosis 1 ... More >> Child Neurofibroma, Plexiform Less << Phase 2 Recruiting May 2022 Sweden ... More >> Skåne University Hospital Recruiting Lund, Sweden, 22241 Contact: Björn Sigurdsson, MD    0046708253552    bjorn.sigurdsson@skane.se    Contact: Erik A Eklund, MD, PhD    0046730785917    erik.eklund@skane.se Less <<
NCT02892344 Mild Asthma Phase 3 Recruiting November 23, 2018 -
NCT00061750 Beta-Thalassemia Phase 3 Completed - United States, California ... More >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027-6062 Children's Hospital Oakland Oakland, California, United States, 94609 Stanford Hospital Stanford, California, United States, 94305-5208 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614-3394 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Less <<
NCT00050349 Carcinoid Neu... More >>roendocrine Tumors Less << Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa University of Iowa Health Care Iowa City, Iowa, United States, 52242-1091 United States, Louisiana LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Deptof LSU Health Sciences (2) New Orleans, Louisiana, United States, 70115 United States, New York Weill Medical College of Cornell Univ. New York, New York, United States, 10021 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97201 Less <<
NCT00076362 Obesity Phase 4 Completed - United States, Arizona ... More >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, California Children's Hospital of Orange County Orange, California, United States, 92868 University of California at San Francisco San Francisco, California, United States, 94143 United States, Colorado University of Colorado Denver, Colorado, United States, 80218 United States, Florida Miami Children'S Hopital Miami, Florida, United States, 33155 United States, Illinois Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, Indiana St. Vincent Children's Center for Cancer and Blood Diseases Indianapolis, Indiana, United States, 46260 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee U of Tennessee HELP Center Memphis, Tennessee, United States, 38103 United States, Texas UT Southwestern Children's Medical Center of Dallas Dallas, Texas, United States, 75390 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02268552 Spinal Muscular Atrophy Phase 1 Phase 2 Recruiting July 23, 2020 Belgium ... More >> Novartis Investigative Site Recruiting Gent, Belgium, 9000 Novartis Investigative Site Recruiting Leuven, Belgium, 3000 Bulgaria Novartis Investigative Site Recruiting Sofia, Bulgaria, 1606 Czechia Novartis Investigative Site Recruiting Prague 5, CZE, Czechia, 15006 Denmark Novartis Investigative Site Recruiting Copenhagen, Denmark, 2100 O Germany Novartis Investigative Site Completed Essen, Germany, 45147 Novartis Investigative Site Withdrawn Freiburg, Germany, 79106 Italy Novartis Investigative Site Recruiting Roma, ITA, Italy, 00165 Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Poland Novartis Investigative Site Recruiting Warsaw, Poland, 04-730 Novartis Investigative Site Recruiting Wroclaw, Poland, 50-420 Russian Federation Novartis Investigative Site Recruiting Ekaterinburg, Russian Federation Novartis Investigative Site Recruiting Saint Petersburg, Russian Federation, 197341 Novartis Investigative Site Recruiting Ufa, Russian Federation, 450000 Less <<
NCT03020199 Plaque Psoriasis Phase 4 Recruiting April 19, 2022 -
NCT00079937 Asthma Phase 3 Completed - -
NCT00079937 - Completed - -
NCT00086268 Non Small Cell Lung Carcinoma Phase 3 Completed - -
NCT00088582 Acromegaly Phase 2 Completed - United States, California ... More >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Medical Center Ann Arbor, Michigan, United States, 48108 United States, New York New York University/VA Medical Center New York, New York, United States, 10010 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22908 Less <<
NCT00310804 - Completed - -
NCT00088595 - Completed - -
NCT00409760 Hypertension Phase 3 Completed - Germany ... More >> Sites in Germany sites in Germany, Germany Less <<
NCT00310804 Influenza Phase 3 Completed - Lithuania ... More >> 2nd Department of Internal Diseases, Panevezys Hospital, Panevezys, Lithuania Dept. Infectious Diseases and Microbiology of Vilnius University Vilnius, Lithuania Less <<
NCT01248468 Pain, Migraine Phase 4 Completed - United States, California ... More >> Anaheim, California, United States San Francisco, California, United States United States, Florida Clearwater, Florida, United States Deland, Florida, United States Jacksonville, Florida, United States Miami, Florida, United States Pembroke Pines, Florida, United States West Palm Beach, Florida, United States United States, Illinois Chicago, Illinois, United States United States, Michigan Ann Arbor, Michigan, United States United States, Missouri Springfield, Missouri, United States United States, New York Bronx, New York, United States Rochester, New York, United States United States, North Carolina Raleigh, North Carolina, United States United States, Ohio Cleveland, Ohio, United States United States, South Carolina Mount Pleasant, South Carolina, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas San Antonio, Texas, United States United States, Utah Salt Lake City, Utah, United States United States, Washington Seattle, Washington, United States Less <<
NCT00088595 Carcinoid Tumors Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Iowa Univ. Of Iowa Holden Cancer Center Iowa City, Iowa, United States, 52242 United States, Louisiana Louisiana State University Medical Center New Orleans, Louisiana, United States, 70112 Less <<
NCT01248468 - Completed - -
NCT02435173 Common Variable Immunodeficien... More >>cy (CVID) More Specifically Activated PI3Kdelta Syndrome (APDS) p110delta-activating Mutation Causing Senescent T Cells Lymphadenopathy and Immunodeficiency (PASLI) Less << Phase 2 Phase 3 Recruiting February 6, 2020 United States, Maryland ... More >> National Institute of Health NIH Recruiting Bethesda, Maryland, United States, 20814 Contact: Sharon Webster    301-496-2771    Sharon.webster@nih.gov    Czechia Novartis Investigative Site Recruiting Prague 5, Czechia, 150 00 Ireland Novartis Investigative Site Recruiting Dublin, Ireland Italy Novartis Investigative Site Recruiting Brescia, Italy, 25123 Netherlands Novartis Investigative Site Recruiting Rotterdam, Netherlands, 3000 CA Russian Federation Novartis Investigative Site Recruiting Moscow, Russian Federation, 117198 United Kingdom Novartis Investigative Site Recruiting Belfast, United Kingdom, BT9 7AB Novartis Investigative Site Recruiting London, United Kingdom, NW3 2PF Less <<
NCT00700271 Hypertension Phase 4 Completed - France ... More >> Investigative sites in France Paris, France Tunisia Investigative sites in Tunisia Tunisia, Tunisia Less <<
NCT02634970 Wet Age-related Macular Degene... More >>ration (Wet AMD) Less << Phase 4 Withdrawn December 2017 -
NCT00698646 Hypertension Phase 4 Completed - United States, Alabama ... More >> Investigative site Birmingham, Alabama, United States United States, Arizona Investigative site Phoenix, Arizona, United States United States, California Investigative Site Escondido, California, United States Investigative site Fresno, California, United States Investigative site Huntington Park, California, United States Investigative Sites Pismo Beach, California, United States United States, Florida Investigative site Miami, Florida, United States Investigative site Ormond Beach, Florida, United States United States, Georgia Investigative site Conyers, Georgia, United States United States, Kentucky Investigative Site Lexington, Kentucky, United States United States, Maine Investigative site Portland, Maine, United States United States, Nevada Investigative site Las Vegas, Nevada, United States United States, New York Investigative site Buffalo, New York, United States United States, North Carolina Investigative site Shelby, North Carolina, United States United States, Ohio Investigative site Carlisle, Ohio, United States United States, Oklahoma Investigative site Oklahoma City, Oklahoma, United States United States, Pennsylvania Investigative site Erie, Pennsylvania, United States United States, South Carolina Investigative Site Greer, South Carolina, United States Investigative Site Taylors, South Carolina, United States United States, Utah Investigative site St George, Utah, United States Less <<
NCT00171639 Prostate Cancer Phase 3 Completed - United States, Arizona ... More >> Southern AZ VA Health Care System Tucson, Arizona, United States, 85723 United States, California VA Medical Center-Long Beach Long Beach, California, United States, 90822 United States, District of Columbia Washington VA Medical Center Washington, District of Columbia, United States, 20422 United States, Illinois West Side VMAC Chicago, Illinois, United States, 60612 Hines VA Medical Center Hines, Illinois, United States, 60141 United States, Missouri Kansas City VMAC Kansas City, Missouri, United States, 64128 United States, New York VAWNY Buffalo Buffalo, New York, United States, 14215 Less <<
NCT00700271 - Completed - -
NCT01207414 Schizophrenia Phase 4 Completed - -
NCT01113047 Essential Hypertension Phase 3 Completed - Germany ... More >> Investigative Site Pirna, Germany Less <<
NCT00698646 - Completed - -
NCT00754884 Fibromyalgia Phase 4 Withdrawn(Study drug was not l... More >>onger available in our country.) Less << - Mexico ... More >> Hospital General Regional No. 45, IMSS Guadalajara, Jalisco, Mexico, 44290 Less <<
NCT01276457 Transplantation Infection Phase 3 Completed - -
NCT02213354 Avian Influenza Phase 2 Completed - United States, Georgia ... More >> Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States, 30030-1705 United States, Iowa University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States, 52242-2600 United States, Maryland University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States, 21201-1509 United States, Missouri Saint Louis University - Center for Vaccine Development Saint Louis, Missouri, United States, 63104-1015 United States, North Carolina Duke Human Vaccine Institute - Duke Clinical Vaccine Unit Durham, North Carolina, United States, 27704 United States, Ohio Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States, 45229-3026 United States, Tennessee Vanderbilt University Medical Center - Vanderbilt Institute for Clinical and Translational Research - Clinical Research Center (VICTR-CRC) Nashville, Tennessee, United States, 37232-0011 United States, Texas University of Texas Medical Branch - Sealy Center for Vaccine Development - Clinical Trials Group Galveston, Texas, United States, 77555-1119 Baylor College of Medicine - Molecular Virology and Microbiology Houston, Texas, United States, 77030-3411 United States, Washington Group Health Research Institute - Seattle - Vaccines and Infectious Diseases Seattle, Washington, United States, 98101-1466 Less <<
NCT01973205 - Completed - -
NCT01973205 Acute Migraine Phase 3 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States United States, California Anaheim, California, United States San Francisco, California, United States United States, Florida Ft Lauderdale, Florida, United States Jupiter, Florida, United States Oviedo, Florida, United States West Palm Beach, Florida, United States United States, Indiana Evansville, Indiana, United States United States, Michigan Ann Arbor, Michigan, United States United States, New Jersey Berlin, New Jersey, United States United States, New York Bronx, New York, United States Rochester, New York, United States Williamsville, New York, United States United States, North Carolina Raleigh, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States Cleveland, Ohio, United States United States, South Carolina Mount Pleasant, South Carolina, United States United States, Utah Salt Lake City, Utah, United States United States, Wisconsin Kenosha, Wisconsin, United States Less <<
NCT00094146 Primary Insulin Hypersecretion... More >> Obesity Less << Phase 2 Completed - United States, Louisiana ... More >> New Orleans Center for Clinical Research New Orleans, Louisiana, United States United States, Tennessee University of Tennessee Memphis, Tennessee, United States, 38103 United States, Wisconsin University of Wisconsin Beers-Murphy Clinical Nutrition Clinic Madison, Wisconsin, United States, 537052 Less <<
NCT01207414 - Completed - -
NCT00142987 IBS-C and IBS With Mixed Bowel... More >> Habits Less << Phase 4 Completed - -
NCT00305903 Alzheimer's Disease Phase 4 Completed - United States, New Jersey ... More >> Manchester, New Jersey, United States, 08759 Less <<
NCT01529359 Irritable Bowel Syndrome Phase 3 Unknown December 2012 France ... More >> Chu L'Archet 2 Recruiting Nice, Alpes Maritimes, France, 06200 Contact: PICHE Thierry, MD    04 92 03 93 67 ext 33    piche.t@chu-nice.fr    Contact: BIEUVELET Séverine, PhD    01 53 86 70 78 ext 33    s.bieuvelet@pileje.com    Principal Investigator: PICHE Thierry, MD Less <<
NCT00983931 - Completed - -
NCT00511121 Chronic Myeloid Leukemia Phase 2 Terminated - -
NCT00983931 Pharmacokinetics ... More >> Healthy Less << Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. - Cetero Research Fargo, North Dakota, United States, 58104 Less <<
NCT00391898 Parkinson's Disease Phase 4 Completed - Spain ... More >> Hospital Universitario Principe de Asturias Alcalá de Henares, Madrid, Spain, 28805 Fundación Hospital de Alcorcón Alcorcón (Madrid, Spain, 28922 Hospital General de Alicante Alicante, Spain, 03010 Centro Médico Teknon Barcelona, Spain, 08022 Hospital de la Santa Creu i de Sant Pau Barcelona, Spain, 08025 Hospital Vall d'Hebron Barcelona, Spain, 08025 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 Corporació Sanitària Parc Taulí Sabadell Barcelona, Spain, 08208 Hospital General Yagüe Burgos, Spain, 09005 Hospital Universitario Virgen de las Nieves Granada, Spain, 18012 Hospital Universitari Bellvitge Princeps d'Espanya L'Hospitalet de Llobregat , Barcelona, Spain, 08907 Hospital Juan Canalejo La Coruña, Spain, 15002 Clínica Ruber Madrid, Spain, 28006 Hospital General Universitario Gregorio Marañon Madrid, Spain, 28007 Fundación Jiménez Díaz Madrid, Spain, 28040 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Universitaria de Navarra Pamplona, Spain, 31008 Policlínica Gipuzkoa San Sebastian, Spain, 20009 Hospital General de Catalunya Sant Cugat del Valles, Barcelona, Spain, 08195 Hospital Universitario Virgen del Rocio Sevilla, Spain, 41013 Hospital Mutua de Terrassa Terrassa, Barcelona, Spain, 08221 Hospital Universitario de la Fe Valencia, Spain, 46009 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Hospital Gral. de Valencia Valencia, Spain, 46014 Less <<
NCT01276457 - Completed - -
NCT00515424 Glaucoma Ocul... More >>ar Hypertension Less << Phase 1 Completed - United States, California ... More >> Artesia, California, United States United States, New York Rochester, New York, United States United States, North Carolina Charlotte, North Carolina, United States Durham, North Carolina, United States United States, Texas Houston, Texas, United States Less <<
NCT02491320 Polycystic Ovary Syndrome Phase 3 Unknown December 2017 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Wanting Wu, Master    15818153730       Contact: Meifang Li, Master    13544426679       Principal Investigator: Hongxia Ma, PhD Less <<
NCT00664742 Metabolic Syndrome Phase 4 Completed - Turkey ... More >> Götzepe Education and Research Hospital Istanbul, Turkey Less <<
NCT00391898 - Completed - -
NCT00552214 - Unknown - Taiwan ... More >> Taipei Blood Center Taiwan Blood Service Foundation (TBSF) 3 Fl. No. 3 Han-Hai Road, Taipei 100, Taiwan Less <<
NCT03518528 - Recruiting December 2018 France ... More >> CHU Angers Recruiting Angers, France, 49100 Contact: CORROENNE ROMAIN    0650678034 ext 33    corroenne.ROMAIN@gmail.com    Contact: BOUET PIERRE EMMANUEL    0241353647    PierreEmmanuel.BOUET@chu-angers.fr Less <<
NCT00664742 - Completed - -
NCT01229176 Typhoid Fever Phase 2 Completed - India ... More >> K.E.M. Hospital Research Centre Pune, Maharastra, India, 411011 Pakistan The Aga Khan University Hospital Karachi, Pakistan, 74800 Less <<
NCT01255423 - Completed - -
NCT02393443 Social Psychology Early Phase 1 Completed - United States, California ... More >> UCLA Department of Psychology Los Angeles, California, United States, 90095-1563 Less <<
NCT01229176 - Completed - -
NCT00390858 Transfusional Iron Overload ... More >> β-thalassemia Major Pediatric Rare Anemia Less << Phase 2 Completed - France ... More >> Novartis Investigative Site Lyon, France Italy Novartis Investigative Site Cagliari, Italy Novartis Investigative Site Genova, Italy Novartis Investigative Site Torino, Italy Less <<
NCT01256580 Choroidal Neovascularization ... More >> Myopia Punctate Inner Choroidopathy (PIC) Multifocal Choroiditis Ocular Histoplasmosis Syndrome Central Serous Chorioretinopathy (CSC) Angioid Streaks Trauma, or Hereditary Eye Diseases Less << Not Applicable Withdrawn(Lack of eligible sub... More >>jects.) Less << September 2013 -
NCT00390858 - Completed - -
NCT01853787 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 4 Completed - Italy ... More >> Clinica di Malattie dell'Apparato Respiratorio, Dipartimento di Scienze Mediche, Università di Ferrara Ferrara, Italy, 44121 : Pneumologia Riabilitativa-Fondazione Maugeri-Istituto Scientifico di Milano- IRCCS Milano, Italy, 20138 Less <<
NCT00125346 Cystic Fibrosis Phase 3 Terminated(per Data Monitoring... More >> Committee recommendation) Less << - -
NCT02637128 MALARIA, FALCIPARUM Phase 4 Completed - Malawi ... More >> Malaria Alert Center, University of Malawi College of Medicine, Blantyre, Malawi Blantyre, Malawi Less <<
NCT01454583 - Completed - -
NCT01255423 Ankle Sprain Phase 3 Completed - United States, Alabama ... More >> Birmingham, Alabama, United States United States, Florida Aventura, Florida, United States Hialeah, Florida, United States Miami, Florida, United States United States, New Jersey Berlin, New Jersey, United States United States, South Carolina Columbia, South Carolina, United States United States, Texas El Paso, Texas, United States Houston, Texas, United States United States, Utah Salt Lake City, Utah, United States Less <<
NCT00409578 Post Acute Coronary Syndrome ... More >> Myocardial Ischemia Less << Phase 2 Completed - United States, New Jersey ... More >> Investigative Site Investigative Site, New Jersey, United States Belgium Investigative Site Investigative Site, Belgium Canada Investigative Site Investigative Site, Canada Czech Republic Investigative Site Investigative Site, Czech Republic Germany Investigative Site Investigative Site, Germany Hungary Investigative Site Investigative Site, Hungary Netherlands Investigative Site Investigative Site, Netherlands Poland Investigative Site Investigative Site, Poland Russian Federation Investigative Site Investigative Site, Russian Federation Spain Investigative Site Investigative Site, Spain Sweden Investigative Site Investigative Site, Sweden Less <<
NCT01454583 - Completed - -
NCT02393456 Social Psychology Early Phase 1 Completed - United States, California ... More >> UCLA Department of Psychology Los Angeles, California, United States, 90095-1563 Less <<
NCT00391976 - Completed - -
NCT00477334 Genital Herpes Phase 4 Completed - -
NCT00409578 - Completed - -
NCT00511771 - - - -
NCT00391976 Cystic Fibrosis Phase 3 Completed - -
NCT00637949 Osteoarthritis Phase 3 Completed - -
NCT00760266 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT01883362 Acute Myeloid Leukemia Phase 2 Completed - -
NCT00760266 - Completed - -
NCT00765674 Hypertension Phase 3 Completed - United States, Colorado ... More >> Investigative Site Denver, Colorado, United States Australia Investigative Site Sydney, Australia Canada Investigative Site Ottawa, Canada Denmark Investigative Site Copenhagen, Denmark Germany Investigative Site Berlin, Germany Israel Investigative Site Jerusalem, Israel Italy Investigative Site Rome, Italy Latvia Investigative Site Riga, Latvia Lithuania Investigative Site Vilnius, Lithuania Romania Investigative Site Bucharest, Romania Sweden Investigative Site Stockholm, Sweden Turkey Investigative Site Ankara, Turkey Less <<
NCT00477334 - Completed - -
NCT00765947 Essential Hypertension ( Mild ... More >>to Moderate) Less << Phase 4 Completed - France ... More >> Investigative Site Paris, France Hungary Investigative Site Budapest, Hungary Romania Investigative Site Bucharest, Romania Slovakia Investigative Site Bratislava, Slovakia Less <<
NCT00765674 - Completed - -
NCT02020330 Plasmodium Falciparum Infectio... More >>n Less << Phase 3 Completed - Myanmar ... More >> Medical Action Myanmar Yangon, Myanmar Less <<
NCT00765947 - Completed - -
NCT00701259 Frequent Heartburn Phase 3 Completed - United States, New Jersey ... More >> Not applicable - enrollment complete Parsippany, New Jersey, United States, 07054 Less <<
NCT00861471 - Terminated(due to slow accrual... More >>) Less << - -
NCT00861471 Prostate Cancer ... More >> Prostatic Neoplasms Less << Phase 1 Phase 2 Terminated(due to slow accrual... More >>) Less << - United States, New York ... More >> Bellevue Hospital New York, New York, United States, 10016 NYU Clinical Cancer Center New York, New York, United States, 10016 NYU Tisch Hospital New York, New York, United States, 10016 Less <<
NCT00958022 Small Cell Lung Cancer Phase 1 Terminated(Based on the tolera... More >>bilty challenges of the combination) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02671266 Body Dysmorphic Disorder ... More >> Obsessive-compulsive Disorder Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital/Harvard Medical School Boston, Massachusetts, United States, 02114 Less <<
NCT02304107 Infertility Phase 3 Completed - Egypt ... More >> BeniSuef University hospitals BeniSuef, Egypt Cairo University Hospitals Cairo, Egypt Less <<
NCT02248922 Chronic Lung Infection With Ps... More >>eudomonas Aeruginosa in Cystic Fibrosis Less << Phase 4 Terminated(Reason for terminat... More >>ion was challenge with enrollment and recruitment. A significant decrease in the eligible patient population was main driver.) Less << - Germany ... More >> Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Germering, Germany, 82110 Novartis Investigative Site Jena, Germany, 07740 Less <<
NCT02671266 - Completed - -
NCT02248922 - Terminated(Reason for terminat... More >>ion was challenge with enrollment and recruitment. A significant decrease in the eligible patient population was main driver.) Less << - -
NCT00537082 - Completed - -
NCT00670449 Multiple Sclerosis Phase 2 Completed - Japan ... More >> Novartis Investigative Site Chiba, Japan, 276-8524 Novartis Investigative Site Ehime, Japan, 791-0295 Novartis Investigative Site Fukuoka, Japan, 807-8555 Novartis Investigative Site Gunma, Japan, 371-8511 Novartis Investigative Site Hyogo, Japan, 650-0017 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Investigative Site Kanagawa, Japan, 259-1193 Novartis Investigative Site Kyoto, Japan, 604-8453 Novartis Investigative Site Kyoto, Japan, 616-8255 Novartis Investigative Site Morioka, Japan, 020-8505 Novartis Investigative Site Niigata, Japan, 951-8520 Novartis Investigative Site Osaka, Japan, 556-0016 Novartis Investigative Site Osaka, Japan, 589-8511 Novartis Investigative Site Osaka, Japan Novartis Investigative Site Sapporo, Japan, 060-8648 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 113-8519 Novartis Investigative Site Tokyo, Japan, 145-0065 Novartis Investigative Site Tokyo, Japan, 162-8666 Novartis Investigative Site Wakayama, Japan, 641-8510 Less <<
NCT00537082 Multiple Sclerosis Phase 2 Completed - Japan ... More >> Novartis Investigative site Sapporo-shi, Hokkaido, Japan Novartis Investigative Site Chiba, Japan, 276-8524 Novartis Investigative Site Ehime, Japan, 791-0295 Novartis Investigative Site Fukuoka, Japan, 807-8555 Novartis Investigative Site Gunma, Japan, 371-8511 Novartis Investigative Site Hyogo, Japan, 650-0017 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Iwate, Japan, 020-8505 Novartis Investigative Site Kanagawa, Japan, 259-1193 Novartis Investigative Site Kyoto, Japan, 604-8453 Novartis Investigative Site Kyoto, Japan, 616-8255 Novartis Investigative Site Niigata, Japan, 951-8520 Novartis Investigative Site Osaka, Japan, 556-0016 Novartis Investigative Site Osaka, Japan, 589-8511 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 145-0065 Novartis Investigative Site Tokyo, Japan, 162-8666 Novartis Investigative Site Wakayama, Japan, 641-8510 Less <<
NCT01022905 HIV Infection ... More >> Rheumatic Disease Cancer Transplant Pediatrics Less << Phase 4 Completed - Switzerland ... More >> University Hospitals of Geneva Geneva, Switzerland, 1211 Less <<
NCT00670449 - Completed - -
NCT00099268 Parkinson's Disease Phase 3 Completed - -
NCT01558739 Primary Myelofibrosis (PMF) ... More >> Post Polycythaemia Myelofibrosis (PPV MF) Post Essential Thrombocythaemia Myelofibrosis (PET-MF) Less << Phase 4 Completed - United Kingdom ... More >> Novartis Investigative Site Cardiff, Wales, United Kingdom, CF14 4XN Novartis Investigative Site Bournemouth, United Kingdom, BH7 7DW Novartis Investigative Site East Yorkshire, United Kingdom, HU16 5JQ Novartis Investigative Site Edinburgh, United Kingdom, EH4 2XU Novartis Investigative Site Leicester, United Kingdom, LE7 5WW Novartis Investigative Site Liverpool, United Kingdom, L7 8XP Novartis Investigative Site London, United Kingdom, SE1 9RT Novartis Investigative Site London, United Kingdom, W12 0HS Novartis Investigative Site Manchester, United Kingdom, M13 9NT Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Less <<
NCT00099268 - Completed - -
NCT00159016 Metastatic Solid Tumors. Phase 2 Withdrawn(the PI is no longer ... More >>work at Hadassah) Less << - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT03693599 Post Partum Hemorrhage Phase 4 Not yet recruiting December 1, 2018 -
NCT00900146 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Terminated(Numerically modest ... More >>lowering of HbA1c with canakinumab in combination with metformin was inadequate to continue patients with T2DM into Period IV of this study.) Less << - -
NCT01178372 Hepatic Encephalopathy Phase 4 Unknown September 2010 India ... More >> G B Pant Hospital Recruiting New Delhi, Delhi, India, 110002 Contact: Barjesh C Sharma, MD,DM    9718599203    drbcsharma@hotmail.com    Principal Investigator: Barjesh C Sharma, MD,DM Less <<
NCT00900146 - Terminated(Numerically modest ... More >>lowering of HbA1c with canakinumab in combination with metformin was inadequate to continue patients with T2DM into Period IV of this study.) Less << - -
NCT01836471 - Completed - -
NCT01836471 Asthma Phase 2 Completed - -
NCT01845025 - Terminated(Due to the action t... More >>o withdraw the Foradil Aerolizer NDA in US; study was discontinued. This was a commercial reason and not due to any change in benefit-risk.) Less << - -
NCT01845025 Persistent Asthma Phase 4 Terminated(Due to the action t... More >>o withdraw the Foradil Aerolizer NDA in US; study was discontinued. This was a commercial reason and not due to any change in benefit-risk.) Less << - -
NCT01682863 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00574652 Cryoglobulinemia Vasculitis Phase 1 Phase 2 Completed - France ... More >> Hôpital de la Pitié Paris, France, 75651 Less <<
NCT02301715 Emotion Paren... More >>t-Child Relations Less << Phase 1 Completed - France ... More >> University Regional Hospital Besançon, Franche-Comté, France, 25000 Less <<
NCT01558739 - Completed - -
NCT01900600 Prior Acute Myocardial Infarct... More >>ion Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l) Reduced Left Ventricle Ejection Fraction (<50%) Symptoms of Heart Failure (NYHA Class II-III) Less << Not Applicable Completed - United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT01911546 Highly-sensitized Kidney Trans... More >>plant Recipients Less << Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00076336 - Completed - -
NCT01748279 COPD Phase 4 Completed - Poland ... More >> Department of Lung Diseases and Tuberculosis, Medical University of Bialystok Bialystok, Poland, 15-540 Less <<
NCT01911546 - Completed - -
NCT01682863 - Completed - -
NCT02576639 Alzheimer's Disease Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Glendale, California, United States, 91206 Novartis Investigative Site Long Beach, California, United States, 90806 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33126 United States, Nebraska Novartis Investigative Site Lincoln, Nebraska, United States, 68502 Belgium Novartis Investigative Site Antwerpen, Belgium, 2060 Germany Novartis Investigative Site Berlin, Germany, 14050 Netherlands Novartis Investigative Site Groningen, GZ, Netherlands, 9713 Novartis Investigative Site Leiden, Netherlands, 2333 CL United Kingdom Novartis Investigative Site Belfast, Northern Ireland, United Kingdom, BT9 6AD Novartis Investigative Site Harrow, United Kingdom, HA1 3UJ Novartis Investigative Site Mid Glamorgan, United Kingdom, CF484DR Less <<
NCT01316601 Crohn's Disease Phase 2 Completed - Switzerland ... More >> Zurich, Switzerland Less <<
NCT02576639 - Completed - -
NCT01753596 Dry Eye Syndrome Phase 3 Withdrawn February 2015 Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00076336 Hepatitis Hep... More >>atitis B, Chronic Cirrhosis Less << Phase 3 Completed - -
NCT00969046 Colon Cancer Phase 1 Completed - Czech Republic ... More >> Novartis Investigative Site Hradec Králové, Czech Republic Novartis Investigative Site Prague, Czech Republic France Novartis Investigative Site Saint-Herblain Cedex, France Novartis Investigative Site Toulouse, France Spain Novartis Investigative Site Barcelona, Spain United Kingdom Novartis Investigative Site London, United Kingdom Less <<
NCT00487825 - Completed - -
NCT01997255 Sturge Weber Syndrome Phase 2 Withdrawn(Site did not want to... More >> pursue study) Less << - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00504959 Subfoveal Choroidal Neovascula... More >>rization (CNV) Secondary to Age-related Macular Degeneration (AMD) Less << Phase 4 Completed - -
NCT00798369 Acute Gout Phase 2 Completed - -
NCT00276926 Hypereosinophilic Syndrome ... More >> Chronic Eosinophilic Leukemia (CEL) Myeloproliferative Disorders Less << Phase 2 Unknown - Italy ... More >> Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Università degli Studi di Bologna Recruiting Bologna, Italy, 40138 Principal Investigator: Giovanni Martinelli, MD          Sub-Investigator: Michela Rondoni, MD          Sub-Investigator: Pier Paolo Piccaluga, MD, PhD          Sub-Investigator: Stefania Paolini, MD          Dipartimento di Medicina Interna - Università di Genova Recruiting Genova, Italy, 16100 Contact: Marco Gobbi, MD    +39 010 3532395    gobbi@unige.it    Principal Investigator: Marco Gobbi, MD          Dipartimento di Biochimica e Biotecnologie Mediche - Università degli Studi di Napoli "Federico II" Recruiting Napoli, Italy, 80131 Contact: Fabrizio Pane, MD    + 39 081 7463135    fabpane@unina.it    Principal Investigator: Fabrizio Pane, MD          Divisione di Ematologia - Università degli Studi di Napoli "Federico II" Recruiting Napoli, Italy, 80131 Contact: Lucio Catalano, MD    + 39 081 7462068    lcatalan@unina.it    Principal Investigator: Bruno Rotoli, MD          Sub-Investigator: Lucio Catalano, MD          S.C. Medicina Interna II ed Ematologia - Laboratorio di Medicina Interna e Molecolare - A.O. San Luigi Recruiting Orbassano, Italy, 10043 Contact: Emanuela Messa, MD    +39 0119026721    emanuelamessa@yahoo.it    Contact: Daniela Cilloni, MD    +39 0119026610    daniela.cilloni@unito.it    Principal Investigator: Giuseppe Saglio, MD          Sub-Investigator: Emanuela Messa, MD          Sub-Investigator: Daniela Cilloni, MD          Divisione di Ematologia - IRCCS Policlinico S. Matteo Recruiting Pavia, Italy, 27100 Contact: Serena Merante, MD    +39 0382502250    s.merante@smatteo.pv.it    Principal Investigator: Mario Lazzarino, MD          Sub-Investigator: Serena Merante, MD          U.O. Ematologia - Dipartimento di Oncologia ed Ematologia, Presidio Ospedaliero di Ravenna Recruiting Ravenna, Italy, 48100 Contact: Eliana Zuffa, MD    +39 0544285752    e.zuffa@ausl.ra.it    Principal Investigator: Alfonso Zaccaria, MD          Sub-Investigator: Eliana Zuffa, MD          U.O. Ematologia - Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy, 42100 Contact: Paolo Avanzini, MD    +39 0522296681    paolo.avanzini@asmn.re.it    Principal Investigator: Luigi Gugliotta, MD          Sub-Investigator: Paolo Avanzini, MD          Cattedra di Ematologia - Università "Tor Vergata" Recruiting Roma, Italy, 00133 Contact: Francesco Buccisano, MD    +39 06 20902674    francesco.buccisano@uniroma2.it    Principal Investigator: Sergio Amadori, MD          Sub-Investigator: Francesco Buccisano, MD          Cattedra di Ematologia - Università "La Sapienza" Recruiting Roma, Italy, 00161 Contact: Giuliana Alimena, MD    +39 06857951    alimena@bce.med.uniroma1.it    Principal Investigator: Franco Mandelli, MD          Sub-Investigator: Giuliana Alimena, MD          Divisione di Ematologia - Casa Sollievo della Sofferenza Recruiting San Giovanni Rotondo, Italy, 71013 Contact: Pellegrino Musto, MD    +39 0882410539    p.musto@tin.it    Principal Investigator: Angelo Michele Carella, MD          Sub-Investigator: Pellegrino Musto, MD          U.O.C. Ematologia e Trapianti - Policlinico "Le Scotte" Recruiting Siena, Italy, 53100 Contact: Monica Bocchia, MD    +39 0577586798    bocchia@unisi.it    Principal Investigator: Francesco Lauria, MD          Sub-Investigator: Monica Bocchia, MD          U.O. Medicina II Divisione - Ospedale Santa Chiara Recruiting Trento, Italy, 38100 Contact: Paolo Vivaldi, MD    +39 0461903307    paolo.vivaldi@tn.it    Principal Investigator: Mauro Pedrazzoli, MD          Sub-Investigator: Paolo Vivaldi, MD          Sub-Investigator: Silvia Cerù, MD          Sub-Investigator: Anna Guella, MD          Clinica Ematologica - Policlinico Universitario Recruiting Udine, Italy, 33100 Contact: Mario Tiribelli, MD    +39 0432559662    mtiribelli@hotmail.com    Principal Investigator: Renato Fanin, MD          Sub-Investigator: Mario Tiribelli, MD Less <<
NCT01653847 End Stage Renal Failure With R... More >>enal Transplant Less << Not Applicable Active, not recruiting June 2020 United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT00666536 - Completed - -
NCT00487825 Rheumatoid Arthritis Phase 2 Completed - -
NCT00666536 Hypertension Phase 4 Completed - United States, Louisiana ... More >> Egan Healthcare Metairie, Louisiana, United States, 70002 Less <<
NCT02763644 Transplant Associated Microang... More >>iopathy TAM Less << Phase 2 Terminated - United States, North Carolina ... More >> Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43210 France Novartis Investigative Site Paris, Cedex 10, France, 75475 Novartis Investigative Site Marseille, France, 13273 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 Less <<
NCT00439244 Osteoporosis Phase 3 Completed - -
NCT00500539 - Completed - -
NCT00798369 - Completed - -
NCT02554786 Asthma Phase 3 Recruiting June 24, 2019 -
NCT00669617 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - United States, Florida ... More >> Novartis Investigative Site Tamarac, Florida, United States, 33321 United States, Louisiana Novartis Investigator Site Lafayette, Louisiana, United States, 70503 United States, Missouri Novartis Investigative Site St Charles, Missouri, United States, 63301-2847 United States, North Carolina Novartis Investigative site Shelby, North Carolina, United States, 28150 United States, Pennsylvania Novartis Investigative Site Beaver, Pennsylvania, United States, 15009 Belgium Novartis Investigative Site Antwerpen, Belgium Germany Novartis Investigative Site Berlin, Germany Novartis Investigator Site Borstel, Germany Novartis Investigative site Dortmund, Germany Novartis Investigative site Hamburg, Germany Novartis Investigative site Hannover, Germany Novartis Investigative site Mainz, Germany Novartis Investigator Site Potsdam, Germany Novartis Investigative site Wiesbaden, Germany Hungary Novartis Investigative site Debrecen, Hungary Novartis Investigative site Deszk, Hungary Novartis Investigative Site Nyiregyhaza, Hungary Less <<
NCT00500539 Asthma Phase 3 Completed - -
NCT02571777 Asthma Phase 3 Recruiting June 3, 2019 -
NCT00669617 - Completed - -
NCT02745080 Psoriatic Arthritis Phase 3 Recruiting March 4, 2020 -
NCT02516592 COPD Phase 4 Unknown January 2017 -
NCT02763046 Ankylosing Spondylitis Phase 4 Recruiting July 1, 2019 Germany ... More >> Novartis Investigative Site Recruiting Bad Doberan, Germany, 18209 Novartis Investigative Site Recruiting Bayreuth, Germany, 95444 Novartis Investigative Site Recruiting Berlin, Germany, 10117 Novartis Investigative Site Recruiting Berlin, Germany, 12161 Novartis Investigative Site Recruiting Berlin, Germany, 12163 Novartis Investigative Site Recruiting Berlin, Germany, 13055 Novartis Investigative Site Recruiting Berlin, Germany, 13125 Novartis Investigative Site Recruiting Berlin, Germany, 14059 Novartis Investigative Site Withdrawn Bonn, Germany, 53105 Novartis Investigative Site Recruiting Chemnitz, Germany, 09130 Novartis Investigative Site Recruiting Cottbus, Germany, 03042 Novartis Investigative Site Recruiting Dresden, Germany, 01069 Novartis Investigative Site Recruiting Dresden, Germany, 01307 Novartis Investigative Site Recruiting Elmshorn, Germany, 25335 Novartis Investigative Site Recruiting Erlangen, Germany, 91056 Novartis Investigative Site Recruiting Frankfurt am Main, Germany, 60528 Novartis Investigative Site Recruiting Freiberg, Germany, 09599 Novartis Investigative Site Recruiting Freiburg, Germany, 79106 Novartis Investigative Site Withdrawn Gifhorn, Germany, 38518 Novartis Investigative Site Recruiting Goettingen, Germany, 37075 Novartis Investigative Site Completed Hamburg, Germany, 22081 Novartis Investigative Site Recruiting Hamburg, Germany, 22143 Novartis Investigative Site Recruiting Hamburg, Germany, 22415 Novartis Investigative Site Terminated Hamburg, Germany, 22767 Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Recruiting Herne, Germany, 44649 Novartis Investigative Site Recruiting Koeln, Germany, 51149 Novartis Investigative Site Recruiting Leipzig, Germany, 04103 Novartis Investigative Site Recruiting Leipzig, Germany, 04109 Novartis Investigative Site Recruiting Luebeck, Germany, 23538 Novartis Investigative Site Recruiting Magdeburg, Germany, 39104 Novartis Investigative Site Recruiting Magdeburg, Germany, 39110 Novartis Investigative Site Recruiting Muenchen, Germany, 81541 Novartis Investigative Site Recruiting Muenchen, Germany, 81675 Novartis Investigative Site Recruiting München, Germany, 80331 Novartis Investigative Site Recruiting Nienburg, Germany, 31582 Novartis Investigative Site Recruiting Nuernberg, Germany, 90443 Novartis Investigative Site Recruiting Puettlingen/saar, Germany, 66346 Novartis Investigative Site Recruiting Rendsburg, Germany, 24768 Novartis Investigative Site Recruiting Saarbruecken, Germany, 66111 Novartis Investigative Site Recruiting Schwerin, Germany, 19055 Novartis Investigative Site Recruiting Sendenhorst, Germany, 48324 Novartis Investigative Site Recruiting Stuttgart, Germany, 70372 Novartis Investigative Site Recruiting Trier, Germany, 54292 Novartis Investigative Site Completed Wuppertal, Germany, 42105 Less <<
NCT02807857 Chronic Heart Failure (CHF) Phase 4 Recruiting June 26, 2019 -
NCT02678312 Pediatric Heart Failure Phase 2 Phase 3 Recruiting April 21, 2021 -
NCT00746330 Asthma Phase 2 Completed - United States, Alabama ... More >> Novartis Investigative Site Mobile, Alabama, United States, 36608 United States, California Novartis Investigative Site Huntington Beach, California, United States, 92647 Novartis Investigative Site Orange, California, United States, 92868 United States, Florida Novartis Investigative Site Hialeah, Florida, United States, 33012 Novartis Investigative Site Pensacola, Florida, United States, 32503 United States, Oklahoma Novartis Investigative Site Oklahoma City, Oklahoma, United States, 73112 Colombia Novartis Investigative Site Barranquilla, Colombia Novartis Investigative Site Bogota, Colombia Peru Novartis Investigative Site Lima, Peru Less <<
NCT00746330 - Completed - -
NCT01048723 - Terminated(Novartis terminated... More >> funding) Less << - -
NCT02855164 Non-alcoholic Steatohepatitis Phase 2 Recruiting April 3, 2020 -
NCT02123108 Liver Transplantation Phase 4 Unknown June 2015 United States, California ... More >> Ronald Reagan UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 Contact: Fady M Kaldas, MD    310-825-5318    fkaldas@mednet.ucla.edu    Contact: Curtis D Holt, PharmD    310-206-4952    cholt@mednet.ucla.edu    Principal Investigator: Fady M Kaldas, MD Less <<
NCT00439244 - Completed - -
NCT01487265 Non Small Cell Lung Cancer Phase 2 Active, not recruiting December 2017 United States, Florida ... More >> Florida Cancer Specialists South Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Florida Cancer Specialists North Saint Petersburg, Florida, United States, 33705 Florida Cancer Specialists East West Palm Beach, Florida, United States, 33401 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less <<
NCT01487265 - Active, not recruiting - -
NCT00902304 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Australia Professor Garry Jennings-Co Principal Investigator Melbourne, Australia Professor Simon Stewart-Principal Investigator Melbourne, Australia Less <<
NCT00171171 Beta-Thalassemia ... More >> Hemosiderosis Less << Phase 3 Completed - Egypt ... More >> Novartis Investigative Site Cairo, Egypt Lebanon Ali Taher Beirut, Lebanon, Riad El Solh 1107 2020 Oman Novartis Investigative Site Muscat, Oman Saudi Arabia Novartis Investigative Site Riyadh, Saudi Arabia Syrian Arab Republic Novartis Investigative Site Damascus, Syrian Arab Republic Less <<
NCT01048723 Sarcoma Phase 2 Terminated(Novartis terminated... More >> funding) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00902304 - Completed - -
NCT02753686 - Recruiting December 2, 2019 Canada, British Columbia ... More >> Novartis Investigative Site Recruiting Burnaby, British Columbia, Canada, V5G 2X6 Novartis Investigative Site Recruiting Richmond, British Columbia, Canada, V7C 5L9 Novartis Investigative Site Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Novartis Investigative Site Recruiting Moncton, New Brunswick, Canada, E1C 8X3 Canada, Ontario Novartis Investigative Site Recruiting Cambridge, Ontario, Canada, N1R 3G2 Novartis Investigative Site Recruiting Kingston, Ontario, Canada, K7L 5P9 Novartis Investigative Site Recruiting Kitchener, Ontario, Canada, N2G 1G3 Novartis Investigative Site Recruiting Newmarket, Ontario, Canada, L3Y 2P9 Novartis Investigative Site Recruiting Ottowa, Ontario, Canada, K1H 8L6 Novartis Investigative Site Recruiting Sault Ste-Marie, Ontario, Canada, P6A 2C4 Novartis Investigative Site Recruiting Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Novartis Investigative Site Recruiting Greenfield Park, Quebec, Canada, J4V 2H1 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3A 1A1 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H4J 1C5 Canada, Saskatchewan Novartis Investigative Site Recruiting Saskatoon, Saskatchewan, Canada, S7N 4H4 Canada Novartis Investigative Site Recruiting Quebec, Canada, G1S 4L8 Less <<
NCT00088608 Cushing's Syndrome Phase 2 Completed - United States, California ... More >> Cedars-Sinai Pituitary Center Los Angeles, California, United States, 90048 United States, Massachusetts Massachusetts General Hospital NE Unit Boston, Massachusetts, United States, 02114 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin Midwest Endocrinology Associates Milwaukee, Wisconsin, United States, 53215 Less <<
NCT00142974 Diabetic Gastropathy Phase 2 Terminated(This study was term... More >>inated early in April 2005 due to low patient enrollment) Less << - Switzerland ... More >> Novartis Basel, Switzerland, 4056 Less <<
NCT02888080 Pulmonary Sarcoidosis Phase 2 Recruiting December 26, 2018 United States, Alabama ... More >> Novartis Investigative Site Active, not recruiting Birmingham, Alabama, United States, 35294-0006 United States, New York Novartis Investigative Site Completed Albany, New York, United States, 12208 United States, Ohio Novartis Investigative Site Active, not recruiting Cleveland, Ohio, United States, 44195 Germany Novartis Investigative Site Active, not recruiting Essen, Germany, 45147 Novartis Investigative Site Active, not recruiting Frankfurt, Germany, 60596 Novartis Investigative Site Active, not recruiting Hannover, Germany, 30625 Netherlands Novartis Investigative Site Active, not recruiting Nieuwegein, Netherlands, 3435 CM Novartis Investigative Site Recruiting Rotterdam, Netherlands, 3015 CE Less <<
NCT00498433 - Terminated(Early termination r... More >>esulted from interim analysis of the ALTITUDE trial) Less << - -
NCT01975337 Kidney Failure, Chronic Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 Less <<
NCT00149851 Symptomatic Gastroespohageal R... More >>eflux Disease Less << Phase 2 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-108 Less <<
NCT00149877 Chronic Constipation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland, 4056 Less <<
NCT00130845 Diabetic Retinopathy Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT03242928 Cocaine-related Disorder Phase 2 Recruiting January 8, 2020 Argentina ... More >> Novartis Investigative Site Recruiting Buenos Aires, Argentina, 1058 Novartis Investigative Site Recruiting Buenos Aires, Argentina, 4634 Novartis Investigative Site Recruiting Buenos Aires, Argentina, C1405B0A Spain Novartis Investigative Site Recruiting San Juan de Alicante, Alicante, Spain, 03550 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Recruiting Barcelona, Spain, 08036 Switzerland Novartis Investigative Site Recruiting Basel, Switzerland, 4025 Novartis Investigative Site Recruiting Zuerich, Switzerland, 8001 Less <<
NCT00232024 Dyspepsia Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-108 Less <<
NCT00498433 Hypertension ... More >>Abdominal Obesity Less << Phase 2 Terminated(Early termination r... More >>esulted from interim analysis of the ALTITUDE trial) Less << - Germany ... More >> Novartis Investigative Site Berlin-Buch, Germany, 13125 Novartis Investigative Site Hannover, Germany, 30159 Less <<
NCT00232102 Dyspepsia Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-108 Less <<
NCT02534909 Paroxysmal Nocturnal Hemoglobi... More >>nuria PNH Less << Phase 2 Recruiting November 1, 2022 Czechia ... More >> Novartis Investigative Site Active, not recruiting Brno Bohunice, Czech Republic, Czechia, 625 00 Novartis Investigative Site Withdrawn Praha 2, Czech Republic, Czechia, 128 20 Japan Novartis Investigative Site Recruiting Fukushima-city, Fukushima, Japan, 960-1295 Novartis Investigative Site Active, not recruiting Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Active, not recruiting Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Recruiting Shinjuku-ku, Tokyo, Japan, 160-0023 Novartis Investigative Site Active, not recruiting Niigata, Japan, 951 8520 Lithuania Novartis Investigative Site Active, not recruiting Vilnius, Lithuania, LT-08661 Less <<
NCT00232089 Dyspepsia Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-108 Less <<
NCT00099229 Bipolar Disorder Phase 3 Completed - United States, Arkansas ... More >> Investigational Site Little Rock, Arkansas, United States, 72211 United States, California Investigational Site Cerritos, California, United States, 90703 Investigational Site San Diego, California, United States, 92126 United States, Florida Investigational Site Port Charlotte, Florida, United States, 33952 United States, Indiana Investigational Site Indianapolis, Indiana, United States, 46222 United States, Kansas Investigational Site Newton, Kansas, United States, 67114 United States, Nevada Investigational Site Las Vegas, Nevada, United States, 89103 United States, North Carolina Investigational Site Raleigh, North Carolina, United States, 27609 United States, Ohio Investigational Site Cincinnati, Ohio, United States, 45267 United States, Oklahoma Investigational Site Oklahoma City, Oklahoma, United States, 73118 United States, Pennsylvania Investigational Site Philadelphia, Pennsylvania, United States, 19124 United States, Texas Investigational Site Austin, Texas, United States, 78756 Investigational Site Bellaire, Texas, United States, 77401 Investigational Site Houston, Texas, United States, 77007 Investigational Site Houston, Texas, United States, 77021 United States, Washington Investigational Site Kirkland, Washington, United States, 98033 France Investigational Site Dijon, France, 21033 Investigational Site Strasbourg, France, 67091 Russian Federation Investigational Site Moscow, Russian Federation, 107076 Investigational Site Moscow, Russian Federation, 113152 Investigational Site Moscow, Russian Federation, 123367 Investigational Site St. Petersburg, Russian Federation, 193019 Less <<
NCT00833664 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> Novum Pharmaceutical Research Services Pittsburg, Pennsylvania, United States, 15206-3817 Less <<
NCT00099216 Vascular Dementia Phase 3 Completed - -
NCT00833586 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> Novum Pharmaceutical Research Services Pittsburgh, Pennsylvania, United States, 15206-3817 Less <<
NCT00833586 - Completed - -
NCT00616681 Seizures Epil... More >>epsy Less << Not Applicable Completed - Canada, Quebec ... More >> MDS Pharma Services Montreal, Quebec, Canada, H4R 2N6 Less <<
NCT02966314 Idiopathic Angioedema Phase 4 Recruiting December 2018 United States, Wisconsin ... More >> UW Madison Recruiting Madison, Wisconsin, United States, 53792 Contact: Mary Jo Jackson, G+BSN    608-265-3556    mmj@medicine.wisc.edu    Contact: Tina Palas, BS    608-265-4554    tmp@medicine.wisc.edu    Principal Investigator: Ravi Viswanathan, MD Less <<
NCT00606099 Chronic Hepatitis B Phase 4 Withdrawn(study was cancelled) - United States, Georgia ... More >> Novartis Atlanta, Georgia, United States, 30308 United States, New York Novartis Flushing, New York, United States, 11355 United States, Virginia Novartis Sterling, Virginia, United States, 20166 Less <<
NCT00618046 Seizures Epil... More >>epsy Less << Not Applicable Completed - United States, Missouri ... More >> Bio-Kinetics Clinical Applications, Inc . Springfield, Missouri, United States, 658902 Less <<
NCT02257385 - Completed - -
NCT00232037 Dyspepsia Phase 3 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-108 Less <<
NCT02257385 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00171678 Osteearthritis Phase 3 Completed - United States, New Jersey ... More >> Novartis Consumer Health Inc. Parsippany, New Jersey, United States Less <<
NCT00171691 Osteoarthritis Phase 3 Completed - United States, New Jersey ... More >> Novartis Consumer Health Inc. Parsippany, New Jersey, United States Less <<
NCT01539915 Psoriasis Phase 1 Completed - Austria ... More >> Novartis Investigative Site Graz, Austria Less <<
NCT01711606 - Terminated - Germany ... More >> Novartis Investigative site Nuremberg, Germany Less <<
NCT01948791 Alzheimer's Disease Phase 4 Completed - China ... More >> Novartis Investigative Site Beijing, China, 100053 Less <<
NCT00834444 - Completed - -
NCT00833664 - Completed - -
NCT00616863 Epilepsy Seiz... More >>ures Less << Not Applicable Completed - Canada, Quebec ... More >> MDS Pharma Services Montreal, Quebec, Canada, H4R 2N6 Less <<
NCT00171626 Osteoarthritis Phase 3 Completed - United States, New Jersey ... More >> Novartis Consumer Health Inc Parsippany, New Jersey, United States Less <<
NCT03399084 Iron Deficiency Anemia Phase 1 Recruiting December 31, 2018 United States, Florida ... More >> Sandoz Investigative Site Recruiting Miami, Florida, United States, 33143 Less <<
NCT00834444 Healthy Phase 1 Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Canada, Ontario Ba Research Co. Toronto, Ontario, Canada, M1P2X4 Less <<
NCT02066324 - Completed - United States, Pennsylvania ... More >> Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01948791 - Completed - -
NCT02245828 Healthy Subjects Phase 1 Completed - United Kingdom ... More >> Novartis Investigative Site Mid Glamorgan, Wales, United Kingdom, CF484DR Less <<
NCT02355028 Exudative Age-Related Macular ... More >>Degeneration Less << Phase 2 Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT00287261 Myelofibrosis ... More >> Myeloid Metaplasia Less << Phase 2 Completed - Australia, Queensland ... More >> Cancer Care Services Brisbane, Queensland, Australia, 4029 Belgium University Hospital Leuven Leuven, Belgium, 3000 France Hopital Avicenne and Paris 13 University Bobigny, France, 93000 Germany Medizinische Klinik Kiel Kiel, Germany, 24105 Israel RAMBAM Medical Center and Technion Haifa, Israel, 31096 Spain Hospital Rafael éndez Murcia, Lorca, Spain, 30800 Less <<
NCT00834431 - Completed - -
NCT00834431 Healthy Phase 1 Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. St. Charles, Missouri, United States, 63301 Canada, Ontario Ba Research Co. Toronto, Ontario, Canada, M1P2X4 Less <<
NCT02355028 - Completed - -
NCT02543086 Plasmodium Falciparum Malaria Phase 1 Terminated - Australia, Queensland ... More >> Novartis Investigative Site Brisbane, Queensland, Australia, 4006 Less <<
NCT00982930 Pseudomonas Aeruginosa ... More >> Cystic Fibrosis Less << Phase 3 Completed - Estonia ... More >> Novartis Investigative Site Tallin, Estonia Russian Federation Novartis Investigative Site Yaroslavl, Russian Federation Less <<
NCT02491281 Primary Osteoarthritis Patient... More >>s Scheduled for Total Knee Replacement Surgery Less << Phase 1 Completed - United States, Arizona ... More >> Novartis Investigative Site Phoenix, Arizona, United States, 85053 Less <<
NCT02663752 Myelodysplastic Syndrome Phase 2 Terminated - Belgium ... More >> Novartis Investigative Site Liege, Belgium, 4000 Less <<
NCT02663752 - Terminated - -
NCT00135824 Healthy Phase 4 Completed - Germany ... More >> Novartis Investigational Site Heidelberg, Germany, 69120 Less <<
NCT02878616 Kidney Transplantation Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90048 Less <<
NCT00439647 Male Osteoporosis Phase 3 Completed - -
NCT01390909 - Completed - -
NCT00439647 - Completed - -
NCT02750813 Refractive Error Not Applicable Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT01390909 - Completed - -
NCT02750813 - Completed - -
NCT00487123 Hypertension Phase 4 Completed - Singapore ... More >> Novartis Investigative Site Singapore, Singapore Less <<
NCT00494884 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Novartis Investigative Site Bochum, Germany Less <<
NCT03074357 - Completed - United States, Minnesota ... More >> Novartis Investigative Site Minneapolis, Minnesota, United States, 55455 Less <<
NCT02871375 - Completed - -
NCT02403206 - Completed - -
NCT00475800 Osteoarthritis Phase 3 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85723 United States, Minnesota Brooklyn Park, Minnesota, United States, 55430 United States, New Mexico Albuquerque, New Mexico, United States, 87109 United States, South Dakota Sioux Falls, South Dakota, United States, 57105 United States, Texas San Antonio, Texas, United States, 78232 Canada, Ontario Novartis Investigative Site Brampton, Ontario, Canada Less <<
NCT02403206 Intumescent Cataract Not Applicable Completed - -
NCT02939170 Refractive Error Not Applicable Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT02939170 - Completed - -
NCT02965820 Presbyopia Not Applicable Completed - -
NCT02965833 Presbyopia Not Applicable Completed - -
NCT02974140 Cataracts Not Applicable Terminated(Management Decision... More >>) Less << - United States, Florida ... More >> Alcon Investigative Site Panama City, Florida, United States, 32405 United States, Minnesota Alcon Investigative Site Stillwater, Minnesota, United States, 55082 United States, Texas Alcon Investigative Site Hurst, Texas, United States, 76054 Less <<
NCT02965833 - Completed - -
NCT03026257 Refractive Errors ... More >> Myopia Hypermetropia Less << Not Applicable Completed - United States, Alabama ... More >> Alcon Investigative Site Birmingham, Alabama, United States, 35233 United States, Ohio Alcon Investigative Site Cleveland, Ohio, United States, 44106 Alcon Investigative Site Columbus, Ohio, United States, 43210 United States, Tennessee Alcon Investigative Site Memphis, Tennessee, United States, 38104 United States, Texas Alcon Investigative Site Houston, Texas, United States, 77204 Canada, Ontario Alcon Investigative Site Waterloo, Ontario, Canada, N2L3G1 Germany Alcon Investigative Site Hildesheim, Germany, 31134 Alcon Investigative Site Jena, Germany, 07745 Less <<
NCT00104442 Alzheimer's Disease Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT03026257 - Completed - -
NCT00639691 Asthma Phase 4 Completed - Canada, Quebec ... More >> Novartis Investigative Site Montreal, Quebec, Canada Less <<
NCT00885794 Diabetic Macular Edema Phase 2 Phase 3 Unknown May 2012 Austria ... More >> Rudolf Foundation Clinic Vienna, Austria, 1030 Less <<
NCT02965820 - Completed - -
NCT00057265 Chronic Hepatitis B Phase 3 Completed - United States, California ... More >> Los Angeles, California, United States Orange, California, United States San Diego, California, United States United States, New Jersey Hackensack, New Jersey, United States United States, Texas Houston, Texas, United States Korea, Republic of Seoul, Korea, Republic of Spain Barcelona, Spain Valencia, Spain Thailand Bangkok, Thailand Turkey Istanbul, Turkey United Kingdom London, United Kingdom Less <<
NCT02775916 Primary Sj?gren's Syndrome Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Hungary Novartis Investigative Site Debrecen, Hungary, 4032 Less <<
NCT03114228 - - - Canada, Ontario ... More >> Novartis Investigative Site Hamilton, Ontario, Canada, L8V 1C3 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H1T 2M4 Less <<
NCT02974140 - Terminated(Management Decision... More >>) Less << - -
NCT00115245 Chronic Hepatitis B Phase 3 Completed - United States, California ... More >> Los Angeles, California, United States Pasadena, California, United States San Francisco, California, United States United States, Florida Miami, Florida, United States Australia Clayton, Australia Wooloongabba, Australia Canada Calgary, Canada Toronto, Canada Winnipeg, Canada China Hong Kong, China France Paris, France Korea, Republic of Seoul, Korea, Republic of Singapore Singapore, Singapore Taiwan Taipei, Taiwan Thailand Bangkok, Thailand Less <<
NCT00124241 Hepatitis B Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States Canada Toronto, Canada China Hong Kong, China France Paris, France Less <<
NCT00128544 Hepatitis B Phase 2 Completed - Hong Kong ... More >> Pokfulam, Hong Kong New Zealand Auckland, New Zealand Singapore Singapore, Singapore Less <<
NCT00131742 Chronic Hepatitis B Phase 3 Completed - China ... More >> Beijing, China Less <<
NCT00132652 Chronic Hepatitis B Phase 3 Completed - United States, California ... More >> San Diego, California, United States United States, New York New York, New York, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States Australia Westmead, Australia Canada, Ontario Toronto, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada China Beijing, China France Nice, France Israel Tel Aviv, Israel New Zealand Auckland, New Zealand Singapore Singapore, Singapore Taiwan Tainan, Taiwan Thailand Chiang Mai, Thailand United Kingdom London, United Kingdom Less <<
NCT00145301 Osteoarthritis Phase 3 Completed - Germany ... More >> Novartis Nuernberg, Germany Less <<
NCT00230074 Amyotrophic Lateral Sclerosis Phase 2 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT00267215 Osteoarthritis Phase 3 Completed - Germany ... More >> Novartis Nuernberg, Germany Less <<
NCT00333099 Malnutrition ... More >>Esophageal Cancer Head and Neck Cancer Less << Phase 4 Completed - France ... More >> Hotel Dieu Clermont-Ferrand, Auvergne, France, 63058 Less <<
NCT00311493 Encephalitis, Tick-Borne Phase 4 Completed - Germany ... More >> Regensburg, Germany Less <<
NCT00167492 Liver Transplantation Phase 4 Withdrawn - United States, Texas ... More >> Memorial Hermann Hospital Houston, Texas, United States, 77030 Less <<
NCT00990795 Cardiac Surgical Procedures Phase 1 Terminated(PI left institution... More >>.) Less << - United States, Texas ... More >> University of Texas Medical School Houston Houston, Texas, United States, 77030 Less <<
NCT01215643 Hepatitis C C... More >>hronic Pain Less << Phase 2 Completed - -
NCT02167854 Breast Cancer Phase 1 Active, not recruiting June 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memoral Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 Less <<
NCT01215643 - Completed - -
NCT01183169 Hepatitis C Phase 2 Completed - -
NCT01576809 Upper Respiratory Infections Phase 3 Completed - Canada, Quebec ... More >> Algorithme Pharma Montreal, Quebec, Canada, H3P3P1 Less <<
NCT01576809 - Completed - -
NCT01183169 - Completed - -
NCT01586962 Upper Respiratory Infections Phase 3 Completed - Canada, Quebec ... More >> Algorithme Pharma Montreal, Quebec, Canada Less <<
NCT01586962 - Completed - -
NCT01291511 Schizophrenia Phase 3 Completed - -
NCT00128245 Keratoconjunctivitis Sicca Not Applicable Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States Less <<
NCT01318694 Hepatitis C Phase 3 Completed - -
NCT01495169 Safety and Tolerability of Ilo... More >>peridone Less << Phase 1 Completed - United States, California ... More >> Novartis Investigative Site Costa Mesa, California, United States, 92626 United States, Florida Novartis Investigative Site North Miami, Florida, United States, 33161 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30308 United States, Idaho Novartis Investigative Site Coeur d'Alene, Idaho, United States, 83814 United States, Maryland Novartis Investigative Site Baltimore, Maryland, United States, 21205 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63044 United States, New Jersey Novartis Investigative Site Marlton, New Jersey, United States, 08053 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45219 Novartis Investigative Site Cleveland, Ohio, United States, 44106-5000 United States, Utah Novartis Investigative Site Salt Lake City, Utah, United States, 84106 Less <<
NCT01500772 Hepatitis C Phase 3 Terminated - -
NCT01500772 - Terminated - -
NCT01052935 Group B Streptococcus (GBS) Di... More >>sease Less << Phase 1 Completed - Switzerland ... More >> Institute for Pharmacokinetic and Analytical Studies Via Mastri, 36, CH - 6853 Ligornetto, Switzerland Less <<
NCT01318694 - Completed - -
NCT01209780 - Completed - -
NCT02871375 Refractive Error Not Applicable Completed - -
NCT00098228 COPD Phase 2 Completed - -
NCT02094443 Hepatitis C L... More >>iver Disease Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Bakersfield, California, United States, 93301 Novartis Investigative Site Lancaster, California, United States, 93534 Novartis Investigative Site San Diego, California, United States, 92114 Novartis Investigative Site San Diego, California, United States, 92128 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63110 United States, Texas Novartis Investigative Site Arlington, Texas, United States, 76012 Novartis Investigative Site Houston, Texas, United States, 77030 Novartis Investigative Site San Antonio, Texas, United States, 78215 United States, Virginia Novartis Investigative Site Newport News, Virginia, United States, 23602 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98101 Novartis Investigative Site Seattle, Washington, United States, 98104 France Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Lyon Cedex 04, France, 69317 Novartis Investigative Site Nice Cedex 3, France, 06202 Novartis Investigative Site Paris, France, 75014 Less <<
NCT02094443 - Completed - -
NCT01209780 Seasonal Influenza Phase 3 Completed - Colombia ... More >> Centro de Atención e Investigación Medica - CAIMED Carrera 42A # 17-50, Bogotá, Colombia Mexico Clinical research institute ,S.C(CRI), Blvd Manuel Avila Camacho 1994 Consultorio 1103 Col. San Lucas Tepetlacalco, C.P.54055 Tlalnepantla Estado de México, Mexico Panama Centro de Salud Magally Ruiz, Street Bolivar Panama - La Chorrera, Panama Clinica Hospital San Fernando, Floor 4 Office 419 via España las Sabanas Panamá, Panama Consultorios America Floor 2 Office 201-1, Via España Vista Hermosa Panamá, Panama Consultorios Medicos San Judas Tadeo Principal Street, Floor 5 Office 507, Villa Lucre Panamá, Panama Philippines Philippine General Hospital Taft Avenue, Manila, Manila, Philippines, 1000 Research Institute for Tropical Medicine, Department of Health Compound FILINVEST Corporate City, Alabang, Muntinlupa City, Philippines, 1781 Research Institute for Tropical Medicine, Department of Health Compound, FILINVEST Corporate City Alabang, Muntinlupa City, Philippines, 1781 University of the East Ramon Magsaysay Medical Center, 64 Aurora Boulevard Barangay Dona Imelda Quezon City, Philippines, 1113 De La Salle Health Sciences Institute Dasmarinas Cavite, Philippines, 4115 Mary Chiles General Hospital, 667 Gastambide St. Sampaloc Manila, Philippines, 1008 Philippine Children's Medical Center, Quezon Avenue corner Agham Road Quezon City, Philippines Less <<
NCT00099541 Non-Small-Cell Lung Cancer ... More >> Pleural Effusion, Malignant Less << Phase 4 Completed - -
NCT02753699 Hepatitis C Phase 3 Completed - -
NCT01970904 Hepatitis C L... More >>iver Disease Less << Not Applicable Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10969 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20099 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Kiel, Germany, 24146 Novartis Investigative Site Köln, Germany, 50937 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Würzburg, Germany, 97080 Poland Novartis Investigative Site Bialystok, Poland, 15-540 Novartis Investigative Site Lublin, Poland, 20-079 Novartis Investigative Site Warszawa, Poland, 01-201 Sweden Novartis Investigative Site Göteborg, Sweden, 416 85 Novartis Investigative Site Luleå, Sweden, SE-971 80 Novartis Investigative Site Lund, Sweden, 221 85 Novartis Investigative Site Malmo, Sweden, SE-205 02 Novartis Investigative Site Stockholm, Sweden, 141 86 Novartis Investigative Site Umea, Sweden, 901 85 United Kingdom Novartis Investigative Site Frimley, Surrey, United Kingdom, GU16 7UJ Novartis Investigative Site Birmingham, United Kingdom, B15 2TT Novartis Investigative Site London, United Kingdom, E1 1BB Novartis Investigative Site London, United Kingdom, SE5 9RS Less <<
NCT00984893 - Completed - Canada, British Columbia ... More >> Vancouver, British Columbia, Canada Canada, Ontario Hamilton, Ontario, Canada Canada Groupe de recherche en rhumatologie et maladies osseuses Inc Quebec, Canada Less <<
NCT00097968 Graft Rejection Phase 3 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Minnesota University of Minnesota, Fairfield University Hospital Minneapolis, Minnesota, United States, 55455 United States, New York Columbia Presbyterian Medical Center New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Tennessee Midstate Cardiology Nashville, Tennessee, United States, 37203 Less <<
NCT02753699 - Completed - -
NCT02427750 Human Influenza Phase 2 Completed - Brazil ... More >> 100 Salvador, Bahia, Brazil, 40420000 Less <<
NCT02427750 - Completed - -
NCT00117754 Tinea Capitis Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01440959 - Completed - -
NCT00109200 Asthma Phase 3 Completed - -
NCT00503022 Wet Age-Related Macular Degene... More >>ration Less << Phase 1 Completed - Switzerland ... More >> Bern, Switzerland United Kingdom Belfast, Northern Ireland, United Kingdom Bristol, United Kingdom Liverpool, United Kingdom London, United Kingdom Nottingham,, United Kingdom Southampton, United Kingdom Wolverhampton, United Kingdom Less <<
NCT01175096 Neuroendocrine Tumors ... More >> Carcinoid Tumor Less << Phase 1 Phase 2 Unknown January 2012 China, Guangdong ... More >> Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences Guangzhou, Guangdong, China, 510080 Less <<
NCT02897245 - Recruiting December 2022 France ... More >> CH Versailles Recruiting Le Chesnay, France Contact: Rousselot Philippe       phrousselot@ch-versailles.fr Less <<
NCT00814788 Prostate Cancer Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00814788 - Completed - -
NCT00238485 Bipolar I Disorder Phase 3 Completed - -
NCT00399659 Opioid-induced Constipation Phase 3 Terminated(This study was term... More >>inated early as a result of regulatory action suspending tegaserod use in 2007) Less << - -
NCT01148797 Colchicine Resistant/Intoleran... More >>t Familial Mediterranean Fever Less << Phase 2 Completed - Israel ... More >> Rambam Health Care Campus Haifa, Israel Shaare Zedek Medical Center Jerusalem, Israel Meir Medical Center Kfar Saba Kfar Saba, Israel Rabin Medical Center Petach Tikva, Israel The Chaim Sheba Medical Center Ramat Gan, Israel Less <<
NCT00390975 Gastroparesis ... More >> Diabetes Less << Phase 4 Terminated(This study was term... More >>inated early as a result of regulatory action suspending tegaserod use in 2007) Less << - United States, Kansas ... More >> The University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Kentucky The University of Louisville Louisville, Kentucky, United States, 40292 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT03103009 Hyperinsulinemic Hypoglycemia ... More >> Post Gastrointestinal Tract Surgery Hypoglycaemia Less << Phase 1 Recruiting March 22, 2019 United States, Colorado ... More >> University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Less <<
NCT00394173 Irritable Bowel Syndrome With ... More >>Diarrhea (IBS-D) Less << Phase 2 Completed - -
NCT00170872 Osteoarthritis ... More >> Rheumatoid Arthritis Less << Phase 3 Completed - -
NCT00414024 Opioid-induced Constipation Phase 3 Terminated(This study was term... More >>inated early as a result of regulatory action suspending tegaserod use in 2007) Less << - United States, New Jersey ... More >> 60 Investigative Sites East Hanover, New Jersey, United States China 2 Investigative Sites Hong Kong, China Egypt 6 Investigative Sites Egypt, Egypt Singapore 1 Investigative Site Singapore, Singapore Taiwan 2 Investigative Sites Taiwan, Taiwan Venezuela 4 Investigative Sites Venezuela, Venezuela Less <<
NCT01025544 Haemophilus Influenzae Type b ... More >>(Hib) Infection Less << Phase 3 Completed - China ... More >> Hebei Province, China Less <<
NCT00506792 Cystic Fibrosis Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-0006 Less <<
NCT00143026 Parkinson's Disease Phase 4 Completed - Australia ... More >> Royal Adelaide Hospital Adelaide, Australia Watkins Medical Center Brisbane, Australia Central Coast Neuroscience Research Gosford, Australia Heidelberg Repatriation Hospital Melbourne, Australia Monash Medical Centre Melbourne, Australia Sir Charles Gairdner Hospital Perth, Australia Concord Hospital Sydney, Australia Southern Neurology, St. George Private Hospital Sydney, Australia Westmead Hospital Sydney, Australia Philippines St. Luke's Medical Centre Manila, Philippines University of Santo Tomas Hospital Manila, Philippines Taiwan Chang Gung Memorial Hospital Linkou, Taiwan Kaohsiung Medical University, Chung-Ho Memorial Hospital Linkou, Taiwan National Taiwan University Hospital Linkou, Taiwan Thailand King Chulalongkorn Memorial Hospital Bangkok, Thailand Maharaj Nakorn Chiangmai Hospital Bangkok, Thailand Siriraj Hospital Bangkok, Thailand Pharmongkutklao Army Hospital Bankok, Thailand Less <<
NCT01440959 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul,, Korea, Republic of, 138-736 Less <<
NCT00171444 Hypertension Phase 4 Completed - -
NCT00100607 Osteoporosis Phase 2 Completed - -
NCT00219245 Traumatic Brain Injury With Pe... More >>rsistent Cognitive Deficits Less << Phase 4 Completed - -
NCT02570854 Anemia, Iron-Deficiency Phase 1 Phase 2 Recruiting February 7, 2020 United States, California ... More >> Novartis Investigative Site Recruiting San Diego, California, United States, 91942 United States, Colorado Novartis Investigative Site Recruiting Lakewood, Colorado, United States, 80228 United States, Florida Novartis Investigative Site Recruiting Orlando, Florida, United States, 32809 United States, Illinois Novartis Investigative Site Recruiting Chicago, Illinois, United States, 60611 United States, Minnesota Novartis Investigative Site Recruiting Minneapolis, Minnesota, United States, 55404 United States, Tennessee Novartis Investigative Site Recruiting Chattanooga, Tennessee, United States, 3740 Czechia Novartis Investigative Site Recruiting Praha, Czechia, 12808 Israel Novartis Investigative Site Recruiting Ashkelon, Israel, 78278 Novartis Investigative Site Recruiting Hadera, Israel, 38100 Novartis Investigative Site Recruiting Jerusalem, Israel, 91120 Novartis Investigative Site Recruiting Petach Tikva, Israel, 49100 Novartis Investigative Site Recruiting Tel Aviv, Israel, 62439 United Kingdom Novartis Investigative Site Recruiting London, United Kingdom, SW17 0QT Less <<
NCT00107939 Bipolar Disorder Phase 3 Completed - United States, Arkansas ... More >> Investigational Site Little Rock, Arkansas, United States, 72201 United States, California Investigational Site Orange, California, United States, 92868 Investigational Site Pico Rivera, California, United States, 90660 Investigational Site San Diego, California, United States, 92108 Investigational Site San Diego, California, United States, 92126 United States, Florida Investigational Site Boca Raton, Florida, United States, 33432 United States, Georgia Investigational Site Atlanta, Georgia, United States, 30308 United States, Illinois Investigational Site Chicago, Illinois, United States, 60640 Investigational Site Joliet, Illinois, United States, 60435 United States, Indiana Investigational Site Indianapolis, Indiana, United States, 46222 United States, Kansas Investigational Site Topeka, Kansas, United States, 66606 United States, Missouri Investigational Site Kansas City, Missouri, United States, 64133 Investigational Site St. Louis, Missouri, United States, 63104 United States, New York Invetigational Site Brooklyne, New York, United States, 11201 Investigational Site Cedarhurst, New York, United States, 11516 Investigational Site New York, New York, United States, 10003 United States, Ohio Investigational Site Cincinnati, Ohio, United States, 45267 Investigational Site Columbus, Ohio, United States, 43210 United States, Rhode Island Investigational Site Providence, Rhode Island, United States, 02903 United States, Texas Investigational Site Bellaire, Texas, United States, 77401 United States, Washington Investigational Site Bellevue, Washington, United States, 98004 United States, Wisconsin Investigational Site West Allis, Wisconsin, United States, 53227 Less <<
NCT00107237 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 United States, North Carolina Duke Univaersity Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Less <<
NCT02662985 Arthritis, Psoriatic Phase 3 Recruiting September 3, 2019 -
NCT00478816 Prophylaxis of Avian Influenza... More >> Vaccine Less << Phase 2 Completed - United Kingdom ... More >> Infectious Diseases Unit Leicester, United Kingdom Less <<
NCT00170911 Osteoporosis Phase 2 Completed - -
NCT03056755 Breast Cancer Phase 2 Recruiting April 10, 2020 -
NCT02546674 Chronic Myeloid Leukemia Phase 4 Recruiting February 18, 2020 -
NCT00408395 Influenza Phase 2 Completed - Finland ... More >> University of Tampere Medical School Tampere, Finland, 33014 Less <<
NCT00117507 Myelodysplastic Syndromes ... More >> Iron Overload Less << Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5821 United States, Michigan Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT02768298 Chronic Heart Failure With Red... More >>uced Ejection Fraction Less << Phase 4 Recruiting December 30, 2019 Germany ... More >> Novartis Investigative Site Recruiting Regensburg, Bavaria, Germany, 93053 Novartis Investigative Site Recruiting Dresden, Sachsen, Germany, 01099 Novartis Investigative Site Recruiting Berlin, Germany, 10117 Novartis Investigative Site Recruiting Berlin, Germany, 10787 Novartis Investigative Site Recruiting Berlin, Germany, 13055 Novartis Investigative Site Completed Berlin, Germany, 13187 Novartis Investigative Site Recruiting Berlin, Germany, 13405 Novartis Investigative Site Completed Bonn, Germany, 53115 Novartis Investigative Site Recruiting Coburg, Germany, 96450 Novartis Investigative Site Recruiting Dresden, Germany, 01277 Novartis Investigative Site Recruiting Dresden, Germany, 01307 Novartis Investigative Site Recruiting Erfurt, Germany, 99089 Novartis Investigative Site Completed Essen, Germany, 45356 Novartis Investigative Site Recruiting Frankfurt, Germany, 60389 Novartis Investigative Site Recruiting Freiburg, Germany, 79106 Novartis Investigative Site Recruiting Goettingen, Germany, 37075 Novartis Investigative Site Completed Guetersloh, Germany, 33332 Novartis Investigative Site Recruiting Hamburg, Germany, 22291 Novartis Investigative Site Recruiting Hannover, Germany, 30625 Novartis Investigative Site Completed Heidelberg, Germany, 69115 Novartis Investigative Site Recruiting Kiel, Germany, 24105 Novartis Investigative Site Recruiting Koblenz, Germany, 56068 Novartis Investigative Site Recruiting Koeln-Nippes, Germany, 50733 Novartis Investigative Site Recruiting Koeln, Germany, 51605 Novartis Investigative Site Recruiting Leverkusen, Germany, 51375 Novartis Investigative Site Recruiting Ludwigsburg, Germany, 71634 Novartis Investigative Site Recruiting Ludwigshafen, Germany, 67063 Novartis Investigative Site Recruiting Mainz, Germany, 55131 Novartis Investigative Site Completed Muehlheim An Der Ruhr, Germany, 45468 Novartis Investigative Site Recruiting Muenchen, Germany, 81675 Novartis Investigative Site Terminated Mönchengladbach, Germany, 41063 Novartis Investigative Site Recruiting Neuwied, Germany, 56564 Novartis Investigative Site Recruiting Nienburg, Germany, 31582 Novartis Investigative Site Completed Oldenburg, Germany, 26133 Novartis Investigative Site Recruiting Rotenburg an der Fulda, Germany, 36199 Novartis Investigative Site Recruiting Rüdersdorf, Germany, 15562 Novartis Investigative Site Recruiting Siegen, Germany, 57072 Novartis Investigative Site Recruiting Ulm, Germany, 89077 Novartis Investigative Site Recruiting Villingen-Schwenningen, Germany, 78052 Novartis Investigative Site Recruiting Worms, Germany, 67550 Novartis Investigative Site Recruiting Wuerzburg, Germany, 97078 Novartis Investigative Site Recruiting Wuppertal, Germany, 42117 Less <<
NCT00118456 Cancer Phase 1 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89125 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77054 Institute of Drug Development/Cancer Therapy and Research Center San Antonio, Texas, United States, 78229 Less <<
NCT02771210 Psoriatic Arthritis ... More >> Axial Spondyloarthritis Enthesitis Less << Phase 3 Recruiting January 8, 2020 -
NCT02721966 Axial Psoratic Arthritis Phase 3 Recruiting June 11, 2019 -
NCT03066609 Plaque Psoriasis Phase 3 Completed - -
NCT03108027 Asthma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Frankfurt Am Main Hessen, Germany, 60596 Novartis Investigative Site Grosshansdorf, Germany, 22947 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Wiesbaden, Germany, 65187 Netherlands Novartis Investigative Site Groningen, GZ, Netherlands, 9713 United Kingdom Novartis Investigative Site Machester, United Kingdom, M23 9QZ Less <<
NCT02696031 Non-radiographic Spondyloarthr... More >>itis Less << Phase 3 Recruiting December 16, 2020 -
NCT03070717 - Active, not recruiting July 1, 2019 Germany ... More >> Novartis Investigative Site Ansbach, Germany, 91522 Novartis Investigative Site Bad Rothenfelde, Germany, 49214 Novartis Investigative Site Berlin, Germany, 10713 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bochum, Germany, 44892 Novartis Investigative Site Bonn, Germany, 53127 Novartis Investigative Site Chemnitz, Germany, 09113 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg I. Br, Germany, 79106 Novartis Investigative Site Göttingen, Germany, 37075 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hösbach, Germany, 63768 Novartis Investigative Site Karlsruhe, Germany, 76133 Novartis Investigative Site Koeln, Germany, 50924 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48145 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site München, Germany, 80336 Novartis Investigative Site München, Germany, 80637 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Regensburg, Germany, 93042 Novartis Investigative Site Tübingen, Germany, 72076 Novartis Investigative Site Wurzburg, Germany, 97080 Less <<
NCT03141086 Circadian Rhythm Disorders Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 92868 Novartis Investigative Site San Diego, California, United States, 92103 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33173 Novartis Investigative Site Oakland Park, Florida, United States, 33334 Novartis Investigative Site Pembroke Pines, Florida, United States, 33026 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30342 United States, Maryland Novartis Investigative Site Chevy Chase, Maryland, United States, 20815 United States, New York Novartis Investigative Site New York, New York, United States, 10019 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45255 Less <<
NCT03386474 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 3 Completed - -
NCT00203671 - Completed - -
NCT03137784 Asthma Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Novartis Investigative Site North Dartmouth, Massachusetts, United States, 02747 United States, Missouri Novartis Investigative Site Saint Louis, Missouri, United States, 63141 United States, New Jersey Novartis Investigative Site Skillman, New Jersey, United States, 08558 United States, North Carolina Novartis Investigative Site Raleigh, North Carolina, United States, 27607 United States, Oregon Novartis Investigative Site Medford, Oregon, United States, 97504 United States, Texas Novartis Investigative Site El Paso, Texas, United States, 79903 Belgium Novartis Investigative Site Erpent, Belgium, 5100 Novartis Investigative Site Hasselt, Belgium, 3500 Novartis Investigative Site Mechelen, Belgium, 2800 Germany Novartis Investigative Site Berlin, Germany, 10119 Novartis Investigative Site Frankfurt, Germany, 60596 Novartis Investigative Site Grosshansdorf, Germany, 22927 Novartis Investigative Site Lubeck, Germany, 23552 Novartis Investigative Site Wiesbaden, Germany, 65187 Japan Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 169-0073 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0014 Latvia Novartis Investigative Site Daugavpils, LVA, Latvia, LV-5417 Novartis Investigative Site Riga, Latvia, LV 1002 Novartis Investigative Site Riga, Latvia, LV-1038 Lithuania Novartis Investigative Site Klaipeda, Lithuania, LT-92231 Novartis Investigative Site Klaipeda, Lithuania, LT-92288 Less <<
NCT00685373 Cryopyrin-Associated Periodic ... More >>Syndromes Familial Cold Autoinflammatory Syndrome Muckle Wells Syndrome Neonatal Onset Multisystem Inflammatory Disease Less << Phase 3 Completed - -
NCT00685373 - Completed - -
NCT03136861 Spondyloarthritis Phase 3 Active, not recruiting February 22, 2019 -
NCT00465985 Muckle Wells Syndrome Phase 3 Completed - United States, California ... More >> Novartis Investigative Site San Francisco, California, United States, 94115 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60612 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53792 France Novartis Investigative Site Le Kremlin Bicetre, France Novartis Investigational Site Lille Cedex, France Novartis Investigative Site Montpellier Cedex, France Novartis Investigative Site Nantes, France Novartis Investigative Site Paris, France Germany Novartis Investigative Site Tubingen, Germany India Novartis Investigative Site New Delhi, India Spain Novartis Investigative Site Barcelona, Spain United Kingdom Novartis Investigative Site London, United Kingdom Less <<
NCT00465985 - Completed - -
NCT01326754 Malaria, Falciparum Not Applicable Completed - Malawi ... More >> Machinga District Hospital Liwonde, Malawi Less <<
NCT00476034 Osteoarthritis Phase 3 Completed - Australia ... More >> Novartis Investigative Site Malvern, Australia Austria Novartis Investigative Site Vienna, Austria Czech Republic Novartis Investigative Site Prague, Czech Republic Finland Novartis Investigative Site Turku, Finland Germany Novartis Investigative Site Dresden, Germany Hungary Novartis Investigative Site Budapest, Hungary Israel Novartis Investigative Site Haifa, Israel Netherlands Novartis Investigative Site Lisse, Netherlands New Zealand Novartis Investigative Site Rotorua, New Zealand Poland Novartis Investigative Site Poznan, Poland Slovakia Novartis Investigative Site Bratislava, Slovakia South Africa Novartis Investigative Site Johannesburg, South Africa Spain Novartis Investigative Site Sevilla, Spain Sweden Novartis Investigative Site Uppsala, Sweden Turkey Novartis Investigative Site Izmir, Turkey Less <<
NCT00467402 Major Depressive Disorder Phase 3 Completed - -
NCT00573768 - Completed - -
NCT01541267 Chronic Kidney Disease ... More >> Proteinuria Less << Phase 4 Completed - -
NCT02380261 Ocular Tolerance ... More >> Skin Tolerance Less << Not Applicable Completed - Brazil ... More >> Novartis Biociencias SA Sao Paulo, Brazil, 04636-000 Less <<
NCT00407212 Parkinson's Disease Phase 1 Phase 2 Completed - -
NCT00573768 Ankle Sprain Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Bramstedt, Germany, 24576 Novartis Investigative Site Bad Nauheim, Germany, 61231 Novartis Investigative Site Bad Zwischenahn, Germany, 26160 Novartis Investigative Site Berlin, Germany, 10589 Novartis Investigative Site Berlin, Germany, 10961 Novartis Investigative Site Berlin, Germany, 12247 Novartis Investigative Site Berlin, Germany, 12349 Novartis Investigative Site Berlin, Germany, 14163 Novartis Investigative Site Berlin, Germany, 14169 Novartis Investigative Site Bochum, Germany, 44789 Novartis Investigative Site Dortmund, Germany, 44263 Novartis Investigative Site Dresden, Germany, 01129 Novartis Investigative Site Dusseldorf, Germany, 40212 Novartis Investigative Site Eichstätt, Germany, 85072 Novartis Investigative Site Hamburg, Germany, 20357 Novartis Investigative Site Hamburg, Germany, 22143 Novartis Investigative Site Hammelburg, Germany, 97762 Novartis Investigative Site Karlsruhe, Germany, 76133 Novartis Investigative Site Kaufbeuren, Germany, 87600 Novartis Investigative Site Lambrecht/Pfalz, Germany, 67466 Novartis Investigative Site Leipzig, Germany, 04109 Novartis Investigative Site Meersburg, Germany, 88709 Novartis Investigative Site Munchen, Germany, 80333 Novartis Investigative Site Munchen, Germany, 80538 Novartis Investigative Site Munchen, Germany, 80798 Novartis Investigative Site Munich, Germany, 80339 Novartis Investigative Site Neustadt/Aisch, Germany, 91413 Novartis Investigative Site Siegen, Germany, 57074 Novartis Investigative Site Stockach, Germany, 78333 Less <<
NCT00424346 Rheumatoid Arthritis Phase 2 Completed - United States, Alabama ... More >> Pinnacle Research Group Anniston, Alabama, United States, 36207 University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Arizona Sun Valley Arthritis Center, Ltd Peoria, Arizona, United States, 85381 Catalina Pointe Arthritis & Rheumatology Specialists Tucson, Arizona, United States, 85704 United States, Florida Arthritis Center Palm Harbor, Florida, United States, 34684 Arthritis Research of Florida, Inc. Palm Harbor, Florida, United States, 34684 United States, Illinois The Arthritis Center Springfield, Illinois, United States, 62704 United States, Missouri St. Louis Cener for Clinical Research St. Louis, Missouri, United States, 63128 United States, New York The Center for Rheumatology Albany, New York, United States, 12206 AAIR Research Center Rochester, New York, United States, 14618 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Washington Tacoma Center for Arthritis Research Tacoma, Washington, United States, 98405 Austria Novartis Vienna, Austria Belgium Novartis Vilvoorde, Belgium Canada, Quebec Novartis Dorval, Quebec, Canada Germany Novartis Nuernberg, Germany Spain Novartis Barcelona, Spain Less <<
NCT00424346 - Completed - -
NCT01006395 Prostate Cancer Phase 2 Phase 3 Recruiting April 2019 Australia, Victoria ... More >> Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Grossmann    61394965000       Principal Investigator: Mathis Grossmann, MD PhD FRACP Less <<
NCT01128192 Hyperglycemia Phase 2 Completed - United States, California ... More >> CMR Center for Metabolic Research VASDHS San Diego, California, United States, 92161 Less <<
NCT01128192 - Completed - -
NCT03257995 Asthma Phase 2 Completed - United States, Massachusetts ... More >> Novartis Investigative Site North Dartmouth, Massachusetts, United States, 02747-3322 United States, Missouri Novartis Investigative Site Saint Louis, Missouri, United States, 63141 United States, New Jersey Novartis Investigative Site Skillman, New Jersey, United States, 08558 United States, North Carolina Novartis Investigative Site Raleigh, North Carolina, United States, 27607 United States, Oregon Novartis Investigative Site Medford, Oregon, United States, 97504 United States, Texas Novartis Investigative Site El Paso, Texas, United States, 79903 Less <<
NCT03152591 Polycystic Ovary Syndrome Phase 2 Completed - United States, Louisiana ... More >> Novartis Investigative Site Baton Rouge, Louisiana, United States, 70808 United States, Missouri Novartis Investigative Site Springfield, Missouri, United States, 65802 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Freiburg, Germany, 79106 Less <<
NCT01245127 Schnitzler Syndrome Phase 2 Completed - Belgium ... More >> UZ Gasthuisberg Leuven, Belgium, 3000 Less <<
NCT00620438 HIV Infections ... More >> Tuberculosis Less << Phase 4 Unknown July 2011 Uganda ... More >> Infectious Diseases Institute, Makerere University Kampala, Uganda, 22418 Less <<
NCT02023905 Low Grade Glioma ... More >> WHO Grade II Astrocytomas Oligodendrogliomas Mixed Oligoastrocytomas Less << Phase 2 Recruiting January 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143-0372 Contact: Jennifer Clarke, MD, MPH    415-353-2966    Jennifer.Clarke@ucsf.edu    Contact: Tiffany Jones    415-353-9641    Tiffany.Jones@ucsf.edu    Principal Investigator: Jennifer Clarke, MD Less <<
NCT02380261 - Completed - -
NCT01190475 Endometriosis Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 Less <<
NCT02504892 Renal Cancer ... More >>Birt-Hogg-Dube Syndrome Less << Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02184624 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 4 Completed - Netherlands ... More >> GSK Investigational Site Almere, Netherlands, 1311 RL GSK Investigational Site Beek, Netherlands, 6191 JW GSK Investigational Site Enschede, Netherlands, 7513 ER GSK Investigational Site Kloosterhaar, Netherlands, 7694 AC GSK Investigational Site Nijverdal, Netherlands, 7442 LS GSK Investigational Site Zutphen, Netherlands, 7207 AE United Kingdom GSK Investigational Site Portsmouth, United Kingdom, PO6 3LY GSK Investigational Site Southampton, United Kingdom, SO16 6YD Less <<
NCT03112603 Graft-versus-host Disease (GVH... More >>D) Less << Phase 3 Recruiting January 2022 -
NCT02184624 - Completed - -
NCT01190475 - Completed - -
NCT01063140 - Completed - United States, Arizona ... More >> CSL Donor Plasma Center Tempe, Arizona, United States, 85282 United States, Illinois CSL Donor Plasma Center Rock Island, Illinois, United States, 61201 United States, Michigan CSL Donor Plasma Center Oak Park, Michigan, United States, 48237 United States, Minnesota CSL Donor Plasma Center St. Paul, Minnesota, United States, 55104 United States, Ohio CSL Donor Plasma Center Cleveland, Ohio, United States, 44109 CSL Donor Plasma Center Springfield, Ohio, United States, 45503 United States, Oklahoma CSL Donor Plasma Center Oklahoma City, Oklahoma, United States, 73103 United States, Oregon CSL Donor Plasma Center Medord, Oregon, United States, 97501 United States, Tennessee CSL Donor Plasma Center Knoxville, Tennessee, United States, 37916 United States, Utah CSL Donor Plasma Center Salt Lake City, Utah, United States, 84115 Less <<
NCT03553329 - Completed - France ... More >> CHU DE Poitiers Poitiers, France, 86021 Less <<
NCT01356862 Breast Cancer Phase 2 Completed - France ... More >> Tenon Hospital Paris, France, 75020 Institut Gustave ROUSSY Villejuif, France, 94805 Less <<
NCT02233543 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Denmark ... More >> Novartis Investigative Site Aarhus, Denmark, 8000 C Novartis Investigative Site Hvidovre, Denmark, 2650 Norway Novartis Investigative Site Bergen, Norway, -N5021 Sweden Novartis Investigative Site Goteborg, Sweden, 413 45 Novartis Investigative Site Uppsala, Sweden, SE-751 85 Less <<
NCT02236611 - Completed - -
NCT02019693 Papillary Renal Cell Carcinoma Phase 2 Recruiting January 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02962388 Essential Thrombocythemia Phase 2 Phase 3 Active, not recruiting November 2022 France ... More >> FILO Tours, France, 37044 Less <<
NCT02588339 Graft Versus Host Disease ... More >> GVHD Less << Phase 2 Active, not recruiting December 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02743780 Ocular Hypertension ... More >> Open-Angle Glaucoma Less << Phase 1 Phase 2 Completed - -
NCT02236611 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 4 Completed - -
NCT02743780 - Completed - -
NCT01359358 - Unknown - Brazil ... More >> Instituto de Física de Sao Carlos - Universidade de Sao Paulo Active, not recruiting Sao Carlos, Sao Paulo, Brazil, 13560-590 Less <<
NCT02233543 - Completed - -
NCT00922311 IgA Nephropathy Phase 4 Completed - China ... More >> Department of Medicine, The University of Hong Kong Hong Kong, China Queen Mary Hospital Hong Kong, China Less <<
NCT01320865 - Withdrawn - United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT03114969 - Completed - Netherlands ... More >> GSK Investigational Site Beek En Donk, Netherlands, 5741 CG GSK Investigational Site Beek, Netherlands, 6191JW GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Hengelo, Netherlands, 7555 DL GSK Investigational Site Hoorn, Netherlands, 1624 NP GSK Investigational Site Kloosterhaar, Netherlands, 7694 AC GSK Investigational Site Nijverdal, Netherlands, 7442 LS GSK Investigational Site Rotterdam, Netherlands, 3051 GV GSK Investigational Site Zutphen, Netherlands, 7207 AE United Kingdom GSK Investigational Site Northwood, Middlesex, United Kingdom, HA6 2RN GSK Investigational Site London, United Kingdom, EC1M 6BQ GSK Investigational Site London, United Kingdom, SW17 0QT GSK Investigational Site Sidcup, Kent, United Kingdom, DA14 6LT Less <<
NCT01931085 - - - -
NCT02814240 Hepatic Steatosis ... More >> Pituitary Gland Failure Less << Not Applicable Unknown - France ... More >> CHU Dijon Bourgogne Recruiting Dijon, France, 21079 Contact: Jean-Michel PETIT    3.80.29.34.53 ext 33    jean-michel.petit@chu-dijon.fr Less <<
NCT03377426 Complicated Urinary Tract Infe... More >>ctions Less << Phase 2 Withdrawn(The trial was termin... More >>ated due to an out-licensing agreement after the new sponsor did not wish to continue the trial) Less << October 28, 2019 United States, Michigan ... More >> Novartis Investigative Site Detroit, Michigan, United States, 48202 United States, New Jersey Novartis Investigative Site Newark, New Jersey, United States, 07102 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98195 Denmark Novartis Investigative Site Odense, Denmark, 5000 Greece Novartis Investigative Site Athens, Greece, 115 27 Less <<
NCT01150201 Kidney Disease Phase 4 Completed - China ... More >> Queen Mary Hospital Hong Kong, China Less <<
NCT00955513 - Completed - -
NCT01680718 Social Psychology Early Phase 1 Completed - United States, California ... More >> UCLA Department of Psychology Los Angeles, California, United States, 90095-1563 Less <<
NCT01905774 - Completed - Israel ... More >> Ha'Emek Medical Center Afula, Israel, 18101 Less <<
NCT00955513 Grade I/II Ankle Sprain Phase 3 Completed - Germany ... More >> Novartis Investigative Site Cologne, Germany Novartis Investigative Site Essen, Germany Novartis Investigative Site Gilching, Germany Novartis Investigative Site Grunwald, Germany Novartis Investigative Site Munchen, Germany Less <<
NCT00331500 Allergic Conjunctivitis Phase 3 Completed - -
NCT02954978 Parkinson Disease ... More >> Parkinsons Disease With Dementia Less << Phase 2 Active, not recruiting July 2020 United States, District of Col... More >>umbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 Less <<
NCT01939418 Metastatic Breast Cancer Phase 1 Phase 2 Terminated(slow recruitment) - Korea, Republic of ... More >> National cancer center Goyangsi, Gyeonggido, Korea, Republic of, 410-769 Less <<
NCT00554515 - Completed - -
NCT02287688 - Completed - United States, California ... More >> GSK Investigational Site Pasadena, California, United States, 91101 Less <<
NCT03531697 Inflammation Following Ocular ... More >>Surgery Less << Phase 1 Recruiting February 15, 2019 Canada ... More >> Sandoz Investigative Site Recruiting Multiple Locations, Canada Sandoz Investigative Site Not yet recruiting Multiple Locations, Canada Less <<
NCT00935558 Breast Cancer Phase 2 Withdrawn(no patients enrolled... More >>) Less << - Denmark ... More >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 Less <<
NCT00732693 Premature Ovarian Failure Phase 4 Completed - United Kingdom ... More >> Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH16 4SA Royal Hospital for Sick Children Edinburgh, United Kingdom, EH9 1LF Less <<
NCT02502526 Cataracts Not Applicable Completed - -
NCT02502526 - Completed - -
NCT02507388 Neovascular Age-Related Macula... More >>r Degeneration Less << Phase 2 Completed - -
NCT00546975 Patients Following Gastrointes... More >>tinal Surgery Less << Not Applicable Terminated(Compliance unaccept... More >>ably low.) Less << - Germany ... More >> Dept of Surgery CCM Berlin, Germany, 10117 Less <<
NCT02700984 Primary Open Angle Glaucoma (P... More >>OAG) Less << Not Applicable Completed - -
NCT02842151 Cataract Not Applicable Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT00911313 Polycystic Ovary Syndrome Not Applicable Completed - Egypt ... More >> Mansoura University Hospitals,OB/GYN department Mansoura, Dakahlia, Egypt, 35511 Less <<
NCT03273907 Primary Open-angle Glaucoma ... More >> Cataract Less << Not Applicable Suspended(Market withdraw of C... More >>yPass) Less << April 2023 United States, Arizona ... More >> Alcon Investigative Site Phoenix, Arizona, United States, 85016 United States, California Alcon Investigative Site Huntington Beach, California, United States, 92647 Alcon Investigative Site Orange, California, United States, 92868 United States, Colorado Alcon Investigative Site Fort Collins, Colorado, United States, 80528 United States, Florida Alcon Investigative Site Jacksonville, Florida, United States, 32256 Alcon Investigative Site Mount Dora, Florida, United States, 32757 Alcon Investigative Site Panama City, Florida, United States, 32405 United States, Georgia Alcon Investigative Site Gainesville, Georgia, United States, 30501 Alcon Investigative Site Marietta, Georgia, United States, 30060 United States, Kansas Alcon Investigative Site Garden City, Kansas, United States, 67846 United States, Michigan Alcon Investigative Site Fraser, Michigan, United States, 48026 United States, Missouri Alcon Investigative Site Saint Louis, Missouri, United States, 63131 Alcon Investivative Site Saint Louis, Missouri, United States, 63131 United States, New Jersey Alcon Investigative Site Vineland, New Jersey, United States, 08361 United States, Pennsylvania Alcon Investigative Site Bala-Cynwyd, Pennsylvania, United States, 19004 Alcon Investigative Site Chambersburg, Pennsylvania, United States, 17201 United States, Texas Alcon Investigative Site Austin, Texas, United States, 78731 Alcon Investigative Site El Paso, Texas, United States, 79902 Alcon Investigative Site Houston, Texas, United States, 77030 United States, Washington Alcon Investigative Site Bellevue, Washington, United States, 98004-3012 United States, Wisconsin Alcon Investigative Site Kenosha, Wisconsin, United States, 53142 Alcon Investigative Site Racine, Wisconsin, United States, 53405 Less <<
NCT03316885 Cataract Not Applicable Active, not recruiting July 2021 Australia, Victoria ... More >> Alcon Investigative Site Footscray, Victoria, Australia, 3011 Alcon Investigative Site Mornington, Victoria, Australia, 3931 Australia Alcon Investigative Site Sydney, Australia, 2067 France Alcon Investigative Site Brest, Cedex, France, 29609 Alcon Investigative Site Lyon, France, 69003 Alcon Investigative Site Paris, France, 75014 Germany Alcon Investigative Site Frankfurt, Germany, 60590 Alcon Investigative Site Heidelberg, Germany, 69120 Italy Alcon Investigative Site Perugia, Italy, 06129 Alcon Investigative Site Pisa, Italy, 56124 Netherlands Alcon Investigative Site Amsterdam, Netherlands, 1105AZ Spain Alcon Investigative Site Jerez De La Frontera, Cadiz, Spain, 11408 Alcon Investigative Site Alcalá De Henares, Spain, 28805 Alcon Investigative Site Oviedo, Spain, 33012 Alcon Investigative Site San Sebastián, Spain, 20014 Alcon Investigative Site Valencia, Spain, 46015 United Kingdom Alcon Investigative Site Sutton, Carshalton, United Kingdom, SM5 1AA Alcon Investigative Site Brighton, United Kingdom, BN2 5BF Alcon Investigative Site London, United Kingdom, EC1V2PD Less <<
NCT03392532 Astigmatism Not Applicable Completed - United States, Georgia ... More >> Alcon Investigative Site Johns Creek, Georgia, United States, 30097 Less <<
NCT03459131 Refractive Errors Not Applicable Completed - United States, Florida ... More >> Alcon Investigative Site Maitland, Florida, United States, 32751 Less <<
NCT03479944 Cataract Not Applicable Active, not recruiting May 2019 Japan ... More >> Alcon Investigative Site Iizuka City, Fukuoka, Japan, 820-0067 Less <<
NCT03579433 Cataract Not Applicable Active, not recruiting April 2019 United States, Florida ... More >> Alcon Investigative Site Mount Dora, Florida, United States, 32757 Alcon Investigative Site Panama City, Florida, United States, 32405 United States, New York Alcon Investigative Site Poughkeepsie, New York, United States, 12603 United States, Pennsylvania Alcon Investigative Site Kingston, Pennsylvania, United States, 18704 United States, South Carolina Alcon Investigative Site Florence, South Carolina, United States, 29501 Alcon Investigative Site Mount Pleasant, South Carolina, United States, 29464 United States, South Dakota Alcon Investigative Site Sioux Falls, South Dakota, United States, 57108 United States, Tennessee Alcon Investigative Site Nashville, Tennessee, United States, 37205 United States, Texas Alcon Investigative Site Nacogdoches, Texas, United States, 75965 Less <<
NCT03628599 Myopia Not Applicable Completed - United States, Illinois ... More >> Alcon Investigative Site Bloomington, Illinois, United States, 61701 United States, Kansas Alcon Investigative Site Pittsburg, Kansas, United States, 66762 United States, Ohio Alcon Investigative Site Powell, Ohio, United States, 43065 United States, Rhode Island Alcon Investigative Site Warwick, Rhode Island, United States, 02888 Less <<
NCT03733730 Cataract Not Applicable Recruiting January 2021 United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Recruiting Fort Worth, Texas, United States, 76134 Less <<
NCT02304042 Delivery Phase 3 Completed - Egypt ... More >> BeniSuef University hospitals BeniSuef, Egypt Cairo University Hospitals Cairo, Egypt Less <<
NCT01755559 Malaria Phase 4 Completed - Niger ... More >> Andoumé Health Centre Maradi, Niger Less <<
NCT01795716 Chronic Myeloid Leukemia Phase 1 Completed - China ... More >> Shanghai Jiaotong University School of Medicine Ruijin Hospital Shanghai, China, 200025 Less <<
NCT01795716 - Completed - -
NCT00354913 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT00354913 - Completed - -
NCT00301015 Uncomplicated Plasmodium Falci... More >>parum Malaria Less << Phase 4 Completed - Tanzania ... More >> Villages Kibaha, Kibaha District, Tanzania Less <<
NCT00333307 Pre-Eclampsia Phase 1 Suspended - United States, Kentucky ... More >> Central Baptist Hospital Lexington, Kentucky, United States, 40503 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT02607332 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT02624219 Avian Influenza ... More >> Influenza Less << Phase 1 Completed - United States, Iowa ... More >> University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States, 52242-2600 United States, Missouri Saint Louis University - Center for Vaccine Development Saint Louis, Missouri, United States, 63104-1015 United States, Ohio Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States, 45229-3039 United States, Texas Baylor College of Medicine - Molecular Virology and Microbiology Houston, Texas, United States, 77030-3411 Less <<
NCT00267176 Osteoarthritis ... More >> Controlled Hypertension Less << Phase 4 Completed - United States, Illinois ... More >> Southern Illinois Clinical Research O'Fallon, Illinois, United States, 62269 Germany Novartis Nuernberg, Germany Less <<
NCT02303418 Post Partum Haemorrhage Phase 3 Recruiting - Egypt ... More >> BeniSuef University hospitals Recruiting BeniSuef, Egypt Contact: Nesreen AA Shehata, MD    +2001227866337    nesoomar@yahoo.com    Cairo university hospitals Recruiting Cairo, Egypt Contact: AbdelGany Hassan, MRCOG, MD    002 01017801604    abdelgany2@gmail.com    Principal Investigator: AbdelGany MA Hassan, MRCOG, MD          Sub-Investigator: Mohamed MM Kotb, MD Less <<
NCT02675439 Advanced/Metastatic Solid Tumo... More >>rs or Lymphomas Less << Phase 1 Recruiting December 2020 United States, Colorado ... More >> University of Colorado School of Medicine Recruiting Aurora, Colorado, United States, 80045 Contact: Tara Wells    720-848-0755    Tara.Wells@ucdenver.edu    Principal Investigator: Wells Messersmith, MD FACP          United States, Illinois University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Matthew Weist    773-702-1835    mweist@medicine.bsd.uchicago.edu    Principal Investigator: Jason Luke, MD          United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Active, not recruiting Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Amanda Stroiney    617-724-4000    Amanda_Stroiney@dfci.harvard.edu    Principal Investigator: Frank Hodi, MD          United States, New York Columbia University Medical Center-Herbert Irving Pavilion Recruiting New York, New York, United States, 10032 Contact: Alex Liu    212-304-5571    awl2132@cumc.columbia.edu    Principal Investigator: Matthew Ingham, MD          United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Recruiting Houston, Texas, United States, 77030-4009 Contact: Krystle Luna    713-563-2690    KALuna@mdanderson.org    Principal Investigator: Funda Meric-Bernstam, MD          United States, Utah University of Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Cherie Peterson    801-587-5598    cherie.peterson@hci.utah.edu    Principal Investigator: Wallace Akerley, MD Less <<
NCT02055612 - Completed - Slovakia ... More >> Novartis Slovakia, s.r.o. Bratislava, Slovakia, 821 04 Less <<
NCT02480049 Healthy Phase 1 Completed - Egypt ... More >> Genuine Research Center GRC Cairo, Egypt Less <<
NCT01613053 - - - China, Sichuan ... More >> Novartis Investigative Site Chengdu, Sichuan, China, 610041 China Novartis Investigative Site Guang zhou, China, 510080 Novartis Investigative Site Shanghai, China, 200025 Less <<
NCT01419639 Neurofibromatosis Type II Phase 2 Completed - United States, New York ... More >> New York University Medical Center New York, New York, United States, 10016 Less <<
NCT02304055 Obstetrics Phase 3 Completed - Egypt ... More >> BeniSuef University hospitals BeniSuef, Egypt Cairo University Hospitals Cairo, Egypt Less <<
NCT01419639 - Completed - -
NCT03659435 Bioequivalence Phase 1 Recruiting November 30, 2018 Germany ... More >> SocraTec R&D GmbH, Clinical Pharmacology Unit Recruiting Erfurt, Thüringen, Germany, 99084 Contact: Cornelius Koch, MD    +49-361-60205 ext 67    cornelius.koch@socratec-pharma.de Less <<
NCT02410759 Post Partum Hemorrhage Phase 3 Unknown - Egypt ... More >> BeniSuef University hospitals Recruiting BeniSuef, Egypt Contact: Nesreen AA Shehata, MD    +2001227866337    nesoomar@yahoo.com    Cairo university hospitals Recruiting Cairo, Egypt Contact: AbdelGany Hassan, MRCOG, MD    002 01017801604    abdelgany2@gmail.com    Principal Investigator: AbdelGany MA Hassan, MRCOG, MD          Sub-Investigator: Mohamed MM Kotb, MD Less <<
NCT02373098 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Turkey ... More >> Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Mecidiyekoy/Istanbul, Turkey, 34394 Novartis Investigative Site Uskudar / Istanbul, Turkey, 34668 Less <<
NCT02507388 - Completed - -
NCT02911857 Periodic Fevers Syndrome Phase 3 Completed - Japan ... More >> Novartis Investigative Site Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 236-0004 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 606-8507 Less <<
NCT02042014 Severe Pulmonary Arterial Hype... More >>rtension Less << Phase 3 Completed - Japan ... More >> Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Mitaka-city, Tokyo, Japan, 181-8611 Less <<
NCT00081926 Chronic Myelogenous Leukemia Phase 4 Completed - United States, New Jersey ... More >> Novartis RIGHT Trial Hotline East Hanover, New Jersey, United States Less <<
NCT02911857 - Completed - -
NCT01185197 Nephrosis, Lipoid Phase 4 Completed - China ... More >> Queen Mary Hospital Hong Kong, China Less <<
NCT00836537 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00781105 Chronic Hepatitis B Phase 4 Completed - China ... More >> Novartis Investigative Site Beijing, China Less <<
NCT00602251 Onychomycosis Not Applicable Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. Saint Charles, Missouri, United States, 63301 Less <<
NCT00520806 Heart Failure, Congestive Phase 2 Phase 3 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Michigan Wayne State University/Detroit Receiving Hospital Detroit, Michigan, United States, 48201 Israel Heart Institute Safed, Israel Less <<
NCT00154349 Philadelphia Chromosome Positi... More >>ve Acute Lymphocytic Leukemia Less << Phase 2 Completed - -
NCT00554515 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00171834 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Completed - United States, Kentucky ... More >> Norton Healthcare/Hospital Inc Louisville, Kentucky, United States, 40232-5070 United States, Missouri Ellis Fisher Cancer Center Columbia, Missouri, United States, 65203 United States, Pennsylvania Hillman Cancer Center Pittsburg, Pennsylvania, United States, 15232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00602342 Onychomycosis Not Applicable Completed - United States, Missouri ... More >> Gateway Medical Research, Inc. Saint Charles, Missouri, United States, 63301 Less <<
NCT00171834 - Completed - -
NCT00172016 Prostate Cancer With at Least ... More >>One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated Less << Phase 4 Completed - -
NCT00219297 Brain Metastasis ... More >> Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Dept. of UC Davis Cancer (3) Sacramento, California, United States, 95817 United States, Massachusetts Dana Farber Cancer Institute SC Boston, Massachusetts, United States, 02115 United States, Michigan Wayne State University/Wertz Clinical Cancer Center Div. of Hematology/Oncology Detroit, Michigan, United States, 48201 United States, Missouri St. Louis University Cancer Center St. Louis, Missouri, United States, 63110 Washington University School of Medicine-Siteman Cancer Ctr St. Louis, Missouri, United States, 63110 United States, New Hampshire Dartmouth Hitchcock Medical Center Oncology Lebanon, New Hampshire, United States, 03756 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10022 Columbia University Medical Center- New York Presbyterian New York, New York, United States, 10032 United States, North Carolina Duke University Medical Center Dept. of DUMC (3) Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00124280 Non-small-cell Lung Carcinoma Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, Texas MD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology Houston, Texas, United States, 77030 Less <<
NCT00225979 Acromegaly Phase 3 Completed - -
NCT00233337 Acute Uncomplicated P. Falcipa... More >>rum Malaria Less << Phase 4 Completed - -
NCT00238472 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00237172 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - -
NCT00117767 Tinea Capitis Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00242554 Prostate Cancer Phase 4 Completed - -
NCT00240942 Severe and Recurrent Endometri... More >>osis Less << Phase 2 Completed - -
NCT00248131 Diabetic Retinopathy Phase 3 Terminated - -
NCT02900651 Diffuse Large B-cell Lymphoma Phase 1 Phase 2 Recruiting August 5, 2019 United States, California ... More >> Novartis Investigative Site Recruiting San Francisco, California, United States, 94115 Novartis Investigative Site Recruiting Santa Monica, California, United States, 90404 Contact: Ruth M. Gonzalez       Rngonzalez@mednet.ucla.edu    Principal Investigator: Zev A. Wainberg          United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Anna Lui    713-563-4667    alui@mdanderson.org    Principal Investigator: Vivek Subbiah          Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Koeln, Germany, 50937 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Japan Novartis Investigative Site Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28041 Less <<
NCT00241020 Advanced Hepatocellular Carcin... More >>oma Less << Phase 3 Completed - -
NCT02887183 Heart Failure Phase 4 Recruiting October 18, 2018 -
NCT00389948 Heartburn Phase 3 Completed - -
NCT00426478 Hypertension Phase 4 Completed - Taiwan ... More >> National Taiwan University Taipei, R.o.c, Taiwan, 100 Less <<
NCT00390390 Heartburn Phase 3 Completed - -
NCT00426621 Osteoarthritis of the Knee Phase 3 Completed - -
NCT00248157 Diabetic Retinopathy Phase 3 Terminated(Inconsistent treatm... More >>ent benefit) Less << - -
NCT00441051 Sunburn Phase 3 Completed - France ... More >> CPCAD Nice, France Less <<
NCT00447694 Beta-thalassemia ... More >> Iron Overload Less << Phase 2 Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 Less <<
NCT01666197 Ankle Sprain Phase 4 Completed - Germany ... More >> Investigator Brühl, Germany Investigator Essen, Germany Investigator Gilching, Germany Investigator Köln, Germany Less <<
NCT00765830 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency Less << Phase 3 Completed - -
NCT00820534 - Completed - -
NCT02867059 Plasmodium Falciparum Malaria Phase 1 Completed - Australia, Queensland ... More >> Q-Pharm Clinics, Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia, 4006 Q-Pharm Clinics Herston, Queensland, Australia, 4006 Less <<
NCT00821574 Hypertension, Dyslypidaemia Phase 4 Completed - -
NCT00646542 Diabetes Mellitus, Type 2 Phase 3 Completed - Argentina ... More >> Buenos Aires, Argentina Australia Heidelberg Heights, Australia Canada Winnipeg, Canada Costa Rica Cartago, Costa Rica Finland Tampere, Finland France Angers, France Germany Dormagen, Germany India Chennai, India Norway Oslo, Norway Russian Federation Saint Petersburg, Russian Federation Spain Alicante, Spain Sweden Lund, Sweden Less <<
NCT00707408 AML Phase 2 Completed - France ... More >> Nantes University Hopspital Nantes, France, 44093 Less <<
NCT00821977 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT01123941 Typhoid Fever Phase 1 Completed - Belgium ... More >> Center for the Evaluation of Vaccination (CEV) Antwerp, Wilrijk (Antwerp), Belgium, 2610 Less <<
NCT01123941 - Completed - -
NCT01196546 Type 2 Diabetes Mellitus Phase 4 Completed - Thailand ... More >> BMA Medical College and Vajira Hospital Bangkok, Thailand King Chulalongkorn Memorial Hospital Bangkok, Thailand Phamongkutklao Hospital Bangkok, Thailand Police General Hospital Bangkok, Thailand Siriraj Hospital Bangkok, Thailand Khon Kaen Hospital Khon Kaen, Thailand Fort Suranaree Hospital Nakhon Ratchasima, Thailand Maharat Nakhon Ratchasima Hospital Nakhon Ratchasima, Thailand Less <<
NCT01265446 Sore Throat Due to a Common Co... More >>ld Less << Phase 3 Completed - Germany ... More >> Socratec Erfurt, Germany Less <<
NCT00820534 Cold Sore Phase 4 Completed - United Kingdom ... More >> Belfast Health and Social Care Trust, Royal Victoria Hospital Belfast, United Kingdom, BT12 6BA Less <<
NCT01272934 Acute Ankle Sprain Phase 3 Completed - Germany ... More >> NCH investigative site Bad Nauheim, Germany NCH investigative site Brühl, Germany NCH investigative site Cologne, Germany NCH investigative site Essen, Germany NCH investigative site Gilching, Germany NCH investigative site, Munich, Germany. Munich, Germany Less <<
NCT01272934 - Completed - -
NCT01193296 Type 2 Diabetes Mellitus Phase 4 Completed - France ... More >> Investigative Site Bondy, France Investigative Site Corbeil, France Investigative Site Marseille, France Investigative Site Nancy, France Investigative Site Paris, France Investigative Site Toulouse, France Investigative Site Venissieux, France Less <<
NCT00132808 Osteopenia Phase 3 Completed - United States, New Jersey ... More >> For information regarding facilities, please contact the Central Contact E. Hanover, New Jersey, United States, 07936 Less <<
NCT00132808 - Completed - -
NCT01265446 - Completed - -
NCT01272947 Acute Blunt Soft Tissue Injuri... More >>es/Contusions Less << Phase 3 Completed - Germany ... More >> NCH investigative site Brühl, Germany NCH investigative site Butzbach, Germany NCH investigative site Cologne, Germany NCH investigative site Essen, Germany NCH investigative site Gilching, Germany NCH investigative site Munich, Germany Less <<
NCT00154388 Life Threatening Diseases Phase 2 Completed - -
NCT00142298 - Completed - -
NCT00219284 Parkinson's Disease With End o... More >>f Dose Wearing Off Less << Phase 4 Completed - -
NCT00219284 - Completed - -
NCT00351507 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00601978 Parkinson's Disease Phase 4 Withdrawn(Business decision br... More >>and strategy; no patients enrolled) Less << - -
NCT00142298 Chronic Hepatitis B Phase 3 Completed - -
NCT00878904 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143-1711 Less <<
NCT00699296 Cutaneous T-Cell Lymphoma ... More >> Leukemia-Lymphoma, Adult T-Cell Less << Phase 2 Terminated - Japan ... More >> University Hospital of Occupational and Environmental Health Fukuoka, Japan Imamura Bun-in Hospital Kagoshima, Japan Kumamoto University Hospital Kumamoto, Japan University of Miyazaki Hospital Miyazaki, Japan Nagasaki University Hospital of Medicine and Dentistry Nagasaki, Japan Okayama University Hospital Okayama, Japan The University of Tokyo Hospital Tokyo, Japan Less <<
NCT00860288 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT01948804 Poor Responders Undergoing IVF Phase 4 Unknown - -
NCT01514526 Adrenocortical Carcinoma Phase 2 Completed - Spain ... More >> Complejo Hospitalario Universitario de Santiago Santiago de Compostela, A Coruña, Spain, 15706 Hospital Universitario Fundación de Alcorcón Alcorcón, Madrid, Spain, 28922 Hospital del Mar Barcelona, Spain, 08003 Hospital Universitario Reina Sofía Córdoba, Spain, 14004 Hospital Universitario Central de Asturias Oviedo, Spain, 33006 Complejo Hospitalario de Navarra Pamplona, Spain, 31008 Fundación Instituto Valenciano de Oncología Valencia, Spain, 46009 Less <<
NCT00931762 Primary Myelofibrosis ... More >> Post-Polycythemia Vera Post-Essential Thrombocytopenia Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic - Scottsdale Scottsdale, Arizona, United States, 85259 United States, California City of Hope National Medical Center Duate, California, United States, 91010 Stanford Comprehensive Cancer Center Stanford, California, United States, 94305 United States, Georgia Medical College of Georgia Augusta, Georgia, United States, 30912 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York New York Prebyterian Hospital - Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT01022970 Eosinophilic Esophagitis Phase 2 Completed - United States, California ... More >> Stanford Medical Center and Lucile Packard Children's Hospital Stanford, California, United States, 94305 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic Minnesota, Minnesota, United States, 55905 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Virginia Oral Alpan, 6210 Old Keene Mill Court, Springfield, Virginia, United States, 22152 Less <<
NCT01206088 CML Nilotinib... More >> Imatinib Resistant Imatinib Intolerant Less << Phase 4 Completed - Korea, Republic of ... More >> St. Mary hospital, Catholic medical center Seoul, Korea, Republic of Less <<
NCT01216085 CML Imatinib Phase 2 Completed - -
NCT01249456 - Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00901979 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT03335085 Healthy Not Applicable Completed - -
NCT01593527 Acute Gouty Arthritis Phase 3 Withdrawn September 2012 -
NCT01602835 - Terminated - -
NCT01310647 Ovarian Diseases Phase 2 Completed - Spain ... More >> La Fe University Hospital. Department of Obstetrics and Gynecology Valencia, Spain, 46026 Less <<
NCT02677181 aGVHD Phase 4 Unknown December 2018 China, Beijing ... More >> Liping Dou Recruiting Beijing, Beijing, China, 100853 Contact: Daihong Liu, doctor    86-13681171597    daihongrm@163.com    Contact: Liping Dou, doctor    86-13681207138    lipingruirui@163.com    Principal Investigator: Daihong Liu, doctor Less <<
NCT01660295 Renal Insufficiency Phase 1 Phase 2 Completed - Hungary ... More >> DRC Drug Research Center Ltd., H-8230 Balatonfüred H-8230 Balatonfüred, Ady E. u., Hungary, 12 Less <<
NCT00808392 Haemophilus Influenzae Type b Phase 3 Completed - China, Hebei ... More >> the CDC of Dingxing county(site no 02) Dingxing, Hebei, China, 072650 The CDC of Zhengding county(site no 01) Zhengding, Hebei, China, 050800 Less <<
NCT00848029 Pre-pandemic Influenza Vaccine Phase 3 Completed - Czech Republic ... More >> Vaccination and Travel Medicine Centre Hradec Kralove, Czech Republic, 500 03 Less <<
NCT00970177 Pandemic Influenza Phase 3 Completed - Belgium ... More >> Gent, Antwerpen, Belgium Germany Wurzburg, Fulda, Neumunster, Balve, Leipzig, Magdeburg Munchen, Germany Switzerland Zurich, Switzerland Less <<
NCT00971542 Pandemic Influenza Phase 3 Completed - Belgium ... More >> Gent, Antwerpen, Belgium Chile Santigo de chile Santiago, Chile Dominican Republic Gazcue Santo Domingo Gazcue Santo Domingo, Dominican Republic Germany Wurzburg, Fulda, Neumunster, Balve, Stuttgart-Feuerbach, Leipzig, Rostock, Mainz, Detmold, Alsfeld Mainz, Germany Netherlands Rotterdam, Netherlands Less <<
NCT00971906 Pandemic Influenza Phase 3 Completed - Belgium ... More >> Gent, Antwerpen Antwerpen, Belgium Germany Munchen, Wurzburg, Balve, Leipzig, Magdeburg, Hamburg, Rostock, Mainz Mainz, Germany Switzerland Basel, Switzerland Zurich, Switzerland Less <<
NCT01000311 Meningococcal Disease Phase 3 Completed - -
NCT00971100 Pandemic Influenza Phase 3 Completed - Belgium ... More >> Gent, Antwerpen, Belgium Dominican Republic Santo Domingo, Dominican Republic Germany Wurzburg, Fulda, Neumunster, Balve, Leipzig, Rostock, Detmold Mainz, Germany Less <<
NCT01037855 - Completed - Chile ... More >> Clinica Indisa Av. Santa Maria, Santiago, Chile, 1810 Colombia Fundación Universitaria de Ciencias de Salud- Hospital San José Calle Bogota, Colombia Nueva EPS: Centro de Especialistas Barrios Unidos - MEDERI Calle 66 # 40-07 - Bogotá, Colombia Hospital local de Yopal E.S.E Calle 9 No. 24-37 - Yopal, Casanare, Colombia Clinica del Country Carrera 16 No. 82-57 Bogotá, Colombia Hospital Universitario Infantil San José Carrera 52 No. 67A-71 - Barrios Unidos - Bogotá, Colombia CAIMED - Centro de Atencion e Investigación Medica Cra. 42 A No. 17-50, Colombia Germany Augustenburger Platz 1, Berlin, Germany Switzerland Policlinique Médicale Universitaire Rue du Bugnon 44, CH-1011 Lausanne, Switzerland Institute of Social and Preventive Medicine, Division of Communicable Diseases Hirschengraben 84, CH-8001 Zürich, Switzerland Less <<
NCT01000311 - Completed - -
NCT01040741 - Completed - Argentina ... More >> Hospital Garrahan Combate de Los Pozos 1881, Ciudad Autónoma de Buenos Aires, Argentina Hospital de Ninos "Dr. Ricardo Gutierrez" Gallo 1330, Ciudad Autónoma de Buenos Aires, Argentina Hospital Nuestra Señora de la Misericordia Belgrano 1500, Córdoba, Argentina Hospital Pediatrico del Niño Jesus Castro Barros 650 - San Martín, Córdoba, Argentina Sanatorio Mayo Privado S.A. Humberto Primo 520, Córdoba, Argentina Hospital Pediatrico "Dr. Humberto Notti" Bandera de los Andes 2603 Villa nueva, Guaymallen Mendoza, Argentina Netherlands Huisartsenpraktijk Bergentheim Kanaalweg West 61, Bergentheim, Netherlands, 7691BV Huisartsenpraktijk Bredero Brederostraat 2/A, Breda, Netherlands, 4819HH Saxenburg Groep, Zorgcentrum Aleida Kramer M.v.d. Thijnensingel 1, Coevorden, Netherlands, 7741GB Huisartsenpraktijk Dennenlaan Dennenlaan 56, Emmen, Netherlands, 7822EL Huisartsenpraktijk de Steenpoort Prinses Julianastraat 25, Genemuiden, Netherlands, 8281CK Huisartsenpraktijk Gramsbergen Voorstraat 3, Gramsbergen, Netherlands, 7783AL Huisartsenpraktijk Oosterhesselen Edveensweg 13, Oosterhesselen, Netherlands, 7861AM Isala Klinieken Zwolle Groot Wezenland 20, Zwolle, Netherlands, 8011JW Less <<
NCT00996138 Influenza Phase 2 Phase 3 Completed - Japan ... More >> Osaka pref. Kagoshima pref., Japan Less <<
NCT01053767 Group B Streptococcus (GBS) Di... More >>sease Less << Phase 1 Completed - Switzerland ... More >> Institute for Pharmacokinetic and Analytical Studies Via Mastri, 36, CH - 6853 Ligornetto, Switzerland Less <<
NCT01067079 - Terminated - China, Hebei ... More >> Jizhou County, Hebei, China, 053200 Less <<
NCT02002689 PTCH1 or SMO Activated Solid a... More >>nd Hematologic Tumors Less << Phase 2 Terminated(Low enrollment) - United States, California ... More >> University of California Davis Cancer Center UC Davis Cancer (3) Sacramento, California, United States, 95817 United States, Colorado Rocky Mountain Cancer Centers RMCC - Aurora Greenwood Village, Colorado, United States United States, Illinois Lurie Children's Hospital of Chicago Developmental Therapeutics Chicago, Illinois, United States, 60611 United States, Minnesota Minnesota Oncology Hematology, P.A. Southdate Medical Center Minneapolis, Minnesota, United States, 55404 United States, Ohio Cleveland Clinic Foundation Cleveland Clinic (19) Cleveland, Ohio, United States, 44195 United States, South Dakota Sanford Research Sanford Health Sioux Falls, South Dakota, United States, 57104 United States, Texas Oncology Consultants Oncology Group Houston, Texas, United States, 77024 MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3) Houston, Texas, United States, 77030 United States, Utah Intermountain Medical Center Intermountain Healthcare Murray, Utah, United States, 84157 United States, Washington Seattle Cancer Care Alliance Skagit Valley Hospital Seattle, Washington, United States, 98109-1023 Less <<
NCT01284257 - Withdrawn - United States, California ... More >> San Francisco investigational site San Francisco, California, United States United States, Colorado Denver Investigational site Denver, Colorado, United States United States, Massachusetts Springfield investigational site Springfield, Massachusetts, United States United States, Michigan Detroit investigational site Detroit, Michigan, United States United States, New York New York investigational site New York, New York, United States United States, Pennsylvania PHILADELPHIA investigational site Philadelphia, Pennsylvania, United States United States, Vermont BURLINGTON investigational site Burlington, Vermont, United States United States, Washington Seattle investigational site Seattle, Washington, United States Less <<
NCT02002689 - Terminated(Low enrollment) - -
NCT01098786 - Completed - Japan ... More >> National Hospital Organization Kumamoto Medical Center Chuo-ku, Kumamoto, Japan, 860-0008 Less <<
NCT01044316 Haemophilus Influenzae Type b ... More >>(Hib) Infection Less << Phase 3 Completed - China ... More >> Hebei Province, China Less <<
NCT01123954 Seasonal Influenza Phase 2 Completed - Vietnam ... More >> Department of examination and vaccination - Institute Pasteur of Ho Chi Minh City (LAM: Laboratoires d'Analysis Medicale) Ho Chi Minh, Vietnam Less <<
NCT01125527 Haemophilus Influenzae Type b ... More >>(Hib) Infection Less << Phase 3 Completed - China ... More >> Hebei Province, China Less <<
NCT01106482 Tick Borne Encephalitis (TBE) Phase 4 Completed - Germany ... More >> Winkelhoferstr. 3 Ehingen, Germany, 89584 Fuggerplatz 1 Kaufering, Germany, 86916 Hauptstrasse 240 Kehl, Germany, 77694 Bismarckstr. 3 Ludwigsburg, Germany, 71634 Am Marktplatz 8 Oberkirch, Germany, 77704 Großbottwarer Str. 47 Oberstenfeld, Germany, 71720 Wilhelmstr. 7 Offenburg, Germany, 77654 Stuttgarter Str. 74 Stuttgart, Germany, 70469 Martin-Niemöller-Str. 2 Traunreut, Germany, 83301 Murnauer Str. 3 Weilheim, Germany, 82362 Less <<
NCT01161264 Seasonal Influenza Phase 3 Completed - United States, Massachusetts ... More >> Cambridge, Massachusetts, United States, 02139 Less <<
NCT01152814 - Completed - -
NCT01101074 - Completed - Italy ... More >> Emilia Romagna, Italy Less <<
NCT01210898 Influenza Phase 3 Completed - Finland ... More >> University of Tampere Medical School, Vaccine Research Center / Tampere yliopisto rokotetutkimuskeskus Biokatu 10, Tampere, Finland, FI-33520 Helsinki South, Vaccine Research Clinic, Vuorikatu 18, 3 floor Helsinki, Finland, FI-00100 Helsinki East, Vaccine Research Clinic, Itäkeskuksen kauppakeskus/Agenttitalo, Turunlinnantie 8, 4.floor Helsinki, Finland, FI-00930 Järvenpää, Vaccine Research Clinic, Yhteiskouluntie 17 Järvenpää, Finland, FI-04400 Kokkola Vaccine Research Clinic, Rantakatu 7 Kokkola, Finland, FI-67100 Kotka Vaccine Research Clinic, Karjalantie 10-12 Kotka, Finland, FI-48600 Kuopio Vaccine Research Clinic, Microkatu 1, N-building, 2nd floor, PL 1188 Kuopio, Finland, 70211 Lahti Vaccine Research Clinic, Vesijärvenkatu 74 Lahti, Finland, FI-15140 Oulu Vaccine Research Clinic, Kiviharjunlenkki 6 Oulu, Finland, FI-90220 Pori Vaccine Research Clinic, Yrjönkatu 23 (4th floor) Pori, Finland, FI-28100 Seinäjoki Vaccine Research Clinic, Keskuskatu 6 Seinäjoki, Finland, FI-60100 Tampere Vaccine Research Clinic, Pinninkatu 47 (1. floor) Tampere, Finland, FI-33100 Espoo Vaccine Research Clinic, Länsituulentie 10, 4th floor Tapiontori 1, Espoo, Finland, FI-02100 Turku Vaccine Research Clinic, Lemminkäisenkatu 14-18 B (4th floor) Turku, Finland, FI-20520 Vantaa East, Vaccine Research Clinic, Asematie 11 a 16 Vantaa, Finland, FI-01300 Vantaa West, Vaccine Research Clinic, Jönsaksentie 6 B, 3rd floor Vantaa, Finland, FI-01600 Less <<
NCT01210885 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 2 Completed - Chile ... More >> CESFAM Gabriela Mistral Santiago, Chile Liceo Carmela Carvajal de Prat Santiago, Chile Pontificia Universidad Católica de Chile Santiago, Chile Colombia CafeSalud M P (Dir. de Investigación y Proyectos Especiales) Bogotá, Colombia Centro de Atencion e Investigacion Medica - CAIMED Bogotá, Colombia Centro de Investigaciones CAFAM Bogotá, Colombia Panama Health Research International Panama City, Panama Indicasat Panama City, Panama Less <<
NCT01152814 Seasonal Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini Chieti, Italy, 66100 Dipartimento di Medicina Clinica e Sperimentale - Sezione di Igiene e Medicina Preventiva, Via Fossato di Mortara, 64/b Ferrara, Italy, 44100 Dipartimento di Scienze della Salute Università di Genova Via Pastore, 1 Genova, Italy, 16132 Centro Satellite. ASL Lanciano - Vasto, sede legale Via S. Spaventa, 37 Lanciano, Italy, 66034 Centro Satellite. Distretto Sanitario di Base di Fossacesia in Via Polidoro-Vasto Lanciano, Italy Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona, 20 Milano, Italy, 20127 Less <<
NCT01214837 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 3 Completed - -
NCT01300416 - Completed - Malaysia ... More >> Hospital Universiti Kebangsaan Malaysia Cheras, Malaysia Hospital Raja Perempuan Zainab II Kota Bharu, Malaysia Hospital Queen Elizabeth Kota Kinabalu, Malaysia Hospital Kuala Lumpur Kuala Lumpur, Malaysia Hospital Tengku Ampuan Afzan Kuantan, Malaysia Hospital Umum Sarawak Kuching, Malaysia Hospital Pulau Pinang Pulau Pinang, Malaysia Hospital Selayang Selayang, Malaysia Hospital Serdang Serdang, Malaysia Less <<
NCT02187783 Tumors With CDK4/6 Pathway Act... More >>ivation Less << Phase 2 Completed - -
NCT01214837 - Completed - -
NCT02186821 Tumors With Aberrations in ALK... More >> or ROS1 Less << Phase 2 Completed - -
NCT02160041 Solid Tumor H... More >>ematologic Malignancies Less << Phase 2 Completed - -
NCT01342796 Seasonal Influenza; ... More >> Influenza; Influenza Due to Unspecified Influenza Virus Human Influenza Less << Phase 2 Completed - Belgium ... More >> Site 21: GZA campus Sint Vincentius Sint Vincentiusstraat 20, Antwerpen, Belgium, 2018 Site 22: Kinderartsenpraktijk Stadsomvaart 5, Hasselt, Belgium, 3500 Less <<
NCT01344057 Seasonal Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio Via dei Vestini, Chieti, Italy, 66100 Department of "Scienze della Salute" University of Genova Via Pastore 1 Genova, Italy, 16132 Satellite: "ASL Lanciano - Vasto", sede legale Via S Spaventa 37 Lanciano, Italy, 66034 Satellite: "Distretto Sanitario di Base di Fossacesia" in Via Polidoro-Vasto Lanciano, Italy Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona 20 Milano, Italy, 20127 Department of "malattie infettive" Ospedale San Gerardo, via Pergolesi 33 Monza, Italy, 20052 Less <<
NCT01226953 Haemophilus Influenzae Type b ... More >>(Hib) Infection Less << Phase 3 Completed - China ... More >> Hebei Province, China Less <<
NCT01404962 Haemophilus Influenzae Type B ... More >>Infection Less << Phase 4 Completed - Korea, Republic of ... More >> Moon's Pediatrics Clinic Gyeonggi-do, Korea, Republic of, 449-812 Wooriai Pediatrics clinic Incheon, Korea, Republic of, 407-818 KyungHee University Hospital Seoul, Korea, Republic of, 130-702 Hanil General Hospital Seoul, Korea, Republic of, 132-703 Yonsei Pediatrics Clinic Seoul, Korea, Republic of, 134-734 Less <<
NCT01422512 Influenza Phase 3 Completed - Germany ... More >> Universität Rostock / Medizinische Fakultät Rostock, Germany, 18057 Less <<
NCT01357265 Influenza Phase 2 Completed - Italy ... More >> Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio Via Dei Vestini, Cheiti, Italy, 66100 Dipartimento di Scienze della Salute Università di Genova Via Pastore, Genova, Italy, 16132 Distretto Sanitario di Base di Fossacesia Via Polidoro-Vasto, Lanciano, Italy ASL Lanciano - Vasto, Via S. Spaventa, Lanciano, Italy, 66034 Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona, Milano, Italy, 20127 Dipartimento di malattie infettive Ospedale San Gerardo Via Pergolesi 33, Monza, Italy, 20052 Less <<
NCT02495129 Primary Sj?gren's Syndrome Phase 1 Phase 2 Withdrawn September 2017 -
NCT00587418 Liver Transplant Recipients Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01344057 - Completed - -
NCT02795416 Psoriasis Phase 3 Withdrawn March 2017 -
NCT02732119 Breast Cancer Phase 1 Phase 2 Active, not recruiting July 31, 2020 -
NCT01286701 Healthy Phase 1 Completed - Canada ... More >> Anapharm Inc. Quebec, Canada, GIV 2K8 Less <<
NCT02474537 Hepatic Impairment Phase 1 Completed - United States, Florida ... More >> University of Miami Miller School of Medicine Clinical Resea Oncology Miami, Florida, United States, 33136 Clinical Pharmacology of Miami, LLC. Miami, Florida, United States, 33142 Orlando Clinical Research Center Orlando, Florida, United States, 32086 United States, Minnesota DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, North Carolina Duke University Medical Center Oncology Durham, North Carolina, United States, 27710 Less <<
NCT01146067 Healthy Phase 1 Completed - -
NCT01160029 Healthy Phase 1 Completed - -
NCT01286688 Fasting Phase 1 Completed - Canada ... More >> Anapharm Inc. Quebec, Canada, GIV 2K8 Less <<
NCT01159158 Healthy Phase 1 Completed - -
NCT01470287 Diphtheria Te... More >>tanus Pertussis Hepatitis B Hemophilus Influenzae B Less << Phase 3 Completed - India ... More >> Rajarajeshwari Medical College and Hospital Bangalore, Karnataka, India Bharathi Vidyapeeth University Pune, Maharashtra, India Medical College Kolkata Kolkatta, West Bengal, India Less <<
NCT02888574 Chronic Pain ... More >>Pelvic Pain Less << Phase 2 Phase 3 Unknown December 2018 Canada, Alberta ... More >> Behavioural Medicine Laboratory Not yet recruiting Calgary, Alberta, Canada, T2N 1N4 Contact: Tavis S Campbell, PhD    40    t.s.campell@ucalgary.ca    Principal Investigator: Tavis S Campbell, PhD          Sub-Investigator: Joshua A Rash, MSc Less <<
NCT01885117 Human Influenza Phase 3 Completed - Germany ... More >> University Medical Center Hamburg-Eppendorf Hamburg, Germany, 20359 Less <<
NCT02864706 Heart Transplantation Phase 4 Completed - Denmark ... More >> Skejby Hospital Aarhus, Denmark, D-8000 University Hospital Rigshospitalet Copenhagen, Denmark, D-2100 Norway University Hospital Rikshospitalet Oslo, Norway, N-0372 Sweden Sahlgrenska University Hospital Gothenburg, Sweden, 41345 Lund University Hospital Lund, Sweden, 22241 Less <<
NCT03393481 Thrombotic Disorders Phase 2 Withdrawn(Project CMAA868A. St... More >>udy CMAA868A2201 cancelled (no patient)) Less << April 17, 2020 -
NCT03398434 Atrial Fibrillation Phase 2 Withdrawn(Study Cancelled befo... More >>re FPFV (no patient enrolled)) Less << January 30, 2020 -
NCT03369912 HCMV Infection Phase 2 Withdrawn(Company decision to ... More >>withdraw before study started) Less << November 15, 2022 -
NCT00561938 Digestive System Diseases Not Applicable Completed - France ... More >> Service d'Hépato-Gastroentérologie, Centre Hospitalier Lyon Sud Lyon, France, 69495 Service d'Hépato-Gastroentérologie, Institut Paoli Calmettes Marseille, France, 13009 Service d'Hépato-Gastroentérologie, CHU Nantes Nantes, France, 44093 Service d' hépato-gastro-entérologie, CHU de ROUEN Rouen, France, 76031 CHU de Rangueil Toulouse, France, 31059 Less <<
NCT03456999 BK Virus Nephropathy Phase 2 Withdrawn(company decision) November 16, 2020 -
NCT01885117 - Completed - -
NCT03596970 Liver Transplantation Phase 3 Withdrawn December 2020 -
NCT02256488 Prophylaxis: Influenza Phase 3 Completed - -
NCT02256488 - Completed - -
NCT00029224 Breast Cancer ... More >> Multiple Myeloma Prostate Cancer Less << Phase 4 Completed - United States, California ... More >> Stockton Hematology Oncology Medical Group Stockton, California, United States, 95204 United States, Florida Osceola Cancer Center Kissimmee, Florida, United States, 34741 United States, Nevada Nevada Cancer Center Las Vegas, Nevada, United States, 89109 United States, New Mexico Hematology-Oncology Associates PC Albuquerque, New Mexico, United States, 87102 New Mexico Oncology Hematology Consultants Albuquerque, New Mexico, United States, 87102 United States, Oregon Hematology Oncology Associates, PC Medforo, Oregon, United States, 97504 United States, Virginia Virginia Physicians, Inc Richmond, Virginia, United States, 23294 Less <<
NCT00002394 Candidiasis, Oral ... More >> HIV Infections Less << Not Applicable Completed - United States, Florida ... More >> Therafirst Med Ctr Fort Lauderdale, Florida, United States, 33308 Associates in Research Fort Myers, Florida, United States, 33901 Clireco Inc Tamarac, Florida, United States, 33321 Infectious Diseases Research Inc Tampa, Florida, United States, 33614 United States, Illinois Northwestern Univ / Division of Infectious Disease Chicago, Illinois, United States, 60611 United States, New Jersey Saint Michaels Med Ctr / Infectious Disease Resch Dpt Newark, New Jersey, United States, 071029880 United States, New York St Vincents Hosp / Clinical Research Program New York, New York, United States, 10011 United States, Texas Univ of Texas Med Branch Galveston, Texas, United States, 77555 United States, Virginia Hampton Roads Med Specialists Hampton, Virginia, United States, 23666 Less <<
NCT00128232 Acromegaly Phase 3 Completed - -
NCT00000174 Alzheimer Disease ... More >> Cognition Disorders Less << Phase 3 Completed - United States, Arizona ... More >> Medici Research Centers Peoria, Arizona, United States, 85381 United States, California University of California, Irvine Orange, California, United States, 92868 United States, Colorado University of Colorado Health Sciences Center Denver, Colorado, United States, 80220 United States, Florida Neuromedical Research Institute (Offices in Ft. Lauderdale, Miami Beach and Boca Raton) Ft. Lauderdale, Florida, United States, 33321 Miami Research Associates Miami, Florida, United States, 33176 Center for Clinical Trials and Research Venice, Florida, United States, 34285 United States, Indiana Indiana University Alzheimer's Center Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis University St. Louis, Missouri, United States, 63104 United States, New Jersey Alzheimer's Research Corporation Lakewood, New Jersey, United States, 08701 United States, New York NYU Medical Center New York, New York, United States, 10016 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oklahoma Pahl Brain Associates, P.C. Oklahoma City, Oklahoma, United States, 73118 United States, Pennsylvania Clinical Studies, Ltd., Philadelphia Philadelphia, Pennsylvania, United States, 19106 United States, Texas St. Paul Medical Center Dallas, Texas, United States, 75235 United States, Washington University of Washington, Seattle Seattle, Washington, United States, 98108 Less <<
NCT00098189 - Completed - -
NCT02715505 Inherited Metabolic Disorders ... More >>IMD Less << Phase 1 Phase 2 Withdrawn(This study was cance... More >>lled with no patients) Less << May 18, 2020 -
NCT00130338 Vascular Dementia Phase 3 Completed - -
NCT00098150 - Completed - -
NCT00141050 ADHD Phase 3 Completed - United States, Texas ... More >> Bayou City Research Houston, Texas, United States, 77007 Less <<
NCT00141063 ADHD Phase 3 Completed - United States, Nevada ... More >> Center for Psychiatry & Behavioral Medicine Las Vegas, Nevada, United States, 89128 Less <<
NCT00145275 Osteopenia Phase 3 Completed - United States, Georgia ... More >> Unavailable, Georgia, United States United States, Illinois Unavailable, Illinois, United States United States, Indiana Unavailable, Indiana, United States United States, Iowa Unavailable, Iowa, United States United States, Kansas Unavailable, Kansas, United States United States, Washington Unavailable, Washington, United States Australia Multiple, Australia Canada Multiple, Canada Russian Federation Multiple, Russian Federation South Africa Multiple, South Africa Less <<
NCT00134966 Parkinson's Disease Phase 3 Completed - -
NCT00171522 Constipation Phase 4 Completed - United States, Arizona ... More >> Harmony Clinical Research Oro Valley, Arizona, United States, 85739 Central Phoenix Medical Clinic, LLC Phoenix, Arizona, United States, 85201 Adobe Gastroenterology, PC Tucson, Arizona, United States, 85712 United States, California Associated Pharmaceutical Research Center, Inc Buena Park, California, United States, 90620 United States, Florida Clinical Trial Management of Boca Raton, Inc. Boca Raton, Florida, United States, 33486 United States, Kansas Health Science Center Pratt, Kansas, United States, 67124 United States, Massachusetts Beth Israel Deacon Medical Center Boston, Massachusetts, United States, 02215 United States, Nebraska Heartland Clinical Research, Inc Omaha, Nebraska, United States, 68134 United States, New Jersey MBS Clinical Research, LLC Margate, New Jersey, United States, 08402 United States, Ohio Midwest Clinical Research Bellbrook, Ohio, United States, 45305 United States, Tennessee Associates in Gastroenterology Hermitage, Tennessee, United States, 37076 United States, Texas R/D Clinical Research, Inc. Lake Jackson, Texas, United States, 77566 United States, Virginia National Clinical Research, Inc Richmond, Virginia, United States, 23294 East Coast Clinical Research Virginia Beach, Virginia, United States, 23454 Less <<
NCT00154362 Conduct Disorder Phase 4 Completed - -
NCT00171652 Osteoarthritis Phase 3 Completed - -
NCT00277550 Constipation and Dyspepsia Phase 4 Withdrawn - -
NCT00348634 Chronic Constipation Phase 4 Terminated(Terminated early du... More >>e to regulatory action suspending tegaserod use in 2007) Less << - United States, Arizona ... More >> Arkansas Gastroenterology, PA North Little Rock, Arizona, United States, 72117 United States, Michigan University of Michigan Medical Center Ann Arbor, Michigan, United States, 48109-0362 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00351585 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00154323 Bipolar Disorder Phase 4 Completed - -
NCT00171665 Osteoarthritis Phase 3 Completed - -
NCT01272947 - Completed - -
NCT01335724 - Completed - -
NCT00234637 Alzheimer's Disease Phase 4 Completed - France ... More >> Département de Gérontologie Clinique Limoges, Cedex, France, 87042 Less <<
NCT01335724 Neck Pain Phase 4 Completed - Germany ... More >> NCH investigative site Cologne, Germany NCH investigative site Essen, Germany NCH investigative site Munich, Germany Less <<
NCT01433107 - Completed - -
NCT01437267 Typhoid Fever Phase 2 Completed - Philippines ... More >> Research Institute for Tropical Medicine (RITM) Alabang, Muntinlupa City, Philippines, 1781 Less <<
NCT00351546 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01448057 Upper Respiratory Tract Infect... More >>ion Nasal Congestion Rhinorrhea Sneezing Less << Phase 3 Completed - Brazil ... More >> Santa Casa De Misericordia De Belo Horizonte - Avenida Francisco Sales 1111, Santa Efigenia Belo Horizonte/MG, Brazil, 30150-221 Sociedade Campineira De Educacao E Instrucao - Rodovia Dom Pedro I, KM 136 Parque das Universidades Campinas/SP, Brazil Instituto de Ensino e Pesquisa Clínica do Ceará, Rua Coronel Jucá, 1952 - Dionísio Torres - Fortaleza/CE, Brazil, 60170-320 Polonio Clinica De Servicios Medicos EM Gastroenterologia E Cirurgia Toracica S/S LTDA - ME, Rua Major Alfredo Servulo de Oliveira Romao, 103, Chacara Braz Miraglia Jau/SP, Brazil, 17210-070 Associacao Fundo De Incentivo A Pesquisa - AFIP - Rua Marselhesa 500 - Vila Clementino Sao Paulo, Brazil : Lal Clinica Centro de Pesquisa e Desenvolvimento Ltda, Rua General Osório, 503, Vila Martina / Valinhos São Paulo, Brazil, 13271-130 Less <<
NCT01437267 - Completed - -
NCT01448057 - Completed - -
NCT01666197 - Completed - -
NCT01796639 - Completed - China, Beijing ... More >> The 309th Hospital of Chinese People's Liberation Army Beijing, Beijing, China, 100000 Beijing Chaoyang Hospital Beijing, Beijing, China, 100020 Peking University First Hospital Beijing, Beijing, China, 100034 Beijing Friendship Hospital Beijing, Beijing, China, 100050 Chinese PLA General Hospital Beijing, Beijing, China, 100853 China, Fujian Fuzhou General Hospital of Nanjing Military Command Fuzhou, Fujian, China, 350025 China, Guangdong The First affiliated Hospital Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Nanfang Hospital Guangzhou, Guangdong, China, 510599 China, Henan The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China, 450052 China, Hubei Tongji Hospital Wuhan, Hubei, China, 430030 China, Hunan The Second Xiangya Hospital of Central South University Changsha, Hunan, China, 410000 China, Liaoning Shenyang Military General Hospital Shenyang, Liaoning, China China, Shandong Jinan Military General Hospital Jinan, Shandong, China, 250000 China, Shanghai Zhongshan Hospital Fudan University Shanghai, Shanghai, China, 200032 Shanghai First People's Hospital Shanghai, Shanghai, China, 200080 China, Shanxi First Affiliated Hospital of Medical College of Xian Jiaotong University Xian, Shanxi, China, 710061 China, Sichuan West China Hospital,Sichuan University Chengdu, Sichuan, China, 610041 China, Zhejiang The First Affiliated Hospital, Zhejiang University Hangzhou, Zhejiang, China, 310003 Less <<
NCT01433107 Tinea Pedis Phase 3 Completed - China ... More >> Peking University First Hospital Beijing, China, 100034 Beijing University Hospital N°3 Beijing, China, 100083 The Second Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong, China, 510120 The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, China, 510630 Chinese Academy of Medical Sciences Jiangsu, China, 21004 Huashan Hospital, Fudan University Shanghai, China, 200040 Less <<
NCT01967550 Osteoarthritis, Knee Phase 3 Completed - Germany ... More >> Bad Hersfeld, Germany Berlin, Germany Hamburg, Germany Munich, Germany Stockach, Germany Less <<
NCT02271854 Muscle Soreness Phase 3 Completed - United States, California ... More >> Lotus Clinical Research, 100 W California Blvd, Pasadena,, California, United States, 91105 Less <<
NCT01568775 End Stage Renal Disease Phase 1 Completed - Germany ... More >> Charité Universitätsmedizin Berlin, Germany Less <<
NCT00049452 Breast Cancer ... More >> Osteoporosis Less << Phase 3 Completed - United States, Connecticut ... More >> Carl and Dorothy Bennett Cancer Center at Stamford Hospital Stamford, Connecticut, United States, 06904 United States, New Jersey Valley Hospital - Paramus Paramus, New Jersey, United States, 07652-2509 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Less <<
NCT03714958 Colorectal Cancer ... More >> Advanced Cancer Metastatic Cancer Less << Phase 1 Not yet recruiting November 2020 -
NCT01967550 - Completed - -
NCT03749681 - Not yet recruiting March 28, 2020 France ... More >> CHRU de Brest Not yet recruiting Brest, France, 29609 Contact: Jean-Philippe Metges       jean-philippe.metges@chu-brest.fr Less <<
NCT03727971 Asthma Infert... More >>ility, Female Less << Phase 2 Not yet recruiting April 1, 2021 Denmark ... More >> Bispebjerg Hospital Copenhagen, Denmark, DK-2400 Less <<
NCT03740334 Acute Lymphoblastic Leukemia A... More >>LL Less << Phase 1 Not yet recruiting September 1, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Andrew E Place, MD, PhD    617-632-2313    andrew_place@dfci.harvard.edu    Principal Investigator: Andrew E Place, MD, PhD Less <<
NCT01699087 Myopia Astigm... More >>atism Less << Not Applicable Completed - -
NCT03042871 Choroidal Neovascularization Phase 4 Recruiting April 2020 China, Guangdong ... More >> ZhongShan Ophthalmic Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Xiaoyan Ding, phD    +8613535022222    dingxy75@gamil.com Less <<
NCT00602446 - Terminated(Due to slow accrual... More >> of patients) Less << - -
NCT02271854 - Completed - -
NCT02035748 Vitreomacular Traction ... More >> Vitreomacular Adhesion Less << Phase 4 Completed - -
NCT02739516 Unexplained Infertility Phase 3 Completed - -
NCT00602446 Breast Cancer ... More >> Iron Overload Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Neuroblastoma Ovarian Cancer Less << Phase 2 Terminated(Due to slow accrual... More >> of patients) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02246777 Glaucoma Not Applicable Completed - Japan ... More >> Contact Alcon Japan, Ltd for Trial Locations Tokyo, Japan, 107-0052 Less <<
NCT02246777 - Completed - -
NCT01699087 - Completed - -
NCT00255788 Breast Cancer Phase 2 Completed - Canada, British Columbia ... More >> British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada, V3V 1Z2 British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT02322229 Vitreomacular Traction ... More >> Vitreomacular Adhesion Less << Phase 4 Completed - Australia ... More >> Contact Alcon Laboratories (Australia) for Trial Locations New South Wales, Australia, 2113 Less <<
NCT02322229 - Completed - -
NCT02339584 Open-Angle Glaucoma ... More >> Ocular Hypertension Less << Phase 3 Completed - -
NCT02339584 - Completed - -
NCT02035748 - Completed - -
NCT02388763 Refractive Error Not Applicable Completed - -
NCT02436304 Otitis Media With Effusion in ... More >>Children Otitis Media Recurrent Less << Phase 3 Completed - -
NCT02388763 - Completed - -
NCT02477605 Vitreoretinal Disease Not Applicable Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT02470429 - Completed - -
NCT02436304 - Completed - -
NCT02495948 - Completed - -
NCT02495948 Refractive Error Not Applicable Completed - -
NCT02470429 Dry Eye Not Applicable Completed - -
NCT02575911 Myopia Hypero... More >>pia Less << Not Applicable Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT02419508 - Completed - -
NCT02477605 - Completed - -
NCT02699684 Refractive Error Not Applicable Completed - -
NCT02699684 - Completed - -
NCT02575911 - Completed - -
NCT02776670 Dry Eye Not Applicable Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT01860326 Hepatic Insufficiency Phase 1 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Orlando Clinical Research Center Orlando, Florida, United States, 32809 Less <<
NCT02730871 Open-angle Glaucoma ... More >> Ocular Hypertension Less << Phase 4 Terminated(Enrollment Challeng... More >>es) Less << - United States, Texas ... More >> Contact Alcon for Locations (Europe, Asia, and Latin America) Fort Worth, Texas, United States, 76134 Less <<
NCT02749396 - Completed - Finland ... More >> Many locations Multiple Locations, Finland Less <<
NCT01084499 Healthy Not Applicable Completed - -
NCT02419508 Open-Angle Glaucoma ... More >> Ocular Hypertension Less << Phase 4 Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT00258258 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 1 Terminated(Withdrawn due to lo... More >>w accrual) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00004251 Endometrial Cancer Phase 2 Completed - -
NCT01051570 - Completed - -
NCT00091299 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-7187 Less <<
NCT00084513 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00561171 Hypertension ... More >>Type II Diabetes Mellitus Less << Phase 2 Completed - Ireland ... More >> Dr. John Barton Ballinasloe, Co Galway, Ireland Less <<
NCT01051570 Prostate Cancer Phase 2 Completed - United States, Illinois ... More >> Northshore University Health System Evanston, Illinois, United States, 60201 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Weisberg Cancer Treatment Center Farmington Hills, Michigan, United States, 48334 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT02424253 Atopic Dermatitis Phase 2 Completed - Belgium ... More >> Belgium Study Site Brussels, Belgium Belgium Study Site Leuven, Belgium Belgium Study Site Liege, Belgium Germany German Study Site Goch, Germany German Study Site Hamburg, Germany German Study Centre Hannover, Germany German Study Site Mainz, Germany German Study Centre Munster, Germany Poland Polish Study Site Bialystock, Poland Polish Study Site Gdansk, Poland Polish Study Site Lodz, Poland Polish Study Site Poznan, Poland Polish Study Site Tarnow, Poland United Kingdom UK Study Centre Blackpool, United Kingdom UK Study Centre Cannock, United Kingdom UK Study Centre Leeds, United Kingdom UK Study Centre Manchester, United Kingdom Less <<
NCT02434328 Neovascular Age-Related Macula... More >>r Degeneration Less << Phase 3 Completed - -
NCT02795832 Atopic Dermatitis Phase 1 Phase 2 Completed - United Kingdom ... More >> MAC Blackpool, United Kingdom MAC Leeds, United Kingdom MAC Manchester, United Kingdom Less <<
NCT02618616 Psoriasis Phase 2 Completed - United States, Alabama ... More >> US Study Centre Mobile, Alabama, United States, 36608 United States, Florida US Study Centre Kissimmee, Florida, United States, 34744 Bulgaria Bulgarian Study Centre Montana, Bulgaria Bulgarian Study Centre Pleven, Bulgaria Bulgarian Study Centre 2 Sofia, Bulgaria Bulgarian Study Centre Sofia, Bulgaria Bulgarian Study Centre Varna, Bulgaria Bulgarian Study Centre Veliko Tarnovo, Bulgaria Poland Polish Study Centre Czestochowa, Poland Polish Study Centre Elbląg, Poland Polish Study Centre Karczew, Poland Polish Study Centre Katowice, Poland Polish Study Centre Krakow, Poland Polish Study Centre Lodz, Poland Polish Study Centre Toruń, Poland United Kingdom UK Study Centre Blackpool, United Kingdom UK Study Centre Cannock, United Kingdom UK Study Centre Leeds, United Kingdom UK Study Centre Manchester, United Kingdom Less <<
NCT02034500 Shigellosis Phase 1 Completed - United Kingdom ... More >> Surrey Clinical Research Center (Surrey CRC) Guildford, Surrey, United Kingdom, GU2 7XP Less <<
NCT03757039 Presbyopia Not Applicable Not yet recruiting January 2019 -
NCT01130376 HIV-1 Infection Phase 1 Terminated(Data from the 12 pa... More >>tients recruited has now been analysed, and it has been determined that it is sufficient to meet the study objectives.) Less << - United Kingdom ... More >> St. Stephen's AIDS Trust London, United Kingdom, SW10 9NH Less <<
NCT02017899 Shigellosis Phase 1 Completed - France ... More >> Centre d'Investigation Clinique en Vaccinologie Cochin-Pasteur (CIC1417) Paris, Paris cedex 14, France, 75679 Less <<
NCT02985671 Postural Low Back Pain ... More >> Mechanical Low Back Pain Less << Phase 3 Not yet recruiting April 1, 2020 -
NCT01232075 Infertility Phase 2 Completed - Egypt ... More >> Ahmed Elgazzar hospital Cairo, Egypt Cairo university hospital Cairo, Egypt Less <<
NCT00259116 Heart Failure, Congestive Phase 2 Completed - Germany ... More >> Charite Hospital Berlin, Germany, 10117 Less <<
NCT00006357 Endometrial Cancer ... More >> Gastrointestinal Stromal Tumor Ovarian Cancer Sarcoma Small Intestine Cancer Less << Phase 1 Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Denmark Aarhus Kommunehospital Aarhus, Denmark, DK-8000 Rigshospitalet Copenhagen, Denmark, 2100 Herlev Hospital - University Hospital of Copenhagen Herlev, Denmark, DK-2730 France Centre Leon Berard Lyon, France, 69373 Institut Gustave Roussy Villejuif, France, F-94805 Netherlands Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Academisch Ziekenhuis Groningen Groningen, Netherlands, 9713 EZ Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA United Kingdom Royal Marsden NHS Trust London, England, United Kingdom, SW3 6JJ Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Less <<
NCT00259103 Labor, Induced Phase 2 Completed - Russian Federation ... More >> Novosibirsk State Medical Academy Novosibirsk, Russian Federation Evidence CPR Saint Petersburg, Russian Federation, 199034 D.O. Ott Research Institute of Obstetrics and Gynecology Saint Petersburg, Russian Federation Less <<
NCT01965119 Relapsed or Refractory Hodgkin... More >> Lymphoma Primary Mediastinal Large B-cell Lymphoma Less << Phase 2 Completed - Korea, Republic of ... More >> Busan University Hospital Busan, Korea, Republic of Dong-A University Busan, Korea, Republic of Kosin University Gospel Hospital Busan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Korean Cancer Center Hospital Seoul, Korea, Republic of, 139-706 Chung-Ang University Hospital Seoul, Korea, Republic of Wonju Severance Christian Hospital Wonju, Korea, Republic of, 220-701 Less <<
NCT03140111 Dry Eye Syndromes ... More >> Primary Sj?gren Syndrome Less << Not Applicable Not yet recruiting March 30, 2018 -
NCT02158689 Poor Responders Not Applicable Completed - Turkey ... More >> Department of Obstetrics and Gynecology, Istanbul University School of Medicine Istanbul, Turkey, 34093 Less <<
NCT01964989 Influenza Virus Phase 3 Completed - -
NCT01336959 Acute Kidney Injury Phase 2 Terminated - United States, California ... More >> Novartis Investigative Site Orange, California, United States, 92686 United States, Michigan Novartis Investigative Site Saginaw, Michigan, United States, 48601 United States, Nebraska Novartis Investigative Site Lincoln, Nebraska, United States, 68506 United States, Ohio Novartis Investigative Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania Novartis Investigative Site Wynnewood, Pennsylvania, United States, 19096 United States, Virginia Novartis Investigative Site Falls Church, Virginia, United States, 22042 Israel Novartis Investigative Site Be'er Sheva, Israel, 84101 Novartis Investigative Site Herzliya, Israel Novartis Investigative Site Jerusalem, Israel, 91031 Novartis Investigative Site Petach Tikva, Israel, 49100 Novartis Investigative Site Rehovot, Israel, 76100 Novartis Investigative Site Tel-Aviv, Israel, 69710 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT01336959 - Terminated - -
NCT00406575 Congestive Heart Failure (CHF) Phase 2 Terminated - Russian Federation ... More >> Russian Scientific Centre of Surgery n.a. B.V.Petrovsky of Russian Academy of Medical Sciences Moscow, Russian Federation, 119992 Educational Scientific Medical Center of the General Management Department of the President of Russian Federation. City Clinical Hospital №51 Moscow, Russian Federation, 121309 Less <<
NCT02443311 Oral Lichen Planus Phase 4 Completed - -
NCT00868465 Uncomplicated Malaria Not Applicable Completed - Kenya ... More >> International Centre for Insect Physiology and Ecology - St. Judes Clinic Mbita, Suba District, Kenya Tanzania Kilimanjaro Christian Medical Centre, Magugu Field Site Moshi, Kilimanjaro Region, Tanzania Less <<
NCT00541385 Malaria Phase 3 Completed - Burkina Faso ... More >> Centre National de Recherche et de Formation sur le Paludisme Ouagadougou, Burkina Faso Congo Ecole de Santé Publique, Faculté de Médecine, Université de Kinshasa Kinshasa, DRC, Congo Côte D'Ivoire Unité de Paludologie de l'Institut Pasteur d'Abidjan Abdijan, Côte D'Ivoire Gabon Medical Research Unit, Albert Schweitzer Hospital Lambaréné, Gabon Kenya Siaya District Hospital, Medical Superintendent's office Siaya Town, Kenya Mali Malaria Research and Training Center, Faculté de Médecine, de Pharmacie et d'Ondonto-stomatologie Bamako, Mali Mozambique Instituto Nacional de Saude, Ministero de Saude Maputo, Mozambique Philippines Puerto Princesa General Hospital Puerto Princesa, Philippines Less <<
NCT00808951 Malaria Phase 4 Completed - Burkina Faso ... More >> Tinto Halidou Bobo-Dioulasso, Houet, Burkina Faso, 01 Less <<
NCT01939886 Malaria Phase 3 Completed - Kenya ... More >> St. Jude's Clinic, ICIPE Thomas Odhiambo Campus Mbita, Nyanza, Kenya, 40305 Less <<
NCT02401425 Complete Miscarriage Phase 2 Phase 3 Completed - Egypt ... More >> Ain Shams University Maternity Hospital Cairo, Egypt Less <<
NCT01017770 Uncomplicated P. Falciparum Ma... More >>laria in Children Less << Phase 4 Completed - Burkina Faso ... More >> Nanoro Nanoro, Boulkiemdé, Burkina Faso, 115 Nanoro Nanoro, Boulkiemdé, Burkina Faso IRSS-DRO/Centre Muraz Bobo-Dioulasso, Bp 545, Burkina Faso, 01 Tinto Halidou Bobo-Dioulasso, Houet, Burkina Faso, 01 Less <<
NCT03597893 Healthy Not Applicable Completed - -
NCT00309283 Autosomal Dominant Polycystic ... More >>Kidney Disease (ADPKD) Less << Phase 3 Completed - Italy ... More >> Hospital "Ospedali Riuniti" Unit of Nephrology and Dialysis Bergamo, Italy, 24128 Hospital "V. Fazzi" - Unit of neprology and Dialysis Lecce, Italy Hospital "Presidio Osp. Maggiore Policlinico" Milan, Italy University "Federico II" of Naples Napoli, Italy Hospital Cà Foncello Treviso, Italy Less <<
NCT01623349 Ovarian Cancer ... More >> Breast Cancer Less << Phase 1 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77230 Less <<
NCT02450799 Pseudophakia Not Applicable Completed - -
NCT02325518 - Completed - -
NCT00393679 Fever Malaria Phase 3 Completed - Burkina Faso ... More >> Centre Muraz/IRSS Bobo-Dioulasso, Burkina Faso Gabon Albert Schweitzer Hospital Lambaréné, Gabon Mozambique Manhiça Health Research Center Manhica, Mozambique Nigeria Hospital Calabar, Nigeria Rwanda Mashshesha and Rukara Kigali, Rwanda Uganda Jinja and Tororo Kampala, Uganda Mbarara, Mbarara, Uganda Zambia Tropical Diseases Research Centre, P O Box 71769, Ndola, Zambia Less <<
NCT02450799 - Completed - -
NCT02156661 Healthy Males Phase 1 Completed - -
NCT02325518 Open-Angle Glaucoma ... More >> Ocular Hypertension Less << Phase 4 Completed - Japan ... More >> Contact Alcon Japan Ltd. for Trial Locations Tokyo, Japan, 107-0052 Less <<
NCT02741024 Malaria Phase 4 Completed - -
NCT03428906 Healthy Not Applicable Completed - China, Beijing ... More >> School of Brain and Cognitive Sciences, Beijing Nornal University Beijing, Beijing, China, 100875 Less <<
NCT02684084 Diabetic Macular Edema Phase 4 Terminated(Study revised signi... More >>ficantly. New trial to be launched.) Less << - Canada, Ontario ... More >> Toronto Retina Institue Toronto, Ontario, Canada, M3C 0G9 North Toronto Eye Care Laser and Eye Specialists Toronto, Ontario, Canada, M3N 2V6 Less <<
NCT00618501 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT02181023 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Italy ... More >> Fondazione Salvatore Maugeri Milan, Italy, 20142 Less <<
NCT00844298 - Completed - -
NCT02658877 Asthma Phase 4 Recruiting April 2019 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Karen Carapetyan       carapk01@nyumc.org    Contact: Bertram Bleck       bleckb01@nyumc.org    Principal Investigator: Joan Reibman, MD Less <<
NCT00844298 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Daegu Fatima Hospital Daegu, Korea, Republic of, 701-600 Kyungpook National University Hospital Daegu, Korea, Republic of, 702-701 Yeungnam University Medical Center Daegu, Korea, Republic of, 712-749 Daegu Catholic University Hospital Daegu, Korea, Republic of National Cancer Center - Korea Goyang, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Jeollanam-do, Korea, Republic of, 519-809 Gyeongsang National University Hospital Jinju, Korea, Republic of, 660-701 Pusan National University Hospital Pusan, Korea, Republic of, 602-739 Inje University Seoul Paik Hospital Seoul, Korea, Republic of, 100-032 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Kyung Hee University Hospital Seoul, Korea, Republic of, 130-702 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center Seoul, Korea, Republic of, 143-729 Ajou University Hospital Suwon, Korea, Republic of, 441-749 Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT00942864 Macular Edema ... More >> Retinal Vein Occlusion Less << Phase 3 Completed - Korea, Republic of ... More >> Dept. of ophthalmology, Kyung Hee University Medical Center Seoul, Korea, Republic of, 130-702 Less <<
NCT00904735 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Italy ... More >> Ospedale Civile Avellino Recruiting Avellino, Italy Contact: Contact Person    39-0825-203-232       Ospedale Bellaria Recruiting Bologna, Italy, I-40139 Contact: Alba A. Brandes, MD    39-51-622-5102    aa.brandes@yahoo.it    Azienda Ospedaliero Careggi Recruiting Florence, Italy, 50139 Contact: Contact Person    39-055-427-7111       Istituto Nazionale Neurologico Carlo Besta Recruiting Milan, Italy, 20133 Contact: Contact Person    39-02-2394-2341       Ospedale Civile di Rovigo Recruiting Rovigo, Italy, 45100 Contact: Contact Person    39-0425-393-016 Less <<
NCT02305693 Infertility Phase 3 Unknown - Egypt ... More >> BeniSuef University hospitals Recruiting BeniSuef, Egypt Contact: Nesreen AA Shehata, MD    +2001227866337    nesoomar@yahoo.com    Cairo University Hospitals Recruiting Cairo, Egypt Contact: AbdelGany MA Hassan, MRCOG, MD    00217801604    abdelgany2@gmail.com    Principal Investigator: AbdelGany MA Hassan, MRCOG, MD Less <<
NCT00387933 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT01155895 Healthy Phase 1 Completed - -
NCT02023359 - Completed - Denmark ... More >> Aalborg Universitetshospital, Clinical Research unit Department of oncology, Klinik Kirurgi-kræft, Hobrovej 18-22 Aalborg, Denmark, 9000 Onkologisk Afdelning, SVS Esbjerg Esbjerg, Denmark, 6700 Department of Oncology, Odense University Hospital Odense, Denmark Less <<
NCT00390364 Colorectal Cancer Phase 2 Terminated(Withdrawn due to lo... More >>w accrual) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01155908 Healthy Phase 1 Completed - -
NCT02799992 Chronic Central Serous Chorior... More >>etinopathy Less << Not Applicable Unknown September 2016 -
NCT02443727 Healthy Early Phase 1 Completed - -
NCT02704546 Methylphenidate Not Applicable Unknown September 2017 Israel ... More >> Sheba medical center Tel-Hashomer, Ramat- Gan, Israel Less <<
NCT00390364 - Terminated(Withdrawn due to lo... More >>w accrual) Less << - -
NCT02946190 Pertussis Phase 2 Completed - Switzerland ... More >> Pediatric clinical trial platform, University Hospitals of Geneva City: Geneva Geneva, Switzerland, 1205 Less <<
NCT00050635 Neoplasms Dia... More >>rrhea Less << Phase 4 Completed - -
NCT00046748 Asthma Phase 3 Completed - -
NCT01218581 the Efficacy of Aromatase Inhi... More >>bitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis Less << Phase 2 Phase 3 Completed - Egypt ... More >> Mansoura University Hospitals Mansoura, Dakahlia, Egypt, 35111 Less <<
NCT00063609 Prostate Cancer Phase 4 Completed - -
NCT00098007 Heart Transplantation Phase 3 Completed - -
NCT01697787 Malaria Phase 4 Completed - Burkina Faso ... More >> Clinical Reaserch Unit Nanoro, Boulkiemdé, Burkina Faso, 218 Less <<
NCT00099242 Alzheimer's Disease ... More >> Dementia, Alzheimer Type Less << Phase 3 Completed - -
NCT00097825 Osteoporosis Phase 3 Completed - -
NCT00100620 Osteoporosis Phase 3 Completed - United States, Alabama ... More >> Center for Education and research on Therapeutics (CERTs) of Musculoskeletal Disorders Birmingham, Alabama, United States, 35294-3708 United States, Georgia United Osteoporosis Centers Gainesville, Georgia, United States, 30501 United States, Maryland Osteoporosis & Clinical Trials Cumberland, Maryland, United States, 21502 United States, Ohio University of Ohio Columbus, Ohio, United States, 43210 United States, Pennsylvania Radiant Research Wyomissing, Pennsylvania, United States, 19610 United States, Virginia McGuire VA Medical Center Richmond, Virginia, United States, 23249 Less <<
NCT00100555 Osteoporosis Phase 3 Completed - United States, Alabama ... More >> Univ. of Alabama/Division of Clinical Immunology and Rheumatology Birmingham, Alabama, United States, 35294 United States, California Radiant Research San DIego, California, United States, 92108 United States, Colorado Denver Arthritis Clinic Denver, Colorado, United States, 80230 United States, Florida Florida Medical Research Institute Gainesville, Florida, United States, 32605 United States, Illinois Northwestern Center for Clinical Research Chicago, Illinois, United States, 60611 United States, Maryland The Center for Rheumatology and Bone Research Wheaton, Maryland, United States, 20902 United States, Michigan Midwest Arthritis Center Kalamazoo, Michigan, United States, 49048-1634 United States, Missouri St. John's Medical Research Springfield, Missouri, United States, 65807 United States, Montana Deaconess Billings Clinic Research Division Billings, Montana, United States, 59101 United States, New Jersey UMDNJ-Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Helen Hayes Hospital - Regional Bone Clinic West Haverstraw, New York, United States, 10993 United States, Ohio Private Practice Mayfield Village, Ohio, United States, 44143 United States, Tennessee The Arthritis Clinic of Jackson Jackson, Tennessee, United States, 38305 United States, Texas Radiant Research Dallas, Texas, United States, 75235 Univ. of North Texas Health Science Center at Fort Worth Fort Worth, Texas, United States, 76107 St. Luke's Episcopal Hospital Ctr for Ortho. Res. and Education Houston, Texas, United States, 77030 United States, Utah Women's Health Center Salt Lake City, Utah, United States, 84117 United States, West Virginia Valley Medical Associates Lewisburg, West Virginia, United States, 24901 Less <<
NCT00967213 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 3 Completed - Korea, Republic of ... More >> Dept. of Ophthalmology, KyungHee Medical Center, #1 Hoegi, Dongdaemun-gu Seoul, Korea, Republic of, 130-702 Less <<
NCT00108836 Anxiety Disorders Phase 2 Completed - United States, California ... More >> Investigational Site Anaheim, California, United States, 92801 Investigational Site Los Angeles, California, United States, 90024 Investigational Site Newport Beach, California, United States, 92660 Investigational Site Redlands, California, United States, 92374 Investigational Site San Diego, California, United States, 92108 United States, Florida Investigational Site Ft. Meyers, Florida, United States, 33712 Investigational Site St. Petersburg, Florida, United States, 33702 Investigational Site West Palm Beach, Florida, United States, 33407 United States, Georgia Investigational Site Atlanta, Georgia, United States, 30308 United States, Illinois Investigational Site Hoffman Estates, Illinois, United States, 60194 Investigational Site Oak Brook, Illinois, United States, 60523 United States, Kansas Investigational Site Overland Park, Kansas, United States, 66211 United States, Ohio Investigational Site Dayton, Ohio, United States, 45408 United States, Oregon Investigational Site Portland, Oregon, United States, 97239 United States, Tennessee Investigational Site Madison, Tennessee, United States, 37115 Investigational Site Memphis, Tennessee, United States, 38119 Canada, Alberta Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, British Columbia Investigational Site Kelowna, British Columbia, Canada, V1Y 2H4 Canada, Ontario Investigational Site Hamilton, Ontario, Canada, 3Z5 Investigational Site Ottawa, Ontario, Canada, 7K4 Investigational Site Toronto, Ontario, Canada, 1R8 Canada, Quebec Investigational Site Montreal, Quebec, Canada, 2N6 Investigational Site Sherbrooke, Quebec, Canada, 4J6 Less <<
NCT00116376 Glioblastoma Multiforme Phase 1 Phase 2 Completed - United States, California ... More >> University of California at Los Angeles Los Angeles, California, United States, 90095 University of California, San Francisco San Francisco, California, United States, 94143 United States, North Carolina The Brain Tumor Center at Duke, Duke University Medical Center Box 3624 DUMC, Trent Drive, Durham, North Carolina, United States, 27710 United States, Texas University of Texas, MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01270347 Cystic Fibrosis Phase 3 Completed - -
NCT02290821 Acute Blunt Soft Tissue Injuri... More >>es/Contusions Less << Phase 3 Completed - United States, Florida ... More >> US Site Bradenton, Florida, United States US Site Port Orange, Florida, United States United States, Idaho US Site Boise, Idaho, United States United States, Michigan US Site Grand Rapids, Michigan, United States United States, Nebraska US Site Omaha, Nebraska, United States United States, New York US Site Brooklyn, New York, United States United States, Ohio US Site Columbus, Ohio, United States United States, Pennsylvania US Site State College, Pennsylvania, United States United States, Texas US Site Bellaine, Texas, United States US Site Houston, Texas, United States Less <<
NCT02290821 - Completed - -
NCT00063479 Osteogenesis Imperfecta Phase 2 Completed - United States, California ... More >> UCLA - Division of Pediatric Nephrology Los Angeles, California, United States, 90024 United States, Delaware Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States, 19899 United States, Idaho Intermountain Orthopedics Boise, Idaho, United States, 83702 United States, Illinois St. Jude Children's Research Hospital Peoria, Illinois, United States, 61637 United States, Nebraska Children's Hospital Omaha, Nebraska, United States, 68198 United States, Ohio Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97201 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 United States, Texas Texas Children's Hosptial Houston, Texas, United States, 77030 Less <<
NCT02382913 Pertussis Phase 1 Completed - Belgium ... More >> Site 02, Center for Vaccinology (CEVAC), Ghent University Hospital Ghent, Belgium Less <<
NCT00131118 Osteogenesis Imperfecta Phase 2 Completed - United States, California ... More >> UCLA Medical Center-Dept of Pediatric Nephrology Los Angeles, California, United States, 90095 United States, Delaware Alfred Dupont Hospital for Children Wilmington, Delaware, United States, 19899 United States, Idaho Intermountains Orthopedics Boise, Idaho, United States, 83702 United States, Nebraska Children's Hospital Omaha, Nebraska, United States, 68198 United States, New Jersey For information regarding facilities, please contact the Central Contact Multiple Locations, New Jersey, United States United States, Ohio Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT03692169 - Recruiting June 30, 2019 China, Guangdong ... More >> Fabao Xu Completed Guangzhou, Guangdong, China, 510000 Zhongshan Ophthalmic Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Less <<
NCT00046254 Osteoporosis ... More >>Hip Fracture Less << Phase 3 Completed - -
NCT00097812 Osteoporosis Phase 3 Completed - United States, California ... More >> The Permanente Medical Group Santa Rosa, California, United States, 95403 United States, Colorado Colorado Center for Bone Research Lakewood, Colorado, United States, 80227 United States, Florida Florida Medical Research Institute Gainsville, Florida, United States, 32605 Radiant Research Stuart, Florida, United States, 34996 United States, Kansas University of Kansas School of Medicine/ Division of Endocrinology Kansas City, Kansas, United States, 66160 United States, Massachusetts Clinical Pharmacology Study Group Worcester, Massachusetts, United States, 01610 United States, Nebraska Arthritis Center of Nebraska Lincoln, Nebraska, United States, 68516 Creighton University Osteoporosis Research Center Omaha, Nebraska, United States, 68131 United States, Oregon Oregon Osteoporosis Center Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Radiant Research Wyomissing, Pennsylvania, United States, 19610 United States, Washington Puget Sound Osteoporosis Center Seattle, Washington, United States, 98144 Germany Novartis Nuernberg, Germany Less <<
NCT02382913 - Completed - -
NCT02379637 Common Cold Associated With Co... More >>ugh Less << Phase 2 Completed - Canada, Quebec ... More >> Chicoutimi, Quebec, Canada Montreal, Quebec, Canada Sherbrook, Quebec, Canada Victoriaville, Quebec, Canada Canada Quebec, Canada Less <<
NCT00049829 Osteoporosis Phase 3 Completed - -
NCT00884897 - Completed - -
NCT01434095 Chronic Central Serous Chorior... More >>etinopathy Less << Not Applicable Completed - Japan ... More >> Department of Ophthalmology, Surugadai Nihon University Hospital Chiyoda-ku, Tokyo, Japan, 101-8309 Less <<
NCT02379637 - Completed - -
NCT01107145 Plasmodium Vivax Malaria Phase 4 Terminated(Extremely slow enro... More >>llment) Less << - Brazil ... More >> Hospital Geral Maternidade de Cruzeiro do Sul Cruzeiro do Sul, Acre, Brazil Hospital Municipal Teonila Alves Anajas, Para, Brazil Centro de Pesquisa em Patologias Tropicais Porto Velho, Rondonia, Brazil Less <<
NCT00884897 Social Cognition ... More >> Social Anxiety Emotional Intelligence Less << Phase 2 Completed - United States, Maryland ... More >> Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP) Catonsville, Maryland, United States, 21228 Less <<
NCT01967472 Malaria Not Applicable Completed - Sierra Leone ... More >> George Brook Health Center Freetown, Sierra Leone Ross Road Health Facility Freetown, Sierra Leone Less <<
NCT01317745 Influenza Phase 1 Completed - United States, Georgia ... More >> Emory Children's Center - Division of Pediatric Infectious Diseases Atlanta, Georgia, United States, 30322 Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States, 30030-2517 United States, Iowa University of Iowa - Infectious Disease Clinic Iowa City, Iowa, United States, 52242-1009 United States, Missouri Saint Louis University - Center for Vaccine Development Saint Louis, Missouri, United States, 63104-1015 United States, Ohio Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States, 45229-3026 Less <<
NCT02389231 Autoimmune Hemolytic Anemia Phase 1 Phase 2 Recruiting December 2019 France ... More >> CHU de Bordeaux Hôpital Haut Lévêque Recruiting Pessac, Aquitaine, France, 33604 Contact: Estibaliz LAZARO, Prof    +33 5 57 65 64 83    estibaliz.lazaro@chu-bordeaux.fr    Sub-Investigator: Fabrice BONNET, Prof          Sub-Investigator: Pierre DUFFAU, MD          Principal Investigator: Estibaliz LAZARO, Prof Less <<
NCT02194049 Extensive Stage Small Cell Lun... More >>g Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> University of California at Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT02222272 - Unknown December 2015 Denmark ... More >> Rigshospitalet Copenhagen, Denmark Finland Helsinki University Central Hospital Helsinki, Finland Germany University of Freiburg Freiburg, Germany University of Muenster Muenster, Germany Hungary St Ivan & St Laszlo Hospital Budapest, Hungary Israel Chaim Sheba Medical Centre Tel-Hashomer, Israel Poland Medical University of Silesia Katowice, Poland Russian Federation St Petersburg State Medical Pavlov University St Petersburg, Russian Federation Saudi Arabia King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia United Kingdom Hammersmith London, United Kingdom Less <<
NCT01972750 First or Second Recurrence of ... More >>Glioblastoma Less << Phase 1 Unknown November 2016 Germany ... More >> Department of Neurology and Center of Integrated Oncology, University Hospital Bonn Bonn, Germany, 53105 Less <<
NCT02240719 Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Multiple Myeloma Less << Phase 1 Active, not recruiting December 2019 United States, California ... More >> University of California Davis Sacramento, California, United States, 95817 Less <<
NCT02182622 Prostate Cancer Phase 1 Unknown - United States, New Jersey ... More >> John Theurer Cancer @ HackensackUMC Not yet recruiting Hackensack, New Jersey, United States, 07601 Contact: Victoria Sica, RN    551-336-8054    vsica@hackensackumc.org    Principal Investigator: Martin E. Gutierrez, MD          Sub-Investigator: Robert S. Alter, MD          Sub-Investigator: Deena M Atieh Graham, MD          Sub-Investigator: Narjust Perez-Florez, MD Less <<
NCT02251288 Avian Influenza ... More >> Immunisation Less << Phase 1 Active, not recruiting October 23, 2018 United States, New York ... More >> University of Rochester Medical Center - Vaccine Research Unit Rochester, New York, United States, 14642-0001 Less <<
NCT02262130 Solar Urticaria Phase 2 Completed - France ... More >> CHU de Angers Angers, France Dermatology department, Centre Hospitalier Régional Universitaire Besançon, France CHU de Caen Caen, France CHU de Dijon Dijon, France CHU de Grenoble Grenoble, France CHRU de Lille Lille, France CHU de Limoges Limoges, France CHU de Montpellier Montpellier, France CHU de Nancy Nancy, France Dermatology department, Hôpital Saint-Louis Paris, France CHU de Reims Reims, France CHU de Rennes Rennes, France CHU de Toulouse Toulouse, France Less <<
NCT02225327 Influenza, Human ... More >> Pneumococcal Infections Less << Phase 4 Completed - -
NCT02254551 - Terminated(Safety lead-in data... More >> did not support continuation of study.) Less << - -
NCT02201459 Chronic Myeloid Leukemia Phase 3 Recruiting August 2019 France ... More >> Franck NICOLINI Recruiting Lyon, France, 04 78 86 22 50 Contact: Franck Nicolini, MD    4 78 86 22 50 ext 33    franck-emmanuel.nicolini@chu-lyon.fr Less <<
NCT02273752 Estrogen Receptor-positive Bre... More >>ast Cancer Gastrinoma Glucagonoma HER2-negative Breast Cancer Insulinoma Mucositis Oral Complications Pancreatic Polypeptide Tumor Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Recurrent Islet Cell Carcinoma Recurrent Renal Cell Cancer Somatostatinoma Stage III Renal Cell Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Renal Cell Cancer Less << Phase 2 Terminated(Slow accrual) - United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02254551 Multiple Myeloma Phase 2 Terminated(Safety lead-in data... More >> did not support continuation of study.) Less << - United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45236 United States, Tennessee Tennessee Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 United States, Texas Texas Transplant Institute/Methodist Healthcare San Antonio, Texas, United States, 78229 Less <<
NCT02277964 - Completed - Switzerland ... More >> University Hospital Basel, Switzerland Basel, Switzerland, 4031 Less <<
NCT02269670 Estrogen Receptor-positive Bre... More >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 2 Active, not recruiting October 2020 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Emory Saint Joseph's Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT02285244 Prolymphocytic Leukemia ... More >> Recurrent Mantle Cell Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Richter Syndrome Less << Phase 2 Withdrawn(Decision made by the... More >> Principal Investigator) Less << - -
NCT02262130 - Completed - -
NCT02291913 Breast Cancer Phase 2 Active, not recruiting January 2019 United States, Florida ... More >> Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Memorial Cancer Center Hollywood, Florida, United States, 33021 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists-East West Palm Beach, Florida, United States, 33401 United States, Indiana Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Tennessee Tennessee Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 United States, Texas Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less <<
NCT02289144 Metastatic Anaplastic Thyroid ... More >>Cancer Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer Less << Phase 2 Recruiting December 2021 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Pamela Kurian    214-648-5874    Pamela.Kurian@UTSouthwestern.edu    Principal Investigator: Saad A Khan, MD Less <<
NCT02298595 Carcinoma, Squamous ... More >> Squamous Cell Carcinoma Oropharyngeal Neoplasms Oropharyngeal Cancer Less << Phase 1 Phase 2 Withdrawn August 2024 -
NCT02301364 Lymphoma Prim... More >>ary Central Nervous System Lymphoma Recurrent/Refractory Secondary Central Nervous System Lymphoma Less << Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02299089 - Completed - -
NCT02321501 Head and Neck Cancer ... More >> Lung Cancer Less << Phase 1 Recruiting June 2024 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02321839 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 4 Recruiting December 2019 Japan ... More >> Sugita Eye Hospital Recruiting Nagoya, Aichi, Japan, 460-0008 Contact: Juntaro Sugita    +81-52-521-6571       Contact: Iichiro Sugira    +81-52-521-6571    iichiro@sugita.or.jp    Nagoya City Univsersity Recruiting Nagoya, Aichi, Japan, 467-8602 Contact: Yuichiro Ogura    +81-52-853-8251 ext 8251    ogura@med.nagoya-cu.ac.jp    Contact: Aki Kato    +81-52-853-8251 ext 8251    akikato@med.nagoya-cu.ac.jp Less <<
NCT02299089 Acromegaly Ne... More >>uroendocrine Tumors Less << Phase 2 Completed - France ... More >> Hospices Civils de Lyon Bron, France CHU Rouen, Hôpital Charles Nicolle Rouen cedex, France Germany Abteilung: Klinische Studien Bad Berka, Germany Charité Campus Virchow Klinikum Berlin, Germany Universitätsklinikum Essen Essen, Germany Italy RCCS Azienda Ospedaliera Universitaria San Martino IST Genova, Italy Fondazione Irccs Ca' Granda Milano, Italy Università degli Studi di Napoli Federico II Napoli, Italy Istituto Clinico Humanitas Rozzano, Italy Sweden Akademiska sjukhuset Uppsala, Sweden Less <<
NCT02323139 MDS Phase 1 Completed - France ... More >> CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49033 CH Henri Duffaut Avignon, France, 84000 CH de la Côte Basque Bayonne, France, 64 100 Hôpital Avicenne Bobigny, France, 93009 Hôpital Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 CH Le Mans Le Mans, France, 72037 IPC-Unité d'Hématologie 3 Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77100 CHU de Montpellier Montpellier, France, 34295 Hôpital Hôtel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hôpital Archet 1 Nice, France, 06202 CHU de Nîmes Nîmes, France, 30029 Hôpital Saint Louis - Service Hématologie Sénior Paris, France, 75010 Hôpital Saint-Louis - Service d'hématologie AJA Paris, France, 75010 Hôpital Cochin Paris, France, 75014 CHU de Haut-Lévèque Pessac, France, 33604 CH Lyon Sud Pierre-Bénite, France, 69495 CH Annecy Genevois Pringy, France, 74374 Hôpital Henri Becquerel Rouen, France, 76038 IUC Oncopole - Médecine interne Toulouse, France, 31059 CHU Nancy-Brabois Vandœuvre-lès-Nancy, France, 54511 Less <<
NCT02325271 - Completed - Germany ... More >> GWT-TUD GmbH / Studienzentrum Hanefeld Dresden, Germany, 01307 Less <<
NCT02328963 Transplantation Infection ... More >> Cytomegalovirus Infection Less << Phase 4 Completed - France ... More >> CHU de Bordeaux Bordeaux, France, 33000 CHU La Cavale Blanche Brest, France, 29609 CHRU Caen - Hôpital de Caen Caen, France, 14033 CHU de Limoges - Hôpital Dupuytren Limoges, France Hôpital Edouard Herriot Lyon, France, 69003 APHP - Hôpital Necker Paris, France, 75015 APHP - Kremlin Bicetre Paris, France, 94275 CHRU Strasbourg Strasbourg, France CHU de Toulouse - Hôpital Rangueil Toulouse, France, 31000 Less <<
NCT02301364 - Completed - -
NCT02273752 - Terminated(Slow accrual) - -
NCT02340780 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting June 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario University Health Network Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec The Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT02342600 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Withdrawn(Supporting company w... More >>ithdrew interest) Less << - -
NCT02383251 Ovarian Cancer Phase 2 Recruiting December 2018 France ... More >> ICO Paul Papin Active, not recruiting Angers, France, 49933 Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Anne Floquet, MD    5 56 33 33 33 ext 033    a.floquet@bordeaux.unicancer.fr    Polyclinique Bordeaux Nord Active, not recruiting Bordeaux, France, 33300 Centre François Baclesse Recruiting Caen, France, 14000 Contact: Emmanuel Sevin, MD    2 31 45 53 97 ext 0033    e.sevin@baclesse.unicancer.fr    Centre Jean Perrin Active, not recruiting Clermont-ferrand, France, 63000 Centre Hospitalier de Dax Enrolling by invitation Dax, France, 40107 Centre Georges François Leclerc Active, not recruiting Dijon, France, 21079 Hôpital André Mignot Recruiting Le Chesnay, France, 78157 Contact: Didier MAYEUR, MD    1 39 63 91 33 ext 0033    dmayeur@ch-versailles.fr    Centre Jean Bernard - Clinique Victor Hugo Recruiting Le Mans, France, 72000 Contact: Hugues BOURGEOIS, MD    2 43 47 94 94 ext 0033    h.bourgeois@cjb72.org    Centre Oscar Lambret Active, not recruiting Lille, France, 59200 Centre Léon Bérard Enrolling by invitation Lyon, France, 69373 Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: Magali PROVANSAL, MD    4 91 22 37 40 ext 0033    provansalm@ipc.unicancer.fr    Hôpital de Mont-de-Marsan Active, not recruiting Mont-de-marsan, France, 40024 ICM Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Michel FABBRO, MD    4 67 61 30 63 ext 0033    michel.fabbro@icm.unicancer.fr    ORACLE - Centre d'Oncologie de Gentilly Recruiting Nancy, France, 54100 Contact: Dominique SPAETH, MD    3 83 93 50 05 ext 0033    oncomed@wanadoo.fr    Centre Catherine de Sienne Recruiting Nantes, France, 44202 Contact: Alain LORTHOLARY, MD    2 28 27 21 71 ext 0033    lortholary.alain@catherinedesienne.fr    Centre Antoine Lacassagne Enrolling by invitation Nice, France, 06189 Centre Hospitalier Régional d'Orléans Active, not recruiting Orléans, France, 45067 Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Site Cochin Active, not recruiting Paris, France, 75014 Clinique Francheville Active, not recruiting Perigueux, France, 20004 Centre Hospitalier Lyon Sud Recruiting Pierre Benite, France, 69495 Contact: Benoît YOU, MD    4 78 86 43 18 ext 0033    benoit.you@chu-lyon.fr    Hôpital Privé des Côtes d'Armor Recruiting Plerin Sur Mer, France, 22190 Contact: Anne-Claire HARDY-BESSARD, MD    2 96 75 22 16 ext 0033    ac.hardy@clin-armoricaine.fr    "Hôpital de la Milétrie - Centre Hospitalier Universitaire de Poitiers - Pôle Régional de Cancérologie" Enrolling by invitation Poitiers, France, 86021 ICO Centre René Gauducheau Active, not recruiting Saint-herblain, France, 44805 Hôpitaux Universitaires de Strasbourg Enrolling by invitation Strasbourg, France, 67000 Centre Paul Strauss Active, not recruiting Strasbourg, France, 67065 Centre Hospitalier de Thonon-les-Bains Recruiting Thonon-les-Bains, France, 74203 Contact: Francesco DEL PIANO, MD    4 50 83 20 65 ext 0033    f-delpiano@ch-hopitauxduleman.fr    ICL Institut de Cancérologie de Lorraine Recruiting Vandoeuvre-les-nancy, France, 54511 Contact: Marie-Christine KAMINSKY, MD    3 83 59 83 63 ext 0033    mc.kaminsky@nancy.unicancer.fr Less <<
NCT02325440 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Unknown April 2016 Germany ... More >> Universitaetsklinikum Muenster, Department of Neurology Recruiting Muenster, Germany, 48149 Contact: Luisa Klotz, PD Dr. med.    +49 251 83444 ext 52    luisa.klotz@ukmuenster.de    Principal Investigator: Luisa Klotz, PD Dr. med. Less <<
NCT02386826 Glioblastoma Multiforme ... More >> Gliosarcoma Colorectal Cancer Renal Cell Carcinoma Less << Phase 1 Recruiting November 2019 United States, Colorado ... More >> Sarah Cannon Research Institute at HealthONE Recruiting Denver, Colorado, United States, 80218 United States, Connecticut Yale School of Medicine Recruiting New Haven, Connecticut, United States, 06520 United States, Missouri HCA Midwest - Kansas City Recruiting Kansas City, Missouri, United States, 64132 United States, Oklahoma Oklahoma University Health Science Center Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Less <<
NCT02395757 Stage 3 Age Related Macular De... More >>generation (AREDS Classification) Less << Not Applicable Unknown September 2018 France ... More >> Hospice Civils de Lyon Recruiting Lyon, France, 69000 Contact: Laurent KODJIKIAN, MD    4 26 10 93 21 ext 0033    laurent.kodjikian@chu-lyon.fr Less <<
NCT02387099 Breast Cancer ... More >> Hormone Receptor Positive Tumor Less << Phase 2 Recruiting March 2018 Germany ... More >> Sana Klinikum Offenbach / German Breast Group Not yet recruiting Neu Isenburg, Hessen, Germany, 63263 Contact: Sibylle Loibl, PD.MD    +49 6102 7840 ext 426    Sibylle.Loibl@GermanBreastGroup.de    Principal Investigator: Sibylle Loibl, MD          TU Dresden Recruiting Dresden, Sachsen, Germany, 01307 Principal Investigator: Karin Kast, MD, Prof          Recruiting Bielefeld, Germany, 33604 University of Erlangen Recruiting Erlangen, Germany, 91054 Recruiting Essen, Germany, 45136 Not yet recruiting Goslar, Germany, 38642 Recruiting Hanau, Germany, 63450 Active, not recruiting Karlsruhe, Germany, 76135 Active, not recruiting Kiel, Germany, 24105 Active, not recruiting Köln, Germany, 50931 Recruiting Mainz, Germany, 55131 Active, not recruiting München, Germany, 80638 Recruiting Rotenburg, Germany, 27356 Recruiting Weinheim, Germany, 69469 Less <<
NCT02325505 - Recruiting August 2019 Brazil ... More >> InCor Heart Institute Recruiting Sao Paulo, Brazil, 05303900 Contact: Bruno G Baldi, MD    551126615695    bruno.guedes2@terra.com.br    InCor Heart Institute Recruiting Sao Paulo, Brazil, 05403900 Contact: Luciana Cassimiro, Coordinator    551126615109    luciana.cassimiro@incor.usp.br    Contact: Kátia Sansivieri, Coordinator    551126615109    katia@incor.usp.br    Principal Investigator: Carlos Roberto Ribeiro Carvalho, MD, PhD          Principal Investigator: Bruno G Baldi, MD          Sub-Investigator: Elieser Watanabe, MD          Sub-Investigator: Maria Luiza Manreza, MD          Sub-Investigator: José Roberto Colombo, MD          Sub-Investigator: Zilda Najjar, MD, PhD          Sub-Investigator: Luiz Fernando Onuchic, MD, PhD Less <<
NCT02420691 Gastrointestinal Cancer Phase 2 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02445469 Parkinson's Disease ... More >> Multiple System Atrophy Progressive Supranuclear Palsy Vascular Parkinsonism Less << Not Applicable Terminated(The results obtaine... More >>d are sufficient) Less << - France ... More >> Service de Neuroradiologie, Hopital Gui de Chauliac, CHU de Montpellier Montpellier, France, 34295 Less <<
NCT02397083 Endometrial Cancer Phase 2 Recruiting September 2026 United States, Texas ... More >> Memorial City Recruiting Houston, Texas, United States, 77024 Lyndon B. Johnson General Hospital (LBJ) Recruiting Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 The Woman's Hospital of Texas Recruiting Houston, Texas, United States, 77054 Less <<
NCT02470923 Smoking Cessation Not Applicable Unknown July 2017 Israel ... More >> Soroka University Medical Center Recruiting Be'er-Sheva, Israel, 8410101 Contact: Tali Shafat, MD Less <<
NCT02478515 Branch Retinal Vein Occlusion Phase 4 Recruiting September 2019 Japan ... More >> Nagoya City Univsersity Recruiting Nagoya, Aichi, Japan, 467-8602 Contact: Yuichiro Ogura    +81-52-853-8251 ext 8251    ogura@med.nagoya-cu.ac.jp    Contact: Aki Kato    +81-52-853-8251 ext 8251    akikato@med.nagoya-cu.ac.jp Less <<
NCT02446145 Acute Myeloid Leukemia Phase 2 Recruiting May 2019 Germany ... More >> Uniklinik RWTH Aachen Recruiting Aachen, Germany Contact: Martina Crysandt, MD          Charite Campus Benjamin Franklin Not yet recruiting Berlin, Germany Contact: Claudia Baldus, Prof.          Klinikum Chemnitz GmbH Recruiting Chemnitz, Germany Contact: Mathias Hänel, MD          Universitätsklinikum Dresden Recruiting Dresden, Germany Contact: Uwe Platzbecker, Prof.          Marienhospital Düsseldorf GmbH Not yet recruiting Düsseldorf, Germany Contact: Aristoteles Giagounidis, MD          Universitätsklinikum Essen Recruiting Essen, Germany Contact: Richard Noppeney, MD          Universitätsklinikum Halle (Saale) Recruiting Halle, Germany Contact: Petra Tschanter, MD          St. Marien-Hospital Hamm Not yet recruiting Hamm, Germany Contact: Heinz A Dürk, MD          Klinikum rechts der Isar der TU München Not yet recruiting München, Germany Contact: Katharina Götze, MD          Klinikum Nürnberg-Nord Recruiting Nürnberg, Germany Contact: Kerstin Schäfer-Eckart, MD          Medizinisches Versorgungszentrum für Blut- und Krebserkrankungen Recruiting Potsdam, Germany Contact: Hartmut Linde, MD          Wissenschaftskontor Nord GmbH & Co KG Not yet recruiting Rostock, Germany Contact: Andreas Lück, MD          Diakonie-Klinikum Schwäbisch Hall gGmbH Recruiting Schwäbisch Hall, Germany Contact: Thomas Geer, MD          Rems-Murr-Klinikum Winnenden Recruiting Winnenden, Germany Contact: Stefani Parmentier, MD          Universitätsklinikum Würzburg Not yet recruiting Würzburg, Germany Contact: Volker Kunzmann, Prof. Less <<
NCT02531932 Breast Cancer Phase 2 Recruiting December 2018 United States, New York ... More >> Mount Sinai Downtown Recruiting New York, New York, United States, 10011 Contact: , MD          Principal Investigator: Paula Klein, MD          Mount Sinai West Recruiting New York, New York, United States, 10019 Principal Investigator: Anupama Goel, MD          Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Amy Tiersten, MD Less <<
NCT02567214 COPD Phase 4 Recruiting June 16, 2018 Canada, Ontario ... More >> Queens University Not yet recruiting Kingston, Ontario, Canada, K7L 2V6 Contact: Sandra Vincent    1613-549-6666 ext 4890    vincents@queensu.ca    Sub-Investigator: Denis O'Donnell, MD          Canada, Quebec McGill University Not yet recruiting Montreal, Quebec, Canada, H2W 1S4 Contact: Dennis Jensen, PhD    1514-398-4184 ext 0472    dennis.jensen@mcgill.ca    Contact: Lauren Tracey    1-514-934-1934 ext 32465    lauren.tracey@mail.mcgill.ca    Sub-Investigator: Dennis Jensen, PhD          Canada Laval University - IUCPQ Recruiting Quebec, Canada, G1V 4G5 Contact: Josée Picard, RN    1418-656-8711 ext 2934    josee.picard@criucpq.ulaval.ca    Contact: Cynthia Brouillard, MSc    1418-656-8711 ext 2912    cynthia.brouillard@criucpq.ulaval.ca    Principal Investigator: François Maltais, MD Less <<
NCT02487823 Non Castrate Metastatic Prosta... More >>te Cancer Less << Phase 1 Terminated(Defect of recruitme... More >>nt) Less << - France ... More >> Institut Paoli Calmettes Marseille, France, 13009 Less <<
NCT02594098 Atopic Dermatitis Phase 2 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT02598505 Heart Failure Phase 3 Unknown September 2016 Italy ... More >> Centro Cardiologico Monzino Recruiting Milano, MI, Italy, 20138 Contact: Piergiuseppe Agostoni, MD. PhD    0039 02 5800 ext 2772       Principal Investigator: Piergiuseppe Agostoni, MD, PhD Less <<
NCT02599129 Alopecia Areata Phase 2 Terminated(low enrollment) - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT02607124 High Grade Glioma ... More >> Diffuse Intrinsic Pontine Glioma Bithalamic High Grade Glioma Less << Phase 1 Phase 2 Active, not recruiting January 2020 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT02599129 - Terminated(low enrollment) - -
NCT02657343 Breast Cancer Phase 1 Phase 2 Recruiting February 2023 United States, Massachusetts ... More >> Massacusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Aditya Bardia, MD    617-724-4000       Principal Investigator: Aditya Bardia, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Sara Tolaney, MD MPH    617-632-3800    sara_tolaney@dfci.harvard.edu    Principal Investigator: Sara Tolaney, MD MPH Less <<
NCT02661438 Bronchiectasis ... More >> Pulmonary Disease, Chronic Obstructive Less << Not Applicable Completed - United States, Florida ... More >> Vero Beach, Florida, United States, 32960 United States, New York Jamaica, New York, United States, 11435 Less <<
NCT02662868 - Completed - Brazil ... More >> Clínica AMO Salvador, Bahia, Brazil Clínica CEHON Salvador, Bahia, Brazil Núcleo de Oncologia da Bahia - NOB Salvador, Bahia, Brazil Centro Regional Integrado de Oncologia (CRIO) Fortaleza, Ceará, Brazil Hospital Haroldo Joaçaba Instituto do Câncer do Ceará Fortaleza, Ceará, Brazil Oncovida Brasília, Distrito Federal, Brazil Hospital Tacchini Bento Gonçalves, Rio Grande do Sul, Brazil CPO - Pucrs Porto Alegre, Rio Grande do Sul, Brazil Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil Hospital Moinhos de Vento Porto Alegre, Rio Grande do Sul, Brazil Hospital Mãe de Deus Porto Alegre, Rio Grande do Sul, Brazil Centro de Pesquisas em Hematologia e Oncologia Santo André, Rio Grande do Sul, Brazil Centro de Pesquisas Oncológicas - CEPON Florianópolis, Santa Catarina, Brazil Centro de Novos Tratamentos de Itajaí Itajaí, Santa Catarina, Brazil Hospital do Câncer de Barretos Barretos, São Paulo, Brazil Hospital Amaral Carvalho Jaú, São Paulo, Brazil InORP Ribeirão Preto, São Paulo, Brazil Centro de Oncologia e Hematologia de Rio Claro Rio Claro, São Paulo, Brazil IEP São Lucas Santo André, São Paulo, Brazil Instituto Nacional do Câncer Rio de Janeiro, Brazil Hospital AC Camargo São Paulo, Brazil Hospital São José São Paulo, Brazil ICESP São Paulo, Brazil Instituto Brasileiro de Controle do Câncer - IBCC São Paulo, Brazil Less <<
NCT02668172 Acromegaly Phase 4 Unknown June 2017 Netherlands ... More >> Erasmus Medical Center Rotterdam, South Holland, Netherlands, 3000CA Less <<
NCT02671006 - Completed - France ... More >> Chu Saint Etienne Saint Etienne, France, 42100 Less <<
NCT02586675 Breast Cancer ... More >> Breast Cancer - Female Breast Cancer - Male Less << Phase 1 Active, not recruiting December 2018 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02706691 FGFR Gene Amplification ... More >> FGFR1 Gene Amplification FGFR2 Gene Amplification FGFR2 Gene Mutation FGFR3 Gene Mutation Head and Neck Squamous Cell Carcinoma Human Papillomavirus Infection Recurrent Head and Neck Carcinoma Recurrent Nasopharynx Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Less << Phase 2 Recruiting June 2025 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637 Contact: Allison Dekker, RN    773-702-2068    adekker@medicine.bsd.uchicago.edu    Principal Investigator: Tanguy Y. Seiwert Less <<
NCT02614508 Recurrent Chronic Lymphocytic ... More >>Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Less << Phase 1 Active, not recruiting October 2022 United States, Georgia ... More >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02687958 Neuroendocrine Carcinoma Phase 2 Recruiting May 2017 Italy ... More >> S.C. Oncologia - Policlinico Active, not recruiting Modena, Emilia - Romagna, Italy, 41124 U.O. Oncologia Medica 1 - AOU Pisana Recruiting Pisa, Tuscany, Italy, 56126 Contact: Cinzia Orlandini, SC          Principal Investigator: Sergio Ricci, MD          Azienda Ospedaliera "Spedali Civili di Brescia" Active, not recruiting Brescia, Italy, 25123 Azienda Ospedaliera Universitaria Careggi Recruiting Florence, Italy, 50134 Contact: Luisa Di Cerbo, SC    +390557947298    luisa.dicerbo@libero.it    Contact: Alessandro Di Costanzo, SC    +390557947298    adicostanzo.oncmed@hotmail.com    Principal Investigator: Francesco Di Costanzo, MD          Principal Investigator: Lorenzo Antonuzzo, MD          Istituto Europeo di Oncologia Active, not recruiting Milano, Italy, 20141 Less <<
NCT02563197 Bronchiectasis Phase 1 Completed - Germany ... More >> Gauting, Bayern, Germany, 82131 Landsberg, Bayern, Germany, 86899 München, Bayern, Germany, 80336 München, Bayern, Germany, 80539 München, Bayern, Germany, 81241 Frankfurt, Hessen, Germany, 60389 Frankfurt, Hessen, Germany, 60596 Neu-Isenburg, Hessen, Germany, 63263 Hannover, Niedersachsen, Germany, 30625 Grosshansdorf, Germany, 22927 Less <<
NCT02733094 Pyoderma Gangrenosum Phase 1 Phase 2 Recruiting December 2020 Germany ... More >> Technical University of Munich Recruiting Munich, Germany, 80802 Contact: Kilian Eyerich, MD, PhD       kilian.eyerich@tum.de Less <<
NCT02750215 Malignant Non-small Cell Neopl... More >>asm of Lung Stage IV Less << Phase 2 Recruiting December 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Rebecca S. Heist, MD    617-724-4000    rheist@partners.org    Principal Investigator: Rebecca S. Heist, MD Less <<
NCT02759718 Non Functioning Pancreatic End... More >>ocrine Tumor Less << Phase 4 Unknown May 2017 -
NCT02720926 Colorectal Cancer ... More >> Gastric Cancer Less << Phase 1 Terminated(Unafavourable toxic... More >>ity profile) Less << - Singapore ... More >> National Cancer Centre singapore Singapore, Singapore Less <<
NCT02780882 Ectopic ACTH Syndrome Phase 2 Withdrawn(Due to stringent inc... More >>lusion/exclusion criteria, study investigator deemed it not feasible.) Less << June 2019 United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT02788877 Macular Edema, Diabetic Phase 4 Recruiting September 2019 Korea, Republic of ... More >> Busan Paik Hospital Not yet recruiting Busanjin-gu, Busan, Korea, Republic of, 614-735 Contact: Hyun Woong Kim, MD, PHD    +82-51-890-6452    maekbak@hanmail.net    Haeundae Paik Hospital Not yet recruiting Haeundae, Busan, Korea, Republic of, 612-030 Contact: Joo Eun Lee, MD, PhD    +82-51-797-2310    jooeun2@gmail.com    Gospel Hospital Not yet recruiting Seo-gu, Busan, Korea, Republic of, 602-702 Contact: Sang Joon Lee, MD, PhD    +82-51-990-6228    hhiatus@gmail.com    Pusan National University Hospital Recruiting Seo-gu, Busan, Korea, Republic of, 602-739 Contact: Ji Eun Lee, MD, PhD    +82-51-240-7957    jlee@pusan.ac.kr    Keimyung University Dongsan Medical Center Not yet recruiting Jung-gu, Daegu, Korea, Republic of Contact: Youchul Kim, MD, PhD    +82-53-250-8026    eyedr@dsmc.or.kr    Kyungpook National University Hospital Not yet recruiting Jung-gu, Daegu, Korea, Republic of Contact: Jae PIl Shin, MD, PhD    +82-53-200-5817    jps11@hanmail.net    Yeungnam University Medical Center Not yet recruiting Nam-gu, Daegu, Korea, Republic of, 705-717 Contact: Min Sagong, MD, PhD    +82-53-620-3443    eyesgm@hotmail.com    Gyeongsang National University Hospital Not yet recruiting Jinju, Gyeongsangnam-do, Korea, Republic of, 660-702 Contact: In Young Chung, MD, PhD    +82-55-750-8728    in0chung@hanmail.net Less <<
NCT02687932 Mitral Valve Insufficiency ... More >> Left Ventricular Dysfunction Less << Phase 4 Completed - Korea, Republic of ... More >> Inha University Hospital Incheon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Samsung Medical Center Seoul, Korea, Republic of Yonsei University Medical Center Seoul, Korea, Republic of Less <<
NCT02833493 - Not yet recruiting October 2019 -
NCT02779257 Gastro-enteropancreatic Neuroe... More >>ndocrine Tumor Less << Phase 4 Withdrawn(Subject passed away ... More >>prior to enrollment) Less << - -
NCT02843490 Neovascular Age-related Macula... More >>r Degeneration Less << Phase 4 Completed - Germany ... More >> Clinical Trial Site, Department of Ophthalmology, University Medical Center Johannes Gutenberg University Mainz Mainz, Germany, 55131 Less <<
NCT02754011 Breast Cancer Phase 1 Recruiting November 2018 France ... More >> Centre Leon Berard Recruiting Lyon, France Contact: Thomas BACHELOT, MD       thomas.bachelot@lyon.unicancer.fr    Principal Investigator: Thomas BACHELOT, MD          Institut de Cancérologie de l'Ouest Recruiting Saint-herblain, France Contact: Mario CAMPONE, MD       mario.campone@ico.unicancer.fr    Principal Investigator: Mario CAMPONE, MD Less <<
NCT02864472 Age-related Macular Degenerati... More >>on Less << Phase 4 Not yet recruiting January 2019 -
NCT02875951 - Unknown December 2017 Belgium ... More >> Katholieke Universiteit Leuven - Clinical Pharmacology and Pharmacotherapeutics Recruiting Leuven, Brabant, Belgium, 3000 Contact: Sandra De Coster, pharmacist    +3216377180    sandra.decoster@pharm.kuleuven.be    Contact: Veerle Foulon, professor    +3216323464    veerle.foulon@pharm.kuleuven.be    Sub-Investigator: Sandra De Coster          Principal Investigator: Veerle Foulon Less <<
NCT02788656 Congestive Heart Failure Not Applicable Recruiting March 2019 United States, Massachusetts ... More >> Brigham and Women's Hospita Recruiting Boston, Massachusetts, United States, 02115 Contact: Lynne Stevenson, MD    617-732-5500    lstevenson@partners.org    Contact: Akshay Desai, MD    917-732-5500    adesai@partners.org Less <<
NCT02838121 Prevention of BMD Loss After T... More >>HR Serum Markers of Bone Turnover Functional Outcomes Less << Phase 3 Completed - Taiwan ... More >> Chang Gung Memorial Hospital Kweishan, Taoyuan, Taiwan, 333 Less <<
NCT02891395 Graft Versus Host Disease Phase 2 Active, not recruiting December 2018 Belgium ... More >> CHU Sart Tilman Liège, Belgium France CHU d'Amiens Amiens, France CHU d'Angers Angers, France CHU Besançon Besancon, France CHU Bordeaux Bordeaux, France Hopital Morvan Brest, France CHU Clémenceau Caen, France HIA de Percy Clamart, France CHU de Clermont Ferrand Clermont Ferrand, France CHU Grenoble Grenoble, France Diseases of Blood Service HURIEZ hospital CHRU de LILLE LIlle, France, 59037 Centre hospitalier et régional de Lille Lille, France CHU de Lyon Lyon, France Institut Paoli Calmettes Marseille, France Hôpital Saint Eloi Montpellier, France CHU Hotel Dieu Nantes, France CHU de Nice Nice, France Hopital NECKER Paris, France Hôpital pitié Salpetrière Paris, France Centre Henri Becquerel Rouen, France CHU de STRASBOURG Strasbourg, France CHU Purpan Toulouse, France Less <<
NCT02854163 Psoriatic Arthritis Phase 2 Active, not recruiting November 1, 2019 United Kingdom ... More >> Aintree University Hospitals NHS Foundation Trust Liverpool, United Kingdom, L9 7AL Less <<
NCT02914626 Glaucoma, Neovascular ... More >> Ranibizumab Less << Phase 3 Unknown October 2018 -
NCT02912754 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 1 Phase 2 Not yet recruiting August 2019 Canada, Ontario ... More >> Sunnybrook Odette Cancer Center Not yet recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Geetha Geetha Yogendran, BSc    416-480-5000 ext 89565    geetha.yogendran@sunnybrook.ca    Contact: Lindsay McCaw, MSc    416-480-6100 ext 4244    lindsay.mccaw@sunnybrook.ca    Principal Investigator: david e spaner, MD          Sunnybrook Odette Cancer Center Toronto, Ontario, Canada, M4N3M5 Less <<
NCT02974803 Melanoma Brai... More >>n Metastases Less << Phase 2 Recruiting June 2020 Canada, Nova Scotia ... More >> QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 1V7 Contact: Robyn J. Macfarlane    902 473-6106       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Elaine McWhirter    905 387-9495 ext 64609       Odette Cancer Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Teresa M. Petrella    416 480-4662       University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Anna Spreafico    416 946-4501 ext 4012       Canada, Quebec Centre hospitalier universitaire de Sherbrooke Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: David Mathieu    819 346-1110 ext 14887       Canada, Saskatchewan Saskatoon Cancer Centre Recruiting Saskatoon, Saskatchewan, Canada, S7N 4H4 Contact: Vijayananda Kundapur    306 655-2740 Less <<
NCT02877212 Immune Thrombocytopenic Purpur... More >>a (ITP) Less << Phase 3 Unknown September 2017 Pakistan ... More >> Armed Forces Bone Marrow Transplant Centre Recruiting Rawalpindi, Punjab, Pakistan, 46000 Contact: Parvez Ahmed, FCPS, MCPS    +92-51-9270076 ext 201    pahmed101@yahoo.com    Contact: Andleeb Hanif, M.Phil    +92-51-9270076 ext 232    andleebhanif123@gmail.com    Principal Investigator: Parvez Ahmed, FCPS, MCPS          Sub-Investigator: Andleeb Hanif, M.Phil          Sub-Investigator: Tariq M Satti, FCPS          Sub-Investigator: Qamar Un Nisa Ch, FCPS          Sub-Investigator: Kamran Mehmood, FCPS Less <<
NCT02976194 Exudative Age-related Macular ... More >>Degeneration Polypoidal Choroidal Vasculopathy Less << Phase 4 Unknown August 2018 Korea, Republic of ... More >> Pusan National University Yangsan Hospital Not yet recruiting Yangsan, Gyeongsangnam-do, Korea, Republic of, 50612 Contact: Ik Soo Byon, MD    +82-55-360-2592    isbyon@naver.com Less <<
NCT02977689 Glioma Phase 2 Withdrawn(Novartis paused all ... More >>study start-up activities due to safety evaluation of IDH305 compound.) Less << April 2020 United States, New York ... More >> Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center New York, New York, United States, 10016 Less <<
NCT03085056 Anaplastic Thyroid Cancer Early Phase 1 Recruiting March 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Eric Sherman, MD    646-888-4234       Contact: David Pfister, MD    646-888-4237       Principal Investigator: Eric Sherman, MD Less <<
NCT02933736 Glioblastoma Multiforme ... More >> Meningioma Less << Early Phase 1 Recruiting April 2019 United States, Arizona ... More >> Barrow Brain and Spine Recruiting Phoenix, Arizona, United States, 85013 Contact: Norissa Honea, RN, PhD    602-406-6267    norissa.honea@dignityhealth.org    Principal Investigator: Nader Sanai, MD Less <<
NCT03149900 - Recruiting October 2018 Germany ... More >> University Clinic Schleswig-Holstein Recruiting Lubeck, Schleswig-Holstein, Germany, 23538 Contact: Diamant Thaci, Prof. Dr.    004945150041601    diamant.thaci@uksh.de Less <<
NCT03248427 Breast Cancer Phase 2 Recruiting May 2019 Spain ... More >> Hospital Clinic de Barcelona Recruiting Barcelona, Spain Contact: Montse Muñoz          Hospital General de Catalunya Recruiting Barcelona, Spain Contact: Xavier González Farré          Hospital Universitari Vall d' Hebron Recruiting Barcelona, Spain Contact: Cristina Saura          Institut Català d'Oncologia l'Hospitalet Not yet recruiting Barcelona, Spain Contact: Juan Miguel Gil          Consorcio Hospitalario Provincial de Castellón Recruiting Castelló, Spain Contact: Eduardo Martínez Dueñas          Hospital San Pedro de Alcántara Recruiting Cáceres, Spain Contact: Santiago Gonzalez          Fundació Privada Hospital Asil de Granollers Not yet recruiting Granollers, Spain Contact: Vanesa Ortega          Centro Integral Oncologico Clara Campal Recruiting Madrid, Spain Contact: Laura García Estevez          Centro Oncológico MD Anderson International España Recruiting Madrid, Spain Contact: Raquel Bratos Lorenzo          Hospital Quirón Madrid Recruiting Madrid, Spain Contact: Lucía González Cortijo          Hospital Rey Juan Carlos Recruiting Madrid, Spain Contact: Sergio Hoyos Simón          Hospital Universitario 12 de octubre Recruiting Madrid, Spain Contact: Eva Ciruelos          Hospital Universitario Fundación de Alcorcón Recruiting Madrid, Spain Contact: Carlos Jara Sánchez          Hospital Universitario Fundación Jiménez Díaz Recruiting Madrid, Spain Contact: Yann Izarzugaza          Hospital Universitari Son Espases Recruiting Palma, Spain Contact: Neus Ferrer Tur          Complexo Hospitalario Universitario de Santiago Recruiting Santiago de Compostela, Spain Contact: Rafael Lopez Lopez          Hospital Virgen del Rocío Recruiting Sevilla, Spain Contact: Alvaro Montaño          Hospital Virgen Macarena Recruiting Sevilla, Spain Contact: Juan Antonio Virizuela Echaburu          Fundación Instituto Valenciano de Oncología Recruiting Valencia, Spain Contact: Joaquin Gavilá          Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain Contact: Begonia Bermejo          Hospital Universitari Arnau de Vilanova de València Recruiting Valencia, Spain Contact: Antonio Llombart Cussac Less <<
NCT00354068 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT03131570 Psoriasis Phase 2 Recruiting October 2020 United States, New York ... More >> The Rockefeller Univesity Recruiting New York, New York, United States, 10065 Contact: Recuitment Specialist    800-782-2737    rucares@rockefeller.edu Less <<
NCT03285412 Breast Cancer Phase 2 Recruiting February 28, 2025 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Aditya Bardia, MD, MPH    617-724-4000    Bardia.Aditya@mgh.harvard.edu    Principal Investigator: Aditya Bardia, MD, MPH          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jaymin Patel, MD    617-667-2100       Principal Investigator: Jaymin Patel, MD Less <<
NCT03008408 Malignant Neoplasms of Female ... More >>Genital Organs Endometrial Carcinoma Less << Phase 2 Recruiting August 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       lmilojev@mdanderson.org Less <<
NCT03292133 Lung Cancer Phase 2 Recruiting March 31, 2025 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Beth Kennedy    617-724-1223    EAKENNEDY@mgh.harvard.edu    Principal Investigator: Zofia Piotrowska, MD Less <<
NCT03294694 Metastatic Hormone-Receptor-Po... More >>sitive (HR+) Breast Cancer HER2-Negative Breast Cancer Metastatic Epithelial Ovarian Cancer Less << Phase 1 Recruiting January 1, 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Aditya Bardia, MD    617-643-2208    abardia1@partners.org    Principal Investigator: Aditya Bardia, MD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Christina Herold, MD    617-632-3800    Christina_Herold@DFCI.HARVARD.EDU    Principal Investigator: Christina Herold, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Christina Herold, MD    617-632-3800    Christina_Herold@DFCI.HARVARD.EDU    Principal Investigator: Christina Herold, MD Less <<
NCT03355794 Diffuse Intrinsic Pontine Glio... More >>ma Malignant Glioma of Brain High Grade Glioma Bithalamic High Grade Glioma Brainstem Glioma Glioblastoma Anaplastic Astrocytoma Less << Phase 1 Recruiting January 1, 2022 United States, District of Col... More >>umbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Eugene Hwang, MD    202-476-5046    ehwang@childrensnational.org    United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Stewart Goldman, MD    312-227-4090    Sgoldman@luriechildrens.org    United States, North Carolina Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: David A Gass, MD    704-381-9900    David.Gass@atriumhealth.org    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Mariko DeWire, MD    513-803-1126    mariko.dewire-schottmiller@cchmc.org    Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Laura Fossett    513-636-9419    Laura.Fossett@cchmc.org    United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Patricia Baxter, MD    832-824-4681    pabaxter@txch.org    United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, MD    206-987-2106    CBDCIntake@seattlechildrens.org Less <<
NCT03307447 Psoriasis Vulgaris Phase 4 Recruiting September 2019 United States, New York ... More >> VA NY Harbor Healthcare System Recruiting Brooklyn, New York, United States, 11209 Contact: Bethanne Wenzel    718-836-6600    Bethanne.wenzel@va.gov    Principal Investigator: Orit Markowitz, MD          Sub-Investigator: Daniel Siegel, MD Less <<
NCT00258271 Leukemia Phase 1 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT03377361 Colorectal Cancer ... More >> Colorectal Tumors Colorectal Carcinoma Colorectal Neoplasm Less << Phase 1 Phase 2 Recruiting November 24, 2022 -
NCT03386071 - - - -
NCT03387475 Myelodysplasia Phase 2 Recruiting June 2020 France ... More >> CHU de GRENOBLE ALPES Recruiting Grenoble, France, 38043 Contact: Sophie PARK    04 76 76 27 77    SPark@chu-grenoble.fr Less <<
NCT03549442 Multiple Myeloma Phase 1 Recruiting May 2021 United States, Pennsylvania ... More >> Univ. of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Alfred Garfall, MD Less <<
NCT03609424 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Not yet recruiting August 30, 2020 -
NCT03358134 Spondylarthropathies Phase 3 Completed - Netherlands ... More >> Academic Medical Center Amsterdam Amsterdam, Noord-Holland, Netherlands, 1105AZ Less <<
NCT03673124 Low Grade Serous Carcinoma Phase 2 Not yet recruiting July 30, 2021 -
NCT00321932 - Completed - -
NCT03595917 B-cell Acute Lymphoblastic Leu... More >>kemia Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL Less << Phase 1 Recruiting November 1, 2024 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Marlise R Luskin, MD          Contact: Jeremy Stewart    617-582-8063    jstewart13@partners.org    Principal Investigator: Marlise Luskin, MD Less <<
NCT00051636 Paget's Disease of Bone Phase 3 Completed - -
NCT00321932 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Osteoporosis Ovarian Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00388505 Cystic Fibrosis Phase 3 Completed - -
NCT00388505 - Completed - -
NCT03455764 Melanoma Phase 1 Phase 2 Recruiting September 30, 2025 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer A Maattala    617-632-3992    jennifera_maattala@dfci.harvard.edu    Principal Investigator: Elizabeth I Buchbinder, MD Less <<
NCT00506415 Alzheimer Disease Phase 3 Completed - -
NCT00051636 - Completed - -
NCT00740129 Paget's Disease of the Bone Phase 4 Completed - Belgium ... More >> Novartis Investigative site Brussels, Belgium Canada Novartis Investigative site Montreal, Canada Novartis Investigative site Quebec, Canada New Zealand Novartis Investigative site Aukland, New Zealand South Africa Novartis Investigative site Cape Town, South Africa Spain Novartis Investigative site Barcelona, Spain Novartis Investigative site Madrid, Spain Novartis Investigative site Salamanca, Spain Novartis Investigative site Valencia, Spain United Kingdom Novartis Investigative site Nottingham, United Kingdom Novartis Investigative site Oxford, United Kingdom Less <<
NCT02232503 - Completed - -
NCT00658333 Renal Transplantation Phase 4 Terminated - -
NCT01778062 Patients With Moderate-to-seve... More >>re COPD With Destroyed Lung by Tuberculosis Less << Phase 3 Completed - Korea, Republic of ... More >> Novartis Investigative Site Anyang-si, Gyeonggi-do, Korea, Republic of, 431-070 Novartis Investigative Site Koyang-si, Gyeonggi-do, Korea, Republic of, 410-773 Novartis Investigative Site Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Incheon, Korea, Republic of, 405-760 Novartis Investigative Site Seoul, Korea, Republic of, 110-102 Novartis Investigative Site Seoul, Korea, Republic of, 130-872 Novartis Investigative Site Seoul, Korea, Republic of, 143-729 Novartis Investigative Site Seoul, Korea, Republic of, 150-713 Novartis Investigative Site Seoul, Korea, Republic of, 152-703 Less <<
NCT02161562 Chronic Spontaneous Urticaria Phase 3 Completed - -
NCT00658333 - Terminated - -
NCT00506415 - Completed - -
NCT01469884 Renal Allograft ... More >> Hepatitis C Less << Phase 4 Completed - Brazil ... More >> Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande Do Sul, Brazil, 90020090 Less <<
NCT01469572 Neuroendocrine Tumors Phase 1 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01778062 - Completed - -
NCT01485536 Lymphoma Phase 2 Terminated(Study halted early ... More >>due to limited response.) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01490749 Esophageal Cancer ... More >> Neoplasms, Esophageal Less << Phase 1 Active, not recruiting May 2020 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01506596 Liposarcoma S... More >>urgically Unresectable Liposarcoma Metastatic Liposarcoma Less << Phase 2 Completed - United States, California ... More >> Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, District of Columbia Washington Cancer Institute Washington, District of Columbia, United States, 20010 United States, Idaho Kootenai Cancer Center Post Falls, Idaho, United States, 83854 United States, Illinois Oncology Specialists, SC Niles, Illinois, United States, 60714 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee West Clinic Memphis, Tennessee, United States, 38120 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02161562 - Completed - -
NCT01506596 - Completed - -
NCT01513356 Breast Cancer Early Phase 1 Completed - Spain ... More >> Hospital Madrid Norte Sanchinarro- CIOCC Madrid, Spain, 28050 Less <<
NCT01485536 - Terminated(Study halted early ... More >>due to limited response.) Less << - -
NCT01508104 Cancer Phase 1 Terminated(funding) - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267-0502 Less <<
NCT01515020 Nosocomial Infection ... More >> Healthcare-associated Infection Less << Phase 3 Terminated(lack of inclusion) - France ... More >> Hopital Beaujon Clichy cedex, France, 92118 Less <<
NCT01496534 Solid Tumors ... More >>Bladder Cancer Less << Phase 1 Terminated(toxicity of combina... More >>tion of medications) Less << - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT01523977 Acute Lymphoblastic Leukemia Phase 1 Active, not recruiting November 2018 United States, California ... More >> UCSF San Francisco, California, United States, 94143 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center New York, New York, United States, 12549 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT01528501 Metastatic Gastric Cancer Phase 2 Terminated(medical/ethical rea... More >>sons) Less << - Germany ... More >> Klinikum rechts der Isar Munic, Bavaria, Germany, 81675 Universitätsklinikum Mannheim Mannheim, Germany, 68167 Less <<
NCT01532700 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 2 Completed - Canada, Ontario ... More >> University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01529450 Basal Cell Carcinoma Not Applicable Completed - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT01529450 - Completed - -
NCT01559025 Type 1 Diabetes ... More >> Insulin Dependent Diabetes Juvenile Onset Diabetes Mellitus Autoimmune Diabetes Less << Phase 3 Unknown March 2017 Brazil ... More >> Federal University of São Paulo Recruiting São Paulo, Brazil, 04022-001 Contact: Tatiana Valente    55119614616    valentetati@yahoo.com.br    Contact: Sergio Dib    551197397776    sergio.dib@unifesp.br    Sub-Investigator: Monica Gabbay Less <<
NCT01550380 Endometrial Cancer Phase 2 Withdrawn - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01551030 Metastatic Transitional Cell C... More >>arcinoma of the Urothelium Less << Phase 2 Active, not recruiting March 2019 United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT01566747 Renal Cell Carcinoma Phase 2 Active, not recruiting September 2018 Ireland ... More >> Beaumont Hospital Dublin, Leinster, Ireland Mater Misericordiae University Hospital Dublin, Leinster, Ireland Mater Private Hospital Dublin, Leinster, Ireland Cork University Hospital Cork, Ireland The Adelaide & Meath Hospital Dublin incorporating the National Children's Hospital Dublin, Ireland Galway University Hospital Galway, Ireland Mid-Western Regional Hospital Limerick, Ireland Waterford Regional Hospital Waterford, Ireland Sweden Karolinska University Hospital Stockholm, Sweden Less <<
NCT01570296 Non-Small Cell Lung Cancer ... More >> Solid Tumors Less << Phase 1 Active, not recruiting April 2019 Singapore ... More >> National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT01564108 Uveitis Related Cystoid Macula... More >>r Edema Steroid-induced Glaucoma - Borderline Less << Phase 2 Completed - United Kingdom ... More >> Moorfields Eye Hospital NHSFT Research and Treatment Centre London, United Kingdom, EC1V 2PD Less <<
NCT01595984 Kidney Failure Phase 3 Active, not recruiting August 2018 France ... More >> Nephrology department, Hospital University of Amiens Amiens, France, 80000 Nephrology Department, University Hospital of Montpellier Montpellier, France, 34285 Less <<
NCT01609673 End Stage Renal Failure With R... More >>enal Transplant Less << Not Applicable Terminated(The inclusion of pr... More >>oposed sample turned to be infeasible due to Ethical Non-approval of 2 research sites and another site no transplant activity since 2012.) Less << - Brazil ... More >> Hospital São João de Deus/Fundação Geraldo Corrêa Divinópolis, MG, Brazil, 35500-227 Hospital Márcio Cunha/Fundação São Francisco Xavier Ipatinga, MG, Brazil, 35160-158 Fundação IMEPEN Juiz de Fora, MG, Brazil, 36036-330 Hospital do Rim de MOntes Claros/Irmandade Nossa Senhora das Mercês Montes Claros, MG, Brazil, 39400-103 Less <<
NCT01616186 Locally Metastatic Malignant N... More >>eoplasm Less << Phase 2 Withdrawn April 2016 -
NCT01562847 - Unknown June 2015 Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT01630824 Chronic Kidney Disease Not Applicable Unknown - Germany ... More >> Department of Nephrology, University of Jena Recruiting Jena, Thuringia, Germany, 07749 Contact: Claudia Schinkoethe    004936419324623    claudia.schinkoethe@med.uni-jena.de Less <<
NCT01610206 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 2 Active, not recruiting December 31, 2018 United States, Maine ... More >> Maine Medical Center (MMP Women's Health) Scarborough, Maine, United States, 04074 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Oklahoma Stephenson Cancer Center University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Texas MD Anderson Houston, Texas, United States, 77030 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 Virginia Commonwealth University Richmond, Virginia, United States, 23298 United States, Wisconsin University of Wisconsin-Madison Madison, Wisconsin, United States, 53792 Less <<
NCT01637090 - Terminated(Poor enrollment) - -
NCT01637090 Cutaneous T-Cell Lymphoma Phase 2 Terminated(Poor enrollment) - United States, Massachusetts ... More >> Boston Medical Center Boston, Massachusetts, United States, 02118 Less <<
NCT01653041 Kidney Transplantation Phase 4 Completed - Brazil ... More >> Hospital do Rim e Hipertensão São Paulo, Brazil, 04038-002 Less <<
NCT01472796 Hypertension Phase 4 Unknown March 2014 United States, Michigan ... More >> Wayne State University, 4201 St. Antoine Recruiting Detroit, Michigan, United States, 48201 Contact: Carol A Muzyk, CCRP    313-745-2378    cmuzyk@med.wayne.edu    Contact: Donna Ford    888-235-5467       Principal Investigator: John M Flack, M.D., M.P.H. Less <<
NCT01666236 Choroidal Neovascularization ... More >> Retinal Pigment Epithelial Detachment Less << Phase 4 Withdrawn(Lack of resources) September 2014 Brazil ... More >> Universidade Federal de São Paulo - Escola Paulista de Medicina São Paulo, SP, Brazil, 04038-034 Less <<
NCT01648465 Gastrointestinal Tumors ... More >> Pancreatic Tumors Gastrointestinal Neuroendocrine Tumors Pancreatic Neuroendocrine Tumors Less << Phase 2 Active, not recruiting September 2018 Greece ... More >> 2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital Athens, Greece, 11522 Dept of Medical Oncology, 251 General Airforce Hospital Athens, Greece, 11525 2nd Dept of Internal Medicine, General Hospital of Athens "Hippokratio" Athens, Greece, 11527 2nd Dept of Internal Medicine, Propaedeutic, University Hospital "Attikon" Athens, Greece, 12462 4th Dept of Internal Medicine, University Hospital "Attiko" Athens, Greece, 12462 3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital Athens, Greece, 14564 2nd Dept of Medical Oncology, Metropolitan Hospital Athens, Greece, 18547 Dept of Medical Oncology, University Hospital of Heraklion Heraklion, Greece, 71110 Dept of Medical Oncology, Ioannina University Hospital Ioannina, Greece, 45110 Division of Oncology, Dept of Internal Medicine, University Hospital of Patras Patra, Greece, 26504 Dept of Medical Oncology, Papageorgiou General Hospital Thessaloniki, Greece, 56429 Dept of Medical Oncology, Thermi Clinic Thessaloniki, Greece, 57001 Less <<
NCT01668173 - Terminated(patient safety) - -
NCT01668173 Myeloproliferative Neoplasms Phase 2 Terminated(patient safety) - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01681199 Coronary Heart Disease ... More >> Atherosclerosis Less << Phase 4 Unknown August 2014 China, Beijing ... More >> Cardiology department ,Beijing Anzhen hospital Recruiting Beijing, Beijing, China, 100029 Contact: Xin Du, PhD    86 15010519643    duxinheart@sina.com    Sub-Investigator: Xin Du, PhD Less <<
NCT01642017 Metastatic Cancer (Different S... More >>olid Tumour Types) Less << Phase 1 Terminated(Slow recruitment ra... More >>te) Less << - France ... More >> Hôpital Saint André Bordeaux, France, 33075 Centre François BACLESSE Caen, France, 14076 Centre Léon BERARD Lyon, France, 69008 Institut Claudius REGAUD Toulouse, France, 31052 Less <<
NCT01693003 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - Brazil ... More >> Pavilhão Pereira Filho Porto Alegre, Rio Grande do Sul, Brazil, 90002-090 Pavilhão Pereira Filho Porto Alegre, RS, Brazil Less <<
NCT01593748 Sarcoma Phase 2 Active, not recruiting April 2, 2019 United States, Arizona ... More >> The University of Arizona Cancer Center Tucson, Arizona, United States United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Iowa University of Iowa Hospitals & Clinics Iowa City, Iowa, United States United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21218 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University at St. Louis Saint Louis, Missouri, United States, 63130 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01676714 Non-Small Cell Lung Cancer ... More >> Colorectal Cancer Less << Phase 2 Completed - United States, California ... More >> University of California Comprehensive Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01676714 - Completed - -
NCT01695473 High Risk Prostate Cancer Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT01712581 Normal Myocardial T1, T2 and T... More >>2* Values Less << Not Applicable Completed - France ... More >> Rouen University Hospital Rouen, France, 76031 Less <<
NCT01703169 Severe Aplastic Anemia ... More >> Very Severe Aplastic Anemia Moderate Aplastic Anemia Less << Phase 2 Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT01703169 - Completed - -
NCT01705132 - Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01718366 MDS Phase 1 Phase 2 Active, not recruiting February 2019 Belgium ... More >> GENT Gent, Belgium, 9000 France Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 Centre Hospitalier de Boulogne sur Mer Boulogne sur Mer, France CHU Le Mans Le MANS, France Hôpital Saint Vincent de Paul Lille, France, 59020 CHU Limoges Limoges, France, 87042 CHU Brabois Nancy, France, 54511 CHU Nantes Nantes, France, 44093 Centre Catherine de Sienne Nantes, France Hôpital saint Louis Paris, France, 75010 Hôpital cochin Paris, France, 75679 Hôpital Necker Paris, France, 75743 CHU Poitiers Poitiers, France, 86021 IUCT Oncopole Toulouse Toulouse, France Less <<
NCT01714765 Metastatic Clear Cell Renal Ca... More >>ncer Less << Phase 1 Completed - United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom, EC1M 7BE Less <<
NCT01719549 Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01719302 Stage III Adult Soft Tissue Sa... More >>rcoma Less << Phase 1 Phase 2 Completed - United States, Vermont ... More >> Fletcher Allen Health Care Burlington, Vermont, United States, 05401 Less <<
NCT01764841 Bronchiectasis Phase 3 Completed - -
NCT01768338 Non-Hodgkin's Lymphoma Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01788176 Complex Regional Pain Syndrome... More >>s Less << Phase 2 Unknown December 2016 Brazil ... More >> Centro de Pesquisa Clínica do Instituto de Medicina e Reabilitação do HCFMUSP Not yet recruiting São Paulo, Brazil, 05716-150 Contact: Pérola G Plapler, MDPhD    55 11 39058512    perolagp@yahoo.com    Contact: Marta Imamura, MDPhD    55 11 39058512    martaimf3@gmail.com    Principal Investigator: Pérola G. Plapler, MDPhD Less <<
NCT01764841 - Completed - -
NCT01797120 Metastatic Breast Cancer Phase 2 Completed - -
NCT01811290 - Active, not recruiting December 2018 United States, Washington ... More >> MS Center at Evergreen Health Kirkland, Washington, United States, 98034 Less <<
NCT01797120 - Completed - -
NCT01822483 Renal Transplantation Phase 4 Completed - Brazil ... More >> Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90020090 Less <<
NCT01830153 Soft Tissue Sarcomas ... More >> Bone Sarcomas Less << Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Asan Medical Center, University of Ulsan College of Medicine Seoul, N/A = Not Applicable, Korea, Republic of, 138-736 Yeongnam University College of Medicine Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of, 301-721 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Yonsei Cancer Center Seoul, Korea, Republic of, 120-752 Korea University Seoul, Korea, Republic of, 126-1 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01773460 Metastatic Breast Cancer Phase 3 Terminated(Study was stopped t... More >>erminated early due to low recruitment.) Less << - Germany ... More >> Klinikum Offenbach Offenbach, Hessen, Germany, 63069 Less <<
NCT01832259 Adenocarcinoma of the Prostate Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01856101 Carcinoma Transitional Cell Phase 2 Terminated(Novartis decided to... More >> stop the marketing of BEZ235) Less << - Belgium ... More >> Clinique Saint-Pierre à Ottignies Ottignies, Brabant Wallon, Belgium, 1340 Epicura- RHMS Baudour Baudour, Hainaut, Belgium, 7331 Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 Hôpital de Jolimont Haine-Saint-Paul, Hainaut, Belgium, 7100 Centre Hospitalier Wallonie Picarde Tournai, Hainaut, Belgium, 7500 CHU de Liège site du Sart Tilman Liège 1, Liège, Belgium, 4000 Clinique du Sud Luxembourg Arlon, Luxembourg, Belgium, 6700 CHU de Mont-Godinne Yvoir, Namur, Belgium, 5530 Cliniques universitaires Saint-Luc Brussel, Belgium, 1200 Universitair Ziekenhuis Gent Gent, Belgium, 9000 Clinique et Maternité Ste Elisabeth Namur, Belgium, 5000 Luxembourg Centre Hospitalier de Luxembourg Luxembourg, Grand-Duché de Luxembourg, Luxembourg, 1210 Less <<
NCT01871311 Colorectal Cancer ... More >> Head and Neck Cancer Less << Phase 1 Recruiting June 2019 United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Lisa Ley, RN    202-687-6653    leyl@georgetown.edu    Contact: Ann W Gramza, MD       ann.w.gramza@gunet.georgetown.edu    Principal Investigator: Ann W Gramza, MD Less <<
NCT01759303 Osteosarcoma ... More >>Metastatic Osteosarcoma Less << Phase 2 Terminated(low accrual) - United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Massachusetts Massachusetts General Hospital/Dana Farber Cancer Institute Boston, Massachusetts, United States, 02114 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01877005 Hodgkin's Lymphoma Phase 2 Completed - Belgium ... More >> UCL Louvain St Luc Brussels, Belgium, 10200 Université Catholique de Louvain Mont Godinne Yvoir, Belgium, 5530 France Chu Cote de Nacre Caen, France, 14000 Hopital Henri Mondor Creteil, France, 94010 Chu Dijon Dijon, France, 21000 Chru de Lille Lille, France, 59037 Centre Leon Berard Lyon, France, 69373 Centre Hospitalier Lyon Sud Lyon, France, 69495 CHU de Nantes, Hotel Dieu Nantes, France, 44093 Centre Henri Becquerel Rouen, France, 76038 Less <<
NCT01880047 Immune Thrombocytopenia ... More >> Platelet Disorder Less << Phase 2 Active, not recruiting March 30, 2019 United States, New York ... More >> Weill Cornell Medicine New York, New York, United States, 10065 Less <<
NCT01885247 - Unknown December 2016 France ... More >> Hospices Civils de Lyon Recruiting Lyon, France, 69004 Principal Investigator: Gilles DEVOUASSOUX, MD Less <<
NCT01886287 Neuroendocrine Carcinoma Phase 2 Terminated(Slow accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01886287 - Terminated(Slow accrual) - -
NCT01888965 Colorectal Cancer ... More >> Pancreas Cancer Less << Phase 2 Terminated(Adverse Event issue... More >>s.) Less << - United States, District of Col... More >>umbia Georgetown University- Lombardi Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT01888965 - Terminated(Adverse Event issue... More >>s.) Less << - -
NCT01889420 - Terminated(Low accrual) - -
NCT01892644 Hemochromatosis ... More >> Myelodysplastic Syndromes Less << Phase 2 Terminated(Failure to recruit ... More >>patients with hemochromatosis to the Deferasirox arm) Less << - Norway ... More >> Haukeland University Hospital, Clinical Trial Unit Bergen, Norway, 5021 Less <<
NCT01911871 - Completed - France ... More >> Hôpital Necker Enfants Malades Paris, France, 75015 Less <<
NCT01948960 Breast Neoplasms Phase 4 Completed - Netherlands ... More >> Maasziekenhuis Pantein Boxmeer, Netherlands Spaarne Gasthuis Hoofddorp, Netherlands Maastricht University Medical Center Maastricht, Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands Radboud university medical center Nijmegen, Netherlands Bernhoven Ziekenhuis Uden, Netherlands Isala Klinieken Zwolle, Netherlands Less <<
NCT01914484 Chronic Phase Chronic Myeloid ... More >>Leukemia Accelerated Phase Chronic Myeloid Leukemia Blastic Phase Chronic Myeloid Leukemia Philadelphia Positive Acute Lymphoblastic Leukemia Resistant to Tyrosine Kinase Inhibitor Therapy Less << Phase 1 Phase 2 Unknown July 2016 Canada, Ontario ... More >> Princess Margaret Hospital / University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Sima Bogomilsky, RN BScN CON(C)    416-946-4646    sima.bogomilsky@uhn.on.ca    Contact: Sonal Malhotra, M.Sc., Ph.D,CCRP    416-946-4501 ext 3449    sonal.malhotra@uhn.ca    Principal Investigator: Dennis Kim, MD/PhD          Sub-Investigator: Jeffrey H Lipton, MD/PhD Less <<
NCT01954693 Tuberous Sclerosis Phase 2 Active, not recruiting August 6, 2018 United Kingdom ... More >> Cardiff University Cardiff, United Kingdom, CF14 4YS Less <<
NCT01965353 Multiple Myeloma in Relapse Phase 1 Active, not recruiting December 2019 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01968616 Macular Edema Due to BRVO/CRVO Not Applicable Recruiting September 2019 Japan ... More >> Department of Ophthalmology, Kyoto University Hospital Recruiting Kyoto, Japan Contact: Nagahisa Yoshimura, MD, PhD    +81-75-751-3248    nagaeye@kuhp.kyoto-u.ac.jp    Contact: Akitaka Tsujikawa, MD. PhD    +81-75-751-3250    tujikawa@kuhp.kyoto-u.ac.jp    Principal Investigator: Nagahisa Yoshimura, M.D, PhD Less <<
NCT01973660 Breast Cancer Phase 2 Completed - Spain ... More >> Hospital de Torrevieja Torrevieja, Alicante, Spain Institut Català d'Oncologia Hospitalet Hospitalet de Llobregat, Barcelona, Spain Hospital Mutua de Terrassa Terrassa, Barcelona, Spain Consorcio Hospitalario Provincial de Castellón Castelló de la Plana, Castellón, Spain Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, Galicia, Spain Hospital Son Llàtzer Palma de Mallorca, Islas Baleares, Spain Hospital Universitario Son Espases Palma de Mallorca, Islas Baleares, Spain Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain Hospital Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain Hospital Universitario Sant Joan de Reus Reus, Tarragona, Spain Hospital Luis Alcanyís de Xàtiva Xàtiva, Valencia, Spain, 46800 Hospital Universitario Infanta Cristina Badajoz, Spain, 06071 Vall d'Hebron University Hospital Barcelona, Spain, 08035 Hospital Clínic de Barcelona Barcelona, Spain Instituto Dexeus Barcelona, Spain Hospital San Pedro de Alcántara Cáceres, Spain, 10003 Hospital Universitario Arnau de Vilanova de Lleida Lleida, Spain Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Clínico San Carlos Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain Hospital Clínico Universitario de Valencia Valencia, Spain Hospital Universitario Arnau de Vilanova de Valencia Valencia, Spain Less <<
NCT01994590 Prostate Cancer Phase 2 Terminated(Sponsor stopped sup... More >>plying study drug) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01889420 Multiple Myeloma in Relapse Phase 1 Terminated(Low accrual) - United States, New Mexico ... More >> UNM Cancer Research and Treatment Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT02021162 - Active, not recruiting October 2018 United States, New York ... More >> Buffalo Neuroimaging Analysis Center Buffalo, New York, United States, 14203 Less <<
NCT01832259 - Completed - -
NCT02024737 - Completed - United Kingdom ... More >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom, S10 2JF Less <<
NCT02027376 Advanced Breast Cancer Phase 1 Completed - Spain ... More >> Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28007 Hospital Clínico Universitario San Carlos Madrid, Spain, 28040 Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41071 Less <<
NCT01799486 HBV-related Liver Cirrhosis Phase 4 Unknown March 2015 -
NCT02027376 - Completed - -
NCT01976390 Renal Failure Not Applicable Active, not recruiting May 2018 United States, Ohio ... More >> The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43212 Less <<
NCT02035124 Advanced Prostate Cancer Phase 2 Withdrawn(Study withdrawn due ... More >>to slow accrual. No patients were enrolled.) Less << - United States, Florida ... More >> Florida Cancer Specialists-South Ft. Myers, Florida, United States, 33916 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Tennessee Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Less <<
NCT02032810 Melanoma Skin... More >> Cancer Less << Phase 1 Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02015208 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Sunnybrook Odette Cancer Center Toronto, Ontario, Canada, M4N3M5 Less <<
NCT02028364 Breast Cancer Phase 2 Active, not recruiting January 2020 Belgium ... More >> institut Jules Bordet Bruxelles, Belgium, 1000 Cliniques Universtaires Saint-Luc Bruxelles, Belgium, 1200 UZ Leuven Leuven, Belgium, 3000 CHU Ambroise Paré Mons, Belgium, 7000 Clinique et Maternité Sainte Elisabeth Namur, Belgium, 5000 Less <<
NCT02036554 Kidney; Complications, Allogra... More >>ft Less << Phase 4 Unknown December 2015 Korea, Republic of ... More >> division of nephrology;Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Chul Woo Yang    82-2-2258-6851    yangch@catholic.ac.kr Less <<
NCT02049294 Steroid and/or Prednisone Depe... More >>ndent Asthma Eosinophilic Bronchitis Less << Phase 2 Phase 3 Completed - Canada, Alberta ... More >> Richard Leigh Calgary, Alberta, Canada Canada, British Columbia University of British Columbia Vancouver, British Columbia, Canada Canada, Ontario McMaster University Hamilton, Ontario, Canada Canada, Quebec University of Laval Laval, Quebec, Canada University of Montreal Montreal, Quebec, Canada Less <<
NCT02055911 Diabetic Macular Edema Phase 4 Withdrawn July 2015 Brazil ... More >> Dept of Ophthalmology - UNIFESP/Hospital São Paulo São Paulo, SP, Brazil, 04023-062 Less <<
NCT02059772 Diabetic Macular Edema Phase 4 Active, not recruiting December 31, 2017 Germany ... More >> Klinik für Augenheilkunde, Klinikum Chemnitz gGmbH Chemnitz, Germany, 09116 Less <<
NCT02061137 Rett's Syndrome Phase 1 Phase 2 Completed - Switzerland ... More >> Department of Neuropediatrics - University Children's Hospital Basel, Switzerland, 4056 Less <<
NCT02086487 Myeloid Leukemia, Chronic Phase 4 Terminated(Because of many uns... More >>een obstacles resulted in poor accrual, study is terminated.) Less << - Saudi Arabia ... More >> National Guard Hospital Riyadh, Central, Saudi Arabia, 11426 King Fahad specialist Hospital Dammam, Eastern, Saudi Arabia Less <<
NCT02093325 Solid Tumor Phase 3 Enrolling by invitation August 2019 Taiwan ... More >> Department of Obstetrics & Gynecology and Department of Oncology Chang Gung Memorial Hospital Chiayi City, Taiwan Department of Obstetrics & Gynecology Chang Gung Memorial Hospital Kaohsiung, Taiwan Division of Gynecologic Oncology, Department of Obstetrics & Gynecology and Division of Oncology Chang Gung Memorial Hospital Linkou, Taiwan Less <<
NCT02106832 Bronchiectasis Phase 3 Completed - -
NCT02038816 Myelodysplastic Syndromes Phase 2 Terminated(accrual too slow, i... More >>nsufficient patients) Less << - Canada, Ontario ... More >> Odette Cancer Centre, Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT02106832 - Completed - -
NCT02086513 Graft Versus Host Disease Phase 1 Terminated - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT02137707 - Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z3 Canada, Nova Scotia Dalhousie University Multiple Sclerosis Research Unit Halifax, Nova Scotia, Canada Canada, Ontario Ottawa General Hospital Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Clinique Neuro Rive-Sud Greenfield Park, Quebec, Canada Montreal Neurological Institute Montreal, Quebec, Canada, H3A 2B4 Centre hospitalier de l'Universite de Montreal (CHUM) Montréal, Quebec, Canada Less <<
NCT02141022 Multiple Sclerosis ... More >> Cognitive Deficits Gilenya Modifying Therapy for MS Less << Not Applicable Completed - United States, New York ... More >> Stony Brook University Stony Brook, New York, United States, 11794 Less <<
NCT02145611 Type 2 Diabetes Mellitus ... More >> Hypertension Endothelial Dysfunction Less << Phase 4 Completed - Brazil ... More >> Fundação Faculdade Regional de Medicina de São José do Rio Preto São José do Rio Preto, São Paulo, Brazil, 15090-000 Less <<
NCT02134899 Autosomal Dominant Polycystic ... More >>Kidney Disease Less << Phase 3 Completed - France ... More >> Bicêtre Hospital Le Kremlin-Bicêtre, France, 94275 Less <<
NCT02152943 Breast Cancer ... More >> Solid Tumors Less << Phase 1 Recruiting July 1, 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02155088 Pancreatic Cancer Phase 1 Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02049541 Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Active, not recruiting December 31, 2018 United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02176681 Haemodialyzed, Type 2 Diabetes Phase 4 Completed - France ... More >> CH d'Amiens Amiens, France, 80054 CH de Besançon Besancon, France, 25030 AURAL Colmar Colmar, France, 68000 Hospices civils de Colmar Colmar, France, 68024 CH de Dijon Dijon, France, 21079 AURAL Mulhouse Mulhouse, France, 68070 CH de Mulhouse Mulhouse, France, 68070 CH de Nancy Nancy, France, 54000 AURAL Clinique Sainte Anne Strasbourg, France, 67000 Clinique Sainte Anne Strasbourg, France, 67000 Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 AURAL Strasbourg Strasbourg, France, 67200 CH de Valenciennes Valenciennes, France, 59300 Less <<
NCT00154219 Osteoarthritis, Hip Phase 3 Completed - United States, New Jersey ... More >> For US Site Information, contact Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Canada Various Sites Multiple Cities, Canada Germany Various Sites Multiple Cities, Germany Italy Various Sites Multiple Cities, Italy United Kingdom Various Sites Multiple Cities, United Kingdom Less <<
NCT02268526 HCMV Phase 2 Completed - United States, California ... More >> Novartis Investigative Site San Francisco, California, United States, 94143 United States, Florida Novartis Investigative Site Gainesville, Florida, United States, 32610 United States, Indiana Novartis Investigative Site Beech Grove, Indiana, United States, 46107 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Wuerzburg, Germany, 97070 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Republic of, 06591 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Novartis Investigative Site Singapore, Singapore, 169608 Taiwan Novartis Investigative Site New Taipei, Taiwan, 33305 Novartis Investigative Site Taichung, Taiwan, 40447 Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT02329223 Chronic Spontaneous Uriticaria Phase 3 Completed - Japan ... More >> Novartis Investigative Site Toyoake-city, Aichi, Japan, 470-1192 Novartis Investigative Site Hiroshima-city, Hiroshima, Japan, 734-8551 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Nishinomiya-city, Hyogo, Japan, 663-8186 Novartis Investigative Site Hitachi-city, Ibaraki, Japan, 317-0077 Novartis Investigative Site Takamatsu-city, Kagawa, Japan, 760-0017 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 213-8507 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 221-0825 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 231-0868 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 236-0004 Novartis Investigative Site Yokosuka-city, Kanagawa, Japan, 238-8558 Novartis Investigative Site Kamimashi-gun, Kumamoto, Japan, 861-3101 Novartis Investigative Site Nagano-city, Nagano, Japan, 381-8551 Novartis Investigative Site Osaka-city, Osaka, Japan, 532-0003 Novartis Investigative Site Sakai-city, Osaka, Japan, 593-8324 Novartis Investigative Site Saitama-city, Saitama, Japan, 330-0854 Novartis Investigative Site Izumo-city, Shimane, Japan, 693-8501 Novartis Investigative Site Kodaira-city, Tokyo, Japan, 187-8510 Novartis Investigative Site Machida-city, Tokyo, Japan, 194-0013 Novartis Investigative Site Meguro-ku, Tokyo, Japan, 153-8515 Novartis Investigative Site Minato-ku, Tokyo, Japan, 107-6206 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-8625 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 161-8521 Novartis Investigative Site Kofu-city, Yamanashi, Japan, 400-8506 Korea, Republic of Novartis Investigative Site Wonju, Gangwon, Korea, Republic of, 220-701 Novartis Investigative Site Hwaseong-si, Gyeonggi-do, Korea, Republic of, 445-170 Novartis Investigative Site Suwon, Gyeonggi-do, Korea, Republic of, 443-380 Novartis Investigative Site Seongnam, Gyeonggi, Korea, Republic of, 13620 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06591 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 152-703 Novartis Investigative Site Busan, Korea, Republic of, 602-715 Novartis Investigative Site Daegu, Korea, Republic of, 705-703 Novartis Investigative Site Gwangju, Korea, Republic of, 501-757 Novartis Investigative Site Incheon, Korea, Republic of, 405-760 Novartis Investigative Site Seoul, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 130-872 Novartis Investigative Site Seoul, Korea, Republic of, 156-755 Less <<
NCT02268526 - Completed - -
NCT02333331 Sarcopenia Phase 2 Completed - -
NCT02336425 Asthma Phase 2 Terminated(This study was term... More >>inated due to the efficacy results from an interim analysis (at the end of treatment epoch) of the Phase II study CQGE031B2201 (NCT01716754).) Less << - -
NCT02956200 Stroke Inflam... More >>mation Less << Phase 2 Unknown December 2018 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Hangzhou, Zhejiang, China, 310000 Less <<
NCT02098161 Leukemia Phase 2 Recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02336425 - Terminated(This study was term... More >>inated due to the efficacy results from an interim analysis (at the end of treatment epoch) of the Phase II study CQGE031B2201 (NCT01716754).) Less << - -
NCT02362789 Psoriasis Phase 3 Completed - Germany ... More >> Novartis Investigative Site Bad Bentheim, Germany, 48455 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44803 Novartis Investigative Site Dippoldiswalde-Schmiedeberg, Germany, 01744 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Gelsenkirchen, Germany, 45883 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Hamburg, Germany, 22391 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Leipzig, Germany, 04105 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Osnabruck, Germany, 49074 Novartis Investigative Site Selters, Germany, 56242 Novartis Investigative Site Stuttgart, Germany, 70176 Novartis Investigative Site Stuttgart, Germany, 70178 Less <<
NCT02371629 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 4 Completed - -
NCT02394561 Plaque Type Psorisis Phase 3 Completed - Italy ... More >> Novartis Investigative Site Milano, (mi), Italy, 20161 Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site L'Aquila, AQ, Italy, 67100 Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bergamo, BG, Italy, 24127 Novartis Investigative Site Benevento, BN, Italy, 82100 Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Brindisi, BR, Italy, 72100 Novartis Investigative Site Brescia, BS, Italy, 25123 Novartis Investigative Site Cagliari, CA, Italy, 09124 Novartis Investigative Site Chieti, CH, Italy, 66100 Novartis Investigative Site Catania, CT, Italy, 95123 Novartis Investigative Site Catanzaro, CZ, Italy, 88100 Novartis Investigative Site Firenze, FI, Italy, 50122 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Grosseto, GR, Italy, 58100 Novartis Investigative Site Lecce, LE, Italy, 73100 Novartis Investigative Site Terracina, LT, Italy, 04019 Novartis Investigative Site Lucca, LU, Italy, 55100 Novartis Investigative Site Macerata, MC, Italy, 62100 Novartis Investigative Site Messina, ME, Italy, 98158 Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site San Donato Milanese, MI, Italy, 20097 Novartis Investigative Site Mantova, MN, Italy, 46100 Novartis Investigative Site Modena, MO, Italy, 41124 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Perugia, PG, Italy, 06100 Novartis Investigative Site Pisa, PI, Italy, 56124 Novartis Investigative Site Parma, PR, Italy, 43100 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Reggio Emilia, RE, Italy, 42123 Novartis Investigative Site Roma, RM, Italy, 00133 Novartis Investigative Site Roma, RM, Italy, 00144 Novartis Investigative Site Roma, RM, Italy, 00161 Novartis Investigative Site Roma, RM, Italy, 00167 Novartis Investigative Site Roma, RM, Italy, 00168 Novartis Investigative Site Roma, RM, Italy, 00189 Novartis Investigative Site Siena, SI, Italy, 53100 Novartis Investigative Site Torino, TO, Italy, 10126 Novartis Investigative Site Erice, TP, Italy, 91016 Novartis Investigative Site Terni, TR, Italy, 05100 Novartis Investigative Site Trieste, TS, Italy, 34129 Novartis Investigative Site Udine, UD, Italy, 33100 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Napoli, Italy, 80131 Less <<
NCT02421172 Hidradenitis Suppurativa (Acne... More >> Inversa) Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90045 United States, Florida Novartis Investigative Site Ormond Beach, Florida, United States, 32174 Novartis Investigative Site Tampa, Florida, United States, 33609 United States, Georgia Novartis Investigative Site Atlanta, Georgia, United States, 30342 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46256 United States, Maryland Novartis Investigative Site Rockville, Maryland, United States, 20850 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 United States, Nebraska Novartis Investigative Site Omaha, Nebraska, United States, 68144 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37215 Denmark Novartis Investigative Site Roskilde, Denmark, 4000 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Bochum, Germany, 44791 Netherlands Novartis Investigative Site Groningen, Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Switzerland Novartis Investigative Site Basel, Switzerland Novartis Investigative Site Zurich, Switzerland, CH-8091 Less <<
NCT02174445 Chronic Myeloid Leukemia Phase 3 Suspended(very slow recruitmen... More >>t rate and a lot of pat. didn't fulfil BCR-ABL requirements) Less << June 2019 Germany ... More >> Universitätsklinikum Aachen Aachen, Germany, 52074 Praxis Dr. Bruder / Dr. Heinrich / Prof. Bangerter Augsburg, Germany, 86150 Universitätsklinikum Bonn Bonn, Germany, 53105 Gemeinschaftspraxis Dresden, Germany, 01307 Praxis Dr. Hauch Erfurt, Germany, 99084 Internistische Schwerpunktpraxis Erlangen oncosearch Erlangen, Germany, 91052 Praxis für Hämatologie/Onkologie Dres. Rudolph, Sengpiel, von Verschuer Essen, Germany, 45136 University Medical Center Freiburg, Germany, 79106 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07747 Universitätsklinik Köln Köln, Germany, 50937 Gemeinschaftspraxis Hämatologie/Onkologie Magdeburg, Germany, 39104 Klinikum Mannheim GmbH Universitätsklinikum Mannheim, Germany, 68167 Überörtliche Gemeinschaftspraxis Hämato-Onkologie Pasing/Fürstenfeldbruck Munich, Germany, 81241 Klinikum rechts der Isar, Technische Universität München München, Germany, 81675 Onkologische Praxis Oldenburg Oldenburg, Germany, 26121 Medizinische Statistik Saarbrücken, GbR Saarbrucken, Germany, 66113 Universitätsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00928811 End Stage Renal Disease Phase 2 Phase 3 Terminated(Investigator left U... More >>niversity 04/2010) Less << - United States, Pennsylvania ... More >> Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19102 Less <<
NCT00946478 Atopic Dermatitis Not Applicable Completed - United States, California ... More >> University of California, San Diego - Dept of Dermatology La Jolla, California, United States, 92037 Less <<
NCT02329223 - Completed - -
NCT00955916 Leukemia Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00930982 - Completed - -
NCT02404350 Psoriatic Arthritis Phase 3 Active, not recruiting January 16, 2019 -
NCT00955916 - Completed - -
NCT00967044 Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00946478 - Completed - -
NCT00968253 Leukemia Acut... More >>e Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00974922 Vitamin D Deficiency ... More >> Hypertension Less << Phase 4 Terminated(Administrative/Spon... More >>sor Business Decision - terminated - study was not completed) Less << - United States, Connecticut ... More >> University of Connecticut Health Center Farmington, Connecticut, United States, 06030 Less <<
NCT00930982 Bronchiectasis Phase 2 Completed - -
NCT00976222 Pigment Epithelial Detachment Phase 4 Completed - Germany ... More >> University Hospital Muenchen Muenchen, Germany, 80336 University Hospital Muenster Muenster, Germany, 48149 Less <<
NCT00978432 Diffuse Large B-cell Lymphoma Phase 2 Terminated(The toxicity seemed... More >> to outweigh the benefit.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00968253 - Completed - -
NCT00978965 - Active, not recruiting December 2018 Austria ... More >> Department of Medicine III, Division of Nephrology Vienna, Austria, A-1090 Less <<
NCT00982124 Osteogenesis Imperfecta Phase 3 Completed - Canada, Quebec ... More >> Shriners Hospital for Children Montreal, Quebec, Canada, H4A0A9 Less <<
NCT00978432 - Terminated(The toxicity seemed... More >> to outweigh the benefit.) Less << - -
NCT00984113 Renal Impairment Phase 1 Terminated(For administrative ... More >>reasons. Enrollment was sufficient to have statistical power without compromising the integrity of the study data) Less << - United States, Minnesota ... More >> DaVita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, Tennessee NOCR-Knoxville Knoxville, Tennessee, United States, 37920 Less <<
NCT00987168 Congenital Hyperinsulinism Phase 2 Completed - France ... More >> Necker Hospital Paris, France, 75015 Less <<
NCT00967044 - Completed - -
NCT00988117 - Completed - -
NCT01014351 Metastatic Melanoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Oncology Hematology of SW Indiana Evansville, Indiana, United States, 47630 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70809 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT00974922 - Terminated(Administrative/Spon... More >>sor Business Decision - terminated - study was not completed) Less << - -
NCT01016093 Beta-Thalassemia ... More >> Bone Marrow Transplantation Less << Phase 2 Phase 3 Unknown December 2011 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT01028313 Chronic Graft-Versus-Host Dise... More >>ase Less << Phase 2 Withdrawn(A decision was made ... More >>to not move forward with the study. No participants were enrolled or treated.) Less << - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT01014351 - Completed - -
NCT01025063 - Completed - -
NCT01028638 - Completed - Netherlands ... More >> University Medical Centre Groningen Groningen, Netherlands, 9700 RB Less <<
NCT01034072 - Completed - United States, New York ... More >> Feinstein Institute for Medical Research Manhasset, New York, United States, 11030 Less <<
NCT01030770 Diabetes Complications Phase 2 Phase 3 Completed - United Kingdom ... More >> Guy's & St. Thomas' Hospital NHS Foundatrion Trust London, United Kingdom, SE1 7EH King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Less <<
NCT00988117 Parkinsons Disease With Dement... More >>ia Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems Less << Phase 4 Completed - United States, California ... More >> UCalifornia SF San Francisco, California, United States, 94117 Less <<
NCT01032148 Hodgkin's Lymphoma ... More >> Non-Hodgkin's Lymphoma Less << Phase 1 Terminated(lack of funding) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01047293 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Utah Cancer Specialists Salt Lake City, Utah, United States Less <<
NCT01045512 Aging Inflamm... More >>ation Less << Phase 2 Terminated(unsufficient recrui... More >>tment) Less << - Germany ... More >> Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Klinik und Poliklinik für Innere Medizin III, Universitätsklinikum Halle (Saale), Ernst-Grube-Strasse 40 Halle (Saale), Sachsen-Anhalt, Germany, 06097 Less <<
NCT01047293 - Completed - -
NCT01052298 Disease, Pulmonary Phase 1 Completed - Germany ... More >> Mannheim, Baden-Württemberg, Germany, 68167 Less <<
NCT01068249 Endometrial Cancer Phase 2 Active, not recruiting April 2021 United States, New Jersey ... More >> Morristown Memorial Hospital, Women's Cancer Center Morristown, New Jersey, United States, 07962 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01051791 - Terminated - -
NCT01080963 Wound Infection Phase 4 Completed - Germany ... More >> Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular surgery Hannover, Germany Less <<
NCT01083589 Non-small Cell Lung Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01051791 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Terminated - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01089595 - Terminated(Novartis is ending ... More >>their research program for Nilotinib in GIST.) Less << - -
NCT01095822 Diabetes Mellitus Phase 4 Unknown March 2011 United States, Maryland ... More >> Dr. Pokov's Polyclinic. 6821 Reisterstown Road Suite 206 Baltimore, Maryland, United States, 21215 Less <<
NCT01070316 - Completed - -
NCT01111526 Graft-Versus-Host Disease Phase 1 Phase 2 Completed - United States, Florida ... More >> H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01111526 - Completed - -
NCT01137916 Aggressive Fibromatosis ... More >> Desmoid Tumor Less << Phase 2 Completed - Germany ... More >> University of Heidelberg, Mannheim University Medical Center Mannheim, Germany, 68167 Less <<
NCT01089595 GIST Metastat... More >>ic Disease Less << Phase 2 Terminated(Novartis is ending ... More >>their research program for Nilotinib in GIST.) Less << - United States, Missouri ... More >> Siteman Cancer Center, Washington University School of Mediciine St Louis, Missouri, United States, 63110 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT01130662 Acute Myeloid Leukemia Phase 1 Completed - United States, Kansas ... More >> University of Kansas Medical Center, Westwood Campus Kansas City, Kansas, United States, 66205 Less <<
NCT01149993 Kidney Transplantation ... More >> Renal Transplantation Reperfusion Injury Less << Phase 4 Withdrawn(FDA clinical hold, I... More >>ND withdrawn.) Less << - -
NCT01070316 Epilepsy Tube... More >>rous Sclerosis Complex Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01155817 Bone Marrow Transplant Failure... More >> Lymphoma, Non-Hodgkin Lymphoma, T-Cell, Peripheral Less << Phase 1 Unknown July 2014 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Canada, British Columbia Gordon and Leslie Diamond Health Care Centre Hematology Administration Vancouver, British Columbia, Canada, V5Z1M9 Less <<
NCT01163929 Breast Cancer Phase 2 Withdrawn(Study closed by Prot... More >>ocol Review Monitoring Committee because of lack of accrual) Less << - -
NCT01115036 Recurrent Glioblastoma Phase 2 Withdrawn(No subjects were enr... More >>olled on this study, so study was closed and IND withdrawn.) Less << April 2012 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01159418 Advanced Solid Tumors Phase 1 Unknown March 2012 Switzerland ... More >> Huniversitätsspitals Basel Basel, Switzerland, 4031 Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland, 6500 Mèdecin Adjoint, ME - CePO, CHUV Lausanne, Switzerland, 1011 Less <<
NCT01178307 - Active, not recruiting July 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01140568 Glioma Phase 2 Terminated(Sponsor contract wa... More >>s not renewed by mutual decision of sponsor and PI.) Less << - United States, California ... More >> The Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093 Less <<
NCT01169636 Hodgkin's Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01185366 Kidney Cancer Phase 2 Active, not recruiting August 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute/Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute - University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT01157858 Polycystic Liver Disease Phase 2 Completed - Netherlands ... More >> Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01183247 Comparative Study ... More >> Immunosuppressive Agents Less << Phase 4 Completed - Switzerland ... More >> Clinic for transplantation immunology and nephrology Basel, Switzerland, 4031 Less <<
NCT01197040 Nephrotic Syndrome Phase 3 Completed - France ... More >> Henri Mondor Hospital Creteil, Val de Marne, France, 94010 Less <<
NCT01167530 Non-small Cell Lung Cancer ... More >> Locally Advanced Disease Less << Phase 1 Unknown July 2014 France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Eric DEUTSCH, MD    33 1 42114413    eric.deutsch@igr.fr    Contact: Jean-Pierr PIGNON, MD    33 1 42114565    jean-pierre.pignon@igr.fr Less <<
NCT01188889 Chronic Myeloid Leukemia Phase 1 Phase 2 Withdrawn(Unable to obtain suf... More >>ficient funding.) Less << December 2017 United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT01181713 - Unknown December 2012 Canada, Ontario ... More >> Sunnybrook Health and Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT01223612 Diabetic Retinopathy Phase 4 Completed - United Kingdom ... More >> Moorfields Eye Hospital London, United Kingdom, EC1V 2PD Less <<
NCT01201538 Growing Vestibular Schwannomas Phase 2 Terminated(Study PI passed awa... More >>y We had trouble recruiting for the drug arm) Less << - Canada, Ontario ... More >> Toronto Western Hospital Toronto, Ontario, Canada, m5t 2s8 University Health Network Toronto, Ontario, Canada, m5t 2s8 Less <<
NCT01217931 Kidney Cancer Phase 2 Active, not recruiting January 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01239472 Transplantation, Homologous ... More >> Immunosuppression Less << Phase 4 Unknown November 2013 Brazil ... More >> Santa Casa de Misericórdia de Belo Horizonte Recruiting Belo Horizonte, Minas Gerais, Brazil, 30150221 Principal Investigator: Andre B Pereira, PhD          Sub-Investigator: Pedro Augusto M Souza, MD          Sub-Investigator: Milton C Soares, MD          Sub-Investigator: Gustavo MC Silva, MD          Sub-Investigator: Cláudia Ribeiro, PhD Less <<
NCT01238965 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 1 Terminated(Adverse Events) - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01262027 Breast Cancer Phase 2 Active, not recruiting December 2017 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01185990 - Unknown August 2011 United States, Minnesota ... More >> Noran Neurological Clinic Recruiting Minneapolis, Minnesota, United States, 55407 Contact: Ann Rechtzigel, BSN    612-708-5357    rex5@frontiernet.net    Principal Investigator: Richard E Golden, MD          Radiant Research Recruiting Minneapolis, Minnesota, United States, 55435 Contact: Anne-Marie Tschida    952-922-7000 ext 4640    anne-marietschida@radiantresearch.com    Principal Investigator: Tami Helmer, MD Less <<
NCT01262027 - Active, not recruiting - -
NCT01261169 - Unknown December 2011 Taiwan ... More >> CGMH Recruiting Taoyuan County, Taiwan, 333 Contact: Hwang Yih Shiou, MD    886-3-3281200 ext 8666    yihshiou.hwang@gmail.com Less <<
NCT01230840 Colonic Inertia Phase 4 Completed - -
NCT01266070 - Terminated(Trial met toxicity ... More >>stopping rule) Less << - -
NCT01242631 Testicular Cancer ... More >> Germ Cell Cancer Less << Phase 2 Completed - Germany ... More >> Vivantes Klinikum am Urban Berlin, Germany, 10967 Universitatsklinikum Essen Essen, Germany, 45122 Universitatsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Hannover Medical School Hannover, Germany, 30625 Universitatsklinikum Schieswig-Holstein - Campus Kiel Kiel, Germany, 24105 Universitatsklinikum Marburg Marburg, Germany, 35043 Klinikum Harlaching München München, Germany, 81545 Universitatsklinikum der Eberhard-Karls-Universitat Tübingen Tübingen, Germany, 72076 Less <<
NCT01275586 Neurofibromatosis ... More >> NF1 Neurofibromas Less << Early Phase 1 Completed - United States, Indiana ... More >> Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Less <<
NCT01270893 Gastrointestinal Cancer Phase 2 Withdrawn(No particapnt recrui... More >>tment.) Less << - -
NCT01266070 Von Hippel-Lindau Syndrome Phase 2 Terminated(Trial met toxicity ... More >>stopping rule) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01275586 - Completed - -
NCT01276522 Schnitzler Syndrome Phase 2 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01283334 - Completed - -
NCT01270321 Thyroid Cancer Phase 2 Active, not recruiting June 2019 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01298934 Primary Myelofibrosis ... More >> Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Post-Essential Thrombocythemia Related Myelofibrosis Less << Phase 1 Phase 2 Unknown July 2015 United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT01306981 Diabetic Retinopathy ... More >> Retinal Neovascularisation Less << Phase 4 Unknown March 2013 United Kingdom ... More >> Moorfields Eye Hospital London, United Kingdom, EC1V 2PD Less <<
NCT01266837 Metastatic Renal Cell Carcinom... More >>a Failure of Exactly One Prior VEGF-targeted Therapy Less << Phase 4 Completed - Germany ... More >> Charitè Campus Benjamin Franklin Berlin, Germany, 12203 Klinik und Poliklinik für Urologie , Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany, 01307 Urologie - Waldkrankenhaus St. Marien Erlangen, Germany, 91054 Klinik für Innere Medizin (Tumorforschung), Universitätsklinikum Essen Essen, Germany, 45122 Zentrum Innere Medizin, Medizinische Hochschule Hannover Hannover, Germany, 30625 Klinik für Urologie und Kinderurologie, Universitätsklinikum des Saarlandes Homburg, Germany, 66421 Klinik für Urologie, Universitätsklinikum Jena Jena, Germany, 07743 5. Medizinische Klinik, Klinikum Nürnberg Nürnberg, Germany, 90419 Less <<
NCT01317875 Myelofibrosis Phase 1 Active, not recruiting September 2020 United States, Florida ... More >> Winter Park, Florida, United States, 32789 United States, Maryland Baltimore, Maryland, United States, 21229 United States, Texas Houston, Texas, United States, 77030 Austria Vienna, Austria China, Jiangsu Nanjing, Jiangsu, China China, Sichuan Chengdu, Sichuan, China China, Zhejiang Hangzhou, Zhejiang, China China Beijing, China France Angers, France Paris, France Pierre-Benite, France Germany Leipzig, Germany Italy Firenze, Italy Milano, Italy Terni, Italy Netherlands Rotterdam, Netherlands United Kingdom Belfast, United Kingdom London, United Kingdom Less <<
NCT01298713 Breast Neoplasms ... More >> mTor Protein Less << Phase 2 Completed - France ... More >> Hopital Hotel Dieu Paris, France, 75004 Less <<
NCT01324635 Recurrent Glioma ... More >> High-grade Meningioma Brain Metastasis Less << Phase 1 Terminated(Arm A - reached goa... More >>l; Arm B - poor accrual) Less << - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01329289 Multiple Myeloma in Relapse ... More >> Multiple Myeloma Less << Phase 2 Withdrawn(Clinical trial being... More >> transferred to Columbia University with the Investigator.) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01341834 Nasopharyngeal Carcinoma, Lymp... More >>homas, Any EBV+ Solid Tumour Less << Phase 1 Active, not recruiting December 2018 Singapore ... More >> National Cancer Center Singapore Singapore, Singapore, 169690 Less <<
NCT01321346 Lymphoblastic Leukemia, Acute,... More >> Childhood Myelogenous Leukemia, Acute, Childhood Hodgkin's Disease Non-Hodgkin's Lymphoma Less << Phase 1 Completed - -
NCT01349114 Diabetes Pre-... More >>hypertension Hypertension Less << Phase 4 Terminated(Sponsor requested t... More >>ermination.) Less << - United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less <<
NCT01349660 Glioblastoma Multiforme Phase 1 Phase 2 Active, not recruiting February 2018 United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Florida Cancer Specialists Saint Petersburg, Florida, United States, 33705 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01283334 Head and Neck Neoplasms ... More >> Cancer of the Head and Neck Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01329900 Lymphoma Phase 2 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01360385 - Completed - Denmark ... More >> Department of Ophthalmology, Glostrup Hospital Copenhagen, Glostrup, Denmark, 2600 Less <<
NCT01349114 - Terminated(Sponsor requested t... More >>ermination.) Less << - -
NCT01361334 Acute Myeloid Leukemia Phase 2 Completed - Germany ... More >> Unviersity Hospital of Münster (UKM) Münster, Germany, 48149 Less <<
NCT01349660 - Active, not recruiting - -
NCT01392183 Kidney Cancer Phase 2 Active, not recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01404650 Gastrointestinal Stromal Tumor Phase 2 Completed - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialists-South Ft. Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Woodlands Medical Center Pensacola, Florida, United States, 32503 Florida Cancer Specialists-North St. Petersburg, Florida, United States, 33705 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01343498 Malignant Solid Tumour Phase 1 Completed - United States, Oklahoma ... More >> Oklahoma University Oklahoma City, Oklahoma, United States, 71304 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01404676 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less <<
NCT01386723 - Terminated - United States, New York ... More >> Weill Cornell Medical College/New York Presbyterian Hospital New York, New York, United States, 10065 Less <<
NCT01404650 - Completed - -
NCT01412892 Neurofibromatosis Type 1 ... More >> Plexiform Neurofibroma Neurofibromatoses Less << Phase 2 Completed - France ... More >> Henri Mondor Hospital Creteil, France, 94010 Less <<
NCT01396499 Leukemia Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01417104 - Terminated(Safety concerns wit... More >>h approved medication identified in an unrelated trial) Less << - -
NCT01400074 Chronic Myeloid Leukemia Phase 3 Unknown June 2014 Korea, Republic of ... More >> Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 Less <<
NCT01424241 Acromegaly Phase 4 Unknown August 2013 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01425242 Hypertension ... More >>Abdominal Aortic Aneurysm Less << Not Applicable Terminated(Insufficient number... More >> of participants) Less << - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1007 MB Less <<
NCT01431794 Resectable Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 Less <<
NCT01434069 Gastrointestinal Tumor Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01437943 Kidney Disease ... More >> Kidney Failure, Chronic Less << Phase 4 Terminated(Novartis has have d... More >>ecided to terminate all clinical investigator-initiated research projects involving aliskiren) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01417104 Atherosclerosis Phase 2 Phase 3 Terminated(Safety concerns wit... More >>h approved medication identified in an unrelated trial) Less << - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT01440582 Myeloma Phase 1 Active, not recruiting February 1, 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01437943 - Terminated(Novartis has have d... More >>ecided to terminate all clinical investigator-initiated research projects involving aliskiren) Less << - -
NCT01453595 - Terminated(Given the number of... More >> toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial.) Less << - -
NCT01453595 Renal Cancer Phase 1 Phase 2 Terminated(Given the number of... More >> toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial.) Less << - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01436227 Von Hippel-Lindau Syndrome Phase 2 Active, not recruiting January 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02435238 - Completed - United Kingdom ... More >> Novartis Investigative Site Plymouth, Devon, United Kingdom, PL6 8DH Novartis Investigative Site Darlington, Durham, United Kingdom, DL3 6HX Novartis Investigative Site Leytonstone, London, United Kingdom, E11 1NR Novartis Investigative Site Salford, Manchester, United Kingdom, M6 8HD Novartis Investigative Site Coventry, Warwickshire, United Kingdom, CV2 2DX Novartis Investigative Site Belfast, United Kingdom, BT12 6BA Novartis Investigative Site Belfast, United Kingdom, BT9 7AB Novartis Investigative Site Cardiff, United Kingdom, CF14 4XW Novartis Investigative Site Chester, United Kingdom, CH2 1UL Novartis Investigative Site Durham, United Kingdom, DH1 6TW Novartis Investigative Site East Yorkshire, United Kingdom, HU16 5JQ Novartis Investigative Site Kent, United Kingdom, CT9 4AN Novartis Investigative Site Leeds, United Kingdom, LS9 7PN Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Novartis Investigative Site Liverpool, United Kingdom, L14 3PE Novartis Investigative Site London, United Kingdom, SE18 4QH Novartis Investigative Site Manchester, United Kingdom, M13 9WL Novartis Investigative Site Manchester, United Kingdom, M23 9LT Novartis Investigative Site Middlesborough, United Kingdom, TS4 3BW Novartis Investigative Site Poole, United Kingdom, BH15 2JB Novartis Investigative Site Sheffield, United Kingdom, S5 7AU Less <<
NCT01409408 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Withdrawn(Due to preliminary r... More >>esults of Altitude Trial.) Less << December 2013 Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, Brazil, 20551030 Less <<
NCT02468232 Heart Failure With Reduced Eje... More >>ction Fraction (HF-rEF) Less << Phase 3 Active, not recruiting August 31, 2020 -
NCT02474069 Moderate to Severe Plaque-type... More >> Psoriasis Less << Phase 3 Completed - -
NCT01467011 - Completed - United States, Texas ... More >> The Methodist Hospital System Houston, Texas, United States, 77030 Less <<
NCT02465528 Tumors With Aberrations in ALK Phase 2 Completed - Czechia ... More >> Novartis Investigative Site Brno, Czech Republic, Czechia, 656 53 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Strasbourg, France, F-67085 Germany Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Mainz, Germany, 55131 Israel Novartis Investigative Site Tel Aviv, Israel, 64239 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Milano, MI, Italy, 20133 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28040 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 Less <<
NCT02468674 Sarcopenia Phase 2 Active, not recruiting December 11, 2018 -
NCT02474082 Psoriasis Phase 3 Completed - Germany ... More >> Novartis Investigative Site Bad Bentheim, Germany, 48455 Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 10247 Novartis Investigative Site Berlin, Germany, 10789 Novartis Investigative Site Berlin, Germany, 13187 Novartis Investigative Site Berlin, Germany, 13578 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Bochum, Germany, 44803 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Darmstadt, Germany, 64283 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Halle, Germany, 06108 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hamburg, Germany, 20354 Novartis Investigative Site Hamburg, Germany, 22391 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Lubeck, Germany, 23538 Novartis Investigative Site Ludwigshafen, Germany, 67063 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Osnabruck, Germany, 49074 Novartis Investigative Site Quedlinburg, Germany, 06484 Novartis Investigative Site Schwerin, Germany, 19055 Novartis Investigative Site Selters, Germany, 56242 Novartis Investigative Site Stade, Germany, 21682 Less <<
NCT02487446 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT02474082 - Completed - -
NCT01463046 Acute Myeloid Leukemia ... More >> Advanced Myelodysplastic Syndrome Less << Phase 1 Active, not recruiting December 2018 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143 Less <<
NCT00835159 Delirium Post... More >>operative Cognitive Dysfunction Less << Phase 4 Completed - United States, New York ... More >> NYU Langone Medical Center, Department of Anesthesiology 550 First Avenue, RR-603 New York, New York, United States, 10016 Less <<
NCT00411619 Tuberous Sclerosis ... More >> Subependymal Giant Cell Astrocytoma Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00411385 Chronic Hepatitis C Phase 3 Completed - -
NCT00403559 Seborrheic Dermatitis Phase 2 Completed - United States, Kentucky ... More >> Dermatology Specialists Louisville, Kentucky, United States, 40202 Less <<
NCT00414076 Leiomyosarcoma ... More >> Uterine Neoplasm Less << Phase 2 Terminated(Low accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02487498 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00413829 Age Related Macular Degenerati... More >>on Less << Phase 2 Completed - Switzerland ... More >> Klinik und Poliklinik fuer Augenheilkunde, Inselspital Bern, Switzerland Less <<
NCT00233454 Systemic Mastocytosis, Aggress... More >>ive (ASM) Leukemia, Mast Cell Hematological Non-mast Cell Lineage Disease (AHNMD) Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Washington University-St. Louis Saint Louis, Missouri, United States, 63110 Less <<
NCT02487446 - Completed - -
NCT00414076 - Terminated(Low accrual) - -
NCT00424515 Mucosal Melanoma ... More >> Acral/Lentiginous Melanoma Chronically Sun Damaged Melanomas Less << Phase 2 Completed - United States, Colorado ... More >> University of Colorado at Denver Health Sciences Center Denver, Colorado, United States, 80045 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00411619 - Completed - -
NCT00233454 - Completed - -
NCT00422344 Renal Cell Carcinoma ... More >> Kidney Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10021 Less <<
NCT00443508 Kidney Diseases Phase 4 Unknown - Israel ... More >> Transplantation department, rabin Medical Center Recruiting Petach Tikva, Israel, 49202 Contact: Eytan Mor, Prof    00937 3 9376528    tikim@clalit.org.il    Principal Investigator: Eytan Mor, Prof          Sub-Investigator: Ruti Rahamimov, Dr          Sub-Investigator: Alex Yusim, Dr Less <<
NCT00264420 Bone Metastases ... More >> Breast Cancer Lung Cancer Prostate Cancer Less << Phase 1 Completed - -
NCT00424515 - Completed - -
NCT02592018 Psoriasis Phase 4 Active, not recruiting December 2018 United States, California ... More >> UCSF Psoriasis and Skin Treatment Center San Francisco, California, United States, 94118 Less <<
NCT02632045 Metastatic Breast Cancer ... More >> Breast Carcinoma Less << Phase 2 Recruiting December 2021 United States, Alabama ... More >> University of Alabama at Birmingham (UAB) Recruiting Birmingham, Alabama, United States, 35294 Contact: Chris Vaklavas, MD    205-934-5677    cvaklavas@uabmc.edu    Principal Investigator: Chris Vaklavas, MD          United States, Illinois Northwestern Medical Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Sarika Jain, MD    312-695-6180    cancertrials@northwestern.edu    Principal Investigator: William Gradishar, MD          United States, New York Albert Einstein University / Montefiore Medical Center Recruiting Bronx, New York, United States, 10461 Contact: Joseph Sparano, MD    718-405-8505    jsparano@montefiore.org    Principal Investigator: Sun Young Oh, MD          Northwell Health/Monter Cancer Center Recruiting Lake Success, New York, United States, 11042 Contact: Mark Hoffman, MD    516-734-8869    MHoffma@northwell.edu    Principal Investigator: Mark Hoffman, MD          NYU Langone Medical Center Recruiting New York, New York, United States, 10016 Contact: Francisco Esteva, MD, PhD    212-731-5657    Francisco.Esteva@nyumc.org    Principal Investigator: Francisco Esteva, MD, PhD          Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: Amy Tiersten, MD    212-241-3300    amy.tiersten@mssm.edu    Principal Investigator: Amy Tiersten, MD          Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Kevin Kalinsky, MD, MS    212-305-1945    kk2693@cumc.columbia.edu    Principal Investigator: Kevin Kalinsky, MD, MS          Weill Cornell Medical Center Recruiting New York, New York, United States, 10065 Contact: Marta Cobham, RN    212-821-0644    ela9082@med.cornell.edu    Principal Investigator: Eleni Andreopoulou, MD          Stony Brook Cancer Center Recruiting Stony Brook, New York, United States, 11794 Contact: Lea Baer, MD    631-638-1000    Lea.Baer@stonybrookmedicine.edu    Principal Investigator: Lea Baer, MD          United States, Tennessee Vanderbilt-Ingham Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Ingrid A Mayer, MD, MSC    800-811-8480    Ingrid.Mayer@vanderbilt.edu    Principal Investigator: Ingrid A Mayer, MD          United States, Wisconsin University of Wisconsin School of Medicine Recruiting Madison, Wisconsin, United States, 53792-001 Contact: Cancer Connect, MD    608-262-5223    cancerconnect@uwcarbone.wisc.edu    Contact    800-622-8922       Principal Investigator: Ruth O'Regan, MD Less <<
NCT01562444 Tick Borne Encephalitis Phase 4 Completed - Czechia ... More >> GSK Investigational Site Hradec Kralove, Czechia, 50002 Less <<
NCT00426049 Coronary Artery Disease ... More >> Coronary Restenosis Less << Phase 3 Unknown - Germany ... More >> German Heart Institute Berlin Recruiting Berlin, Germany, 13353 Principal Investigator: Eckart Fleck, Professor Less <<
NCT02712723 Breast Cancer Phase 2 Recruiting April 2023 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Issam Makhoul, MD          United States, California City of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Yuan Yuan, MD          Cancer Research Collaboration Not yet recruiting Santa Ana, California, United States, 92705 Contact: Shlomit Ein-Gal, MD          United States, Florida University of Miami Sylvester Comprehensive Cancer Center Recruiting Deerfield Beach, Florida, United States, 33442 Contact: Mohammad Jahanzeb, MD          United States, Kansas University of Kansas Cancer Center - West Recruiting Kansas City, Kansas, United States, 66112 Contact    913-945-7552    ctnursenav@kumc.edu    University of Kansas Cancer Center - Overland Park Recruiting Overland Park, Kansas, United States, 66210 Contact    913-945-7552    ctnursenav@kumc.edu    University of Kansas Cancer Center - Westwood Recruiting Westwood, Kansas, United States, 66205 Contact    913-945-7552    ctnursenav@kumc.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Aditya Bardia, MD          United States, Missouri University of Kansas Cancer Center - South Recruiting Kansas City, Missouri, United States, 64131 Contact    913-945-7552    ctnursenav@kumc.edu    University of Kansas Cancer Center - North Recruiting Kansas City, Missouri, United States, 64154 Contact    913-945-7552    ctnursenav@kumc.edu    University of Kansas Cancer Center - Lee's Summit Recruiting Lee's Summit, Missouri, United States, 64064 Contact    913-945-7552    ctnursenav@kumc.edu    United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Meghna Trivedi, MD          United States, Wisconsin University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53705 Contact: Kari Wisinski, MD Less <<
NCT02722941 Multiple Myeloma Phase 2 Recruiting June 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Caitlyn Ward    813-745-1344    caitlyn.ward@moffitt.org    Contact: Taiga Nishihori    813-745-8156    taiga.nishihori@moffitt.org    Principal Investigator: Taiga Nishihori, M.D.          Sub-Investigator: Melissa Alsina, M.D.          Sub-Investigator: Claudio Anasetti, M.D.          Sub-Investigator: Ernesto Ayala, M.D.          Sub-Investigator: Rachid Baz, M.D.          Sub-Investigator: Brian Betts, M.D.          Sub-Investigator: Hugo Fernandez, M.D.          Sub-Investigator: Jingsong Zhang, M.D., Ph.D.          Sub-Investigator: Mohamed Kharfan-Dabaja, M.D.          Sub-Investigator: Farhad Khimani, M.D.          Sub-Investigator: Frederick Locke, M.D.          Sub-Investigator: Asmita Mishra, M.D.          Sub-Investigator: Jose Ochoa-Bayona, M.D.          Sub-Investigator: Lia Perez, M.D.          Sub-Investigator: Joseph Pidala, M.D., Ph.D.          Sub-Investigator: Kenneth Shain, M.D., Ph.D. Less <<
NCT02751242 - Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02736227 Liver Transplantation Not Applicable Recruiting March 2019 United States, Illinois ... More >> Northwestern University Comprehensive Transplant Center Recruiting Chicago, Illinois, United States, 60611 Contact: Josh Levitsky, MD    312-695-4413 Less <<
NCT02649673 Small Cell Lung Cancer ... More >> Ovarian Cancer Less << Phase 1 Phase 2 Recruiting July 27, 2019 United States, Florida ... More >> Florida Cancer Specialists-Sarasota Recruiting Sarasota, Florida, United States, 34232 United States, Oklahoma Oklahoma University Health Science Center/Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Less <<
NCT02774512 Colon Cancer Early Phase 1 Withdrawn(none participant has... More >> been enrolled and recruited during the first year after competent autority autorisation.) Less << November 2017 France ... More >> Institut Bergonié Bordeaux, France, 33076 Less <<
NCT01562444 - Completed - -
NCT02974686 Kidney Transplant Rejection ... More >> Gastrointestinal Disorder, Functional Less << Phase 4 Recruiting December 2019 United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Rowena Delos Santos, MD    314-362-4547    delossantos@wustl.edu    Principal Investigator: Rowena Delos Santos, MD          Sub-Investigator: Timothy Horwedel, PharmD          Sub-Investigator: Jennifer Hagopian, PharmD Less <<
NCT03119623 Heart Failure With Reduced Eje... More >>ction Fraction Less << Phase 4 Withdrawn(Lost funding prior t... More >>o study commencing) Less << August 2019 -
NCT03168568 Heart Failure Phase 4 Recruiting June 30, 2019 Switzerland ... More >> University Heart Center Zurich Recruiting Zurich, Switzerland, 8091 Contact: Frank Ruschitzka, MD    +41442553353    frank.ruschitzka@usz.ch Less <<
NCT03243721 Multiple Sclerosis Not Applicable Active, not recruiting December 2019 United States, Ohio ... More >> Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT03284242 End Stage Renal Disease ... More >> Kidney Transplant Less << Not Applicable Not yet recruiting December 31, 2019 United States, Kentucky ... More >> University of Kentucky Medical Center Not yet recruiting Lexington, Kentucky, United States, 40536 Less <<
NCT03053284 Congenital Hyperinsulinism ... More >> Insulinoma Hyperinsulinism Less << Phase 2 Withdrawn(Funding was withdraw... More >>n by Sponsor prior to start of study) Less << April 2018 -
NCT02035696 Influenza Phase 1 Phase 2 Completed - -
NCT02046148 GBS Disease Phase 2 Completed - United States, Colorado ... More >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Florida GSK Investigational Site Clearwater, Florida, United States, 33759 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29425 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 Less <<
NCT03332511 Chronic Myeloid Leukemia, Chro... More >>nic Phase Less << Phase 4 Completed - -
NCT02035696 - Completed - -
NCT03413722 - Recruiting November 1, 2019 United States, Kansas ... More >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Less <<
NCT03462251 Breast Cancer ... More >> Hormone Receptor Positive Tumor HER 2 Negative Breast Cancer Less << Phase 3 Recruiting June 30, 2025 Germany ... More >> Gemeinschaftspraxis für Hämatologie und Onkologie Recruiting Ravensburg, Baden-Wuerttemberg, Germany, 88212 Contact: Thomas Decker, Prof.    +49 751 3661970    thomas.decker@onkonet.eu Less <<
NCT03285607 Breast Cancer ... More >> Cancer of Breast Less << Phase 1 Withdrawn(Drug provider decide... More >>d not to move forward with the study.) Less << February 28, 2021 -
NCT03434262 Anaplastic Astrocytoma ... More >> Anaplastic Ependymoma Anaplastic Ganglioglioma Anaplastic Meningioma Anaplastic Oligodendroglioma Pleomorphic Xanthoastrocytoma, Anaplastic Atypical Teratoid/Rhabdoid Tumor Brain Cancer Brain Tumor Central Nervous System Neoplasms Choroid Plexus Carcinoma CNS Embryonal Tumor With Rhabdoid Features Ganglioneuroblastoma of Central Nervous System CNS Tumor Embryonal Tumor of CNS Ependymoma Glioblastoma Glioma Glioma, Malignant Medulloblastoma Medulloblastoma; Unspecified Site Medulloepithelioma Neuroepithelial Tumor Neoplasms Neoplasms, Neuroepithelial Papillary Tumor of the Pineal Region (High-grade Only) Pediatric Brain Tumor Pineal Parenchymal Tumor of Intermediate Differentiation (High-grade Only) Pineoblastoma Primitive Neuroectodermal Tumor Recurrent Medulloblastoma Refractory Brain Tumor Neuroblastoma. CNS Glioblastoma, IDH-mutant Glioblastoma, IDH-wildtype Medulloblastoma, Group 3 Medulloblastoma, Group 4 Glioma, High Grade Neuroepithelial Tumor, High Grade Medulloblastoma, SHH-activated and TP53 Mutant Medulloblastoma, SHH-activated and TP53 Wildtype Medulloblastoma, Chromosome 9q Loss Medulloblastoma, Non-WNT Non-SHH, NOS Medulloblastoma, Non-WNT/Non-SHH Medulloblastoma, PTCH1 Mutation Medulloblastoma, WNT-activated Ependymoma, Recurrent Glioma, Recurrent High Grade Glioma, Recurrent Malignant Embryonal Tumor, NOS Glioma, Diffuse Midline, H3K27M-mutant Embryonal Tumor With Multilayered Rosettes (ETMR) Ependymoma, NOS, WHO Grade III Ependymoma, NOS, WHO Grade II Medulloblastoma, G3/G4 Ependymoma, RELA Fusion Positive Less << Phase 1 Recruiting March 2025 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tabatha E. Doyle, RN    901-595-2544    tabatha.doyle@stjude.org    Principal Investigator: Giles W. Robinson, MD Less <<
NCT02215226 - Completed - South Africa ... More >> Respiratory and Meningeal Pathogen Research Unit Soweto, Johannesburg, Gauteng, South Africa, 2013 Less <<
NCT02173704 - Completed - -
NCT02046148 - Completed - -
NCT02173704 Meningococcal Disease Phase 3 Completed - Taiwan ... More >> GSK Investigational Site Taipei, Taiwan, 10041 GSK Investigational Site Taipei, Taiwan, 10449 Less <<
NCT03568136 Dermatitis, Atopic ... More >> Eczema, Atopic Neurodermatitis, Atopic Less << Phase 2 Recruiting July 2020 Germany ... More >> Carl Gustav Carus University Hospital, Department of Dermatology Recruiting Dresden, Germany, 01307 SRH Wald-Klinikum Gera, Center for Clinical Studies Recruiting Gera, Germany, 07548 Hannover Medical School, Department for Dermatology, Allergy and Venereology Recruiting Hannover, Germany, 30625 Less <<
NCT02270944 Infections, Streptococcal Phase 2 Completed - United States, California ... More >> GSK Investigational Site Redding, California, United States, 96001 United States, Kansas GSK Investigational Site Lenexa, Kansas, United States, 66219 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Michigan GSK Investigational Site Stevensville, Michigan, United States, 49127 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84109 Belgium GSK Investigational Site Antwerp, Belgium GSK Investigational Site Ghent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 Czechia GSK Investigational Site Hradec Kralove, Czechia, 50002 Less <<
NCT03207334 Acute Myeloid Leukemia Phase 2 Withdrawn(Insufficient funding... More >>) Less << January 2022 United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT03501368 Melanoma Unre... More >>sectable Melanoma Advanced Melanoma Less << Phase 2 Recruiting June 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Deanryan DeAquino    813-745-3998    deanryan.deaquino@moffitt.org    Contact: Zeynep Eroglu, M.D.    813-745-7488    zeynep.eroglu@moffitt.org    Principal Investigator: Zeynep Eroglu, M.D. Less <<
NCT02270944 - Completed - -
NCT03775109 Alcoholic Hepatitis Phase 2 Recruiting December 2019 United Kingdom ... More >> Blackpool Teaching Hospitals Not yet recruiting Blackpool, United Kingdom Contact: Peter Isaacs          University Hospitals Bristol NHS Foundation Trust Not yet recruiting Bristol, United Kingdom Contact: Anne McCune          Cambridge University Hospitals NHS Foundation Trust Not yet recruiting Cambridge, United Kingdom Contact: Michael Allison          Derby Teaching Hospitals NHS Foundation Trust Not yet recruiting Derby, United Kingdom Contact: Andrew Austin          Glasgow Royal Infirmary, Greater Glasgow & Clyde Not yet recruiting Glasgow, United Kingdom, G4 0SF Contact: Ewan Forrest          Leeds Teaching Hospitals NHS Trust Not yet recruiting Leeds, United Kingdom Contact: Richard Parker          Aintree University Hospital Not yet recruiting Liverpool, United Kingdom Contact: Cyril SIEBERHAGEN          Royal Liverpool and Broadgreen University Hospitals NHS Trust Not yet recruiting Liverpool, United Kingdom Contact: Paul Richardson          Imperial College Healthcare NHS Foundation Trust Recruiting London, United Kingdom, W2 1NY Contact: Mark Thursz    020 3312 5359       Chelsea and Westminster Hospital NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: Matthew Foxton          King's College Hospital NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: Vishal Patel          Royal Free London NHS Foundation Trust Not yet recruiting London, United Kingdom Contact: David Patch          The Newcastle Upon Tyne Hospitals NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom Contact: Steve Masson          Nottingham University Hospitals NHS Trust Not yet recruiting Nottingham, United Kingdom Contact: Stephen Ryder          John Radcliffe Hospital, Oxford University NHS Foundation Trust Not yet recruiting Oxford, United Kingdom, OX3 9DU Contact: Jeremy Cobbold          Plymouth Hospitals NHS Trust Not yet recruiting Plymouth, United Kingdom Contact: Ashwin Dhanda          Sheffield Teaching Hospitals NHS Foundation Trust Not yet recruiting Sheffield, United Kingdom Contact: Amer Al-Joudeh          University Hospital Southampton NHS Foundation Trust Not yet recruiting Southampton, United Kingdom Contact: Mark Wright Less <<
NCT00038194 Prostate Cancer Phase 1 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00049959 Basal Cell Carcinoma ... More >> Nevoid Basal Cell Carcinoma Syndrome Gorlin Syndrome Less << Phase 3 Terminated - -
NCT00823004 Ovarian Stimulation Phase 1 Phase 2 Completed - Iran, Islamic Republic of ... More >> Research and clinical center for infertility Yazd, Iran, Islamic Republic of, 8916877391 Less <<
NCT03603795 Acute Myeloid Leukemia Phase 2 Recruiting September 2024 France ... More >> CHU ANGERS - Maladies du sang Not yet recruiting Angers, France, 49933 Contact: Mathilde HUNAULT, Dr    02 41 35 45 82    mahunault@chu-angers.fr    CH de la Côte Basque - Hématologie Not yet recruiting Bayonne, France, 64109 Contact: Anne BANOS, Dr    +33 5 59 44 38 32    abanos@ch-cotebasque.fr    CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Aurélie RAVINET, Dr    04 73 75 00 65    aravinet@chu-clermontferrand.fr    CHU Grenoble - Hématologie Clinique Recruiting Grenoble, France, 38043 Contact: Claude-Eric BULABOIS, Dr    04 76 76 57 55    cebulabois@chu-grenoble.fr    Institut Paoli-Calmettes - Hématologie 2 Not yet recruiting Marseille, France, 13000 Contact: Norbert VEY, Pr    +33 4 91 22 36 95    veyn@ipc.unicancer.fr    Hôpital Saint-Eloi - Hématologie Clinique Not yet recruiting Montpellier, France, 34295 Contact: Yosr HICHERI, Dr    +33 4 67 33 24 18    y-hicheri@chu-montpellier.fr    HOPITAL E. MULLER - Hématologie Not yet recruiting Mulhouse, France, 68070 Contact: Mario OJEDA-URIBE, Dr    +33(0)3 89 64 77 55    ojeda-uribem@ghrmsa.fr    CHU HOTEL DIEU - Hématologie Clinique Not yet recruiting Nantes, France, 44093 Contact: Pierre PETERLIN, Dr    +33(0)2 40 08 32 71    pierre.peterlin@chu-nantes.fr    CHU Caremeau Not yet recruiting Nîmes, France, 30029 Contact: Eric JOURDAN, Dr    04 66 68 32 31    eric.jourdan@chu-nimes.fr    CHU La Milétrie - Hématologie Clinique Not yet recruiting Poitiers, France, 86000 Contact: Maria-Pilar GALLEGO-HERNANZ, Dr    +33(0)5 49 44 44 44    maria-pilar.gallego-hernanz@chu-poitiers.fr    CHU Pontchaillou Not yet recruiting Rennes, France, 35033 Contact: Marc BERNARD, Dr    02 40 08 32 71    marc.bernard@chu-rennes.fr    CHU Hautepierre - Hématologie Not yet recruiting Strasbourg, France, 67098 Contact: Bruno LIOURE, Dr    +33(0)3 88 12 76 76    bruno.lioure@chru-strasbourg.fr    Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie Recruiting Toulouse, France, 31059 Contact: Christian RECHER, Pr    +33 5 31 15 63 55    recher.christian@iuct-oncopole.fr    Sponsor FILO Not yet recruiting Tours, France, 37044 Contact: Mélanie COTTOT, Mrs    +33247478899    m.dupin@chu-tours.fr    CHU de Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Caroline BONMATI, Dr    03 83 15 52 49    c.bonmati@chu-nancy.fr Less <<
NCT00081874 Leukemia Mant... More >>le Cell Lymphoma Myelofibrosis Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00058188 Osteoporosis ... More >>Prostate Cancer Less << Phase 3 Active, not recruiting December 2020 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611-3013 Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States, 60611 John H. Stroger Hospital of Cook County Chicago, Illinois, United States, 60612 Less <<
NCT00128297 Breast Cancer ... More >> Neoplasm Metastasis Less << Phase 4 Completed - Spain ... More >> Spanish Breast Cancer Research Group (GEICAM) San Sebastián de los Reyes, Madrid, Spain, 28700 Less <<
NCT00114556 Osteoporosis ... More >>Liver Transplantation Fractures Less << Phase 4 Completed - Australia, New South Wales ... More >> Royal Prince Alfred Hospital Sydney, New South Wales, Australia, 2050 Less <<
NCT00130494 Breast Cancer ... More >> Neoplasm Metastasis Less << Phase 3 Terminated - Spain ... More >> Spanish Breast Cancer Research Group (GEICAM) San Sebastián de los Reyes, Madrid, Spain, 28700 Less <<
NCT00050531 Leukemia, Myeloid, Chronic Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00134355 Prostate Cancer Phase 2 Completed - -
NCT00164008 Osteopenia Co... More >>mplications of Heart-lung Transplant Other Complications of Lung Transplant Less << Phase 4 Completed - -
NCT00129740 Leukemia, Myelogenous, Chronic Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00159484 Colon Cancer ... More >>Colorectal Cancer Less << Phase 1 Phase 2 Active, not recruiting December 2017 United States, California ... More >> U.S.C./Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00183833 Colon Cancer ... More >>Colorectal Cancer Less << Phase 1 Completed - United States, California ... More >> USC/Norris Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00088231 Acute Myelogenous Leukemia ... More >> Agnogenic Myeloid Metaplasia Chronic Myelogenous Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00131274 Idiopathic Pulmonary Fibrosis ... More >> Lung Disease Pulmonary Fibrosis Less << Phase 2 Phase 3 Completed - -
NCT00187174 Tumors Brain ... More >>Tumors Rhabdomyosarcoma Sarcoma, Soft Tissue Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00176410 Aortic Valve Stenosis Phase 2 Unknown December 2009 Germany ... More >> University of Leipzig - Heart Center Recruiting Leipzig, Saxony, Germany, 04289 Contact: Claudia Walther, MD    xx49-341-8651428    waltherc@medizin.uni-leipzig.de    Sub-Investigator: Claudia A Walther, MD Less <<
NCT00188825 COPD Emphysem... More >>a Alpha-1 Antitrypsan Deficiency Less << Phase 3 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00185588 Pancreatic Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00201955 Keratoconjunctivitis Sicca Phase 3 Completed - -
NCT00201981 Keratoconjunctivitis Sicca Phase 3 Completed - -
NCT00196417 Heparin-Induced Thrombocytopen... More >>ia Less << Phase 4 Unknown - Germany ... More >> Ernst-Moritz-Arndt University, Depts. of Transfusion Medicine / Trauma surgery Greifswald, Germany, 17489 Less <<
NCT00185588 - Completed - -
NCT00215943 Multiple Myeloma Phase 3 Terminated(Poor accrual, chang... More >>es in management of newly diagnosed myeloma patients, new drugs/more effective regimens.) Less << - United States, Florida ... More >> Morton Plant Hospital Clearwater, Florida, United States, 33756 Watson Clinic Lakeland, Florida, United States, 33805 Fawcett Memorial Hospital Port Charlotte, Florida, United States, 33949 H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Puerto Rico San Juan VA Hospital San Juan, Puerto Rico, 00921 Less <<
NCT00209079 Gastric Adenocarcinoma Phase 2 Terminated(Terminated 4/17/07.... More >> Drug sponsor withdrew.) Less << - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00219726 Chronic Myeloid Leukemia Phase 2 Completed - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT00215943 - Terminated(Poor accrual, chang... More >>es in management of newly diagnosed myeloma patients, new drugs/more effective regimens.) Less << - -
NCT00210119 Myeloid Leukemia, Chronic Phase 2 Terminated - France ... More >> Centre Hospitalier Universitaire de Bordeaux Bordeaux, France, 33076 Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest Bordeaux, France, 33076 Centre Hospitalier de Versailles Le Chesnay, France, 78150 Hôpital Edouard Herriot Lyon, France, 69437 Hôpital Archet Nice, France, 06200 Hôpital Saint Louis Paris, France, 75010 Centre Hospitalier Universitaire de Poitiers Poitiers, France, 86000 Less <<
NCT00219752 Chronic Myeloid Leukemia Phase 2 Completed - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT00226954 Urologic Neoplasms Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00230464 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Texas ... More >> Audie L Murphy VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT00208273 Breast Cancer Phase 2 Completed - France ... More >> CRLC Val d'Aurelle Montpellier, France, 34298 Less <<
NCT00233493 - Unknown - United States, Ohio ... More >> Neil Korman, MD Recruiting Cleveland, Ohio, United States, 44106 Contact: ZsaZsa Hann    216-844-5899    zsazsa.hann@uhhs.com Less <<
NCT00240045 Type 2 Hepatorenal Syndrome ... More >> Refractory Ascites Less << Phase 2 Phase 3 Completed - Canada, Alberta ... More >> University of Alberta Edmonton, Alberta, Canada, T6G 2E1 Less <<
NCT00257868 Delirium Phase 3 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT00230334 Eosinophilia ... More >>Hypereosinophilic Syndrome Less << Phase 2 Withdrawn(Withdrawn by PI due ... More >>to insufficient accrual) Less << - -
NCT00242333 COPD Phase 2 Completed - Bulgaria ... More >> Specialized Hospital for Active Treatment Pneumophthysiatric Disease "Kudoglu" Plovdiv, Bulgaria, 4000 Regional Dispensary for Pulmonary Diseases Rousse Rousse, Bulgaria, 7002 5-th Multiprofile Hospital for Active Treatment Sofia, Bulgaria, 1233 MHAT “Alexandrovska” Sofia, Bulgaria, 1431 Specialized Hospital for Active Treatment of Pulmonary Diseases "Sveta Sofia" Sofia, Bulgaria, 1431 Central Clinical Base – Medical Institute – Ministry of the Interior Sofia, Bulgaria, 1606 Military Medical Academy Sofia, Bulgaria, 1606 UMHAT “Stara Zagora” EAD Stara Zagora, Bulgaria, 6003 University Hospital Varna, Bulgaria, 9010 Hungary Tudogyintezete Nodradgardony Balassagyarmat, Hungary, 2661 III. district Outpatient Clinic Budapest, Hungary, 1033 Diagnostic Units Hungary Ltd Budapest, Hungary, 1036 Gyogyir XI. Kht.II. Tudogondozo Intezet Budapest, Hungary, 1221 Selye Janos Hospital Komarom, Hungary, 2900 Karolona Hospital Mosonmagyarovar, Hungary, 9200 Szabolcs Szatmar Bereg Megyei Josa Andras Korhaz Nyiregyhaza, Hungary, 4400 Fejer County Szent Gyorgy Hospital Szekesfehervar, Hungary, 8001 Vas County Markusovszky Hospital Szombathely, Hungary, 9700 Poland Szpital Wojewodzki Bielsko-Biala, Poland, 43-316 10 Wojskowy Szpital Kliniczny Z Poliklinika Bydgoszcz, Poland, 85-681 Samodzielny Publiczny Centralny Szpital Kliniczny SAM Katowice, Poland, 40-752 Specjalistyczny Osrodek Alergologiczny ALL-MED Krakow, Poland, 31-023 Barlicki University Hospital Lodz, Poland, 90-153 Szpital ZOZ Olawa, Poland, 55-200 Specjalistyczna Przychodnia Lekarska “Medikard” Plock, Poland, 09-402 Wielkopolskie Centrum Chorob Pluc I Gruzlicy Poznan, Poland, 60-569 Romania Spitalul Clinic de Urgenta Floreasca Bucharest, Romania, 11641 Spitalul de Pneumo Ftiziologie “Sf. Stefan” Bucharest, Romania, 20122 Spitalul Clinic "Colentina" Bucharest, Romania, 20125 Institutul National de Boli Infectioase Bucharest, Romania, 21105 Spitalul Clinic de Boli Infectioase si Tropicale " Dr. Victor Babes " Bucharest, Romania, 30317 Institutul de Pneumologie " Marius Nasta " Bucharest, Romania, 50159 Spitalul Clinic de Urgenta Constanta Constanta, Romania, 900591 Less <<
NCT00291135 Breast Cancer Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00291135 - Completed - -
NCT00297037 Oral Lichen Planus Phase 2 Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00297037 - Completed - -
NCT00303732 Kidney Cancer ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00222183 Lupus Erythematosus, Cutaneous... More >> Lupus Erythematosus, Discoid Less << Not Applicable Withdrawn(Head of the study ha... More >>s left the institution. Study never started.) Less << - Germany ... More >> Department of Dermatology, University of Leipzig Leipzig, Saxony, Germany, 04103 Less <<
NCT00263198 Breast Neoplasms Phase 2 Terminated(unacceptable toxici... More >>ty) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00317720 Breast Cancer ... More >> Neoplasm Metastasis Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00298883 End Stage Renal Disease ... More >> Kidney Transplantation Less << Phase 1 Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00329381 Asthma Phase 4 Completed - United States, Mississippi ... More >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT00298324 Graft vs Host Disease Phase 3 Terminated(Due to slow accrual... More >>) Less << - France ... More >> Hopital St. Louis Paris, France, 75475 Germany University Regensburg Regensburg, Germany, 93042 Italy Ospedale San Martino Genova, Italy, 16132 Netherlands University Hospital Maastricht, Netherlands, 6202 Spain Hospital Clínico Universitario Valencia, Spain, 46010 Sweden Karolinska University Hospital Huddinge, Sweden, 141 86 Switzerland University Hospital Basel, Switzerland, 4031 Turkey University Faculty of Medicine Ankara, Turkey, 06260 Less <<
NCT00315107 Acromegaly Phase 2 Unknown - Canada, Quebec ... More >> CHUM - Notre-Dame Hospital Recruiting Montreal, Quebec, Canada, H2L 4M1 Principal Investigator: Omar Serri, MD Less <<
NCT02819648 Pulpitis Phase 4 Completed - Egypt ... More >> Faculty of Oral & Dental Medicine Giza, Egypt, 11553 Less <<
NCT00343499 Atrial Fibrillation Phase 4 Terminated(Inability to recrui... More >>t) Less << - United States, Utah ... More >> McKay Dee Hospital Ogden, Utah, United States, 84403 LDS Hospital Salt Lake City, Utah, United States, 84143 Dixie Regional Medical Center St. George, Utah, United States, 84770 Less <<
NCT00317720 - Completed - -
NCT00348790 Brain and Central Nervous Syst... More >>em Tumors Sarcoma Less << Phase 2 Completed - United States, Illinois ... More >> Hematology-Oncology Associates of Illinois Chicago, Illinois, United States, 60611-2998 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Washington University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195-6043 Less <<
NCT00352846 Non-Hodgkin's Lymphoma ... More >> Lymphoma Less << Phase 3 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00373061 - Completed - United States, North Carolina ... More >> Ppd Development, Llc Morrisville, North Carolina, United States, 27560-7200 Less <<
NCT00337545 Colorectal Cancer Phase 2 Completed - United States, Washington ... More >> Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT00372307 Vitiligo Vulgaris Phase 2 Completed - Belgium ... More >> University Hospital Ghent Ghent, Belgium, 9000 Less <<
NCT00374803 End Stage Renal Disease (ESRD) Phase 4 Completed - United States, Ohio ... More >> The Christ Hospital Cincinnati, Ohio, United States, 45267 University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT00348790 - Completed - -
NCT00375895 Chronic Hepatitis C ... More >> Evidence of Liver Transplantation Less << Phase 3 Terminated(Insufficient enroll... More >>ment) Less << - France ... More >> Service d'Hépatologie - Hôpital Jean Minjoz Besançon, France, 25030 Service d'Hépatogastroentérologie - Hôpital Beaujon Clichy, France, 92118 Service d'Hépatologie et Gastroentérologie - CH Henri Mondor Créteil, France, 94010 Service des Maladies de l'Appareil Digestif - CHRU Claude Huriez Lille, France, 59037 Service de Chirurgie Générale - Hôpital Edouard Herriot Lyon, France, 69437 Chirurgie Générale - Hôpital de la Conception Marseille, France, 13385 Service d'Hépato-gastro-entérologie - Hôpital Saint Eloi Montpellier, France, 34295 Chirurgie Viscérale et Digestive - Hôpital de l'Archet Nice, France, 06200 Service de Chirurgie Générale - Hôpital Cochin Paris, France, 75679 Service des Maladies du Foie - Hôpital Pontchaillou Rennes, France, 35033 Service de Chirurgie Générale et Transplantation Multi-organe - Hôpital de la Hautepierre Strasbourg, France, 67098 Service d'Hépato-gastro-entérologie - Hôpital de Rangueil Toulouse, France, 31403 Centre Hépato-Biliaire - Hôpital Paul Brousse Villejuif, France, 94804 Less <<
NCT00376311 Osteoarthritis Phase 2 Terminated - Belgium ... More >> St Luc University Hospital, Department of Rheumatology, Université Catholique de Louvain Brussels, Belgium, B-1200 Less <<
NCT00352846 - Completed - -
NCT00383240 Asthma Phase 3 Completed - -
NCT00381485 - Completed - -
NCT00374803 - Completed - -
NCT00383435 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00382161 Impotence Phase 3 Withdrawn(not enough patients ... More >>meeting inclusion criteria) Less << December 2007 Germany ... More >> University Hospital of the Saarland Homburg, Saarland, Germany, 66421 Less <<
NCT00383552 Asthma Phase 3 Completed - -
NCT00383435 - Completed - -
NCT00383721 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00383240 - Completed - -
NCT00390195 Hepatocellular Carcinoma Phase 1 Phase 2 Unknown June 2011 Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Her-Shyong Shiah, M.D.    +886-6-208-3422 ext 65113    hsshiah@nhri.org.tw    Principal Investigator: Li-Tzong Chen, M.D., Ph.D.          Sub-Investigator: Jang-Yang Chang, M.D.          Sub-Investigator: Wu-Chou Su, M.D.          Sub-Investigator: Her-Shyong Shiah, M.D.          Tri-Service General Hospital Active, not recruiting Taipei, Taiwan, 11490 Less <<
NCT00383721 - Completed - -
NCT00383552 - Completed - -
NCT00384969 Renal Cell Carcinoma Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT00393042 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 3 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60608 Northbrook HALP Clinic/ADHD Research Center Northbrook, Illinois, United States, 60062 Less <<
NCT00393042 - Completed - -
NCT00393263 Lichen Sclerosus Phase 2 Completed - United States, District of Col... More >>umbia Center for VulvoVaginal Disorders Washington, District of Columbia, United States, 21012 Less <<
NCT00402662 Metastatic Melanoma Phase 2 Terminated(unexpected level of... More >> toxicity) Less << - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520-8028 Less <<
NCT00381485 Asthma Phase 3 Completed - -
NCT00446004 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center and Montefiore University Hospital locations) Pittsburgh, Pennsylvania, United States, 15232 / 15213 Less <<
NCT00402428 Chronic Hepatitis C Phase 3 Completed - -
NCT00446368 Carcinoma, Renal Cell Phase 2 Completed - United States, Texas ... More >> Baylor College of Medicine - Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00451997 Leukemia, Myeloid ... More >> Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00443937 Renal Transplantation Phase 4 Completed - Germany ... More >> Charité-Universitätsmedizin Berlin, Germany, 10117 Less <<
NCT00466102 Breast Cancer Phase 2 Unknown December 2012 Germany ... More >> Dr. med. Christoph Mundhenke Kiel, Schleswig-Holstein, Germany, 24105 Less <<
NCT00446316 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center and Montefiore University Hospital locations) Pittsburgh, Pennsylvania, United States, 15232 / 15213 Less <<
NCT00473642 Age-Related Maculopathy ... More >> Choroidal Neovascularization Less << Phase 4 Completed - United States, Oklahoma ... More >> Eagle Mountain Vision Tulsa, Oklahoma, United States, 74132 Less <<
NCT00468936 Heart Transplant Patients Phase 3 Unknown December 2009 Canada, Quebec ... More >> McGill University Health Centre Recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Charlene Barber    514 934 1934 ext 36764    charlene.barber@muhc.mcgill.ca    Principal Investigator: Nadia Giannetti Less <<
NCT00402766 Mesothelioma Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00473642 - Completed - -
NCT00485485 - Completed - -
NCT00486317 Osteoarthritis Phase 1 Completed - Denmark ... More >> CCBR A/S Ballerup, Denmark, 2750 Less <<
NCT01336296 Kidney Transplant Recipients Phase 4 Completed - United States, Ohio ... More >> University of Cincinnati Medical Center Cincinnati, Ohio, United States, 45267 Less <<
NCT00473005 Breast Cancer Phase 1 Terminated(Principal Investiga... More >>tor (Dr. Guardino) left Stanford) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00485485 Head and Neck Cancer ... More >> Squamous Cell Cancer Less << Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01336296 - Completed - -
NCT01338090 - Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT01345136 Neurofibromatosis Type 2 ... More >> Neuroma, Acoustic Less << Phase 2 Active, not recruiting February 1, 2020 United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095-7286 Less <<
NCT00486434 Osteoarthritis Phase 3 Completed - Czech Republic ... More >> CCBR Czech Pardubice, Czech Republic, 53002 Denmark CCBR Aalborg Aalborg, Denmark, 9000 CCBR Ballerup Ballerup, Denmark, 2750 CCBR Vejle Vejle, Denmark, 7100 Estonia CCBR Estonia Tallinn, Estonia, 10128 Hong Kong CCBR Hong Kong Hong Kong, Hong Kong Poland Centrum Osteoporozy i Chorób Kostno Stawowych, ul. Waryńskiego 6/2 Bialystok, Poland, 15-461 CCBR Poland Warsaw, Poland, 04703 Romania CCBR Romania Bucharest, Romania, 030463 Less <<
NCT01363128 Leukemia Phase 2 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01376622 - Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT01336842 Solid Tumors ... More >>Non-Small Cell Lung Cancer (NSCLC) Less << Phase 1 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 Less <<
NCT01387659 Diabetes Immu... More >>nosuppression Less << Phase 4 Terminated(Study terminated du... More >>e to slow enrollment) Less << - United States, Texas ... More >> University of Texas Medical Branch Galveston, Texas, United States, 77555 Less <<
NCT00486369 Osteoarthritis Phase 1 Completed - Denmark ... More >> CCBR A/S Ballerup, Denmark, 2750 Less <<
NCT01385293 - Terminated(The trial was stopp... More >>ed at the first stage due to futility) Less << - -
NCT01417806 Small Cell Lung Cancer Phase 2 Unknown December 2016 United States, Florida ... More >> VA. Medical Center Recruiting Miami, Florida, United States, 33125 Contact: Niramol Savaraj, M.D.    305-575-3143    nsavaraj@med.miami.edu    Contact: Vy Dinh, M.D.    305-575-3143    vdinh@med.miami.edu    Principal Investigator: Niramol Savaraj, M.D. Less <<
NCT01399918 Renal Cell Carcinoma Phase 2 Active, not recruiting July 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07939 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Less <<
NCT01385956 Pancreatic Cancer Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01419665 Follicular Lymphoma Phase 3 Completed - -
NCT01425411 Hypertension ... More >>Left Ventricular Hypertrophy Less << Phase 4 Completed - Turkey ... More >> Mustafa Kemal University School of Medicine, Department of Cardiology Antioch, Turkey, 31100 Less <<
NCT01390350 Schnitzler Syndrome Phase 2 Completed - Germany ... More >> Allergie-Centrum-Charité, Charité University Berlin, Germany, 10117 Dept. of Dermatology, Klinikum Darmstadt Darmstadt, Germany Dept. of Dermatology, University Heidelberg Heidelberg, Germany Dept. of Dermatology, University Münster Münster, Germany Dept. of Dermatology, University Tübingen Tübingen, Germany Less <<
NCT01428635 Leukemia Chro... More >>nic Myeloid Leukemia Myelofibrosis Less << Phase 2 Active, not recruiting January 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01424371 - Unknown June 2013 Canada, British Columbia ... More >> Fraser Health Authority Recruiting Surrey, British Columbia, Canada, V3T 5H5 Principal Investigator: PAUL G VAN BUYNDER, MBBS MPH Less <<
NCT01432106 Hypertension ... More >>Metabolic Syndrome Less << Phase 1 Withdrawn(Novartis terminated ... More >>all projects involving aliskiren. Findings of the DMC overseeing the ALTITUDE clinical trial found a higher incidence of adverse events.) Less << - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48106 Less <<
NCT01470209 Solid Tumors ... More >>Lung Cancer Less << Phase 1 Completed - United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01464229 - Completed - -
NCT01385293 Prostate Cancer ... More >> Metastatic (Spread to Other Areas of the Body) Less << Phase 2 Terminated(The trial was stopp... More >>ed at the first stage due to futility) Less << - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less <<
NCT01480791 Hypertension ... More >>Diabetes Less << Phase 2 Withdrawn(Because of results o... More >>f Altitude trial, this trial was cancelled.) Less << - Canada, Quebec ... More >> Cardiovascular Prevention Centre, Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT01484041 Breast Cancer Phase 1 Phase 2 Terminated(Decision by company... More >> to cease development of dovitinib) Less << - United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT01484041 - Terminated(Decision by company... More >> to cease development of dovitinib) Less << - -
NCT01487317 Delirium Phase 3 Completed - France ... More >> Pitié Salpetriere Hospital Paris, France, 75013 Less <<
NCT01484860 Adenocarcinoma of the Pancreas... More >> Metastatic Disease Less << Phase 2 Terminated - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01477606 Acute Myeloid Leukemia Phase 2 Active, not recruiting June 2020 -
NCT01504776 Mantle Cell Lymphoma Phase 1 Completed - United States, Georgia ... More >> Georgia Regents University Augusta, Georgia, United States, 30912 Less <<
NCT01488487 - Completed - -
NCT01464229 Major Depressive Disorder Phase 4 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01524692 Adenoid Cystic Carcinoma Phase 2 Completed - United States, Virginia ... More >> University of Virginia Health System Charlottesville, Virginia, United States, 22908 Less <<
NCT01521715 Locally Advanced and/or Metast... More >>atic Renal Cell Carcinoma Carcinoma, Renal Cell Clear-cell Metastatic Renal Cell Carcinoma Less << Phase 4 Completed - Germany ... More >> Urolog. Klinik im Waldkrankenhaus St. Marien, Friedrich-Alexander-Universität Erlangen, Germany, 91054 Universitätsklinikum Essen, Klinik f. Urologie Essen, Germany, 45122 Med. Klinik II, Johann-Wolfgang-Goethe-Universität Frankfurt, Germany, 60590 Medizinisches Versorgungszentrum (MVZ) Osthessen GmbH Fulda, Germany, 36043 Universitätsmedizin Greifswald Greifswald, Germany, 17475 Medizinische Hochschule Hannover Hannover, Germany, 30625 Ludwig-Maximilians-Universität (LMU) München, Klinikum Grosshadern München, Germany, 81377 Universitätsklinikum Münster Münster, Germany, 48149 Less <<
NCT01501604 Lung Cancer B... More >>reast Cancer Colorectal Cancer Cholangiocarcinoma Solid Tumors Less << Phase 2 Withdrawn(The study has been c... More >>losed due to lack of accrual) Less << - -
NCT01579929 Lung Cancer Phase 1 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT01545427 Scleroderma Phase 2 Terminated(Frequent adverse ev... More >>ents occurred early in treatment with poor tolerability.) Less << - Canada, Ontario ... More >> Lawson Health Research Institute London, Ontario, Canada, N6A 4V2 Less <<
NCT01583257 Quality of Life Phase 1 Phase 2 Completed - Canada, Nova Scotia ... More >> QEII Health Sciences Center, MOTP Halifax, Nova Scotia, Canada, B3H 2Y9 Less <<
NCT01488487 Advanced Adult Hepatocellular ... More >>Carcinoma Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, North Carolina University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01592097 - Completed - United States, California ... More >> Keck School of Medicine of the University of Southern Calfornia Los Angeles, California, United States, 90033 Less <<
NCT01524692 - Completed - -
NCT01636466 Kidney Failure, Chronic Phase 3 Terminated(Feasibility) - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01636466 - Terminated(Feasibility) - -
NCT01580592 - Completed - -
NCT01580592 Cold Contact Urticaria Phase 2 Completed - Germany ... More >> University Aachen Aachen, Germany Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin Berlin, Germany, 10117 Hautklinik Mainz Mainz, Germany Less <<
NCT01642732 Prostate Cancer Phase 1 Terminated(Lack of accrual and... More >> funding expires in June, 2014.) Less << - United States, District of Col... More >>umbia Georgetown University Washington, D.C., District of Columbia, United States, 20057 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT01642732 - Terminated(Lack of accrual and... More >> funding expires in June, 2014.) Less << - -
NCT01651039 Multiple Myeloma Phase 2 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT00871338 Neisseria Meningitidis ... More >> Haemophilus Influenzae Type b Less << Phase 2 Completed - United Kingdom ... More >> GSK Investigational Site Ely, Cambridgeshire, United Kingdom, CB7 4HF GSK Investigational Site Southampton, Hampshire, United Kingdom, SO16 6YD GSK Investigational Site Oxford, Oxfordshire, United Kingdom, OX3 7LJ GSK Investigational Site Bristol, United Kingdom, BS2 8AE GSK Investigational Site London, United Kingdom, SW17 0QT Less <<
NCT00812019 Influenza Phase 1 Phase 2 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Germany Universitätsklinikum Gießen und Marburg GmbH Gießen, Germany, 35392 Less <<
NCT01678105 Recurrent Adenoid Cystic Carci... More >>noma of the Salivary Glands Metastatic Adenoid Cystic Carcinoma of the Salivary Glands Salivary Gland Cancers ACC Less << Phase 2 Completed - Canada, Ontario ... More >> Tom Baker Cancer Centre Calgary, Ontario, Canada, T2N 4N2 Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT00871338 - Completed - -
NCT01651039 - Completed - -
NCT01686815 - Unknown December 2015 United States, Massachusetts ... More >> Freedom Trail Clinic Recruiting Boston, Massachusetts, United States, 02114 Contact: Liana J Petruzzi, BA    617-912-7882    lpetruzzi@partners.org    Contact: Leah N Briggs, BS    617-912-7848    lbriggs@partners.org    Principal Investigator: David C Henderson, MD Less <<
NCT01680796 Multiple Myeloma Phase 1 Withdrawn(The target drug, dov... More >>itinib, failed as a single agent in prior studies in patients with heavily treated multiple myeloma.) Less << - -
NCT01702415 Cystic Fibrosis Phase 4 Withdrawn(Lack of funding) December 2015 United Kingdom ... More >> Papworth Hospital NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom, CB23 3RE Less <<
NCT01755871 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Terminated(lack of recruitment... More >>) Less << - Germany ... More >> Heinrich Heine Universität Düsseldorf Düsseldorf, Nord-Rhein Westfahlen, Germany, 40225 Less <<
NCT01769547 Advanced Malignant Pleural Mes... More >>othelioma MPM Less << Phase 2 Terminated(Stage 1 accrual com... More >>pleted. Study did not proceed to Stage 2 accrual.) Less << - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Ottawa General Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Northeast Cancer Centre, Health Sciences North Sudbury, Ontario, Canada, P3E 5J1 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 1X6 Less <<
NCT01717898 - Terminated(Dose limiting toxic... More >>ities on lowest dose level) Less << - -
NCT01801280 - Completed - -
NCT01816256 Myeloproliferative Neoplasms (... More >>MPN) Polycythemia Vera (PV) Essential Thrombocythemia (ET) Myelofibrosis (MF) Less << Not Applicable Recruiting April 2019 Canada, Ontario ... More >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Devyani Premkumar       Devyani.Premkumar@sunnybrook.ca    Principal Investigator: Jeannie Callum          Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Vikas Gupta, MD, FRCP       vikas.gupta@uhn.ca    Principal Investigator: Vikas Gupta, MD, FRCP Less <<
NCT01801280 Bioavailability ... More >> Drug Interactions Less << Phase 4 Completed - Germany ... More >> Charité Hospital Campus Mitte Berlin, Germany, 10117 Less <<
NCT00962624 Meningococcal Meningitis, Sero... More >>group A Meningococcal Meningitis, Serogroup B Meningococcal Meningitis, Serogroup C Meningococcal Meningitis, Serogroup Y Meningococcal Meningitis, Serogroup W Less << Phase 2 Completed - United Kingdom ... More >> Manchester Medical Microbiology Partnership Manchester, United Kingdom, M13 9WZ Less <<
NCT01819389 Leukemia, Myeloid, Chronic, BC... More >>R-ABL Positive Less << Phase 3 Completed - Mexico ... More >> Servicio de Hematologia, Hospital Universitario "José E. Gonzalez" Monterrey, Nuevo Leon, Mexico, 64460 Less <<
NCT00901940 Meningitis Se... More >>pticemia Less << Phase 3 Completed - United Kingdom ... More >> University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine Oxford, United Kingdom, OX3 7LJ Less <<
NCT01917318 Post Traumatic Stress Disorder Phase 2 Completed - United States, Colorado ... More >> University of Colorado Depression Center; Clinical and Translational Research Center (CTRC) Aurora, Colorado, United States, 80045 Less <<
NCT01830361 Acute Myeloid Leukemia Phase 2 Active, not recruiting September 2020 Germany ... More >> Klinikum Chemnitz gGmbH, Klinik für Innere Medizin III Chemnitz, Germany Universitätsklinikum Dresden Medizinische Klinik und Poliklinik I Dresden, Germany Marien Hospital Düsseldorf, Germany Universitätsklinikum Erlangen, Medizinische Klinik 5 Erlangen, Germany Klinikum der Johann-Wolfgang-Goethe Universität Frankfurt Main, Germany Universitätsklinikum Heidelberg Heidelberg, Germany Universitätsklinikum Jena, Klinik für Innere Medizin II Jena, Germany Universitätsklinikum Gießen und Marburg GmbH Marburg, Germany Universitätsklinikum Münster Münster, Germany Städtisches Klinikum Nord Nürnberg, Germany Klinikum der Universität Regensburg Regensburg, Germany Less <<
NCT01717898 Castrate-resistant Prostate Ca... More >>ncer Less << Phase 1 Phase 2 Terminated(Dose limiting toxic... More >>ities on lowest dose level) Less << - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT01921673 Gastric Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01920802 - Completed - -
NCT01929889 - Terminated(Low recruitment) - -
NCT01870505 Metastatic or Locally-advanced... More >> Unresectable Breast Cancer Less << Phase 1 Active, not recruiting May 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01933516 Indolent B-cell Non-Hodgkin's ... More >>Lymphoma Less << Phase 1 Completed - Japan ... More >> Investigative Site Tachikawa, Tokyo, Japan, 190-0014 Less <<
NCT01920802 Healthy Phase 4 Completed - United States, New York ... More >> New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT01936519 Immunosuppression ... More >> Renal Failure Less << Not Applicable Active, not recruiting December 2019 United States, Pennsylvania ... More >> Penn State College of Medicine; Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT01935128 Renal Transplant Phase 4 Active, not recruiting December 2020 United States, Ohio ... More >> University of Toledo, Health Science Campus Toledo, Ohio, United States, 43614 Less <<
NCT01929889 Schizophrenia ... More >> Schizoaffective Disorder Less << Phase 4 Terminated(Low recruitment) - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT02023151 - Completed - -
NCT02062892 Kidney Transplantation Phase 4 Withdrawn(Patients meeting the... More >> inclusion/ exclusion criteria did not agree to participate. It became obvious that recruitment goals could not be met.) Less << - -
NCT02023151 Allergic Asthma Phase 4 Completed - United States, Maryland ... More >> Johns Hopkins Asthma & Allergy Center Baltimore, Maryland, United States, 21212 Less <<
NCT02087748 - Completed - -
NCT02087748 Pain Delayed ... More >>Onset Muscle Soreness Less << Phase 4 Completed - United States, California ... More >> Lotus Clinical Research, LLC Pasadena, California, United States, 91105 Less <<
NCT02125084 Prostate Cancer Phase 1 Active, not recruiting January 2019 United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Florida Cancer Center Saint Petersburg, Florida, United States, 33705 United States, Ohio Oncology Hematology Care Inc. Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Less <<
NCT02000882 Brain Metastases ... More >> Breast Cancer Metastatic Breast Cancer Less << Phase 2 Active, not recruiting December 2018 United States, Texas ... More >> Please contact Zuzanne Bristow for list of sites Multiple Locations, Texas, United States Less <<
NCT02118987 Drug Allergy Phase 1 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02084446 Transplantation Infection ... More >> Cytomegalovirus Infections Less << Phase 4 Unknown August 2015 Brazil ... More >> Hospital Geral de Fortaleza Fortaleza, Ceará, Brazil, 60175-295 Less <<
NCT02126904 - Unknown - Japan ... More >> Yokohama City University Medical Center Recruiting Yokohama, Kanagawa, Japan, 232-0024 Contact: Maiko Inoue, M.D.    81 45 261 5656 ext 7458    maicoo@urahp.yokohama-cu.ac.jp    Principal Investigator: Maiko Inoue, M.D. Less <<
NCT02169115 - Completed - -
NCT02151864 Hepatocellular Carcinoma ... More >> Cirrhosis Less << Phase 1 Active, not recruiting January 2019 United States, California ... More >> UCSD Moores Cancer Center La Jolla, California, United States, 92093 Less <<
NCT02113878 Carcinoma, Squamous Cell of He... More >>ad and Neck HPV Positive Oropharyngeal Squamous Cell Carcinoma Hypopharyngeal Cancer Early Invasive Cervical Squamous Cell Carcinoma Carcinoma of Larynx Cancer of Nasopharynx Less << Phase 1 Active, not recruiting March 2020 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02113397 - Terminated(Insufficient enroll... More >>ment) Less << - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT02169115 Symptomatic Dermographism Phase 2 Completed - Germany ... More >> University Dermatology Freiburg Freiburg, Germany, 79104 Dermatology University Mainz Mainz, Germany, 55131 Less <<
NCT02195973 Recurrent Ovarian Cancer Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT02130466 Melanoma Soli... More >>d Tumors Less << Phase 1 Phase 2 Recruiting July 10, 2021 United States, Arizona ... More >> Call for Information (Investigational Site 0030) Recruiting Tucson, Arizona, United States, 85719 United States, California Call for Information (Investigational Site 0001) Recruiting Los Angeles, California, United States, 90025 Call for Information (Investigational Site 0003) Recruiting Los Angeles, California, United States, 90095 United States, Indiana Call for Information (Investigational Site 0031) Recruiting Fort Wayne, Indiana, United States, 46845 United States, Massachusetts Call for Information (Investigational Site 0002) Recruiting Boston, Massachusetts, United States, 02215 United States, Pennsylvania Call for Information (Investigational Site 0007) Recruiting Philadelphia, Pennsylvania, United States, 19104 Australia Merck Sharp & Dohme Recruiting North Ryde, Australia Contact: Australian Medical Information Centre    61 2 8988 8428       Canada, Quebec Merck Canada Recruiting Kirkland, Quebec, Canada, H9H 4M7 Contact: Medical Information Centre Centre d'information medicale Merck Canada Inc.    514-428-8600 / 1-800-567-2594 Less <<
NCT02185690 Lungcancer Phase 1 Recruiting April 2019 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G1Z2 Contact: Quincy Chu, MD    780-432-8248    quincy.chu@albertahealthservices.ca    Sub-Investigator: Quincy Chu, MD          Canada, Ontario Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Peter Ellis, MD    905-387-9711 ext 64609    Peter.Ellis@jcc.hhsc.ca    Sub-Investigator: Peter Ellis, MD          The Ottawa Hospital Regional Cancer Centre Recruiting Ottawa, Ontario, Canada, K1G 3Y9 Contact: Scott Laurie, MD    613-737-7700 ext 70175    slaurie@ottawahospital.on.ca    Sub-Investigator: Scott Laurie, MD          Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G2M9 Contact: Natasha Leighl, MD    416-946-4645    Natasha.Leighl@uhn.ca    Contact: Maggie Sawczak, CRA    416-946-4501 ext 5444    Maggie.Sawczak@uhn.ca    Principal Investigator: Natasha Leighl, MD Less <<
NCT01368796 Influenza Vaccine Phase 4 Completed - Canada, British Columbia ... More >> University of British Columbia, VITALiTY Research Center Vancouver, British Columbia, Canada Canada, Manitoba University of Manitoba, Department of Medicine Winnipeg, Manitoba, Canada Canada, Nova Scotia Canadian Centre for Vaccinology Dalhousie University Halifax, Nova Scotia, Canada Canada, Ontario McMaster University Hamilton, Ontario, Canada The Ottawa Hospital Research Institute, University of Ottawa Ottawa, Ontario, Canada University of Toronto, Mt Sinai Hospital Toronto, Ontario, Canada Canada, Quebec McGill University Health Center - Vaccine Study Center Montreal, Quebec, Canada Unité de Recherche en Santé Publique (CHUQ), Quebec City, Quebec, Canada Less <<
NCT02201212 TSC1 TSC2 ... More >> Tuberous Sclerosis Complex MTOR Less << Phase 2 Active, not recruiting January 2022 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02220855 Thymoma Phase 2 Active, not recruiting November 1, 2018 United States, Indiana ... More >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT02236572 Breast Cancer Phase 2 Unknown September 2018 United States, Connecticut ... More >> Yale University New Have, Connecticut, United States, 06520 Less <<
NCT02254668 Intimal Proliferation ... More >> Immunosuppression Less << Phase 4 Recruiting February 2023 Switzerland ... More >> University Hospital Zurich, Division of Cardiology Recruiting Zurich, Switzerland, 8091 Contact: Christian Templin, MD, PhD    +41 (0)44 / 255 9585    christian.templin@usz.ch    Contact: Frank Ruschitzka, Professor    +41 (0)44 / 255 3957    frank.ruschitzka@usz.ch    Principal Investigator: Christian Templin, MD, PhD Less <<
NCT02229136 Stomatitis Or... More >>al Mucositis Neoplasm of the Breast Malignant Tumor of Breast Less << Phase 2 Active, not recruiting September 30, 2019 United States, Texas ... More >> 12 sites incl Yakima, WA, Boulder, CO, and Austin, TX US, Texas, United States Less <<
NCT02313051 Metastatic Breast Cancer Phase 2 Unknown December 2017 China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting Beijing, China, 100021 Contact: Binghe Xu, MD, Ph.D    +86-10-87788826    xubinghe@medmail.com.cn    Contact: Ying Fan, MD    861087788114    fanyingfy@medmail.com.cn    Principal Investigator: Binghe Xu, MD, Ph.D          Sub-Investigator: Ying Fan, MD Less <<
NCT02329132 - Completed - Japan ... More >> Kagawa University Faculty of Medicine Miki, Kagawa, Japan, 761-0793 Less <<
NCT02228681 Advanced, Persistent, or Recur... More >>rent Endometrial Cancer Less << Phase 2 Active, not recruiting - -
NCT02376985 Breast Cancer Phase 3 Recruiting May 31, 2019 Japan ... More >> Tokai University, School of Medicine Recruiting Isehara, Kanagawa, Japan, 259-1193 Contact: Naoki Niikura       niikura@is.icc.u-tokai.ac.jp    Contact: Yoshihide Ota    +81 463-93-1121    yotaorsg@ybb.ne.jp Less <<
NCT02353728 Chronic Myeloid Leukemia Phase 2 Recruiting January 2019 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Contact: Tania Curcio    212-746-2571    tjc9003@med.cornell.edu    Principal Investigator: Ellen Ritchie, MD Less <<
NCT02408380 - Unknown December 2015 Canada, Quebec ... More >> McGill University Recruiting Montreal, Quebec, Canada, H3A 2B4 Contact: Leslie Fitz-Gerald, MSc    5143987192 ext 00510    leslie.fitz-gerald@mail.mcgill.ca    Principal Investigator: David Haegert, MD Less <<
NCT02308904 THALASSEMIA MAJOR Not Applicable Recruiting June 2018 United States, California ... More >> UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Sylvia T Singer, MD    510-428-3169    TSinger@mail.cho.org Less <<
NCT02379247 Breast Cancer Phase 1 Phase 2 Active, not recruiting July 2019 United States, Kansas ... More >> University of Kansas Cancer Center Kansas City, Kansas, United States, 66205 University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States, 66210 United States, Missouri University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States, 64064 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT02345824 Glioblastoma ... More >>Glioma Less << Phase 1 Active, not recruiting January 2020 United States, Virginia ... More >> University of Virginia Health System Charlottesville, Virginia, United States, 22908 Less <<
NCT02506556 Metastatic Breast Cancer Phase 2 Unknown December 2018 Australia, Victoria ... More >> Peter MacCallum Cancer Centre Recruiting East Melbourne, Victoria, Australia, 3002 Contact: MEDONC1 Team clinical trials unit    +61396561111    trials.medonc1@petermac.org    Contact: Terese Masters    +61396561111 ext 3642    terese.masters@petermac.org Less <<
NCT01441193 HIV Infection Phase 1 Terminated(Enrollments were su... More >>spended due to delta-V2 Env unavailability, following the EMA/CHMP/BWP/534898/2008 guideline, not allowing the use of a retest date) Less << - Italy ... More >> Policlinico di Modena, Divisione di Malattie Infettive Modena, Italy, 41100 Azienda Ospedaliera San Gerardo, Divisione di Malattie Infettive Monza, Italy, 20052 IFO - S. Gallicano, Dermatologia Infettiva Rome, Italy, 00153 Less <<
NCT02537223 Squamous Cell Carcinoma of Hea... More >>d and Neck Locoregionally Advanced Less << Phase 1 Recruiting March 2020 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M3G 2M9 Contact: Aaron Hansen, M.D.    416-946-4501 ext 5606       Principal Investigator: Aaron Hansen, M.D. Less <<
NCT02539459 Sporadic Angiomyolipomas (AMLs... More >>) Less << Phase 2 Terminated(Extreme toxicity, m... More >>et toxicity stopping rules) Less << - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States United States, New York Memorial Sloan Kettering New York, New York, United States United States, North Carolina Duke University Health System Durham, North Carolina, United States United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 University of Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas M D Anderson Cancer Center Houston, Texas, United States Less <<
NCT02282371 Head and Neck Squamous Cell Ca... More >>ncer Less << Phase 1 Active, not recruiting October 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07939 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Less <<
NCT02524119 Hepatocellular Carcinoma Phase 2 Recruiting September 2021 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Payal Dixit, MD    214-648-7097    Payal.Dixit@UTSouthwestern.edu    Principal Investigator: Muhammad Beg, MD Less <<
NCT02580708 Non-small Cell Lung Cancer Phase 1 Phase 2 Terminated(Discontinued develo... More >>pment of rociletinib in NSCLC. Stopped enrollment of new patients into all studies involving rociletinib.) Less << - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Tennessee Tennessee Oncology, PLLC - The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 22031 Less <<
NCT02577926 Polycythemia Vera (PV) ... More >> Essential Thrombocythemia (ET) Less << Phase 2 Recruiting December 2022 Germany ... More >> Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie Recruiting Mannheim, Baden-Württemberg, Germany, 68167 Contact: Eva Langfelder, Prof. Dr.    +49 (0)621 383 41 31    eva.lengfelder@umm.de    Universitätsklinikum Ulm Klinik für Innere Medizin III Recruiting Ulm, Baden-Württemberg, Germany, 89081 Contact: Konstanz Döhner, Prof. Dr.    +49 (0)731 500 45543    konstanze.doehner@uniklinik-ulm.de    Rems-Murr Klinikum Winnenden Recruiting Winnenden, Baden-Württemberg, Germany, 71364 Contact: Stefani Parmentier, Dr.       stefani.parmentier@rems-murr-kliniken.de    Contact: Markus Schaich, Dr.       markus.schaich@rems-murr-kliniken.de    Studienzentrum Aschaffenburg Recruiting Aschaffenburg, Bayern, Germany, 63739 Contact: Martine Klausmann, Dr.       mk@klausmann.de    III. Medizinischen Klinik des Klinikums rechts der Isar der TU München Recruiting Müchen, Bayern, Germany, 81675 Contact: Philipp Jost, Dr. med.       philipp.jost@tum.de    Klinikum Nürnberg Nord Medizinische Klinik 5 Recruiting Nürnberg, Bayern, Germany, 90419 Contact: Marinela Augustin, Dr.    +49 (0) 911 398 3085    Marinela.Augustin@klinikum-nuernberg.de    Universitätsmedizin Mainz III. Medizinische Klinik und Poliklinik Recruiting Mainz, Hessen, Germany, 55131 Contact: Thomas Kindler, PD Dr.    +49 (0)6131 17-5046    thomas.kindler@unimedizin-mainz.de    Universitätsklinikum Bonn Medizinische Klinik und Poliklinik III Recruiting Bonn, Nordrhein-Westfalen, Germany, 53105 Contact: Dominik Wolf, Prof. Dr.    +49 (0)228 287 17233    dominik.wolf@ukb.uni-bonn.de    Johanniter-Krankenhaus Rheinhausen GmbH Hämatologie / Internistische Onkologie / Tagesklinik Recruiting Duisburg, Nordrhein-Westfalen, Germany, 47228 Contact: Jan Sebastian Balleisen, Dr. med.       s.balleisen@johanniter-rheinhausen.de    Universitätsklinikum Düsseldorf Klinik für Hämatologie, Onkologie und Klinische Immunologie Recruiting Düsseldorf, Nordrhein-Westfalen, Germany, 40225 Contact: Norbert Gattermann, Prof. Dr.       gattermann@med.uni-duesseldorf.de    Universitätsklinikum Essen Klinik für Hämatologie Recruiting Essen, Nordrhein-Westfalen, Germany, 45122 Contact: Göthert Joachim, Dr.       joachim.goethert@uk-essen.de    Mühlenkreiskliniken Johannes Wesling Klinikum Minden Klinik für Hämatologie, Onkologie und Palliativmedizin Recruiting Minden, Nordrhein-Westfalen, Germany, 32429 Contact: Martin Griesshammer, Prof. Dr.    +49 (0)571 790 4201    Martin.Griesshammer@muehlenkreiskliniken.de    Zentralklinikum Medizinische Klinik A Hämatologie, Hämostaseologie, Onkologie und Pneumologie Recruiting Münster, Nordrhein-Westfalen, Germany, 48149 Contact: Tim Sauer, Dr.    +49 (0) 251 83 52818    tim.sauer@ukmuenster.de    Marienhospital Recruiting Düsseldorf, North Rhine Westphalia, Germany, 40479 Contact: Aristoteles Giagounidis, Prof    +49 2 11 44 00 -25 01    aristoteles.giagounidis@vkkd-kliniken.de    Principal Investigator: Aristoteles Giagounidis, Prof          Zentrum für ambulante Hämatologie und Onkologie (ZAHO) Not yet recruiting Siegburg, North Rhine Westphalia, Germany, 53721 Contact: Stefan Fronhoffs, Dr.    +49 2241/59540    SFronhoffs@zaho-rheinland.de    Uniklinik RWTH Aachen Recruiting Aachen, NRW, Germany, 52074 Contact: Steffen Koschmieder, Prof. Dr.    00492418036102    skoschmieder@ukaachen.de    Contact: Susanne Isfort, Dr.    00492418037411    sisfort@ukaachen.de    Universitätsklinikum Magdeburg Recruiting Magdeburg, Sachesen-Anhalt, Germany, 39120 Contact: Denise Wolleschak, Dr.    0049 391 6713271    denise.wolleschak@med.ovgu.de    Universitätsklinikum Halle (Saale) Recruiting Halle (Saale), Sachsen-Anhalt, Germany, 06120 Contact: Haifa K. Al-Ali, PD Dr. med.    0345 5574959    innere4@uk-halle.de    Klinikum Chemnitz gGmbH Klinik für Innere Medizin III Recruiting Chemnitz, Sachsen, Germany, 09113 Contact: Hänel Mathias, PD Dr.    +49 (0)371 333 43045    m.haenel@skc.de    Universitätsklinikum Dresden Medizinische Klinik und Poliklinik I Recruiting Dresden, Sachsen, Germany, 01307 Contact: Uwe Platzbecker, Prof. Dr.    +49 (0)351 - 458 2583    uwe.platzbecker@uniklinikum-dresden.de    Charité Universitätsmedizin Berlin Med. Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie Recruiting Berlin, Germany, 13353 Contact: Philipp LeCoutre, PD Dr.    +49 30 450 665 307    philipp.lecoutre@charite.de    Universitätsklinikum Freiburg - Klinik für Innere Medizin I Recruiting Freiburg, Germany, 79106 Contact: Nikolas von Bubnoff, Prof. Dr.    +49 (0) 761 270-33210    nikolas.bubnoff@uniklinik-freiburg.de    Universitätsklinikum Hamburg Eppendorf Klinik und Poliklinik für Onkologie, Hämatologie und KMT mit Sektion Pneumologie Recruiting Hamburg, Germany, 20246 Contact: Philippe Schafhausen, PD Dr.    +49n (0)40 7410 57122    schafhausen@uke.de    Universitätsklinik Jena - Klinik für Innere Medizin II Recruiting Jena, Germany, 07705 Contact: Florian Heidel, Prof. Dr.    +49 3641 9-324210    Florian.Heidel@med.uni-jena.de Less <<
NCT02513667 ALK-positive Non-small Cell Lu... More >>ng Cancer Less << Phase 2 Recruiting August 2019 United States, Texas ... More >> UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Jessica Saltarski    214-648-7023    Jessica.Saltarski@UTSouthwestern.edu    Principal Investigator: Saad Khan, MD Less <<
NCT02554591 - Terminated(Changes in treatmen... More >>t plans affecting drug therapy choices) Less << - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00486434 - Completed - -
NCT00504400 Type 2 Idiopathic Macular Tela... More >>ngiectasia Less << Phase 2 Completed - Germany ... More >> Department of Ophthalmology, University of Bonn Bonn, Germany Less <<
NCT00510224 Prostate Cancer Phase 2 Terminated(Stopped at interim ... More >>analyses phase due to lack of efficacy) Less << - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT00501826 Leukemia Lymp... More >>hoblastic Lymphoma Leukemia, Lymphoblastic, Acute Less << Phase 2 Recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00493571 Myelodysplastic Syndromes ... More >> MDS Less << Phase 1 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00500188 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00510965 Choroidal Neovascularization Phase 2 Completed - Germany ... More >> University of Bonn Bonn, Germany, 53127 Less <<
NCT00511303 Chronic Myeloid Leukemia Phase 2 Completed - -
NCT00495859 Newly Registered Patients for ... More >>Primary Liver Transplantation Less << Not Applicable Unknown April 2011 Germany ... More >> Department of Surgery, Ruprecht-Karls University Recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact: Peter Schemmer, MD    +4962215636500    peter.schemmer@med.uni-heidelberg.de    Contact: Arash Nickkholgh, MD    +4962215638584    arash.nickkholgh@med.uni-heidelberg.de    Principal Investigator: Peter Schemmer, MD          Sub-Investigator: Arash Nickkholgh, MD Less <<
NCT00510224 - Terminated(Stopped at interim ... More >>analyses phase due to lack of efficacy) Less << - -
NCT00521300 Acromegaly Phase 4 Completed - Norway ... More >> Endocrinology Unit, Department of Medicine, Haukeland University Hospital Bergen, Norway Endocrinology Unit, Department of Medicine, Aker University Hospital Oslo, Norway Endocrinology Unit, Department of Medicine, Rikshospitalet-Radiumhospitalet Medical Center Oslo, Norway Endocrinology Unit, Department of Medicine, University Hospital of North Norway Tromsø, Norway Department of Endocrinology, St. Olavs Hospital Trondheim, Norway, 7006 Less <<
NCT00512213 Major Abdominal Surgery Not Applicable Completed - Switzerland ... More >> Department of Visceral Surgery, University Hospital Center Lausanne, Switzerland, 1011 Less <<
NCT00520052 Osteoporosis Not Applicable Completed - United Kingdom ... More >> Wirral Hospitals Universirt NHS Trust Upton, Wirral, Merseyside, United Kingdom, CH48 5PE Less <<
NCT00525798 Osteoporosis Phase 3 Completed - United States, Georgia ... More >> United Osteporosis Centers Gainesville, Georgia, United States, 30501 United States, Michigan Michigan Bone & Mineral Clinic PC, Detroit, Michigan, United States, 48236 United States, Oregon Oregon Osteoporosis Center Portland, Oregon, United States, 97213 Brazil CCBR Brazil Rio de Janeiro, Brazil, 22271-100 China CCBR China Beijing, China, 102206 Czech Republic CCBR Czech Pardubice, Czech Republic, 53002 Denmark CCBR Aalborg Aalborg, Denmark, 9000 CCBR Ballerup Ballerup, Denmark, 2750 CCBR Vejle Vejle, Denmark, 7100 Estonia CCBR Estonia Tallinn, Estonia, 10128 France Hopital Edouard Herriot Lyon, France, 69437 Hong Kong CCBR Hong Kong Hong Kong, Hong Kong Italy Department of Internal Medicine, University of Florence Florence, Italy Lithuania CCBR Lithuania Vilnius, Lithuania, 10323 Poland CCBR Poland Warsaw, Poland, 04703 Romania CCBR Romania Bucharest, Romania, 030463 Less <<
NCT00524849 Metastatic Breast Cancer ... More >> Bone Metastases Less << Phase 2 Phase 3 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT00527475 Macular Degeneration Phase 2 Completed - United States, California ... More >> California Retina Consultants & Research Foundation Santa Barbara, California, United States, 93103 United States, Michigan Associated Retinal Consultants Ann Arbor, Michigan, United States, 49301 United States, Texas Texas Retina Associates Arlington, Texas, United States, 76012 Less <<
NCT00527475 - Completed - -
NCT00529802 - Completed - -
NCT00542763 Primary Sjogren's Syndrome Phase 1 Completed - Germany ... More >> University Hospital Muenster Muenster, NRW, Germany, 48129 Less <<
NCT00490698 Kidney Cancer ... More >> Renal Cell Carcinoma Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00525798 - Completed - -
NCT00500110 Prostate Cancer Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00541814 Chronic Allograft Nephropathy Phase 4 Unknown February 2010 United Kingdom ... More >> University Hospital Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Less <<
NCT00500110 - Completed - -
NCT00504244 Systemic Lupus Erythematosus Phase 3 Terminated(Insufficient recrui... More >>tment) Less << - Netherlands ... More >> Erasmus MC Rotterdam, Netherlands, 3015 CE Less <<
NCT00507273 - Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00529802 Carcinoma, Renal Cell Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Oncology/Hematology Associates Peoria, Illinois, United States, 61615 United States, Massachusetts Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina The University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00507832 Prurigo Nodularis Phase 2 Completed - Germany ... More >> Department of Dermtology, University of Münster Münster, Germany, 48149 Less <<
NCT00511043 Lymphoma, Large-Cell, Diffuse Phase 2 Terminated(Manufacturer stoppe... More >>d drug development) Less << - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 South Carolina Oncology Associates Columbia, North Carolina, United States, 29210 Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00512902 Alveolitis Sy... More >>stemic Sclerosis Less << Phase 1 Phase 2 Completed - United States, California ... More >> UCLA David Geffen School of Medicine, Division of Rheumatology Los Angeles, California, United States, 90095 Less <<
NCT00490698 - Completed - -
NCT00522548 Transplants and Implants Phase 4 Terminated(enrollment halted i... More >>n order to have all patients complete follow-up by Jan 2011) Less << - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4322 Less <<
NCT00552071 Acromegaly Phase 4 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00552071 - Completed - -
NCT00522548 - Terminated(enrollment halted i... More >>n order to have all patients complete follow-up by Jan 2011) Less << - -
NCT00555581 Systemic Sclerosis Phase 2 Completed - United States, New York ... More >> Hospital for Special Surgery New York, New York, United States, 10021 Less <<
NCT00555581 - Completed - -
NCT00563615 Constipation Not Applicable Unknown October 2006 China ... More >> Caritas Medical Centre Recruiting Hong Kong, China Sub-Investigator: Yat Wah Yeung, Dr          Princess Margaret Hospital Recruiting Hong Kong, China Sub-Investigator: King Sun Chu, Dr          Sub-Investigator: Ka Man Ng, Dr          Sub-Investigator: Wing Hang Wong, Dr          Sub-Investigator: Hon Yeun, Dr          Yan Chai Hospital Recruiting Hong Kong, China Sub-Investigator: Wai Keung Kwan, Dr Less <<
NCT00558961 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Terminated(Unsatisfactory enro... More >>llment) Less << - Canada, Quebec ... More >> Charles Lemoyne Hospital Greenfield Park, Quebec, Canada, J4V 2H1 Jewish General Hospital Montreal, Quebec, Canada, H4T 1E2 Less <<
NCT00582556 Prostate Cancer Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00533624 End Stage Renal Disease Phase 2 Phase 3 Completed - United States, Florida ... More >> University of Miami Miller School of Medicine Miami, Florida, United States, 33136 Less <<
NCT00594230 Myelodysplastic Syndromes (MDS... More >>) Less << Phase 2 Terminated(Per protocol, the r... More >>esults of a planned interim analysis demonstrated insufficient efficacy and led to early termination of the study.) Less << - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00582556 - Completed - -
NCT00594230 - Terminated(Per protocol, the r... More >>esults of a planned interim analysis demonstrated insufficient efficacy and led to early termination of the study.) Less << - -
NCT00599326 Porphyria Cutanea Tarda Phase 3 Completed - United States, Texas ... More >> UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials Dallas, Texas, United States, 75390-8802 Less <<
NCT00610961 - Completed - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00512902 - Completed - -
NCT00615927 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00619216 - Completed - United States, North Carolina ... More >> University of North Carolina-Chapel Hill Chapel Hill, North Carolina, United States, 27599-7211 Less <<
NCT00574197 Gastrointestinal Symptoms ... More >> Heart Transplantation Less << Phase 4 Completed - United States, California ... More >> Cedars- Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT00599326 - Completed - -
NCT00629525 - Completed - -
NCT00615927 - Completed - -
NCT00613132 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00632255 - Completed - United Kingdom ... More >> Haematology Department. Catherine Lewis Centre. Hammersmith Hospital. Du Cane Road. London, United Kingdom, W12 0HS Less <<
NCT00634894 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 2 Withdrawn(Study halted with no... More >> registration, the drug company sponsor withdrew support.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00627991 Cerebrovascular Accident Not Applicable Withdrawn - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00657891 Asthma Phase 4 Completed - United States, Nebraska ... More >> Creighton University Medical Center Omaha, Nebraska, United States, 68131 Less <<
NCT02293668 Infertility Not Applicable Completed - Turkey ... More >> Istanbul University School of Medicine Istanbul, Turkey, 34093 Less <<
NCT00629525 Hormone Refractory Prostate Ca... More >>ncer Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University MEdical Center Durham, North Carolina, United States, 27710 Less <<
NCT00677092 Nephrogenic Systemic Fibrosis Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00680498 Age-Related Macular Degenerati... More >>on Less << Phase 4 Completed - United States, Illinois ... More >> Illinois Retina Associates Oak Park, Illinois, United States, 60304 Less <<
NCT00667953 Melanoma Adva... More >>nced Melanoma Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00732888 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center and Montefiore University Hospital locations) Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00713284 Renal Transplantation Phase 4 Completed - United States, California ... More >> California Pacific Medical Center; Barry S. Levin, MD Department of Transplantation San Francisco, California, United States, 94115 Less <<
NCT00745953 Metabolic Syndrome ... More >> Lipotoxicity Less << Phase 4 Unknown August 2009 United States, Texas ... More >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Less <<
NCT00749372 Myelodysplastic Syndrome (MDS) Not Applicable Completed - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10065 Less <<
NCT00756340 Recurrent or Refractory Solid ... More >>Tumors CNS Malignancies Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00805129 Bladder Cancer ... More >> Metastatic Transitional Cell Carcinoma Less << Phase 2 Active, not recruiting December 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00732784 Healthy Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Clinical and Translational Research Center (Hillman Cancer Center location) Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00811200 Uveal Melanoma Phase 2 Phase 3 Unknown - -
NCT00821587 Hepatitis C Phase 4 Completed - -
NCT00841581 Pigment Epithelial Detachment Phase 2 Completed - Canada, Ontario ... More >> Ivey Eye Institute London, Ontario, Canada, N6A 4G5 Less <<
NCT00858663 Head and Neck Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00867334 Colorectal Neoplasm ... More >> Colorectal Cancer Less << Phase 1 Phase 2 Completed - United States, Virginia ... More >> Virginia Cancer Specialists, PC Fairfax, Virginia, United States, 22031 Inova Fairfax Hospital Department of Surgery Falls Church, Virginia, United States, 22042 Less <<
NCT00804622 Chronic Hepatitis B Phase 2 Completed - China ... More >> Department of Medicine, Queen Mary Hospital Hong Kong, China Less <<
NCT00907179 Non-Small Cell Lung Cancer Phase 1 Terminated(Widespread use firs... More >>tline Pemetrexed; slow recruitment; funding withdrawn..) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00909363 Wiskott-Aldrich Syndrome ... More >> Thrombocytopenia Bleeding Less << Phase 2 Active, not recruiting June 2020 United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10065 Less <<
NCT00935961 HEAD & NECK Cancer Phase 1 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07939 United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00939159 Myelodysplastic Syndrome Phase 2 Terminated(Low Accrual) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00821587 - Completed - -
NCT00939159 - Terminated(Low Accrual) - -
NCT00961038 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 1 Completed - Germany ... More >> Hannover, Niedersachsen, Germany, 30625 Less <<
NCT00966992 Uterine Cervical Neoplasms Phase 2 Terminated(Lack of enrollment) - United States, Missouri ... More >> Washington University St. Louis, Missouri, United States, 63110 Less <<
NCT00865280 Skin Diseases, Infectious Phase 3 Terminated(Terminated) - United States, California ... More >> Paratek Recruiting Site Fountain Valley, California, United States, 92708 Parateck Recruiting Site La Mesa, California, United States, 91942 Paratek Recruiting Site Oceanside, California, United States, 92056 Paratek Recruiting Site San Diego, California, United States, 92114 Paratek Recruiting Site San Jose, California, United States, 95154 United States, Georgia Parateck Recruiting Site Columbus, Georgia, United States, 31904 Paratek Recruiting Site Savannah, Georgia, United States, 31406 Less <<
NCT00966992 - Terminated(Lack of enrollment) - -
NCT00967928 Cervical Cancer Phase 1 Withdrawn(Lack of enrollment) December 2010 -
NCT00981370 Anemia, Sickle Cell ... More >> Transfusion Hemosiderosis Less << Phase 3 Terminated(1 consented patient... More >> never started on study drug, lost to follow up) Less << - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT00981370 - Terminated(1 consented patient... More >> never started on study drug, lost to follow up) Less << - -
NCT00982033 Heart Failure Phase 4 Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00985946 Neuroendocrine Tumors Phase 2 Terminated(Study did not meet ... More >>statistical requirements to continue.) Less << - United States, Wisconsin ... More >> University of Wisconsin, Madison Madison, Wisconsin, United States, 53792 Less <<
NCT00985946 - Terminated(Study did not meet ... More >>statistical requirements to continue.) Less << - -
NCT00994110 - Completed - -
NCT00994110 Pancreatic Cancer Phase 3 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00994253 Hypertension ... More >>Diabetes Type 2 Less << Phase 4 Withdrawn(Due to safety concer... More >>ns re the concomitant use of aliskiren with an ACEi or ARB.) Less << December 2012 United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 Less <<
NCT01004510 Malignant Pleural Effusion ... More >> Non Small Cell Lung Cancer Less << Phase 2 Terminated(failure to accrue p... More >>rojected number of patients) Less << - United States, New York ... More >> Rochester General Hospital Rochester, New York, United States, 14621 Less <<
NCT01000051 Thrombocytopenia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00952991 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00982033 - Completed - -
NCT00677092 - Completed - -
NCT01004510 - Terminated(failure to accrue p... More >>rojected number of patients) Less << - -
NCT01009346 Head and Neck Cancer Phase 1 Phase 2 Terminated(Toxicity) - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21231 Less <<
NCT01005797 Renal Cancer ... More >>Non Small Cell Lung Cancer (NSCLC) Soft Tissue Sarcoma Less << Phase 1 Completed - United States, South Carolina ... More >> Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Less <<
NCT01009346 - Terminated(Toxicity) - -
NCT01013597 Thyroid Carcinoma Phase 2 Completed - United States, Wisconsin ... More >> St. Vincent Regional Cancer Center CCOP Green Bay, Wisconsin, United States, 54301 University of Wisconsin - Madison Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01013597 - Completed - -
NCT01023542 Renal Impairment ... More >> Liver Transplantation Everolimus Less << Phase 2 Phase 3 Unknown December 2014 Germany ... More >> Regensburg University Hospital Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Andreas A Schnitzbauer, MD    +49-941944 ext 6770    andreas.schnitzbauer@klinik.uni-r.de Less <<
NCT01031212 Tumors Phase 1 Withdrawn(The investigator has... More >> left the institution (UCSF) prior to study start-up) Less << June 2013 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT01031628 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Terminated(Lack of feasibility... More >> secondary to slow accrual) Less << - United States, California ... More >> Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States, 90048 Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, District of Columbia Washington Cancer Institute Washington, District of Columbia, United States, 20010 United States, Illinois Northwestern University Chicago, Illinois, United States, 60622 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52246 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Carolinas Hematology Oncology Associates Charlotte, North Carolina, United States, 28203 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01031628 - Terminated(Lack of feasibility... More >> secondary to slow accrual) Less << - -
NCT01044303 Transplant; Failure, Kidney Phase 4 Completed - United States, North Carolina ... More >> East Carolina University Greenville, North Carolina, United States, 27834 Less <<
NCT01044303 - Completed - -
NCT01046305 - Active, not recruiting November 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01060865 Blood Pressure, High Phase 4 Terminated(The participants si... More >>gned an old version of the informed consent.) Less << - Israel ... More >> Clalit health services Hertsliyah, Hasharon Area, Israel Less <<
NCT01063478 Non-Small Cell Lung Cancer Phase 1 Terminated(Poor accrual) - United States, Illinois ... More >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 Less <<
NCT01072266 Solid Tumor A... More >>dvanced Cancer Metastatic Cancer Less << Phase 1 Completed - United States, Maryland ... More >> Baltimore, Maryland, United States United States, Tennessee Nashville, Tennessee, United States Less <<
NCT01074086 AML Phase 1 Completed - France ... More >> Sophie Park Paris, France, 75014 Less <<
NCT01090973 - Terminated(Pharmaceutical comp... More >>any request.) Less << - -
NCT01111058 Head and Neck Cancer Phase 2 Active, not recruiting July 2018 United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Illinois-Chicago Chicago, Illinois, United States, 60612 The University of Chicago Medical Center Chicago, Illinois, United States, 60637 Ingalls Cancer Research Center Harvey, Illinois, United States, 60426 United States, Kansas University of Kansas Kansas City, Kansas, United States, 66160 United States, Louisiana Louisianna State University Shreveport, Louisiana, United States, 71130 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Mississippi University of Mississippi Jackson, Mississippi, United States, 39216 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas The University of Texas Medical Branch at Galveston Galveston, Texas, United States, 77555 Less <<
NCT01071928 Urothelial Carcinoma Phase 2 Withdrawn(Lack of efficacy of ... More >>experimental treatment) Less << - -
NCT01090973 Non-Hodgkin's Lymphoma Phase 2 Terminated(Pharmaceutical comp... More >>any request.) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01127763 - Completed - -
NCT01133678 Head and Neck Cancer Phase 2 Active, not recruiting October 2018 United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60637 NorthShore University Health System Evanston, Illinois, United States, 60201 Less <<
NCT01044667 Lung Transplantation Not Applicable Terminated(poor enrollment and... More >> lack of study staff) Less << - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-4753 Less <<
NCT01127763 Breast Cancer Phase 2 Completed - United States, New York ... More >> NYU Clinical Cancer Center New York, New York, United States, 10016 Less <<
NCT01018225 Nocturia Phase 4 Withdrawn(Study was cancelled ... More >>due to lack of enrollment) Less << July 2010 -
NCT01129557 - Terminated - -
NCT01145391 Hypertension Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT01138423 Hypertension ... More >>Abdominal Obesity Metabolic Syndrome Less << Phase 4 Completed - Netherlands ... More >> UMC Utrecht Utrecht, Netherlands, 3508 GA Less <<
NCT01129557 Proteinuric Kidney Disease ... More >> Diabetic Nephropathy Hypertensive Nephrosclerosis IgA Nephropathy Focal Segmental Glomerulosclerosis Glomerulopathy (Obesity-associated) Glomerulonephritis, Membranous Less << Phase 4 Terminated - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01145391 - Completed - -
NCT01165983 - Completed - -
NCT01170936 Urticaria Vas... More >>culitis Less << Phase 2 Completed - Germany ... More >> Charité-Universitätsmedizin Berlin Berlin, Germany, 10117 Less <<
NCT01204203 Mesothelioma Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01182168 Bladder Cancer ... More >> Renal Pelvis Cancer Ureter Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01204203 - Completed - -
NCT01226732 Metastatic or Unresectable Sol... More >>id Tumor Malignancy Less << Phase 1 Completed - United States, Florida ... More >> Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Oklahoma Oklahoma University Oklahoma City, Oklahoma, United States, 71304 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01230502 Liver Transplant Not Applicable Terminated(insufficient study ... More >>population to meet study objective) Less << - United States, Wisconsin ... More >> University of Wisconsin- Madison Madison, Wisconsin, United States, 53792 Less <<
NCT02682719 Diastolic Dysfunction Phase 2 Unknown December 2018 Ireland ... More >> The STOP-HF Service, St Michael's Hosptial Recruiting Dun Laoghaire, Dublin, Ireland Contact: Alison Sheerin, RGN    0035312713071    A.Sheerin@stmichaels.ie    Contact: Fiona Ryan, BPharm, PhD    00353861708998    fiona@heartbeat-trust.org Less <<
NCT01243944 Polycythemia Vera Phase 3 Completed - -
NCT01222143 Acute Myeloid Leukemia Phase 1 Phase 2 Terminated - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01230502 - Terminated(insufficient study ... More >>population to meet study objective) Less << - -
NCT01165983 Diabetes Type 2 Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center, Joslin Foot Center & Microcirculation Laboratory Boston, Massachusetts, United States, 02215 Less <<
NCT01245179 Sickle Cell Disease Phase 1 Active, not recruiting July 2023 United States, Georgia ... More >> Augusta University Augusta, Georgia, United States, 30912 Less <<
NCT01226732 - Completed - -
NCT01222936 Small Cell Lung Carcinoma Phase 2 Completed - Germany ... More >> Klinik für Onkologie und Haematologie Frankfurt am Main, Germany, 60488 Klinikum Kassel Innere Medizin Kassel, Germany, 34125 Italy Azienda Ospedaliera "S. G. Moscati" Avellino, AV, Italy, 83100 Istituto Nazionale Ricerca sul Cancro Genova, GE, Italy, 16132 U.O. di Oncologia Medica Palermo, PA, Italy, 90141 Ospedale Maggiore di Parma Parma, PR, Italy, 43100 Azienda Ospedaliera San Camillo Forlanini Rome, RM, Italy, 00151 Az. San. Ospedaliera Molinette S. Giovanni Battista di Torino Torino, TO, Italy, 10126 Less <<
NCT01252251 Uveal Melanoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01243944 - Completed - -
NCT01253161 Neuroendocrine Tumors ... More >> Carcinoid Tumors Less << Phase 2 Active, not recruiting December 2020 United States, California ... More >> Stanford Cancer Institute Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01274182 Rheumatoid Arthritis Phase 1 Phase 2 Completed - -
NCT01252251 - Completed - -
NCT01300962 Metastatic Breast Cancer Phase 1 Active, not recruiting December 2018 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT01274182 - Completed - -
NCT01294826 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Less << Phase 1 Completed - United States, Washington ... More >> Swedish Medical Center Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT01313559 Castrate Resistant Prostate Ca... More >>ncer Chemotherapy Naive Prostate Cancer Prostate Cancer Less << Phase 2 Terminated(Slow accrual) - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Pennsylvania Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01305941 - Completed - -
NCT01313559 - Terminated(Slow accrual) - -
NCT01330238 Low Back Pain Phase 2 Completed - Finland ... More >> Institute of Clinical Sciences, Department of Physical and Rehabilitation Medicine, University of Oulu Oulu, Finland, 90014 Less <<
NCT00550199 Solid Tumors Phase 1 Terminated(Study terminated du... More >>e to LBH589 toxicity.) Less << - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00550277 - Completed - -
NCT01305941 HER-2 Positive Breast Cancer Phase 2 Completed - United States, Alabama ... More >> University Of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Carolinas Healthcare System Charlotte, North Carolina, United States, 28203 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37212 Less <<
NCT00550277 Renal Cell Carcinoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Louisiana Baton Rouge General Medical Center Baton Rouge, Louisiana, United States, 70806 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT00559520 Undernutrition Phase 4 Completed - France ... More >> CHU de NICE, Department of Vascular Surgery Nice, France, 06000 Less <<
NCT00563758 Constipation ... More >>Chronic Disease Less << Not Applicable Terminated - China ... More >> Queen Mary Hospital Hong Kong, China Less <<
NCT02053922 Postpartum Hemorrhage Phase 3 Completed - Egypt ... More >> Ain Shams Maternity Hospital Cairo, Egypt Less <<
NCT00567697 Central Retinal Vein Occlusion... More >> Macular Edema Less << Phase 3 Completed - Norway ... More >> Bettina Kinge, Retinaklinikken Aleris Oslo, Norway, 0264 Ingar Stene Johansen Oslo, Norway Vegard Forsaa Stavanger, Norway Kristian Fossen Tromsø, Norway Less <<
NCT00570921 - Completed - -
NCT00580281 Gastric Cancer ... More >> Leukemia Chronic Myelogenous Leukemia Less << Not Applicable Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00556088 Solid Tumors Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00582790 Kidney Cancer Phase 2 Terminated(slow accrual) - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00570921 Breast Cancer Phase 2 Completed - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT00589732 Coronary Artery Disease Phase 4 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Samsung Medical Center Seoul, Korea, Republic of St. Mary's Catholic Medical Center Seoul, Korea, Republic of Yonsei University Medical Center Seoul, Korea, Republic of Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT00594555 Chronic Myeloid Leukemia, Blas... More >>t Crisis Acute Myeloid Leukemia Less << Phase 2 Withdrawn(Principal Investigat... More >>or resigned position with the University of Cincinnati, closing study at this site will reopen study in new position) Less << November 2008 United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT00582790 - Terminated(slow accrual) - -
NCT01055795 Advanced Solid Tumors Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01108445 Advanced Non-clear Cell Renal ... More >>Cell Carcinoma Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Melvin and Bran Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Michigan Karmanos Cancer Institute/Wayne State University Detroit, Michigan, United States, 48201 United States, Missouri Washington Univ in St. Louis-School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke Univeristy Medical Center Durham, North Carolina, United States, 27708 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Tennessee SCRI Nashville, Tennessee, United States, 37203 The Vanderbilt Clinic, Henry-Joyce Cancer Center Nashville, Tennessee, United States, 37212 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba, Med Onc, Dept Hem and Onc Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario London Health Sciences Center London, Ontario, Canada, N6A-4L6 United Kingdom Cambridge Cancer Trials Centre Cambridge, England, United Kingdom, CB2 0QQ The Royal Marsden NHS London, England, United Kingdom, 8W3 6JJ The Christie Hospital NHS Manchester, England, United Kingdom, M20 4BX Weston Park Hospital Sheffield, England, United Kingdom, S10 2SJ Churchill Hospital Headington, Oxford, United Kingdom, OX3 7LJ Beatson West Scotland Cancer Centre Glasgow, Scottland, United Kingdom, G12 0YN Less <<
NCT01148628 Advanced Solid Tumors Phase 1 Unknown December 2011 Italy ... More >> Fondazione IRCSS Istituto Nazionale dei Tumori Milan, Italy, 20133 Istituto Europeo di Oncologia Milan, Italy, 20141 Switzerland Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland, 6500 Less <<
NCT00119158 - Completed - -
NCT02308865 Lung Cancer Metastatic Not Applicable Recruiting October 2020 France ... More >> CHRU, Hôpital Claude Huriez Recruiting Lille, France, 59000 Contact: LICIA TOUZET       licia.touzet@CHRU-LILLE.FR    Contact: XAVIER DHALLUIN       Xavier.DHALLUIN@CHRU-LILLE.FR    Principal Investigator: Licia Touzet, MD          Sub-Investigator: Xavier Dhalluin, MD Less <<
NCT00590343 Metastatic Neuroendocrine Tumo... More >>rs Less << Phase 2 Completed - United States, Louisiana ... More >> Neuroendocrine Clinic Kenner, Louisiana, United States, 70065 Less <<
NCT01174888 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01194908 - Terminated(Slow accrual) - -
NCT01125293 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 1 Phase 2 Active, not recruiting February 2020 United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Massachusetts Milford Hospital Boston, Massachusetts, United States, 01757 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02377193 Renal Transplant Rejection Phase 4 Completed - France ... More >> UHToulouse Toulouse, France, 31059 Less <<
NCT01194908 Breast Cancer ... More >> Breast Tumors Breast Neoplasms Less << Phase 1 Phase 2 Terminated(Slow accrual) - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30329 Less <<
NCT01108445 - Completed - -
NCT01226056 Advanced Solid Tumors Phase 1 Phase 2 Suspended(toxicity (protocol a... More >>mendment under approval)) Less << December 2012 Italy ... More >> Istituto Europeo di Oncologia, Milano, Italy, 20141 Less <<
NCT01283789 Metastatic Breast Cancer Phase 2 Active, not recruiting April 2017 United States, Kansas ... More >> University of Kansas Medical Centner Kansas City, Kansas, United States, 66160 Less <<
NCT02323178 CMML Thromboc... More >>ytopenia Less << Phase 1 Phase 2 Active, not recruiting December 2019 France ... More >> CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49 033 CH Victor Dupouy Argenteuil, France, 95107 Hôpital Avicenne Bobigny, France, 93009 Hôpital privé Sévigné Cesson-Sévigné, France, 35510 CHU Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 CH Le Mans Le Mans, France, 72037 CHRU de Limoges Limoges, France, 87046 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli Calmettes Marseille, France, 13009 Centre Hospitalier de Meaux Meaux, France, 77100 CHU de Nantes Nantes, France, 44093 Centre Catherine de Sienne Nantes, France, 44277 Hôpital Archet 1 Nice, France, 06202 Hôpital Saint Louis - Service d'hématologie AJA Paris, France, 75010 Hôpital Saint Louis - Service d'hématologie séniors Paris, France, 75010 CHU de Haut-Lévèque Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86021 Centre Hospitalier de la région d'Annecy Pringy cedex, France, 74374 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Hôpital Purpan - Médecine interne Toulouse, France, 31059 Hôpital Purpan - Service d'Hématologie Clinique Toulouse, France, 31059 CHU Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT02661763 - Completed - Zambia ... More >> University Teaching Hosptial Lusaka, Zambia Less <<
NCT02638909 Colorectal Adenocarcinoma ... More >> Cholangiocarcinoma Pancreatic Adenocarcinoma Hepatocellular Adenocarcinoma Gastric Adenocarcinoma Esophageal Adenocarcinoma Less << Phase 2 Terminated(Lack of Enrollment) - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University, Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, New York Laura & Isaac Permutter Cancer Center at NYU Langone New York, New York, United States, 10016 United States, Ohio The Ohio State University, James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT01497496 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Active, not recruiting December 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01496976 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Active, not recruiting December 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02826070 Hepatitis B, Chronic Phase 4 Unknown October 2017 China, Beijing ... More >> 302 Military Hospital Of China Beijing, Beijing, China Beijing Ditan Hospital Beijing, Beijing, China BeiJing YouAn Hospital ,Capital Medical University Beijing, Beijing, China Department of infectious disease, First Hospital of Peking University Beijing, Beijing, China People's Hospital of Beijing University Beijing, Beijing, China China, Chongqing The Second Affiliated of ChongQing University of Medical Science Chongqing, Chongqing, China China, Guangdong Department of Infectious Disease, Nanfang Hospital Guangzhou, Guangdong, China No. 8 People's Hospital In GuangZhou Guangzhou, Guangdong, China The Third Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China China, Hubei Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China China, Hunan Xiangya Hospital Central-South Univrsity Changsha, Hunan, China China, Jiangsu No.81 Hospital of PLA Nanjing, Jiangsu, China China, Jilin First Hospital .Jilin Unniversity Changchun, Jilin, China China, Liaoning ShengJing Hospital of China Medical University Shengyang, Liaoning, China China, Shandong JiNan Infectious Diseases Hospital Jinan, Shandong, China China, Shanghai Changhai Hospital affiliated to Second Military Medical University Shanghai, Shanghai, China Huashan Hospital，Fudan University Shanghai, Shanghai, China Shanghai Ruijin Hospital Shanghai, Shanghai, China China, Shanxi Tangdu Hospital XiAn, Shanxi, China China, Zhejiang The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, Zhejiang, China Less <<
NCT01589029 Proliferative Diabetic Retinop... More >>athy Less << Phase 1 Terminated(The results of the ... More >>interim analysis showed that the primary endpoint was not met) Less << - Switzerland ... More >> Department of Ophthalmology, Triemli Hospital Zurich Zurich, Switzerland, 8063 Less <<
NCT02414724 Lymphoma Soli... More >>d Neoplasm Less << Phase 1 Terminated(PI left institute) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01400100 Pancreatic Fistula Not Applicable Completed - Germany ... More >> Department of Surgery, St. Josef Hospital, Ruhr University of Bochum Bochum, NRW, Germany, 44791 Less <<
NCT02809222 Myelodysplastic Syndrome ... More >> Secondary Acute Myeloid Leukemia Less << Not Applicable Recruiting March 2019 France ... More >> Clinical Research Center, University Hospital, Tours Active, not recruiting Tours, France, 37044 Department of Haematology and Cell Therapy, University Hospital, Tours Recruiting Tours, France, 3704 Principal Investigator: Emmanuel GYAN, MD, PhD Less <<
NCT03087071 Colorectal Cancer Phase 2 Recruiting December 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       evilar@mdanderson.org Less <<
NCT01784978 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(Lack of recruitment... More >>) Less << - France ... More >> Hopital Bordeaux University Bordeaux, France Greece ALEXANDRA General Hospital of Athens Athens, Greece, 11528 Spain Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital del Mar Barcelona, Spain, 08003 Hospital Universitario 12 de Octubre Madrid, Spain, 28026 Hospital Clínico San Carlos Madrid, Spain, 28040 Clara Campal. Hospital Sanchinarro Madrid, Spain, 28050 Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital General Universitario de Valencia Valencia, Spain Less <<
NCT03191955 - Recruiting August 2020 United Kingdom ... More >> Royal Infirmary of Edinburgh Recruiting Edinburgh, Lothian, United Kingdom, EH16 4SA Contact: Richard J Skipworth, MD    +441315361000    richard.skipworth@nhslothian.scot.nhs.uk    Principal Investigator: Michael I Ramage, MBChB Less <<
NCT01862965 Chronic Graft-versus-host Dise... More >>ase Less << Phase 2 Active, not recruiting June 2018 Germany ... More >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07743 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany, 55101 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universitätsklinikum Ulm Ulm, Germany, 89081 Deutsche Klinik fuer Diagnostik GmbH Wiesbaden, Germany, 65191 Less <<
NCT01797523 Endometrial Cancer Phase 2 Active, not recruiting October 2020 United States, Florida ... More >> Sacred Heart Health Systems Pensacola, Florida, United States, 32504 United States, New Jersey MD Anderson Cooper Cancer Center Voorhees, New Jersey, United States, 08043 United States, Texas Memorial City Medical Center Houston, Texas, United States, 77024 Lyndon B Johnson General Hospital Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 The Woman's Hospital of Texas Houston, Texas, United States, 77054 Less <<
NCT02858921 Melanoma Phase 2 Recruiting November 2020 Australia, New South Wales ... More >> Westmead Hospital Recruiting Sydney, New South Wales, Australia, 2145 Contact: Monica Osorio    +612 9911 7200    Monica.Osorio@melanoma.org.au    Principal Investigator: Matteo Carlino          Melanoma Institute Australia Recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: Alexander Menzies Less <<
NCT01908556 is to Identify Biomarkers That... More >> Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. Less << Phase 4 Unknown - Germany ... More >> Frauenklinik University Hospital Erlangen, Bavaria, Germany, 91054 Less <<
NCT03457285 Ankylosing Spondylitis Not Applicable Recruiting May 31, 2019 Ireland ... More >> Physiotherapy Department, Saint James's Hospital Recruiting Dublin, Ireland Contact: Ciarán Brennan, MSc, BSc Less <<
NCT01958112 Cervical Cancer Phase 2 Terminated(Drug supply) - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02038010 HER2-positive Breast Cancer ... More >> Recurrent Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 1 Active, not recruiting March 2020 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03075709 - Enrolling by invitation September 30, 2021 Canada, Saskatchewan ... More >> Regina Qu'Appelle Health Region Regina, Saskatchewan, Canada Less <<
NCT02044237 Trichotillomania ... More >> Alexithymia Quality of Life Less << Not Applicable Completed - Switzerland ... More >> University of Zurich, Switzerland Less <<
NCT02138929 Esophageal Cancer Phase 1 Active, not recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02264665 - Recruiting June 5, 2019 -
NCT02358161 Pancreatic Cancer Phase 1 Phase 2 Unknown September 2015 Netherlands ... More >> Academic Medical Center Recruiting Amsterdam, Netherlands, 1105 AZ Contact: J. W. Wilmink, MD, PhD    31 20 5665955    j.w.wilmink@amc.uva.nl    Contact: E. van Daalen    31 20 5668229    trialmedonc@amc.uva.nl    Principal Investigator: J. W. Wilmink, MD, PhD Less <<
NCT02444390 Metastatic Breast Cancer Not Applicable Active, not recruiting October 2021 France ... More >> Institut de Cancérologie de l'Ouest/Paul Papin Angers, France Centre Jean Perrin Clermont-Ferrand, France Centre Léon Bérard Lyon, France Institut de Cancérologie de l'Ouest/Rene Gauducheau Nantes, France Centre Antoine Lacassagne Nice, France Institut Curie Paris, France Clinique Armoricaine de Radiologie Saint-Brieuc, France INSTITUT DE CANCEROLOGIE Lucien Neuwirth St PRIEST EN JAREZ, France Centre Paul Strauss Strasbourg, France Institut Claudius Regaud Toulouse, France Institut de Cancerologie de Lorraine Alexis Vautrin Vandoeuvre-les-nancy, France Gustave Roussy Villejuif, France Less <<
NCT02471430 HIV Infection Phase 1 Phase 2 Recruiting February 2020 United States, Massachusetts ... More >> Massachusetts General Hospital CRS (MGH CRS) Recruiting Boston, Massachusetts, United States, 02114 Contact: Theresa Flynn, R.N., M.S.N., A.N.P, B.S.N.    (617) 724-0072    tflynn@partners.org Less <<
NCT02576626 COPD Phase 4 Completed - Netherlands ... More >> UMCG Groningen, Netherlands, 9700RB Less <<
NCT02099747 Severe Aplastic Anemia Phase 3 Recruiting June 2021 -
NCT02691988 Pulmonary Disease, Chronic Obs... More >>tructive Less << Not Applicable Unknown June 2017 Netherlands ... More >> Radboud University Medical Centre, Department of Primary and Community Care Recruiting Nijmegen, Netherlands, 6500 HB Contact: Tjard R Schermer, PhD    +31 24 3614611    tjard.schermer@radboudumc.nl    Contact: Lisette van den Bemt, PhD    +31 24 3619588    lisette.vandenbemt@radboudumc.nl    Principal Investigator: Tjard R Schermer, PhD Less <<
NCT02757989 MDS Not Applicable Recruiting April 2021 France ... More >> CHU d'Amiens Recruiting Amiens, France, 80054 Contact: Amandine Charbonnier, MD    +33 3 22 45 59 14    charbonnier.amandine@chu-amiens.fr    Principal Investigator: Amandine Charbonnier, MD          CHU d'Angers Recruiting Angers, France, 49933 Contact: Sylvain Thépot, MD    +33 2 41 35 44 66    sylvain.thepot@chu-angers.fr    Principal Investigator: Sylvain Thépot, MD          CHU Jean Minjoz Recruiting Besançon, France, 25030 Contact: Eric Deconinck, MD, PHD    +33 3 81 66 83 51    edeconinck@chu-besancon.fr    Principal Investigator: Eric Deconinck, MD, PHD          Principal Investigator: Ana Berceanu, MD          Hôpital Avicenne Not yet recruiting Bobigny, France, 93009 Contact: Thorsten Braun, MD    +33 1 48 95 70 57    thorsten.braun@aphp.fr    Principal Investigator: Thorsten Braun, MD          CHU de Haut Lévèque Recruiting Bordeaux, France, 33604 Contact: Edouard Forcade, MD    +33 5 57 65 67 27    edouard.forcade@chu-bordeaux.fr    Principal Investigator: Edouard Forcade, MD          Principal Investigator: Sophie Dimicoli-Salazar, MD          CHRU Côte de Nacre Recruiting Caen, France, 14033 Contact: Stéphane Cheze, MD    +33 2 31 27 23 60    cheze-s@chu-caen.fr    Principal Investigator: Stéphane Cheze, MD          Principal Investigator: Oumedaly Reman, MD          CHU Estaing Recruiting Clermont Ferrand, France, 63000 Contact: Jacques Olivier Bay, MD    +33 4 73 75 00 65    jobay@chu-clermontferrand.fr    Principal Investigator: Jacques Olivier Bay, MD          Principal Investigator: Benoit De Renzis, MD          Hôpital Henri Mondor Not yet recruiting Créteil, France, 94010 Contact: Andrea Toma, MD    +33 1 49 81 20 60    andrea.toma@aphp.fr    Principal Investigator: Andrea Toma, MD          CHU de Grenoble Recruiting Grenoble, France, 38043 Contact: Martin Carré, MD    +33 4 76 76 57 55    mcarre1@chu-grenoble.fr    Principal Investigator: Martin Carré, MD          Principal Investigator: Sophie Park, MD, PHD          CH Le Mans Not yet recruiting Le Mans, France, 72037 Contact: Kamel Laribi, MD    +33 2 43 43 43 61    klaribi@ch-lemans.fr    Principal Investigator: Kamel Laribi, MD          Hôpital Saint Vincent de Paul Recruiting Lille, France, 59020 Contact: Laurent Pascal, MD, PHD    +33 3 20 87 45 32    pascal.laurent@ghicl.net    Principal Investigator: Laurent Pascal, MD, PHD          Hôpital Huriez Recruiting Lille, France, 59037 Contact: Ibrahim Yakoub-Agha, MD, PHD    +33 3 20 44 55 51    ibrahim.yakoub-agha@chru-lille.fr    Principal Investigator: Ibrahim Yakoub-Agha, MD, PHD          Hôpital Dupuytren Not yet recruiting Limoges, France, 87042 Contact: Pascal Turlure, MD    +33 5 55 05 80 39    pascal.turlure@chu-limoges.fr    Principal Investigator: Marie-Pierre Gourin, MD          Principal Investigator: Pascal Turlure, MD          Centre hospitalier Lyon Sud Recruiting Lyon, France, 69495 Contact: Hélène Labussière-Wallet, MD, PHD    +33 4 78 86 22 05    helene.labussiere-wallet@chu-lyon.fr    Principal Investigator: Hélène Labussière-Wallet, MD, PHD          Principal Investigator: Eric Wattel, MD, PHD          CHRU de Montpellier Recruiting Montpellier, France, 34295 Contact: Nathalie Fegueux, MD    +33 4 67 33 83 63    n-fegueux@chu-montpellier.fr    Principal Investigator: Nathalie Fegueux, MD          CHU de Nantes Recruiting Nantes, France, 44093 Contact: Patrice Chevallier, MD    +33 2 40 08 33 33    patrice.chevallier@chu-nantes.fr    Principal Investigator: Patrice Chevallier, MD          Principal Investigator: Pierre Peterlin, MD          CHU de Nice Recruiting Nice, France, 06202 Contact: Thomas Cluzeau, MD    +33 4 92 03 58 44    cluzeau.t@chu-nice.fr    Principal Investigator: Thomas Cluzeau, MD          CHU de Nîmes Not yet recruiting Nîmes, France, 30029 Contact: Stefan Wickenhauser, MD    +33 4 66 68 32 31    stefan.wickenhauser@chu-nimes.fr    Principal Investigator: Stefan Wickenhauser, MD          Hôpital Saint Louis Recruiting Paris, France, 75010 Contact: Marie Robin, MD    +33 1 42 49 96 60    marie.robin@aphp.fr    Principal Investigator: Marie Robin, MD          Principal Investigator: Marie Sébert, MD          Hôpital Pitié Salpétrière Not yet recruiting Paris, France, 75013 Contact: Stéphanie Nguyen-Quoc, MD    +33 1 42 16 28 25    stephanie.nguyen-quoc@aphp.fr    Principal Investigator: Stéphanie Nguyen-Quoc, MD          Hôpital Cochin Not yet recruiting Paris, France, 75014 Contact: Lise Willems, MD    +33 1 58 41 26 70    lise.willems@aphp.fr    Principal Investigator: Lise Willems, MD          Hôpital Necker Recruiting Paris, France, 75015 Contact: Olivier Hermine, MD, PHD    +33 1 44 49 53 68    olivier.hermine@aphp.fr    Principal Investigator: Olivier Hermine, MD, PHD          Principal Investigator: Felipe Suarez, MD          CH Joffre Not yet recruiting Perpignan, France, 66046 Contact: Laurence Sanhes, MD    +33 4 68 61 64 48    laurence.sanhes@ch-perpignan.fr    Principal Investigator: Laurence Sanhes, MD          CHU de Poitiers Recruiting Poitiers, France, 86021 Contact: Natacha Maillard, MD    +33 5 48 44 44 44    natacha.maillard@chu-poitiers.fr    Principal Investigator: Jose Miguel Torregrosa Diaz, MD          Principal Investigator: Natacha Maillard, MD          CHU de Reims Not yet recruiting Reims, France, 51092 Contact: Chantal Himberlin, MD    +33 3 26 78 36 44    chimberlin@chu-reims.fr    Principal Investigator: Chantal Himberlin, MD          Hôpital Pontchaillou Not yet recruiting Rennes, France, 35033 Contact: Stanislas Nimubona, MD    +33 2 99 28 95 21    stanislas.nimubona@chu-rennes.fr    Principal Investigator: Stanislas Nimubona, MD          Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Aspasia Stamatoullas, MD          Principal Investigator: Aspasia Stamatoullas, MD          Institut de cancérologie Lucien Neuwirth Not yet recruiting Saint-Priest-en-Jarez, France, 42271 Contact: Jérôme Cornillon, MD    +33 4 77 91 70 60    jerome.cornillon@icloire.fr    Principal Investigator: Jérôme Cornillon, MD          Hôpital civil Not yet recruiting Strasbourg, France, 67091 Contact: Shanti Natarajan-Amé, MD    +33 3 88 11 67 28    shanti.ame@chru-strasbourg.fr    Principal Investigator: Shanti Natarajan-Amé, MD          IUCT-Oncopole Recruiting Toulouse, France, 31059 Contact: Anne Huynh, MD    +33 5 31 15 61 91    huynh.anne@iuct-oncopole.fr    Principal Investigator: Anne Huynh, MD          Principal Investigator: Odile Beyne-Rauzy, MD, PHD          Principal Investigator: Christian Recher, MD, PHD          Hôpital Bretonneau Not yet recruiting Tours, France, 37000 Contact: Emmanuel Gyan, MD, PHD    +33 2 47 25 87 78    e.gyan@chu-tours.fr    Principal Investigator: Emmanuel Gyan, MD, PHD          Hôpital de Brabois Recruiting Vandoeuvre les nancy, France, 54550 Contact: Maud D'Aveni, MD    +33 3 83 15 30 30    m.daveni-piney@chru-nancy.fr    Principal Investigator: Maud D'Aveni, MD Less <<
NCT02802163 Multiple Myeloma Phase 1 Phase 2 Withdrawn(study drug unavailab... More >>le) Less << December 2020 -
NCT02380248 Dry Eye Not Applicable Completed - India ... More >> Contact Alcon India for Trial Locations Karnataka, India, 560048 Less <<
NCT02403193 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 1 Phase 2 Recruiting December 2020 United States, Florida ... More >> H.Lee Moffitt Cancer center Recruiting Tampa, Florida, United States, 33612 Contact: Alberto Chiappori, MD Less <<
NCT03090165 Triple Negative Breast Cancer Phase 1 Phase 2 Recruiting September 2019 United States, Illinois ... More >> University of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Ayesha Zaidi    312-413-1902    azaidi22@uic.edu    Principal Investigator: Kent Hoskins, MD          United States, Michigan Michigan State University Recruiting Lansing, Michigan, United States, 48910 Contact: Karen Luellen    517-975-9534    karen.luellen@hc.msu.edu    Principal Investigator: Deimante Tamkus, MD          United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Alison Haegler    732-235-8060    agh46@cinj.rutgers.edu    Principal Investigator: Nancy Chan, MD          United States, Pennsylvania Penn State Cancer Institute Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Sean Flemings    717-531-5364    sfleming1@pennstatehealth.psu.edu    Principal Investigator: Cristina Truica, MD          United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect    608-262-5223    cancerconnect@uwcarbone.wisc.edu Less <<
NCT03207529 Malignant Neoplasm of Breast Phase 1 Not yet recruiting January 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       mskaruturi@mdanderson.org Less <<
NCT01895049 Kidney Transplantation ... More >> Cytomegalovirus Less << Phase 4 Completed - Brazil ... More >> Hospital do Rim e Hipertensao São Paulo, Brazil, 04038-002 Less <<
NCT03283384 Breast Neoplasms Phase 2 Recruiting February 2025 Netherlands ... More >> Jeroen Bosch Ziekenhuis Not yet recruiting 's-Hertogenbosch, Netherlands Contact: J. Tol          Ziekenhuisgroep Twente (Twenteborg ZH Almelo) Not yet recruiting Almelo, Netherlands Contact: E. Siemerink          Ziekenhuis Amstelland Not yet recruiting Amstelveen, Netherlands Contact: A. van Zweeden          Nederlands Kanker Instituut - Antoni van Leeuwenhoek Not yet recruiting Amsterdam, Netherlands Contact: S. Linn          Onze Lieve Vrouwe Gasthuis (Oost) Not yet recruiting Amsterdam, Netherlands Contact: J. Meerum Terwogt          Stichting Reinier Haga Groep (Reinier de Graaf Gasthuis) Not yet recruiting Delft, Netherlands Contact: K. Beelen          Stichting Deventer Ziekenhuisgroep Rielerenk Not yet recruiting Deventer, Netherlands Contact: L. Kessels          Catharina Ziekenhuis Not yet recruiting Eindhoven, Netherlands Contact: B. Vriens          Maxima Medisch Centrum (Eindhoven) Not yet recruiting Eindhoven, Netherlands Contact: M. Dercksen          Groene Hart Ziekenhuis (Bleuland) Not yet recruiting Gouda, Netherlands Contact: J. Hokken          Spaarne Gasthuis (Haarlem-Zuid) Not yet recruiting Haarlem, Netherlands Contact: P. Kuijer          Ziekenhuis St. Jansdal Not yet recruiting Harderwijk, Netherlands Contact: J. Ropela          Tergooiziekenhuizen (Hilversum) Not yet recruiting Hilversum, Netherlands Contact: S. Luykx-de Bakker          Westfriesgasthuis Not yet recruiting Hoorn, Netherlands Contact: S. van den Heiligenberg          Leiden University Medical Center Recruiting Leiden, Netherlands Contact: Judith R Kroep, MD PhD          Academisch Ziekenhuis Maastricht Not yet recruiting Maastricht, Netherlands Contact: M. de Boer          Canisius-Wilhelmina Ziekenhuis Not yet recruiting Nijmegen, Netherlands Contact: C. Mandigers          Bravis Ziekenhuis (Roosendaal) Not yet recruiting Roosendaal, Netherlands Contact: H. Droogendijk          Antonius Ziekenhuis Sneek Not yet recruiting Sneek, Netherlands Contact: G. Veldhuis          Ziekenhuis Rivierenland Not yet recruiting Tiel, Netherlands Contact: C. Kruijtzer-Schimmel          VieCuri Medisch Centrum (Venlo) Not yet recruiting Venlo, Netherlands Contact: A. van de Wouw          Streekziekenhuis Koningin Beatrix Not yet recruiting Winterswijk, Netherlands Contact: P. Schiphorst          Isala (Zwolle) Not yet recruiting Zwolle, Netherlands Contact: A. Honkoop Less <<
NCT03333187 Bone Marrow Fibrosis Phase 2 Recruiting March 20, 2023 Germany ... More >> Universitätsklinkum Aachen Recruiting Aachen, Germany, 52074 Contact: Edgar Jost, PD Dr.       ejost@ukaachen.de    Principal Investigator: Edgar Jost, PD Dr.          Sub-Investigator: Martina Crysandt, Dr.          HELIOS Klinikum Berlin-Buch Recruiting Berlin, Germany, 13125 Contact: Herrad Baurmann, Dr.       herrad.baurmann@helios-kliniken.de    Principal Investigator: Herrad Baurmann, Dr.          Sub-Investigator: Stephan Fuhrmann, Dr.          Universitätsklinikum Bonn Recruiting Bonn, Germany, 53105 Contact: Dominik Wolf, Prof. Dr.       dominik.wolf@ukb.uni-bonn.de    Principal Investigator: Dominik Wolf, Prof. Dr.          Sub-Investigator: Karin Mayer, Dr.          Universitätsklinikum Düsseldorf Recruiting Düsseldorf, Germany, 40225 Contact: Guido Kobbe, Prof. Dr.       Kobbe@med.uni-duesseldorf.de    Principal Investigator: Guido Kobbe, Prof. Dr.          Sub-Investigator: Thomas Schröder, PD Dr.          Universitätsklinikum Essen Recruiting Essen, Germany, 45147 Contact: Joachim Göthert, Dr.       Joachim.Goethert@uk-essen.de    Principal Investigator: Joachim Göthert, Dr.          Sub-Investigator: Jürgen Novotny, PD Dr.          Klinikum Frankfurt (Oder) GmbH Not yet recruiting Frankfurt (Oder), Germany, 15236 Contact: Michael Kiehl, Prof. Dr.          Contact: Olaf Hopfer, Dr.          Principal Investigator: Olaf Hopfer, Dr.          Sub-Investigator: Georgios Fellas          Universitätsklinkum Halle Recruiting Halle (Saale), Germany, 06120 Contact: Haifa Kathrin Al-Ali, PD Dr.       haifa.al-ali@uk-halle.de    Principal Investigator: Haifa Kathrin Al-Ali, PD Dr.          Sub-Investigator: Nadja Jäkel, Dr.          University Medical Center Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Nicolaus Kroeger, Prof. Dr.    +49-40-7410-55864    n.kroeger@uke.de    Contact: Marion Heinzelmann    +49-40-7410-54188    mheinzel@uke.de    Principal Investigator: Nicolaus Kroeger, Prof. Dr.          Sub-Investigator: Christine Wolschke, Dr.          Universitätsklinikum Jena Recruiting Jena, Germany, 07747 Contact: Inken Hilgendorf, PD Dr.       Inken.Hilgendorf@med.uni-jena.de    Principal Investigator: Inken Hilgendorf, PD Dr.          Sub-Investigator: Nils Winkelmann, Dr.          University Hospital Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser, Prof. Dr.       Dietger.Niederwieser@medizin.uni-leipzig.de    Principal Investigator: Dietger Niederwieser, Prof. Dr.          Sub-Investigator: Vladan Vucinic, Dr.          Universitätsmedizin der Johannes Gutenberg-Universität Mainz Recruiting Mainz, Germany, 55131 Contact: Eva Wagner, Dr.       eva.wagner@unimedizin-mainz.de    Principal Investigator: Eva Wagner-Drouet, Dr.          Sub-Investigator: Thomas Kindler, PD Dr.          Universitätsmedizin Mannheim Recruiting Mannheim, Germany, 68167 Contact: Stefan Klein, PD Dr.       Stefan.Klein@medma.uni-heidelberg.de    Principal Investigator: Stefan Klein, PD Dr.          Sub-Investigator: Andreas Reiter, Prof. Dr.          Johannes Wesling Klinikum Minden Recruiting Minden, Germany, 32429 Contact: Martin Griesshammer, Prof. Dr.       martin.griesshammer@muehlenkreiskliniken.de    Principal Investigator: Martin Griesshammer, Prof. Dr.          Sub-Investigator: Hans-Joachim Tischler, Dr.          Universitätsklinikum Münster Recruiting Munster, Germany, 48149 Contact: Matthias Stelljes, Prof. Dr.       Matthias.Stelljes@ukmuenster.de    Principal Investigator: Eva Eßeling, Dr.          Sub-Investigator: Matthias Stelljes, Prof. Dr.          Klinikum Nürnberg Recruiting Nürnberg, Germany, 90419 Contact: Kerstin Schäfer-Eckart, Dr.       Kerstin.Schaefer-Eckart@klinikum-nuernberg.de    Principal Investigator: Kerstin Schäfer-Eckart, Dr.          Sub-Investigator: Knut Wendelin, Dr,          Robert-Bosch-Krankenhaus Stuttgart Recruiting Stuttgart, Germany, 70376 Contact: Martin Kaufmann, Dr.       Martin.Kaufmann@rbk.de    Principal Investigator: Martin Kaufmann, Dr.          Sub-Investigator: Matthias Vöhringer, Dr.          Universitätsmedizin Tübingen Recruiting Tübingen, Germany, 72076 Contact: Wolfgang Bethge, Prof. Dr.       Wolfgang.Bethge@med.uni-tuebingen.de    Principal Investigator: Wolfgang Bethge, Prof. Dr.          Sub-Investigator: Christoph Faul, Dr.          Universitätsklinkum Ulm Recruiting Ulm, Germany, 89081 Contact: Konstanze Döhner, Prof. Dr.       Konstanze.Doehner@uniklinik-ulm.de    Principal Investigator: Konstanze Döhner, Prof. Dr.          Sub-Investigator: Frank Stegelmann, Dr. Less <<
NCT02763124 Astigmatism Not Applicable Completed - United States, Georgia ... More >> Gainesville Eye Associates Gainesville, Georgia, United States, 30501 Less <<
NCT03668431 Metastatic Colorectal Cancer Phase 2 Recruiting March 1, 2021 United States, Massachusetts ... More >> Massachusetts General Hosital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Ryan Corcoran, MD    617-724-4000       Principal Investigator: Ryan Corcoran, MD          Dana Farber Cancer Institite Recruiting Boston, Massachusetts, United States, 02215 Contact: Marios Giannakis, MD    617-632-3000    MGIANNAKIS@PARTNERS.ORG    Principal Investigator: Marios Giannakis, MD Less <<
NCT02281292 Diabetic Macular Edema Phase 1 Withdrawn(Management Decision) June 2017 -
NCT01376726 HIV Infections Phase 1 Completed - United States, Alabama ... More >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, Tennessee Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States, 37232-2582 United States, Washington Seattle Vaccine and Prevention CRS Seattle, Washington, United States, 98109-1024 Less <<
NCT02515942 Geographic Atrophy Phase 2 Completed - United States, Texas ... More >> Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT01393340 Nasal Polyposis ... More >> Asthma Less << Phase 2 Completed - Belgium ... More >> University Hospital, Ghent Ghent, Belgium, 9000 UZ Gasthuisberg Leuven, Belgium, 3000 Less <<
NCT02063321 - Unknown December 2015 -
NCT02380248 - Completed - -
NCT03105609 - Recruiting December 31, 2020 Australia, Victoria ... More >> Centre for Eye Research Australia Recruiting East Melbourne, Victoria, Australia, 3002 Contact: Anne E Weymouth, PhD    99298959 ext 613    anneew@unimelb.edu.au    Principal Investigator: Marc G Sarossy, FRANZCO          Sub-Investigator: Wilson Heriot, FRACO FRACS          Sub-Investigator: Bryan Matthews, FRANZCO          Sub-Investigator: Anne E Weymouth, PhD          Sub-Investigator: Xavier Hadoux, PhD Less <<
NCT01845701 Malaria Phase 3 Completed - Cameroon ... More >> L'Hopital de District Ngong, Garoua, Garoua, North, Cameroon Baptist Hospital Mutengene, South West, Cameroon Less <<
NCT00939900 Avascular Necrosis of Femoral ... More >>Head Less << Phase 3 Completed - Korea, Republic of ... More >> Seoul national University Bundang Hospital Seongnam-Si, Gyeonggi-do, Korea, Republic of, 463-707 Less <<
NCT00939900 - Completed - -
NCT01380288 Alzheimer's Disease Not Applicable Completed - Korea, Republic of ... More >> Holy Family Hospital, The Catholic Univerisy of Korea, School of Medicine Bucheon, Korea, Republic of Busan National University Hospital Busan, Korea, Republic of Busan Paik Hospital, Inje University College of Medicine Busan, Korea, Republic of Changwon Fatima Hospital Changwon, Korea, Republic of Daegu Fatima Hospital Daegu, Korea, Republic of Keimyung University School of Medicine Daegu, Korea, Republic of Kyungpook National University School of Medicine Daegu, Korea, Republic of Myongji Hospital, Kwandong University College of Medicine Goyang, Korea, Republic of Dongguk University International Hospital Ilsan, Korea, Republic of National Health Insurance Corporation Ilsan Hospital Ilsan, Korea, Republic of Inha University College of Medicine Incheon, Korea, Republic of Gyeongsang National University College of Medicine Jinju, Korea, Republic of Chonnam National University, Medical School Kwangju, Korea, Republic of Seoul National Unviersity College of Medicine, Clinical neuroscience center, Seoul National Unviersity Bundang Hospital Seongnam, Korea, Republic of The Catholic Univerisy of Korea, School of Medicine Seoul, Korea, Republic of Pusan National University Yangsan Hospital Yangsan, Korea, Republic of Less <<
NCT03639740 Axial Spondyloarthritis ... More >> Ankylosing Spondylitis Less << Phase 4 Recruiting February 2021 Denmark ... More >> Reumatologisk Afdeling, Aarhus Universitetshospital Not yet recruiting Aarhus, Denmark, 8000 Principal Investigator: Anne G Loft, MS DMSc          Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet - Frederiksberg Recruiting Frederiksberg, Denmark, 2000 Principal Investigator: Bente Jensen, MD PhD          Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet Glostrup Recruiting Glostrup, Denmark, 2600 Contact: Mikkel Østergaard, MD PhD DMSc          Principal Investigator: Mikkel Østergaard, MD PhD DMSc          Sub-Investigator: Susanne J Pedersen, MD PhD          Sub-Investigator: Sengül Seven, MD          Sub-Investigator: Inge J Sørensen, MD PhD          Kong Christian X´s Gigthospital Not yet recruiting Gråsten, Denmark, 6300 Principal Investigator: Oliver Hendricks, MD PhD          Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet - Gentofte Recruiting Hellerup, Denmark, 2900 Principal Investigator: Ole R Madsen, MD PhD DMSc          Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet - Nordsjællands Hospital Hillerød Not yet recruiting Hillerød, Denmark, 3400 Principal Investigator: Jesper Nørregaard, MD DMSc          Reumatologisk Afdeling, Regionshospitalet Nordjylland, Hjørring Not yet recruiting Hjørring, Denmark, 9800 Principal Investigator: Marcin Kowalski, MD PhD          Reumatologisk afdeling, Sjællands Universitetshospital, Køge Not yet recruiting Køge, Denmark, 4600 Principal Investigator: Bo Ejbjerg, MD PhD          Reumatologisk Afdeling, Odense Universitetshospital Not yet recruiting Odense, Denmark, 5000 Principal Investigator: Hans C Horn, consultant          Reumatologisk Afdeling, Regionshospitalet Silkeborg Not yet recruiting Silkeborg, Denmark, 8600 Principal Investigator: Rene Østgaard, MD PhD Less <<
NCT00038610 - Completed - -
NCT00038649 - Terminated(Sponsor discontinue... More >>d providing study drug.) Less << - -
NCT00038675 Chronic Myelomonocytic Leukemi... More >>a Chronic Myeloid Leukemia Polycythemia Vera Hypereosinophilic Syndrome Mastocytosis Less << Not Applicable Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02555189 Hormone-Resistant Prostate Can... More >>cer Metastatic Prostate Carcinoma Prostate Carcinoma Metastatic in the Bone Stage IV Prostate Cancer Less << Phase 1 Phase 2 Recruiting May 2021 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: David Smith, MD    734-763-6537       United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Gurkamal Chatta, MD       Gurkamal.Chatta@RoswellPark.org    Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Susan Slovin, MD, PhD    646-422-4470       United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: William Kevin Kelly, MD    215-955-8874       Contact: Clinical Trials Office    215-955-1661       Principal Investigator: William Kevin Kelly, MD          Sub-Investigator: Robert Den, MD          Sub-Investigator: Jean Hoffman-Censits, MD          Sub-Investigator: Jianqing Lin, MD          Sub-Investigator: Leonard Gomella, MD          Sub-Investigator: Edouard Trabulsi, MD          Sub-Investigator: Costas Lallas, MD Less <<
NCT02063269 Alzheimer's Disease Not Applicable Unknown June 2017 Korea, Republic of ... More >> Seoul Metropolitan Government Seoul National University Boramae Medical Center Seoul, Korea, Republic of, 156-707 Less <<
NCT00038610 Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02398500 Age-related Macular Degenerati... More >>on (AMD) Less << Phase 1 Phase 2 Terminated(Management decision... More >>) Less << - United States, Texas ... More >> Call Alcon Call Center for Trial Locations Fort Worth, Texas, United States, 76134 Less <<
NCT00038649 Myelogenous Leukemia, Chronic,... More >> Chronic Phase Less << Phase 2 Terminated(Sponsor discontinue... More >>d providing study drug.) Less << - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02427295 Acromegaly Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: minseon Kim, PhD    82-2-3010-3245    mskim@amc.seoul.kr Less <<
NCT01779310 - Completed - -
NCT01272596 - Completed - Germany ... More >> NeuroCure Clinical Reserach Center, Charité Universitaetsmedizin Berlin, Germany, 10117 Less <<
NCT00048672 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00113360 Neuroendocrine Carcinoma ... More >> Islet Cell Carcinoma Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00123630 Esophagitis Phase 2 Completed - United States, Utah ... More >> University of Utah HSC Salt Lake City, Utah, United States, 84132 Less <<
NCT01775020 Sepsis Septic... More >> Shock Less << Early Phase 1 Completed - -
NCT00119158 Atopic Dermatitis Phase 4 Completed - United States, Colorado ... More >> National Jewish Research Medical Center Denver, Colorado, United States, 80206 United States, Illinois Northwestern University School of Medicine Chicago, Illinois, United States, 60611 United States, Texas University of Texas at Houston Medical School Houston, Texas, United States, 77030 Less <<
NCT00123630 - Completed - -
NCT00202059 Breast Cancer Phase 3 Completed - United States, Minnesota ... More >> Park Nicollet Institute St. Louis Park, Minnesota, United States, 55416 Less <<
NCT00208026 Netherton Syndrome Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00208026 - Completed - -
NCT00113360 - Completed - -
NCT00226200 Asthma Not Applicable Terminated(Completed) - United States, Mississippi ... More >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT00251225 Prostate Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00253318 Breast Cancer Phase 1 Terminated(Toxicity and Lack o... More >>f Efficacy) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77230-1439 Less <<
NCT02834663 Age-related Macular Degenerati... More >>on Less << Phase 4 Unknown December 2018 -
NCT00290368 Hayfever Phase 2 Completed - United Kingdom ... More >> National Heart & Lung Institute Clinical Studies Unit London, United Kingdom, SW3 6HP Less <<
NCT00251225 - Completed - -
NCT00296244 Liver Cirrhosis ... More >> Liver Transplant Disorder Less << Phase 4 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00296244 - Completed - -
NCT00328458 Central Nervous System Neoplas... More >>ms Head and Neck Neoplasms Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00336817 Immunosuppression Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00297830 - Completed - -
NCT00286871 Chronic Hepatitis C ... More >> Organ Transplantation Immunosuppression Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00336817 - Completed - -
NCT00139152 Lung Disease Phase 4 Completed - United States, Nebraska ... More >> Creighton University Division of Allergy & Immunology Omaha, Nebraska, United States, 68131 United States, New York Albany Medical College Albany, New York, United States, 12208 Less <<
NCT00336895 Immunosuppression Not Applicable Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00336895 - Completed - -
NCT00297830 Heart Transplantation ... More >> Liver Transplantation Bone Resorption Less << Phase 2 Phase 3 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00361595 Osteoporosis Not Applicable Completed - United States, Ohio ... More >> The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT00354523 Solid Tumor T... More >>hyroid Cancer Less << Phase 1 Phase 2 Terminated(Study closed follow... More >>ing Phase I portion, insufficient activity to continue to Phase II.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00361595 - Completed - -
NCT00395421 Chronic Hepatitis C Phase 2 Completed - United States, Georgia ... More >> Atlanta, Georgia, United States United States, Virginia Fairfax, Virginia, United States Less <<
NCT01936376 - Unknown June 2015 United States, Massachusetts ... More >> Harvard Medical School - Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Sushrut Waikar, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Robert Haddad, MD          United States, Texas University of Texas MD Anderson Recruiting Houston, Texas, United States, 77030 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Bonnie Glisson, MD          Sub-Investigator: Ala Abudayyeh, MD Less <<
NCT00374140 - Completed - -
NCT00423189 Age-Related Macular Degenerati... More >>on Less << Phase 4 Terminated(Lack of efficacy) - United States, Texas ... More >> Vitreoretinal Consultants Houston, Texas, United States, 77030 Less <<
NCT00423189 - Terminated(Lack of efficacy) - -
NCT00449748 - Completed - -
NCT00374140 Small Cell Lung Cancer Phase 2 Completed - United States, Ohio ... More >> UPMC Cancer Center - Teramana Cancer Center - Steubenville Steubenville, Ohio, United States, 43952 United States, Pennsylvania UPMC Cancer Center - Beaver Beaver, Pennsylvania, United States, 15009 UPMC Cancer Center - Clairton Clairton, Pennsylvania, United States, 15025 UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Center - Oakbrook Commons - Greensburg Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Center - Indiana Indiana, Pennsylvania, United States, 15701 UPMC Cancer Center - John P. Murtha Pavilion - Johnstown Johnstown, Pennsylvania, United States, 15901 UPMC Cancer Center - McKeesport McKeesport, Pennsylvania, United States, 15132 UPMC Cancer Center - Monroeville Monroeville, Pennsylvania, United States, 15146 UPMC Cancer Center - Sewickley Medical Oncology/Hematology Group Moon, Pennsylvania, United States, 15108 UPMC Cancer Center - New Castle New Castle, Pennsylvania, United States, 16105 UPMC Cancer Center - St. Margaret's Pittsburgh, Pennsylvania, United States, 15215 UPMC Cancer Center - Mercy Pittsburgh, Pennsylvania, United States, 15219 University of Pittsburgh Cancer Institute - Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Cancer Center - Passavant Pittsburgh, Pennsylvania, United States, 15237 UPMC Cancer Center - Upper St. Clair Pittsburgh, Pennsylvania, United States, 15241 UPMC Cancer Center - Uniontown Uniontown, Pennsylvania, United States, 15401 UPMC Cancer Center - Washington Washington, Pennsylvania, United States, 15301 UPMC Cancer Center - North Hills Wexford, Pennsylvania, United States, 15090 Less <<
NCT00457964 Tuberous Sclerosis ... More >> Lymphangioleiomyomatosis Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00449748 Systemic Mastocytosis Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00463489 Breast Cancer Not Applicable Completed - United States, California ... More >> Los Angeles Biomedical (LABIOMED) Research Institue at Harbor-UCLA Medical Center Torrance, California, United States, 90502 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Centre Boston, Massachusetts, United States, 02215 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Canada, British Columbia Bcca - Csi Kelowna, British Columbia, Canada, V1Y 5L3 Canada, Ontario Cambridge Memorial Hospital Cambridge, Ontario, Canada, N1R 3G2 Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Grand River Regional Cancer Centere Kitchener, Ontario, Canada, N2G 1G3 London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Algoma District Cancer Program Sault Ste. Marie, Ontario, Canada, P6A 2C4 Scarborough Hospital Scarborough, Ontario, Canada, M1P 2V5 Niagara Health System St. Catharines, Ontario, Canada, L2R 7C6 Thunder Bay Regional Health Science Centre Thunder Bay, Ontario, Canada, P7B 6V4 Sunnybrook Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Trillium Healthcare Centre Toronto, Ontario, Canada, M9C 1A5 Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 CHUM - Hotel Dieu de Montreal Montreal, Quebec, Canada, H2W 1T8 Less <<
NCT00402532 Lung Transplantation Phase 3 Completed - Germany ... More >> Hannover Medical School, Division of Thoracic and Cardiovascular Surgery Hannover, Germany, 30625 Less <<
NCT00604500 Asthma COPD Phase 3 Completed - -
NCT00604500 - Completed - -
NCT00598689 - Completed - -
NCT00611689 Refractory Malignancy ... More >> Solid Tumors Less << Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00611793 Refractory Malignancy ... More >> Advanced Malignancies Less << Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00632489 - Completed - -
NCT00448149 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - United States, Texas ... More >> The Methodist Hospital Research Institute Houston, Texas, United States, 77030 Less <<
NCT00632489 Breast Cancer Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00645788 Cystic Fibrosis Phase 2 Completed - -
NCT00598689 Corneal Epithelium Defect Phase 4 Completed - United States, Georgia ... More >> EyeCare One Augusta, Georgia, United States, 30907 Less <<
NCT00639392 Sickle Cell Disease Phase 1 Phase 2 Withdrawn(Ended early due to i... More >>nability to identify eligible subjects) Less << - United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00645788 - Completed - -
NCT00657852 Bone Disease, Metabolic Phase 4 Completed - Spain ... More >> Hospital Clinic i Provincial of Barcelona Barcelona, Spain, 08036 Less <<
NCT00652834 Gastrointestinal Lesions ... More >> Signs and Symptoms, Digestive Less << Phase 4 Completed - United States, California ... More >> University of California, Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT00652834 - Completed - -
NCT00219765 Chronic Myeloid Leukemia Phase 1 Phase 2 Terminated - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT00690677 Colorectal Cancer Phase 2 Completed - United States, Washington ... More >> Swedish Medical Center Seattle, Washington, United States, 98104 Less <<
NCT00673218 Allergy Phase 4 Unknown November 2012 United States, Nebraska ... More >> Creighton University Omaha, Nebraska, United States, 68131 Less <<
NCT00273559 - Unknown December 2008 United States, Florida ... More >> Florida Hospital Transplant Center Orlando, Florida, United States, 32804 Less <<
NCT00287105 Acute Lymphoblastic Leukemia ... More >> Philadelphia Chromosome Less << Phase 2 Completed - France ... More >> Service d'hématologie pédiatrique CHRU Amiens, France, 80080 Service hématologie pédiatrique Hôpital Saint-Jacques Besancon, France, 25000 Service d'hémato-oncologie - Hôpital des Enfants Pellegrin Bordeaux, France, 33076 Hôpital Morvan Brest, France, 29200 Hématologie oncologie pédiatrique-CHU Caen Caen, France Hémato-Oncologie et Thérapie Cellulaire Pédiatrique - Hôtel Dieu Clermont-Ferrand, France, 63058 Hémato-Oncologie Pédiatrique - Hôpital d'Enfants Dijon, France, 21034 Pédiatrie CHU - Hôpital Nord Grenoble, France, 38043 Hôpital Jeanne de Flandre Lille, France, 59037 Limoges University Hospital Limoges, France, 87042 Hôpital DEBROUSSE Institut d'hématologie et d'oncologie pédiatrique Lyon, France Hôpital Arnaud de Villeneuve Montpellier, France Hématologie Pédiatrique - Hôpital Trousseau Paris, France, 75571 Hémato-immunologie-Robert Debré Paris, France Hématologie Hôpital Jean Bernard Poitiers, France, 86021 Hématologie pédiatrique-Hopital américain Reims, France Service d'hématologie pédiatrique - Hôpital Sud Rennes, France, 35033 Service d'Immuno Hémato Oncologie Pédiatrique - Hôpital Charles Nicolle Rouen, France, 76031 Hématologie, Oncologie pédiatrique-CHU Saint Etienne Saint Etienne, France Hopital des enfants Toulouse, France CHU- Centre Gatien de Clocheville Tours, France, 37044 Hôpital d'enfants Vandoeuvre Les Nancy, France, 54511 Less <<
NCT00323362 Lung Cancer Phase 2 Terminated(Toxicity) - United States, New Jersey ... More >> Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Saint Peter's University Hospital New Brunswick, New Jersey, United States, 08903 Less <<
NCT00676221 Kidney Transplant Phase 4 Unknown September 2008 Canada, Alberta ... More >> Foothills Medical Centre Calgary, Alberta, Canada, T2N2T9 Less <<
NCT00302705 Hypertension Phase 4 Completed - Spain ... More >> Hospital Clínico Universitario de Santiago Santiago de Compostela, Spain, 15706 Less <<
NCT00323362 - Terminated(Toxicity) - -
NCT00323739 - Completed - -
NCT00260247 Metabolic Clearance Rate Phase 4 Completed - Denmark ... More >> University of Southern Denmark Odense, Denmark, 5210 Less <<
NCT03746197 Lupus Erythematosus, Systemic Not Applicable Recruiting July 1, 2020 United States, Colorado ... More >> Natinal Jewish Health Recruiting Denver, Colorado, United States, 80220 Contact: Elizabeth Kozora, PhD    303-398-1071    kozorae@njhealth.org    Contact: Rebecca Smith, MS    303-398-1193    smithrm@njhealth.org Less <<
NCT00418496 Renal Cancer ... More >>Melanoma Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00390156 Unspecified Adult Solid Tumor Phase 1 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143-1705 Less <<
NCT00323739 Kidney Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Gainsville Hematology Oncology Associates Gainesville, Florida, United States, 32605 Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Louisiana Baton Rouge General Medical Center Baton Rouge, Louisiana, United States, 70806 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00470704 Breast Cancer Phase 2 Active, not recruiting December 2019 United States, Alabama ... More >> University fo Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Illinois University of Chicago Chicago, Illinois, United States, 60452 United States, Massachusetts Dana-Farber at Faulkner Hospital Boston, Massachusetts, United States, 02130 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00385853 Glioblastoma Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00529035 - Active, not recruiting - -
NCT00382070 Breast Cancer Phase 3 Active, not recruiting October 2018 -
NCT00369850 Breast Cancer ... More >> Osteoporosis Less << Phase 3 Completed - Australia, New South Wales ... More >> Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Australia, Queensland Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia, 4029 France Institut Bergonie Bordeaux, France, 33076 Italy Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 European Institute of Oncology Milano, Italy, 20141 New Zealand Dunedin Hospital Dunedin, New Zealand Peru Instituto Nacional de Enfermedades Neoplasicas Lima, Peru, 34 South Africa Groote Schuur Hospital Cape Town, South Africa, 7925 Spain Hospital Ruber Internacional Madrid, Spain, 28034 Switzerland Kantonspital Aarau Aarau, Switzerland, CH-5001 Inselspital Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Ospedale Beata Vergine Mendrisio, Switzerland, CH-6850 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Less <<
NCT00549822 - Terminated(Slow Accrual) - -
NCT00479934 Scleroderma, Localized ... More >> Scleroderma, Systemic Less << Phase 2 Completed - France ... More >> Service de Dermatologie et services de médecine interne et vasculaire - Hôpital St André - CHU de Bordeaux Bordeaux, France, 33076 Service de Rhumatologie, Hôpital Pellegrin-Tondu CHU de Bordeaux Bordeaux, France, 33076 Service de Dermatologie - CHG Libourne Libourne, France, 33500 Service de dermatologie - CHU de Limoges Limoges, France, 87042 Service de Médecin interne - Hôpital central Nancy, France, 54035 Service de Médecine interne - Hôpital Saint Louis Paris, France, 75475 Service de Dermatologie - CHG Périgueux Perigueux, France, 24000 Service de Dermatologie - service de médecine interne et vasculaire - hopital haut Lévêque - av.de magellan Pessac, France, 33604 Service de Rhumatologie - CHU de Strasbourg Strasbourg, France, 67098 Service de Dermatologie - CHU de Toulouse - Hopital Purpan Toulouse, France, 31059 Toulouse Cedex Service de Médecine interne - CHU de Tours Tours, France, 37044 Néphrologie et Médecine interne - CH de Valenciennes Valenciennes, France, 59322 Less <<
NCT00591734 - Completed - -
NCT00549822 Breast Cancer Phase 2 Terminated(Slow Accrual) - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00651482 Kidney Neoplasms ... More >> Kidney (Renal Cell) Cancer Less << Phase 2 Terminated(slow accrual) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00529035 Graft Versus Host Disease Phase 1 Active, not recruiting August 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00651482 - Terminated(slow accrual) - -
NCT00684411 - Completed - -
NCT00738751 Lung Cancer H... More >>ead and Neck Cancer Less << Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00805961 Glioblastoma Multiforme Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00591734 Metastatic Melanoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Pennsylvania Consultants in Medical Oncology and Hematology Drexel Hill, Pennsylvania, United States, 19026 United States, Tennessee Chattanooga Oncology & Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00827359 Renal Cell Carcinoma ... More >> Renal Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Dana-Farber Cancer Institute Boston, Massachusetts, United States United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00684411 T Cell Non-Hodgkin Lymphoma Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00849550 Unspecified Adult Solid Tumor,... More >> Protocol Specific Cancer Less << Phase 1 Completed - United States, Illinois ... More >> Ingalls Cancer Research Center Harvey, Illinois, United States, 60426 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT00760370 Multiple Myeloma ... More >> Breast Cancer Less << Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Vejle Hospital Vejle, Denmark, 7100 Less <<
NCT00856050 - Completed - -
NCT00903162 Breast Cancer Phase 2 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80217 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Newton Wellesley Hospital Newton, Massachusetts, United States, 02462 Less <<
NCT00874211 - Active, not recruiting January 2019 -
NCT00903162 - Completed - -
NCT00936585 - Terminated(Study halted by the... More >> sponsor) Less << - -
NCT00936611 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 2 Active, not recruiting December 2021 United States, Colorado ... More >> Rocky Mountain Cancer Centers Denver, Colorado, United States, 80220 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00805961 - Completed - -
NCT00972335 - Terminated(Study terminated ea... More >>rly due to slow accrual) Less << - -
NCT00972335 Intracranial Meningioma Phase 2 Terminated(Study terminated ea... More >>rly due to slow accrual) Less << - United States, Florida ... More >> Florida Hospital Cancer Insitute Orlando, Florida, United States, 32804 United States, Kentucky Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee UT Cancer Insititute Memphis Memphis, Tennessee, United States, 38104 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT00976248 - Completed - -
NCT00962533 Hepatitis B, Chronic Phase 4 Completed - China, Beijing ... More >> 302 Military Hospital of China BeiJing, Beijing, China Beijing Ditan Hospita Beijing, Beijing, China Beijing Friendship Hospital Attached to the Capital Medical University Beijing, Beijing, China BeiJing YouAn Hospital ,Capital Medical University BeiJing, Beijing, China Department of infectious disease, First Hospital of Peking University Beijing, Beijing, China People'S Hospital Under Beijnig University Beijing, Beijing, China China, Chongqing The Second Affiliated of ChongQing University of Medical Science ChongQing, Chongqing, China China, Guangdong Department of infectious disease, Nanfang Hospital Guangzhou, Guangdong, China No. 8 People's Hospital In GuangZhou GuangZhou, Guangdong, China The Third Hospital of Sun Yat-Sen University GuangZhou, Guangdong, China China, Hubei Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China China, Hunan Xiangya Hospital Central-South Univrsity ChangSha, Hunan, China China, Jiangsu No.81 Hospital of PLA NanJing, Jiangsu, China China, Jilin First Hospital .Jilin Unniversity ChangChun, Jilin, China China, Liaoning ShengJing Hospital of China Medical University ShenYang, Liaoning, China China, Shandong JiNan Infectious Diseases Hospital JINan, Shandong, China China, Shanghai Changhai Hospital affiliated to Second Military Medical University ShangHai, Shanghai, China Huashan Hospital，Fudan University ShangHai, Shanghai, China No.85 Hospital of PLA ShangHai, Shanghai, China Shanghai Ruijin Hospital ShangHai, Shanghai, China China, Shanxi Tangdu Hospital XiAn, Shanxi, China China, Sichuan West China Hospital.SiChuan University ChengDu, Sichuan, China China, Zhejiang The First Affiliated Hospital of College of Medicine ，Zhejiang University HangZhou, Zhejiang, China The Sixth People's Hospital of Hangzhou Hangzhou, Zhejiang, China Less <<
NCT00856050 Leiomyosarcoma Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01011075 Non-small Cell Lung Cancer Phase 2 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States, 87102 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 United States, Washington Univ. of Washington Fred Hutchinson Cancer Research Center (UW-FHCRC) Seattle, Washington, United States, 98109-1024 Less <<
NCT00976248 Waldenstrom's Macroglobulinemi... More >>a Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00981799 Relapsed T-Cell Acute Lymphobl... More >>astic Leukemia Relapsed T-Cell Lymphoblastic Lymphoma Less << Phase 1 Phase 2 Terminated(Slow accrual rate) - -
NCT01011075 - Completed - -
NCT00140803 Age-Related Macular Degenerati... More >>on Less << Phase 2 Completed - United States, New York ... More >> Manhattan Eye, Ear & Throat Hospital New York, New York, United States, 10021 Canada, British Columbia Vh/UBC Eye Care Centre Vancouver, British Columbia, Canada, V5Z 3N9 Less <<
NCT01065467 Melanoma Mali... More >>gnant Melanoma Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01058408 Head and Neck Cancer Phase 1 Terminated - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00193349 Lung Cancer Phase 2 Completed - -
NCT00222144 Lung Cancer Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Missouri VA Medical Center Kansas City, Missouri, United States, 64128 Less <<
NCT00193180 - Completed - -
NCT00259168 Insulin Resistance ... More >> Impaired Fasting Glucose Less << Phase 4 Completed - Denmark ... More >> Endothelial laboratory, Cardiology clinic Y-research, H:S Bispebjerg Hospital Bispebjerg Bakke, Copenhagen, Copenhagen NV, Denmark, 2400 Less <<
NCT00242203 Breast Neoplasms Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00283504 ALLERGIC ASTHMA Phase 4 Completed - -
NCT00193180 Breast Cancer Phase 2 Completed - United States, Georgia ... More >> Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Louisiana Baton Rouge General Medical Center Baton Rouge, Louisiana, United States, 70806 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01139138 Colorectal Cancer ... More >> Colorectal Carcinoma Colorectal Tumors Neoplasms, Colorectal Less << Phase 1 Phase 2 Completed - Australia, South Australia ... More >> The Queen Elizabeth Hospital Adelaide, South Australia, Australia, 5011 Less <<
NCT00283504 - Completed - -
NCT01087008 Multiple Myeloma Phase 4 Active, not recruiting December 2018 Spain ... More >> Hospital Universitari Germans Trias I Pujol Badalona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Vall d'Hebrón Barcelona, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain Hospital Jose María Morales Meseguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Hospital Universitario Son Dureta Palma de Mallorca, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital Universitario de Canarias Tenerife, Spain Hospital Clínico Universitario de Valencia Valencia, Spain Hospital Universitario Dr. Peset. Valencia, Spain Hospital Universitario La Fe Valencia, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain Less <<
NCT00301873 Brain Tumors ... More >>Osteoporosis Central Nervous System(CNS)Malignancies Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00325325 Kidney Diseases Phase 2 Unknown - Spain ... More >> Hospital Ramón y Cajal Recruiting Madrid, Spain, 28034 Principal Investigator: Julio Pascual, MD Less <<
NCT01122199 Neoplasm Metastases Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01211327 Vernal Keratoconjunctivitis Phase 4 Completed - Rwanda ... More >> Kabgayi Hospital Gitarama/Muhanga, Rwanda Less <<
NCT00392821 Kidney Cancer Phase 1 Phase 2 Completed - United States, Florida ... More >> Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00936585 Colitis Crohn... More >>'s Disease Inflammatory Bowel Disease Less << Not Applicable Terminated(Study halted by the... More >> sponsor) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01273610 Breast Neoplasms ... More >> HER2/Neu Positive Geriatric Health Services Less << Phase 2 Active, not recruiting June 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 City of Hope Antelope Valley Lancaster, California, United States, 93534 South Pasadena Cancer Center Pasadena, California, United States, 91030 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, North Carolina, United States, 27599 Duke University Medical Center Durham, North Carolina, United States, 27704 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00343616 Breast Cancer ... More >> Cognitive/Functional Effects Fatigue Psychosocial Effects of Cancer and Its Treatment Less << Phase 3 Completed - Australia, New South Wales ... More >> Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 St. Vincent's Hospital - Melbourne Fitzroy, Victoria, Australia, 3065 Cabrini Hospital Malvern, Victoria, Australia, 3144 Belgium Institut Jules Bordet Brussels, Belgium, 1000 Italy European Institute of Oncology Milan, Italy, 20141 New Zealand Auckland City Hospital Auckland, New Zealand, 1 Switzerland Universitaetsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 International Breast Cancer Study Group Bern, Switzerland, CH-3008 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 United Kingdom Ninewells Hospital Dundee, Scotland, United Kingdom, DD1 9SY Less <<
NCT00301873 - Completed - -
NCT01352312 Chronic Lymphocytic Leukemia ... More >> B-Cell Non-Hodgkin's Lymphoma Less << Phase 1 Terminated(Insufficient accrua... More >>l over 12 mo period) Less << - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00426153 Polycystic Kidney, Autosomal D... More >>ominant Polycystic Liver Disease Hepatomegaly Liver Diseases Kidney, Polycystic Abdominal Pain Less << Phase 2 Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00392821 - Completed - -
NCT00426153 - Completed - -
NCT00461773 Hormone-Sensitive Breast Cance... More >>r Breast Cancer Less << Phase 2 Unknown May 2010 United States, Connecticut ... More >> Yale University, Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06520 Less <<
NCT01438554 Solid Tumors ... More >>Thyroid Cancer Soft-tissue Sarcoma Cholangiocarcinoma Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01218555 Solid Organ Malignancies ... More >> Adenoidcystic Carcinoma Neuroendocrine Tumors Less << Phase 1 Completed - United States, Georgia ... More >> Grady Health System Atlanta, Georgia, United States, 30303 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01398631 - Completed - Netherlands ... More >> Meander Medical Centre Amersfoort, Netherlands Gelre Hospital Apeldoorn, Netherlands Reinier de Graaf Gasthuis Delft, Netherlands Medical Centre Haaglanden Den Haag, Netherlands University Medical Centre Groningen Groningen, Netherlands Medical Centrum Haaglanden Leidschendam, Netherlands St Antonius Hospital Nieuwegein, Netherlands St Antonius Hospital Utrecht, Netherlands University Medical Centre Utrecht Utrecht, Netherlands Hofpoort Hospital Woerden, Netherlands Less <<
NCT01460940 - Completed - -
NCT01460940 Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma Less << Phase 2 Completed - United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 United States, Ohio The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00499603 Breast Cancer Phase 2 Unknown April 2017 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00421317 Melanoma Phase 2 Terminated(Study stopped at th... More >>e end of the first step) Less << - France ... More >> Centre Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Hospitalier Regional Universitaire Lille, France, 59035 Centre Leon Berard Lyon, France, 69373 Centre Val d'Aurelle Paul Lamarque Montpellier, France, 34298 Institut Curie Paris, France, 75248 Centre Paul Strauss Strasbourg, France, 67065 Hopital Universitaire de Hautepierre Strasbourg, France, 67098 Institut Claudius Regaud Toulouse, France, 31052 Centre Gustave Roussy Villejuif, France, 94805 Less <<
NCT01496118 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting December 2019 United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists South Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists North Saint Petersburg, Florida, United States, 33705 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 RHHP/Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, New Jersey Hematology-Oncology Associates - Northern NJ Morristown, New Jersey, United States, 07962 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 United States, Tennessee Tennessee Oncology-Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37205 United States, Texas The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less <<
NCT00499603 - Unknown - -
NCT01497392 Adenocarcinoma of the Pancreas... More >> Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01515969 Non-small Cell Lung Cancer (NS... More >>CLC), Recurrent Non-small Cell Lung Cancer (NSCLC), Stage IV Less << Phase 1 Terminated(Patient safety - Un... More >>acceptable toxicity) Less << - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT01529554 Acute Coronary Syndromes Phase 1 Phase 2 Recruiting December 31, 2019 Switzerland ... More >> University Hospital Bern Recruiting Bern, Switzerland Contact: Stephan Windecker, Professor       stephan.windecker@insel.ch    Principal Investigator: Stephan Windecker, Professor          University Hospital Geneva Recruiting Geneva, Switzerland Contact: Francois Mach, Professor       francois.mach@hcuge.ch    Principal Investigator: Francois Mach, Professor          Cardiocentro Ticino Recruiting Lugano, Switzerland Contact: Tiziano Moccetti, Professor          Contact       tiziano.moccetti@cardiocentro.org    Principal Investigator: Tiziano Moccetti, Professor          University Hospital Zurich Recruiting Zurich, Switzerland Contact: Andrea Denegri, MD    +41 44 255 ext 99 78    andrea.denegri@usz.ch    Principal Investigator: Andrea Denegri, MD Less <<
NCT01540253 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01543763 Metastatic Solid Tumors Phase 1 Active, not recruiting January 2020 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143 Less <<
NCT01458366 Non-Hodgkin's Lymphoma Phase 1 Phase 2 Active, not recruiting October 2021 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01582009 - Terminated(pts off study, PI l... More >>eft institute) Less << - -
NCT01529255 Hepatitis B, Chronic Phase 4 Unknown December 2015 China, Beijing ... More >> 302 Military Hospital Of China Beijing, Beijing, China Beijing Ditan Hospita Beijing, Beijing, China Beijing Friendship Hospital Attached To The Capital Medical University Beijing, Beijing, China BeiJing YouAn Hospital ,Capital Medical University Beijing, Beijing, China Department of Infectious Disease, First Hospital of Peking University Beijing, Beijing, China People's Hospital Under Beijnig University Beijing, Beijing, China China, Chongqing The Second Affiliated of ChongQing University of Medical Science Chongqing, Chongqing, China China, Guangdong Department of Infectious Disease, Nanfang Hospital Guangzhou, Guangdong, China No. 8 People's Hospital In GuangZhou Guangzhou, Guangdong, China The Third Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China China, Hubei Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China China, Hunan Xiangya Hospital Central-South Univrsity Changsha, Hunan, China China, Jiangsu No.81 Hospital of PLA Nanjing, Jiangsu, China China, Jilin First Hospital .Jilin Unniversity Changchun, Jilin, China China, Liaoning ShengJing Hospital of China Medical University Shengyang, Liaoning, China China, Shandong JiNan Infectious Diseases Hospital Jinan, Shandong, China China, Shanghai Changhai Hospital affiliated to Second Military Medical University Shanghai, Shanghai, China Huashan Hospital，Fudan University Shanghai, Shanghai, China No.85 Hospital of PLA Shanghai, Shanghai, China Shanghai Ruijin Hospital Shanghai, Shanghai, China China, Shanxi Tangdu Hospital Xian, Shanxi, China China, Sichuan West China Hospital.SiChuan University Chengdu, Sichuan, China China, Zhejiang The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, Zhejiang, China The Sixth People's Hospital of Hangzhou Hangzhou, Zhejiang, China Less <<
NCT01582009 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Terminated(pts off study, PI l... More >>eft institute) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00579826 - Completed - -
NCT00607113 Neuroendocrine Carcinoma Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00607113 - Completed - -
NCT01462214 Metastatic Renal Cell Cancer Phase 1 Phase 2 Completed - Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands VU University Medical Center Amsterdam, Netherlands, 1081 HV NKI-AVL Amsterdam, Netherlands Haga Ziekenhuis Den Haag, Netherlands Medisch Centrum Haaglanden Den Haag, Netherlands Universitair Medisch Centrum Groningen Groningen, Netherlands Spaarne Ziekenhuis Hoofddorp Hoofddorp, Netherlands Medisch Centrum Leeuwarden Leeuwarden, Netherlands University Hospital Maastricht Maastricht, Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands UMC St Radboud Nijmegen Nijmegen, Netherlands Sint Franciscus Gasthuis Rotterdam Rotterdam, Netherlands Isala Klinieken Zwolle Zwolle, Netherlands Less <<
NCT00574769 Prostate Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Westside Prostate Cancer Center, University of Southern California Beverly Hills, California, United States, 90211 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00579826 Breast Cancer Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00640978 Pancreatic Cancer Phase 2 Terminated(Significant Adverse... More >> Effects - Futility) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01656252 - Terminated(Study stopped per N... More >>ovartis request due to futility from another study.) Less << - -
NCT01656252 Acute Myeloid Leukemia Phase 1 Phase 2 Terminated(Study stopped per N... More >>ovartis request due to futility from another study.) Less << - United States, Massachusetts ... More >> University of Massachusetts Worcester Worcester, Massachusetts, United States, 01655 United States, Minnesota Mayo Clinic, Rochester Rochester, Minnesota, United States, 55905 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn State Hershey Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00669344 Cognitive Impairment Phase 4 Completed - Singapore ... More >> Singapore General Hospital Singapore, Singapore, 169608 Less <<
NCT01707225 Gastrointestinal Bleeding Phase 1 Completed - United States, Virginia ... More >> Virginia Commonwealth University Health System Richmond, Virginia, United States, 23298 Less <<
NCT00640978 - Terminated(Significant Adverse... More >> Effects - Futility) Less << - -
NCT01795209 Branch Retinal Vein Occlusion ... More >> Macular Edema Less << Phase 4 Active, not recruiting December 2017 Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyunggi-do, Korea, Republic of, 463-707 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01753713 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Less << Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01753713 - Completed - -
NCT00747994 - Completed - France ... More >> CHU Lariboisière Paris, Ile de France, France, 75010 Less <<
NCT00784485 Asthma Phase 4 Terminated(Terminated due to p... More >>oor enrollment.) Less << - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 Less <<
NCT01682213 Melanoma Phase 2 Active, not recruiting September 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00782626 Glioma Low-gr... More >>ade Glioma Astrocytoma Less << Phase 2 Completed - United States, Arizona ... More >> Phoenix Children's Hospital Center for Cancer and Blood Disorders Phoenix, Arizona, United States, 85016 United States, Colorado The Children's Hospital Denver, Colorado, United States, 80045 United States, Florida University of Florida College of Medicine Gainesville, Florida, United States, 32610 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Maryland John Hopkins Medical Center Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York New York University New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Institute New York, New York, United States, 10174 United States, Oregon Doernbecher Children's Hospital Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01707225 - Completed - -
NCT00782626 - Completed - -
NCT00789841 - Completed - Denmark ... More >> Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A Aarhus, Denmark, 8000 Less <<
NCT01848145 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Florida Cancer Specialists-North Saint Petersburg, Florida, United States, 33705 United States, Ohio Oncology Hematology Associates Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Less <<
NCT01848145 - Completed - -
NCT01922492 Partial Pancreatectomy Due to ... More >>Benign Pancreatic Neoplasm Less << Not Applicable Unknown December 2017 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00942682 Neuroendocrine Tumor ... More >> Carcinoid Tumor Pancreatic Neuroendocrine Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00896012 Kidney Transplantation Phase 4 Unknown December 2010 United States, New York ... More >> Buffalo General Hospital Multi-Organ Transplant Department Buffalo, New York, United States, 14203 Less <<
NCT00942734 - Completed - -
NCT02048943 Duct Cell Adenocarcinoma of th... More >>e Pancreas Recurrent Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Withdrawn(Lack of funding) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00942734 Head And Neck Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02128724 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - United Kingdom ... More >> Churchill Hospital Oxford, Oxon, United Kingdom, OX3 7LE Less <<
NCT02109913 Hormone Receptor Positive Mali... More >>gnant Neoplasm of Breast Metastatic Breast Cancer Less << Not Applicable Active, not recruiting January 2019 Netherlands ... More >> VU University Medical Center Amsterdam, Noord-Holland, Netherlands, 1007 MB Flevoziekenhuis Almere, Netherlands BovenIJ Ziekenhuis Amsterdam, Netherlands The Netherlands Cancer Institute Amsterdam, Netherlands Gelre Apeldoorn, Netherlands Rijnstate Ziekenhuis Arnhem, Netherlands Amphia Ziekenhuis Breda, Netherlands Reinier de Graaf Groep Delft, Netherlands Haga Den Haag, Netherlands MC Haaglanden Den Haag, Netherlands Gemini Den Helder, Netherlands Deventer Ziekenhuis Deventer, Netherlands Maxima Medisch Centrum Eindhoven, Netherlands Groene Hart Ziekenhuis Gouda, Netherlands Tergooi ziekenhuizen Hilversum, Netherlands Spaarne Ziekenuis Hoofddorp, Netherlands MC Leeuwarden Leeuwarden, Netherlands LUMC Leiden, Netherlands Canisius Ziekenhuis Nijmegen, Netherlands Bravis Roosendaal And Bergen Op Zoom, Netherlands Erasmus University Medical Center Rotterdam, Netherlands Ikazia Rotterdam, Netherlands Vlietland Schiedam, Netherlands Orbis MC Sittard, Netherlands Elisabeth - Tweesteden Tilburg, Netherlands UMC Utrecht Utrecht, Netherlands VieCuri Venray, Netherlands Isala Zwolle, Netherlands Less <<
NCT02143726 Refractory Hurthle Cell Thyroi... More >>d Cancer Less << Phase 2 Recruiting - United States, Florida ... More >> Mayo Clinic in Florida Suspended Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Site Public Contact    312-695-1301    cancer@northwestern.edu    Principal Investigator: Maria Matsangou          United States, Iowa Siouxland Regional Cancer Center Recruiting Sioux City, Iowa, United States, 51101 Contact: Site Public Contact    712-252-0088       Principal Investigator: Donald B. Wender          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Site Public Contact    800-865-1125       Principal Investigator: Francis P. Worden          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact    855-776-0015       Principal Investigator: Ashish V. Chintakuntlawar          United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Site Public Contact    402-354-5144       Principal Investigator: Yungpo B. Su          United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact    212-639-7592       Principal Investigator: Eric J. Sherman          Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, North Carolina Southeastern Medical Oncology Center-Clinton Recruiting Clinton, North Carolina, United States, 28328 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Goldsboro Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-587-9077    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Wayne Memorial Hospital Recruiting Goldsboro, North Carolina, United States, 27534 Contact: Site Public Contact    919-731-6687    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Jacksonville Recruiting Jacksonville, North Carolina, United States, 28546 Contact: Site Public Contact    910-353-0824    ecooke@cancersmoc.com    Principal Investigator: James N. Atkins          Southeastern Medical Oncology Center-Wilson Suspended Wilson, North Carolina, United States, 27893 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu    Principal Investigator: Bhavana Konda          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Site Public Contact    215-728-4790       Principal Investigator: Jessica R. Bauman          United States, Wisconsin Mercy Health System Recruiting Janesville, Wisconsin, United States, 53547 Contact: Site Public Contact    800-928-1103       Principal Investigator: Emily G. Robinson Less <<
NCT01893372 Leukemia Phase 2 Active, not recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02145715 Multiple Myeloma Phase 1 Phase 2 Unknown January 2016 United Kingdom ... More >> Birmingham Heartlands Hospital Birmingham, UK, United Kingdom, B9 5SS Royal Liverpool University Hospital Liverpool, United Kingdom, L7 8XP St Bartholomew's Hospital London, United Kingdom, EC1A 7BE University College London Hospitals NHS Foundation Trust London, United Kingdom, WC1E 6AG Guy's Hospital London, United Kingdom Less <<
NCT02137837 Breast Cancer Phase 3 Suspended(lack of accrual) May 2022 -
NCT00691873 Asthma Phase 4 Completed - United States, Mississippi ... More >> University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT00703807 Endometrial Cancer Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00704847 Osteoarthritis Phase 3 Terminated(Male subjects were ... More >>terminated due to an imbalance in prostate cancer events) Less << - United States, Alabama ... More >> Achieve Clinical Research, LLC Tuscaloosa, Alabama, United States, 35406 United States, California Center for Healthy Aging Sacramento, California, United States, 95817 United States, Illinois Northwestern Center for Clinical Research Chicago, Illinois, United States, 60611 United States, Missouri Midwest Pharmaceutical Research St. Peters, Missouri, United States, 63376 United States, North Carolina Thurston Arthritis Research Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Rheumatology Clinical Research Unit Beachwood, Ohio, United States, 44122 Belgium Hospital Universitaire St. Luc, UCL 5390 Brussels, Belgium, 1200 Canada Centre de Rhumatologie St-Louis Sainte-Foy (Québec), Canada, G1W 4R4 Czech Republic CCBR Czech Pardubice, Czech Republic, 53002 Denmark CCBR Aalborg Aalborg, Denmark, 9000 CCBR Ballerup Ballerup, Denmark, 2750 CCBR Vejle Vejle, Denmark, 7100 Hong Kong CCBR Hong Kong Hong Kong, Hong Kong Poland Centrum Osteoporozy i Chorób Kostno Stawowych, ul. Waryńskiego 6/2 Bialystok, Poland, 15-461 CCBR Poland Warsaw, Poland, 04703 Romania CCBR Romania Bucharest, Romania, 030463 Spain Hospital Universitario de la Paz Madrid, Spain, 28046 United Kingdom Little Common Surgery East Sussex, United Kingdom, TN 39 4SP Less <<
NCT00993642 Breast Cancer Early Phase 1 Withdrawn(Lack of accrual) - United States, Louisiana ... More >> Tulane Cancer Center, Comprehensive Clinic, CTRC New Orleans, Louisiana, United States, 70112 Less <<
NCT00697619 - Completed - -
NCT00697619 Nasopharyngeal Cancer Phase 2 Completed - China, Guangdong ... More >> Li Zhang Guangzhou, Guangdong, China Less <<
NCT00704847 - Terminated(Male subjects were ... More >>terminated due to an imbalance in prostate cancer events) Less << - -
NCT00712985 Breast Cancer Phase 3 Completed - United States, Pennsylvania ... More >> Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00710216 Hepatitis B, Chronic Phase 4 Withdrawn(Sponsor withdraw) - Germany ... More >> University Hospital Ulm Ulm, Germany, 89081 Less <<
NCT00710801 - Completed - Canada, Alberta ... More >> University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2B7 Less <<
NCT00788060 Renal Cell Carcinoma Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT00715468 - Completed - Canada, Quebec ... More >> Hôpital Maisonneuve-Rosemont Montréal, Quebec, Canada, H1T 2M4 Less <<
NCT00729846 Age Related Macular Degenerati... More >>on Choroidal Neovascularization Macular Edema Less << Phase 2 Completed - United States, California ... More >> California Retina Consultants Bakersfield, California, United States, 93309 California Retina Consultants Santa Barbara, California, United States, 93103 Less <<
NCT00729846 - Completed - -
NCT00743288 Multiple Myeloma Phase 1 Phase 2 Completed - United States, California ... More >> Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309-0633 James R. Berenson MD, Incorporated West Hollywood, California, United States, 90069 United States, Colorado Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States, 80218 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 Less <<
NCT00743288 - Completed - -
NCT00749515 Transfusion-dependent Hemachro... More >>matosis Thalassemia Major Sickle Cell Disease Less << Phase 4 Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT03428126 Malignant Neoplasms of Digesti... More >>ve Organs Colorectal Cancer Colon Cancer Less << Phase 2 Enrolling by invitation November 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01866553 Chronic Myeloid Leukemia Phase 2 Terminated(insufficient enroll... More >>ment) Less << - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark Finland Helsinki University Hospital Helsinki, Finland Netherlands VU University Medical Center Amsterdam, Netherlands Norway Trondheim University Hospital Trondheim, Norway Sweden Uppsala University Hospital Uppsala, Sweden Less <<
NCT00731861 Neoplasm Metastasis ... More >> Carcinoma Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01626352 Diffuse Large B-Cell Lymphoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists North Saint Petersburg, Florida, United States, 33705 Space Coast Cancer Center Titusville, Florida, United States, 32796 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 RHHP/Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 Oklahoma University Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology-Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT02073487 Breast Cancer Phase 2 Active, not recruiting June 2019 United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Houston Methodist Hospital Willowbrook Houston, Texas, United States, 77070 Houston Methodist Hospital Sugar Land Sugar Land, Texas, United States, 77479 Less <<
NCT03225664 Lung Diseases Due to External ... More >>Agents Non-Small Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting May 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT01934894 Metastatic Breast Cancer With ... More >>Intracranial Metastases Less << Phase 2 Terminated(Study was terminate... More >>d due to lack of significant signal of efficacy) Less << - United States, Florida ... More >> Florida Cancer Specialists - South Fort Myers, Florida, United States, 33916 Florida Cancer Specialists-North Saint Petersburg, Florida, United States, 33705 United States, Ohio Oncology Hematology Care Inc. Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01934894 - Terminated(Study was terminate... More >>d due to lack of significant signal of efficacy) Less << - -
NCT00712985 - Completed - -
NCT02605746 Glioblastoma ... More >>Brain Metastases Less << Early Phase 1 Unknown September 2017 United States, Arizona ... More >> Barrow Brain and Spine Recruiting Phoenix, Arizona, United States, 85013 Contact: Norissa Honea, RN, PhD    602-406-6267    norissa.honea@dignityhealth.org    Principal Investigator: Nader Sanai, MD Less <<
NCT02055690 Ovarian Neoplasms ... More >> Neoplasms, Ovarian Ovarian Cancer Less << Phase 1 Phase 2 Terminated(Safety) - United Kingdom ... More >> Royal United Hospital Bath NHS Trust Bath, United Kingdom, BA1 3NG City Hospital Birmingham, United Kingdom, B18 7GH University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom, BS1 3NU University Collage London Hospitals NHS Foundation Trust London, United Kingdom, NW1 2PG The Royal Marsden NHS Foundation Trust London, United Kingdom, SM2 5PT The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Clatterbridge Centre for Oncology NHS Foundation Trust Merseyside, United Kingdom, CH63 4JY Mount Vernon Cancer Centre (East and North Herts NHS Trust) Middlesex, United Kingdom, HA6 2RN Freeman Hospital (Newcastle-upon-Tyne Hospitals NHS Foundation Trust) Newcastle-upon-Tyne And Wear, United Kingdom, NE7 7DN Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom, OX3 9DU Less <<
NCT03299088 KRAS Gene Mutation ... More >> Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 1 Recruiting March 1, 2021 United States, California ... More >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Jonathan W. Riess    916-734-7771    jwriess@ucdavis.edu    Principal Investigator: Jonathan W. Riess Less <<
NCT03577197 - Recruiting December 31, 2020 Netherlands ... More >> Multiple hospitals in the Netherlands (see Eligibility) Recruiting Maastricht, Netherlands Contact: Vivianne CG Tjan-Heijnen, MD, PhD    +31 (0) 43 3877025    vcg.tjan.heijnen@mumc.nl Less <<
NCT03091257 Multiple Myeloma Phase 1 Recruiting December 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Noopur S. Raje, MD    617-726-3810       Principal Investigator: Noopur S. Raje, MD          United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffery Zonder, MD    313-576-8673    zonderj@karmanos.org    Principal Investigator: Jeffery Zonder, MD Less <<
NCT03533231 Dental Pulp Necrosis ... More >> Periapical Abscess Root Canal Infection Less << Phase 4 Completed - -
NCT01626352 - Completed - -
NCT00852423 Malaria in Pregnancy Phase 3 Completed - Burkina Faso ... More >> ISSR/Centre Muraz Nanoro, Burkina Faso ISSR/Centre Muraz Nazoanga, Burkina Faso Ghana Kwame Nkrumah University of Science & Technology, Kumasi Ejisu Sekyere East, Ashanti Region, Ghana Kwame Nrumah University of Science and Technology, Kumasi Juaben Government Hospital, Ashanti Region, Ghana Effiduase Government Hospital Effiduase, Ghana Malawi College of Medicine, University of Malawi Chikwawa District Hospital, Blantyre, Malawi Zambia St Paul Hospital Nchelenge, Nchelenge District, Zambia Less <<
NCT00866619 Malaria Phase 3 Completed - Burkina Faso ... More >> GSK Investigational Site Ouagadougou, Burkina Faso Gabon GSK Investigational Site Lambaréné, Gabon Ghana GSK Investigational Site Kintampo, Ghana GSK Investigational Site Knust- Kumasi, Ghana Kenya GSK Investigational Site Kilifi, Kenya, 80108 GSK Investigational Site Kisumu, Kenya Malawi GSK Investigational Site Lilongwe, Malawi Mozambique GSK Investigational Site Maputo, Mozambique Tanzania GSK Investigational Site Dar-es-Salaam, Tanzania GSK Investigational Site Tanga, Tanzania Less <<
NCT01132079 Atopic Dermatitis Not Applicable Completed - Germany ... More >> Dept. of Dermatology, University of Kiel Kiel, Germany, 24105 Less <<
NCT01339052 - Active, not recruiting - -
NCT03070301 Neuroendocrine Tumors Phase 2 Recruiting February 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Jeffrey Clark, MD    617-724-4000       Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Jennifer Chan, MD          Beth Israel Deaconess Medical Center Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Andrea Bullock, MD    617-667-2100       United States, New York Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Diane Reidy-Lagunes, MD,MS    646-888-4185       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Diane Reidy-Lagunes, MD    646-888-4185       Contact: Nitya Raj, MD    646-888-4849       Principal Investigator: Diane Reidy-Lagunes, MD          United States, Texas Md Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Arvind Dasari, MD Less <<
NCT00253565 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00985192 - Completed - -
NCT00276575 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT01339052 Glioblastoma Phase 2 Active, not recruiting August 2018 United States, California ... More >> University of California, Los Angeles Los Angeles, California, United States, 90095 University of California, San Francisco San Francisco, California, United States, 94143 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Texas UT, MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT00673335 brca1 Mutation Carrier ... More >> brca2 Mutation Carrier Breast Cancer Hereditary Breast/Ovarian Cancer (brca1, brca2) Less << Phase 3 Active, not recruiting February 2022 France ... More >> Institut Sainte Catherine Avignon, France, 84082 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Hopital Arnaud de Villeneuve Montpellier, France, 34295 Centre Catherine de Sienne Nantes, France, 02 Centre Antoine Lacassagne Nice, France, 06189 Centre Hospitalier General de Niort Niort, France, 79021 Hopital Saint Michel Paris, France, 75015 Hotel Dieu de Paris Paris, France, 75181 Institut Curie Hopital Paris, France, 75248 CHU Poitiers Poitiers, France, 86021 Polyclinique De Courlancy Reims, France, F-51100 Centre Eugene Marquis Rennes, France, 35042 Centre Henri Becquerel Rouen, France, 76038 Centre Rene Huguenin Saint Cloud, France, 92211 CHU Sainte-Etienne - Hopital Nord Saint-Étienne, France, 42055 Centre Paul Strauss Strasbourg, France, 67065 Institut Claudius Regaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00134680 Metastatic Breast Cancer Phase 2 Completed - United States, District of Col... More >>umbia Lombardi Cancer Institute, Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Siteman Cancer Center, Washington University St. Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00985192 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, California ... More >> Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States, 91801 Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 St. Jude Heritage Medical Group at Virginia K. Crosson Cancer Center Fullerton, California, United States, 92835 Antelope Valley Cancer Center Lancaster, California, United States, 93534 Pacific Shores Medical Group Long Beach, California, United States, 90813 Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Translational Oncology Research International (TORI) Network Los Angeles, California, United States, 90095 North Valley Hematology/Oncology Medical Group Northridge, California, United States, 91328 Wilshire Oncology Medical Group, Inc. Pomona, California, United States, 91767 Cancer Care Associates Medical Group, Inc. Redondo Beach, California, United States, 90277 TORI REDONDO BEACH (Cancer Care Associates Medical Group, Inc.) Redondo Beach, California, United States, 90277 Sansum Medical Clinic Santa Barbara, California, United States, 93105 Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara, California, United States, 93105 Central Coast Medical Oncology Corporation Santa Maria, California, United States, 93454 Trivalley Oncology Hematology Westlake village, California, United States, 91361 United States, Georgia Suburban Hematology-Oncology Associates, P.A. Lawrenceville, Georgia, United States, 30045 Northwest Georgia Oncology Centers, P.C. Marietta, Georgia, United States, 30060 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89109 Less <<
NCT00248482 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00433589 Breast Cancer Phase 3 Active, not recruiting - Netherlands ... More >> Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Less <<
NCT01057342 Lung Cancer Phase 2 Completed - Switzerland ... More >> Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Olten Olten, Switzerland, CH-4600 Onkologie Schaffhausen Schaffhausen, Switzerland, CH-8200 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 Klinik Hirslanden Zurich, Switzerland, CH-8032 Less <<
NCT00611715 Breast Cancer Phase 2 Terminated(low accrual) - United States, Georgia ... More >> Central Georgia Hematology/Oncology Associates, P.C. Macon, Georgia, United States, 31201 United States, Kentucky Jennie Stuart Medical Center Hopkinsville, Kentucky, United States, 42240 Purchase Cancer Group Paducah, Kentucky, United States, 42002 United States, Tennessee Memorial Health Care System Chattanooga, Tennessee, United States, 37404 The Jones Clinic - Germantown Germantown, Tennessee, United States, 38138 Jackson-Madison County Hospital Jackson, Tennessee, United States, 38301 Tennessee Cancer Specialists Knoxville, Tennessee, United States, 37909 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37067 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00265200 Carcinoma, Non-Small Cell Lung... More >> Carcinoma, Small Cell Lung Metastases Less << Phase 2 Terminated(funding discontinue... More >>d by sponsor) Less << - United States, Kentucky ... More >> James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 Less <<
NCT00265200 - Terminated(funding discontinue... More >>d by sponsor) Less << - -
NCT00611715 - Terminated(low accrual) - -
NCT00626782 - Completed - -
NCT00626782 Glaucoma Phase 2 Phase 3 Completed - United States, Pennsylvania ... More >> Wills Eye Hospital, Glaucoma Service Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00295646 Breast Cancer Phase 3 Unknown June 2016 -
NCT00512993 Breast Cancer Phase 3 Completed - -
NCT00117611 Sinusitis Phase 4 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00651261 Leukemia Phase 3 Active, not recruiting - -
NCT00912340 Breast Cancer Phase 2 Completed - United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States, 60611 United States, Wisconsin University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00912340 - Completed - -
NCT00630344 Prostate Cancer Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00630344 - Completed - -
NCT00925132 Metastatic Melanoma Phase 1 Phase 2 Terminated(Change in the numbe... More >>r of approved drugs for metastatic melanoma) Less << - United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT00930475 Breast Cancer Phase 1 Phase 2 Unknown - Germany ... More >> Charité, university medicine, Berlin, CCM Recruiting Berlin, Germany, 10177 Principal Investigator: Jan Eucker, Dr. med. Less <<
NCT00960739 Neuroblastoma Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69373 Hôpital des Enfants Toulouse, France, 31059 Less <<
NCT00216047 Breast Cancer Phase 1 Phase 2 Terminated(Low patient enrollm... More >>ent; toxicities) Less << - United States, Indiana ... More >> Elkhart Clinic Elkhart, Indiana, United States, 46515 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 AP&S Clinic Terre Haute, Indiana, United States, 47804 Less <<
NCT00216151 Multiple Myeloma Phase 2 Terminated(Study terminated du... More >>e to low patient enrollment.) Less << - United States, Indiana ... More >> Elkhart Clinic Elkhart, Indiana, United States, 46515 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Providence Medical Group Terre Haute, Indiana, United States, 47802 AP&S Clinic Terre Haute, Indiana, United States, 47804 Less <<
NCT01094704 Cystic Fibrosis Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27516 Less <<
NCT00651261 - Active, not recruiting - -
NCT00925132 - Terminated(Change in the numbe... More >>r of approved drugs for metastatic melanoma) Less << - -
NCT01094704 - Completed - -
NCT01107509 Carcinoma, Renal Cell Not Applicable Completed - Canada, Ontario ... More >> St. Joseph's Healthcare Hamilton, Ontario, Canada, L8N 4A6 Less <<
NCT01122641 Insulin Resistance ... More >> Microvascular Disease Less << Phase 3 Completed - United Kingdom ... More >> Diabetes and Vascular Research Department Exeter, Devon, United Kingdom, EX2 5AX Less <<
NCT01166139 Systemic Sclerosis Phase 2 Completed - United States, New York ... More >> Hospital for Special Surgery New York, New York, United States, 10021 Less <<
NCT01215136 Transitional Cell Carcinoma ... More >> Bladder Carcinoma Urothelial Carcinoma Less << Phase 2 Active, not recruiting June 2018 United States, Alabama ... More >> University of Alabama Hematology Oncology Clinic at Medical West Birmingham, Alabama, United States, 35294 United States, Illinois Northwestern University, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46219 United States, Michigan Metro Health Cancer Care Wyoming, Michigan, United States, 49519 United States, Nebraska Nebraska Cancer Specialists Omaha, Nebraska, United States, 68114 United States, New York Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center New York, New York, United States, 10029 United States, South Carolina MUSC Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Less <<
NCT01263951 Differentiated Thyroid Cancer Phase 2 Active, not recruiting - United States, Pennsylvania ... More >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01280968 Nicotine Dependence Phase 2 Completed - United States, North Carolina ... More >> Duke Center for Nicotine & Smoking Cessation Research Durham, North Carolina, United States, 27705 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00458237 Breast Cancer Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00496600 Refractory Malignancy Phase 1 Completed - United States, New Jersey ... More >> The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT00522665 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 IN Onc/Hem Associates Indianapolis, Indiana, United States, 46202 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 St. Vincent Hospital & Health Centers Indianapolis, Indiana, United States, 46206 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Monroe Medical Associates Munster, Indiana, United States, 46321 Center for Cancer Care, Inc., P.C. New Albany, Indiana, United States, 47150 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 Less <<
NCT01520103 Her2-negative Metastatic Breas... More >>t Cancer Her2-negative Locally Advanced Breast Cancer Less << Phase 2 Completed - Germany ... More >> Hämatologisch-onkologische Gemeinschaftspraxis, Münster Münster, Germany, 48149 Less <<
NCT01166139 - Completed - -
NCT00686218 Leukemia Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 South Pasadena Cancer Center South Pasadena, California, United States, 91030 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00597506 Colorectal Adenocarcinoma Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00458237 - Completed - -
NCT01061788 Advanced Solid Tumors, Non-sma... More >>ll Cell Lung Cancer Less << Phase 1 Active, not recruiting June 2019 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01740648 Recurrent Rectal Cancer ... More >> Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 1 Active, not recruiting December 31, 2022 United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States Less <<
NCT00613054 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00597506 - Completed - -
NCT00943358 Influenza Phase 1 Completed - United Kingdom ... More >> University Hospitals Leicester Leicester, United Kingdom, LE1 5WW Less <<
NCT01864070 Liver Cancer Phase 1 Withdrawn - -
NCT00867217 Breast Cancer Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Westwood, Kansas, United States, 66205 Cancer Centers of Kansas, P.A. Wichita, Kansas, United States, 67214 Less <<
NCT01280968 - Completed - -
NCT02001818 Chronic Myeloid Leukaemia Phase 2 Recruiting December 2021 Australia, South Australia ... More >> Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Tim Hughes, MBBS, MD,FRACP, FRCPA    +61 8 822 3330    timothy.hughes@health.sa.gov.au    Principal Investigator: Tim Hughes, MBBS, MD, FRACP, FRCPA Less <<
NCT00563108 Graft vs Host Disease ... More >> Hematopoietic Stem Cell Transplantation Less << Not Applicable Unknown December 2008 China ... More >> The University of Hong Kong Recruiting Hong Kong, China Sub-Investigator: AYH Leung, Dr          Sub-Investigator: Eric Tse, Dr          Sub-Investigator: YL Kwong, Prof          Sub-Investigator: Raymond Liang, Prof          Sub-Investigator: AKW Lie, Dr          Sub-Investigator: WY Au, Dr Less <<
NCT02086552 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 2 Active, not recruiting January 30, 2019 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02113800 Poorly Differentiated Malignan... More >>t Neuroendocrine Carcinoma Neuroendocrine Carcinoma, Grade 3 Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma] That Switched to G3 Neuroendocrine Tumor, Grade 3 and Disease Progression as Measured by Response Evaluation Criteria in Solid Tumors (RECIST 1.1.) Less << Phase 2 Recruiting February 2019 Germany ... More >> Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Campus Virchow-Klinikum Recruiting Berlin, Germany, 13353 Contact: Marianne Pavel, Prof. Dr.       marianne.pavel@charite.de    Principal Investigator: Marianne Pavel, Prof. Dr. Less <<
NCT01031381 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01056601 Pancreatic Cancer Phase 2 Terminated(Funding not availab... More >>le) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01092533 Uveitis, Intermediate Phase 3 Completed - Germany ... More >> Charité Universitätsmedizin Berlin, Augenklinik Berlin, Germany, 13353 Universitäts-Augenklinik Freiburg Freiburg, Germany, 79106 Universitätsklinikum Heidelberg, Interdisziplinäres Uveitiszentrum Heidelberg, Germany, 69120 Augenklinik der Ludwig-Maximilians-Universität München München, Germany, 80336 Augenabteilung am St. Franziskus-Hospital Münster Münster, Germany, 48145 Less <<
NCT01031381 - Completed - -
NCT01154335 Metastatic Colorectal Cancer Phase 1 Completed - United States, Florida ... More >> Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01902173 Adult Solid Neoplasm ... More >> Recurrent Colon Carcinoma Recurrent Melanoma Recurrent Ovarian Carcinoma Stage IIIC Colon Cancer Stage IIIC Ovarian Cancer Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << Phase 1 Phase 2 Suspended(Temporarily stopped ... More >>for assessment. Contact ctsucontact@westat.com for specifics) Less << - United States, California ... More >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 California Pacific Medical Center-Pacific Campus San Francisco, California, United States, 94115 UCSF Medical Center-Mount Zion San Francisco, California, United States, 94115 United States, Colorado University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Oregon Clackamas Radiation Oncology Center Clackamas, Oregon, United States, 97015 Providence Milwaukie Hospital Milwaukie, Oregon, United States, 97222 Providence Newberg Medical Center Newberg, Oregon, United States, 97132 Providence Willamette Falls Medical Center Oregon City, Oregon, United States, 97045 Providence Portland Medical Center Portland, Oregon, United States, 97213 Providence Saint Vincent Medical Center Portland, Oregon, United States, 97225 Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington PeaceHealth Southwest Medical Center Vancouver, Washington, United States, 98664 Less <<
NCT01154335 - Completed - -
NCT00867217 - Completed - -
NCT01202877 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02248571 Breast Cancer Recurrent ... More >> HER2/Neu-negative Carcinoma of Breast Hormone Receptor Positive Malignant Neoplasm of Breast Less << Phase 4 Completed - Germany ... More >> iOMEDICO AG Freiburg, Baden-Wuerttemberg, Germany, 79108 Less <<
NCT01202877 - Completed - -
NCT02404844 Breast Cancer Phase 2 Completed - Germany ... More >> iOMEDICO AG Freiburg, Baden-Württemberg, Germany, 79108 Less <<
NCT01056601 - Terminated(Funding not availab... More >>le) Less << - -
NCT00080678 Metastatic Cancer ... More >> Prostate Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Texas M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT01297452 Solid Tumors Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02330965 - Completed - United States, California ... More >> Jordan Research & Education Institute: Sutter Alta Bates Summit Berkeley, California, United States, 94705 University of Southern California Los Angeles, California, United States, 90033 University of California, Davis Sacramento, California, United States, 95817 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Michigan University of Michigan Health System -Multiple Sclerosis Center Ann Arbor, Michigan, United States, 48109 Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota Minneapolis Clinic of Neurology Golden Valley, Minnesota, United States, 55422 United States, New Mexico University of New Mexico: Health Sciences Center Albuquerque, New Mexico, United States, 87131 United States, New York South Shore Neurologic Associates - Multiple Sclerosis Care Center Patchogue, New York, United States, 11772 United States, North Carolina Carolinas Medical Center (CMC) Charlotte, North Carolina, United States, 28207 United States, Ohio Cleveland Clinic: Mellen Center for Multiple Sclerosis Cleveland, Ohio, United States, 44195 United States, Oregon Providence Multiple Sclerosis Center Portland, Oregon, United States, 97225 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Less <<
NCT02756247 Lymphoma Mant... More >>le Cell Lymphoma Follicular Lymphoma Diffuse Large B Cell Lymphoma Less << Phase 1 Active, not recruiting May 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 Less <<
NCT02689141 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting October 2021 Germany ... More >> German CLL Study Group Cologne, Germany, 50935 Less <<
NCT02637219 - Completed - United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less <<
NCT01499160 Breast Neoplasms ... More >> Endocrine Breast Diseases Neoplasm Metastasis Less << Phase 2 Terminated(low accrual) - United States, Maryland ... More >> University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Less <<
NCT01565096 Diabetes Mellitus Type II Phase 4 Unknown - Germany ... More >> ikfe GmbH Recruiting Mainz, Germany, 55116 Contact: Thomas Forst, Prof., MD    +49 6131 576 36 16    thomasf@ikfe.de    Contact: Swantje Anders    +49 6131 327 90 22    s.anders@ikfe-cro.de Less <<
NCT02494882 Acute Lymphoblastic Leukemia Phase 1 Active, not recruiting June 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01732107 Bladder Cancer Phase 2 Terminated(Development of dovi... More >>tinib was stopped.) Less << - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 United States, Pennsylvania Fox Chase Cancer Center Extramural Research Program Rockledge, Pennsylvania, United States, 19046 Less <<
NCT01732107 - Terminated(Development of dovi... More >>tinib was stopped.) Less << - -
NCT01499160 - Terminated(low accrual) - -
NCT01911507 Recurrent Non-small Cell Lung ... More >>Cancer Less << Phase 1 Recruiting December 2018 United States, California ... More >> University of California, Davis Recruiting Sacramento, California, United States, 95817 Contact: Corinne Turrell    916-734-3089    corinne.turrell@ucdmc.ucdavis.edu    Principal Investigator: Karen L. Kelly          UCSF Helen Diller Family Comprehensive Cancer Center Active, not recruiting San Francisco, California, United States, 94115 Less <<
NCT03072693 Heart Failure With Reduced Eje... More >>ction Fraction Less << Not Applicable Not yet recruiting July 31, 2020 -
NCT02413918 Bipolar Disorder Phase 4 Completed - United States, Texas ... More >> UT Health Science Center San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01735643 Type 2 Diabetes Mellitus Early Phase 1 Completed - Germany ... More >> West German Center of Diabetes and Health Düsseldorf, Germany, 40591 Less <<
NCT01490983 Chronic Myeloid Leukemia Not Applicable Terminated(Terminated due to l... More >>ack of funding) Less << - United States, North Carolina ... More >> UNC Healthcare Chapel Hill, North Carolina, United States, 27599 Rex Cancer Center Raleigh, North Carolina, United States, 27607 Rex Cancer Center - Wakefield Raleigh, North Carolina, United States, 27614 Less <<
NCT02520063 Breast Cancer Phase 1 Phase 2 Recruiting February 2021 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Christos Vaklavas, M.D.    205-934-5677    cvaklavas@uabmc.edu    Principal Investigator: Christos Vaklavas, M.D.          Principal Investigator: Andres Forero-Torres, M.D. Less <<
NCT01934634 Metastatic Pancreatic Cancer Phase 1 Unknown - United States, Texas ... More >> 2 Sites incl Tyler, TX and Dallas, TX, Texas, United States Less <<
NCT02518750 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Non-Hodgkin's Leukemia, T-Cell Leukemia, B-Cell Less << Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00956072 Gastrointestinal Stromal Tumor Phase 3 Terminated(low accrual) - Italy ... More >> European Organization for Research and Treatment of Cancer Naples, Italy, 80131 Less <<
NCT02413918 - Completed - -
NCT02669875 Liver Cirrhosis ... More >> Hypertension, Portal Less << Phase 2 Completed - United Kingdom ... More >> Liver Unit, Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH164TJ Less <<
NCT02780128 Neuroblastoma ... More >> Cancer Less << Phase 1 Recruiting May 2026 United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Alana Fitzsimmons, BS    267-425-2131    fitzsimmoa@email.chop.edu    Principal Investigator: Yael P Mossé, MD          Sub-Investigator: John M Maris, MD          Sub-Investigator: Rochelle Bagatell, MD Less <<
NCT00425646 Lung Cancer Phase 2 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT03232892 Non-small Cell Lung Cancer Phase 2 Recruiting September 22, 2021 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Collin Blakely, MD    877-827-3222    cancertrials@ucsf.edu Less <<
NCT00723203 - Terminated(Terminated early du... More >>e to a lack of efficacy) Less << - -
NCT00151073 Hormone-Refractory Prostate Ca... More >>ncer Less << Phase 2 Completed - United States, Michigan ... More >> The University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00165347 Multiple Myeloma Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00723203 Leukemia Phase 2 Terminated(Terminated early du... More >>e to a lack of efficacy) Less << - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 South Pasadena Cancer Center Pasadena, California, United States, 91030 Less <<
NCT00180011 Asthma Phase 2 Phase 3 Completed - United States, New York ... More >> Columbia University New York, New York, United States, 10032 Less <<
NCT00193258 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 1 Phase 2 Completed - -
NCT00760981 Graft vs Host Disease Phase 1 Unknown December 2009 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Washington Fred Hutchinson Cancer Research Center (FHCRC) Seattle, Washington, United States, 98109 Less <<
NCT00139932 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 4 Completed - -
NCT00151671 Liver Cancer ... More >>Hepatocellular Carcinoma Cirrhosis Liver Fibrosis Less << Phase 2 Phase 3 Terminated(insufficient enroll... More >>ment rate) Less << - France ... More >> Service de Réanimation Chirurgicale - Hôpital Pontchaillou Rennes, France, 35033 Less <<
NCT00772161 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 1 Phase 2 Completed - Germany ... More >> University Hospital Freiburg, Dep. for Child & Adolescent Psychiatry Freiburg, Germany, D-79104 Less <<
NCT00781261 Osteonecrosis Phase 2 Unknown December 2013 Australia, New South Wales ... More >> Royal North Shore Hospital, Department of Rheumatology Recruiting Sydney, New South Wales, Australia, 2065 Contact: Monique Macara    +61294631888    monique.macara@sydney.edu.au    Contact: Professor Lyn March       lyn.march@sydney.edu.au    Sub-Investigator: David Little, Prof          Principal Investigator: Lyn M March, Prof          Australia, Queensland Princess Alexandra Hospital Recruiting Brisbane, Queensland, Australia, 4102 Contact: Genni Lynch    (07) 3176 6640    Genni_Lynch@health.qld.gov.au    Principal Investigator: Cameron Cooke, Dr          Royal Brisbane and Womens Hospital Recruiting Herston, Queensland, Australia, 4029 Contact: A/Prof Emma Duncan       e.duncan@uq.edu.au    Contact: Janelle McFarlane       j.mcfarlane@uq.edu.au    Principal Investigator: A/Prof Emma Duncan          Australia, South Australia The Queen Elizabeth Hospital Recruiting Adelaide, South Australia, Australia, 5011 Contact: Catherine Hill, A/Prof    +618 82226688    Catherine.Hill@health.sa.gov.au    Contact: Sarah Downie-Doyle    +618 8133 4029    Sarah.Downie-Doyle2@health.sa.gov.au    Principal Investigator: Catherine Hill, A/Prof          Australia, Victoria Cabrini Hospital Recruiting Melbourne, Victoria, Australia, 3144 Contact: Rachelle Buchbinder    +613 95081652    rachelle.buchbinder@med.monash.edu.au    Principal Investigator: Rachelle Buchbinder, Prof Less <<
NCT00792766 Tuberous Sclerosis ... More >> Angiolipoma Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00193258 - Completed - -
NCT00807755 Lung Cancer U... More >>nspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(Number of known tox... More >>icities observed despite a treatment-naïve population) Less << - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00762346 Non Small Cell Lung Cancer ... More >> Bone Metastases High NTX Level Less << Phase 4 Completed - China, Guangdong ... More >> cancer center, Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT00811590 Peutz-Jeghers Syndrome Phase 2 Terminated(The study was ended... More >> early due to low enrollment.) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00811590 - Terminated(The study was ended... More >> early due to low enrollment.) Less << - -
NCT00813592 Cancer Phase 2 Terminated(Original PI left an... More >>d company withdrew support.) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00827567 Breast Cancer Phase 2 Terminated(Slow accrual) - United States, Pennsylvania ... More >> Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00765687 Non-small Cell Lung Cancer ... More >> Bone Metastases Less << Phase 4 Completed - China, Guangdong ... More >> SunYat-senU GuangZhou, Guangdong, China Less <<
NCT00827567 - Terminated(Slow accrual) - -
NCT00835159 - Completed - -
NCT00840450 Ovarian Cancer Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, New York ... More >> NYU cancer center New York, New York, United States, 10016 Less <<
NCT00840450 - Terminated(Due to slow accrual... More >>) Less << - -
NCT00844480 Bone Loss Phase 2 Terminated(difficulty in enrol... More >>lment) Less << - United States, Illinois ... More >> Rehabilitation Institute of Chicago Chicago, Illinois, United States, 60611 Less <<
NCT00305695 Hereditary Breast and Ovarian ... More >>Cancer Syndrome Osteoporosis Ovarian Carcinoma Less << Phase 2 Active, not recruiting - -
NCT00831792 Prostate Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00816426 Tuberculosis Phase 1 Completed - Korea, Republic of ... More >> Pusan National Unversity Hospital (PNUH) Busan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of National Medical Center Seoul, Korea, Republic of Less <<
NCT00554918 Metastatic Cancer ... More >> Prostate Cancer Less << Phase 2 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom, B15 2TH Gloucestershire Oncology Centre at Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Gloucestershire Royal Hospital Gloucester, England, United Kingdom, GL1 3NN Ipswich Hospital Ipswich, England, United Kingdom, IP4 5PD Mid Kent Oncology Centre at Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Christie Hospital Manchester, England, United Kingdom, M20 4BX Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Walsall Manor Hospital Walsall, England, United Kingdom, WS2 9PS Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ayr Hospital Ayr, Scotland, United Kingdom, KA6 6DX Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Crosshouse Hospital Kilmarnock, Scotland, United Kingdom, KA2 OBE Wishaw General Hospital Wishaw, Scotland, United Kingdom, ML2 0DP Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Glan Clwyd Hospital Rhyl, Denbighshire, Wales, United Kingdom, LL 18 5UJ Less <<
NCT00844480 - Terminated(difficulty in enrol... More >>lment) Less << - -
NCT01289912 Tuberous Sclerosis Complex Phase 2 Completed - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00774384 Meningococcal Infections Phase 2 Completed - United Kingdom ... More >> UBHT Bristol, Avon, United Kingdom, BS2 8HU North Bristol NHS Trust Bristol, Avon, United Kingdom Less <<
NCT00813592 - Terminated(Original PI left an... More >>d company withdrew support.) Less << - -
NCT02559765 - Completed - United Kingdom ... More >> The University of Glasgow Glasgow, United Kingdom, G12 8LL Less <<
NCT00358163 Metastatic Non-hematologic Mal... More >>ignancies Less << Phase 1 Unknown April 2010 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00634634 Metastatic Breast Cancer Phase 1 Phase 2 Active, not recruiting May 2019 United States, District of Col... More >>umbia Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Cooper Hospital/University Medical Center Voorhees, New Jersey, United States, 08690 Less <<
NCT00115115 Kidney Transplantation ... More >> ESRD Less << Phase 4 Completed - Germany ... More >> University Hospital Mannheim Mannheim, Baden-Wuerttemberg, Germany, 68135 Less <<
NCT00160966 Polyomavirus Infections Phase 4 Completed - Germany ... More >> Department of Internal Medicine, University of Giessen Giessen, Germany, 35392 Less <<
NCT00169039 Schizophrenia Phase 4 Terminated - United States, Massachusetts ... More >> Commonwealth Research Center Jamaica Plain, Massachusetts, United States, 02130 Less <<
NCT01289912 - Completed - -
NCT00169091 Schizophrenia Phase 4 Terminated - United States, Massachusetts ... More >> Commonwealth Research Center Jamaica Plain, Massachusetts, United States, 02130 Less <<
NCT00252408 Osteoporosis Phase 4 Completed - Denmark ... More >> The Osteoporosis Clinic, Aarhus Sygehus Aarhus, Denmark, DK-8000 Less <<
NCT00080171 - Unknown October 2015 United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 21201 Johns Hopkins University Baltimore, Maryland, United States, 21224 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Memorial Hospital of Rhode Island / Brown University Pawtucket, Rhode Island, United States, 02860 Less <<
NCT00788775 Mucosal Lentiginous Melanoma ... More >> Acral Melanoma Melanoma Less << Phase 2 Completed - United States, California ... More >> The Angeles Clinic and Research Institute Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00169026 Schizophrenia ... More >> Dual Diagnosis Schizoaffective Disorder Psychotic Disorder Substance Abuse Alcohol Abuse Less << Phase 4 Terminated - United States, Massachusetts ... More >> Commonwealth Research Center Jamaica Plain, Massachusetts, United States, 02130 Less <<
NCT00004205 Breast Cancer Phase 3 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 France Institut Bergonie Bordeaux, France, 33076 Switzerland Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Less <<
NCT00788775 - Completed - -
NCT00804336 Neuroendocrine Tumor ... More >> Carcinoid Tumor Pancreatic Neuroendocrine Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Less <<
NCT00819546 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00749320 Renal Cell Carcinoma Not Applicable Active, not recruiting February 2019 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01099436 Breast Cancer Phase 3 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT02080559 Meningitis Phase 4 Completed - United Kingdom ... More >> Oxford Vaccine Group, Centre for Clininal Vaccinology & Tropical Medicine Oxford, United Kingdom, OX3 7LE Less <<
NCT01136395 Kidney Transplantation ... More >> Rituximab Living Donors Immunology Virus Less << Phase 2 Active, not recruiting May 2019 Germany ... More >> Department of Internal Medicine, University of Giessen Giessen, Germany, D-35392 Less <<
NCT00936858 Thyroid Cancer Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01184326 - Completed - -
NCT01104571 Breast Cancer Phase 3 Active, not recruiting September 2025 United Kingdom ... More >> Wythenshawe Hospital Manchester, England, United Kingdom, M23 9LJ Less <<
NCT01184326 Solid Tumor K... More >>idney Cancer Less << Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00536419 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 4 Unknown September 2008 Brazil ... More >> Hospital de Clinicas de Porto Alegre Recruiting Porto Alegre, RS, Brazil, 90035-003 Contact: Clarissa F Paim    55-51-21018094    cfpaim@hcpa.ufrgs.br    Principal Investigator: Luis Augusto P Rohde, MD          Sub-Investigator: Claudia M Szobot, MD Less <<
NCT01248247 Lung Cancer Phase 2 Active, not recruiting June 2019 United States, Connecticut ... More >> Yale Universtiy New Haven, Connecticut, United States, 06520 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01790295 Primary Myelofibrosis ... More >> Post Polycythemia Vera Myelofibrosis Post Essential Thrombocythemia Myelofibrosis Less << Phase 2 Active, not recruiting February 2021 United States, Georgia ... More >> Emory Hospital Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University, Robert h. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, North Carolina Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27103 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Canada Princess Margaret Cancer Centre, University of Toronto Toronto, Canada, M5G 2M9 United Kingdom University of Oxford Oxford, United Kingdom, OX3 9DS Less <<
NCT00138294 Influenza Phase 4 Completed - United States, Texas ... More >> Scott & White Hospital and Clinic Temple, Texas, United States, 76508 Scott & White Hospital and Clinic Waco, Texas, United States, 76710 Less <<
NCT01232478 Cystic Fibrosis Phase 3 Completed - United States, Alabama ... More >> UAB/CHS Cystic Fibrosis Center Birmingham, Alabama, United States, 35233 United States, Arizona Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, Connecticut Connecticut Children's Medical Center Hartford, Connecticut, United States, 06106 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Maine Maine Medical Center Portland, Maine, United States, 04101 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, New York Women and Children's Hospital of Buffalo Buffalo, New York, United States, 14222 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Akron Children's Hospital Akron, Ohio, United States, 44308 Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Toledo Children's Hospital Toledo, Ohio, United States, 43606 United States, Utah Primary Children's Medical Center Salt Kale City, Utah, United States, 84113 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 Less <<
NCT00138294 - Completed - -
NCT01418781 - Withdrawn(Funding withdrawn by... More >> the funding agency; study could not be performed.) Less << - United States, Minnesota ... More >> Minneapolis VA Medical Center Minneapolis, Minnesota, United States, 55123 Less <<
NCT03035123 Heart Failure Not Applicable Recruiting June 30, 2020 France ... More >> Clinique Ambroise Paré Recruiting Neuilly-sur-Seine, France, 92200 Principal Investigator: Olivier Belliard, MD          Clinique du Mont Louis Recruiting Paris, France, 75011 Principal Investigator: Fabrice Larrazet, MD          Hopital AP-HP Saint-Antoine Recruiting Paris, France, 75012 Principal Investigator: Ariel Cohen, MD PhD          Hôpital AP-HP Pitié-Salpêtrière Not yet recruiting Paris, France, 75013 Principal Investigator: Françoise Pousset, MD          Institut Mutualiste Montsouris Recruiting Paris, France, 75014 Principal Investigator: Christelle Diakov, MD          Centre Cardiologique du Nord Recruiting Saint Denis, France, 93200 Principal Investigator: Thierry Laperche, MD Less <<
NCT00814385 Influenza Phase 1 Phase 2 Completed - United Kingdom ... More >> University Hospitals Leicester Leicester, Leicestershire, United Kingdom, LE1 5WW Clincal Trials Unit Leicester Royal Infirmary Leicester, United Kingdom, LE1 5WW Less <<
NCT00459186 Metastatic, Androgen Independe... More >>nt Prostate Cancer Prostate Cancer Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Oregon Oregon Health Science University Portland, Oregon, United States Less <<
NCT02247583 - Completed - Belgium ... More >> Katholieke Universiteit Leuven - Klinische Farmacologie en Farmacotherapie Leuven, Belgium, 3000 Less <<
NCT02592265 - Completed - -
NCT01617733 Nelson Syndrome Phase 2 Terminated(Inadequate patient ... More >>recruitment) Less << - United Kingdom ... More >> Barts and the London NHS Trust London, United Kingdom The Christie Hospital NHS Foundation Trust Manchester, United Kingdom Oxford University Hospitals NHS Trust Oxford, United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom, S10 2JF Less <<
NCT02985125 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Recruiting December 2022 United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Michael J Pishvaian, MD, PhD    202-444-2144    pishvaim@georgetown.edu    Contact: Syed Hasan    202-687-2939    smh92@georgetown.edu Less <<
NCT01379469 Alpha-1-antitrypsin Deficiency... More >> Liver Cirrhosis Less << Phase 2 Recruiting January 2020 United States, Missouri ... More >> Washington University in St. Louis School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Teresa Arb, RN, BSN, CCRC    3147471217    arbt@wustl.edu    Principal Investigator: David A Rudnick, MD, PhD          Sub-Investigator: Kevin M. Korenblat, MD          United States, Pennsylvania Children's Hospital of Pittsburgh, UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15201 Contact: Robert H Squires, M.D.    412-692-7506    squiresr@upmc.edu    Contact: Adam D Kufen, RN    412-692-8929    adam.kufen@chp.edu    Principal Investigator: Robert H. Squires, JR., M.D.          Sub-Investigator: Alejandro Hoberman, M.D.          Sub-Investigator: Ira Bergman, M.D., PhD.          University of Pittsburgh Medical Center, Presbyterian Hospital Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Robert H. Squires, M.D.    412-692-7506    squiresr@upmc.edu    Principal Investigator: Robert H. Squires, M.D.          Sub-Investigator: George Michalopoulos, M.D., PhD.          Sub-Investigator: Shahid Malik, M.D.          Sub-Investigator: Kapil Chopra, M.D.          Sub-Investigator: Michael Dunn, M.D.          Sub-Investigator: Philip Orons, M.D.          Sub-Investigator: Mitchell Tublin, M.D.          Sub-Investigator: Allesandro Furlan, M.D. Less <<
NCT00028847 Leukemia Phase 1 Phase 2 Unknown - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Clinique Universitaire De Mont-Godinne Mont-Godinne Yvoir, Belgium, 5530 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 10P 1HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Leiden University Medical Center Leiden, Netherlands, 2300 RC Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, 6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT02550743 Rectal Cancer Phase 1 Terminated(lack of accural) - United States, Rhode Island ... More >> Rhode Island Hospital and The Miriam Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT01028092 Renal Transplant Phase 3 Completed - France ... More >> CHU Amiens Amiens, France CHU Pellegrin - Bordeaux Bordeaux, France CHRU de BREST Brest, France, 29609 CHU Cote de Nacre Caen, France CHU Clermont Ferrand Clermont Ferrand, France CHU Dijon Dijon, France CHU Lille Lille, France CHU Limoges Limoges, France CHU Montpellier Montpellier, France CHU Nice Nice, France AP-HP Hopital Necker Paris, France CHU Poitiers Poitiers, France CHU Reims Reims, France CHU Rennes Rennes, France CHU Rouen Rouen, France Hopitaux Universitaires de Strasbourg Strasbourg, France CHU Rangueil - Toulouse Toulouse, France CHU Tours Tours, France Less <<
NCT00601510 Gastric Cancer Phase 1 Completed - Germany ... More >> Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT00323063 Breast Cancer Phase 2 Terminated(Slow accrual) - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, New Jersey Cooper Hospital/University Medical Center Camden, New Jersey, United States, 08103 Rutgers Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Mountainside Hospital Montclair, New Jersey, United States, 07042 Jersey Shore Cancer Center at Jersey Shore University Medical Center Neptune City, New Jersey, United States, 07754 Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Saint Peter's University Hospital New Brunswick, New Jersey, United States, 08903 NJ Medical School Newark, New Jersey, United States, 07103 Less <<
NCT01694589 Resectable Pancreatic Cancer Early Phase 1 Withdrawn(Lack of accrual) - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT00459186 - Completed - -
NCT00216112 Ovarian Cancer Phase 2 Completed - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Elkhart Clinic Elkhart, Indiana, United States, 46515 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Center for Cancer Care, Inc., P.C. New Albany, Indiana, United States, 47150 AP&S Clinic Terre Haute, Indiana, United States, 47804 Less <<
NCT01700400 Non Small Cell Lung Cancer Phase 1 Completed - United States, Arizona ... More >> University of Arizona Cancer Center Tuscon, Arizona, United States, 85724 United States, Kentucky University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 United States, Washington Cancer Research And Biostatistics Clinical Trials Consortium Seattle, Washington, United States, 98101 Less <<
NCT00902811 Uncomplicated Falciparum Malar... More >>ia Less << Phase 4 Unknown December 2009 Myanmar ... More >> Dabhine and Mingan Clinic Recruiting Sittwe, Rakhine, Myanmar Contact: Pyay Phyo Aung       frank_smithuis@yahoo.com    Principal Investigator: Pyay Phyo Aung, MD          Myit Kyi Nar Clinic Recruiting Kachin, Myanmar Contact: Mya Nee Nyo       frank_smithuis@yahoo.com    Principal Investigator: Mya Nee Nyo, MD          Myothugyi Rural Health Center, Bu Thee Daung Recruiting Maungdaw, Myanmar Contact: Arkar Linn Naing       frank_smithuis@yahoo.com    Principal Investigator: Arkar Linn Naing, MD          Lashio Clinic Recruiting Shan, Myanmar Contact: Naing Nyo, MD          Principal Investigator: Naing Zaw, MD Less <<
NCT02246127 Neuroendocrine Tumors Phase 3 Recruiting June 2020 -
NCT01452113 Diabetes Mellitus Phase 2 Completed - France ... More >> UH Toulouse Toulouse, France, 31059 Less <<
NCT01938742 Influenza Phase 2 Completed - United States, Georgia ... More >> Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States, 30030-1705 United States, Iowa University of Iowa - Infectious Disease Clinic Iowa City, Iowa, United States, 52242-1009 United States, Ohio Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States, 45229-3026 United States, Texas University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston Galveston, Texas, United States, 77555-5302 Less <<
NCT00369031 HIV Infections Phase 1 Terminated(Safety issues) - United Kingdom ... More >> St George's Vaccine Institute London, England, United Kingdom, SW17 0RE Less <<
NCT00843531 Neuroendocrine Tumors Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00440544 Tuberculosis Phase 1 Terminated(Safety Issues) - United Kingdom ... More >> St George's Vaccine Institute London, England, United Kingdom, SW17 0RE Less <<
NCT01153425 - Completed - -
NCT01746602 Healthy Phase 3 Terminated - Austria ... More >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00962507 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT03404076 - Recruiting December 1, 2019 Germany ... More >> University Center Mannheim Recruiting Mannheim, Germany Contact: Peter Hohenberger, MD    0049621383 ext 3433    studien@gisg.de    Contact: Bernd Kasper, MD    0049621383 ext 3433    studien@gisg.de    Principal Investigator: Peter Hohenberger, MD Less <<
NCT01153425 Osteoporosis, Osteopenia Phase 4 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01024946 - Completed - -
NCT01259063 Bladder Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00870337 Endometrial Cancer Phase 2 Completed - France ... More >> Hotel Dieu de Paris Paris, France, 75181 Less <<
NCT02997969 HIV Infections Phase 1 Unknown September 2017 South Africa ... More >> Aurum Tembisa CRS Recruiting Johannesburg, Gauteng, South Africa, 1632 Contact: Modulakgotla Sebe    27-87-1351645    msebe@auruminstitute.org    Contact: Gladys Kobane    27-87-1351533    gkobane@auruminstitute.org    Isipingo CRS Recruiting Westville, Kwa Zulu Natal, South Africa, 3630 Contact: Arendevi Pather    27-31-9027494    Arendevi.Pather@mrc.ac.za    Contact: Girisha Kistnasami, BSc, DPM    27-31-9027494    girisha.kistnasami@mrc.ac.za    Aurum Institute Klerksdorp CRS Recruiting Klerksdorp, North West Province, South Africa, 2571 Contact: Craig Innes    27-87-1351587    cinnes@auruminstitute.org    Contact: Tania Adonis    27-87-1351587    tadonis@auruminstitute.org    Tanzania National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS Recruiting Mbeya, Tanzania Contact: Nyanda Elias       nelias@nimr-mmrc.org    Contact: Lucas Maganga    255-25-2503364    lmaganga@nimr-mmrc.org    Zambia Matero Reference Clinic CRS Recruiting Lusaka, Zambia Contact: Stewart Reid    260-966-747677    stewart.reid@cidrz.org    Contact: Bupe N Sichalwe    260-966848889    bupe.sichalwe@cidrz.org Less <<
NCT01661283 Malignant Peripheral Nerve She... More >>ath Tumors MPNST Sarcoma Less << Phase 2 Unknown December 2017 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-0024 United States, District of Columbia Children's National Medical Center Washington D.C., District of Columbia, United States, 20010 United States, Illinois Ann and Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21218 National Cancer Institute Bethesda, Maryland, United States, 20892-1101 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University in St. Louis St. Louis, Missouri, United States, 63130 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Less <<
NCT00323063 - Terminated(Slow accrual) - -
NCT00101101 Lymphoma Phase 2 Active, not recruiting March 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT01734512 Pediatric Recurrent Progressiv... More >>e Low-grade Gliomas Pediatric Progressive Low-grade Gliomas Less << Phase 2 Recruiting November 2022 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Ghirish Dhall, MD    323-361-8147    GDhall@chla.usc.edu    Contact: Ashley Margol, MD       amargol@chla.usc.edu    Principal Investigator: Ghirish Dhall, MD          Sub-Investigator: Ashley Margol, MD          University of California, Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Tom B Davidson, MD    310-825-6708    tdavidson@mednet.ucla.edu    Contact: Anthony Wang       acwang@mednet.ucla.edu    Principal Investigator: Tom B Davidson, MD          Sub-Investigator: Anthony Wang, MD          Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Joseph Torkildson, MD    510-428-3272    jtorkildson@mail.cho.org    Contact: Caroline Hastings, MD    (510) 428-3272    chastings@mail.cho.org    Principal Investigator: Joseph Torkildson, MD          Sub-Investigator: Caroline Hastings, MD          University of California, San Diego Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: John Crawford, MD,MS    858-966-4930    jrcrawford@rchsd.org    Contact: Jennifer Elster, MD       jelster@rchsd.org    Principal Investigator: John Crawford, MD,MS          Sub-Investigator: Janet Elster, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Sabine Mueller, MD    877-827-3222    cancertrials@ucsf.edu    Contact: Anu Banerjee, MD       cancertrials@ucsf.edu    Principal Investigator: Sabine Mueller, MD          Sub-Investigator: Anu Banerjee, MD          United States, District of Columbia Children's National Medical Center Not yet recruiting Washington, District of Columbia, United States, 20010 Contact: Lindsay Kilburn, MD    202-476-3854    lkilburn@cnmc.org    Contact: Roger Packard, MD       rpackard@nmc.org    Principal Investigator: Lindsay Kilburn, MD          Sub-Investigator: Roger Packard, MD          United States, Florida University of Florida Recruiting Gainesville, Florida, United States, 32611 Contact: Sridharan Gururangan, FRCP    352-294-8347    sridharan.gururangan@neurosurgery.ufl.edu    Contact: Duane Mitchell, MD, PhD    352-294-5232    duane.mitchell@neurosurgery.ufl.edu    Principal Investigator: Sridharan Gururangan, FRCP          Sub-Investigator: Duane Mitchell, MD, PhD          United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Stewart Goldman, MD    312-227-4873    sgoldman@luriechildrens.org    Contact: Rishi Lulla, MD    (312) 227-4873    rlulla@luriechildrens.org    Principal Investigator: Stewart Goldman, MD          Sub-Investigator: Rishi Lulla, MD          United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21218 Contact: Kenneth Cohen, M.D.       kcohen@jhmi.edu    Contact: Eric Raabe, M.D., PhD.       eraabe2@jhmi.edu    Principal Investigator: Kenneth Cohen, M.D.          Sub-Investigator: Eric Raabe, M.D., PhD.          United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Susan Chi, MD    617-632-2291    susan_chi@dfci.harvard.edu    Contact: Daphne Haas-Kogan, MD       dhaas-kogan@lroc.harvard.edu    Principal Investigator: Susan Chi, MD          Sub-Investigator: Daphne Haas-Kogan, MD          United States, Minnesota Children's Hospitals and Clinics of Minneapolis Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Christopher Moertel, M.D.    612-626-2778    moert001@umn.edu    Contact: Anne Bendel, M.D.    612-813-5940    anne.bendel@childrensmn.org    Principal Investigator: Christopher Moertel, M.D.          Sub-Investigator: Anne Bendel, M.D.          United States, Missouri St. Louis Children's Hospital, Washington University Recruiting Saint Louis, Missouri, United States, 63130 Contact: Karen Gauvain, MD    314-286-2790    gauvain_k@kids.wustl.edu    Contact: Josh Rubin, MD       rubin_j@kids.wustl.edu    Principal Investigator: Karen Gauvain, MD          Sub-Investigator: Josh Rubin, MD          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Jonathan Finlay, MD    614-722-4087    jonathan.finlay@nationwidechildrens.org    Contact: Mohamed AbdelBaki, MD       mohamed.abdelbaki@NationwideChildrens.org    Principal Investigator: Jonathan Finlay, MD          Sub-Investigator: Mohamed AbdelBaki, MD          United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Kellie Nazemi, MD    503-494-1543    nazemik@ohsu.edu    Contact: Rebecca Loret De Mola, DO,MCR       loretdem@ohsu.edu    Principal Investigator: Kellie Nazemi, MD          Sub-Investigator: Rebecca Loret De Moya, DO,MCR          United States, Pennsylvania The Children's Hospital Of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Jane Minturn, MD, PhD    267-426-5026    minturn@email.chop.edu    Contact: Angela Waanders, MD, MPH       waandersa@email.chp.edu    Principal Investigator: Jane Minturn, MD, PhD          Sub-Investigator: Angela Waanders, MD, MPH          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Amar Gajjar, MD    901-595-2615    Amar.Gajjar@STJUDE.ORG    Contact: Ibrahim Qaddoumi, MD    901-595-2365    ibrahim.qaddoumi@stjude.org    Principal Investigator: Amar Gajjar, MD          Sub-Investigator: Ibrahim Qaddoumi, MD          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Nicholas Whipple, MD,MPH    801-662-4700    nicholas.whipple@hsc.utah.edu    Contact: Carol Bruggers, MD    801-662-4700    carol.bruggers@imail.org    Principal Investigator: Nicholas Whipple, MD,MPH          Sub-Investigator: Carol Bruggers, MD          United States, Washington University of Washington, Seattle Recruiting Seattle, Washington, United States, 98195 Contact: Sarah Leary, MD    206-667-7955    sarah.leary@seattlechildrens.org    Contact: Nick Vitanza, MD    206-667-7955    rnicholas.vitanza@seattlechildrens.org    Principal Investigator: Sarah Leary, MD          Sub-Investigator: Nick Vitanza, MD Less <<
NCT00105248 Respiratory Tract Infections Not Applicable Completed - Switzerland ... More >> Basel institute for clinical epidemiology Basel, Switzerland, 4031 Less <<
NCT00101101 - Active, not recruiting - -
NCT00136409 Myelofibrosis ... More >> Myeloid Metaplasia Agnogenic Myeloid Metaplasia Chronic Myelomonocytic Leukemia Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00386984 Carcinoma, Hepatocellular Phase 3 Completed - Germany ... More >> University Medical Center Freiburg Freiburg, Baden-Württemberg, Germany, 79106 Less <<
NCT00286624 Type 1 Diabetes Mellitus ... More >> Hypoglycemia Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01629615 Breast Cancer Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber at Faulkner Hospital Boston, Massachusetts, United States, 02130 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Spain Hospital Universitario Vall d´Hebron Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT00399893 Prader-Willi Syndrome Not Applicable Terminated(Inadequate recruitm... More >>ent) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00409292 Pancreatic Cancer Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01259063 - Completed - -
NCT00419770 Mucormycosis Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 UCSF San Francisco, California, United States, 94143 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Ohio Summa Health Systems Akron, Ohio, United States, 44304 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT01024946 Malignant Pleural Mesothelioma Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00409292 - Completed - -
NCT00399893 - Terminated(Inadequate recruitm... More >>ent) Less << - -
NCT00424801 Microvascular Angina ... More >> Hypertension Less << Not Applicable Terminated(Due to recent findi... More >>ngs relating MRI contrast to nephrogenic systemic fibrosis) Less << December 2008 Denmark ... More >> Aarhus Hospital Aarhus, Denmark, 8000 Less <<
NCT00461929 Chronic Myeloid Leukemia ... More >> Gastrointestinal Stromal Cell Tumors Chromosome Abnormality Less << Phase 4 Terminated(study terminated 12... More >>Feb09 due to low recruitment) Less << - Canada, Ontario ... More >> Mount Sinai Hospital Toronto, Ontario, Canada, M5G 2M9 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00419770 - Completed - -
NCT00516165 - Completed - -
NCT00466609 Obsessive Compulsive Disorder Phase 4 Completed - Brazil ... More >> Institute of Psychiatry Sao Paulo, SP, Brazil, 05403-010 Less <<
NCT00798343 Influenza Phase 1 Completed - United Kingdom ... More >> University Hospitals Leicester Leicester, Leicestershire, United Kingdom, LE1 5WW Less <<
NCT00908531 Operable Breast Neoplasms Phase 3 Terminated(Poor recruitement) June 2024 Denmark ... More >> Dept. of Breast Surgery; Aalborg Sygehus Aalborg, Denmark, DK-9000 Dept. of Breast Surgery; Rigshospitalet Copenhagen, Denmark, DK-2100 Dept. of Surgery; Sydvestjysk Sygehus Esbjerg Esbjerg, Denmark, DK-6700 Dept. of Breast Surgery; Herlev Hospital Herlev, Denmark, DK-2730 Dept. of Oncology; Odense University Hospital Odense, Denmark, DK-5000 Depart. of Breast Surgery, Ringsted Sygehus Ringsted, Denmark, 4100 Dept. of Breast Surgery; Vejle Sygehus Vejle, Denmark, DK-7100 Dept. of Breast Surgery; Regionshospitalet Viborg Viborg, Denmark, DK-8800 Dept. of Surgery; Århus Sygehus Århus, Denmark, DK-8000 Less <<
NCT00516165 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00869999 - Completed - -
NCT01067326 - Terminated(Novartis ended all ... More >>studies regarding Aliskiren.) Less << - -
NCT00869999 Diffuse Large B-cell Lymphoma Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconsess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01067326 Endothelial Dysfunction Phase 3 Terminated(Novartis ended all ... More >>studies regarding Aliskiren.) Less << - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT00219739 Chronic Myeloid Leukemia Phase 3 Completed - France ... More >> University Hospital Poitiers, France, 86021 Less <<
NCT01120028 Kidney Transplantation Phase 2 Phase 3 Active, not recruiting February 2019 United Kingdom ... More >> Oxford Radcliffe Hospitals NHS Trust Oxford, Oxon, United Kingdom, OX3 7LJ University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom Addenbrooke's Hospital NHS Trust Cambridge, United Kingdom University Hospital of Wales Cardiff, United Kingdom University Hospitals Coventry & Warwickshire Coventry, United Kingdom Royal Infirmary Edinburgh, United Kingdom Western Infirmary Glasgow, United Kingdom Hull and East Yorkshire Hospitals NHS Trust Hull, United Kingdom Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom Royal Liverpool and Broadgreen University Hospitals NHS Trust Liverpool, United Kingdom Bart's and the London NHS Trust London, United Kingdom Guy's and St Thomas's NHS Trust London, United Kingdom Kings College Hospital NHS Trust London, United Kingdom Royal Free Hampstead NHS Trust London, United Kingdom Central Manchester NHS Trust Manchester, United Kingdom Newcastle-upon-Tyne Hospitals NHS Trust Newcastle, United Kingdom Nottingham University Hospitals NHS Trust Nottingham, United Kingdom Plymouth Teaching Hospitals NHS Trust Plymouth, United Kingdom Portsmouth Hospitals NHS Trust Portsmouth, United Kingdom Sheffield Teaching Hospitals NHS Trust Sheffield, United Kingdom Less <<
NCT01207492 - Active, not recruiting - -
NCT01711658 Non-HPV Locally Advanced Head ... More >>and Neck Cancer Less << Phase 2 Active, not recruiting March 31, 2023 United States, Alabama ... More >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California University of California, San Diego La Jolla, California, United States, 92093 Sutter General Hospital Sacramento, California, United States, 95816 University of California San Francisco San Francisco, California, United States, 94143 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Georgia Emory University Atlanta, Georgia, United States, 30308 United States, Kentucky James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States, 40202 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73190 United States, Pennsylvania Fox Chase Cancer Center Buckingham Furlong, Pennsylvania, United States, 18925 United States, Texas University of Texas Southwestern Medical School Dallas, Texas, United States, 75390 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Quebec McGill Cancer Centre at McGill University Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT01621204 Immune Thrombocytopenic Purpur... More >>a Less << Phase 3 Recruiting January 2019 Canada, Alberta ... More >> University of Alberta Hospital Recruiting Edmonton, Alberta, Canada, T6G2G3 Contact: Loree Larratt, MD    780-407-7021    llarratt@ualberta.ca    Contact: Ovais Shaikh    780-407-6090    Ovais.Shaikh@albertahealthservices.ca    Principal Investigator: Loree Laratt, MD          Sub-Investigator: Irwindeep Sandhu, MD          Canada, British Columbia Vancouver General Hospital Terminated Vancouver, British Columbia, Canada, V5Z1M9 Canada, Ontario Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8N 3Z5 Contact: Donald M Arnold, MD    905-525-9140 ext 28603    arnold@mcmaster.ca    Contact: Erin Jamula, MSc    905-525-9140 ext 21845    jamulae@mcmaster.ca    Principal Investigator: Donald M Arnold, MD          London Health Sciences Center Recruiting London, Ontario, Canada, N6A5W9 Contact: Cyrus Hsia, MD    519-685-8500 ext 56060    cyrus.hsia@lhsc.on.ca    Contact: Maisam Abouzeenni       Maisam.Abouzeenni@lhsc.on.ca    Principal Investigator: Cyrus Hsia, MD          Ottawa Hospital Recruiting Ottawa, Ontario, Canada, K1H8L6 Contact: Alan Tinmouth, MD    613-737-8899 ext 73914    Atinmouth@toh.ca    Contact: Holly Carr       hcarr@ohri.ca    Principal Investigator: Alan Tinmouth, MD          Sunnybrook Hospital Recruiting Toronto, Ontario, Canada, M4N3M5 Contact: Yulia Lin, MD    416-480-6100 ext 2781    Yulia.Lin@sunnybrook.ca    Principal Investigator: Yulia Lin, MD          St.Micheal's Hospital Recruiting Toronto, Ontario, Canada, M5B1W8 Contact: Michelle Sholzberg, MD    416-864-6060    SholzbergM@smh.ca    Contact: Aziz Jiwajee    416-864-5354    JiwajeeA@smh.ca    Principal Investigator: Michelle Sholzberg, MD          Canada, Quebec Hopital Maisonneuve-Rosemont Recruiting Montreal, Quebec, Canada, H1T2M4 Contact: Jeannine Kassis, MD    514-252-3404    jkassis.hmr@ssss.gouv.qc.ca    Contact: Julie Trinh Lu, B.Sc, DESS    514-252-3400 ext 3336    jtlu.hmr@ssss.gouv.qc.ca    Principal Investigator: Jeannine Kassis, MD          Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T1E2 Contact: Mark Blostein, MD    514-340-8214    mark.blostein@mgill.ca    Contact: Vivian Pananis    514-340-8222 ext 5982    vpananis@gmail.com    Principal Investigator: Mark Blostein, MD          Netherlands The Haga Hospital Not yet recruiting The Hague, Netherlands Contact: Sufia Amini    31 702102556    s.amini@hagaziekenhuis.nl    Contact: Okke Eissen    31 702101844    o.eissen@hagaziekenhuis.nl    Principal Investigator: Martin Schipperus, MD Less <<
NCT01207492 Pigmented Villonodular Synovit... More >>is Diffuse-type Giant Cell Tumor Tenosynovial Giant Cell Tumor Less << Phase 2 Active, not recruiting December 2018 United States, California ... More >> Sarcoma Oncology Center Santa Monica, California, United States, 90403 Stanford University Medical Center Stanford, California, United States, 94305 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00704301 Delirium Phase 4 Terminated(The study is premat... More >>urely terminated due to a safety issue) Less << - Netherlands ... More >> Medical Center Leeuwarden Leeuwarden, Friesland, Netherlands, 8901 BR Gelre Hospitals; lukas site Apeldoorn, Gelderland, Netherlands, 7300 DS Medical Center Alkmaar Alkmaar, Noord-Holland, Netherlands, 1800 AM Erasmus Medical Center Rotterdam, Zuid-Holland, Netherlands, 3000 CA University Medical Center Utrecht Utrecht, Netherlands, 3508 GA Diakonessenhuis Utrecht, Netherlands, 3582 KE Less <<
NCT00784446 Stage IV Colorectal Cancer Phase 1 Phase 2 Completed - Germany ... More >> Medical Clinic for Haematology and Oncology Cologne, NRW, Germany, 50937 Städische Kliniken Esslingen Esslingen, Germany, 73730 Klinikum St. Georg gGmbH Leipzig, Germany, 04129 Johannes-Gutenberg-Universität Mainz Mainz, Germany, 55131 Klinikum Mannheim Mannheim, Germany, 68167 Prosper-Hospital Recklinghausen, Germany, 45659 Leopoldina Krankenhaus Schweinfurt, Germany, 97422 Universitätsklinik Ulm Ulm, Germany, 89081 Less <<
NCT00927966 Sarcoma Solid... More >> Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02072057 Cancer Cachexia Phase 2 Active, not recruiting April 2020 Switzerland ... More >> Division of Hematology/Oncolgy, University Clinic of Medicine, Kantonsspital Aarau AG Aarau, AG, Switzerland, 5001 Division of Hematology/Oncology, Kantonsspital Olten Olten, SO, Switzerland, 4600 Less <<
NCT00147017 - Completed - United Kingdom ... More >> Royal Brompton Hospital/NHLI Imperial College London London, United Kingdom, SW3 6LY Less <<
NCT01803763 Chronic Urticaria ... More >> Chronic Idiopathic Urticaria Chronic Spontaneous Urticaria Less << Phase 2 Phase 3 Completed - Switzerland ... More >> Department of Rheumatology, Clinical Immunology and Allergology, Bern University Hospital Bern, Switzerland, 3010 Less <<
NCT01218035 Hip Osteoarthritis Phase 4 Completed - Finland ... More >> Turku University Hospital Turku, Finland, 20520 Less <<
NCT01238692 Diffuse Large B Cell Lymphoma Phase 2 Unknown December 2016 Canada, Nova Scotia ... More >> Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada, H3T 1E2 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Sacré-Cœur Hospital Montreal, Quebec, Canada, H4J 1C5 Less <<
NCT01791387 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 2 Unknown June 2015 New Zealand ... More >> Auckland Hospital Auckland, New Zealand, 1142 Less <<
NCT00586443 Solid Tumors Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01549431 Multiple Myeloma Phase 1 Active, not recruiting December 2018 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00210184 Gastric Cancer Phase 2 Completed - France ... More >> Centre Hospitalier Universitaire de Bordeaux Bordeaux, France, 33076 Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest Bordeaux, France, 33076 Hopital Robert Boulin Libourne, France, 33700 Centre Hospitalier Universitaire de Pau Pau, France, 64000 Clinique Francheville Perigueux, France, 24000 Centre Hospitalier Universitaire de Villeneuve sur Lot Villeneuve sur Lot, France, 47000 Less <<
NCT00881049 Metastatic Melanoma Phase 2 Completed - China, Bejing ... More >> Beijing Cancer Hospital Beijing, Bejing, China, 10036 Less <<
NCT00891033 Multiple Myeloma Phase 1 Terminated(This study was term... More >>inated because the drug company stopped making the study drug) Less << - United States, Arkansas ... More >> Myeloma Institute for Research and Therapy University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00892398 Glaucoma Not Applicable Completed - Canada, Quebec ... More >> Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T2M4 Less <<
NCT02707575 Age-related Macular Degenerati... More >>on Less << Not Applicable Unknown May 2018 Korea, Republic of ... More >> Inje University Ilsan Paik Hospital Recruiting Goyang, Korea, Republic of Contact: Joo Youn Shin       jyshin0511@gmail.com    Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of Contact: HS Kang       hskang09@gmail.com Less <<
NCT00905242 Kidney Transplantation Phase 4 Completed - United States, North Carolina ... More >> Brody School of Medicine at East Carolina University Greenville, North Carolina, United States, 27834 Less <<
NCT00915603 Metastatic Breast Cancer Phase 2 Completed - United States, California ... More >> Wilshire Oncology Medical Group LaVerne, California, United States, 91750 United States, Connecticut Eastern Connecticut Hematology Oncology Norwich, Connecticut, United States, 06360 United States, Florida Aventura Medical Center Aventura, Florida, United States, 33180 Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Associates Bethesda, Maryland, United States, 20817 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center Columbus, Ohio, United States, 43219 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Texas Oncology Dallas, Texas, United States, 75246 United States, Virginia Fairfax Northern Virginia Hem-Onc Fairfax, Virginia, United States, 22031 Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00878436 - Completed - -
NCT00878436 Prostate Cancer ... More >> Prostatic Neoplasms Less << Phase 1 Phase 2 Completed - United States, New Jersey ... More >> The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York North Shore University Hospital-Monter Cancer Center Lake Success, New York, United States, 11042 NYU Cancer Center New York, New York, United States, 10016 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00851370 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Withdrawn(Unable to find eligi... More >>ble subjects- study closed) Less << - United States, Colorado ... More >> National Jewish Health Denver, Colorado, United States, 80206 Less <<
NCT00928642 Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 2 Completed - United States, Washington ... More >> Madigan Army Medical Center Tacoma, Washington, United States, 98431 Less <<
NCT00928642 - Completed - -
NCT00917345 - Unknown May 2009 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: VinCent Wu, MD    +886937223278 Less <<
NCT02487498 - Completed - -
NCT00915603 - Completed - -
NCT02551224 Pulmonary Disease, Chronic Obs... More >>tructive (COPD) Less << Not Applicable Completed - Argentina ... More >> Novartis Investigative Site Caba, Buenos Aires, Argentina, C1426ABP Novartis Investigative Site Florida, Buenos Aires, Argentina, B1602DQD Novartis Investigative Site La Plata, Buenos Aires, Argentina, 1900 Novartis Investigative Site Mar del Plata, Buenos Aires, Argentina, 7600 Novartis Investigative Site Vicente Lopez, Buenos Aires, Argentina, B1602DOH Novartis Investigative Site Buenos Aires, Argentina, B1842DID Novartis Investigative Site Buenos Aires, Argentina, C1120AAC Novartis Investigative Site Buenos Aires, Argentina, C1425AUA Novartis Investigative Site Caba, Argentina Novartis Investigative Site Ciudad Autonoma de Bs As, Argentina, C1425FVH Less <<
NCT02547714 Plaque Psoriasis Phase 4 Completed - Japan ... More >> Novartis Investigative Site Nagoya city, Aichi, Japan, 467-8602 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 814-0180 Novartis Investigative Site Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Osaka-city, Osaka, Japan, 550-0012 Novartis Investigative Site Shimotsuke-city, Tochigi, Japan, 329-0498 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 102-8798 Novartis Investigative Site Itabashi-ku, Tokyo, Japan, 173-8606 Novartis Investigative Site Itabashi-ku, Tokyo, Japan, 173-8610 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-8471 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141 8625 Novartis Investigative Site Shinjuku-Ku, Tokyo, Japan, 169-0073 Less <<
NCT02551224 - Completed - -
NCT02550106 CHRONIC SPONTANEOUS URTICARIA Phase 4 Completed - France ... More >> Novartis Investigative Site Paris, Cedex 10, France, 75475 Novartis Investigative Site Angers, France, 49033 Novartis Investigative Site Argenteuil, France, 95107 Novartis Investigative Site Besancon Cedex, France, 25030 Novartis Investigative Site Bobigny Cedex, France, 93009 Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Chalons-en-Champagne, France, 51005 Novartis Investigative Site Clermont Ferrand cedex 1, France, 63003 Novartis Investigative Site Dijon, France, 21034 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site LILLE Cedex, France, 59037 Novartis Investigative Site Lille, France, 59000 Novartis Investigative Site Limoges cedex, France, 87042 Novartis Investigative Site Lyon cedex 04, France, 69317 Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Montpellier cedex 5, France, 34295 Novartis Investigative Site Nantes, France, 44035 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Nimes Cedex, France, 30029 Novartis Investigative Site Paris, France, 75014 Novartis Investigative Site Paris, France, 75877 Novartis Investigative Site Quimper, France, 29000 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rennes Cedex 9, France, 35033 Novartis Investigative Site Rouen, France, 76031 Novartis Investigative Site Saint-Etienne, France, 42055 Novartis Investigative Site Toulon Cedex 9, France, 83800 Novartis Investigative Site Toulouse Cedex, France, 31400 Novartis Investigative Site Vandoeuvre Les Nancy, France, 54511 Less <<
NCT00404989 - Recruiting January 2099 United States, North Carolina ... More >> Registry Coordinating Center Recruiting Wilmington, North Carolina, United States, 28403 Less <<
NCT02516605 Primary Biliary Cholangitis Phase 2 Completed - -
NCT01848028 - Recruiting July 2026 Germany ... More >> Nationwide group of dermatological centers, hospitals and medical offices Recruiting Hamburg, Germany Contact: Matthias Augustin, Prof. Dr.       m.augustin@uke.de    Principal Investigator: Matthias Augustin, Prof. Dr. Less <<
NCT00120523 - Completed - -
NCT00193856 Prostate Cancer Phase 3 Completed - Australia, New South Wales ... More >> Campbelltown Hospital Campbelltown, New South Wales, Australia, 2560 St George Hospital Kogarah, New South Wales, Australia, 2217 Lismore Hospital Lismore, New South Wales, Australia, 2480 Liverpool Hospital Liverpool, New South Wales, Australia, 1871 Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Nepean Cancer Care Centre Penrith, New South Wales, Australia, 2751 Royal North Shore Hospital Sydney, New South Wales, Australia, 2069 Riverina Cancer Care Centre Wagga Wagga, New South Wales, Australia, 2650 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Illawarra Cancer Care Centre Wollongong, New South Wales, Australia Australia, Queensland Royal Brisbane Hospital Herston, Queensland, Australia, 4029 Mater QRI South Brisbane, Queensland, Australia, 4101 John Flynn Private Hospital Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, Tasmania Launceston General Hospital Launceston, Tasmania, Australia, 7250 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 8006 Andrew Love Cancer Care Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 New Zealand Auckland Hospital Auckland, New Zealand, 1001 Christchurch Hospital Christchurch, New Zealand, 4710 Dunedin Hospital Dunedin, New Zealand Waikato Hospital Hamilton, New Zealand, 3200 Palmerston North Hospital Palmerston North, New Zealand Wellington Hospital Wellington, New Zealand, 7902 Less <<
NCT01733082 - Recruiting March 2021 United States, Massachusetts ... More >> Recruiting Cambridge, Massachusetts, United States, 02139 Less <<
NCT02991807 PTEN Gene Mutation ... More >> PTEN Hamartoma Tumor Syndrome Less << Phase 1 Phase 2 Recruiting June 2019 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94305 Contact: Jaelyn Edwards    650-736-1235    jedwrds@stanford.edu    Contact: Stephanie Ghassan    650-736-1235    stephgh@stanford.edu    Principal Investigator: Antonio Hardan, MD          United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Amelia Diplock    617-919-1476    Amelia.Diplock@childrens.harvard.edu    Contact: Rajna Filip-Dhima, MS    617-919-7068    Rajna.Filip-Dhima@childrens.harvard.edu    Principal Investigator: Mustafa Sahin, MD, PhD          United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44104 Contact: Komeisha Rose    216-445-8798    ROSEK2@ccf.org    Principal Investigator: Rabi Hanna, MD          Sub-Investigator: Charis Eng, MD,PhD Less <<
NCT02622581 - Recruiting December 2022 Germany ... More >> Pius-Hospital Recruiting Oldenburg, Germany, 26121 Contact: F. Griesinger, Prof.    +49 441 229 1611    Frank.griesinger@pius-hospital.de Less <<
NCT00120523 Atopic Dermatitis Phase 3 Completed - -
NCT00743808 - Completed - -
NCT00859040 Meningioma Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center, Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00859040 - Completed - -
NCT03349801 - Recruiting February 28, 2022 Denmark ... More >> Righospitalet Copenhagen Not yet recruiting Copenhagen, Denmark Principal Investigator: Michael Larsen, Prof.          France Centre Hospitalier Intercommunal de Creteil Recruiting Créteil, France Principal Investigator: Eric Souied, Prof.          Centre d'Investigation Clinique Centre National d'Ophtalmologie des Quinze-Vingts Not yet recruiting Paris, France Principal Investigator: José-Alain Sahel, Prof.          Germany University Hospital Bonn Recruiting Bonn, Germany Principal Investigator: Frank Holz, Prof.          University Hospital Cologne Recruiting Cologne, Germany Principal Investigator: Claudia Dahlke, Prof.          Department of Ophthalmology, University of Freiburg Recruiting Freiburg, Germany Principal Investigator: Hansjürgen Agostini, Prof.          University Eye Hospital Munich Not yet recruiting Munich, Germany Principal Investigator: Armin Wolf, Prof.          St. Franziskus Hospital Not yet recruiting Münster, Germany Principal Investigator: Daniel Pauleikhoff, Prof.          Universtiy Hospital Tuebingen Not yet recruiting Tübingen, Germany Principal Investigator: Laura Kuhlwein, Prof.          University Eye Hospital Ulm Not yet recruiting Ulm, Germany Principal Investigator: Gabriele Lang, Prof.          Italy Luigi Sacco Hospital Not yet recruiting Milan, Italy Principal Investigator: Giovanni Staurenghi, Prof.          Ospedale San Raffaele Not yet recruiting Milan, Italy Principal Investigator: Francesco Bandello, Prof.          G.B.Bietti Eye Foundation Not yet recruiting Rom, Italy Principal Investigator: Maria Cristina Parravano, Prof.          Netherlands Radboud University Medical Centre Not yet recruiting Leiden, Netherlands Principal Investigator: Camiel Boon, Prof.          Radboud University Medical Centre Not yet recruiting Nijmegen, Netherlands Principal Investigator: Carel Hoyng, Prof.          Portugal Centre for Clinical Trials, AIBILI Recruiting Coimbra, Portugal Principal Investigator: Rufino Silva, Prof.          Centro Hospitalar de São João, E.P.E. Not yet recruiting Porto, Portugal Principal Investigator: Angela Carneiro, Prof.          United Kingdom Moorfields Eye Hospital Not yet recruiting Belfast, United Kingdom Principal Investigator: Ruth Hogg, Prof.          Gloucestershire Hospitals NHS Foundation Trust Not yet recruiting Gloucester, United Kingdom Principal Investigator: Emily Fletcher, Prof.          Moorfields Eye Hospital Not yet recruiting London, United Kingdom Principal Investigator: Adnan Tufail, Prof. Less <<
NCT02547714 - Completed - -
NCT02626377 Breast Cancer ... More >> Colorectal Cancer Prostate Cancer Alzheimer Disease Age-related Macular Degeneration Parkinson Disease Cardiac Disease Ischemic Stroke Hemorrhagic Stroke Less << Not Applicable Recruiting October 2025 France ... More >> CHRU de Besançon Recruiting Besançon, France, 25030 Contact: Morgane CHOTARD    0370632183 ext +33    mchotard@chu-besancon.fr    Contact: Cécile ROLLER    0370632178    croller@chu-besancon.fr    Centre Georges François Leclerc Recruiting Dijon, France, 21079 Contact: Valérie BOYEAU    0345348089 ext +33    VBoyeau@cgfl.fr    Contact: Geneviève LAPORTE    0345348089 ext +33    GLaporte@cgfl.fr    CHU de DIJON Recruiting Dijon, France, 21079 Contact: Ophélie HOCHART    0380293592 ext +33    ophelie.hochart@chu-dijon.fr Less <<
NCT00859222 Malignant Glioma Phase 1 Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Virginia University of Virginia, Department of Neurology Charlottesville, Virginia, United States, 22908 Less <<
NCT00859222 - Completed - -
NCT01454973 - Completed - United States, Texas ... More >> ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT02104661 Multiple Sclerosis Phase 2 Completed - United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom, E1 1BB Less <<
NCT01663207 - Completed - United States, Texas ... More >> ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT01663220 - Completed - United States, Texas ... More >> ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT02036619 - Completed - Belgium ... More >> OLV Aalst Aalst, Belgium, 9300 UZA Antwerpen, Belgium, 2560 OLV Aalst-site Asse Asse, Belgium, 1730 Imelda Bonheiden Bonheiden, Belgium, 2820 AZ St Jan Brugge, Belgium, 8000 Kliniek St Jan Brussel Brussel, Belgium, 1000 UZ Leuven Leuven, Belgium, 3000 Less <<
NCT00920348 - Active, not recruiting December 2022 Canada, Alberta ... More >> Health Sciences Centre Calgary, Alberta, Canada, T2N 4N1 Canada, British Columbia St-Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia Halifax Infirmary Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Kingston General Hospital Kingston, Ontario, Canada, K7L 2V6 Ottawa Hospital General Ottawa, Ontario, Canada, K1H 8L6 University of Toronto Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec Montreal Chest Institute Montreal, Quebec, Canada, H2X 2P4 Canada, Saskatchewan Royal University Hospital Saskatoon, Saskatchewan, Canada, S7N 0W8 Canada Institut universitaire de cardiologie et de pneumologie de Québec Quebec, Canada, G1V 4G5 Less <<
NCT02346344 - Completed - United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 United States, Texas ICON Development Solutions, Gault Lane San Antonio, Texas, United States, 78209 Less <<
NCT02075697 - Recruiting October 2025 Spain ... More >> Hospital Universitari German Trias y Pujol. Recruiting Badalona, Barcelona, Spain Fundación Hospital Alcorcón Recruiting Alcorcón, Madrid, Spain Hospital General Universitario de Alicante Recruiting Alicante, Spain Hospital Clinic Recruiting Barcelona, Spain Hospital del Mar. IMAS Recruiting Barcelona, Spain Hospital Universitario Reina Sofía Recruiting Córdoba, Spain Hospital Universitario de Gran Canaria Dr Negrín Recruiting Las Palmas, Spain Hospital Infanta Leonor Recruiting Madrid, Spain Hospital Universitario 12 de Octubre Recruiting Madrid, Spain Hospital Universitario de la Princesa Recruiting Madrid, Spain Hospital Clínico Universitario Virgen de la Victoria Recruiting Málaga, Spain Hospital Universitario Virgen Macarena de Sevilla Recruiting Sevilla, Spain Hospital General Universitario de Valencia Recruiting Valencia, Spain Less <<
NCT02443922 Type 2 Diabetes Not Applicable Unknown December 2015 -
NCT01257542 Common Cold I... More >>nfections, Upper Respiratory Tract Less << Phase 4 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Florida ... More >> DMI Research Pinellas, Florida, United States, 33782-4533 United States, Indiana Concentrics Center for Research Indianapolis, Indiana, United States, 46240 United States, Oregon Cyn3rgy Research Gresham, Oregon, United States, 97030 United States, Tennessee Clinical Research Associates Incorporated Nashville, Tennessee, United States, 37203 Less <<
NCT00512499 Osteoporosis ... More >>Fractures Less << Not Applicable Completed - Canada, Quebec ... More >> Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT01257542 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03760588 Breast Cancer Female ... More >> Heart Failure Less << Phase 2 Not yet recruiting April 2022 -
NCT02523287 Safety Markers of Adjuvanted I... More >>nfluenza Vaccine Less << Phase 4 Active, not recruiting December 2017 Belgium ... More >> Center for Vaccinology Ghent, East-Flanders, Belgium, 9000 Less <<
NCT03292094 - Active, not recruiting December 3, 2027 South Africa ... More >> Hypertension Research and Training Clinic Potchefstroom, North West, South Africa, 2531 Less <<
NCT00359047 Osteoporosis Not Applicable Active, not recruiting December 2025 Canada ... More >> CHUdeQuebec, CHUL Quebec, Canada, G1V 4G2 Less <<
NCT01642186 Fibrolamellar Carcinoma ... More >> Fibrolamellar Liver Cancer Less << Phase 2 Active, not recruiting July 2019 United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 United States, Maryland John Hopkins Medical Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01265810 Oral Complaints ... More >> Renal Cell Carcinoma Hepatocellular Carcinoma Gastrointestinal Stromal Tumors Less << Phase 3 Completed - Netherlands ... More >> The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Centre (LUMC) Leiden, Netherlands, 2300 RC Less <<
NCT01819415 - Completed - -
NCT01819415 Exudative Age Related Macular ... More >>Degeneration Less << Not Applicable Completed - Canada, Quebec ... More >> Maisonneuve Rosemont Hospital Montreal, Quebec, Canada, H1T2M4 Less <<
NCT00150891 - Completed - Germany ... More >> Department of Internal Medicine, University of Giessen Giessen, Germany, D-35392 Less <<
NCT01745068 Osteoporosis With Current Frag... More >>ility Fracture Less << Not Applicable Active, not recruiting June 2019 Canada, Quebec ... More >> Centre hospitalier Hôtel-Dieu d'Amos Amos, Quebec, Canada, J9T 2S2 CSSS du Roché Percé (Centre hospitalier de Chandler) Chandler, Quebec, Canada, G0C 1K0 Hôpital de Hull Gatineau, Quebec, Canada, J8Y 1W7 Hôpital Charles Lemoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 Hôpital Jean-Talon Montreal, Quebec, Canada, H2E1S6 Hôpital Sacré-Coeur de Montréal Montreal, Quebec, Canada, H4J 1C5 Centre hospitalier régional de Lanaudière Saint-Charles-Borromée, Quebec, Canada, J6E 6J2 Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H5N4 CSSS de St-Jérôme (Hôpital régional de St-Jérôme) St-Jérôme, Quebec, Canada, J7Z 5T3 Less <<
NCT02181101 Breast Neoplasms Phase 3 Completed - Germany ... More >> Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt Munich, Bavaria, Germany, 80337 Less <<
NCT02925234 Cancer Tumors... More >> Neoplasm Neoplasia Less << Phase 2 Recruiting December 2019 Netherlands ... More >> Meander Medical Center Not yet recruiting Amersfoort, Utrecht, Netherlands, 3818 ES Contact: H.J. Bloemendal, MD, PhD          Principal Investigator: H.J. Bloemendal, MD, PhD          Netherlands Cancer Institute Recruiting Amsterdam, Netherlands, 1066CX Contact: E.E. Voest, prof.    0031205129111    DRUP@nki.nl    Contact: D.L. vd Velden, MD    0031205129111    DRUP@nki.nl    AZVU Not yet recruiting Amsterdam, Netherlands, 1081 HV Contact: H Verheul, prof          Principal Investigator: H Verheul, prof          Amphia Hospital Not yet recruiting Breda, Netherlands Contact: A.J. Ten Tije, MD, PhD          Principal Investigator: A.J. Ten Tije, MD, PhD          Maxima Medisch Centrum Not yet recruiting Eindhoven, Netherlands, 5631 BM Contact: G Vreugdenhil, MD, PhD          Principal Investigator: G Vreugdenhil, MD, PhD          Orbis Concern Not yet recruiting Geleen, Netherlands, 6162 BG Contact: F L Erdkamp, MD          Principal Investigator: F L Erdkamp, MD          University Medical Center Groningen Not yet recruiting Groningen, Netherlands Contact: D.J.A. de Groot, MD, PhD          Principal Investigator: D.J.A. de Groot, MD, PhD          Leiden University Medical Center Not yet recruiting Leiden, Netherlands Contact: A.J. Gelderblom, MD, PhD          Principal Investigator: A.J. Gelderblom, MD, PhD          Maastricht University Medical Center Not yet recruiting Maastricht, Netherlands Contact: A. Hoeben, MD, PhD          Principal Investigator: A. Hoeben, MD, PhD          Radboud umc Not yet recruiting NIjmegen, Netherlands, 6225GA Contact: C.M.L. van Herpen, MD, PhD          Principal Investigator: C.M.L. van Herpen, MD, PhD          St. Fransicus Gasthuis Not yet recruiting Rotterdam, Netherlands, 3045 PM Contact: A P Hamberg, MD          Principal Investigator: A P Hamberg, MD          Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: M.J.A. de Jonge, MD, PhD          Principal Investigator: M.J.A. de Jonge, MD, PhD          St. Elisabeth Not yet recruiting Tilburg, Netherlands, 5022 GC Contact: L.V. Beerepoot, MD, PhD          Principal Investigator: L.V. Beerepoot, MD, PhD          University Medical Center Utrecht Not yet recruiting Utrecht, Netherlands, 3584CX Contact: M.H.G. Langenberg, MD, PhD          Principal Investigator: M.H.G. Langenberg, MD, PhD Less <<
NCT01320085 BRAF or NRAS Mutant Metastatic... More >> Melanoma Less << Phase 2 Active, not recruiting June 30, 2019 United States, Arkansas ... More >> Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Moffitt 5 Tampa, Florida, United States, 33612 United States, Oregon Oregon Health & Science University OHSU 2 Portland, Oregon, United States, 97239 United States, Pennsylvania St. Luke's Hospital and Health Network St. Luke's Cancer Network (2) Bethlehem, Pennsylvania, United States United States, South Carolina Cancer Centers of the Carolinas CCC Faris Greenville, South Carolina, United States, 29605 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Muenchen, Germany, 80336 Italy Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Napoli, Italy, 80131 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Maastricht, Netherlands, 5800 Novartis Investigative Site Nijmegen, Netherlands, 6525 GA Switzerland Novartis Investigative Site Chur, Switzerland, 7000 Novartis Investigative Site Zürich, Switzerland, 8091 Less <<
NCT01777776 - Terminated(Study was withdrawn... More >> due to scientific and business considerations.) Less << - -
NCT01777776 Locally Advanced Metastatic BR... More >>AF Mutant Melanoma Less << Phase 1 Phase 2 Terminated(Study was withdrawn... More >> due to scientific and business considerations.) Less << - United States, Colorado ... More >> University of Colorado Dept of Oncology Aurora, Colorado, United States, 80045 United States, Michigan Karmanos Cancer Institute Dept of Oncology Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center Dept Oncology NY, New York, United States, 90033 United States, Oregon Oregon Health & Science University Dept. of OHSU (3) Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University Medical Center SC - Dept of Oncology . Nashville, Tennessee, United States, 37232 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, South Australia Novartis Investigative Site Woodville, South Australia, Australia, 5011 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2X 3J4 Netherlands Novartis Investigative Site Utrecht, Netherlands, 3584CX Less <<
NCT01763164 Metastatic or Unresectable Cut... More >>aneous Melanoma Less << Phase 3 Active, not recruiting July 31, 2019 -
NCT02555540 Prevention of Infections With ... More >>Bordetella Pertussis Less << Phase 4 Active, not recruiting December 2017 Belgium ... More >> Center for Vaccinology Ghent, East-Flanders, Belgium, 9000 Less <<
NCT02843529 Alzheimer Disease ... More >> Mild Cognitive Impairment Memory Disorders Cognitive Impairment Dementia Presymptomatic Disease Less << Not Applicable Enrolling by invitation February 2019 -
NCT01801358 Uveal Melanoma Phase 1 Phase 2 Terminated(The trial was termi... More >>nated for scientific reasons.) Less << - United States, Massachusetts ... More >> Dana Farber Cancer Institute Dept. Onc Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center Dept of Onc.. NY, New York, United States, 90033 France Novartis Investigative Site Paris, France, 75231 Germany Novartis Investigative Site Essen, Germany, 45147 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Madrid, Spain, 28050 United Kingdom Novartis Investigative Site London, United Kingdom, SW3 6JJ Less <<
NCT01352273 Advanced Solid Tumors Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States, 33612 United States, Oregon Oregon Health & Science University OHSU 3 Portland, Oregon, United States, 97239 United States, Utah University of Utah / Huntsman Cancer Institute Huntman 2 Salt Lake City, Utah, United States, 84103 Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E3 Norway Novartis Investigative Site Oslo, Norway, NO-0379 Spain Novartis Investigative Site Madrid, Spain, 28050 Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 Less <<
NCT01801358 - Terminated(The trial was termi... More >>nated for scientific reasons.) Less << - -
NCT03664518 Thrombocytopenia Purpura ... More >> Chronic HBV Infection Less << Phase 2 Not yet recruiting May 31, 2020 China, Tianjin ... More >> Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences Active, not recruiting Tianjin, Tianjin, China, 300020 Less <<
NCT00171873 Neuroendocrine Tumors Phase 3 Unknown December 2013 Germany ... More >> Novartis Investigative Site Bochum, Germany Novartis Investigative Site Dresden, Germany Novartis Investigative Site Halle, Germany Novartis Investigative Site Hamburg, Germany Novartis Investigative Site Kiel, Germany Novartis Investigative Site Leipzig, Germany Novartis Investigative Site Mainz, Germany Novartis Investigative Site Marburg, Germany, 35033 Novartis Investigative Site Marburg, Germany Novartis Investigative Site Munchen, Germany Less <<
NCT00171873 - Unknown - -
NCT01562899 Metastatic Pancreatic Adenocar... More >>cinoma BRAF Mutated Melanoma Less << Phase 2 Terminated(Study was withdrawn... More >> due to scientific and business considerations.) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States, 84103 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Toulouse Cedex 9, France, 31059 Italy Novartis Investigative Site Napoli, Italy, 80131 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT02583256 Influenza Phase 3 Completed - Finland ... More >> Novartis Investigational Site- 001 Espoo, Etelä-Suomen lääni, Finland, 02230 Novartis Investigational Site- 002 Helsinki, Etelä-Suomen lääni, Finland, 00100 Novartis Investigational Site- 003 Helsinki, Etelä-Suomen lääni, Finland, 00100 Novartis Investigational Site- 004 Järvenpää, Etelä-Suomen lääni, Finland, 04400 Novartis Investigational Site- 005 Kokkola, Länsi-Suomen lääni, Finland, 67100 Novartis Investigational Site- 007 Pori, Länsi-Suomen lääni, Finland, 28100 Novartis Investigational Site- 009 Tampere, Länsi-Suomen lääni, Finland, 33100 Novartis Investigational Site- 010 Turku, Länsi-Suomen lääni, Finland, 20520 Novartis Investigational Site- 006 Oulu, Finland, 90220 Philippines Novartis Investigational Site- 303 Laguna, Matro Manila, Philippines, 1781 Novartis Investigational Site- 304 Muntinlupa, National Capital Region, Philippines, 1781 Novartis Investigational Site- 305 Muntinlupa, National Capital Region, Philippines, 1781 Novartis Investigational Site- 306 Cavite, Philippines, 4114 Thailand Novartis Investigational Site- 325 Pathum Thani, Bangkok, Thailand, 12120 Novartis Investigational Site- 327 Bangkok, Krung Thep Maha Nakhon [Bangko, Thailand, 10400 Novartis Investigational Site- 320 Bangkok, Samut Prakan, Thailand, 10400 Novartis Investigational Site- 323 Bangkok, Thailand, 10330 Less <<
NCT02610400 Malaria Phase 3 Recruiting August 2017 Namibia ... More >> University of Namibia Multidisciplinary Research Centre Recruiting Windhoek, Namibia Contact: Davis Mumbengegwi, PhD    +264 (0) 61-206-3908    dmumbengegwi@unam.na Less <<
NCT00079001 - Completed - -
NCT02638259 Rheumatoid Arthritis Phase 3 Completed - -
NCT00079001 Metastatic Cancer ... More >> Prostate Cancer Less << Phase 3 Completed - -
NCT00576680 Pancreatic Neuroendocrine Tumo... More >>r Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02638259 - Completed - -
NCT00903188 Renal Transplantation Phase 4 Unknown April 2015 Belgium ... More >> Erasme University Hospital Recruiting Brussels, Belgium, 1070 Contact: Daniel Abramowicz, MD/PhD    +32/2/555 35 32    dabram@ulb.ac.be    Principal Investigator: Daniel Abramowicz, MD/PhD          University Hospital Brussels Recruiting Brussels, Belgium, 1090 Contact: Jacques Sennesael, MD/PhD    +32/2/477 60 55    Jacques.Sennesael@uzbrussel.be    Principal Investigator: Jacques Sennesael, MD          University Hospital Antwerp Recruiting Edegem, Belgium, 2650 Contact: Jean-Louis Bosmans, MD/PhD    +32/3/821 37 92    jeanlouis.bosmans@ua.ac.be    Contact: Angelika Jurgens, Study Coord.    +32/3/821 34 21    Angelika.Jurgens@uza.be    Principal Investigator: Jean-Louis Bosmans, MD/PhD          University Hospital, Ghent Recruiting Gent, Belgium, 9000 Contact: Patrick Peeters, MD/PhD    +32/9/332 45 13    patrick.peeters@ugent.be    Principal Investigator: Patrick Peeters, MD          University Hospital of Liege Recruiting Liège, Belgium, 4000 Contact: Catherine Bonvoisin, MD/PhD    +32/4/366 82 58    catherine.bonvoisin@chu.ulg.ac.be    Principal Investigator: Catherine Bonvoisin, MD Less <<
NCT00785629 Chronic Kidney Disease Not Applicable Completed - United States, Colorado ... More >> Denver Nephrologists, PC Denver, Colorado, United States, 80230 Less <<
NCT00270712 - Active, not recruiting December 2017 United States, Alabama ... More >> University of Alabama - Division of Nephrology Birmingham, Alabama, United States, 35294 United States, Iowa University of Iowa - Nephrology Division Iowa City, Iowa, United States, 52242 United States, Minnesota Hennepin County Medical Center - Division of Nephrology Minneapolis, Minnesota, United States, 55415 University of Minnesota Dept of Surgery - Transplantation Division Minneapolis, Minnesota, United States, 55455 Mayo Clinic - Division of Nephrology Rochester, Minnesota, United States, 55905 Canada, Alberta University of Alberta - Division of Nephrology & Immunology Edmonton, Alberta, Canada, T6G 2S2 Canada, Manitoba Health Sciences Center - Section of Nephrology Winnipeg, Manitoba, Canada, R3A 1R9 Less <<
NCT00785629 - Completed - -
NCT02404311 HIV Infection Phase 1 Phase 2 Unknown January 2017 South Africa ... More >> CAPRISA eThekwini CRS Durban, KwaZulu-Natal, South Africa, 4001 Isipingo CRS Durban, KwaZulu-Natal, South Africa, 4133 Emavundleni Desmond Tutu HIV Centre CRS Cape Town, Western Cape, South Africa, 7750 Aurum Institute for Health Research Klerksdorp, South Africa, 2570 Perinatal HIV Research Unit Soweto, South Africa, 2013 Less <<
NCT02158624 Visual Disorder Due to Age-rel... More >>ated Macula Degeneration Less << Not Applicable Unknown December 2015 Japan ... More >> Department of Ophthalmology, Kyushu University Hospital Recruiting Maidashi, Higashiku, Fukuoka-city, Fukuoka, Japan, 812-8582 Contact: Yuji Oshima, MD. PhD    +81-92-642-5648    yuji@eye.med.kyushu-u.ac.jp Less <<
NCT03087448 Non-small Cell Lung Cancer Phase 1 Phase 2 Recruiting March 2021 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Less <<
NCT01058655 - Completed - -
NCT01248416 Idiopathic Short Stature Phase 3 Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Nemours Children's Clinic Orlando, Florida, United States, 32801 United States, Pennsylvania Nemours Children's Clinic- Jefferson Philadelphia, Pennsylvania, United States, 19107 Chile Veronica Mericq, MD Santiago, Chile Less <<
NCT01248416 - Completed - -
NCT02819882 - Recruiting June 2024 Spain ... More >> Hospital General de Elche Recruiting Elche, Alicante, Spain, 03203 Althaia-Xarxa Assistencial de Manresa Recruiting Manresa, Barcelona, Spain, 08243 Consorci Sanitari de Terrassa Recruiting Terrassa, Barcelona, Spain, 08227 Hospital Universitario Donostia Recruiting San Sebastián, Donostia, Spain, 20014 Hospital Dr. Negrín Recruiting Las Palmas de Gran Canaria, Gran Canaria, Spain, 35010 Hospital Universitario Fundación Alcorcón Recruiting Alcorcón, Madrid, Spain, 28922 Hospital Universitario de Fuenlabrada Recruiting Fuenlabrada, Madrid, Spain, 28942 Hospital Universitario Severo Ochoa Recruiting Leganés, Madrid, Spain, 28911 Hospital Infanta Sofía Recruiting San Sebastián de los Reyes, Madrid, Spain, 28702 Hospital Son Llatzer Recruiting Palma de Mallorca, Mallorca, Spain, 07198 Complejo Hospitalario de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Hospital Universitario de Canarias Recruiting Santa Cruz de Tenerife, Tenerife, Spain, 38320 Hospital de Sagunto Recruiting Sagunto, Valencia, Spain, 46520 Hospital Universitario de Basurto Recruiting Bilbao, Vizcaya, Spain, 48013 Complejo Hospitalario Universitario A Coruña Recruiting A Coruña, Spain, 15006 Complejo Hospitalario Universitario de Albacete Recruiting Albacete, Spain, 02006 Hospital San Juan de Alicante Recruiting Alicante, Spain, 03550 Hospital del Mar Recruiting Barcelona, Spain, 08003 Hospital Clinic de Barcelona Recruiting Barcelona, Spain, 08036 Hospital Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08041 ICO L´Hospitalet Recruiting Barcelona, Spain, 08908 Hospital Universitario Germans Trias i Pujol Recruiting Barcelona, Spain, 08916 Hospital Moisés Broggi_institut Catalá D´Oncologia Recruiting Barcelona, Spain, 08970 Hospital San Pedro de Alcántara Not yet recruiting Cáceres, Spain, 10003 Hospital Universitario Reina Sofía Recruiting Córdoba, Spain, 14004 Hospital de León Recruiting León, Spain, 24071 Hospital Lucus Augusti Recruiting Lugo, Spain, 27003 Hospital Universitario La Princesa Recruiting Madrid, Spain, 28006 Hospital General Universitario Gregorio Marañón Recruiting Madrid, Spain, 28007 Hospital Clínico Universitario Virgen de la Arrixaca Recruiting Murcia, Spain, 30120 Hospital Universitario de Málaga Recruiting Málaga, Spain, 29010 Hospital Clínico Universitario de Salamanca Recruiting Salamanca, Spain, 37007 Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain, 41013 Hospital Virgen de la Salud Recruiting Toledo, Spain, 45004 IVO-Instituto Valenciano de Oncología Recruiting Valencia, Spain, 46009 Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46010 Hosital General de Valencia Recruiting Valencia, Spain, 46014 Hospital Universitario Dr. Peset Recruiting Valencia, Spain, 46017 Hospital Clínico Lozano Blesa Recruiting Zaragoza, Spain, 50009 Hospital Miguel Servet Recruiting Zaragoza, Spain, 50009 Hospital Nuestra Señora de Sonsoles Recruiting Ávila, Spain, 05004 Less <<
NCT01337765 Unspecified Adult Solid Tumor,... More >> Protocol Specific Solid Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 Less <<
NCT01680094 HIV Infection Phase 1 Phase 2 Completed - Denmark ... More >> Department of Infectious Diseases, Aarhus University Hospital Aarhus, Denmark, 8200 Less <<
NCT01058655 Gastrointestinal Cancer Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01313390 Head and Neck Cancer Phase 1 Phase 2 Terminated(Lack of recruitment... More >>) Less << - United Kingdom ... More >> UCL Cancer Institute London, England, United Kingdom, WC1E 6DD Less <<
NCT00470223 Sarcoma Phase 3 Terminated(IDMC decision upon ... More >>interim efficacy analysis) Less << April 2025 France ... More >> Centre Paul Papin Angers, France, 49036 Institut Gustave Roussy Angers, France, 49036 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 CHU Hopital A. Morvan Brest, France, 29609 CHU de Caen Caen, France, 14033 Centre Regional Francois Baclesse Caen, France, 14076 CHR Clermont Ferrand, Hotel Dieu Clermont-Ferrand, France, 63003 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Universitaire de Dijon Dijon, France, 21079 CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Hopital Edouard Herriot - Lyon Lyon, France, 69437 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 CHU de la Timone Marseille, France, 13385 Hopital d'Enfants de la Timone Marseille, France, 13385 CHU Nord Marseille, France, 13915 Hopital Arnaud de Villeneuve Montpellier, France, 34295 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hopital de l'Archet CHU de Nice Nice, France, F-06202 Institut Curie Hopital Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancerologie de la Loire Saint Priest en Jarez, France, 42270 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31059 C.H. Bastien de Clocheville Tours, France, 3700 CHRU de Tours - Hopital Trousseau Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT01820364 Melanoma Phase 2 Terminated(Study was withdrawn... More >> due to scientific and business considerations.) Less << - United States, Tennessee ... More >> Sarah Cannon Research Institute Onc Dept Nashville, Tennessee, United States, 37203 Australia, Victoria Novartis Investigative Site East Melbourne, Victoria, Australia, 3002 Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Germany Novartis Investigative Site Heidelberg, Germany, 69120 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Zuerich, Switzerland, 8091 Less <<
NCT01820364 - Terminated(Study was withdrawn... More >> due to scientific and business considerations.) Less << - -
NCT02565576 Myasthenia Gravis, Generalized Phase 2 Completed - Canada, Quebec ... More >> Novartis Investigative Site Montreal, Quebec, Canada, H3A 2BA Novartis Investigative Site Québec, Quebec, Canada, G1J 1Z4 Denmark Novartis Investigative Site Aarhus, Denmark, 8000 C Novartis Investigative Site Copenhagen, Denmark, 2100 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Halle, Germany, 06120 Novartis Investigative Site Muenchen, Germany, 81377 Russian Federation Novartis Investigative Site Samara, Samara Region, Russian Federation, 443095 Novartis Investigative Site Barnaul, Russian Federation, 656024 Novartis Investigative Site Kazan, Russian Federation, 420021 Novartis Investigative Site Novosibirsk, Russian Federation, 630087 Novartis Investigative Site S-Petersburg, Russian Federation, 194354 Taiwan Novartis Investigative Site Tainan, Taiwan ROC, Taiwan, 70421 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan Less <<
NCT02563067 Asthma Phase 3 Active, not recruiting September 19, 2019 -
NCT02566031 COPD Phase 4 Completed - Korea, Republic of ... More >> Novartis Investigative Site Chuncheon, Gangwon-do, Korea, Republic of, 24253 Novartis Investigative Site Wonju, Gangwon-Do, Korea, Republic of, 26426 Novartis Investigative Site Anyang-si, Gyeonggi-do, Korea, Republic of, 14068 Novartis Investigative Site Guri-si, Gyeonggi-do, Korea, Republic of, 471-701 Novartis Investigative Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Novartis Investigative Site Suwon-si, Gyeonggi-do, Korea, Republic of, 16499 Novartis Investigative Site Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 02559 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 08308 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Gwangju, Korea, Republic of, 61469 Novartis Investigative Site Incheon, Korea, Republic of, 403-720 Novartis Investigative Site Incheon, Korea, Republic of, 405 760 Novartis Investigative Site Jeju, Korea, Republic of, 63241 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Republic of, 04763 Novartis Investigative Site Seoul, Korea, Republic of, 05030 Novartis Investigative Site Seoul, Korea, Republic of, 06273 Novartis Investigative Site Seoul, Korea, Republic of, 06591 Novartis Investigative Site Seoul, Korea, Republic of, 110-746 Novartis Investigative Site Seoul, Korea, Republic of, 150-713 Novartis Investigative Site Seoul, Korea, Republic of, 156-707 Novartis Investigative Site Ulsan, Korea, Republic of, 44033 Less <<
NCT02607774 Moderate to Severe Plaque Psor... More >>iasis Less << Phase 1 Completed - United States, Alabama ... More >> Novartis Investigative Site Birmingham, Alabama, United States, 35205 United States, Arizona Novartis Investigative Site Phoenix, Arizona, United States, 85032 United States, Arkansas Novartis Investigative Site Hot Springs, Arkansas, United States, 71913 United States, New Jersey Novartis Investigative Site Fair Lawn, New Jersey, United States, 07410 Novartis Investigative Site Verona, New Jersey, United States, 07044 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75230 Novartis Investigative Site Webster, Texas, United States, 77004 United States, Virginia Novartis Investigative Site Norfolk, Virginia, United States, 23507 Less <<
NCT02626221 - Completed - Argentina ... More >> Novartis Investigative Site Caba, Buenos Aires, Argentina, C1062ABK Novartis Investigative Site Ciudad Autonoma de Bs As, Buenos Aires, Argentina, C1114AAJ Novartis Investigative Site Ciudad Autonoma de Bs As, Buenos Aires, Argentina, C1425BEA Novartis Investigative Site Lobos, Buenos Aires, Argentina Novartis Investigative Site Buenos Aires, Nueve De Julio, Argentina, B6500BWQ Novartis Investigative Site Rosario, Santa Fe, Argentina, 2000 Novartis Investigative Site Rosario, Santa Fe, Argentina, S2000BRH Novartis Investigative Site Buenos Aires, Argentina, C1425DKG Novartis Investigative Site Mendoza, Argentina, M5502EZA Novartis Investigative Site Salta, Argentina, 4400 Brazil Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 21941-913 Novartis Investigative Site Alphaville / Barueri, Sao Paulo, Brazil, 06454-010 Novartis Investigative Site Guarulhos, SP, Brazil, 07051-000 Novartis Investigative Site Santo Andre, SP, Brazil, 09060-650 Novartis Investigative Site Sao Paulo, SP, Brazil, 05437-000 Colombia Novartis Investigative Site Medellin, Antioquia, Colombia Novartis Investigative Site Barranquilla, Atlantico, Colombia Novartis Investigative Site Bogotá, Cundinamarca, Colombia Novartis Investigative Site Medellín, Colombia Costa Rica Novartis Investigative Site San José, Costa Rica Novartis Investigative Site San Rafael Escazu, Costa Rica Dominican Republic Novartis Investigative Site Santiago, Republica Dominicana, Dominican Republic Novartis Investigative Site Santo Domingo, Republica Dominicana, Dominican Republic Novartis Investigative Site Santo Domingo, Dominican Republic Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Honduras Novartis Investigative Site San Pedro Sula, Honduras, 21102 Novartis Investigative Site San Pedro Sula, Honduras Novartis Investigative Site Tegucigalpa, Honduras Panama Novartis Investigative Site Panama, Panama Peru Novartis Investigative Site Jesus Maria, Lima, Peru, 11 Novartis Investigative Site San Martin de Porres, Lima, Peru, 31 Less <<
NCT02720107 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Ostfildern, Baden-Wuerttemberg, Germany, 73760 Novartis Investigative Site Altenholz-Stift, Germany, 24161 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Berlin, Germany, 10713 Novartis Investigative Site Berlin, Germany, 12163 Novartis Investigative Site Berlin, Germany, 13347 Novartis Investigative Site Böblingen, Germany, 71032 Novartis Investigative Site Celle, Germany, 29223 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erbach, Germany, 64711 Novartis Investigative Site Frankfurt, Germany, 60313 Novartis Investigative Site Göttingen, Germany, 37073 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Klingenmünster, Germany, 76889 Novartis Investigative Site Lappersdorf, Germany, 93138 Novartis Investigative Site Leverkusen, Germany, 51375 Novartis Investigative Site Mönchengladbach, Germany, 41239 Novartis Investigative Site München, Germany, 81829 Novartis Investigative Site Neuburg an der Donau, Germany, 86633 Novartis Investigative Site Siegen, Germany, 57076 Novartis Investigative Site Singen, Germany, 78224 Novartis Investigative Site Troisdorf, Germany, 53844 Novartis Investigative Site Ulm, Germany, 89073 Novartis Investigative Site Unterhaching, Germany, 82008 Less <<
NCT02554890 Acute Heart Failure Phase 4 Completed - -
NCT02690701 Chronic Plaque Psoriasis Phase 4 Completed - United States, California ... More >> Novartis Investigative Site Los Angeles, California, United States, 90033 Novartis Investigative Site Santa Ana, California, United States, 92701 United States, Maryland Novartis Investigative Site Rockville, Maryland, United States, 20850 United States, Missouri Novartis Investigative Site Saint Louis, Missouri, United States, 63117 United States, New York Novartis Investigative Site Buffalo, New York, United States, 14221 Novartis Investigative Site New York, New York, United States, 10025 1737 United States, Oregon Novartis Investigative Site Portland, Oregon, United States, 97223 Novartis Investigative Site Portland, Oregon, United States, 97239 United States, Pennsylvania Novartis Investigative Site Exton, Pennsylvania, United States, 19341 United States, Texas Novartis Investigative Site Dallas, Texas, United States, 75246-1613 Novartis Investigative Site Houston, Texas, United States, 77004 United States, Utah Novartis Investigative Site Salt Lake City, Utah, United States, 84132 Less <<
NCT02595970 Psoriasis Phase 3 Completed - France ... More >> Novartis Investigative Site Limoges cedex, Haute Vienne, France, 87000 Novartis Investigative Site Amiens cedex 1, France, 80054 Novartis Investigative Site Antony, France, 92160 Novartis Investigative Site Argenteuil, France, 95107 Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Brest, France, 29609 Novartis Investigative Site La Rochelle, France, 17019 Novartis Investigative Site Le Mans Cedex 09, France, 72037 Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Martigues, France, 13500 Novartis Investigative Site Metz, France, 57077 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Paris, France, 75014 Novartis Investigative Site Paris, France, 75877 Novartis Investigative Site Rouen, France, 76031 Novartis Investigative Site Toulon Cedex 9, France, 83800 Novartis Investigative Site Toulouse Cedex, France, 31400 Less <<
NCT02720536 Chronic Iron Overload Phase 3 Active, not recruiting July 2, 2019 Austria ... More >> Novartis Investigative Site Vienna, Austria, 1140 Greece Novartis Investigative Site Athens, GR, Greece, GR-115 27 Novartis Investigative Site Patra - RIO, GR, Greece, 265 04 Novartis Investigative Site Thessaloniki, GR, Greece, 546 42 Italy Novartis Investigative Site Catania, CT, Italy, 95125 Novartis Investigative Site Cona, FE, Italy, 44100 Novartis Investigative Site Genova, GE, Italy, 16128 Novartis Investigative Site Cagliari, ITA, Italy, 09121 Novartis Investigative Site Lecce, LE, Italy, 73100 Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Palermo, PA, Italy, 90127 Novartis Investigative Site Palermo, PA, Italy, 90146 Novartis Investigative Site Verona, VR, Italy, 37126 Novartis Investigative Site Napoli, Italy, 80138 Less <<
NCT02595814 - Terminated - -
NCT02649218 Chronic Spontaneous Urticaria Phase 2 Active, not recruiting May 7, 2019 -
NCT02748863 Psoriasis Phase 3 Completed - -
NCT00379678 - Completed - United States, Colorado ... More >> National Jewish Medical and Research Center Denver, Colorado, United States, 80206 Less <<
NCT02752776 Moderate to Severe Plaque Psor... More >>iasis Less << Phase 4 Completed - -
NCT02792218 Relapsing Multiple Sclerosis Phase 3 Active, not recruiting May 16, 2019 -
NCT02758548 Atopic Asthma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Hamburg, Germany, 20354 Novartis Investigative Site Lübeck, Germany, 23552 Italy Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Pisa, PI, Italy, 56124 Novartis Investigative Site Roma, RM, Italy, 00168 Netherlands Novartis Investigative Site Almelo, Netherlands, 7609 PP Novartis Investigative Site Harderwijk, Netherlands, 3840 AC Spain Novartis Investigative Site Sabadell, Barcelona, Spain, 08208 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46017 United Kingdom Novartis Investigative Site Chertsey, Surrey, United Kingdom, KT16 0PZ Novartis Investigative Site Bradford, West Yorkshire, United Kingdom, BD9 6RJ Novartis Investigative Site Manchester, United Kingdom, M23 9QZ Less <<
NCT02750592 Ankylosing Spondylitis Phase 3 Completed - Japan ... More >> Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-8556 Novartis Investigative Site Kita-gun, Kagawa, Japan, 761-0793 Novartis Investigative Site Nankoku city, Kochi, Japan, 783 8505 Novartis Investigative Site Tenri, Nara, Japan, 632-8552 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-0013 Novartis Investigative Site Kawachinagano-city, Osaka, Japan, 586-8521 Novartis Investigative Site Suita-city, Osaka, Japan, 565 0871 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-8560 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0054 Less <<
NCT02966353 Primary Myelofibrosis ... More >> Post-Polycythemia Vera-Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis Less << Phase 2 Active, not recruiting February 15, 2019 Austria ... More >> Novartis Investigative Site Vienna, Austria, A-1090 Belgium Novartis Investigative Site Antwerpen, Belgium, 2060 Novartis Investigative Site Leuven, Belgium, 3000 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1413 Novartis Investigative Site Sofia, Bulgaria, 1756 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 1M9 Germany Novartis Investigative Site Halle/S., Germany, 06120 Greece Novartis Investigative Site Thessaloniki, GR, Greece, 570 10 Novartis Investigative Site Athens, Greece, 11527 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Palermo, PA, Italy, 90127 Japan Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 125167 Novartis Investigative Site Moscow, Russian Federation, 129110 Novartis Investigative Site Petrozavodsk, Russian Federation, 185019 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Alicante, Comunidad Valenciana, Spain, 03010 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Turkey Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Kocaeli, Turkey, 41380 Less <<
NCT02826603 Plaque Psoriasis Phase 3 Completed - -
NCT02957409 - Active, not recruiting October 12, 2020 Canada, Alberta ... More >> Novartis Investigative Site Calgary, Alberta, Canada, T2N 4Z6 Novartis Investigative Site Calgary, Alberta, Canada Novartis Investigative Site Edmonton, Alberta, Canada, T6G 2C8 Canada, British Columbia Novartis Investigative Site Maple Ridge, British Columbia, Canada, V2X 2P8 Novartis Investigative Site North Vancouver, British Columbia, Canada, V7M 2H4 Canada, Manitoba Novartis Investigative Site Winnipeg, Manitoba, Canada, R2H 2A6 Canada, New Brunswick Novartis Investigative Site Moncton, New Brunswick, Canada, E1G 1A7 Canada, Nova Scotia Novartis Investigative Site Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Novartis Investigative Site Brampton, Ontario, Canada, L6W 2X7 Novartis Investigative Site Burlington, Ontario, Canada, L7M 4Y1 Novartis Investigative Site Cambridge, Ontario, Canada, N1R 6V6 Novartis Investigative Site Newmarket, Ontario, Canada, L3Y 2P6 Novartis Investigative Site Oakville, Ontario, Canada, L6K 3W7 Novartis Investigative Site Sarnia, Ontario, Canada, N7T 4X3 Novartis Investigative Site Scarborough, Ontario, Canada, M1P 2V5 Novartis Investigative Site Sudbury, Ontario, Canada, P3E 5M9 Novartis Investigative Site Toronto, Ontario, Canada, M5G 2N2 Novartis Investigative Site Waterloo, Ontario, Canada, N2T 0C1 Novartis Investigative Site Weston, Ontario, Canada, M9N 1W4 Canada, Quebec Novartis Investigative Site Chicoutimi, Quebec, Canada, G7H 5H6 Novartis Investigative Site Greenfield Park, Quebec, Canada, J4V 2G8 Novartis Investigative Site Joliette, Quebec, Canada, J6E 6J2 Novartis Investigative Site Laval, Quebec, Canada, H7M 3L9 Novartis Investigative Site Levis, Quebec, Canada, G6V 4Z5 Novartis Investigative Site Montreal, Quebec, Canada, H1T 1C8 Novartis Investigative Site Montreal, Quebec, Canada, H3G 1A4 Novartis Investigative Site Sainte-Foy, Quebec, Canada, G1V 4G5 Novartis Investigative Site Sherbrooke, Quebec, Canada, J1H 5N4 Novartis Investigative Site St-George, Quebec, Canada, G5Y 4T8 Novartis Investigative Site St-Jean-sur-Richelieu, Quebec, Canada, J3A 1C3 Novartis Investigative Site Trois-Rivieres, Quebec, Canada, G8Z 3R9 Canada Novartis Investigative Site Quebec, Canada, G1R 2J6 Less <<
NCT02998671 Acne Vulgaris Phase 2 Terminated(Futility) - United States, California ... More >> Novartis Investigative Site Culver City, California, United States, 90230 Novartis Investigative Site Sacramento, California, United States, 95819 United States, North Carolina Novartis Investigative Site High Point, North Carolina, United States, 27262 United States, Pennsylvania Novartis Investigative Site Hershey, Pennsylvania, United States, 17033 United States, Texas Novartis Investigative Site Austin, Texas, United States, 78759 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Bonn, Germany, 53111 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Pommelsbrunn, Germany, 91224 Netherlands Novartis Investigative Site Bergen op Zoom, Netherlands, 4624 VT Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Leiden, Netherlands, 2333 CL Less <<
NCT02798211 Psoriatic Arthritis Phase 4 Active, not recruiting October 1, 2018 -
NCT02900378 Chronic Heart Failure With Red... More >>uced Ejection Fraction Less << Phase 3 Completed - -
NCT02927366 Pulmonary Arterial Hypertensio... More >>n Less << Phase 2 Recruiting December 27, 2018 United States, Pennsylvania ... More >> Novartis Investigative Site Recruiting Pittsburgh, Pennsylvania, United States, 15261 United States, Wisconsin Novartis Investigative Site Recruiting Milwaukee, Wisconsin, United States, 53215 Germany Novartis Investigative Site Recruiting Dresden, Germany, 01307 Novartis Investigative Site Recruiting Giessen, Germany, 35392 Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Recruiting Munchen, Germany, 80639 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03722 Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 06351 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taipei, Taiwan, 10048 United Kingdom Novartis Investigative Site Recruiting Cambridge, Cambridgeshire, United Kingdom, CB23 3RE Less <<
NCT02924727 Acute Myocardial Infarction Phase 3 Recruiting April 27, 2020 -
NCT00410501 Healthy Phase 1 Completed - India ... More >> Novartis Mumbai, India Less <<
NCT00418509 Healthy Phase 1 Completed - United Kingdom ... More >> Novartis Horsham, United Kingdom Less <<
NCT02913105 Non-alcoholic Steatohepatitis ... More >>NASH Less << Phase 2 Recruiting November 15, 2019 -
NCT00419796 Osteoarthritis With Controlled... More >> Hypertension Less << Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT02962895 Primary Sjogren's Syndrome Phase 2 Recruiting June 30, 2020 -
NCT00422175 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States Less <<
NCT02992483 Multiple Myeloma (MM), Lymphom... More >>a, Large B-Cell, Diffuse (DLBCL), Lymphoma Less << Phase 1 Recruiting April 15, 2020 United States, Ohio ... More >> Novartis Investigative Site Recruiting Columbus, Ohio, United States, 43210 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Recruiting Heidelberg, Victoria, Australia, 3084 France Novartis Investigative Site Recruiting Nantes Cedex 1, France, 44093 Germany Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Recruiting Kiel, Germany, 24105 Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Recruiting Fukuoka-city, Fukuoka, Japan, 811-1395 Spain Novartis Investigative Site Recruiting Salamanca, Castilla Y Leon, Spain, 37007 Less <<
NCT03005288 Diabetes Mellitus, Type 2 Phase 2 Active, not recruiting May 8, 2019 United States, California ... More >> Novartis Investigative Site Anaheim, California, United States, 92801 United States, Florida Novartis Investigative Site Miami Lakes, Florida, United States, 33014 Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Miami, Florida, United States, 33143 Novartis Investigative Site Orlando, Florida, United States, 32804 United States, Louisiana Novartis Investigative Site Baton Rouge, Louisiana, United States, 70808 United States, New Jersey Novartis Investigative Site Berlin, New Jersey, United States, 08009 United States, New York Novartis Investigative Site New York, New York, United States, 10019 United Kingdom Novartis Investigative Site Merthyr Tydfil, Mid Glamorgan, United Kingdom, CF484DR Less <<
NCT00303251 Melanoma Phase 1 Phase 2 Completed - United States, Kentucky ... More >> James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 Less <<
NCT02961218 Sickle Cell Anemia Phase 2 Recruiting June 3, 2020 United States, Florida ... More >> Novartis Investigative Site Recruiting Miami, Florida, United States, 33136 United States, Georgia Novartis Investigative Site Recruiting Atlanta, Georgia, United States, 30329 Novartis Investigative Site Recruiting Augusta, Georgia, United States, 30912 United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10029 United States, North Carolina Novartis Investigative Site Recruiting Greenville, North Carolina, United States, 27834 United States, Pennsylvania Novartis Investigative Site Recruiting Philadelphia, Pennsylvania, United States, 19104-4399 Germany Novartis Investigative Site Recruiting Hamburg, Germany, 20246 Israel Novartis Investigative Site Recruiting Afula, Israel, 1834111 South Africa Novartis Investigative Site Recruiting Johannesburg, Guateng, South Africa, 2193 Turkey Novartis Investigative Site Recruiting Adana, Turkey, 01330 Novartis Investigative Site Recruiting Ankara, Turkey, 06100 Novartis Investigative Site Recruiting Mersin, Turkey, 33343 United Kingdom Novartis Investigative Site Recruiting London, United Kingdom, E1 1BB Novartis Investigative Site Recruiting London, United Kingdom, SE1 7EH Novartis Investigative Site Recruiting London, United Kingdom, SE5 9RS Novartis Investigative Site Recruiting Staffordshire, United Kingdom, WS11 5XY Less <<
NCT00409019 Chronic Hepatitis B Phase 4 Withdrawn(Study cancelled With... More >>drawn before enrollment of any participants) Less << - -
NCT03275064 Wounds and Injuries Phase 2 Recruiting September 16, 2019 United States, Arizona ... More >> Novartis Investigative Site Recruiting Phoenix, Arizona, United States, 85053 United States, California Novartis Investigative Site Recruiting La Mesa, California, United States, 91942 United States, Florida Novartis Investigative Site Recruiting Longwood, Florida, United States, 32750 Novartis Investigative Site Recruiting Miami Lakes, Florida, United States, 33014 United States, Illinois Novartis Investigative Site Recruiting Chicago, Illinois, United States, 60612 United States, Indiana Novartis Investigative Site Recruiting Greenwood, Indiana, United States, 46143 Czechia Novartis Investigative Site Recruiting Brno, Czech Republic, Czechia, 66250 Novartis Investigative Site Recruiting Mlada Boleslav, Czech Republic, Czechia, 29301 Novartis Investigative Site Recruiting Kladno, Czechia, 272 59 Novartis Investigative Site Recruiting Pardubice, Czechia, 53002 Denmark Novartis Investigative Site Recruiting Aarhus C, Denmark, DK 8000 Novartis Investigative Site Recruiting Hvidovre, Denmark, 2650 Sweden Novartis Investigative Site Terminated Kungsbacka, Sweden, 434 80 Less <<
NCT00419887 Healthy Phase 1 Completed - China ... More >> Novartis Beijing, China Less <<
NCT00414765 Metastatic Renal Cell Carcinom... More >>a Metastatic Melanoma Less << Phase 1 Phase 2 Completed - United States, California ... More >> USC/Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Kentucky James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00412529 - Completed - -
NCT00418769 Healthy Phase 1 Completed - -
NCT02993224 Transfusion-dependent Thalasse... More >>mia Non-transfusion-dependent Thalassemia Less << Phase 2 Recruiting December 27, 2020 Egypt ... More >> Novartis Investigative Site Recruiting Alexandria, Egypt, 21131 Novartis Investigative Site Recruiting Cairo, Egypt, 11562 Novartis Investigative Site Recruiting Zagazig, Egypt, 44519 Lebanon Novartis Investigative Site Recruiting Hazmiyeh, Beirut, Lebanon, PO BOX 213 Saudi Arabia Novartis Investigative Site Recruiting Al Ahsa, SAU, Saudi Arabia Novartis Investigative Site Recruiting Jeddah, Saudi Arabia, 21423 Novartis Investigative Site Recruiting Jeddah, Saudi Arabia, 21589 Novartis Investigative Site Recruiting Riyadh, Saudi Arabia, 11117 Thailand Novartis Investigative Site Recruiting Bangkok noi, Bangkok, Thailand, 10700 Novartis Investigative Site Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Novartis Investigative Site Recruiting Bangkok, Thailand, 10400 Turkey Novartis Investigative Site Recruiting Ankara, Turkey, 06100 Novartis Investigative Site Recruiting Antalya, Turkey, 07070 Novartis Investigative Site Recruiting Istanbul, Turkey, 34093 Less <<
NCT00419159 Colorectal Cancer Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT00412529 Hepatitis B C... More >>hronic Hepatitis B Less << Phase 3 Completed - Korea, Republic of ... More >> Holy Family Hospital_Bucheon Bucheon,Kyunggi, Korea, Republic of Inje University Busan Paik Hospital Busan, Korea, Republic of Yeungnam University Medical Center Daegu, Korea, Republic of Gachon Univ. Gil Medical Center Hospital Incheon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Kangnam Sacred Heart Hospital Seoul, Korea, Republic of Korea University Medical Center_Anam Seoul, Korea, Republic of The Catholic University of Korea Seoul, Korea, Republic of Less <<
NCT00232050 Asthma Phase 3 Completed - -
NCT00419159 - Completed - -
NCT00420615 Solid Tumors Phase 1 Completed - United States, Texas ... More >> The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03299686 Asthma Phase 2 Recruiting September 26, 2019 -
NCT00420524 Advanced Malignancies ... More >> Tumors Less << Phase 1 Completed - United States, California ... More >> University of California San Diego/Moores Cancer Center La Jolla, California, United States, 92093-0987 United States, New Mexico Cancer Research and Treatment Center Albuquerque, New Mexico, United States, 87131-5636 United States, Texas Institute for Drug Development Cancer Therapy & Research Center/The University of Texas Health Science San Antonio, Texas, United States, 78229 South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT00219323 Asthma Phase 3 Completed - Japan ... More >> This study is not being conducted in the United States Tokyo, Japan Less <<
NCT03350815 Ankylosing Spondylitis Phase 4 Recruiting May 12, 2020 -
NCT00442741 Solid Tumors Phase 1 Withdrawn(pts. will be capture... More >>d in core) Less << - -
NCT00421044 Advanced Malignancies ... More >> Tumors Less << Phase 1 Completed - United States, California ... More >> University of California San Diego/Moores Cancer Center La Jolla, California, United States, 92093-0987 United States, Texas Institute for Drug Development Cancer Therapy & Research Center/The University of Texas Health Science Center San Antonio, Texas, United States, 78229 South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT03379727 Acute Myeloid Leukemia Phase 3 Recruiting December 30, 2021 -
NCT03373461 IgA Nephropathy Phase 2 Recruiting April 6, 2021 Australia, New South Wales ... More >> Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site Recruiting Melbourne, Victoria, Australia, 3050 Belgium Novartis Investigative Site Recruiting Edegem, Antwerpen, Belgium, 2650 Novartis Investigative Site Recruiting Leuven, Belgium, 3000 Novartis Investigative Site Recruiting Roeselare, Belgium, 8800 Denmark Novartis Investigative Site Recruiting Aalborg, Denmark, 9000 Finland Novartis Investigative Site Recruiting HUS, Finland, 00029 Netherlands Novartis Investigative Site Recruiting Groningen, Netherlands, 9713 GZ Norway Novartis Investigative Site Recruiting Bergen, Norway, 5021 Novartis Investigative Site Recruiting Loerenskog, Norway, NO-1478 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 119228 Novartis Investigative Site Recruiting Singapore, Singapore, 169608 Sweden Novartis Investigative Site Recruiting Stockholm, Sweden, 141 86 Taiwan Novartis Investigative Site Recruiting New Taipei City, Taiwan, 23561 Novartis Investigative Site Recruiting Taichung, Taiwan, 40705 Thailand Novartis Investigative Site Recruiting Bangkok, Thailand, 10400 United Kingdom Novartis Investigative Site Recruiting Cambridge, Cambrigdeshire, United Kingdom, CB2 0QQ Novartis Investigative Site Recruiting Leicester, United Kingdom, LE5 4PW Novartis Investigative Site Recruiting London, United Kingdom, SE5 9RS Novartis Investigative Site Recruiting London, United Kingdom, W12 0HS Novartis Investigative Site Recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Less <<
NCT03372083 Iron Over Load Phase 4 Recruiting November 14, 2019 Italy ... More >> Novartis Investigative Site Recruiting Cona, FE, Italy, 44100 Novartis Investigative Site Recruiting Cagliari, ITA, Italy, 09121 Novartis Investigative Site Recruiting Napoli, Italy, 80138 Lebanon Novartis Investigative Site Recruiting Hazmiyeh, Beirut, Lebanon, PO BOX 213 Oman Novartis Investigative Site Recruiting Muscat, Oman, 123 Russian Federation Novartis Investigative Site Recruiting Moscow, Russian Federation, 117198 Thailand Novartis Investigative Site Recruiting Bangkok noi, Bangkok, Thailand, 10700 Novartis Investigative Site Completed Muang, Chiangmai, Thailand, 50200 United Arab Emirates Novartis Investigative Site Recruiting Dubai, United Arab Emirates, 9115 Less <<
NCT03440736 Psoriasis Met... More >>abolic Syndrome Less << Phase 4 Recruiting March 30, 2021 -
NCT03439046 Breast Cancer Phase 3 Recruiting October 31, 2021 Italy ... More >> Novartis Investigative Site Recruiting Bari, BA, Italy, 70124 Novartis Investigative Site Recruiting Bergamo, BG, Italy, 24127 Novartis Investigative Site Recruiting Benevento, BN, Italy, 82100 Novartis Investigative Site Recruiting Bologna, BO, Italy, 40139 Novartis Investigative Site Recruiting Brindisi, BR, Italy, 72100 Novartis Investigative Site Recruiting Brescia, BS, Italy, 25123 Novartis Investigative Site Recruiting Cremona, CR, Italy, 26100 Novartis Investigative Site Recruiting Catania, CT, Italy, 95124 Novartis Investigative Site Recruiting Catania, CT, Italy, 95125 Novartis Investigative Site Recruiting Cona, FE, Italy, 44100 Novartis Investigative Site Recruiting San Giovanni Rotondo, FG, Italy, 71013 Novartis Investigative Site Recruiting Genova, GE, Italy, 16132 Novartis Investigative Site Recruiting Livorno, LI, Italy, 57124 Novartis Investigative Site Recruiting Monza, MB, Italy, 20900 Novartis Investigative Site Recruiting Macerata, MC, Italy, 62100 Novartis Investigative Site Recruiting Messina, ME, Italy, 98158 Novartis Investigative Site Recruiting Milano, MI, Italy, 20132 Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Novartis Investigative Site Recruiting Nuoro, NU, Italy, 08100 Novartis Investigative Site Recruiting Palermo, PA, Italy, 90127 Novartis Investigative Site Recruiting Palermo, PA, Italy, 90146 Novartis Investigative Site Recruiting Padova, PD, Italy, 35100 Novartis Investigative Site Recruiting Aviano, PN, Italy, 33081 Novartis Investigative Site Recruiting Prato, PO, Italy, 59100 Novartis Investigative Site Recruiting Fano, PU, Italy, 61032 Novartis Investigative Site Recruiting Faenza, RA, Italy, 48018 Novartis Investigative Site Recruiting Roma, RM, Italy, 00128 Novartis Investigative Site Recruiting Roma, RM, Italy, 00168 Novartis Investigative Site Recruiting Roma, RM, Italy, 00189 Novartis Investigative Site Recruiting Salerno, SA, Italy, 84131 Novartis Investigative Site Recruiting Candiolo, TO, Italy, 10060 Novartis Investigative Site Recruiting Torino, TO, Italy, 10128 Novartis Investigative Site Recruiting Udine, UD, Italy, 33100 Novartis Investigative Site Recruiting Negrar, VR, Italy, 37024 Novartis Investigative Site Recruiting Bologna, Italy, 40138 Novartis Investigative Site Recruiting Napoli, Italy, 80131 Novartis Investigative Site Recruiting Napoli, Italy, 80138 Novartis Investigative Site Recruiting Perugia, Italy, 06129 Less <<
NCT03344640 Tendinopathy Phase 2 Recruiting December 6, 2019 United States, Arizona ... More >> Novartis Investigative Site Recruiting Phoenix, Arizona, United States, 85053 Novartis Investigative Site Recruiting Tucson, Arizona, United States, 85712 United States, Florida Novartis Investigative Site Recruiting Miami Lakes, Florida, United States, 33014 Novartis Investigative Site Recruiting Tampa, Florida, United States, 33603 Czechia Novartis Investigative Site Recruiting Brno, Czech Republic, Czechia, 66250 Novartis Investigative Site Recruiting Kolin, Czech Republic, Czechia, 280 02 Novartis Investigative Site Recruiting Prague 6, Czechia, 160 00 Novartis Investigative Site Recruiting Praha, Czechia Germany Novartis Investigative Site Recruiting Berlin, Germany, 10117 Novartis Investigative Site Recruiting Erlangen, Germany, 91054 Novartis Investigative Site Recruiting Hamburg, Germany, 22415 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2333 CL United Kingdom Novartis Investigative Site Recruiting Glasgow, United Kingdom, G51 4TF Less <<
NCT00490776 Cutaneous T-Cell Lymphoma Phase 2 Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham/ The Kirklin Clinic Birmingham, Alabama, United States, 35233 United States, California UCLA Medical Center School of Medicine/ Dpt of Hematology-Oncology Los Angeles, California, United States, 90095 United States, Colorado University of Colorado Health Sciences Center/Anschutz Cancer Pavillion Aurora, Colorado, United States, 80010 United States, Florida Florida Academic Dermatology Centers Miami, Florida, United States, 33136 United States, Georgia Medical College of Georgia Augusta, Georgia, United States, 30912 United States, Illinois Rush Presbyterian Hospital/St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, Missouri St. Louis University Cancer Cennter St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Our Lady of Mercy Medical Center/Comprehensive Cancer Center Bronx, New York, United States, 10466 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 NYU Clinical Cancer Center New York, New York, United States, 10016 United States, North Carolina Wake University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Oklahoma University of Oklahoma-Tulsa Tulsa, Oklahoma, United States, 74104 United States, Oregon Craig Okada Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pittsburg Medical Center Pittsburg, Pennsylvania, United States, 15213 United States, Tennessee The Jones Clinic Germantown, Tennessee, United States, 38138 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-102 Less <<
NCT00492869 Kidney Transplantation Phase 1 Phase 2 Completed - -
NCT00466063 - Completed - -
NCT03517540 Non-alcoholic Steatohepatitis Phase 2 Recruiting July 27, 2020 United States, Arizona ... More >> Novartis Investigative Site Recruiting Chandler, Arizona, United States, 85224 United States, Florida Novartis Investigative Site Recruiting Palmetto Bay, Florida, United States, 33157 United States, Indiana Novartis Investigative Site Recruiting Indianapolis, Indiana, United States, 46237 United States, Louisiana Novartis Investigative Site Recruiting Metairie, Louisiana, United States, 70006 Novartis Investigative Site Recruiting Shreveport, Louisiana, United States, 71103 United States, North Carolina Novartis Investigative Site Recruiting Asheville, North Carolina, United States, 28801 Novartis Investigative Site Recruiting Morehead City, North Carolina, United States, 28557 United States, Tennessee Novartis Investigative Site Recruiting Germantown, Tennessee, United States, 38138 Czechia Novartis Investigative Site Recruiting Prague, Czechia, 12000 Estonia Novartis Investigative Site Recruiting Tallinn, Estonia, 10617 Novartis Investigative Site Recruiting Tartu, Estonia, 51014 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169608 Less <<
NCT00478634 Colorectal Cancer ... More >> Colorectal Carcinoma Colorectal Tumors Neoplasms, Colorectal Less << Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72701 United States, California Comprehensive nBlood and Cancer Care Bakersfield, California, United States, 93309 UCSD - Moores Cancer Center La Jolla, California, United States, 92037 Comprehensive Cancer Care Los Angeles, California, United States, 90095 North Valley Hematology/Oncology Medical Group: The Thomas & Dorothy Leavey Cancer Center Northridge, California, United States, 91325 Cancer Care Associates Medical Group, Inc. Redondo Beach, California, United States, 90277 United States, Connecticut Norwalk Hospital Norwalk, Connecticut, United States, 06850 United States, District of Columbia Gerogetown University Lombardi Cancer Center Washington, District of Columbia, United States, 20057 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois Oncology Specialists Park Ridge, Illinois, United States, 60068 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Richmond University Medical Center Staten Island, New York, United States, 10310 United States, North Carolina UNC School of Medicine Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Oncology/Hematology Associates Bethlehem, Pennsylvania, United States, 18017 United States, Texas Arlington Cancer Center Arlington, Texas, United States, 76012 Less <<
NCT00515086 Glioblastoma Multiforme Phase 2 Terminated(Early termination d... More >>ue to slow enrollment and protocol-defined stopping rule.) Less << - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke University - Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45219 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT03551626 Malignant Melanoma Phase 3 Recruiting October 22, 2021 -
NCT03560739 Multiple Sclerosis Phase 2 Recruiting July 26, 2019 United States, California ... More >> Novartis Investigative Site Recruiting Fullerton, California, United States, 92835 United States, Colorado Novartis Investigative Site Recruiting Basalt, Colorado, United States, 81621 Novartis Investigative Site Recruiting Boulder, Colorado, United States, 80301 United States, Florida Novartis Investigative Site Recruiting Miami, Florida, United States, 33136 Novartis Investigative Site Recruiting Tampa, Florida, United States, 33609 Novartis Investigative Site Recruiting Tampa, Florida, United States, 33612 Novartis Investigative Site Recruiting West Palm Beach, Florida, United States, 33407 United States, Indiana Novartis Investigative Site Recruiting Indianapolis, Indiana, United States, 46256 United States, Missouri Novartis Investigative Site Recruiting Ozark, Missouri, United States, 65721 United States, Tennessee Novartis Investigative Site Recruiting Knoxville, Tennessee, United States, 37922 United States, Texas Novartis Investigative Site Recruiting Round Rock, Texas, United States, 78681 Novartis Investigative Site Recruiting Sherman, Texas, United States, 75092 Austria Novartis Investigative Site Recruiting Vienna, Austria, 1010 Novartis Investigative Site Recruiting Vienna, Austria, 1090 Czechia Novartis Investigative Site Recruiting Havirov, Czech Republic, Czechia, 736 01 Novartis Investigative Site Recruiting Hradec Kralove, CZE, Czechia, 500 05 Novartis Investigative Site Recruiting Pardubice, Czechia, 532 03 Less <<
NCT01631058 Chronic Renal Failure (CRF) ... More >> Graft Failure Transplant; Failure, Kidney Renal Transplant Rejection Less << Phase 4 Recruiting June 2019 Brazil ... More >> Clinical Hospital of the School of Medicine, University of Sao Paulo Recruiting Sao Paulo, SP, Brazil, 05403900 Principal Investigator: Elias David-Neto, PhD          Sub-Investigator: Francine B. Lemos, PhD          Sub-Investigator: Nelson Z. Galante, PhD          Sub-Investigator: Fabiana Agena, MS          Sub-Investigator: William C Nahas, PhD          Sub-Investigator: Wilson Jacob-Filho, PhD          Sub-Investigator: Marcelo Altona, MD          Sub-Investigator: Daisa R David, PhD          Sub-Investigator: Flavio J Paula, PhD          Sub-Investigator: Paschoalina Romano, MS          Sub-Investigator: Persio AR Ebner, Biol          Sub-Investigator: Maria da Luz Fernandes, MS          Sub-Investigator: Veronica PC Coelho, PhD          Sub-Investigator: Venceslau A Coelho, MD          Sub-Investigator: Fabio Di Nizio, MD          Clinical Hospital of the School of Medicine, University of Sao Paulo Recruiting Sao Paulo, SP, Brazil, 05403900 Principal Investigator: Elias David-Neto, PhD          Sub-Investigator: Francine B. Lemos, PhD          Sub-Investigator: Nelson Z. Galante, PhD          Sub-Investigator: Fabiana Agena, MS Less <<
NCT00493766 Hormone Refractory Prostate Ca... More >>ncer Less << Phase 1 Terminated(Because of a strate... More >>gic decision by Novartis) Less << - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115-6-84 United States, Missouri Washing University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT03580369 Chronic Spontaneous Urticaria Phase 3 Recruiting May 20, 2021 United States, Maryland ... More >> Novartis Investigative Site Recruiting Waldorf, Maryland, United States, 20602 United States, North Carolina Novartis Investigative Site Recruiting Asheville, North Carolina, United States, 28801 United States, Vermont Novartis Investigative Site Recruiting South Burlington, Vermont, United States, 05403 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M4V 1R2 Canada Novartis Investigative Site Recruiting Quebec, Canada, G1V 4W2 Germany Novartis Investigative Site Recruiting Langenau, Germany, 89129 Novartis Investigative Site Recruiting Memmingen, Germany, 87700 Hungary Novartis Investigative Site Recruiting Szeged, Csongrad, Hungary, 6720 Novartis Investigative Site Recruiting Debrecen, Hungary, 4032 Novartis Investigative Site Recruiting Pecs, Hungary, 7632 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08003 Less <<
NCT00535418 Breast Cancer Phase 2 Phase 3 Completed - -
NCT03466203 Obesity Phase 1 Recruiting June 24, 2019 United States, Florida ... More >> Novartis Investigative Site Recruiting Jacksonville, Florida, United States, 32216 Novartis Investigative Site Recruiting Miami, Florida, United States, 33126 United States, Kansas Novartis Investigative Site Recruiting Overland Park, Kansas, United States, 66212 United States, Nebraska Novartis Investigative Site Recruiting Lincoln, Nebraska, United States, 68502 United States, North Carolina Novartis Investigative Site Recruiting High Point, North Carolina, United States, 27265 United States, Pennsylvania Novartis Investigative Site Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Recruiting Knoxville, Tennessee, United States, 37920 Less <<
NCT03580356 Chronic Spontaneous Urticaria Phase 3 Recruiting April 30, 2021 -
NCT00581997 Pulmonary Fibrosis Secondary t... More >>o Systemic Sclerosis Less << Phase 2 Terminated(Concerns about risk... More >> of bronchoscopy procedure in the selected patient population and frequency of SAEs observed to date.) Less << - -
NCT00515086 - Terminated(Early termination d... More >>ue to slow enrollment and protocol-defined stopping rule.) Less << - -
NCT00582426 Chemotherapy-induced Diarrhea Phase 3 Completed - Brazil ... More >> Biocâncer Belo Horizonte, Brazil CEPON-Centro de Pesquisas Oncologicas Florianópolis, Brazil Hospital Sao Lucas- Faculdade de Medicina da PUCRS Porto Alegre, Brazil Clínica AMO Salvador, Brazil Nucleo de Oncologia da Bahia Salvador, Brazil Faculdade de Medicina do ABC Santo André, Brazil Hosital Alemão Oswaldo Cruz São Paulo, Brazil Hospital A C Camargo/ Fundação Antonio Prudente São Paulo, Brazil Hospital das Clínicas - FMUSP São Paulo, Brazil Instituto Arnaldo Vieira de Carvalho - IAVC São Paulo, Brazil UNIFESP São Paulo, Brazil Less <<
NCT00582426 - Completed - -
NCT00644878 Chronic Myelogenous Leukemia -... More >> Chronic Phase Less << Phase 4 Completed - United States, California ... More >> USC Norris Cancer Center Jane Anne Nohl Los Angeles, California, United States, 90033 United States, Florida Innovative Medical Research of South Florida Dept.ofInnovativeMedResearch Miami Shores, Florida, United States, 33138 United States, Georgia Georgia Health Sciences University Dept. of MCG Augusta, Georgia, United States, 30912 United States, Idaho Kootenai Medical Center Dept.ofKootenai Med.Ctr. Coeur d'Alene, Idaho, United States, 83814 United States, Indiana Indiana Blood and Marrow Institute Beach Grove, Indiana, United States, 46107 United States, Iowa University of Iowa Hospitals & Clinics Univ of Iowa Hosp & Clinic Iowa City, Iowa, United States, 52242 United States, Louisiana LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans, Louisiana, United States, 70115 United States, Maryland St. Agnes Hospital Baltimore, Maryland, United States, 21229 United States, New York Montefiore Medical Center Medical Center Bronx, New York, United States, 10467 SUNY Upstate Medical Center Syracuse, New York, United States, 13210 Westchester Medical Center Munger Pavillion (2) Valhalla, New York, United States, 10595 United States, North Carolina Wake Forest University Baptist Medical Center Hematology and Oncology Winston-Salem, North Carolina, United States, 27157 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29615 United States, Tennessee University of Tennessee Cancer Institute Cancer Institute Memphis, Tennessee, United States, 38104 United States, Texas South Texas Institute of Cancer S. Tex Inst.- Corpus Christi Corpus Christi, Texas, United States, 78405 Baylor College of Medicine - Breast Care Dan L Duncan Cancer Ctr Houston, Texas, United States, 77030 United States, Utah Central Utah Clinic Central Utah Clinic (7) Provo, Utah, United States, 84604 United States, Wisconsin Froedert Memorial Lutheran Hospital Dept.ofFroedert Memorial Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03759860 Diabetic Macular Edema Phase 4 Active, not recruiting July 30, 2020 Korea, Republic of ... More >> Hallym University Kangnam Sacred Heart Hospital Seoul, Korea, Republic of Less <<
NCT03163420 Irreversible Pulpitis Phase 2 Phase 3 Unknown July 2017 Egypt ... More >> Faculty of Oral and dental medicine, Cairo University Cairo, Egypt Less <<
NCT00616408 - Completed - Italy ... More >> Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples Naples, Italy, 80131 Less <<
NCT00667862 Prostate Cancer Phase 2 Completed - United States, Maryland ... More >> University of Maryland Baltimore, Maryland, United States, 21201 Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Missouri Washington University St. Louis, Missouri, United States, 63130 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53706-1481 Less <<
NCT00688909 Breast Cancer Phase 4 Completed - -
NCT00622505 Multiple Myeloma Phase 4 Completed - -
NCT00395395 Postmenopausal Osteoporosis Phase 1 Completed - Denmark ... More >> Multiple Cities, Denmark Less <<
NCT00757757 Prostate Cancer ... More >> Bone Metastases Less << Phase 1 Phase 2 Terminated - United States, Nevada ... More >> NV Cancer Institute Las Vegas, Nevada, United States, 89135 United States, Texas CTRC San Antonio, Texas, United States, 78229 Less <<
NCT00669916 Plaque Psoriasis Phase 1 Phase 2 Completed - -
NCT00411125 Postmenopausal Osteoporosis Phase 1 Completed - Denmark ... More >> Copenhagen, Denmark Less <<
NCT00669916 - Completed - -
NCT00134953 Cognitive Symptoms Phase 3 Terminated(The Principal Inves... More >>tigator left the clinic and there was no one who could take over this study.) Less << - -
NCT03172780 Osteoarthritis, Knee Phase 3 Completed - India ... More >> Yashoda Hospital - Malakpet Hyderabad, Andhra Pradesh, India, 500036 Yashoda Hospital -Secunderabad Secunderabad, Andhra Pradesh, India, 500003 Yashoda Hospital -Somajiguda Somajiguda, Andhra Pradesh, India, 500082 King George Hospital Visakhapatnam, Andhra Pradesh, India, 530002 Riddhi Medical Nursing Home Ahmedabad, Gujarat, India, 380008 Rathi Hospital Ahmedabad, Gujarat, India, 380015 Sanjivani Superspeciality Hospital Pvt. Ltd Ahmedabad, Gujarat, India, 380015 B.J Medical College & Civil Hospital Ahmedabad, Gujarat, India, 380016 GMERS Medical College & Civil Hospital Ahmedabad, Gujarat, India, 380061 SSG Hospital and Medical College Baroda, Gujarat, India, 39000 Medistar Multispeciality Hospital Himmatnagar, Gujarat, India, 383001 Shree Giriraj Multispeciality Hospital Rajkot, Gujarat, India, 360005 Anand Multispeciality Hospital Vadodara, Gujarat, India, 390016 Parul Sevashram Hospital Vadodara, Gujarat, India, 391760 Omega Hospital Mangalore, Karnataka, India, 575002 Mysore Medical College and Research Institute Mysore, Karnataka, India, 570001 Sree Narayana Institute of Medical Science Ernakulam, Kerala, India, 683594 Sir J. J. Group of Hospital and Grant Government Hospital Mumbai, Maharashtra, India, 400008 Lokmanya Tilak Municipal Medical College & General Hospital Mumbai, Maharashtra, India, 400022 Government Medical College and Hospital Nagpur, Maharashtra, India, 440003 Jasleen Hospital Nagpur, Maharashtra, India, 440012 Institute of Medical sciences and Lata Mangeshkar Nagpur, Maharashtra, India, 600001 Supe Heart and Diabetes Hospital & Research Centre Nashik, Maharashtra, India, 422002 BJ medical college & Sassoon General Hospital Pune, Maharashtra, India, 411001 Sancheti Institute for Orthopedics & Rehabilitation Pune, Maharashtra, India, 411005 BhaktiVedanta Hospital and Research Institute Thane, Maharashtra, India, 401107 IMS and SUM Hospital Bhubaneshwar, Odisha, India, 751003 Govt Stanley Medical College & Hospital Chennai, Tamil Nadu, India, 600001 M.V. Hospital & Research Centre Lucknow, Uttar Pradesh, India, 226003 Ajanta Research Centre Lucknow, Uttar Pradesh, India, 226005 OM surgical Centre and Maternity Home Varanasi, Uttar Pradesh, India, 221007 Institute of Post Graduate Medical Education and Research (IPGMER), Department of Orthopaedics Kolkata, West Bengal, India, 700020 Less <<
NCT00770601 NOMID CINCA S... More >>yndrome Less << Phase 3 Terminated - United States, Maryland ... More >> National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), 9 Bethesda, Maryland, United States, 20892 Less <<
NCT00219232 Alzheimer's Disease Phase 3 Completed - -
NCT00805675 Hepatitis B Virus Phase 3 Completed - China ... More >> Department of Medicine, Queen Mary Hospital Hong Kong, China Less <<
NCT01713725 Chronic Urticaria Phase 2 Completed - Spain ... More >> Hospital Santiago Apostol Vitoria, Alava, Spain, 01004 Clinica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital de Basurto Bilbao, Vizvaya, Spain, 48013 Hospital Clinic Barcelona, Spain, 08036 Less <<
NCT00702052 Lymphoma, Mantle- Cell Phase 2 Completed - -
NCT00825539 Schizophrenia Phase 1 Phase 2 Completed - United States, California ... More >> West LA VA Healthcare Center (UCLA) Los Angeles, California, United States, 90073 United States, Illinois Department of Psychiatry & Behavioural Sciences, Feinberg School of Medicine (Northwestern University) Chicago, Illinois, United States, 60611 United States, Maryland Maryland Psychiatric Research Centre, Spring Grove Hospital Grounds Baltimore, Maryland, United States, 21228 United States, Massachusetts Massachusetts General Hospital (Freedom Trail Clinic) Boston, Massachusetts, United States, 02115 United States, Missouri Washington University St Louis, Missouri, United States, 63110 United States, New York Columbia University New York, New York, United States, 10032 United States, North Carolina JUH Clinical Research (Duke University), Butner, North Carolina, United States, 27509 Less <<
NCT00805675 - Completed - -
NCT01318928 Digestive System Disorders ... More >> Adverse Effects Less << Phase 4 Unknown October 2016 Norway ... More >> Holtanklinikken, Bø i Telemark Bø, Telemark, Norway, 3500 Less <<
NCT01278758 Metastatic Cancer Phase 1 Terminated - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center, Hematology/Oncology Dept. Indiannapolis, Indiana, United States, 46202 United States, Maryland Hematology /Oncology Associates Rockville, Maryland, United States, 20850 United States, Michigan Joseph Ford Cancer Center/Clinical Trials Office, Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00862706 Compensated Chronic Hepatitis ... More >>B Less << Phase 4 Withdrawn(Stopped with Patient... More >>s) Less << - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, New York Hepatobiliary Associates of New York Bayside, New York, United States, 11358 United States, Texas Liver Associates of Texas Houston, Texas, United States, 77030 Liver Specialist of Texas Houston, Texas, United States, 77030 Puerto Rico Fundacion de Investigacion de Diego San Juan, Puerto Rico, 00909 Less <<
NCT00870584 Persistent Allergic Asthma Phase 4 Completed - -
NCT00867113 Gastrointestinal Stromal Tumor... More >> (GIST) Less << Phase 2 Completed - -
NCT00867113 - Completed - -
NCT00877149 Compensated Chronic Hepatitis ... More >>B Less << Phase 4 Completed - China ... More >> Beijing Ditan Hospital Beijing, China First Hospital of Peking University Peking, China Peking University People's Hospital Peking, China Ruijin Hospital, Affiliated to 2nd Medical university Shanghai, China Less <<
NCT00878072 Herpes Labialis Phase 2 Phase 3 Completed - United States, California ... More >> Women's Health Care at Frost Street San Diego, California, United States United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Indiana Medisphere Medical Research Center, LLC Evansville, Indiana, United States, 47714 United States, Missouri Clayton Medical Research St. Louis, Missouri, United States, 63117 United States, New York Rochester Clinical Research, Inc. Rochester, New York, United States United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oregon Westover Heights Clinic Portland, Oregon, United States, 97210 United States, Pennsylvania Primary Physicians Research, Inc Pittsburgh, Pennsylvania, United States United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 R/D Clinical Research, Inc Lake Jackson, Texas, United States, 77566 R/D Clinical Research Lake Jackson, Texas, United States, 77566 Less <<
NCT00928889 - Completed - -
NCT00248144 Recurrent Herpes Labialis Phase 4 Completed - -
NCT00870584 - Completed - -
NCT00928889 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> People's Liberation Army. The Military General Hospital of BeiJing BeiJing, China, 100020 Peiking University First Hospital BeiJing, China, 100034 Chinese PLA General Hospital Beijing, China, 100853 The First Affiliated Hospital, Zhongshan (Sun Yat-sen) University Guangzhou, China, 510080 The Second Affiliated Hospital, Zhongshan (Sun Yat-sen) University Guangzhou, China, 510120 Nanfang Hospital, the Affiliated South Hospital of the Southern Medical University Guangzhou, China, 510515 Less <<
NCT00617851 Influenza Phase 3 Completed - Dominican Republic ... More >> Centro de Salud Galvan Santo Domingo, Dominican Republic Hosp. Nuestra Sra. Altagracia Santo Domingo, Dominican Republic Less <<
NCT00987545 Keloids Phase 2 Terminated(Negative pharmacody... More >>namics due to lack of Interleukin-13 signature in biomarker data from Part I of the study.) Less << - United States, New Jersey ... More >> TKL Research, Inc Paramus, New Jersey, United States, 07652 United States, New York Skin Search of Rochester/Dermatology Associates Rochester, New York, United States, 14623 United States, North Carolina Dermatology Consulting Services High Point, North Carolina, United States, 27262 United States, Virginia Virginia Clinical Research, Inc. Norfold, Virginia, United States, 23507 Less <<
NCT00913653 Heart Failure Phase 2 Completed - Russian Federation ... More >> GOUVPO Russian Peoples´ Friendship University, Center of Applied Moscow, Russian Federation, 117198 Less <<
NCT01019980 Fever Phase 4 Terminated(Placebo - Active Dr... More >>ug Not Available. No patients received drug. There are no study results to disclose.) Less << - Venezuela ... More >> Hospital de niños "J. M. de los Rios", Distrito Metropolitano Caracas, Venezuela Ciudad Hospitalaria Enrique Tejera, Valencia Estado Carabobo, Venezuela Less <<
NCT01019980 - Terminated(Placebo - Active Dr... More >>ug Not Available. No patients received drug. There are no study results to disclose.) Less << - -
NCT00845871 Transfusional Hemosiderosis Phase 4 Completed - -
NCT01022996 - Completed - -
NCT01009281 Crohn's Disease ... More >> Inflammatory Bowel Disease Less << Phase 2 Terminated - United States, Connecticut ... More >> Conneticut Gastroenterology Institute, 39 Brewster Road Bristol, Connecticut, United States, 06010 United States, New York Long Island Clinical Research Associates, LLP Great Neck, New York, United States, 11021 Mount Sinai, One Gustave L. Levy Place, Box 1118 New York, New York, United States, 10029 United States, North Carolina UNC School of Medicine, Room 7200 MBRB, 103 Mason Farm Road, Chapel Hill,, North Carolina, United States, 27599-7032 Wake Research Asspcoates. ::C. 3100 Duraleigh Road, Suite 304 Raleigh, North Carolina, United States, 27612 Less <<
NCT01030055 Neoplasms Can... More >>cer Tumors Less << Phase 1 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 University of California at Los Angeles Los Angeles, California, United States, 90095 United States, North Carolina Duke University Medical Center Cancer Dept Durham, North Carolina, United States, 27710 United States, Utah University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01030952 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Sir Run Run Shaw Hospital, 3 East Qingchun Road Hangzhou, China, 310016 Shanghai Tongji Hospital, 389 Xinchun Road Shanghai, China, 200065 Shanghai Sixth People's Hospital, 600 Xuanshan Road Shanghai, China, 200233 Less <<
NCT01030952 - Completed - -
NCT01294618 Chronic Myelogenous Leukemia Phase 2 Completed - France ... More >> Hospices Civils de Lyon Lyon, France, 69003 Less <<
NCT01022996 Hodgkin Lymphoma Phase 2 Completed - United States, California ... More >> University of California at Los Angeles UCLS School of Medicine Los Angeles, California, United States, 90095 United States, Colorado Rocky Mountain Cancer Centers RMCC - Aurora Greenwood Village, Colorado, United States United States, Florida MD Anderson Cancer Center - Orlando Orlando, Florida, United States, 32806 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Emory University Med School Atlanta, Georgia, United States, 30322 United States, Illinois Lurie Children's Hospital of Chicago Robert H. Lurie Comp Cancer Chicago, Illinois, United States, 60611 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Karmanos Cancer Institute Karmanos-1 Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic - Rochester Mayo Lymphoma Group Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr StudyCoordinator:CLBH589B2201 St. Louis, Missouri, United States, 63110 United States, New York New York Presbyterian Hospital Weill Cornell Med Ctr New York, New York, United States, 10021 United States, North Carolina Duke University Medical Center Duke University Medical Ctr Durham, North Carolina, United States, 27710 United States, Tennessee University of Tennessee Cancer Institute Univ Tennessee Cancer Memphis, Tennessee, United States, 38104 United States, Texas University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) Houston, Texas, United States, 77030-4009 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Clinical Science Center - H4 Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01068613 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - United States, California ... More >> Advanced Clinical Research Institute, 1211 W. La Palma Ave Anaheim, California, United States, CA United States, Illinois Sneeze, Wheeze, & Itch Associates, LLC, 2010 Jacobssen Drive Normal, Illinois, United States, IL61761 United States, South Carolina Spartanburg Medical Research, 485 Simuel Road Spartanburg, South Carolina, United States, SC 29303 United States, Tennessee New Orleans Center for Clinical Research - Knoxville, 1928 Alcoa Highway Knoxville, Tennessee, United States, TN 37920 Less <<
NCT01110889 Major Depressive Disorder Phase 3 Completed - -
NCT00617851 - Completed - -
NCT01105507 Cryopyrin Associated Periodic ... More >>Syndrome Less << Phase 3 Completed - Canada ... More >> Alberta Children's Hospital, Department of Pediatrics Calgary, Canada Queen Elizabeth II Hospital Halifax, Canada Less <<
NCT01088880 Familial Mediterranean Fever Phase 2 Completed - Turkey ... More >> Istanbul Medical Faculty, Dept of Rheumatology, Capa Istanbul, Turkey Less <<
NCT01129336 First or Second Line HER2-nega... More >>tive Breast Cancer Metastatic Disease Without Bone Metastasis Less << Phase 4 Completed - -
NCT01126892 Chronic Myeloid Leukemia Phase 3 Completed - Colombia ... More >> Hospital San José, Bogotá, Colombia Bogota, Colombia Venezuela Banco Municipal de Sangre Caracas, Venezuela Less <<
NCT01098838 Advanced Solid Tumors Phase 1 Completed - United States, North Carolina ... More >> UNC/ Lineberger Comprehensive Cancer Center Dept. of LinbergerCancerCtr(2) Chapel Hill, North Carolina, United States, 27599-7295 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 United States, Tennessee Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States, 37203 Less <<
NCT01131325 CML Philadelp... More >>hia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels Less << Phase 4 Terminated - United States, Nevada ... More >> Comprehensive Cancer Centers of Nevada CCC of Nevada (1) Las Vegas, Nevada, United States, 89109 United States, Texas Cancer Center of the High Plains Amarillo, Texas, United States, 79106 Baylor Health Care System/Sammons Cancer Center Dept. of Sammons Cancer (2) Dallas, Texas, United States, 75246 Less <<
NCT01490125 - Completed - -
NCT01129336 - Completed - -
NCT01646125 Advanced Non Small Cell Lung C... More >>ancer (NSCLC) Less << Phase 2 Terminated(An interim analysis... More >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) Less << - -
NCT01693614 - Completed - -
NCT01490840 Fatigue in Multiple Sclerosis Phase 4 Terminated(The study stopped d... More >>ue to slow enrollment and low participant compliance.) Less << - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52062 Novartis Investigative Site Alzenau, Germany, 63755 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Bad Mergentheim, Germany, 97980 Novartis Investigative Site Bamberg, Germany, 96052 Novartis Investigative Site Bayreuth, Germany, 95445 Novartis Investigative Site Berlin, Germany, 10437 Novartis Investigative Site Berlin, Germany, 10625 Novartis Investigative Site Berlin, Germany, 10691 Novartis Investigative Site Berlin, Germany, 12587 Novartis Investigative Site Berlin, Germany, 13347 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44787 Novartis Investigative Site Böblingen, Germany, 71032 Novartis Investigative Site Dortmund, Germany, 44135 Novartis Investigative Site Erbach, Germany, 64711 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Frankfurt, Germany, 65929 Novartis Investigative Site Hamburg, Germany, 22179 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Kassel, Germany, 34121 Novartis Investigative Site Leipzig, Germany, 04299 Novartis Investigative Site Potsdam, Germany, 14471 Novartis Investigative Site Prien, Germany, 83209 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Siegen, Germany, 57076 Novartis Investigative Site Sinsheim, Germany, 74889 Novartis Investigative Site Stuttgart, Germany, 70174 Novartis Investigative Site Stuttgart, Germany, 70178 Novartis Investigative Site Teupitz, Germany, 15755 Novartis Investigative Site Unterhaching, Germany, 82008 Less <<
NCT01646125 - Terminated(An interim analysis... More >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) Less << - -
NCT01490840 - Terminated(The study stopped d... More >>ue to slow enrollment and low participant compliance.) Less << - -
NCT01110902 Major Depressive Disorder Phase 3 Completed - -
NCT01491932 Dyskinesias P... More >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents Less << Phase 2 Completed - -
NCT01693614 Diffuse Large B-cell Lymphoma,... More >> Mantle Cell Lymphoma, Follicular Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Nebraska University of Nebraska Medical Center Univ Nebraska Omaha, Nebraska, United States, 68198 United States, New York Memorial Sloan Kettering Dept of Onc. New York, New York, United States, 10017 United States, South Carolina Medical University of South Carolina -Hollings Cancer Center Medical Univ of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) Houston, Texas, United States, 77030 Belgium Novartis Investigative Site Brugge, Belgium, 8000 Novartis Investigative Site Yvoir, Belgium, 5530 France Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Novartis Investigative Site Rennes, France, 35019 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Wurzburg, Germany, 97080 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Korea, Republic of Novartis Investigative Site Gyeonggi-do, Korea, Korea, Republic of, 10408 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Spain Novartis Investigative Site Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Turkey Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Samsun, Turkey, 55139 Less <<
NCT01698905 Chronic Myeloid Leukemia Phase 2 Active, not recruiting February 6, 2025 -
NCT01493414 Myelofibrosis Phase 3 Completed - -
NCT01497262 Multiple Sclerosis Phase 3 Completed - Argentina ... More >> Novartis Investigative Site Caba, Buenos Aires, Argentina, 1425 Novartis Investigative Site Guaymallen, Mendoza, Argentina, M5507XAD Novartis Investigative Site San Miguel de Tucuman, Tucumán, Argentina, T4000DPB Novartis Investigative Site San Miguel de Tucumán, Tucumán, Argentina, 4000 Novartis Investigative Site Cordoba, Argentina, X5004CDT Novartis Investigative Site Salta, Argentina, A4400ANG Novartis Investigative Site Salta, Argentina, A4400BKZ Brazil Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20270-004 Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 21941-590 Novartis Investigative Site Porto Alegre, RS, Brazil, 90610-000 Colombia Novartis Investigative Site Barranquilla, Atlantico, Colombia Novartis Investigative Site Bogotá, Cundinamarca, Colombia, 110111 Novartis Investigative Site Bogotá, Colombia, 00000 Novartis Investigative Site Bogotá, Colombia Novartis Investigative Site Cali, Colombia Jordan Novartis Investigative Site Amman, Jordan, 11942 Novartis Investigative Site Irbid, Jordan, 22110 Malaysia Novartis Investigative Site Kuala Lumpur, Malaysia, 50586 Novartis Investigative Site Kuala Lumpur, Malaysia, 59100 Novartis Investigative Site Penang, Malaysia, 10990 Mexico Novartis Investigative Site Mexico, Distrito Federal, Mexico, 06700 Novartis Investigative Site México, Distrito Federal, Mexico, 10700 Novartis Investigative Site Monterrey, Nuevo León, Mexico, 64060 Novartis Investigative Site San Nicolas De Los Garza, Nuevo León, Mexico, 66480 Novartis Investigative Site San Luis Potosí, Mexico, 78240 Panama Novartis Investigative Site Panama City, Panamá, Panama Peru Novartis Investigative Site La Perla, Callao, Peru, 04 Novartis Investigative Site Jesus Maria, Lima, Peru, 11 Novartis Investigative Site San Isidro, Lima, Peru, 27 Less <<
NCT01708174 Medulloblastoma Phase 2 Completed - -
NCT01613950 Stomach Neoplasms Esophageal N... More >>eoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States, 77030-4009 Germany Novartis Investigative Site Köln, Germany, 50924 Novartis Investigative Site Würzburg, Germany, 97080 Japan Novartis Investigative Site Chuo-ku, Tokyo, Japan Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Republic of, 738-736 Switzerland Novartis Investigative Site Bellinzona, Switzerland, 6500 Taiwan Novartis Investigative Site Taipei, Taiwan, 10048 Less <<
NCT01498887 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - -
NCT01497262 - Completed - -
NCT01708174 - Completed - -
NCT01499667 Relapsing Remitting Multiple S... More >>clerosis (RRMS) Less << Phase 3 Terminated(Based on recent pub... More >>lications, determination of natalizumub washout period was no longer relevant.) Less << - -
NCT01499667 - Terminated(Based on recent pub... More >>lications, determination of natalizumub washout period was no longer relevant.) Less << - -
NCT01491529 Dyskinesias P... More >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents Less << Phase 2 Completed - -
NCT01685138 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT01713946 Tuberous Sclerosis Complex-ass... More >>ociated Refractory Seizures Less << Phase 3 Completed - -
NCT01513460 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01758380 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01713946 - Completed - -
NCT01518101 Type 2 Diabetes Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10115 Novartis Investigative Site Berlin, Germany, 13055 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Falkensee, Germany, 14612 Novartis Investigative Site Meissen, Germany, 01662 Novartis Investigative Site Neunkirchen, Germany, 57290 Novartis Investigative Site Saarlouis, Germany, 66740 Novartis Investigative Site Völlkingen, Germany, 66333 Less <<
NCT00333138 - Completed - -
NCT01514448 Metastatic Renal Cell Carcinom... More >>a (mRCC) Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Chemnitz, Germany, 09130 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hannover, Germany, 30559 Novartis Investigative Site Hof, Germany, 95028 Novartis Investigative Site Kassel, Germany, 34125 Novartis Investigative Site Langen, Germany, 63225 Novartis Investigative Site Leipzig, Germany, 04357 Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Ravensburg, Germany, 88214 Novartis Investigative Site Velbert, Germany, 42551 Novartis Investigative Site Wiesbaden, Germany, 65191 Novartis Investigative Site Wolfsburg, Germany, 38440 Less <<
NCT01514461 Familial Chylomicronemia Syndr... More >>ome (FCS) Less << Phase 3 Completed - United States, Washington ... More >> Novartis Investigative Site Seatlle, Washington, United States, 98104 Canada, Quebec Novartis Investigative Site Chicoutimi, Quebec, Canada, G7H 7P2 Novartis Investigative Site Ste-Foy, Quebec, Canada, G1V4M6 Canada Novartis Investigative Site Ouest-Montreal, Canada, H2W1R7 France Novartis Investigative Site Bron, France, 69677 Novartis Investigative Site Nantes, France, 44093 Novartis Investigative Site Paris Cedex 13, France, 75651 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Köln, Germany, 50937 Netherlands Novartis Investigative Site Meibergdreef 9, Netherlands, 1105 AZ South Africa Novartis Investigative Site Cape Town, South Africa, 7925 Spain Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M13 9NT Less <<
NCT01513460 - Completed - -
NCT01634061 Castration-resistant Prostate ... More >>Cancer Less << Phase 1 Completed - United States, California ... More >> Cedars Sinai Medical Center SC Los Angeles, California, United States, 90048 United States, New Jersey Hackensack University Medical Center Hackensack Univ Hackensack, New Jersey, United States, 07601 Belgium Novartis Investigative Site Brussels, Belgium, BE-B-1200 Novartis Investigative Site Wilrijk, Belgium, 2610 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Sutton, United Kingdom, SM2 5PT Less <<
NCT00333138 Multiple Sclerosis Phase 2 Completed - Canada ... More >> Novartis Investigational site Montreal, Canada Novartis Investigational site Ottawa, Canada Novartis Investigational site Toronto, Canada Novartis Investigational site Vancouver, Canada Denmark Novartis Investigational site Copenhagen, Denmark Finland Novartis Investigational site Helsinki, Finland Novartis Investigational site Turku, Finland France Novartis Investigational site Lille, France Novartis Investigational site Marseille, France Germany Novartis Investigational site Schwendi, Germany Novartis Investigational site Wurzburg, Germany Italy Novartis Investigational site Gallarate, Italy Novartis Investigational site Genova, Italy Novartis Investigational site Milano, Italy Novartis Investigational site Roma, Italy Poland Novartis Investigational site Warszawa, Poland Portugal Novartis Investigational site Coimbra, Portugal Novartis Investigational site Lisboa, Portugal Spain Novartis Investigational site Barcelona, Spain Novartis Investigational site Madrid, Spain Novartis Investigational site Malaga, Spain Novartis Investigational site Sevilla, Spain Novartis Investigational site Valencia, Spain Switzerland Novartis Investigational site Basel, Switzerland Novartis Investigational site Zurich, Switzerland United Kingdom Novartis Investigational site Newcastle upon Tyne, United Kingdom Less <<
NCT01519661 - Completed - -
NCT01520922 Chronic Lymphocytic Leukemia (... More >>CLL) Leukaemia, Lymphocytic, Chronic Less << Phase 2 Completed - -
NCT03400176 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 1 Recruiting October 21, 2019 United States, Ohio ... More >> Novartis Investigative Site Recruiting Columbus, Ohio, United States, 43210 United States, Tennessee Novartis Investigative Site Recruiting Nashville, Tennessee, United States, 37203 Less <<
NCT03497897 Inflammatory Acne Phase 2 Recruiting October 18, 2019 United States, Louisiana ... More >> Novartis Investigative Site Recruiting New Orleans, Louisiana, United States, 70115 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2333 CL Less <<
NCT01514461 - Completed - -
NCT01520922 - Completed - -
NCT03553823 Chronic Plaque-type Psoriasis Phase 2 Recruiting August 2, 2019 United States, South Carolina ... More >> Novartis Investigative Site Recruiting Charleston, South Carolina, United States, 29414 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Less <<
NCT00503451 Non-Hodgkin Lymphoma ... More >> Neoplasms Less << Phase 1 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Netherlands Novartis Investigative Site Rotterdam, Netherlands Less <<
NCT01514448 - Completed - -
NCT02160951 Multiple Myeloma Phase 1 Completed - Japan ... More >> Novartis Investigative Site Nagoya-city, Aichi, Japan, 467-8602 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 602-8566 Novartis Investigative Site Okayama-city, Okayama, Japan, 701-1192 Less <<
NCT01519661 Pulmonary Infections ... More >> Pseudomonas Aeruginosa in Cystic Fibrosis Less << Phase 4 Completed - -
NCT02221505 cKIT-positive Solid Tumors ... More >> AML Less << Phase 1 Terminated - Australia, Victoria ... More >> Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Less <<
NCT00383578 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... More >> Investigative Centers Nurnberg, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT02048787 Renal Impairment Phase 1 Completed - Bulgaria ... More >> Novartis Investigative Site Sofia, Bulgaria, 1612 Czech Republic Novartis Investigative Site Praha 4, Czech Republic, 140 59 Germany Novartis Investigative Site Berlin, Germany, 14050 Romania Novartis Investigative Site Bucuresti, Romania Less <<
NCT01324492 Lung Neuroendocrine Neoplasm Phase 1 Completed - China, Beijing ... More >> Novartis Investigative Site Beijing, Beijing, China, 100730 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510030 China, Jilin Novartis Investigative Site Changchun, Jilin, China China, Liaoning Novartis Investigative Site Shenyang, Liaoning, China Less <<
NCT00663169 Arthritis, Gouty Phase 2 Completed - United States, Alabama ... More >> Novartis Investigator Site Birmingham, Alabama, United States, 35249 United States, New Jersey Novartis Investigator Site New Brunswick, New Jersey, United States, 08901 Switzerland Novartis Investigator Site Lausanne, Switzerland United Kingdom Novartis Investigator Site Glasgow, United Kingdom Less <<
NCT00956410 Alzheimer Disease Phase 2 Completed - France ... More >> Novartis Investigative Site Bordeaux, France Sweden Novartis Investigative Site Stockholm, Sweden Switzerland Novartis Investigative Site Basel, Switzerland United Kingdom Novartis Investigative Site Southampton, United Kingdom Less <<
NCT00663169 - Completed - -
NCT00929968 Allergic Rhinitis Phase 2 Completed - United States, Pennsylvania ... More >> Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 Canada, Ontario Novartis Investigative Site Ottawa, Ontario, Canada Less <<
NCT02961062 Postoperative Ocular Pain Afte... More >>r PRK Surgery Less << Phase 2 Completed - United States, Maryland ... More >> Novartis Investigative Site Chevy Chase, Maryland, United States, 20815 United States, South Dakota Novartis Investigative Site Sioux Falls, South Dakota, United States, 57108 United States, Utah Novartis Investigative Site Draper, Utah, United States, 84020 United States, Virginia Novartis Investigative Site Norfolk, Virginia, United States, 23502 Less <<
NCT01124864 Non-small-cell Lung Cancer Phase 2 Completed - United States, California ... More >> University of California at Los Angeles UCLA - Santa Monica Los Angeles, California, United States, 90095 United States, Maryland Maryland Oncology Hematology, P.A. Dept. of Assoc. Onc/Hem Rockville, Maryland, United States, 20850 United States, Massachusetts Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02215 United States, Pennsylvania St. Luke's Hospital and Health Network St Luke's Bethlehem, Pennsylvania, United States Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Creteil, France, 94000 Novartis Investigative Site Marseille cedex 20, France, 13915 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Oldenburg, Germany, 26121 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 137-701 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Groningen, Netherlands, 9713 GZ Norway Novartis Investigative Site Oslo, Norway, NO-0379 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Badalona, Catalunya, Spain, 08916 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Turkey Novartis Investigative Site Izmir, Turkey, 35040 Less <<
NCT00014638 Breast Cancer Phase 4 Completed - United States, California ... More >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 Long Beach Memorial Breast Center Long Beach, California, United States, 90806 United States, Florida Cancer Research Network, Inc. Hollywood, Florida, United States, 33020 Oncology-Hematology Group of South Florida Miami, Florida, United States, 33176 Pharm Research Pinecrest, Florida, United States, 33156 Cancer Research Network Inc. Plantation, Florida, United States, 33324 Good Samaritan Medical Center West Palm Beach, Florida, United States, 33401 United States, Illinois Illinois Oncology, Ltd. Belleville, Illinois, United States, 62221 Joliet Oncology/Hematology Associates, Ltd. Joliet, Illinois, United States, 60435 Memorial Medical Center Springfield, Illinois, United States, 62781 Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Louisiana Southwest Oncology Association Lafayette, Louisiana, United States, 70503 United States, New Mexico New Mexico Oncology-Hematology Albuquerque, New Mexico, United States, 87109 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 United States, Ohio Oncology Partnership Network Cincinnati, Ohio, United States, 45238 United States, Tennessee Memphis Cancer Center Memphis, Tennessee, United States, 38119 Dial Research Associates, Inc. Nashville, Tennessee, United States, 37205 United States, Texas Center for Oncology Research and Treatment, Medical City Hospital Dallas, Texas, United States, 75230 United States, Utah Intermountain Hematology/Oncology Associates, Inc. Salt Lake City, Utah, United States, 84124 United States, Washington Cascade Cancer Center Kirkland, Washington, United States, 98034-3013 Less <<
NCT00651209 Hepatitis B, Chronic Phase 4 Completed - Argentina ... More >> Novartis Buenos Aires, Argentina Brazil Novartis Sao Paulo, Brazil Germany Novartis Frankfurt, Germany Thailand Novartis Bangkok, Thailand Less <<
NCT01912378 Autism Disorder Phase 1 Withdrawn(unable to launch the... More >> study due to lack of participation with Autism Clinic) Less << - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94118 Less <<
NCT01262586 Type II Diabetes Mellitus Phase 3 Completed - Germany ... More >> Novartis Investigative Site Mainz, Germany Less <<
NCT01269684 Kidney Transplantation Phase 4 Withdrawn(No patient has never... More >> been included in the trial) Less << - Switzerland ... More >> Novartis Investigative Site Zurich, Switzerland Less <<
NCT01124864 - Completed - -
NCT00367471 Neoplasms, Breast Phase 1 Active, not recruiting December 31, 2018 United States, California ... More >> Novartis Investigative Site La Jolla, California, United States, 92093-0987 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46202 United States, North Carolina Novartis Investigative Site Greensboro, North Carolina, United States, 27403 Less <<
NCT00170976 HYPERTENSION Phase 3 Completed - Germany ... More >> Sites in germany Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01297569 Diabetic Macular Edema Phase 4 Completed - Norway ... More >> Novartis Investigative Site Oslo, Norway, 0264 Less <<
NCT00350168 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals Corp E. Hanover, New Jersey, United States, 07936 Less <<
NCT01309698 Type 2 Diabetes Phase 4 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT02468193 Cushing's Syndrome ... More >> Ectopic Corticotropin Syndrome Adrenal Adenoma Adrenal Carcinoma AIMAH PPNAD Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Fukushima-city, Fukushima, Japan, 960-1295 Novartis Investigative Site Yokohama, Kanagawa, Japan, 245-8575 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Chiba, Japan, 260-8677 Less <<
NCT01279473 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - Japan ... More >> Novartis Investigative Site Aichi, Japan Less <<
NCT01353508 Hypertension Phase 2 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation, 117198 Less <<
NCT00742105 Cancer Solid ... More >>Tumor Advanced Solid Tumor Less << Phase 1 Terminated - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kobe-shi, Hyogo, Japan, 650-0017 Less <<
NCT00396656 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharma Ag Basel, Switzerland Less <<
NCT01356381 Type 2 Diabetes Mellitus Phase 4 Completed - United Kingdom ... More >> Novartis Investigative Site Newcastle Upon Tyne, United Kingdom, NE4 5PL Less <<
NCT00396656 - Completed - -
NCT01406977 Hypophosphatasia Phase 2 Completed - Germany ... More >> Novartis Investigative Site Wuerzburg, Germany, 97074 Less <<
NCT01407003 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Novartis Investigative Site Miami, Florida, United States, 33126 Less <<
NCT00412997 Tumors Cutane... More >>ous T-Cell Lymphoma Less << Phase 1 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT00120536 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00391690 Prostate Cancer Phase 4 Completed - Germany ... More >> Novartis Investigative Site Tuebingen, Germany Less <<
NCT00138515 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00138541 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00138580 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00448227 - Completed - -
NCT00138593 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00448227 Herpes Simplex Phase 2 Completed - United States, Alabama ... More >> Pediatric Infectious Disease Of University of Alabama Birmingham, Alabama, United States United States, Illinois Children's Memorial Hospital Chicago Chicago, Illinois, United States United States, Michigan Children's Hospital of Michigan Detroit, Michigan, United States United States, Nebraska Archana Chatterjee Omaha, Nebraska, United States, 68131 United States, Ohio University Hospital Cased Medical Center Rainbow Babies and Children's Hospital Cleveland, Ohio, United States United States, Texas UT Southwestern Medical Center Dallas, Texas, United States Less <<
NCT01442259 Mild Moderate ... More >> or Severe Renal Impairment Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Kiel, Germany Less <<
NCT00138619 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00138554 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00170924 Diastolic Dysfunction ... More >> Hypertension Less << Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00170937 METABOLIC SYNDROME ... More >> HYPERTENSION PRE-HYPERTENSION Less << Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT00170963 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00170989 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171002 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171015 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171041 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E.Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00171054 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171028 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT00171067 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171080 Hypertension Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171132 Hypertension Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171054 - Completed - -
NCT00139555 Hypertension ... More >>Left Ventricular Hypertrophy Less << Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01353508 - Completed - -
NCT00171366 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT00171106 Diastolic Dysfunction, Symptom... More >>atic Heart Failure Less << Phase 4 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171353 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171535 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00171574 Hypertension ... More >>Diabetic Nephropathy Less << Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00171093 HYPERTENSION ... More >>HYPERCHOLESTEROLEMIA Less << Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals E. Hanover, New Jersey, United States, 07936 Less <<
NCT00171769 Persistent Nonvalvular Atrial ... More >>Fibrillation Less << Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00171600 Hypertension ... More >>Early Diabetic Nephropathy Less << Phase 4 Terminated - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00219011 Heart Failure Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Germany Investigative Centers, Germany Less <<
NCT00219063 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Less <<
NCT00219076 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Germany Investigative Centers, Germany Less <<
NCT00219089 Hypertension, Diabetes Mellitu... More >>s Less << Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00219193 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00171561 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00219128 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00219310 Recurrent Genital Herpes (RGH) Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Less <<
NCT00219180 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00219024 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Germany Investigative Centers, Germany Less <<
NCT00237250 Prediabetic State Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00237263 Parkinson's Disease Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00219115 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT01474434 Coronary Artery Disease ... More >> Hypertriglyceridemia Less << Phase 2 Terminated(The study was termi... More >>nated based on interim analysis. See detailed description.) Less << - United States, California ... More >> Novartis Investigative Site Pasadena, California, United States, 91105 Less <<
NCT00219167 Hypertension Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01474434 - Terminated(The study was termi... More >>nated based on interim analysis. See detailed description.) Less << - -
NCT00996307 Influenza Phase 2 Phase 3 Completed - -
NCT00241007 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00658320 - Completed - -
NCT00333567 Pain Phase 4 Completed - Germany ... More >> Novartis Nuernberg, Germany Less <<
NCT00136799 Mixed Dyslipidemia ... More >> Hypercholesterolemia Less << Phase 3 Completed - China ... More >> Novartis Shangai, China Less <<
NCT00498303 Seasonal Influenza ... More >> Vaccine Less << Phase 3 Completed - Germany ... More >> Werksarztzentrum Herborn Herborn, Germany, 35745 Less <<
NCT00658320 Kidney Transplantation Phase 3 Completed - Japan ... More >> Novartis Pharma K.K., Japan Tokyo, Japan, 106-8618 Less <<
NCT00413049 Hypertension Phase 3 Completed - China ... More >> China-Japan Friendship Hospital Beijing, China, 100029 People's hospital affiliated Beijing University Beijing, China, 100044 The third Xiangya hospital of central south University Changsha, China, 410003 The first hospital affiliated the third military Medical University Chongqing, China, 400038 The third hospital affiliated the third military Medical University Chongqing, China, 400042 Union hospital affiliated Fujian medical University Fuzhou, China, 350001 The first hospital affiliated Fujian medical University Fuzhou, China, 350005 The second hospital affiliated Jiangxi medical school Nanchang, China, 330006 Institute of Hypertension, Ruijin Hospital Shanghai, China, 200025 Zhongshan hospital affiliated Fudan University Shanghai, China, 200032 The sixth people's hospital of Shanghai Shanghai, China, 200233 The first hospital affiliated school of medical of Xi'an Jiaotong University Xi'an, China, 710061 Less <<
NCT00413049 - Completed - -
NCT00651105 Type-2 Diabetes ... More >> Healthy Less << Phase 3 Completed - Germany ... More >> Novartis Investigator Site Bad Lauterberg im Harz, Germany Novartis Investigator Site Berlin, Germany Less <<
NCT00579345 Influenza Phase 3 Completed - Poland ... More >> 5 Krakow, Poland, 25-381 1 Krakow, Poland, 30-969 3 Krakow, Poland, 31-115 2 Krakow, Poland, 31-202 4 Krakow, Poland, 31-832 Less <<
NCT02399202 Renal Impairment Phase 1 Completed - Bulgaria ... More >> Novartis Investigative Site Sofia, Bulgaria, 1612 Germany Novartis Investigative Site Berlin, Germany, 14050 Less <<
NCT00996307 - Completed - -
NCT00579345 - Completed - -
NCT00531063 Renal Transplantation Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00645411 - Completed - -
NCT00736047 Smokers Phase 2 Completed - Germany ... More >> Novartis Investigative Site Mainz, Germany Novartis Investigator Site Neuss, Germany Less <<
NCT00531440 Renal Transplantation Phase 3 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00451412 Thromboembolism Phase 3 Completed - Germany ... More >> Novartis investigative sites Nürnberg, Germany Less <<
NCT00973349 Influenza Phase 2 Phase 3 Completed - United States, Florida ... More >> Miami Research Associates Miami, Florida, United States, 33143 United States, Kansas Johnson County Clin-Trials Lenexa, Kansas, United States, 66219 United States, Nebraska Meridien Clinical Research Omaha, Nebraska, United States, 68134 United States, New York Regional Clinical Research Endwell, New York, United States, 13760 Rochester Clinical Research, Inc Rochester, New York, United States, 14609 United States, North Carolina Triangle Medical Research Associates Cary, North Carolina, United States, 27518 Triangle Medical Research Associates Raleigh, North Carolina, United States, 27609 Carolina Medical Trials Winston-Salem, North Carolina, United States, 27103 United States, Ohio Prestige Clinical Research Franklin, Ohio, United States, 45005 United States, Oklahoma IPS Research Oklahoma City, Oklahoma, United States, 73103 United States, Pennsylvania West Ridge Family Practice (adult) Erie, Pennsylvania, United States, 16506 Primary Physicians Research Inc. (adult) Jefferson Hills, Pennsylvania, United States, 15025 United States, Rhode Island Omega Clinical Research Warwick, Rhode Island, United States, 02886 United States, Texas Research Across America Dallas, Texas, United States, 75234 West Houston Clinical Research Service Houston, Texas, United States, 77055 United States, Utah J.Lewis Research, Inc./Foothill Family Clinic Salt Lake City, Utah, United States, 84109 J. Lewis Research, Inc./Foothill Family Clinic South Salt Lake City, Utah, United States, 84121 United States, Virginia PI-Coor Clinical Research Burke, Virginia, United States, 22015 PI Coor Clinical Research Fairfax, Virginia, United States, 22030 Virginia Commonwealth University Richmond, Virginia, United States, 23219 Mexico Instituto Nacional de Ciencias Tlalpan, Mexico, 14000 Less <<
NCT00299832 Hypertension Phase 3 Completed - Japan ... More >> Novartis Pharmaceuticals Japan, Japan Less <<
NCT00645411 Influenza Phase 2 Phase 3 Completed - -
NCT00841763 Pandemic Influenza Disease Phase 3 Completed - Finland ... More >> Tampere Vaccine Research Clinic (15 sites) Tampere, Finland, 33100 Germany 12 Sites München, Germany, 80799 Less <<
NCT00848887 Influenza Phase 1 Completed - Belgium ... More >> UCL St. Luc - Pharmacy Brussel, Belgium, 1200 Less <<
NCT00841763 - Completed - -
NCT00646737 Kidney Transplantation Phase 4 Completed - Brazil ... More >> Novartis Investigative Site Sao Paulo, Brazil Less <<
NCT00446524 Hypertension Phase 3 Completed - Japan ... More >> Novartis Investigative Site Fukuoka, Japan Less <<
NCT00956761 Seasonal Influenza Phase 2 Completed - Italy ... More >> Site 2: Ufficio Igiene e Sanità Pubblica di Lanciano, ASL Lanciano - Vasto, sede legale Via S. Spaventa, 37 Lanciano, Italy, 66034 Site 3: Pianiga Distretto n. 2 - Area Sud - Azienda ULSS 13 Mirano-Via Nazionale 48 Pianiga, Italy, 30034 Less <<
NCT00035087 Colorectal Neoplasms ... More >> Colonic Neoplasms Less << Phase 2 Completed - United States, New Jersey ... More >> Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States, 08901 Less <<
NCT00973349 - Completed - -
NCT03176264 Metastatic Colorectal Cancer Phase 1 Completed - Australia, New South Wales ... More >> Novartis Investigative Site St Leonards, New South Wales, Australia, 2065 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00646503 Hepatitis B, Chronic Phase 4 Completed - China ... More >> Novartis Investigative Site Beijing, China Less <<
NCT00956761 - Completed - -
NCT01219699 Advanced Solid Tumors With an ... More >>Alteration of the PIK3CA Gene Estrogen Receptor Positive Breast Cancer Less << Phase 1 Active, not recruiting December 25, 2018 United States, California ... More >> UCSF Medical Center UCSF Mount Zion San Francisco, California, United States, 94143 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Tennessee Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(4) Nashville, Tennessee, United States, 37203 Vanderbilt Univeristy SC Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center/University of Texas MD Anderson Houston, Texas, United States, 77030-4009 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Wurzburg, Germany, 97080 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 United Kingdom Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Less <<
NCT03087942 Renal Insufficiency Phase 1 Completed - United States, Florida ... More >> Novartis Investigative Site Orlando, Florida, United States, 32809 Germany Novartis Investigative Site Grunstadt, Germany, 67269 Less <<
NCT00061763 Beta-thalassemia ... More >> Myelodysplastic Syndromes Fanconi Syndrome Anemia, Diamond-Blackfan Anemia, Aplastic Less << Phase 2 Completed - United States, California ... More >> Children's Hospital Oakland Oakland, California, United States, 94609 Stanford Hospital Stanford, California, United States, 94305-5208 United States, Illinois Northwest Medical Specialists Arlington Heights, Illinois, United States, 60004 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Less <<
NCT00452621 Encephalitis, Tick-Borne Phase 4 Completed - Germany ... More >> Center 7 Aschaffenburg, Germany, 63741 Center 2 Bobingen, Germany, 86399 Center 11 Eberbach /Neckar, Germany, 69412 Center 4 Kaufering, Germany, 86916 Center 15 Pegnitz, Germany, 91257 Center 1 Weilheim i. OB, Germany, 82362 Center 8 Wiesloch, Germany, 69168 Center 16 Zirndorf, Germany, 90513 Less <<
NCT00324025 Cryptococcal Meningitis Phase 2 Terminated - United States, Alabama ... More >> University of Alabama School of Medicine Birmingham, Alabama, United States, 35233 United States, Texas Department of Medicine/Infectious Disease, MC 7881, University of Texas Health Science Center San Antonio, Texas, United States, 78229 Less <<
NCT01452464 - Completed - United States, California ... More >> Riverside Medical Center Campus, 10800 Magnolia Ave Riverside, California, United States, 92505 San Diego Medical Center Campus, 4647 Zion Ave 92120 San Diego, California, United States, 92120 Fontana Medical Center Campus Valley Annex, 16994 E. Valley Blvd., Fontana, California, United States, 92335 Less <<
NCT00149942 Kidney Transplantation ... More >> Liver Transplantation Less << Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT01512251 BRAF Mutant Metastatic Melanom... More >>a Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less <<
NCT01512251 - Completed - -
NCT00067080 Anemia, Sickle Cell Phase 2 Completed - -
NCT00267202 Allergic Asthma Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States Less <<
NCT01709903 - Completed - -
NCT00171756 Hypertension Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00267202 - Completed - -
NCT00367315 Knee Osteoarthritis Phase 3 Completed - Germany ... More >> Novartis Nuernberg, Germany Switzerland Novartis Basel, Switzerland Less <<
NCT01709903 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT01424644 Meningococcal Meningitis Phase 4 Completed - United States, Alabama ... More >> Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615 Birmingham, Alabama, United States, 35205 United States, California Prairie Fields Family Medicine, 350 W. 23rd Street, Suite A Fremont, California, United States, 68025 Madera Family Medical Group, 1111 W. Fourth Street Madera, California, United States, 93637 United States, Colorado Clinical Research Advantage / Colorado Springs Health Partners, 6340 Barnes Road Colorado Springs, Colorado, United States, 80922 United States, Florida Dayton Clinical Research, 1100 Salem Ave Dayton, Florida, United States, 45406 Altamonte Pediatric Associates, 101 N. Country Club Rd. #113 Lake Mary, Florida, United States, 32746 United States, Georgia Pediatrics and Adolescent Medicine, 2155 Post Oak Tritt Road, Suite 100 Marietta, Georgia, United States, 30062 United States, Iowa Clinical Research Advantage / Ridge Family Physicians, 201 Ridge Street, Suite 201 Council Bluffs, Iowa, United States, 51503 United States, Maryland Columbia Medical Practice, 5450 Knoll North Drive, Suite 215 Columbia, Maryland, United States, 21045 United States, Massachusetts Roslindale Pediatrics Associates, 1153 Centre Street, Suite 31 Boston, Massachusetts, United States, 02130 United States, Nebraska Bellevue Family Practice, 2206 Longo Suite 201 Bellevue, Nebraska, United States, 68005 Complete Children's Health, 8201 Northwoods Drive Lincoln, Nebraska, United States, 68505 Meridian Clinical Research, 3319 North, 107th Street Omaha, Nebraska, United States, 68134 United States, New York Pediatrics and Adolescent Medicine, 120 Stonebridge Parkway, Suite 410 Woodstock, New York, United States, 30189 United States, North Carolina Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 Raleigh, North Carolina, United States, 27609 United States, Ohio Ohio Pediatric Research Association, 7371 Brandt Pike Suite C Huber Heights, Ohio, United States, 45424 United States, Rhode Island Omega Medical Research, 400 Bald Hill Road Warwick, Rhode Island, United States, 02886 Italy HOSPITAL"SAN MARTINO". Department of Health Sciences University of Genoa Via Pastore, 1, Genoa, Italy, 16132 Hospital "Maggiore della Carità". Pediatric Clinic Corso Mazzini, 18, Novara, Italy, 28100 Hospital of Taranto- Unit of Hygiene and Publich Health Vaccination Center Viale Magna Grecia, 173, Taranto, Italy, 74016 Less <<
NCT01593514 Meningitis Me... More >>ningococcal Disease Septicaemia Less << Phase 4 Completed - United Kingdom ... More >> Oxford Vaccine Group Oxford, Oxfordshire, United Kingdom, OX3 7LE Less <<
NCT01424644 - Completed - -
NCT00284947 Kidney Transplantation ... More >> Adverse Effects Less << Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00400647 Maintenance Kidney Transplant Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00097786 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00104104 Multiple Myeloma Phase 4 Completed - -
NCT00097786 - Completed - -
NCT00396604 Pulmonary Disease, Chronic Obs... More >>tructive COPD Lung Diseases, Obstructive Less << Phase 2 Phase 3 Completed - Belgium ... More >> Novartis Vilvoorde, Belgium Less <<
NCT03167242 Acute Uncomplicated Plasmodium... More >> Falciparum Malaria Less << Phase 2 Recruiting October 25, 2019 Burkina Faso ... More >> Novartis Investigative Site Recruiting Nanoro, Burkina Faso Gabon Novartis Investigative Site Recruiting Lambarene, Gabon Gambia Novartis Investigative Site Recruiting Banjul, Gambia, 273 Kenya Novartis Investigative Site Recruiting Kombewa, Kenya Novartis Investigative Site Recruiting Siaya, Kenya, 2300 Mali Novartis Investigative Site Recruiting Sotuba, Mali Mozambique Novartis Investigative Site Recruiting Chokwe, Mozambique Thailand Novartis Investigative Site Recruiting Ratchabari, Thailand, 70180 Novartis Investigative Site Recruiting Tak, Thailand, 63140 Uganda Novartis Investigative Site Recruiting Masaka, Uganda Novartis Investigative Site Recruiting Tororo, Uganda Vietnam Novartis Investigative Site Recruiting Binh Phuoc Province, VNM, Vietnam, 830000 Less <<
NCT00104104 - Completed - -
NCT00098059 - Completed - -
NCT03301896 Solid Tumors Phase 1 Recruiting December 20, 2021 United States, California ... More >> Novartis Investigative Site Recruiting Los Angeles, California, United States, 90095 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Belgium Novartis Investigative Site Recruiting Wilrijk, Belgium, 2610 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Japan Novartis Investigative Site Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03080 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Less <<
NCT00110617 - Completed - -
NCT00235391 Thalassemia S... More >>ickle Cell Disease Diamond Blackfan Anemia Myelofibrosis Less << Phase 3 Completed - -
NCT00110617 Sickle Cell Disease ... More >> Iron Overload Hemolytic Anemia Less << Phase 2 Completed - -
NCT00124709 - Terminated - -
NCT00124709 Atopic Dermatitis Phase 4 Terminated - -
NCT00237159 Prostate Cancer Patients With ... More >>Bone Metastasis Less << Phase 4 Completed - -
NCT00241111 Prostate Cancer With Bone Meta... More >>stasis Less << Phase 4 Completed - -
NCT00417196 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT00235391 - Completed - -
NCT00417261 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT00426218 Arthritis, Juvenile Rheumatoid Phase 1 Phase 2 Completed - Italy ... More >> Novartis Investigative site Origgio, Italy Less <<
NCT00098059 Herpes Simplex Phase 3 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233-1711 United States, Colorado The Children's Hospital Denver, Colorado, United States, 80218 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202-3830 United States, New York Columbia University Medical Center New York, New York, United States, 10032 State University of New York at Stony Brook, New York, United States, 11794-3362 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, Texas Children's Medical Center of Dallas Dallas, Texas, United States, 75235 Baylor College of Medicine/Texas Children's Hospital Houston, Texas, United States, 77030 Panama Panama Minister of Health Ciudad de David, Chiriqui, Panama Panama Minister of Health Ciudad de Panama, Panama Less <<
NCT00267150 - Completed - -
NCT00416702 Hepatic Insufficiency Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT01867021 - Completed - -
NCT00267150 Pancreas Transplantation ... More >> Kidney Transplantation Less << Phase 3 Completed - Germany ... More >> Universitätsklinikum Charité Campus Virchow Klinikum Berlin Nephrologie und Internistische Intensivmedizin Berlin, Germany, 13353 Less <<
NCT01867021 Influenza Phase 4 Completed - Czech Republic ... More >> Site 71 - Ordinace všeobecného lékaře Kbel 163, Benátky nad Jizerou, Czech Republic, 294 71 Site 70 - Vaccination and Travel Medicine Centre Poliklinika II., Bratri Stefanu 895, Hradec Kralove, Czech Republic, 500 03 Philippines Site 61 - Research Institute for Tropical Medicine DOH Compound Filinvest Corporate City, Alabang Muntinlupa City, Philippines Site 60 - De La Salle Health Sciences Institute, Room 6210 and 6206 De La Salle Angelo King Medical Research Center Congressional Road, Dasmarinas City, Cavite, Philippines, 4114 Site 63 - Our Lady of Lourdes Hospital, 46 P. Sanchez Street, Sta. Mesa, Manila, Philippines Site 62 - Research Institute for Tropical Medicine DOH Compound, Filinvest Corporate City Alabang, Muntinlupa City, Philippines South Africa Site 33 - TREAD Research , Room 41, 8th Floor, Department of Cardiology, Tygerberg Hospital, Francie van Zijl Drive Province of the Western Cape, Cape Town, South Africa, 7500 Site 43 - Allergy Diagnostic & Clinical Research Unit, UCT Lung Institute, George Street Province of the Western Cape, Cape Town, South Africa, 7700 Site 34 - Synopsis Research, Room 8, First floor, Fountain Centre, Belmont Road Rondebosch, Cape Town, South Africa, 7700 Site 41 - Tiervlei Trial Centre, Karl Bremer Hospital, c/o Mike Pienaar Boulevard & Frans Conradie Avenue, Bellville Western Cape, Cape Town, South Africa, 7530 Site 45 - 343 Randles Road Sydenham, Durban, South Africa, 4091 Site 44 - Dr B van der Berg and Associates, 162 Pretoria Road, Rynfield Benoni, Gauteng, South Africa, 1511 Site 31 - MD Search, 1 Paul Smit Street Boksburg North, Gauteng, South Africa, 1459 Site 32 - EMMED Research, Emmed Research, 641 5th Avenue Eloffsdal, Gauteng, South Africa, 0084 Site 35 - I Engelbrecht Research (Pty) Ltd, 174 Cradock Avenue Lyttleton, Gauteng, South Africa, 0157 Site 36 - Midrand Medical Centre, Shop #1, Health Emporium, Cnr Church and Market Street Midrand, Gauteng, South Africa, 1685 Site 39 - Medicross Sophiatown, Cnr Edward and Millar Streets Sophiatown, Gauteng, South Africa, 2092 Site 38 - Perinatal HIV Research Unit, New Nurses Home, Chris Hani Baragwanath Academic Hospital, Chris Hani Road Soweto, Gauteng, South Africa, 1862 Site 37 - Excellentis Clinical Trial Consultants, Suite 201, York Building, 72 York Street, George, South Africa, 6529 Site 40 - Newtown Clinical Research Centre, Suite 3, Newgate Centre, 104 Jeppe Street Newtown, Johannesburg, South Africa, 2113 Site 46 - Helderberg Clinical Trials Centre, Suite 7G&H Arun Place Sir Lowry's Pass Road, Somerset West, South Africa, 7130 Thailand Site 53 - Clinical Trials Unit, Office for Research and Development, His Majesty the King's 80th Birthday December 2007 Building, 3rd floor, room 307, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Rd. Bangkoknoi, Bangkok, Thailand, 10700 Site 52 - 1. Faculty of Medicine, Chulalongkorn University Rama 4 Rd., Pathumwan, Bangkok, Thailand, 10300 Site 52 - 2. Queen Saovabha Memorial Institute Thai Red Cross Society, Rama 4 Rd., Pathumwan, Bangkok, Thailand, 10300 Site 51 - Faculty of Medicine, Srinakharinwirot University, HRH Princess, Sirindhorn Medical Center Ongkarak, Nakhorn, Nayok, Thailand, 26120 Less <<
NCT00413413 - Completed - -
NCT00413413 Hypertension Phase 3 Completed - China ... More >> Beijing ChaoYang Hospital, Affiliate of Capital University of Medical Sciences Beijing, China, 100020 Beijing General Hospital of Beijing Military Region Beijing, China, 100700 Beijing Hospital Beijing, China, 100730 The First People's Hospital of Hangzhou Hangzhou, China, 310006 The Second Affiliated Hospital of Medical College of Zhejiang University Hangzhou, China, 310006 The First Affiliated Hospital of Medical College of Zhejiang University Hangzhou, China, 310007 Southeast University Affiliated Zhong Da Hospital Nanjing, China, 210009 The First Affiliated Hospital of Nanjing Medical University Nanjing, China, 210029 Second Military Medical University Affiliated Changzheng Hospital Shanghai, China, 200003 Department of cardiology, Ruijin hospital; Shanghai, China, 200025 Department of cardiology, Ruijin hospital Shanghai, China, 200025 Fudan University affiliated zhongshan hospital Shanghai, China, 200032 Second Military Medical University Affiliated Changhai Hospital Shanghai, China, 200433 The First Affiliated Hospital of China Medical University Shenyang, China, 110001 The people's Hospital of Liaoning Province Shenyang, China, 110016 Second Hospital of Hebei University of Medical Sciences Shijiazhuang, China, 050050 The People's Hospital of Hebei Provincial Shijiazhuang, China, 050051 The Second Affiliated Hospital of Soochow University Suzhou, China, 215004 The First Affiliated Hospital of Soochow University Suzhou, China, 215006 Less <<
NCT00171119 Hypertension ... More >>Diabetic Nephropathy Less << Phase 4 Terminated - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01148459 Malaria Phase 3 Completed - Kenya ... More >> GSK Investigational Site Kisian, Kenya GSK Investigational Site Kisumu, Kenya Less <<
NCT00513487 Allergic Rhinitis Not Applicable Completed - Australia ... More >> Novartis Investigative site Sydney, Australia Less <<
NCT00375648 Pain Phase 3 Completed - France ... More >> Novartis Investigative Site Monpellier, France Less <<
NCT00311753 Embolism Phase 3 Completed - Germany ... More >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT00412789 Tumors Phase 1 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan Less <<
NCT00405652 Liver Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigative Site Nuernberg, Germany Less <<
NCT00368277 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00368277 - Completed - -
NCT00405652 - Completed - -
NCT01325181 Chronic Central Serous Chorior... More >>etinopathy Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> • Department of Ophthalmology, Seoul National University College of Medicine Seoul, Gyeonggi-do, Korea, Republic of Less <<
NCT00267189 - Completed - -
NCT00267189 Liver Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigational Site Germany, Germany Switzerland Novartis Investigative Site Basel, Switzerland Less <<
NCT00396227 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00404820 Osteoporosis Phase 3 Completed - Germany ... More >> For site information contact Novartis Pharmaceuticals Multiple Cities, Germany Less <<
NCT01325181 - Completed - -
NCT00351884 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT00404820 - Completed - -
NCT00154297 - Completed - -
NCT00909324 Dry Eye Syndromes Phase 4 Completed - India ... More >> Novartis Investigational Site Delhi, India, 110088 Less <<
NCT00847678 Cryptococcal Meningitis Phase 2 Terminated - South Africa ... More >> Novartis Investigative Site South Africa, South Africa Less <<
NCT00939588 Hypertension Phase 2 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation Less <<
NCT00154297 Renal Transplantation Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00920933 Healthy Phase 1 Phase 2 Completed - Germany ... More >> Novartis Investigative Site Grosshansdorf, Germany Less <<
NCT00909324 - Completed - -
NCT00396357 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Novartis Investigative Site Investigative Centers, Germany Less <<
NCT00987870 Psoriasis Art... More >>hritis Less << Phase 1 Phase 2 Completed - Germany ... More >> Novartis Investigator Site Berlin, Germany Less <<
NCT00676312 Postmenopausal Osteoporosis Phase 1 Completed - Switzerland ... More >> Novartis Investigative site Basel, Switzerland Less <<
NCT00454051 - Completed - -
NCT00454051 Asthma Phase 4 Completed - France ... More >> Novartis Investigator site Rueil-Malmaison, France Less <<
NCT02852239 Renal Impairment Phase 1 Recruiting July 5, 2019 United States, California ... More >> American Institute of Research Recruiting Los Angeles, California, United States, 900017 Contact    213-481-7142       Principal Investigator: Michael Guice          United States, Florida Omega Research Consultants, LLC Recruiting DeBary, Florida, United States, 32713 Contact    386-668-4202       Principal Investigator: Banji Awosika          United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 Contact    856-753-7335       Principal Investigator: Michael Hassman          United States, North Carolina Wake Research Associates Oncology Recruiting Raleigh, North Carolina, United States, 27612 Contact    919-781-2514       Principal Investigator: Wayne L Harper Less <<
NCT00288561 Age-Related Macular Degenerati... More >>on (ARMD) Less << Phase 2 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00776009 Attention-Deficit/Hyperactivit... More >>y Disorder (ADHD) Less << Phase 4 Completed - United States, Arkansas ... More >> Clinical Study Center, LLC Little Rock, Arkansas, United States, 72205 United States, Florida Florida Clinical Research Center, LLC Bradenton, Florida, United States, 34208 Miami Research Associates South Miami, Florida, United States, 33143 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Nevada Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States, 89128 United States, Texas Bayou City Research Houston, Texas, United States, 77007 Claghorn-Lesem Research Clinic Houston, Texas, United States, 77008 Behavioral Neurology Lubbock, Texas, United States, 79423 Less <<
NCT00776009 - Completed - -
NCT00294086 Chronic Heart Failure Phase 2 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00170859 Heart Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigational Site Various Cities, Germany Less <<
NCT01156415 Major Depressive Disorder Phase 3 Terminated - -
NCT02873650 Hepatic Impairment Phase 1 Recruiting June 19, 2020 United States, California ... More >> American Institute of Research Recruiting Los Angeles, California, United States, 900017 Contact    213-481-7142       Principal Investigator: Michael Guice          United States, Florida Omega Research Consultants, LLC Recruiting DeBary, Florida, United States, 32713 Contact    386-668-4202       Principal Investigator: Banji Awosika          United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 Contact    856-753-7335       Principal Investigator: Michael Hassman          United States, North Carolina Wake Research Associates Oncology Recruiting Raleigh, North Carolina, United States, 27612 Contact    919-781-2514       Principal Investigator: Wayne L Harper Less <<
NCT01197287 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 1 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Less <<
NCT00644059 Influenza, Human Phase 3 Completed - -
NCT00636961 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - Germany ... More >> Novartis Investigator Site Berlin, Germany Novartis Investigator Site Mönchengladbach, Germany Novartis Investigator Site Wiesbaden, Germany Less <<
NCT00645346 Invasive Group B Streptococcus... More >> (GBS) Disease Less << Phase 1 Completed - Switzerland ... More >> Institute for Pharmacokinetic and Analytical Studies I.P.A.S. Ligornetto, Switzerland, 6853 Less <<
NCT00718341 Fragile X Syndrome Phase 2 Completed - France ... More >> Novartis Investigator Site Bron cedex, France, 69677 Italy Novartis Investigator Site Rome, Italy, 00168 Switzerland Novartis Investigator Site Lausanne, Switzerland, 1011 Less <<
NCT00622713 Alzheimer's Disease Phase 4 Completed - France ... More >> Novartis Investigative Site Rueil-Malmaison, France Less <<
NCT00644059 - Completed - -
NCT00332462 Liver Transplantation Phase 4 Completed - Germany ... More >> Novartis Investigational Site Various Cities, Germany Less <<
NCT00332462 - Completed - -
NCT00369278 Renal Transplantation Phase 3 Completed - Germany ... More >> Novartis Investigational Site Various Cities, Germany Less <<
NCT00636961 - Completed - -
NCT00369278 - Completed - -
NCT00372697 Acromegaly Phase 3 Completed - Italy ... More >> Novartis Investigative Site Brescia, Italy Less <<
NCT00622713 - Completed - -
NCT00372697 - Completed - -
NCT01351103 Pancreatic Cancer ... More >> BRAF Mutant Colorectal Cancer Melanoma Triple Negative Breast Cancer Head and Neck Squamous Cell Cancer Cervical Squamous Cell Cancer Esophageal Squamous Cell Cancer Lung Squamous Cell Cancer Less << Phase 1 Recruiting August 20, 2020 United States, California ... More >> Novartis Investigative Site Recruiting Los Angeles, California, United States, 90024 United States, Maryland Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287-0013 Contact: Ashley Elza O'Connor    +1 410 502 2377    aoconnor@jhmi.edu    Principal Investigator: Roisin Connolly          United States, Massachusetts Dana Farber Cancer Institute SC Withdrawn Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute SC-7 Recruiting Boston, Massachusetts, United States, 02215 Contact: Marios Giannakis, M.D., Ph.D.    617-632-6805    Marios_Giannakis@dfci.harvard.edu    Principal Investigator: Marios Giannakis, M.D., Ph.D.          United States, Michigan University of Michigan Comprehensive Cancer Center Onc Dept. Not yet recruiting Ann Arbor, Michigan, United States, 48109-0944 Contact: Cancer AnswerLine    800-865-1125       Principal Investigator: David Smith          Karmanos Cancer Institute Wayne St Recruiting Detroit, Michigan, United States, 48201 Contact: DeQuindalyn Moore    313-576-9371    moored@karmanos.org    Principal Investigator: Ulka A. Vaishampayan          United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson 2 Recruiting Houston, Texas, United States, 77030-4009 Contact: Stepanek M. Vanda    713-792-2921    vstepane@mdanderson.org    Principal Investigator: Filip P. Janku          Netherlands Novartis Investigative Site Recruiting Rotterdam, Netherlands, 3075 EA Novartis Investigative Site Recruiting Utrecht, Netherlands, 3584CX Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Novartis Investigative Site Recruiting Madrid, Spain, 28050 Less <<
NCT03623243 Multiple Sclerosis Phase 3 Not yet recruiting January 14, 2020 -
NCT00409708 - Completed - -
NCT01263808 Healthy Volunteers ... More >> Chronic Obstructive Pulmonary Disease Less << Phase 1 Completed - United States, Florida ... More >> Novartis investigative site Miami, Florida, United States, 33126 Less <<
NCT01429337 Hepatic Impairment Phase 1 Recruiting August 14, 2019 United States, Texas ... More >> Novartis Investigator site Not yet recruiting Houston, Texas, United States, 77030 Novartis Investigator site Not yet recruiting San Antonio, Texas, United States, 78215 Belgium Novartis Investigative Site Terminated Bruxelles, Belgium, 1200 Bulgaria Novartis Investigative Site Recruiting Sofia, Bulgaria, 1618 Germany Novartis Investigative Site Terminated Berlin, Germany, 14050 Novartis Investigative Site Terminated Frankfurt, Germany, 60590 Lithuania Novartis Investigator site Not yet recruiting Kaunas, Lithuania, LT-50161 Poland Novartis Investigative Site Terminated Warszawa, Poland, 02 106 Romania Novartis Investigative Site Recruiting Cluj, Napoca, Romania, 400006 Less <<
NCT00549601 - Completed - -
NCT00409708 Attention Deficit Hyperactivit... More >>y Disorder Less << Phase 2 Completed - United States, Texas ... More >> Novartis Pharmaceuticals Investigational site Houston, Texas, United States, 77007 Less <<
NCT00425308 Renal Transplantation Phase 3 Completed - France ... More >> Novartis Investigative Site Paris, France Less <<
NCT00434590 Kidney Transplantation Phase 4 Terminated(The study has been ... More >>stopped because of the lack of enrollment) Less << - Italy ... More >> Novartis Investigative Site Bologna, Italy Less <<
NCT00549601 Alzheimer's Disease Phase 4 Completed - Spain ... More >> Novartis Investigative Site Barcelona, Spain Less <<
NCT00438360 Chronic Plaque Psoriasis Phase 3 Completed - Italy ... More >> Novartis Investigative Site Bari, Italy Less <<
NCT00434590 - Terminated(The study has been ... More >>stopped because of the lack of enrollment) Less << - -
NCT00232115 Perioral Dermatitis Phase 3 Completed - Germany ... More >> Novartis Pharmaceuticals Nürnberg, Germany Less <<
NCT00425308 - Completed - -
NCT00438360 - Completed - -
NCT03650400 Asthma Phase 2 Not yet recruiting January 28, 2020 -
NCT03052517 Asthma Phase 3 Recruiting November 18, 2022 -
NCT00171548 - Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT01677741 Neoplasms, Brain Phase 1 Recruiting September 2, 2019 -
NCT00460577 Acute Bronchial Obstruction, A... More >>sthma Less << Phase 4 Completed - Venezuela ... More >> Novartis Investigator site - five sites in Caracas Caracas, Venezuela Novartis Investigator Site Maracaibo, Venezuela Less <<
NCT00277472 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT01270906 Neoplasms Can... More >>cer Tumors Less << Phase 1 Terminated - United Kingdom ... More >> Novartis Investigative Site Glasgow, United Kingdom Novartis Investigative Site Sutton, United Kingdom Less <<
NCT01089855 Neuropathic Pain Phase 4 Completed - Morocco ... More >> Novartis Investigational Site Rabat, Morocco Less <<
NCT01456611 Osteo Arthritis of the Knee Phase 3 Completed - -
NCT01200589 - Terminated(The study stopped d... More >>ue to futility.) Less << - -
NCT00149994 Liver Transplant Phase 4 Completed - Switzerland ... More >> Novartis Basel, Switzerland Less <<
NCT00284089 - Completed - -
NCT00101738 Kidney Transplantation Phase 3 Completed - -
NCT01200589 Non-Hodgkin's Lymphoma Phase 3 Terminated(The study stopped d... More >>ue to futility.) Less << - -
NCT00229138 Kidney Transplantation Phase 4 Completed - United States, New Jersey ... More >> Novartis East Hanover, New Jersey, United States, 07936 Less <<
NCT00992719 Influenza Phase 2 Completed - United States, Maryland ... More >> University of Maryland Baltimore Baltimore, Maryland, United States, 21201 United States, Missouri Saint Louis University - Center for Vaccine Development St. Louis, Missouri, United States, 63104 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232-2573 United States, Texas Baylor College of Medicine - Department of Molecular Virology and Microbiology Houston, Texas, United States, 77030 United States, Washington Group Health Cooperative Seattle, Washington, United States, 98101 Less <<
NCT00284089 Subfoveal Choroidal Neovascula... More >>rization(CNV) Secondary to Age-related Macular Degeneration (AMD) Less << Phase 1 Phase 2 Completed - Japan ... More >> Novartis Tokyo, Japan Less <<
NCT00149994 - Completed - -
NCT00310856 Meningococcal Meningitis Phase 2 Completed - Canada, Ontario ... More >> Children's Hospital of Eastern Ontario Research Institute Ottawa, Ontario, Canada, K1H 8L1 Herridge Community Health Clinic Ottawa, Ontario, Canada, K1S 0G8 Canada Clinical Trials Research Center, Department of Pediatrics, Dalhousie University, IWK Health Center Halifax, Canada, B3K 6R8 Less <<
NCT00460577 - Completed - -
NCT00601731 Meningococcal Disease Phase 2 Completed - Canada ... More >> Clinical Trials Research Center Halifax, Canada Vaccine Evaluation Center Vancouver, Canada United Kingdom Oxford Vaccine Group Oxford, United Kingdom, OX3 7LJ Less <<
NCT00601731 - Completed - -
NCT01410474 Bacterial Meningitis Phase 3 Completed - China, Taiwan ... More >> Mackay Memorial Hospital, Taipei, Taiwan, China, 10002 National Taiwan University Hospital Taipei, Taiwan, China, 10002 Far Eastern Memorial Hospital, Taipei, Taiwan, China, 22060 Less <<
NCT00992719 - Completed - -
NCT00310856 - Completed - -
NCT01018732 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 2 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United States, Washington Seattle, Washington, United States Less <<
NCT01547715 - Completed - -
NCT01410474 - Completed - -
NCT01163240 - Completed - -
NCT01547715 Bacterial Meningitis Phase 3 Completed - India ... More >> Osmania Medical College Ethics Commitee, Niloufer Hospital Hyderabad, Andrapradesh, India, 500004 Bharati Vidyapeeth University Institutional Ethics Commitee Katraj, Dhankawadi, India, 411043 Padmasree Dr. D.Y Patil medical College Pune, Maharashtra, India, 411018 Seth GS Medical College and KEM Hospital Mumbai, Maharastra, India, 400012 Less <<
NCT00559975 Influenza Infection Phase 1 Completed - Switzerland ... More >> Institute for Pharmacokinetic and Analytical Studies Ligornetto, Switzerland, 6853 Less <<
NCT01453348 - Completed - -
NCT01018732 - Completed - -
NCT01453348 Meningococcal Disease ... More >> Meningococcal Meningitis Hepatitis A Hepatitis B Less << Phase 3 Completed - Germany ... More >> 03, Novartis Investigational Site Berlin, Germany, 10117 02, Novartis Investigational Site Hamburg, Germany, 20359 01, Novartis Investigational Site München, Germany, 80802 04, Novartis Investigational Site Rostock, Germany, 18057 Less <<
NCT00464672 Influenza Phase 3 Completed - Argentina ... More >> Site 2: C1425AWK Buenos Aires, Argentina Site 1: X5000BJH Cordoba, Argentina Less <<
NCT00464672 - Completed - -
NCT01148017 Meningococcal Meningitis Phase 3 Completed - United States, Alabama ... More >> Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615 Birmingham, Alabama, United States, 35205 United States, California Premier Health Research 9317 Firestone Blvd. Downey, California, United States, 90241 Kaiser Permanente Oakland 3505 Broadway, 6th Floor, Room 624 Oakland, California, United States, 94611 Center for Clinical Trials, LLC 16415 S. Colorado Ave., Suite 308 Paramount, California, United States, 90723 Center for Clinical Trials, LLC 16660 Paramount Blvd., Suite 301 Paramount, California, United States, 90723 Kaiser Permanente Pleasanton 7601 Stoneridge Drive, Second Floor Pleasanton, California, United States, 94588 Kaiser Permanente San Francisco 2200 O'Farrell St., Sixth Floor San Francisco, California, United States, 94115 Kaiser Permanente Santa Clara 710 Lawrence Expressway, Pediatric Clinic Department Santa Clara, California, United States, 95051 United States, Illinois Children's Memorial Hospital 2300 Children's Plaza, Box 155 Chicago, Illinois, United States, 60614 United States, Kentucky Kentucky Pediatric/Adult Research 201 South Fifth Street, Suite 102 Bardstown, Kentucky, United States, 40004 United States, Maryland 28 Annapolis Pediatrics, 200 Forbes Street, Suite 200 Annapolis, Maryland, United States, 21401 United States, Ohio Senders Pediatrics 2054 South Green Road Cleveland, Ohio, United States, 44121 United States, Pennsylvania Pediatric Medical Associates 160 West Germantown Pike Suite D2 East Norriton, Pennsylvania, United States, 19402 Children's Health Care 2501 West 12th Street Erie, Pennsylvania, United States, 16505 Pennridge Pediatric Associates 270 Main Street Harleysville, Pennsylvania, United States, 19438 Kid's Way Pediatrics 3068 Innovation Way Hermitage, Pennsylvania, United States, 16148 Pediatric Medical Associates 1077 Rydal Road Suite 300 Rydal, Pennsylvania, United States, 19046 Pennridge Pediatric Associates 711 Lawn Avenue Sellersville, Pennsylvania, United States, 18960 PEAK Research 2859 Washington Rd., Ste. 412B Upper Saint Clair, Pennsylvania, United States, 15241 Less <<
NCT01311505 Tuberculosis Phase 1 Completed - Philippines ... More >> Pfizer Investigational Site Dasmariñas City, Philippines, 4114 Less <<
NCT01885611 Hansen's Disease Phase 1 Phase 2 Withdrawn(There was a problem ... More >>with funding and with the acquisition of the lab assays) Less << June 2018 Philippines ... More >> Philippine General Hospital Manila, Philippines, 1000 Less <<
NCT01148017 - Completed - -
NCT01682876 Meningococcal Disease Phase 3 Completed - United States, Alabama ... More >> Site 12 - Alabama Clinical Therapeutics, LLC 52 Medical Park East Drive, Suite 203 Birmingham, Alabama, United States, 35235 United States, California Site 13 - Benchmark Research,1355 Florin Road, Suite 10 Sacramento, California, United States, 95822 United States, Florida Site 5 - Altamonte Pediatric Associates 101 N Country Club Rd, Suite 115 Lake Mary, Florida, United States, 32746 United States, Georgia Site 10 - Pediatrics and Adolescent Medicine 2155 Post Oak Tritt Rd, Suite 100 Marietta, Georgia, United States, 30062 Site 11 - Pediatrics and Adolescent Medicine 120 Stonebridge Parkway, Suite 410 Woodstock, Georgia, United States, 30189 United States, Indiana Site 4 - Bluegrass Clinical Research, Inc. New Albany, Indiana, United States, 46298 United States, Iowa Site 16 - Ridge Family Practice, 201 Ridge Street, Suite 201 Council Bluffs, Iowa, United States, 51503 United States, Kentucky Site 3 - Brownboro Park Pediatrics. 5512 Bardstown Rd, Suite 2 Louisville, Kentucky, United States, 40291 United States, Louisiana Site 15 - Benchmark Research, 3800 Houma Blvd., Suite 345 Metaire, Louisiana, United States, 70006 United States, Michigan Site 2 - Southwestern Medical Clinic Niles, Michigan, United States, 49120 Site 7 - Southwestern Medical Clinic, Lakeland HealthCare Affiliate Stevensville, Michigan, United States, 49127 United States, Nebraska Site 18 - Bellevue Family Practice/Clinical Research Advantage 2206 Longo, Suite 201 Bellevue, Nebraska, United States, 68005 Site 6 - Meridian Clinical Research, Meridian Clinical Research 1103 Galvin Road South #G Bellevue, Nebraska, United States, 68005 Site 17 - Prairie Fields Family Medicine/Clinical Research Advantage, Inc., 350 W. 23rd Street, Suite A Fremont, Nebraska, United States, 68025 Site 24 - Pediatric Partners 750 East 29th St. Fremont, Nebraska, United States, 68025 Site 1 - Meridian Clinical Research Omaha, Nebraska, United States, 68134 United States, New York Site 14 - United Medical Associates, PC., 4417 Vestal Parkway East Vestal, New York, United States, 13850 United States, Ohio Site 23 - Rapid Medical Research, Inc., 3619 Park East Dr., Suite 300 Cleveland, Ohio, United States, 44122 Site 19 - Senders Pediatrics 2054 South Green Road South Euclid, Ohio, United States, 44121 United States, Texas Site 8 - Benchmark Research, 1015 E 32nd Street, Suite 303 Austin, Texas, United States, 78705 Site 9 - Benchmark Research, 4504 Boat Club Rd., Suite 400A Ft. Worth, Texas, United States, 76135 United States, Utah Site 20 - Advanced Clinical Research, 3590 West 9000 South, Suite 300 West Jordan, Utah, United States, 84088 Less <<
NCT01311505 - Completed - -
NCT01725217 Meningococcal Disease Phase 3 Completed - Russian Federation ... More >> Federal State Budgetary Institution 'State Scientific Center 'Institution of Immunology' of the Russian Federal Biomedical Agency' Kashirskoye highway, Moscow, Russian Federation, 115478 Institution of the Russian Academy of Sciences "Scientific Center for Children Health RAMS" Lomonosovskiy avenue, Moscow, Russian Federation, 119991 Federal Budgetary Institution of Science 'St-Petersburg Scientific-Research Institution of Epidemiology and Microbiology by name of Pasteur' Mira street, St-Petersburg, Russian Federation, 197101 Federal State Institution 'Scientific-Research Institution of Children's Infections of the Russian Federal Biomedical Agency' Prof.Popova street, St-Petersburg, Russian Federation, 197022 Less <<
NCT01682876 - Completed - -
NCT01139021 Meningococcal Disease Phase 3 Completed - Czech Republic ... More >> amostatná ordinace praktického lékaře pro děti a dorost Jindřichův Hradec Hradec, Czech Republic Dětské oddělení nemocnice Náchod Náchod, Czech Republic Dětské oddělení nemocnice Pardubice Pardubice, Czech Republic Finland University of Tampere Medical School, Vaccine Research Center Tampere Biokatu 10, Tampere, Finland, 33520 Espoo Vaccine Research Clinic, Espoo, Finland Helsinki East, Vaccine Research Clinic, Helsinki, Finland Helsinki South, Vaccine Research Clinic, Helsinki, Finland Järvenpää, Vaccine Research Clinic Järvenpää, Finland Kokkola Vaccine Research Clinic Kokkola, Finland Kotka Vaccine Research Clinic Kotka, Finland Kuopio Vaccine Research Clinic Kuopio, Finland Lahti Vaccine Research Clinic Lahti, Finland Oulu Vaccine Research Clinic Oulu, Finland Pori Vaccine Research Clinic Pori, Finland Seinäjoki Vaccine Research Clinic Seinäjoki, Finland Tampere Vaccine Research Clinic Tampere, Finland Turku Vaccine Research Clinic Turku, Finland Vantaa East, Vaccine Research Clinic Vantaa, Finland Vantaa West, Vaccine Research Clinic Vantaa, Finland Less <<
NCT00856297 Meningococcal Meningitis Phase 3 Completed - United States, Alabama ... More >> 37, 50 Birmingham Pediatric Associates 806 Saint Vincent's Drive, Suite 615 Birmingham, Alabama, United States, 35205 United States, California 6 Kaiser Permanente Fremont 39400 Paseo Padre Parkway Fremont, California, United States, 94538 7 Kaiser Permanente Fresno 4785 North First Street, 3rd Floor Fresno, California, United States, 93726 8 Kaiser Permanente Hayward 27303 Sleepy Hollow Ave., 1st Floor, MOB Hayward, California, United States, 94545 Admin Kaiser Permanente Vaccine Study Center One Kaiser Plaza, Ordway Building - 16th Floor Oakland, California, United States, 94612 9 Kaiser Permanente Roseville 1840 Sierra Gardens Drive, Vaccine Studies Roseville, California, United States, 95661 11 Kaiser Permanente Sacramento 6600 Bruceville Rd., Pediatric Station C Sacramento, California, United States, 95823 Kaiser Permanente, 6600 Bruceville Rd. Sacramento, California, United States, 95823 10 Kaiser Permanente San Jose 276 International Circle, Family Health Center, Unit B1 San Jose, California, United States, 95119 United States, Georgia 2 PAMPA 2155 Post Oak Tritt Road, Suite 100 Marietta, Georgia, United States, 30062 3 PAMPA 120 Stonebridge Parkway Ste. 410 Woodstock, Georgia, United States, 30189 United States, Kentucky 53 Pediatric/Adult Research Inc. 201 South Fifth Street, Suite 102 Bardstown, Kentucky, United States, 40004 United States, Ohio 38 Akron Children's Hospital One Perkins Square Akron, Ohio, United States, 44308 43 Dr. Senders and Associates 2054 South Green Road South Euclid, Ohio, United States, 44121 United States, Pennsylvania 19 Children's Health Care West 4671 West Lake Road Erie, Pennsylvania, United States, 16505 21 Greenville Medical Centre Inc 90 Shenango Street Greenville, Pennsylvania, United States, 16125 24 (seen at site 21) Family Healthcare Partners 420 Hillcrest Avenue Grove City, Pennsylvania, United States, 16127 23 Pediatric Associates of Latrobe 210 Weldon Street Latrobe, Pennsylvania, United States, 15650 14 Squirrel Hill Office 4070 Beechwood Blvd Pittsburgh, Pennsylvania, United States, 15217 16 Pediatric Alliance Greentree Division 969 Greentree Road Suite 100 Pittsburgh, Pennsylvania, United States, 15220 15 South Hills Pediatrics 4411 Stilley Road Pittsburgh, Pennsylvania, United States, 15227 13 Pediatric Alliance Southwestern 850 Clairton Blvd. Pittsburgh, Pennsylvania, United States, 15236 20 Pediatric Alliance Arcadia Division 9000 Perry Highway Suite 120 Pittsburgh, Pennsylvania, United States, 15237 12 & 18 Primary Physicians Research, Inc. 1580 McLaughlin Run Road Pittsburgh, Pennsylvania, United States, 15241 Admin Primary Physicians Research, Inc. 1580 McLaughlin Run Road Pittsburgh, Pennsylvania, United States, 15241 35 Pennridge Pediatric Associates 711 Lawn Avenue Sellersville, Pennsylvania, United States, 18960 22 Laurel Pediatrics 140 Wayland Smith Drive Uniontown, Pennsylvania, United States, 15401 25 Family Practice Medical Associates South 2581 Washington Road Suite 211 Upper Saint Clair, Pennsylvania, United States, 15241 PEAK Research, LLC, 2589 Washington Road, Suite 412B Upper Saint Clair, Pennsylvania, United States United States, Texas 47 UTMB Galveston Office of Pediatric Clinical Trials Children's Hospital 301 University Blvd., Rm 1 288H Galveston, Texas, United States, 77555 United States, Utah 56 J. Lewis Research, Inc/Foothill Family Clinic South 6360 South 3000 East, Suite 100 Salt Lake City, Utah, United States, 84121 United States, Washington 45 Group Health Research Institute 1730 Minor Ave, Suite 1600 Seattle, Washington, United States, 98101 Less <<
NCT03340506 Melanoma Non ... More >>Small Cell Lung Cancer Solid Tumor Rare Cancers High Grade Glioma Less << Phase 4 Recruiting July 17, 2023 United States, Arizona ... More >> Honor Health Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Kristina Will    623-238-7671    Kristina.Will@honorhealth.com    Principal Investigator: Michael Gordon          United States, Ohio James Cancer Hospital & Solove Research Institute-Ohio State Recruiting Columbus, Ohio, United States, 43210 Contact: Tomasina Wall    614-366-7421    Tomasina.Wall@osumc.edu    Principal Investigator: Kari L. Kendra          United States, Texas Mary Crowley Research Center Recruiting Dallas, Texas, United States, 75251 Contact: Christy Lacy    214-658-1941    clacy@marycrowley.org    Principal Investigator: Minal Barve          France Novartis Investigative Site Recruiting Paris, France, 75970 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Madrid, Spain, 28040 Novartis Investigative Site Recruiting Madrid, Spain, 28050 Less <<
NCT01027351 Meningococcal Disease Phase 2 Completed - United Kingdom ... More >> Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, United Kingdom, OX3 7LJ Less <<
NCT01139021 - Completed - -
NCT01026974 Meningococcal Disease Phase 2 Completed - United Kingdom ... More >> Oxford Vaccine Group, Center for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, United Kingdom, OX3 7LJ Less <<
NCT00856297 - Completed - -
NCT01027351 - Completed - -
NCT01725217 - Completed - -
NCT01423084 - Completed - -
NCT01026974 - Completed - -
NCT02519010 Healthy Phase 1 Completed - Egypt ... More >> Genuine Research Center GRC Cairo, Egypt Less <<
NCT01423084 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 3 Completed - Australia, Queensland ... More >> Royal Children's Hospital Herston, Queensland, Australia, 4029 AusTrials Pty Ltd-Suites 6, 10 & 11, Peninsula Specialist Centre Kippa-Ring, Queensland, Australia, 4021 AusTrials Pty Ltd-Suite 5, Level 1, 14 Primrose Street Sherwood, Queensland, Australia, 4075 Australia, South Australia Women's and Children's Hospital, 72 King William Road North Adelaide, South Australia, Australia, 5006 Australia, Victoria Murdoch Children's Research Institute-Level 5, 207 Bouverie St-University of Melbourne Melbourne, Victoria, Australia, 3010 Australia, Western Australia Telethon Institute for Child Heath Research-cnr Hamilton Street and Roberts Road-Subiaco, Western Australia, Australia, 6008 Canada, British Columbia TASC Research Services, 1-15243 91st Avenue Surrey, British Columbia, Canada, V3R 8P8 Canada, Nova Scotia Colchester Regional Hospital Colchester Research Group, 68 Robie Street Truro, Nova Scotia, Canada, B2N 1L2 Canada, Ontario Albion Finch Medical Centre, 1620 Albion Road, Suite 106 Etobicoke, Ontario, Canada, M9V 4B4 Medicor Research Inc, 359 Riverside, Suite 200 Sudbury, Ontario, Canada, P3E 1H5 SKDS Research Inc, 221-679 Davis Dr.Newmarket Toronto, Ontario, Canada, L3Y 5G8 Dr. Hartley Garfield Medicine Professional Corporation, 790 Bay Street, Suite 540 Toronto, Ontario, Canada, M5G 1N8 Devonshire Clinical Research INC, 423 Devonshire Ave., Suite 301 Woodstock, Ontario, Canada, N4S 5P5 Less <<
NCT00262041 Prevention of Meningococcal Di... More >>sease Less << Phase 2 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States, 55905 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15241 United States, Washington Seattle, Washington, United States, 98101 Less <<
NCT02816970 Healthy Phase 1 Completed - Egypt ... More >> Genuine Research Center GRC Cairo, Egypt, 11757 Less <<
NCT00262041 - Completed - -
NCT01705379 - Withdrawn April 2016 -
NCT02386800 Splenomegaly Phase 4 Recruiting September 17, 2020 -
NCT00387634 Tick Born Encephalitis Phase 4 Completed - Czech Republic ... More >> Hradec Kralove, Czech Republic, 500 03 Less <<
NCT02479867 Healthy Phase 1 Completed - Egypt ... More >> Genuine Research Center GRC Cairo, Egypt Less <<
NCT03757338 Healthy Volunteers Phase 1 Completed - New Zealand ... More >> Zenith Clinical Site Dunedin, New Zealand, 9010 Less <<
NCT00667602 Meningococcal Meningitis Phase 3 Completed - Germany ... More >> Site 22 Bad Kreuznach, Germany, 55543 Site 38 Bad Lobenstein, Germany, 07356 Site 24 Balve, Germany, 58802 Site 3 Berlin, Germany, 12589 Site 27 Berlin, Germany, 12619 Site 20 Berlin, Germany, 12627 Site 26 Berlin, Germany, 12627 Site 13 Berlin, Germany, 13189 Site 31 Berlin, Germany, 13189 Site 25 Berlin, Germany, 13347 Site 15 Bönnigheim, Germany, 74357 Site 39 Eschwege, Germany, 37269 Site 32 Flensburg, Germany, 24937 Site 16 Frankenthal, Germany, 67227 Site 33 Glücksburg, Germany, 24960 Site 35 Hamburg, Germany, 22147 Site 2 Kehl, Germany, 77694 Site 28 Mainz, Germany, 55127 Site 44 Mainz, Germany, 55131 Site 43 München-Ramersdorf, Germany, 81669 Site 42 Neuhaus am Rennweg, Germany, 98724 Site 21 Neumünster, Germany, 24534 Site 9 Neumünster, Germany, 24534 Site 10 Oberstenfeld, Germany, 71720 Site 4 Stuttgart, Germany, 70193 Site 19 Stuttgart, Germany, 70469 Site 30 Weilheim i OB, Germany, 82362 Site 6 Wiesloch, Germany, 69168 Less <<
NCT01339923 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 3 Completed - Brazil ... More >> Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP) Rua dos Coelhos, 300 - Boa Vista, Recife/PE, Brazil, 50070-550 Site 54- Associação Obras Sociais Irmã Dulce, Avenida Bonfim, nº 161 Largo de Roma, Salvador/BA-CEP, Brazil, 40420-000 Site 53 - CRIE UNIFESP Rua Borges Lagoa 770, Sao Paulo, Brazil, 04038002 Site 50 - Associacao Fundo de Incentivo a Psicofarmacologia Rua Marselhesa 500 Vila Clementino, Sao Paulo, Brazil, 04020-060 Hungary Site 37 - Praxis Dr Julianna Kovacs Honved utca 2, Bordany, Hungary, 6795 Site 40 - General Pediatric Practice Hacsek Poth Iren u 80, Budapest, Hungary Site 42 - Praxis Dr Eszter Bari Szentharomsag ter 10, Csongrad, Hungary, 6640 Site 34 - General Pediatric Practice Somorjai Bajcsi ut 32, Debrecen, Hungary, 4025 Site 32 - Praxis Dr Eleonora Konya Fo utca 12, Malyi, Hungary, 3434 Site 31 - General Practice Dr Olga Fekete Kando Kalman utca 1, Miskolc, Hungary, 3534 Site 30 - General Practice Dr Simko Selyemret u. 1., Miskolc, Hungary, 3527 Site 33 - General Pediatric Practice Ujhelyi Szent Istvan u 10, Nyiregyhaza, Hungary, 4400 Site 35 - Praxis Dr Eva Kovacs Csongradi sgt 63, Szeged, Hungary, 6723 Site 36 - General Practice Dr Edit Oszlacs Debreceni utca 10-14, Szeged, Hungary, 6723 Peru Site 80 - Hospital Nacional docente Madre Nino San Bartolome Av Alfonso Ugarte, Lima, Peru Site 82 - Investigaciones Medicas en Salud INMENSA Jr Jose de la Torre Ugarte Lince, Lima, Peru Site 81 - Via Libre Jr Paraguay Cercado de Lima, Lima, Peru Spain Site 15 Almeria, Spain, 04007 Site 16 Almeria, Spain, 04120 Site 20 Barcelona, Spain, 08195 Site 17 Madrid, Spain, 28041 Site 18 Madrid, Spain, 28935 Site 11 Ourense, Spain, 32005 Site 13 Pontevedra, Spain, 36002 Site 10 Santiago de Compostela, Spain, 15706 Site 14 Sevilla, Spain, 41014 Less <<
NCT01994629 Meningococcal Disease Phase 2 Completed - Italy ... More >> Dipartimento di Prevenzione S C Igiene e Sanita Pubblica Chiavari, ASL4 Chiavarese Regione Liguria Corso Dante 163, Italy, 16043 Ospedale Maggiore della Carita Novara, Corso Mazzini 18, Italy, 28100 ASL Sassari 1 Servizio Igiene Pubblica Sassari, Via Amendola 55, Italy, 07100 AOU Meyer Dip Scienze per la Salute della Donna e Bambino Firenze, Viale Pieraccini 24, Italy, 50139 Less <<
NCT01542866 Age Related Macular Degenerati... More >>on (AMD) Less << Not Applicable Completed - -
NCT00667602 - Completed - -
NCT01994629 - Completed - -
NCT01339923 - Completed - -
NCT01345721 Meningococcal Disease Phase 3 Completed - Germany ... More >> Dr. Johannes Kandzora and Dr. Kathrin Kandzora Am Teich 11, Neumuenster, Germany, 24534 Bogda-Maria Kniese, Boyneburgstr 7, Eschwege, Germany, 37269 Dr Goertz Martin Kimmig GroBbottwarer Str 47, Oberstenfeld, Germany, 71720 Dr med Walter Otto Heinrichstrasse 16 A, Fulda, Germany, 36037 Dr med Kerstin Pscherer Hellersdorfer Str 237, Berlin, Germany, 12627 Dr Renate Mangelsdorf-Taxis Kirchstrasse 2, Bonnigheim, Germany, 74357 Dr. Christoph Wittermann Murnauer Str 3, Weilheim, Germany, 82362 Ute Jessat Rathausstr 6, Gluecksburg, Germany, 24960 Dr med Luise Schroeter Schoenwalder Str 28, Berlin, Germany, 13347 Dr med Ulrich Pfletschinger Stuttgarter Strasse 74, Stuttgart Feuerbach, Germany, 70469 Dr Lothar Maurer Welschgasse 39, Frankenthal, Germany, 67227 Less <<
NCT00262002 - Completed - -
NCT01345721 - Completed - -
NCT00414947 Healthy Phase 1 Completed - China ... More >> Novartis Investigative Site Beijing, China Less <<
NCT01274897 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 3 Completed - Korea, Republic of ... More >> Department of Pediatrics, Kosin University Gospel Hospital Busan, Korea, Republic of Department of Pediatrics, Seoul National University Bundang Hospital Gyeonggi-do, Korea, Republic of Deaprtment of Pediatrics, Inha University Hospital Incheon, Korea, Republic of Division of Infectious Diseases, Inha University Hospital Incheon, Korea, Republic of Pediatrics and Adolescent medicine, Myongji Hospital Kwandong University Kyunggi, Korea, Republic of Department of Pediatrics, Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Division of Infection Diseases, Seoul National University Hospital Seoul, Korea, Republic of Division of Infectious Diseases, Korea University Guro Hospital Seoul, Korea, Republic of Less <<
NCT00310817 - Completed - -
NCT00262002 Prevention of Meningococcal Di... More >>sease Less << Phase 2 Completed - Canada, British Columbia ... More >> Vaccine Evaluation Center Vancouver, British Columbia, Canada Canada, Nova Scotia Clinical Trial Research Center Halifax, Nova Scotia, Canada United Kingdom Oxford Vaccine Group Oxford, United Kingdom Less <<
NCT00806195 Meningitis Me... More >>ningococcal Infection Less << Phase 3 Completed - -
NCT01911221 - Completed - -
NCT01274897 - Completed - -
NCT00310817 Meningococcal Meningitis Phase 2 Completed - Finland ... More >> University of Tampere Medical School Tampere, Finland Poland Oddz. Neuroinfekcji, Szpital Jana Pawla II, Krakow Samodzielny ZOZ, Lubartów, Poland Less <<
NCT01478347 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 3 Completed - Italy ... More >> UOC Medicina Interna 2, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 Less <<
NCT02141516 Meningococcal Disease Phase 3 Completed - Italy ... More >> 12, Novartis Investigational Site Firenze, Italy, 50139 11, Novartis Investigational Site Genova, Italy, 16132 10, Novartis Investigational Site Milano, Italy, 20122 14, Novartis Investigational Site Padova, Italy, 35128 13, Novartis Investigational Site Roma, Italy, 00165 Poland 31, Novartis Investigational Site Krakow, Poland, 31-302 33, Novartis Investigational Site Warszawa, Poland, 04-730 30, Novartis Investigational Site Wroclaw, Poland, 50-345 Russian Federation 42, Novartis Investigational Site Moscow, Russian Federation, 117198 41, Novartis Investigational Site Moscow, Russian Federation, 117997 43, Novartis Investigational Site Yekaterinburg, Russian Federation, 620149 Spain 21, Novartis Investigational Site Barcelona, Spain, 08035 22, Novartis Investigational Site Madrid, Spain, 28046 23, Novartis Investigational Site Madrid, Spain, 46026 20, Novartis Investigational Site Santiago De Compostela, Spain, 15706 24, Novartis Investigational Site Valencia, Spain, 46026 United Kingdom 53, Novartis Investigational Site London, United Kingdom, WC1N 3JH 52, Novartis Investigational Site Manchester, United Kingdom, M13 9WL 50, Novartis Investigational Site Oxford, United Kingdom, OX3 7LE 51, Novartis Investigational Site Southampton, United Kingdom, SO16 6YD Less <<
NCT00806195 - Completed - -
NCT02141516 - Completed - -
NCT03606408 Cushing's Syndrome Phase 2 Recruiting October 24, 2023 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 0944 Contact: Benjamin Bailey    734-615-8914    bebailey@med.umich.edu    Principal Investigator: Richard Auchus          Austria Novartis Investigative Site Recruiting Vienna, Austria, A-1090 Italy Novartis Investigative Site Recruiting Napoli, Italy, 80131 Japan Novartis Investigative Site Recruiting Nagoya, Aichi, Japan, 460-0001 Novartis Investigative Site Recruiting Nishinomiya city, Hyogo, Japan, 663 8501 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Gyeonggi-do, Korea, Republic of, 110744 Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03722 Less <<
NCT01911221 Prevention of the Meningococca... More >>l Disease Less << Phase 3 Completed - Germany ... More >> Novartis site Marburg, Germany, 35037 Less <<
NCT02584933 ALK Positive Malignancies Phase 4 Recruiting December 14, 2020 -
NCT00474526 Meningitis, Meningococcal Phase 3 Completed - -
NCT01478347 - Completed - -
NCT00661713 Meningococcal Disease Phase 2 Phase 3 Completed - Chile ... More >> Site 13: Liceo Diego Aracena de Lo Barnechea Monseñor Escrivá de Balaguer 14630, Lo Barnechea, Santiago, Chile Site 41: Colegio Antonio Hermida Fabres Av. Coronel Alejandro Sepúlveda n° 6801, Chile Site 43: Liceo José Victorino Lastarria Av. Miguel Claro n° 32, Chile Site 51: Centro Para vacunas en Desarrollo. Hospital de Niños Roberto del Rio Av. Prof Zañartu 1085, Chile Site 15: Liceo Carmela Carvajal de Prat Avda. Italia 980, Chile Site 14: Colegio Parroquial Santa Rosa de Lo Barnechea Avda. Raúl Labbé Nº 13.799, Chile Site 42: Centro Educacional Eduardo de la Barra Calle A, n° 6301, Chile Site 61: Facultad de Medicina. Universidad de Valparaíso. Hontaneda # 2653. Valparaíso, Chile Site 11: Complejo Educacional Eduardo Cuevas Valdés Lo Barnechea, Chile Site 12: Colegio San Jose de Lo Barnechea Santiago, Chile Less <<
NCT00657709 Serogroup B Meningococcal Meni... More >>ngitis Less << Phase 3 Completed - -
NCT00847145 - Completed - -
NCT00474526 - Completed - -
NCT00626327 Meningococcal Infections Phase 3 Completed - -
NCT02116803 Solid Tumors Phase 2 Phase 3 Completed - United States, Nevada ... More >> Novartis Investigative Site Las Vegas, Nevada, United States, 89169 United States, New York Novartis Investigative Site Bronx, New York, United States, 10467-2490 Austria Novartis Investigative Site Salzburg, Austria, 5020 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 Italy Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Torino, TO, Italy, 10153 Japan Novartis Investigative Site Osaka-city, Osaka, Japan, 545-8586 Spain Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 Less <<
NCT00657709 - Completed - -
NCT00661713 - Completed - -
NCT01214850 N. Meningitidis Carriage Phase 3 Completed - United Kingdom ... More >> Clinical Research Center, University of Surrey Surrey, England, United Kingdom Bristol Children's Vaccine Center, University of Bristol, Bristol, England, United Kingdom Royal Liverpool and Broad Green University Hospital Trust Liverpool, England, United Kingdom St Georges Vaccine Institute, St Georges, University of London London, England, United Kingdom Manchester Welcome Trust Clinical Research Facility, University of Manchester Manchester, England, United Kingdom The James Cook University Hospital Middlesbrough, England, United Kingdom Cripps Health Centre, University Park Nottingham, England, United Kingdom University of Oxford, Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine Oxford, England, United Kingdom Clinical Research Facility, Royal Hallamshire Hospital Sheffield, England, United Kingdom Wellcome Trust Clinical Research Facility, University of Southampton Southampton, England, United Kingdom Less <<
NCT02116803 - Completed - -
NCT03040973 Advanced Solid Tumors Which Ar... More >>e cMET-dependent Less << Phase 4 Recruiting May 20, 2019 Denmark ... More >> Novartis Investigative Site Recruiting Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Recruiting Dijon Cedex, Cote D Or, France, 21034 Germany Novartis Investigative Site Recruiting Hannover, Germany, 30625 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28040 Less <<
NCT01214850 - Completed - -
NCT00560313 Meningococcal Disease Phase 2 Completed - Italy ... More >> Azienda USL 7 of Siena Siena, Italy, 53100 Less <<
NCT00626327 - Completed - -
NCT00847145 Meningococcal Disease Phase 3 Completed - -
NCT00560313 - Completed - -
NCT00488683 Meningococcal Disease Phase 2 Completed - United Kingdom ... More >> Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine Headington, Oxford, United Kingdom, OX3 7LJ Less <<
NCT01973218 Meningococcal Disease Phase 3 Completed - Korea, Republic of ... More >> 06 Kosin University Gospel Hospital 34, amnam-dong Seo-gu, Busan, Korea, Republic of, 602-702 05 YuKorea University Ansan Hospital 23, Jeokgeum-ro, Danwon-gu Ansan-si, Gyeonggi-do, Korea, Republic of, 425-707 04 Pusan National University Yangsan Hospital 20 Geumo-ro, Mulgeum-eup Yangsan-si, Gyeongnam, Korea, Republic of, 626-770 07 Seoul National University Bundang Hospital 82, Gumi-ro 173 Beon-gil Bundang-gu, Seongnam, Korea, Republic of, 463-707 01 Seoul National University Hospital 101 Daehang-ro, Jongno-gu, Seoul, Korea, Republic of, 110-744, 03 Ewha Womans University Mokdong Hospital, Department of Pediatrics, 911-1 Mokdong Yangcheon-gu, Seoul, Korea, Republic of, 158-710 02 Inha University Hospital 7-206, 3rd street, Shinheung-dong, Jung-gu Incheon, Korea, Republic of, 400-711 Less <<
NCT00488683 - Completed - -
NCT01973218 - Completed - -
NCT01802879 Hematologic Neoplasms Phase 2 Active, not recruiting November 22, 2018 United States, California ... More >> City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1) Duarte, California, United States, 91010-3000 United States, Georgia Georgia Regents University SC-2 Augusta, Georgia, United States, 30912 United States, Massachusetts Dana Farber Cancer Institute Reg. Ped Boston, Massachusetts, United States, 02215 United States, Utah University of Utah / Huntsman Cancer Institute SC-2 Salt Lake City, Utah, United States, 84103 Israel Novartis Investigative Site Jerusalem, Israel, 91120 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Salamanca, Castilla Y Leon, Spain, 37007 Less <<
NCT02022137 Liver Cirrhosis Not Applicable Completed - Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán México city, D.f., Mexico, 1400 Less <<
NCT01494727 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01794793 Cushing's Disease ... More >> Acromegaly Neuroendocrine Tumors Pituitary Tumors Ectopic ACTH Secreting (EAS) Tumors Dumping Syndrome Prostate Cancer Melanoma Negative for bRAF Melanoma Negative for nRAS Less << Phase 4 Recruiting June 12, 2023 -
NCT01434680 Meningococcal Disease ... More >> Meningococcal Meningitis Less << Phase 2 Completed - Poland ... More >> NZOZ Bioscience Sp zoo ul Czerkaska, Bydgoszcz, Poland Department Infection Disease ZOZ Dept Infection Disease ZOZ, Debica, Poland Centrum Medyczne Graniczna Sp zoo ul Graniczna 45, Katowice, Poland NZOZ HIPOKRATES IIspzoo Ul Strzelecka 2, Krakow, Poland Wojewodzki Specjalistyczny Szpital im dr Wl Bieganskiego ul. Kniaziewicza 1-5, Lodz, Poland Specjalistyczny Zespol Ul Krysiewicza, Poznan, Poland NZLA Michalkowice Jarosz i Partnerzy Spolka Lekarska NZLA Michalkowice Jarosz Partnerzy Spolka Lekarska, Siemianowice Slaskie, Poland Zespol Przychodni Specjalistycznych SP ZOZ w Tarnowie E Szczeklik Hospital, Tarnów, Poland Samodzielny Zespol Publicznych Zakladow Opieki Zdrowotnej w Ul Prusicka 5355, Trzebnica, Poland Klinika Pediatrii Centrum Medycznego Ksztalcenia Podyplomowe Ceglowska 80, Warszawa, Poland Amicur_Krystyna Lechka-Florianska i Partnerzy Ul O Bujwida, Wroclaw, Poland Less <<
NCT01434680 - Completed - -
NCT01742299 GIST and CML Phase 4 Recruiting April 21, 2023 -
NCT01735890 Healthy Phase 1 Completed - -
NCT01735955 GIST and CML Phase 4 Recruiting April 28, 2023 -
NCT00518180 Meningococcal Meningitis ... More >> Human Papillomavirus Infection Pertussis Tetanus Less << Phase 3 Completed - Costa Rica ... More >> San Jose, Costa Rica San Jose, Costa Rica Less <<
NCT02017860 Neoplasms Phase 2 Active, not recruiting October 31, 2019 Japan ... More >> Novartis Investigative Site Matsuyama, Ehime, Japan, 791-0280 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Osaka-city, Osaka, Japan, 540-0006 Novartis Investigative Site Kitaadachi-gun, Saitama, Japan, 362-0806 Less <<
NCT01037829 - Completed - Argentina ... More >> Buenos Aires, Argentina, 1706 Cordoba, Argentina, X5000 Villa Nueva de Guaymallen, Argentina, 5519 Italy Bari, Italy, 79124 Cagliari, Italy, 09126 Como, Italy, 22100 Milano, Italy, 20126 Milano, Italy, 20157 Monza, Italy, 20052 Prato, Italy, 59100 Roma, Italy, 00135 Rome, Italy, 00168 Siena, Italy, 53100 Trieste, Italy, 34100 Udine, Italy, 33100 Vicenza, Italy, 36100 Netherlands Podiumweg Ilsselstein, Netherlands Less <<
NCT01789281 Neoplasms Phase 4 Recruiting May 12, 2023 -
NCT00616421 Meningococcal Infections Phase 3 Completed - -
NCT00616421 - Completed - -
NCT00450437 Meningococcal Infections ... More >> Meningococcal Meningitis Less << Phase 3 Completed - -
NCT02292121 Obesity Metab... More >>olic Diseases Nutrition Disorders Body Weight Less << Not Applicable Recruiting January 2018 France ... More >> Groupe Hospitalier Pitié-Salpêtrière Recruiting Paris, France, 75013 Contact: Christine POITOU, MD, PhD    +33142175771    christine.poitou-bernert@psl.aphp.fr    Principal Investigator: Christine POITOU, MD, PhD Less <<
NCT00474487 - Completed - -
NCT02307383 Bacterial Colonization Phase 2 Unknown October 2015 Spain ... More >> Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: Juan Carlos Ramos       ramosramosjc@gmail.com Less <<
NCT00450437 - Completed - -
NCT01863745 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Active, not recruiting October 4, 2023 Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Gifu-city, Gifu, Japan, 501-1194 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Yokohama-city, Kanagawa, Japan, 241-8515 Novartis Investigative Site Kumamoto City, Kumamoto, Japan, 860-8556 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Kurashiki, Okayama, Japan, 701-0192 Novartis Investigative Site Osaka-city, Osaka, Japan, 540-0006 Novartis Investigative Site Suita-city, Osaka, Japan, 565 0871 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT00518180 - Completed - -
NCT02773095 Cardiovascular Disease ... More >> Diabetes Type II Breast Cancer Asthma Less << Not Applicable Active, not recruiting September 2019 -
NCT00474487 Meningococcal Meningitis ... More >> Meningococcal Infections Less << Phase 3 Completed - Argentina ... More >> Buenos Aires, Argentina Buenos Aires, Argentina, C1406DGI Colombia Cali, Colombia; Bogota, Colombia Cali; Bogota, Colombia Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.90mL

0.58mL

0.29mL

14.52mL

2.90mL

1.45mL

29.04mL

5.81mL

2.90mL
 

Historical Records

Categories

Inhibitors/Agonists
Anti-Infection
Antibacterial

Tags: Lactitol | D-Lactitol | Antibacterial | Natural Products-Other Structure | Anti-Infection | By Structure | 585-86-4